<?xml version="1.0" encoding="UTF-8"?>
<corpus source="DS3">
    <document id="DS3.d0" origId="1000214">
        <sentence id="DS3.d0.s0" origId="1000214-0" text="Angiotensin II blockade with saralasin.">
            <entity id="DS3.d0.s0.e0" origId="P01019,B0ZBE2,B2R5S1" charOffset="0-14" type="protein" text="Angiotensin II"/>
            <entity id="DS3.d0.s0.e1" origId="36736,5464275,6324663" charOffset="29-38" type="compound" text="saralasin"/>
            <pair e1="DS3.d0.s0.e1" e2="DS3.d0.s0.e0" id="DS3.d0.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d1" origId="1000376">
        <sentence id="DS3.d1.s0" origId="1000376-1" text="Adult female Mink were fed rations containing 1.1, 1.8, 4.8, 8.3 and 15.0 ppm mercury as methyl mercury chloride over a 93 day period.">
            <entity id="DS3.d1.s0.e0" origId="P15382,A8MWV9,A7LFK2,C7S316,Q6FHJ6,A7LFK4" charOffset="13-17" type="protein" text="Mink"/>
            <entity id="DS3.d1.s0.e1" origId="24182" charOffset="96-112" type="compound" text="mercury chloride"/>
            <pair e1="DS3.d1.s0.e1" e2="DS3.d1.s0.e0" id="DS3.d1.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d2" origId="10021296">
        <sentence id="DS3.d2.s0" origId="10021296-10" text="CONCLUSIONS: Increased expression of only the PKC-alpha and PKC-gamma isoforms correlates with increasing levels of paclitaxel resistance in Mes-sa cells in this in vitro experimental model.">
            <entity id="DS3.d2.s0.e0" origId="P17252,Q7Z727" charOffset="46-55" type="protein" text="PKC-alpha"/>
            <entity id="DS3.d2.s0.e1" origId="P05129" charOffset="60-69" type="protein" text="PKC-gamma"/>
            <entity id="DS3.d2.s0.e2" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="116-126" type="compound" text="paclitaxel"/>
            <entity id="DS3.d2.s0.e3" origId="P48163" charOffset="141-144" type="protein" text="Mes"/>
            <pair e1="DS3.d2.s0.e2" e2="DS3.d2.s0.e1" id="DS3.d2.s0.i0" interaction="False" />
            <pair e1="DS3.d2.s0.e2" e2="DS3.d2.s0.e0" id="DS3.d2.s0.i1" interaction="False" />
            <pair e1="DS3.d2.s0.e2" e2="DS3.d2.s0.e3" id="DS3.d2.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d2.s1" origId="10021296-2" text="METHODS: Paclitaxel-resistant subclones (T30 and T30-Res) of the Mes-sa human uterine sarcoma cell line were selected through exposure to paclitaxel in vitro.">
            <entity id="DS3.d2.s1.e0" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="9-19" type="compound" text="Paclitaxel"/>
            <entity id="DS3.d2.s1.e1" origId="24941247" charOffset="41-44" type="compound" text="T30"/>
            <entity id="DS3.d2.s1.e2" origId="24941247" charOffset="49-52" type="compound" text="T30"/>
            <entity id="DS3.d2.s1.e3" origId="P48163" charOffset="65-68" type="protein" text="Mes"/>
            <entity id="DS3.d2.s1.e4" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="138-148" type="compound" text="paclitaxel"/>
            <pair e1="DS3.d2.s1.e0" e2="DS3.d2.s1.e3" id="DS3.d2.s1.i0" interaction="False" />
            <pair e1="DS3.d2.s1.e1" e2="DS3.d2.s1.e3" id="DS3.d2.s1.i1" interaction="False" />
            <pair e1="DS3.d2.s1.e4" e2="DS3.d2.s1.e3" id="DS3.d2.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d2.s2" origId="10021296-5" text="Finally, the influence of PKC activity (i.e., translocation to the plasma membrane, confirmed by Western blot of plasma membrane bound protein) on resistance to paclitaxel was examined with the MTT assay in cells preincubated with PMA.">
            <entity id="DS3.d2.s2.e0" origId="O95477,B7XCW9,B2RUU2" charOffset="120-134" type="protein" text="membrane bound"/>
            <entity id="DS3.d2.s2.e1" origId="36314,441276,44155032,4666,5352019,53313247,6713921,6915727" charOffset="161-171" type="compound" text="paclitaxel"/>
            <entity id="DS3.d2.s2.e2" origId="64966" charOffset="194-197" type="compound" text="MTT"/>
            <entity id="DS3.d2.s2.e3" origId="122634,22833501,27924,4792" charOffset="231-234" type="compound" text="PMA"/>
            <pair e1="DS3.d2.s2.e1" e2="DS3.d2.s2.e0" id="DS3.d2.s2.i0" interaction="False" />
            <pair e1="DS3.d2.s2.e3" e2="DS3.d2.s2.e0" id="DS3.d2.s2.i1" interaction="False" />
            <pair e1="DS3.d2.s2.e2" e2="DS3.d2.s2.e0" id="DS3.d2.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d2.s3" origId="10021296-6" text="RESULTS: The indices of relative paclitaxel resistance of Mes-sa, Mes-sa-T30, and Mes-sa-T30-Res were 1-, 5-, and 11-fold, respectively.">
            <entity id="DS3.d2.s3.e0" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="33-43" type="compound" text="paclitaxel"/>
            <entity id="DS3.d2.s3.e1" origId="P48163" charOffset="58-61" type="protein" text="Mes"/>
            <entity id="DS3.d2.s3.e2" origId="P48163" charOffset="66-69" type="protein" text="Mes"/>
            <entity id="DS3.d2.s3.e3" origId="24941247" charOffset="73-76" type="compound" text="T30"/>
            <entity id="DS3.d2.s3.e4" origId="P48163" charOffset="66-69" type="protein" text="Mes"/>
            <entity id="DS3.d2.s3.e5" origId="24941247" charOffset="89-92" type="compound" text="T30"/>
            <pair e1="DS3.d2.s3.e0" e2="DS3.d2.s3.e1" id="DS3.d2.s3.i0" interaction="False" />
            <pair e1="DS3.d2.s3.e3" e2="DS3.d2.s3.e1" id="DS3.d2.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d2.s4" origId="10021296-8" text="Only PKC-alpha and PKC-gamma expression increased with increasing indices of paclitaxel resistance.">
            <entity id="DS3.d2.s4.e0" origId="P17252,Q7Z727" charOffset="5-14" type="protein" text="PKC-alpha"/>
            <entity id="DS3.d2.s4.e1" origId="P05129" charOffset="19-28" type="protein" text="PKC-gamma"/>
            <entity id="DS3.d2.s4.e2" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="77-87" type="compound" text="paclitaxel"/>
            <pair e1="DS3.d2.s4.e2" e2="DS3.d2.s4.e1" id="DS3.d2.s4.i0" interaction="False" />
            <pair e1="DS3.d2.s4.e2" e2="DS3.d2.s4.e0" id="DS3.d2.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d2.s5" origId="10021296-9" text="Interestingly, PMA induction of PKC activity reversed resistance to paclitaxel in all cell lines by 2- to 3-fold, and this reversal of drug resistance was associated with a time-dependent translocation of PKC-alpha and PKC-gamma to the plasma membrane compartment.">
            <entity id="DS3.d2.s5.e0" origId="122634,22833501,27924,4792" charOffset="15-18" type="compound" text="PMA"/>
            <entity id="DS3.d2.s5.e1" origId="36314,441276,44155032,4666,53313247,5352019,6713921,6915727" charOffset="68-78" type="compound" text="paclitaxel"/>
            <entity id="DS3.d2.s5.e2" origId="P17252,Q7Z727" charOffset="205-214" type="protein" text="PKC-alpha"/>
            <entity id="DS3.d2.s5.e3" origId="P05129" charOffset="219-228" type="protein" text="PKC-gamma"/>
            <pair e1="DS3.d2.s5.e1" e2="DS3.d2.s5.e3" id="DS3.d2.s5.i0" interaction="False" />
            <pair e1="DS3.d2.s5.e1" e2="DS3.d2.s5.e2" id="DS3.d2.s5.i1" interaction="False" />
            <pair e1="DS3.d2.s5.e0" e2="DS3.d2.s5.e3" id="DS3.d2.s5.i2" interaction="False" />
            <pair e1="DS3.d2.s5.e0" e2="DS3.d2.s5.e2" id="DS3.d2.s5.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d3" origId="10021299">
        <sentence id="DS3.d3.s0" origId="10021299-4" text="A polymorphism in the WAF1 gene, a C-to-A transversion at codon 31 resulting in the change of a serine (Ser) to an arginine (Arg), is well known.">
            <entity id="DS3.d3.s0.e0" origId="P38936,A0A024RCX5" charOffset="22-26" type="protein" text="WAF1"/>
            <entity id="DS3.d3.s0.e1" origId="5951" charOffset="104-107" type="compound" text="Ser"/>
            <entity id="DS3.d3.s0.e2" origId="6322,90867653" charOffset="115-123" type="compound" text="arginine"/>
            <pair e1="DS3.d3.s0.e1" e2="DS3.d3.s0.e0" id="DS3.d3.s0.i0" interaction="False" />
            <pair e1="DS3.d3.s0.e2" e2="DS3.d3.s0.e0" id="DS3.d3.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d4" origId="10021319">
        <sentence id="DS3.d4.s0" origId="10021319-0" text="Nitric oxide stimulates the stress-activated protein kinase p38 in rat renal mesangial cells.">
            <entity id="DS3.d4.s0.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS3.d4.s0.e1" origId="G3V617,Q56A33" charOffset="60-63" type="protein" text="p38"/>
            <pair e1="DS3.d4.s0.e0" e2="DS3.d4.s0.e1" id="DS3.d4.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d4.s1" origId="10021319-3" text="Here, we demonstrate that exposure of glomerular mesangial cells to compounds releasing NO, including spermine-NO and (Z)-1- (N-methyl-N-(6-(N-methylammoniohexyl)amino)diazen)-1-ium-1,2-diolate (MAHMA-NO), results in an activation of the stress-activated p38-mitogen-activated protein kinase (p38-MAPK) cascade as measured by the phosphorylation of the activator of transcription factor-2 (ATF2) in an immunocomplex kinase assay.">
            <entity id="DS3.d4.s1.e0" origId="1103" charOffset="102-110" type="compound" text="spermine"/>
            <entity id="DS3.d4.s1.e1" origId="G3V617,Q56A33" charOffset="255-291" type="protein" text="p38-mitogen-activated protein kinase"/>
            <entity id="DS3.d4.s1.e2" origId="G3V617,Q56A33" charOffset="255-258" type="protein" text="p38"/>
            <pair e1="DS3.d4.s1.e0" e2="DS3.d4.s1.e2" id="DS3.d4.s1.i0" interaction="False" />
            <pair e1="DS3.d4.s1.e0" e2="DS3.d4.s1.e1" id="DS3.d4.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d4.s2" origId="10021319-6" text="The longer-lived NO donor spermine-NO causes a comparable rapid activation of the p38-MAPK pathway; however, the increased activation state of p38-MAPK was maintained for several hours before control values were reattained after 24 h of stimulation.">
            <entity id="DS3.d4.s2.e0" origId="1103" charOffset="26-34" type="compound" text="spermine"/>
            <entity id="DS3.d4.s2.e1" origId="G3V617,Q56A33" charOffset="82-85" type="protein" text="p38"/>
            <entity id="DS3.d4.s2.e2" origId="G3V617,Q56A33" charOffset="143-146" type="protein" text="p38"/>
            <pair e1="DS3.d4.s2.e0" e2="DS3.d4.s2.e1" id="DS3.d4.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d4.s3" origId="10021319-8" text="Both MAHMA-NO and spermine-NO cause a rapid activation of p44-MAPK after 10 min of stimulation.">
            <entity id="DS3.d4.s3.e0" origId="1103" charOffset="18-26" type="compound" text="spermine"/>
            <entity id="DS3.d4.s3.e1" origId="P21708" charOffset="58-66" type="protein" text="p44-MAPK"/>
            <pair e1="DS3.d4.s3.e0" e2="DS3.d4.s3.e1" id="DS3.d4.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d5" origId="10021336">
        <sentence id="DS3.d5.s0" origId="10021336-0" text="Inhibition of in vitro enteric neuronal development by endothelin-3: mediation by endothelin B receptors.">
            <entity id="DS3.d5.s0.e0" origId="P48299,A2APU5" charOffset="55-67" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s0.e1" origId="44284481" charOffset="55-65" type="compound" text="endothelin"/>
            <pair e1="DS3.d5.s0.e1" e2="DS3.d5.s0.e0" id="DS3.d5.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s1" origId="10021336-11" text="We suggest that endothelin-3/endothelin B normally prevents the premature differentiation of crest-derived precursors migrating to and within the fetal bowel, enabling the precursor population to persist long enough to finish colonizing the bowel.">
            <entity id="DS3.d5.s1.e0" origId="P48299,A2APU5" charOffset="16-28" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s1.e1" origId="44284481" charOffset="16-26" type="compound" text="endothelin"/>
            <pair e1="DS3.d5.s1.e1" e2="DS3.d5.s1.e0" id="DS3.d5.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s2" origId="10021336-1" text="The terminal colon is aganglionic in mice lacking endothelin-3 or its receptor, endothelin B.">
            <entity id="DS3.d5.s2.e0" origId="P48299,A2APU5" charOffset="50-62" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s2.e1" origId="44284481" charOffset="50-60" type="compound" text="endothelin"/>
            <pair e1="DS3.d5.s2.e1" e2="DS3.d5.s2.e0" id="DS3.d5.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s3" origId="10021336-2" text="To analyze the effects of endothelin-3/endothelin B on the differentiation of enteric neurons, E11-13 mouse gut was dissociated, and positive and negative immunoselection with antibodies to p75(NTR )were used to isolate neural crest- and non-crest-derived cells.">
            <entity id="DS3.d5.s3.e0" origId="P48299,A2APU5" charOffset="26-38" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s3.e1" origId="44284481" charOffset="26-36" type="compound" text="endothelin"/>
            <entity id="DS3.d5.s3.e2" origId="46174171" charOffset="95-98" type="compound" text="E11"/>
            <entity id="DS3.d5.s3.e3" origId="P12265" charOffset="108-111" type="protein" text="gut"/>
            <entity id="DS3.d5.s3.e4" origId="Q8CFT3" charOffset="190-193" type="protein" text="p75"/>
            <pair e1="DS3.d5.s3.e2" e2="DS3.d5.s3.e0" id="DS3.d5.s3.i0" interaction="False" />
            <pair e1="DS3.d5.s3.e2" e2="DS3.d5.s3.e4" id="DS3.d5.s3.i1" interaction="False" />
            <pair e1="DS3.d5.s3.e2" e2="DS3.d5.s3.e3" id="DS3.d5.s3.i2" interaction="False" />
            <pair e1="DS3.d5.s3.e1" e2="DS3.d5.s3.e0" id="DS3.d5.s3.i3" interaction="False" />
            <pair e1="DS3.d5.s3.e1" e2="DS3.d5.s3.e4" id="DS3.d5.s3.i4" interaction="False" />
            <pair e1="DS3.d5.s3.e1" e2="DS3.d5.s3.e3" id="DS3.d5.s3.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s4" origId="10021336-3" text="mRNA encoding endothelin B was present in both the crest-and non-crest-derived cells, but that encoding preproendothelin-3 was detected only in the non-crest-derived population.">
            <entity id="DS3.d5.s4.e0" origId="44284481" charOffset="14-24" type="compound" text="endothelin"/>
            <entity id="DS3.d5.s4.e1" origId="P48299,A2APU5" charOffset="104-122" type="protein" text="preproendothelin-3"/>
            <pair e1="DS3.d5.s4.e0" e2="DS3.d5.s4.e1" id="DS3.d5.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s5" origId="10021336-4" text="The crest- and non-crest-derived cells were exposed in vitro to endothelin-3, IRL 1620 (an endothelin B agonist), and/or BQ 788 (an endothelin B antagonist).">
            <entity id="DS3.d5.s5.e0" origId="P48299,A2APU5" charOffset="64-76" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s5.e1" origId="16130933" charOffset="78-86" type="compound" text="IRL 1620"/>
            <entity id="DS3.d5.s5.e2" origId="44284481" charOffset="64-74" type="compound" text="endothelin"/>
            <entity id="DS3.d5.s5.e3" origId="3081333" charOffset="121-127" type="compound" text="BQ 788"/>
            <entity id="DS3.d5.s5.e4" origId="44284481" charOffset="91-101" type="compound" text="endothelin"/>
            <pair e1="DS3.d5.s5.e1" e2="DS3.d5.s5.e0" id="DS3.d5.s5.i0" interaction="False" />
            <pair e1="DS3.d5.s5.e2" e2="DS3.d5.s5.e0" id="DS3.d5.s5.i1" interaction="False" />
            <pair e1="DS3.d5.s5.e3" e2="DS3.d5.s5.e0" id="DS3.d5.s5.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s6" origId="10021336-5" text="Neurons and glia developed only in cultures of crest-derived cells, and did so even when endothelin-3 was absent and BQ 788 was present.">
            <entity id="DS3.d5.s6.e0" origId="P48299,A2APU5" charOffset="89-101" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s6.e1" origId="3081333" charOffset="117-123" type="compound" text="BQ 788"/>
            <pair e1="DS3.d5.s6.e1" e2="DS3.d5.s6.e0" id="DS3.d5.s6.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s7" origId="10021336-6" text="endothelin-3 inhibited neuronal development, an effect that was mimicked by IRL 1620 and blocked by BQ 788.">
            <entity id="DS3.d5.s7.e0" origId="P48299,A2APU5" charOffset="0-12" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s7.e1" origId="16130933" charOffset="76-84" type="compound" text="IRL 1620"/>
            <entity id="DS3.d5.s7.e2" origId="3081333" charOffset="100-106" type="compound" text="BQ 788"/>
            <pair e1="DS3.d5.s7.e1" e2="DS3.d5.s7.e0" id="DS3.d5.s7.i0" interaction="False" />
            <pair e1="DS3.d5.s7.e2" e2="DS3.d5.s7.e0" id="DS3.d5.s7.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s8" origId="10021336-7" text="endothelin-3 failed to stimulate the incorporation of (3H)thymidine or bromodeoxyuridine.">
            <entity id="DS3.d5.s8.e0" origId="P48299,A2APU5" charOffset="0-12" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s8.e1" origId="6035,6918942" charOffset="71-88" type="compound" text="bromodeoxyuridine"/>
            <pair e1="DS3.d5.s8.e1" e2="DS3.d5.s8.e0" id="DS3.d5.s8.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s9" origId="10021336-8" text="Smooth muscle development in non-crest-derived cell cultures was promoted by endothelin-3 and inhibited by BQ 788.">
            <entity id="DS3.d5.s9.e0" origId="P48299,A2APU5" charOffset="77-89" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s9.e1" origId="3081333" charOffset="107-113" type="compound" text="BQ 788"/>
            <pair e1="DS3.d5.s9.e1" e2="DS3.d5.s9.e0" id="DS3.d5.s9.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d5.s10" origId="10021336-9" text="In contrast, transcription of laminin alpha1, a smooth muscle-derived promoter of neuronal development, was inhibited by endothelin-3, but promoted by BQ 788.">
            <entity id="DS3.d5.s10.e0" origId="P19137,F8VQ40" charOffset="30-44" type="protein" text="laminin alpha1"/>
            <entity id="DS3.d5.s10.e1" origId="P48299,A2APU5" charOffset="121-133" type="protein" text="endothelin-3"/>
            <entity id="DS3.d5.s10.e2" origId="3081333" charOffset="151-157" type="compound" text="BQ 788"/>
            <pair e1="DS3.d5.s10.e2" e2="DS3.d5.s10.e1" id="DS3.d5.s10.i0" interaction="False" />
            <pair e1="DS3.d5.s10.e2" e2="DS3.d5.s10.e0" id="DS3.d5.s10.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d6" origId="10021342">
        <sentence id="DS3.d6.s0" origId="10021342-0" text="oko meduzy mutations affect neuronal patterning in the zebrafish retina and reveal cell-cell interactions of the retinal neuroepithelial sheet.">
            <entity id="DS3.d6.s0.e0" origId="Q1A5L2" charOffset="0-10" type="protein" text="oko meduzy"/>
            <entity id="DS3.d6.s0.e1" origId="638015" charOffset="113-120" type="compound" text="retinal"/>
            <pair e1="DS3.d6.s0.e1" e2="DS3.d6.s0.e0" id="DS3.d6.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d6.s1" origId="10021342-3" text="Despite the lack of lamination, at least seven retinal cell types differentiate in oko meduzy.">
            <entity id="DS3.d6.s1.e0" origId="638015" charOffset="47-54" type="compound" text="retinal"/>
            <entity id="DS3.d6.s1.e1" origId="Q1A5L2" charOffset="83-93" type="protein" text="oko meduzy"/>
            <pair e1="DS3.d6.s1.e0" e2="DS3.d6.s1.e1" id="DS3.d6.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d6.s2" origId="10021342-6" text="In genetically mosaic animals, cell-cell interactions are sufficient to rescue the phenotype of oko meduzy retinal neuroepithelial cells.">
            <entity id="DS3.d6.s2.e0" origId="Q1A5L2" charOffset="96-106" type="protein" text="oko meduzy"/>
            <entity id="DS3.d6.s2.e1" origId="638015" charOffset="107-114" type="compound" text="retinal"/>
            <pair e1="DS3.d6.s2.e1" e2="DS3.d6.s2.e0" id="DS3.d6.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d7" origId="10021344">
        <sentence id="DS3.d7.s0" origId="10021344-2" text="We describe the characterization of a novel zebrafish zinc-finger gene, terra, which contains a DNA binding domain similar to that of the Drosophila dsx gene.">
            <entity id="DS3.d7.s0.e0" origId="23994" charOffset="54-58" type="compound" text="zinc"/>
            <entity id="DS3.d7.s0.e1" origId="Q9W7K3" charOffset="72-77" type="protein" text="terra"/>
            <entity id="DS3.d7.s0.e2" origId="P23023,A0A0B4LGS9,A0A0B4KGR7,A0A0B4KFS4" charOffset="149-152" type="protein" text="dsx"/>
            <pair e1="DS3.d7.s0.e0" e2="DS3.d7.s0.e2" id="DS3.d7.s0.i0" interaction="False" />
            <pair e1="DS3.d7.s0.e0" e2="DS3.d7.s0.e1" id="DS3.d7.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d8" origId="10021349">
        <sentence id="DS3.d8.s0" origId="10021349-3" text="Since Meis2 has recently been shown to be upregulated by retinoic acid in P19 EC cells (Oulad-Abdelghani, M., Chazaud, C., Bouillet, P., Sapin, V., Chambon, P. and Dollé, P. (1997) Dev.">
            <entity id="DS3.d8.s0.e0" origId="P97367,Q3TYM2,Q3UJ35,B1AWK4,Q6GU28" charOffset="6-11" type="protein" text="Meis2"/>
            <entity id="DS3.d8.s0.e1" origId="444795" charOffset="57-70" type="compound" text="retinoic acid"/>
            <pair e1="DS3.d8.s0.e1" e2="DS3.d8.s0.e0" id="DS3.d8.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d9" origId="10021361">
        <sentence id="DS3.d9.s0" origId="10021361-1" text="BACKGROUND: The adaptor protein Gads is a Grb2-related protein originally identified on the basis of its interaction with the tyrosine-phosphorylated form of the docking protein Shc.">
            <entity id="DS3.d9.s0.e0" origId="P62993,B0LPF3" charOffset="42-46" type="protein" text="Grb2"/>
            <entity id="DS3.d9.s0.e1" origId="6057,90983769" charOffset="126-134" type="compound" text="tyrosine"/>
            <entity id="DS3.d9.s0.e2" origId="P29353" charOffset="178-181" type="protein" text="Shc"/>
            <pair e1="DS3.d9.s0.e1" e2="DS3.d9.s0.e2" id="DS3.d9.s0.i0" interaction="False" />
            <pair e1="DS3.d9.s0.e1" e2="DS3.d9.s0.e0" id="DS3.d9.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d9.s1" origId="10021361-7" text="The constitutive interaction between Gads and SLP-76 was mediated by the carboxy-terminal SH3 domain of Gads and a 20 amino-acid proline-rich region in SLP-76.">
            <entity id="DS3.d9.s1.e0" origId="Q13094" charOffset="46-52" type="protein" text="SLP-76"/>
            <entity id="DS3.d9.s1.e1" origId="614,57240853,8988" charOffset="129-136" type="compound" text="proline"/>
            <entity id="DS3.d9.s1.e2" origId="Q13094" charOffset="152-158" type="protein" text="SLP-76"/>
            <pair e1="DS3.d9.s1.e1" e2="DS3.d9.s1.e0" id="DS3.d9.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d10" origId="10021364">
        <sentence id="DS3.d10.s0" origId="10021364-2" text="In contrast to Pak family members, SPS1 family members do not bind and are not activated by GTP-bound p21Rac and Cdc42.">
            <entity id="DS3.d10.s0.e0" origId="6830" charOffset="92-95" type="compound" text="GTP"/>
            <entity id="DS3.d10.s0.e1" origId="P40793,M9NFF8" charOffset="113-118" type="protein" text="Cdc42"/>
            <pair e1="DS3.d10.s0.e0" e2="DS3.d10.s0.e1" id="DS3.d10.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d11" origId="10021368">
        <sentence id="DS3.d11.s0" origId="10021368-8" text="In abnormal limbs, both Shh and the reporter were ectopically induced in the anterior region, whereas in normal limbs the reporter and Shh were restricted to the zone of polarising activity (ZPA).">
            <entity id="DS3.d11.s0.e0" origId="Q62226" charOffset="24-27" type="protein" text="Shh"/>
            <entity id="DS3.d11.s0.e1" origId="Q62226" charOffset="135-138" type="protein" text="Shh"/>
            <entity id="DS3.d11.s0.e2" origId="73659099" charOffset="191-194" type="compound" text="ZPA"/>
            <pair e1="DS3.d11.s0.e2" e2="DS3.d11.s0.e0" id="DS3.d11.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d12" origId="10021369">
        <sentence id="DS3.d12.s0" origId="10021369-5" text="Mammalian APC2, which closely resembles APC in overall domain structure, was functionally analyzed and shown to contain two SAMP domains, both of which are required for binding to conductin.">
            <entity id="DS3.d12.s0.e0" origId="O95996" charOffset="10-14" type="protein" text="APC2"/>
            <entity id="DS3.d12.s0.e1" origId="7156993" charOffset="124-128" type="compound" text="SAMP"/>
            <entity id="DS3.d12.s0.e2" origId="Q9Y2T1,E7ES00" charOffset="180-189" type="protein" text="conductin"/>
            <pair e1="DS3.d12.s0.e1" e2="DS3.d12.s0.e0" id="DS3.d12.s0.i0" interaction="False" />
            <pair e1="DS3.d12.s0.e1" e2="DS3.d12.s0.e2" id="DS3.d12.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d13" origId="10021383">
        <sentence id="DS3.d13.s0" origId="10021383-9" text="We find that several Ubx-regulated genes in the Drosophila haltere are not repressed by Ubx in butterfly hindwings, but that Distal-less (Dll) expression is regulated by Ubx in a unique manner in butterflies.">
            <entity id="DS3.d13.s0.e0" origId="P83949,D8FT40" charOffset="21-24" type="protein" text="Ubx"/>
            <entity id="DS3.d13.s0.e1" origId="P83949,D8FT40" charOffset="88-91" type="protein" text="Ubx"/>
            <entity id="DS3.d13.s0.e2" origId="50909902" charOffset="138-141" type="compound" text="Dll"/>
            <entity id="DS3.d13.s0.e3" origId="P83949,D8FT40" charOffset="88-91" type="protein" text="Ubx"/>
            <pair e1="DS3.d13.s0.e2" e2="DS3.d13.s0.e0" id="DS3.d13.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d14" origId="10021384">
        <sentence id="DS3.d14.s0" origId="10021384-11" text="JNK2 functions in a cell-type-specific and stimulus-dependent manner, being required for apoptosis of immature thymocytes induced by anti-CD3 antibody but not for apoptosis induced by anti-Fas antibody, UVC or dexamethasone.">
            <entity id="DS3.d14.s0.e0" origId="Q9WTU6,Q5NCK8,Q8C094" charOffset="0-4" type="protein" text="JNK2"/>
            <entity id="DS3.d14.s0.e1" origId="5743" charOffset="210-223" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d14.s0.e1" e2="DS3.d14.s0.e0" id="DS3.d14.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d14.s1" origId="10021384-8" text="The lack of JNK2 also resulted in partial resistance of thymocytes to anti-CD3 antibody in vitro, but had little or no effect on apoptosis induced by anti-Fas antibody, dexamethasone or ultraviolet-C (UVC) radiation.">
            <entity id="DS3.d14.s1.e0" origId="Q9WTU6,Q5NCK8,Q8C094" charOffset="12-16" type="protein" text="JNK2"/>
            <entity id="DS3.d14.s1.e1" origId="5743" charOffset="169-182" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d14.s1.e1" e2="DS3.d14.s1.e0" id="DS3.d14.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d15" origId="10021386">
        <sentence id="DS3.d15.s0" origId="10021386-6" text="Y-27632 blocked focus formation by RhoA and its guanine-nucleotide exchange factors Dbl and mNET1.">
            <entity id="DS3.d15.s0.e0" origId="764" charOffset="48-55" type="compound" text="guanine"/>
            <entity id="DS3.d15.s0.e1" origId="Q8C067,A2AET8,A2AEU1,Q8BLE2" charOffset="84-87" type="protein" text="Dbl"/>
            <entity id="DS3.d15.s0.e2" origId="Q9Z206,Q3USZ7" charOffset="92-97" type="protein" text="mNET1"/>
            <pair e1="DS3.d15.s0.e0" e2="DS3.d15.s0.e1" id="DS3.d15.s0.i0" interaction="False" />
            <pair e1="DS3.d15.s0.e0" e2="DS3.d15.s0.e2" id="DS3.d15.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d16" origId="10021387">
        <sentence id="DS3.d16.s0" origId="10021387-0" text="Vac1p coordinates Rab and phosphatidylinositol 3-kinase signaling in Vps45p-dependent vesicle docking/fusion at the endosome.">
            <entity id="DS3.d16.s0.e0" origId="P32609" charOffset="0-5" type="protein" text="Vac1p"/>
            <entity id="DS3.d16.s0.e1" origId="16738692,53477912" charOffset="26-46" type="compound" text="phosphatidylinositol"/>
            <entity id="DS3.d16.s0.e2" origId="P38932" charOffset="69-75" type="protein" text="Vps45p"/>
            <pair e1="DS3.d16.s0.e1" e2="DS3.d16.s0.e0" id="DS3.d16.s0.i0" interaction="False" />
            <pair e1="DS3.d16.s0.e1" e2="DS3.d16.s0.e2" id="DS3.d16.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d16.s1" origId="10021387-4" text="Another of these proteins, Vac1p/Pep7p/Vps19p, associates with Pep12p and binds phosphatidylinositol 3-phosphate (PI(3)P), the product of the Vps34 phosphatidylinositol 3-kinase (PI 3-kinase) (1) (2).">
            <entity id="DS3.d16.s1.e0" origId="P32609" charOffset="27-32" type="protein" text="Vac1p"/>
            <entity id="DS3.d16.s1.e1" origId="P32609" charOffset="33-38" type="protein" text="Pep7p"/>
            <entity id="DS3.d16.s1.e2" origId="P32609" charOffset="39-45" type="protein" text="Vps19p"/>
            <entity id="DS3.d16.s1.e3" origId="P32854" charOffset="63-69" type="protein" text="Pep12p"/>
            <entity id="DS3.d16.s1.e4" origId="6857403" charOffset="80-112" type="compound" text="phosphatidylinositol 3-phosphate"/>
            <entity id="DS3.d16.s1.e5" origId="643964" charOffset="114-120" type="compound" text="PI(3)P"/>
            <entity id="DS3.d16.s1.e6" origId="P22543" charOffset="142-147" type="protein" text="Vps34"/>
            <entity id="DS3.d16.s1.e7" origId="16738692,53477912" charOffset="80-100" type="compound" text="phosphatidylinositol"/>
            <pair e1="DS3.d16.s1.e5" e2="DS3.d16.s1.e0" id="DS3.d16.s1.i0" interaction="False" />
            <pair e1="DS3.d16.s1.e5" e2="DS3.d16.s1.e1" id="DS3.d16.s1.i1" interaction="False" />
            <pair e1="DS3.d16.s1.e5" e2="DS3.d16.s1.e3" id="DS3.d16.s1.i2" interaction="False" />
            <pair e1="DS3.d16.s1.e5" e2="DS3.d16.s1.e6" id="DS3.d16.s1.i3" interaction="False" />
            <pair e1="DS3.d16.s1.e5" e2="DS3.d16.s1.e2" id="DS3.d16.s1.i4" interaction="False" />
            <pair e1="DS3.d16.s1.e7" e2="DS3.d16.s1.e0" id="DS3.d16.s1.i5" interaction="False" />
            <pair e1="DS3.d16.s1.e7" e2="DS3.d16.s1.e1" id="DS3.d16.s1.i6" interaction="False" />
            <pair e1="DS3.d16.s1.e7" e2="DS3.d16.s1.e3" id="DS3.d16.s1.i7" interaction="False" />
            <pair e1="DS3.d16.s1.e7" e2="DS3.d16.s1.e6" id="DS3.d16.s1.i8" interaction="False" />
            <pair e1="DS3.d16.s1.e7" e2="DS3.d16.s1.e2" id="DS3.d16.s1.i9" interaction="False" />
            <pair e1="DS3.d16.s1.e4" e2="DS3.d16.s1.e0" id="DS3.d16.s1.i10" interaction="False" />
            <pair e1="DS3.d16.s1.e4" e2="DS3.d16.s1.e1" id="DS3.d16.s1.i11" interaction="False" />
            <pair e1="DS3.d16.s1.e4" e2="DS3.d16.s1.e3" id="DS3.d16.s1.i12" interaction="False" />
            <pair e1="DS3.d16.s1.e4" e2="DS3.d16.s1.e6" id="DS3.d16.s1.i13" interaction="False" />
            <pair e1="DS3.d16.s1.e4" e2="DS3.d16.s1.e2" id="DS3.d16.s1.i14" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d17" origId="10021389">
        <sentence id="DS3.d17.s0" origId="10021389-7" text="Addition of dATP (which stimulates the procaspase-processing factor Apaf-1 (8) (9)) overcame inhibition of caspase activation by Bcl-2, but did not prevent the control of cytochrome c release from mitochondria by Bcl-2.">
            <entity id="DS3.d17.s0.e0" origId="15993" charOffset="12-16" type="compound" text="dATP"/>
            <entity id="DS3.d17.s0.e1" origId="O14727" charOffset="68-74" type="protein" text="Apaf-1"/>
            <entity id="DS3.d17.s0.e2" origId="P99999,G4XXL9" charOffset="171-183" type="protein" text="cytochrome c"/>
            <pair e1="DS3.d17.s0.e0" e2="DS3.d17.s0.e1" id="DS3.d17.s0.i0" interaction="False" />
            <pair e1="DS3.d17.s0.e0" e2="DS3.d17.s0.e2" id="DS3.d17.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d18" origId="10021405">
        <sentence id="DS3.d18.s0" origId="10021405-2" text="Recent experimental advances indicate that interactions between the high-affinity immunoglobulin E receptor and the tyrosine kinase Lyn with cholesterol- and sphingolipid-rich regions within the plasma membrane are important for receptor function.">
            <entity id="DS3.d18.s0.e0" origId="6057,90983769" charOffset="116-124" type="compound" text="tyrosine"/>
            <entity id="DS3.d18.s0.e1" origId="P07948,Q6NUK7,A8K379" charOffset="132-135" type="protein" text="Lyn"/>
            <entity id="DS3.d18.s0.e2" origId="5997" charOffset="141-152" type="compound" text="cholesterol"/>
            <pair e1="DS3.d18.s0.e2" e2="DS3.d18.s0.e1" id="DS3.d18.s0.i0" interaction="False" />
            <pair e1="DS3.d18.s0.e0" e2="DS3.d18.s0.e1" id="DS3.d18.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d19" origId="10021457">
        <sentence id="DS3.d19.s0" origId="10021457-0" text="Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice.">
            <entity id="DS3.d19.s0.e0" origId="962" charOffset="8-13" type="compound" text="water"/>
            <entity id="DS3.d19.s0.e1" origId="Q02013" charOffset="90-101" type="protein" text="aquaporin-1"/>
            <pair e1="DS3.d19.s0.e0" e2="DS3.d19.s0.e1" id="DS3.d19.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d19.s1" origId="10021457-2" text="Freeze-fracture electron microscopy (FFEM) of rat TDLH has shown an exceptionally high density of intramembrane particles (IMPs), which were proposed to consist of tetramers of aquaporin-1 (AQP1) water channels.">
            <entity id="DS3.d19.s1.e0" origId="Q02013" charOffset="177-188" type="protein" text="aquaporin-1"/>
            <entity id="DS3.d19.s1.e1" origId="Q02013" charOffset="190-194" type="protein" text="AQP1"/>
            <entity id="DS3.d19.s1.e2" origId="962" charOffset="196-201" type="compound" text="water"/>
            <pair e1="DS3.d19.s1.e2" e2="DS3.d19.s1.e0" id="DS3.d19.s1.i0" interaction="False" />
            <pair e1="DS3.d19.s1.e2" e2="DS3.d19.s1.e1" id="DS3.d19.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d19.s2" origId="10021457-3" text="In this study, transepithelial osmotic water permeability (Pf) was measured in isolated perfused segments (0.5-1 mm) of TDLH in wild-type (+/+), AQP1 heterozygous (+/-), and AQP1 null (-/-) mice.">
            <entity id="DS3.d19.s2.e0" origId="962" charOffset="39-44" type="compound" text="water"/>
            <entity id="DS3.d19.s2.e1" origId="Q02013" charOffset="145-149" type="protein" text="AQP1"/>
            <entity id="DS3.d19.s2.e2" origId="Q02013" charOffset="174-178" type="protein" text="AQP1"/>
            <pair e1="DS3.d19.s2.e0" e2="DS3.d19.s2.e1" id="DS3.d19.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d19.s3" origId="10021457-9" text="These results demonstrate that AQP1 is the principal water channel in TDLH and support the view that osmotic equilibration along TDLH by water transport plays a key role in the renal countercurrent concentrating mechanism.">
            <entity id="DS3.d19.s3.e0" origId="Q02013" charOffset="31-35" type="protein" text="AQP1"/>
            <entity id="DS3.d19.s3.e1" origId="962" charOffset="53-58" type="compound" text="water"/>
            <entity id="DS3.d19.s3.e2" origId="962" charOffset="137-142" type="compound" text="water"/>
            <pair e1="DS3.d19.s3.e1" e2="DS3.d19.s3.e0" id="DS3.d19.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d20" origId="10021459">
        <sentence id="DS3.d20.s0" origId="10021459-2" text="Wild-type (Wt) and IL-8r-/- mice were systemically immunized to ovalbumin (OVA) and were exposed with either single or multiple challenge of aerosolized phosphate-buffered saline (OVA/PBS) or OVA (OVA/OVA).">
            <entity id="DS3.d20.s0.e0" origId="Q9DAV6" charOffset="64-73" type="protein" text="ovalbumin"/>
            <entity id="DS3.d20.s0.e1" origId="24978514" charOffset="153-178" type="compound" text="phosphate-buffered saline"/>
            <pair e1="DS3.d20.s0.e1" e2="DS3.d20.s0.e0" id="DS3.d20.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d21" origId="10021461">
        <sentence id="DS3.d21.s0" origId="10021461-10" text="In conclusion, the renal and osmoregulatory effects of chronic RLX administration to conscious rats resemble the physiological changes of pregnancy in several respects: (a) marked increases in ERPF and GFR with a mediatory role for nitric oxide; (b) attenuation of the renal circulatory response to angiotensin II; and (c) reduction in plasma osmolality.">
            <entity id="DS3.d21.s0.e0" origId="78144" charOffset="63-66" type="compound" text="RLX"/>
            <entity id="DS3.d21.s0.e1" origId="145068" charOffset="232-244" type="compound" text="nitric oxide"/>
            <entity id="DS3.d21.s0.e2" origId="P01015" charOffset="299-313" type="protein" text="angiotensin II"/>
            <pair e1="DS3.d21.s0.e1" e2="DS3.d21.s0.e2" id="DS3.d21.s0.i0" interaction="False" />
            <pair e1="DS3.d21.s0.e0" e2="DS3.d21.s0.e2" id="DS3.d21.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d21.s1" origId="10021461-7" text="In contrast, the renal vasoconstrictory response to angiotensin II was attenuated by the RLX treatment.">
            <entity id="DS3.d21.s1.e0" origId="P01015" charOffset="52-66" type="protein" text="angiotensin II"/>
            <entity id="DS3.d21.s1.e1" origId="78144" charOffset="89-92" type="compound" text="RLX"/>
            <pair e1="DS3.d21.s1.e1" e2="DS3.d21.s1.e0" id="DS3.d21.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d22" origId="10021464">
        <sentence id="DS3.d22.s0" origId="10021464-10" text="These results indicate that osmotically driven water transport across microvessels in adult lung occurs by a transcellular route through AQP1 water channels and that the microvascular endothelium is a significant barrier for airspace-capillary osmotic water transport.">
            <entity id="DS3.d22.s0.e0" origId="962" charOffset="47-52" type="compound" text="water"/>
            <entity id="DS3.d22.s0.e1" origId="P29972,A0A024RA31" charOffset="137-141" type="protein" text="AQP1"/>
            <entity id="DS3.d22.s0.e2" origId="962" charOffset="142-147" type="compound" text="water"/>
            <entity id="DS3.d22.s0.e3" origId="962" charOffset="142-147" type="compound" text="water"/>
            <pair e1="DS3.d22.s0.e0" e2="DS3.d22.s0.e1" id="DS3.d22.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d22.s1" origId="10021464-1" text="The mammalian lung expresses water channel aquaporin-1 (AQP1) in microvascular endothelia and aquaporin-4 (AQP4) in airway epithelia.">
            <entity id="DS3.d22.s1.e0" origId="962" charOffset="29-34" type="compound" text="water"/>
            <entity id="DS3.d22.s1.e1" origId="P29972,A0A024RA31" charOffset="43-54" type="protein" text="aquaporin-1"/>
            <entity id="DS3.d22.s1.e2" origId="P29972,A0A024RA31" charOffset="56-60" type="protein" text="AQP1"/>
            <entity id="DS3.d22.s1.e3" origId="P55087,F1DSG4" charOffset="94-105" type="protein" text="aquaporin-4"/>
            <entity id="DS3.d22.s1.e4" origId="P55087,F1DSG4" charOffset="107-111" type="protein" text="AQP4"/>
            <pair e1="DS3.d22.s1.e0" e2="DS3.d22.s1.e4" id="DS3.d22.s1.i0" interaction="False" />
            <pair e1="DS3.d22.s1.e0" e2="DS3.d22.s1.e1" id="DS3.d22.s1.i1" interaction="False" />
            <pair e1="DS3.d22.s1.e0" e2="DS3.d22.s1.e3" id="DS3.d22.s1.i2" interaction="False" />
            <pair e1="DS3.d22.s1.e0" e2="DS3.d22.s1.e2" id="DS3.d22.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d22.s2" origId="10021464-2" text="To test whether these water channels facilitate fluid movement between airspace, interstitial, and capillary compartments, we measured passive and active fluid transport in AQP1 and AQP4 knockout mice.">
            <entity id="DS3.d22.s2.e0" origId="962" charOffset="22-27" type="compound" text="water"/>
            <entity id="DS3.d22.s2.e1" origId="P29972,A0A024RA31" charOffset="173-177" type="protein" text="AQP1"/>
            <entity id="DS3.d22.s2.e2" origId="P55087,F1DSG4" charOffset="182-186" type="protein" text="AQP4"/>
            <pair e1="DS3.d22.s2.e0" e2="DS3.d22.s2.e2" id="DS3.d22.s2.i0" interaction="False" />
            <pair e1="DS3.d22.s2.e0" e2="DS3.d22.s2.e1" id="DS3.d22.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d22.s3" origId="10021464-5" text="Microvascular endothelial water permeability, measured by a related pleural surface fluorescence method in which the airspace was filled with inert perfluorocarbon, was reduced more than 10-fold in AQP1 (-/-) vs. (+/+) mice.">
            <entity id="DS3.d22.s3.e0" origId="962" charOffset="26-31" type="compound" text="water"/>
            <entity id="DS3.d22.s3.e1" origId="6393" charOffset="148-163" type="compound" text="perfluorocarbon"/>
            <entity id="DS3.d22.s3.e2" origId="P29972,A0A024RA31" charOffset="198-202" type="protein" text="AQP1"/>
            <pair e1="DS3.d22.s3.e0" e2="DS3.d22.s3.e2" id="DS3.d22.s3.i0" interaction="False" />
            <pair e1="DS3.d22.s3.e1" e2="DS3.d22.s3.e2" id="DS3.d22.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d22.s4" origId="10021464-7" text="Both approaches indicated a more than twofold reduction in lung water accumulation in AQP1 (-/-) vs. (+/+) mice in response to a 5- to 10-cm H2O increase in pulmonary artery pressure for five minutes.">
            <entity id="DS3.d22.s4.e0" origId="962" charOffset="64-69" type="compound" text="water"/>
            <entity id="DS3.d22.s4.e1" origId="P29972,A0A024RA31" charOffset="86-90" type="protein" text="AQP1"/>
            <pair e1="DS3.d22.s4.e0" e2="DS3.d22.s4.e1" id="DS3.d22.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d22.s5" origId="10021464-9" text="Jv (measured in percent fluid uptake at 30 min, n = 5) in (+/+) mice was 6.0 +/- 0.6 (37 degrees C), increased to 16 +/- 1 by beta-agonists, and inhibited to less than 2.0 by amiloride, ouabain, or cooling to 23 degrees C. Jv (with isoproterenol) was not affected by aquaporin deletion (18.9 +/- 2.2 (+/+); 16.4 +/- 1.5 AQP1 (-/-); 16.3 +/- 1.7 AQP4 (-/-)).">
            <entity id="DS3.d22.s5.e0" origId="16231" charOffset="175-184" type="compound" text="amiloride"/>
            <entity id="DS3.d22.s5.e1" origId="439501" charOffset="186-193" type="compound" text="ouabain"/>
            <entity id="DS3.d22.s5.e2" origId="3779" charOffset="232-245" type="compound" text="isoproterenol"/>
            <entity id="DS3.d22.s5.e3" origId="P29972,A0A024RA31" charOffset="320-324" type="protein" text="AQP1"/>
            <entity id="DS3.d22.s5.e4" origId="P55087,F1DSG4" charOffset="345-349" type="protein" text="AQP4"/>
            <pair e1="DS3.d22.s5.e2" e2="DS3.d22.s5.e4" id="DS3.d22.s5.i0" interaction="False" />
            <pair e1="DS3.d22.s5.e2" e2="DS3.d22.s5.e3" id="DS3.d22.s5.i1" interaction="False" />
            <pair e1="DS3.d22.s5.e1" e2="DS3.d22.s5.e4" id="DS3.d22.s5.i2" interaction="False" />
            <pair e1="DS3.d22.s5.e1" e2="DS3.d22.s5.e3" id="DS3.d22.s5.i3" interaction="False" />
            <pair e1="DS3.d22.s5.e0" e2="DS3.d22.s5.e4" id="DS3.d22.s5.i4" interaction="False" />
            <pair e1="DS3.d22.s5.e0" e2="DS3.d22.s5.e3" id="DS3.d22.s5.i5" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d23" origId="10021465">
        <sentence id="DS3.d23.s0" origId="10021465-7" text="GM-CSF plays an important role in GBS clearance in vivo, mediated in part by its role in enhancing superoxide and hydrogen peroxide production and bacterial killing by alveolar macrophages.">
            <entity id="DS3.d23.s0.e0" origId="P01587,Q5SX78" charOffset="0-6" type="protein" text="GM-CSF"/>
            <entity id="DS3.d23.s0.e1" origId="5359597" charOffset="99-109" type="compound" text="superoxide"/>
            <entity id="DS3.d23.s0.e2" origId="784" charOffset="114-131" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS3.d23.s0.e2" e2="DS3.d23.s0.e0" id="DS3.d23.s0.i0" interaction="False" />
            <pair e1="DS3.d23.s0.e1" e2="DS3.d23.s0.e0" id="DS3.d23.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d24" origId="10021466">
        <sentence id="DS3.d24.s0" origId="10021466-5" text="Either chlamydial or human HSP 60 induced E-selectin, ICAM-1, and VCAM-1 expression on ECs similar to levels induced by Escherichia coli lipopolysaccharide (LPS).">
            <entity id="DS3.d24.s0.e0" origId="P10809,A0A024R3X4" charOffset="27-33" type="protein" text="HSP 60"/>
            <entity id="DS3.d24.s0.e1" origId="P16581" charOffset="42-52" type="protein" text="E-selectin"/>
            <entity id="DS3.d24.s0.e2" origId="P05362" charOffset="54-60" type="protein" text="ICAM-1"/>
            <entity id="DS3.d24.s0.e3" origId="P19320" charOffset="66-72" type="protein" text="VCAM-1"/>
            <entity id="DS3.d24.s0.e4" origId="11970143" charOffset="137-155" type="compound" text="lipopolysaccharide"/>
            <pair e1="DS3.d24.s0.e4" e2="DS3.d24.s0.e1" id="DS3.d24.s0.i0" interaction="False" />
            <pair e1="DS3.d24.s0.e4" e2="DS3.d24.s0.e2" id="DS3.d24.s0.i1" interaction="False" />
            <pair e1="DS3.d24.s0.e4" e2="DS3.d24.s0.e0" id="DS3.d24.s0.i2" interaction="False" />
            <pair e1="DS3.d24.s0.e4" e2="DS3.d24.s0.e3" id="DS3.d24.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d25" origId="10021468">
        <sentence id="DS3.d25.s0" origId="10021468-4" text="Haploinsufficiency of myotonic dystrophy protein kinase (DMPK), DM locus-associated homeodomain protein (DMAHP) and/or titration of RNA-binding proteins by expanded CUG sequences have been hypothesized to underlie the multi-system defects observed in DM.">
            <entity id="DS3.d25.s0.e0" origId="P54265,E9Q6J9" charOffset="22-55" type="protein" text="myotonic dystrophy protein kinase"/>
            <entity id="DS3.d25.s0.e1" origId="P54265,E9Q6J9" charOffset="57-61" type="protein" text="DMPK"/>
            <entity id="DS3.d25.s0.e2" origId="P70178" charOffset="64-103" type="protein" text="DM locus-associated homeodomain protein"/>
            <entity id="DS3.d25.s0.e3" origId="P70178" charOffset="105-110" type="protein" text="DMAHP"/>
            <entity id="DS3.d25.s0.e4" origId="10133607" charOffset="165-168" type="compound" text="CUG"/>
            <pair e1="DS3.d25.s0.e4" e2="DS3.d25.s0.e0" id="DS3.d25.s0.i0" interaction="False" />
            <pair e1="DS3.d25.s0.e4" e2="DS3.d25.s0.e2" id="DS3.d25.s0.i1" interaction="False" />
            <pair e1="DS3.d25.s0.e4" e2="DS3.d25.s0.e1" id="DS3.d25.s0.i2" interaction="False" />
            <pair e1="DS3.d25.s0.e4" e2="DS3.d25.s0.e3" id="DS3.d25.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d26" origId="10021492">
        <sentence id="DS3.d26.s0" origId="10021492-1" text="Solid dispersion composed of the poly(ethylene oxide) (PEO)-carboxyvinylpolymer (CP) interpolymer complex containing phenacetin (PHE) was prepared by using nine grades of PEO having different molecular weights from 2000 to 4500000.">
            <entity id="DS3.d26.s0.e0" origId="6354" charOffset="38-52" type="compound" text="ethylene oxide"/>
            <entity id="DS3.d26.s0.e1" origId="P54098,E5KNU5" charOffset="55-58" type="protein" text="PEO"/>
            <entity id="DS3.d26.s0.e2" origId="4754" charOffset="117-127" type="compound" text="phenacetin"/>
            <entity id="DS3.d26.s0.e3" origId="P54098,E5KNU5" charOffset="171-174" type="protein" text="PEO"/>
            <pair e1="DS3.d26.s0.e0" e2="DS3.d26.s0.e1" id="DS3.d26.s0.i0" interaction="False" />
            <pair e1="DS3.d26.s0.e2" e2="DS3.d26.s0.e1" id="DS3.d26.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d26.s1" origId="10021492-8" text="It was found that the amount of the PEO-CP complex formation by hydrogen bonding changed depending on the molecular weight of PEO.">
            <entity id="DS3.d26.s1.e0" origId="P54098,E5KNU5" charOffset="36-39" type="protein" text="PEO"/>
            <entity id="DS3.d26.s1.e1" origId="783" charOffset="64-72" type="compound" text="hydrogen"/>
            <entity id="DS3.d26.s1.e2" origId="P54098,E5KNU5" charOffset="126-129" type="protein" text="PEO"/>
            <pair e1="DS3.d26.s1.e1" e2="DS3.d26.s1.e0" id="DS3.d26.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d27" origId="10021500">
        <sentence id="DS3.d27.s0" origId="10021500-3" text="In cell-attached patches, channel activity was increased by the application of either N2, 2'-O-dibutyrylguanosine 3',5'-cyclic monophosphate (DBcGMP, 100 microM) or 8-bromoguanosine 3',5'-cyclic monophosphate (8BrcGMP, 100 microM), and it was inhibited by KT5823 (10 microM), a membrane-permeable specific inhibitor of cGMP-dependent protein kinase (PKG).">
            <entity id="DS3.d27.s0.e0" origId="54262165" charOffset="95-113" type="compound" text="dibutyrylguanosine"/>
            <entity id="DS3.d27.s0.e1" origId="104767" charOffset="165-208" type="compound" text="8-bromoguanosine 3',5'-cyclic monophosphate"/>
            <entity id="DS3.d27.s0.e2" origId="108152,3843" charOffset="256-262" type="compound" text="KT5823"/>
            <entity id="DS3.d27.s0.e3" origId="Q13976" charOffset="350-353" type="protein" text="PKG"/>
            <pair e1="DS3.d27.s0.e2" e2="DS3.d27.s0.e3" id="DS3.d27.s0.i0" interaction="False" />
            <pair e1="DS3.d27.s0.e0" e2="DS3.d27.s0.e3" id="DS3.d27.s0.i1" interaction="False" />
            <pair e1="DS3.d27.s0.e1" e2="DS3.d27.s0.e3" id="DS3.d27.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d27.s1" origId="10021500-5" text="Furthermore, atrial natriuretic peptide (ANP, 10 nM) increased channel activity, which was also prevented by the application of KT5823 (10 microM).">
            <entity id="DS3.d27.s1.e0" origId="P01160" charOffset="13-39" type="protein" text="atrial natriuretic peptide"/>
            <entity id="DS3.d27.s1.e1" origId="P01160" charOffset="41-44" type="protein" text="ANP"/>
            <entity id="DS3.d27.s1.e2" origId="108152,3843" charOffset="128-134" type="compound" text="KT5823"/>
            <pair e1="DS3.d27.s1.e2" e2="DS3.d27.s1.e0" id="DS3.d27.s1.i0" interaction="False" />
            <pair e1="DS3.d27.s1.e2" e2="DS3.d27.s1.e1" id="DS3.d27.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d28" origId="10021731">
        <sentence id="DS3.d28.s0" origId="10021731-6" text="light type III cells show peculiar dense core light vesicles, labelled protein A-gold particles immunoreactive to 5-HT.">
            <entity id="DS3.d28.s0.e0" origId="O43557" charOffset="0-5" type="protein" text="light"/>
            <entity id="DS3.d28.s0.e1" origId="O43557" charOffset="46-51" type="protein" text="light"/>
            <entity id="DS3.d28.s0.e2" origId="23985" charOffset="81-85" type="compound" text="gold"/>
            <entity id="DS3.d28.s0.e3" origId="5202" charOffset="114-118" type="compound" text="5-HT"/>
            <pair e1="DS3.d28.s0.e3" e2="DS3.d28.s0.e0" id="DS3.d28.s0.i0" interaction="False" />
            <pair e1="DS3.d28.s0.e2" e2="DS3.d28.s0.e0" id="DS3.d28.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d29" origId="10021768">
        <sentence id="DS3.d29.s0" origId="10021768-1" text="The genes encoding the three major targets of conventional insecticides are: Rdl, which encodes a gamma-aminobutyric acid receptor subunit (Rdl); para, which encodes a voltage-gated sodium channel (PARA); and Ace, which encodes insect acetylcholinesterase (AChE).">
            <entity id="DS3.d29.s0.e0" origId="Q8WVC0" charOffset="77-80" type="protein" text="Rdl"/>
            <entity id="DS3.d29.s0.e1" origId="119" charOffset="104-121" type="compound" text="aminobutyric acid"/>
            <entity id="DS3.d29.s0.e2" origId="Q8WVC0" charOffset="140-143" type="protein" text="Rdl"/>
            <entity id="DS3.d29.s0.e3" origId="5360545" charOffset="182-188" type="compound" text="sodium"/>
            <entity id="DS3.d29.s0.e4" origId="P22303" charOffset="235-261" type="protein" text="acetylcholinesterase (AChE"/>
            <pair e1="DS3.d29.s0.e1" e2="DS3.d29.s0.e4" id="DS3.d29.s0.i0" interaction="False" />
            <pair e1="DS3.d29.s0.e1" e2="DS3.d29.s0.e0" id="DS3.d29.s0.i1" interaction="False" />
            <pair e1="DS3.d29.s0.e3" e2="DS3.d29.s0.e4" id="DS3.d29.s0.i2" interaction="False" />
            <pair e1="DS3.d29.s0.e3" e2="DS3.d29.s0.e0" id="DS3.d29.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d30" origId="10021877">
        <sentence id="DS3.d30.s0" origId="10021877-4" text="The aim of this clinical study was to estimate the level of: total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), and triglycerides (TG), in group I which consisted of 17 patients with splenomegaly, which had developed during portal hypertension caused by liver cirrhosis, and group II 7 patients with splenomegaly caused by myeloproliferative disease.">
            <entity id="DS3.d30.s0.e0" origId="5997" charOffset="67-78" type="compound" text="cholesterol"/>
            <entity id="DS3.d30.s0.e1" origId="5997" charOffset="89-100" type="compound" text="cholesterol"/>
            <entity id="DS3.d30.s0.e2" origId="5997" charOffset="89-100" type="compound" text="cholesterol"/>
            <entity id="DS3.d30.s0.e3" origId="Q14746,B1ALW7" charOffset="127-132" type="protein" text="LDL-C"/>
            <pair e1="DS3.d30.s0.e0" e2="DS3.d30.s0.e3" id="DS3.d30.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d31" origId="10021912">
        <sentence id="DS3.d31.s0" origId="10021912-0" text="Isoxazoline GPIIb/IIIa antagonists bearing a phosphoramidate.">
            <entity id="DS3.d31.s0.e0" origId="12304501" charOffset="0-11" type="compound" text="Isoxazoline"/>
            <entity id="DS3.d31.s0.e1" origId="P08514" charOffset="12-17" type="protein" text="GPIIb"/>
            <entity id="DS3.d31.s0.e2" origId="211207" charOffset="45-60" type="compound" text="phosphoramidate"/>
            <pair e1="DS3.d31.s0.e0" e2="DS3.d31.s0.e1" id="DS3.d31.s0.i0" interaction="False" />
            <pair e1="DS3.d31.s0.e2" e2="DS3.d31.s0.e1" id="DS3.d31.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d31.s1" origId="10021912-2" text="They were found to bind GPIIb/IIIa with high affinity and were potent antagonists of ADP mediated platelet aggregation.">
            <entity id="DS3.d31.s1.e0" origId="P08514" charOffset="24-29" type="protein" text="GPIIb"/>
            <entity id="DS3.d31.s1.e1" origId="6022" charOffset="85-88" type="compound" text="ADP"/>
            <pair e1="DS3.d31.s1.e1" e2="DS3.d31.s1.e0" id="DS3.d31.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d32" origId="10021913">
        <sentence id="DS3.d32.s0" origId="10021913-0" text="Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.">
            <entity id="DS3.d32.s0.e0" origId="P45452,Q53H33" charOffset="24-30" type="protein" text="MMP-13"/>
            <entity id="DS3.d32.s0.e1" origId="22497" charOffset="36-52" type="compound" text="phosphinic acids"/>
            <pair e1="DS3.d32.s0.e1" e2="DS3.d32.s0.e0" id="DS3.d32.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d33" origId="10021915">
        <sentence id="DS3.d33.s0" origId="10021915-1" text="The ketomethylene phenylalanal and alanal analogues of Cbz-Val-Phe-H and Cbz-Val-Ala-H have been prepared and the Ki values versus chicken gizzard smooth muscle calpain were determined.">
            <entity id="DS3.d33.s0.e0" origId="446207" charOffset="18-30" type="compound" text="phenylalanal"/>
            <entity id="DS3.d33.s0.e1" origId="448397" charOffset="24-30" type="compound" text="alanal"/>
            <entity id="DS3.d33.s0.e2" origId="72430" charOffset="55-68" type="compound" text="Cbz-Val-Phe-H"/>
            <entity id="DS3.d33.s0.e3" origId="5479503" charOffset="73-86" type="compound" text="Cbz-Val-Ala-H"/>
            <entity id="DS3.d33.s0.e4" origId="P00789" charOffset="161-168" type="protein" text="calpain"/>
            <pair e1="DS3.d33.s0.e3" e2="DS3.d33.s0.e4" id="DS3.d33.s0.i0" interaction="False" />
            <pair e1="DS3.d33.s0.e0" e2="DS3.d33.s0.e4" id="DS3.d33.s0.i1" interaction="False" />
            <pair e1="DS3.d33.s0.e2" e2="DS3.d33.s0.e4" id="DS3.d33.s0.i2" interaction="False" />
            <pair e1="DS3.d33.s0.e1" e2="DS3.d33.s0.e4" id="DS3.d33.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d33.s1" origId="10021915-2" text="The ketomethylene isosteres were significantly less potent than the corresponding dipeptide aldehydes, and this loss in activity is attributed to the absence of a critical interaction between the P1-P2 amide bond and the peptide binding region of calpain.">
            <entity id="DS3.d33.s1.e0" origId="2826723" charOffset="202-207" type="compound" text="amide"/>
            <entity id="DS3.d33.s1.e1" origId="P00789" charOffset="247-254" type="protein" text="calpain"/>
            <pair e1="DS3.d33.s1.e0" e2="DS3.d33.s1.e1" id="DS3.d33.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d34" origId="10021918">
        <sentence id="DS3.d34.s0" origId="10021918-0" text="Substituted heterocyclic analogs as selective COX-2 inhibitors in the flosulide class.">
            <entity id="DS3.d34.s0.e0" origId="P00403,U5Z487" charOffset="46-51" type="protein" text="COX-2"/>
            <entity id="DS3.d34.s0.e1" origId="71246" charOffset="70-79" type="compound" text="flosulide"/>
            <pair e1="DS3.d34.s0.e1" e2="DS3.d34.s0.e0" id="DS3.d34.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d34.s1" origId="10021918-1" text="Substituted heterocyclic analogs in the Flosulide class were investigated as potential selective cyclooxygenase-2 inhibitors.">
            <entity id="DS3.d34.s1.e0" origId="71246" charOffset="40-49" type="compound" text="Flosulide"/>
            <entity id="DS3.d34.s1.e1" origId="P35354" charOffset="97-113" type="protein" text="cyclooxygenase-2"/>
            <pair e1="DS3.d34.s1.e0" e2="DS3.d34.s1.e1" id="DS3.d34.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d35" origId="10021924">
        <sentence id="DS3.d35.s0" origId="10021924-0" text="Selective inactivation of protein tyrosine phosphatase PTP1B by sulfone analogue of naphthoquinone.">
            <entity id="DS3.d35.s0.e0" origId="6057,90983769" charOffset="34-42" type="compound" text="tyrosine"/>
            <entity id="DS3.d35.s0.e1" origId="P18031,B4DSN5,A8K3M3" charOffset="55-60" type="protein" text="PTP1B"/>
            <entity id="DS3.d35.s0.e2" origId="8530" charOffset="84-98" type="compound" text="naphthoquinone"/>
            <pair e1="DS3.d35.s0.e2" e2="DS3.d35.s0.e1" id="DS3.d35.s0.i0" interaction="False" />
            <pair e1="DS3.d35.s0.e0" e2="DS3.d35.s0.e1" id="DS3.d35.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d35.s1" origId="10021924-2" text="In this study, the effect of sulfone analogue of naphthoquinone on the activities of PTP1B and other PTPs was examined.">
            <entity id="DS3.d35.s1.e0" origId="8530" charOffset="49-63" type="compound" text="naphthoquinone"/>
            <entity id="DS3.d35.s1.e1" origId="P18031,B4DSN5,A8K3M3" charOffset="85-90" type="protein" text="PTP1B"/>
            <pair e1="DS3.d35.s1.e0" e2="DS3.d35.s1.e1" id="DS3.d35.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d36" origId="10021925">
        <sentence id="DS3.d36.s0" origId="10021925-0" text="Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates.">
            <entity id="DS3.d36.s0.e0" origId="P09955" charOffset="22-40" type="protein" text="carboxypeptidase B"/>
            <entity id="DS3.d36.s0.e1" origId="85628174" charOffset="72-87" type="compound" text="anisylazoformyl"/>
            <pair e1="DS3.d36.s0.e1" e2="DS3.d36.s0.e0" id="DS3.d36.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d36.s1" origId="10021925-1" text="Anisylazoformyllysine (CH3OC6H4-N = N-CO-Lys-OH) is rapidly hydrolyzed at the acyl-lysine linkage by the zinc-enzyme porcine carboxypeptidase B.">
            <entity id="DS3.d36.s1.e0" origId="54502714" charOffset="0-21" type="compound" text="Anisylazoformyllysine"/>
            <entity id="DS3.d36.s1.e1" origId="866,5962,57449" charOffset="15-21" type="compound" text="lysine"/>
            <entity id="DS3.d36.s1.e2" origId="23994" charOffset="105-109" type="compound" text="zinc"/>
            <entity id="DS3.d36.s1.e3" origId="P09955" charOffset="125-143" type="protein" text="carboxypeptidase B"/>
            <pair e1="DS3.d36.s1.e1" e2="DS3.d36.s1.e3" id="DS3.d36.s1.i0" interaction="False" />
            <pair e1="DS3.d36.s1.e0" e2="DS3.d36.s1.e3" id="DS3.d36.s1.i1" interaction="False" />
            <pair e1="DS3.d36.s1.e2" e2="DS3.d36.s1.e3" id="DS3.d36.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d37" origId="10021941">
        <sentence id="DS3.d37.s0" origId="10021941-0" text="Synthesis and PLA2-inhibitory properties of 2(R)-acetamido-alkylphosphomethanols with a variable aggregate anchor.">
            <entity id="DS3.d37.s0.e0" origId="P04054" charOffset="14-18" type="protein" text="PLA2"/>
            <entity id="DS3.d37.s0.e1" origId="178" charOffset="49-58" type="compound" text="acetamido"/>
            <pair e1="DS3.d37.s0.e1" e2="DS3.d37.s0.e0" id="DS3.d37.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d38" origId="10021942">
        <sentence id="DS3.d38.s0" origId="10021942-0" text="Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition.">
            <entity id="DS3.d38.s0.e0" origId="12695" charOffset="0-22" type="compound" text="Trifluoromethyl ketone"/>
            <entity id="DS3.d38.s0.e1" origId="O00519,Q9UG55" charOffset="37-63" type="protein" text="fatty acid amide hydrolase"/>
            <pair e1="DS3.d38.s0.e0" e2="DS3.d38.s0.e1" id="DS3.d38.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d38.s1" origId="10021942-1" text="The examination of a series of trifluoromethyl ketone inhibitors of fatty acid amide hydrolase (FAAH, oleamide hydrolase, anandamide amidohydrolase) is detailed in efforts that define structural and conformational properties that contribute to enzyme inhibition and substrate binding.">
            <entity id="DS3.d38.s1.e0" origId="12695" charOffset="31-53" type="compound" text="trifluoromethyl ketone"/>
            <entity id="DS3.d38.s1.e1" origId="O00519,Q9UG55" charOffset="68-94" type="protein" text="fatty acid amide hydrolase"/>
            <entity id="DS3.d38.s1.e2" origId="O00519,Q9UG55" charOffset="96-100" type="protein" text="FAAH"/>
            <entity id="DS3.d38.s1.e3" origId="5283387" charOffset="102-110" type="compound" text="oleamide"/>
            <entity id="DS3.d38.s1.e4" origId="2185,5281969" charOffset="122-132" type="compound" text="anandamide"/>
            <pair e1="DS3.d38.s1.e4" e2="DS3.d38.s1.e1" id="DS3.d38.s1.i0" interaction="False" />
            <pair e1="DS3.d38.s1.e4" e2="DS3.d38.s1.e2" id="DS3.d38.s1.i1" interaction="False" />
            <pair e1="DS3.d38.s1.e3" e2="DS3.d38.s1.e1" id="DS3.d38.s1.i2" interaction="False" />
            <pair e1="DS3.d38.s1.e3" e2="DS3.d38.s1.e2" id="DS3.d38.s1.i3" interaction="False" />
            <pair e1="DS3.d38.s1.e0" e2="DS3.d38.s1.e1" id="DS3.d38.s1.i4" interaction="False" />
            <pair e1="DS3.d38.s1.e0" e2="DS3.d38.s1.e2" id="DS3.d38.s1.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d38.s2" origId="10021942-2" text="The results imply an extended bound conformation, highlight a role for the presence, position, and stereochemistry of a delta cis double bond, and suggest little apparent role for C11-C18/C22 of the fatty acid amide substrates.">
            <entity id="DS3.d38.s2.e0" origId="P17516" charOffset="180-183" type="protein" text="C11"/>
            <entity id="DS3.d38.s2.e1" origId="Q3SYG4,A0A090N7W2,A0A090N8P4" charOffset="184-187" type="protein" text="C18"/>
            <entity id="DS3.d38.s2.e2" origId="2826723" charOffset="210-215" type="compound" text="amide"/>
            <pair e1="DS3.d38.s2.e2" e2="DS3.d38.s2.e0" id="DS3.d38.s2.i0" interaction="False" />
            <pair e1="DS3.d38.s2.e2" e2="DS3.d38.s2.e1" id="DS3.d38.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d39" origId="10021953">
        <sentence id="DS3.d39.s0" origId="10021953-3" text="All patients received 2 mg.kg-1 propofol at a rate of 200 mg.min-1, followed by a continuous infusion of 4 mg.kg-1.hr-1.">
            <entity id="DS3.d39.s0.e0" origId="4943" charOffset="32-40" type="compound" text="propofol"/>
            <entity id="DS3.d39.s0.e1" origId="P13987,Q6FHM9" charOffset="61-66" type="protein" text="min-1"/>
            <pair e1="DS3.d39.s0.e0" e2="DS3.d39.s0.e1" id="DS3.d39.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d40" origId="10021955">
        <sentence id="DS3.d40.s0" origId="10021955-11" text="Light anaesthesia occurred in four (16%) children, all in the propofol group.">
            <entity id="DS3.d40.s0.e0" origId="O43557" charOffset="0-5" type="protein" text="Light"/>
            <entity id="DS3.d40.s0.e1" origId="4943" charOffset="62-70" type="compound" text="propofol"/>
            <pair e1="DS3.d40.s0.e1" e2="DS3.d40.s0.e0" id="DS3.d40.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d41" origId="10022001">
        <sentence id="DS3.d41.s0" origId="10022001-0" text="Simultaneous production of IFN-gamma, IFN-alpha/beta and nitric oxide in peritoneal macrophages from TDM-treated mice.">
            <entity id="DS3.d41.s0.e0" origId="P01580" charOffset="27-36" type="protein" text="IFN-gamma"/>
            <entity id="DS3.d41.s0.e1" origId="145068" charOffset="57-69" type="compound" text="nitric oxide"/>
            <pair e1="DS3.d41.s0.e1" e2="DS3.d41.s0.e0" id="DS3.d41.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d42" origId="10022007">
        <sentence id="DS3.d42.s0" origId="10022007-1" text="In vitro effects of bovine somatotropin (bST) and insulin plus dexamethasone on lipolysis were evaluated using chronic cultures (48 h) of adipose tissue from lactating cows.">
            <entity id="DS3.d42.s0.e0" origId="P01246,B0FPG6" charOffset="20-39" type="protein" text="bovine somatotropin"/>
            <entity id="DS3.d42.s0.e1" origId="A5PJB2" charOffset="50-57" type="protein" text="insulin"/>
            <entity id="DS3.d42.s0.e2" origId="5743" charOffset="63-76" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d42.s0.e2" e2="DS3.d42.s0.e0" id="DS3.d42.s0.i0" interaction="False" />
            <pair e1="DS3.d42.s0.e2" e2="DS3.d42.s0.e1" id="DS3.d42.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d42.s1" origId="10022007-2" text="Treatments were control (culture medium alone), bST (100 ng/ml), insulin (100 ng/ml) plus dexamethasome (10 nM), and insulin plus dexamethasone plus bST.">
            <entity id="DS3.d42.s1.e0" origId="A5PJB2" charOffset="65-72" type="protein" text="insulin"/>
            <entity id="DS3.d42.s1.e1" origId="A5PJB2" charOffset="117-124" type="protein" text="insulin"/>
            <entity id="DS3.d42.s1.e2" origId="5743" charOffset="130-143" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d42.s1.e2" e2="DS3.d42.s1.e0" id="DS3.d42.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d42.s2" origId="10022007-6" text="When measured in the presence of maximal concentrations of adenosine analog, isoproterenol caused an increase in lipolysis above basal, which was twofold greater for explants cultured with insulin plus dexamethasone plus bST than for explants cultured with insulin plus dexamethasone.">
            <entity id="DS3.d42.s2.e0" origId="469074" charOffset="59-75" type="compound" text="adenosine analog"/>
            <entity id="DS3.d42.s2.e1" origId="3779" charOffset="77-90" type="compound" text="isoproterenol"/>
            <entity id="DS3.d42.s2.e2" origId="A5PJB2" charOffset="189-196" type="protein" text="insulin"/>
            <entity id="DS3.d42.s2.e3" origId="5743" charOffset="202-215" type="compound" text="dexamethasone"/>
            <entity id="DS3.d42.s2.e4" origId="A5PJB2" charOffset="257-264" type="protein" text="insulin"/>
            <entity id="DS3.d42.s2.e5" origId="5743" charOffset="270-283" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d42.s2.e1" e2="DS3.d42.s2.e2" id="DS3.d42.s2.i0" interaction="False" />
            <pair e1="DS3.d42.s2.e0" e2="DS3.d42.s2.e2" id="DS3.d42.s2.i1" interaction="False" />
            <pair e1="DS3.d42.s2.e3" e2="DS3.d42.s2.e2" id="DS3.d42.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d42.s3" origId="10022007-9" text="The addition of insulin plus dexamethasone to chronic cultures better maintained the intracellular signaling system, including sensitivity and responsiveness to adenosine inhibition of lipolysis.">
            <entity id="DS3.d42.s3.e0" origId="A5PJB2" charOffset="16-23" type="protein" text="insulin"/>
            <entity id="DS3.d42.s3.e1" origId="5743" charOffset="29-42" type="compound" text="dexamethasone"/>
            <entity id="DS3.d42.s3.e2" origId="57476835,60961" charOffset="161-170" type="compound" text="adenosine"/>
            <pair e1="DS3.d42.s3.e2" e2="DS3.d42.s3.e0" id="DS3.d42.s3.i0" interaction="False" />
            <pair e1="DS3.d42.s3.e1" e2="DS3.d42.s3.e0" id="DS3.d42.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d43" origId="10022010">
        <sentence id="DS3.d43.s0" origId="10022010-8" text="Supplementation with 50 microM of ferric chloride to the medium completely reversed the inhibitory effects of the antibodies and lactoferrin.">
            <entity id="DS3.d43.s0.e0" origId="24380,68541" charOffset="34-49" type="compound" text="ferric chloride"/>
            <entity id="DS3.d43.s0.e1" origId="P24627,B9VPZ5" charOffset="129-140" type="protein" text="lactoferrin"/>
            <pair e1="DS3.d43.s0.e0" e2="DS3.d43.s0.e1" id="DS3.d43.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d44" origId="10022061">
        <sentence id="DS3.d44.s0" origId="10022061-1" text="Microsensors used in microbial ecology are reviewed with emphasis on new sensor developments (NO3-, NO2-, NH4+, CO2, H2, H2S and CH4 microsensors as well as fiberoptical microsensors for O2, temperature and pH).">
            <entity id="DS3.d44.s0.e0" origId="P06681,Q8N6L6,B4DQI1,Q5JP69,A0A0G2JL69,Q53HP3,B4DV48" charOffset="112-115" type="protein" text="CO2"/>
            <entity id="DS3.d44.s0.e1" origId="783" charOffset="117-119" type="compound" text="H2"/>
            <pair e1="DS3.d44.s0.e1" e2="DS3.d44.s0.e0" id="DS3.d44.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d45" origId="10022066">
        <sentence id="DS3.d45.s0" origId="10022066-1" text="Thermophilic anaerobic treatment of sulphur-rich paper mill wastewater (0.8-3.1 gCOD/1, 340-850 mgSO4/l; COD:SO4 3.4-5.3) was studied in three laboratory-scale, upflow anaerobic sludge blanket (UASB) reactors and in bioassays.">
            <entity id="DS3.d45.s0.e0" origId="24083" charOffset="96-101" type="compound" text="mgSO4"/>
            <entity id="DS3.d45.s0.e1" origId="P14678,Q66K91" charOffset="81-84" type="protein" text="COD"/>
            <pair e1="DS3.d45.s0.e0" e2="DS3.d45.s0.e1" id="DS3.d45.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d46" origId="10022067">
        <sentence id="DS3.d46.s0" origId="10022067-1" text="This paper reviews the operation of a full-scale, fixed-bed digester treating a citric acid production wastewater with a COD:sulphate ratio of 3-4:1.">
            <entity id="DS3.d46.s0.e0" origId="311" charOffset="80-91" type="compound" text="citric acid"/>
            <entity id="DS3.d46.s0.e1" origId="P14678,Q66K91" charOffset="121-124" type="protein" text="COD"/>
            <entity id="DS3.d46.s0.e2" origId="1117" charOffset="125-133" type="compound" text="sulphate"/>
            <pair e1="DS3.d46.s0.e2" e2="DS3.d46.s0.e1" id="DS3.d46.s0.i0" interaction="False" />
            <pair e1="DS3.d46.s0.e0" e2="DS3.d46.s0.e1" id="DS3.d46.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d46.s1" origId="10022067-3" text="Detailed analysis of the digester biomass after 5 years of operation indicated that H2 and propionate-utilising SRB had outcompeted hydrogenophilic methanogens and propionate syntrophs.">
            <entity id="DS3.d46.s1.e0" origId="783" charOffset="84-86" type="compound" text="H2"/>
            <entity id="DS3.d46.s1.e1" origId="1032" charOffset="91-101" type="compound" text="propionate"/>
            <entity id="DS3.d46.s1.e2" origId="P50991" charOffset="112-115" type="protein" text="SRB"/>
            <entity id="DS3.d46.s1.e3" origId="1032" charOffset="164-174" type="compound" text="propionate"/>
            <pair e1="DS3.d46.s1.e0" e2="DS3.d46.s1.e2" id="DS3.d46.s1.i0" interaction="False" />
            <pair e1="DS3.d46.s1.e1" e2="DS3.d46.s1.e2" id="DS3.d46.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d46.s2" origId="10022067-7" text="In the presence of sulphate (2 g/l-1; COD/sulphate ratio of 6:1), acetate conversion was severely inhibited, resulting in effluent acetate concentrations of up to 4000 mg.l-1.">
            <entity id="DS3.d46.s2.e0" origId="1117" charOffset="19-27" type="compound" text="sulphate"/>
            <entity id="DS3.d46.s2.e1" origId="P14678,Q66K91" charOffset="38-41" type="protein" text="COD"/>
            <entity id="DS3.d46.s2.e2" origId="1117" charOffset="42-50" type="compound" text="sulphate"/>
            <entity id="DS3.d46.s2.e3" origId="176" charOffset="66-73" type="compound" text="acetate"/>
            <entity id="DS3.d46.s2.e4" origId="176" charOffset="131-138" type="compound" text="acetate"/>
            <pair e1="DS3.d46.s2.e0" e2="DS3.d46.s2.e1" id="DS3.d46.s2.i0" interaction="False" />
            <pair e1="DS3.d46.s2.e3" e2="DS3.d46.s2.e1" id="DS3.d46.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d47" origId="10022068">
        <sentence id="DS3.d47.s0" origId="10022068-5" text="Together with the co-disposal of organic wastes, algal biomass is generated as an independent carbon source for SRB production.">
            <entity id="DS3.d47.s0.e0" origId="5462310" charOffset="94-100" type="compound" text="carbon"/>
            <entity id="DS3.d47.s0.e1" origId="P50991" charOffset="112-115" type="protein" text="SRB"/>
            <pair e1="DS3.d47.s0.e0" e2="DS3.d47.s0.e1" id="DS3.d47.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d48" origId="10022070">
        <sentence id="DS3.d48.s0" origId="10022070-1" text="Compounds of interest in this work are methanethiol (MeSH), dimethyl sulfide (Me2S), dimethyl polysulfides (Me2Sx) and carbon disulfide (CS2) since these volatiles have been identified as predominant odorants in the emission of a wide range of activities in the bio-industry (e.g.">
            <entity id="DS3.d48.s0.e0" origId="878" charOffset="39-51" type="compound" text="methanethiol"/>
            <entity id="DS3.d48.s0.e1" origId="1068" charOffset="60-76" type="compound" text="dimethyl sulfide"/>
            <entity id="DS3.d48.s0.e2" origId="6348" charOffset="119-135" type="compound" text="carbon disulfide"/>
            <entity id="DS3.d48.s0.e3" origId="P0DML3,B1A4H9,A6NIT4" charOffset="137-140" type="protein" text="CS2"/>
            <pair e1="DS3.d48.s0.e0" e2="DS3.d48.s0.e3" id="DS3.d48.s0.i0" interaction="False" />
            <pair e1="DS3.d48.s0.e1" e2="DS3.d48.s0.e3" id="DS3.d48.s0.i1" interaction="False" />
            <pair e1="DS3.d48.s0.e2" e2="DS3.d48.s0.e3" id="DS3.d48.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d49" origId="10022083">
        <sentence id="DS3.d49.s0" origId="10022083-5" text="The results show that the physical order of the tested clones was 5'-g14-5 &amp;gt; g12-2 &amp;gt; g10-8 &amp;gt; g4-5 &amp;gt; g16-7 &amp;gt; g8-3 &amp;gt; g12-5 &amp;gt; g6-20-3'.">
            <entity id="DS3.d49.s0.e0" origId="2738139" charOffset="69-72" type="compound" text="g14"/>
            <entity id="DS3.d49.s0.e1" origId="5795340" charOffset="80-83" type="compound" text="g12"/>
            <entity id="DS3.d49.s0.e2" origId="Q16635,A6XNE1" charOffset="102-106" type="protein" text="g4-5"/>
            <entity id="DS3.d49.s0.e3" origId="447467" charOffset="112-115" type="compound" text="g16"/>
            <entity id="DS3.d49.s0.e4" origId="5795340" charOffset="133-136" type="compound" text="g12"/>
            <entity id="DS3.d49.s0.e5" origId="5473838" charOffset="144-146" type="compound" text="g6"/>
            <pair e1="DS3.d49.s0.e3" e2="DS3.d49.s0.e2" id="DS3.d49.s0.i0" interaction="False" />
            <pair e1="DS3.d49.s0.e0" e2="DS3.d49.s0.e2" id="DS3.d49.s0.i1" interaction="False" />
            <pair e1="DS3.d49.s0.e1" e2="DS3.d49.s0.e2" id="DS3.d49.s0.i2" interaction="False" />
            <pair e1="DS3.d49.s0.e5" e2="DS3.d49.s0.e2" id="DS3.d49.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d50" origId="10022118">
        <sentence id="DS3.d50.s0" origId="10022118-1" text="The cyclin-dependent kinase inhibitor p21waf1/Cip1 is a downstream effector of the p53-dependent cell growth arrest.">
            <entity id="DS3.d50.s0.e0" origId="53378893" charOffset="21-37" type="compound" text="kinase inhibitor"/>
            <entity id="DS3.d50.s0.e1" origId="P38936,A0A024RCX5" charOffset="46-50" type="protein" text="Cip1"/>
            <entity id="DS3.d50.s0.e2" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="83-86" type="protein" text="p53"/>
            <pair e1="DS3.d50.s0.e0" e2="DS3.d50.s0.e1" id="DS3.d50.s0.i0" interaction="False" />
            <pair e1="DS3.d50.s0.e0" e2="DS3.d50.s0.e2" id="DS3.d50.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d51" origId="10022119">
        <sentence id="DS3.d51.s0" origId="10022119-1" text="The Met tyrosine kinase - the HGF receptor - induces cell transformation and metastasis when constitutively activated.">
            <entity id="DS3.d51.s0.e0" origId="6057,90983769" charOffset="8-16" type="compound" text="tyrosine"/>
            <entity id="DS3.d51.s0.e1" origId="P08581,A0A024R728,A0A024R759,B4DLF5" charOffset="30-42" type="protein" text="HGF receptor"/>
            <pair e1="DS3.d51.s0.e0" e2="DS3.d51.s0.e1" id="DS3.d51.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d52" origId="10022120">
        <sentence id="DS3.d52.s0" origId="10022120-0" text="Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.">
            <entity id="DS3.d52.s0.e0" origId="90983769" charOffset="0-8" type="compound" text="Tyrosine"/>
            <entity id="DS3.d52.s0.e1" origId="Q13191,B3KSS7" charOffset="50-55" type="protein" text="Cbl-b"/>
            <pair e1="DS3.d52.s0.e0" e2="DS3.d52.s0.e1" id="DS3.d52.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d52.s1" origId="10022120-1" text="Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites.">
            <entity id="DS3.d52.s1.e0" origId="Q13191,B3KSS7" charOffset="0-5" type="protein" text="Cbl-b"/>
            <entity id="DS3.d52.s1.e1" origId="Q13191,B3KSS7" charOffset="69-74" type="protein" text="Cbl-b"/>
            <entity id="DS3.d52.s1.e2" origId="57240853,614,8988" charOffset="175-182" type="compound" text="proline"/>
            <entity id="DS3.d52.s1.e3" origId="90983769" charOffset="212-220" type="compound" text="tyrosine"/>
            <pair e1="DS3.d52.s1.e2" e2="DS3.d52.s1.e0" id="DS3.d52.s1.i0" interaction="False" />
            <pair e1="DS3.d52.s1.e3" e2="DS3.d52.s1.e0" id="DS3.d52.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d52.s2" origId="10022120-2" text="In the present study, we demonstrate that upon engagement of the T cell receptor (TCR), endogenous Cbl-b becomes rapidly tyrosine-phosphorylated.">
            <entity id="DS3.d52.s2.e0" origId="Q13191,B3KSS7" charOffset="99-104" type="protein" text="Cbl-b"/>
            <entity id="DS3.d52.s2.e1" origId="90983769" charOffset="121-129" type="compound" text="tyrosine"/>
            <pair e1="DS3.d52.s2.e1" e2="DS3.d52.s2.e0" id="DS3.d52.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d52.s3" origId="10022120-3" text="In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- (Syk/Zap-70) and Src- (Fyn/Lck) family kinases, with Syk kinase inducing the most prominent effect.">
            <entity id="DS3.d52.s3.e0" origId="Q13191,B3KSS7" charOffset="30-35" type="protein" text="Cbl-b"/>
            <entity id="DS3.d52.s3.e1" origId="90983769" charOffset="58-66" type="compound" text="tyrosine"/>
            <entity id="DS3.d52.s3.e2" origId="P43405,A0A024R244,A0A024R273" charOffset="84-87" type="protein" text="Syk"/>
            <entity id="DS3.d52.s3.e3" origId="P43403" charOffset="90-100" type="protein" text="Syk/Zap-70"/>
            <entity id="DS3.d52.s3.e4" origId="P06239,Q573B4" charOffset="116-119" type="protein" text="Lck"/>
            <entity id="DS3.d52.s3.e5" origId="P43405,A0A024R244,A0A024R273" charOffset="90-93" type="protein" text="Syk"/>
            <pair e1="DS3.d52.s3.e1" e2="DS3.d52.s3.e2" id="DS3.d52.s3.i0" interaction="False" />
            <pair e1="DS3.d52.s3.e1" e2="DS3.d52.s3.e0" id="DS3.d52.s3.i1" interaction="False" />
            <pair e1="DS3.d52.s3.e1" e2="DS3.d52.s3.e3" id="DS3.d52.s3.i2" interaction="False" />
            <pair e1="DS3.d52.s3.e1" e2="DS3.d52.s3.e4" id="DS3.d52.s3.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d52.s4" origId="10022120-5" text="A Tyr-316 Cbl-binding site in Syk was required for the association with and for the maximal tyrosine phosphorylation of Cbl-b.">
            <entity id="DS3.d52.s4.e0" origId="6057" charOffset="2-5" type="compound" text="Tyr"/>
            <entity id="DS3.d52.s4.e1" origId="P43405,A0A024R244,A0A024R273" charOffset="30-33" type="protein" text="Syk"/>
            <entity id="DS3.d52.s4.e2" origId="90983769" charOffset="92-100" type="compound" text="tyrosine"/>
            <entity id="DS3.d52.s4.e3" origId="Q13191,B3KSS7" charOffset="10-15" type="protein" text="Cbl-b"/>
            <pair e1="DS3.d52.s4.e0" e2="DS3.d52.s4.e1" id="DS3.d52.s4.i0" interaction="False" />
            <pair e1="DS3.d52.s4.e0" e2="DS3.d52.s4.e3" id="DS3.d52.s4.i1" interaction="False" />
            <pair e1="DS3.d52.s4.e2" e2="DS3.d52.s4.e1" id="DS3.d52.s4.i2" interaction="False" />
            <pair e1="DS3.d52.s4.e2" e2="DS3.d52.s4.e3" id="DS3.d52.s4.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d53" origId="10022122">
        <sentence id="DS3.d53.s0" origId="10022122-3" text="We have investigated the localization of Bcr-Abl in 32D myeloid cells attached to the extracellular matrix.">
            <entity id="DS3.d53.s0.e0" origId="P00519,Q59FK4,A0A024R8E2" charOffset="41-48" type="protein" text="Bcr-Abl"/>
            <entity id="DS3.d53.s0.e1" origId="60210951" charOffset="52-55" type="compound" text="32D"/>
            <pair e1="DS3.d53.s0.e1" e2="DS3.d53.s0.e0" id="DS3.d53.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d53.s1" origId="10022122-4" text="We have found that Bcr-Abl displays a polarized distribution, colocalizing with a subset of filamentous actin at trailing portions of migrating 32D cells, and localizes on the cortical F-actin and on vesicle-like structures in resting 32D cells.">
            <entity id="DS3.d53.s1.e0" origId="P00519,Q59FK4,A0A024R8E2" charOffset="19-26" type="protein" text="Bcr-Abl"/>
            <entity id="DS3.d53.s1.e1" origId="60210951" charOffset="144-147" type="compound" text="32D"/>
            <entity id="DS3.d53.s1.e2" origId="60210951" charOffset="235-238" type="compound" text="32D"/>
            <pair e1="DS3.d53.s1.e1" e2="DS3.d53.s1.e0" id="DS3.d53.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d54" origId="10022126">
        <sentence id="DS3.d54.s0" origId="10022126-1" text="Par-4 is a widely expressed leucine zipper protein that confers sensitization to apoptosis induced by exogenous insults.">
            <entity id="DS3.d54.s0.e0" origId="Q96IZ0" charOffset="0-5" type="protein" text="Par-4"/>
            <entity id="DS3.d54.s0.e1" origId="6106" charOffset="28-35" type="compound" text="leucine"/>
            <pair e1="DS3.d54.s0.e1" e2="DS3.d54.s0.e0" id="DS3.d54.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d55" origId="10022127">
        <sentence id="DS3.d55.s0" origId="10022127-4" text="In contrast to TIF1alpha, but like TIF1beta, TIF1 does not interact with nuclear receptors in yeast two-hybrid or GST pull-down assays and does not interfere with retinoic acid response in transfected mammalian cells.">
            <entity id="DS3.d55.s0.e0" origId="O15164,A0A024R784" charOffset="15-24" type="protein" text="TIF1alpha"/>
            <entity id="DS3.d55.s0.e1" origId="Q13263" charOffset="35-43" type="protein" text="TIF1beta"/>
            <entity id="DS3.d55.s0.e2" origId="444795" charOffset="163-176" type="compound" text="retinoic acid"/>
            <pair e1="DS3.d55.s0.e2" e2="DS3.d55.s0.e0" id="DS3.d55.s0.i0" interaction="False" />
            <pair e1="DS3.d55.s0.e2" e2="DS3.d55.s0.e1" id="DS3.d55.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d56" origId="10022130">
        <sentence id="DS3.d56.s0" origId="10022130-0" text="Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21.">
            <entity id="DS3.d56.s0.e0" origId="P42574" charOffset="0-9" type="protein" text="Caspase 3"/>
            <entity id="DS3.d56.s0.e1" origId="P38936,A0A024RCX5" charOffset="97-100" type="protein" text="p21"/>
            <entity id="DS3.d56.s0.e2" origId="446800" charOffset="105-108" type="compound" text="ILP"/>
            <entity id="DS3.d56.s0.e3" origId="P38936,A0A024RCX5" charOffset="139-142" type="protein" text="p21"/>
            <pair e1="DS3.d56.s0.e2" e2="DS3.d56.s0.e0" id="DS3.d56.s0.i0" interaction="False" />
            <pair e1="DS3.d56.s0.e2" e2="DS3.d56.s0.e1" id="DS3.d56.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d56.s1" origId="10022130-3" text="We recently reported that activation of Caspase 3 is regulated by complex formation with p21 or ILP.">
            <entity id="DS3.d56.s1.e0" origId="P42574" charOffset="40-49" type="protein" text="Caspase 3"/>
            <entity id="DS3.d56.s1.e1" origId="P38936,A0A024RCX5" charOffset="89-92" type="protein" text="p21"/>
            <entity id="DS3.d56.s1.e2" origId="446800" charOffset="96-99" type="compound" text="ILP"/>
            <pair e1="DS3.d56.s1.e2" e2="DS3.d56.s1.e0" id="DS3.d56.s1.i0" interaction="False" />
            <pair e1="DS3.d56.s1.e2" e2="DS3.d56.s1.e1" id="DS3.d56.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d56.s2" origId="10022130-4" text="In the present study, we investigated the binding domain with p21 and ILP to further characterize the Caspase 3 inactivation machinery.">
            <entity id="DS3.d56.s2.e0" origId="P38936,A0A024RCX5" charOffset="62-65" type="protein" text="p21"/>
            <entity id="DS3.d56.s2.e1" origId="446800" charOffset="70-73" type="compound" text="ILP"/>
            <entity id="DS3.d56.s2.e2" origId="P42574" charOffset="102-111" type="protein" text="Caspase 3"/>
            <pair e1="DS3.d56.s2.e1" e2="DS3.d56.s2.e2" id="DS3.d56.s2.i0" interaction="False" />
            <pair e1="DS3.d56.s2.e1" e2="DS3.d56.s2.e0" id="DS3.d56.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d56.s3" origId="10022130-5" text="Our results show that Caspase 3 contains p21 binding domain in the N-terminus and ILP binding domain in the active site.">
            <entity id="DS3.d56.s3.e0" origId="P42574" charOffset="22-31" type="protein" text="Caspase 3"/>
            <entity id="DS3.d56.s3.e1" origId="P38936,A0A024RCX5" charOffset="41-44" type="protein" text="p21"/>
            <entity id="DS3.d56.s3.e2" origId="446800" charOffset="82-85" type="compound" text="ILP"/>
            <pair e1="DS3.d56.s3.e2" e2="DS3.d56.s3.e0" id="DS3.d56.s3.i0" interaction="False" />
            <pair e1="DS3.d56.s3.e2" e2="DS3.d56.s3.e1" id="DS3.d56.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d56.s4" origId="10022130-8" text="Here, we propose the Caspase 3 inactivation system by p21 and ILP as new essential system in the regulation of cell death.">
            <entity id="DS3.d56.s4.e0" origId="P42574" charOffset="21-30" type="protein" text="Caspase 3"/>
            <entity id="DS3.d56.s4.e1" origId="P38936,A0A024RCX5" charOffset="54-57" type="protein" text="p21"/>
            <entity id="DS3.d56.s4.e2" origId="446800" charOffset="62-65" type="compound" text="ILP"/>
            <pair e1="DS3.d56.s4.e2" e2="DS3.d56.s4.e0" id="DS3.d56.s4.i0" interaction="False" />
            <pair e1="DS3.d56.s4.e2" e2="DS3.d56.s4.e1" id="DS3.d56.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d57" origId="10022137">
        <sentence id="DS3.d57.s0" origId="10022137-5" text="EGF-R activation was measured in isolated ileal enterocytes by probing an EGF-R immunoprecipitate with an antibody to phosphotyrosine.">
            <entity id="DS3.d57.s0.e0" origId="Q01279,Q9WVF5,Q9EP98,Q3TQS6" charOffset="0-5" type="protein" text="EGF-R"/>
            <entity id="DS3.d57.s0.e1" origId="Q01279,Q9WVF5,Q9EP98,Q3TQS6" charOffset="74-79" type="protein" text="EGF-R"/>
            <entity id="DS3.d57.s0.e2" origId="30819" charOffset="118-133" type="compound" text="phosphotyrosine"/>
            <pair e1="DS3.d57.s0.e2" e2="DS3.d57.s0.e0" id="DS3.d57.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d58" origId="10022138">
        <sentence id="DS3.d58.s0" origId="10022138-11" text="The worst survival rate was found for patients with bilirubin levels of greater than 3 mg/dL (P&amp;lt;.0001), plateletcounts less than 100.000/mL (P&amp;lt;.0001), prothrombin time greater than 15 seconds (P = .03) or partial thromboplastin time greater than 40 seconds (P&amp;lt;.04).">
            <entity id="DS3.d58.s0.e0" origId="5280352" charOffset="52-61" type="compound" text="bilirubin"/>
            <entity id="DS3.d58.s0.e1" origId="P00734" charOffset="157-168" type="protein" text="prothrombin"/>
            <pair e1="DS3.d58.s0.e0" e2="DS3.d58.s0.e1" id="DS3.d58.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d59" origId="10022139">
        <sentence id="DS3.d59.s0" origId="10022139-1" text="BACKGROUND/PURPOSE: The proto-oncogene C-KIT encodes a receptor tyrosine kinase C-KIT.">
            <entity id="DS3.d59.s0.e0" origId="P05532,F7DD14" charOffset="39-44" type="protein" text="C-KIT"/>
            <entity id="DS3.d59.s0.e1" origId="6057,90983769" charOffset="64-72" type="compound" text="tyrosine"/>
            <entity id="DS3.d59.s0.e2" origId="P05532,F7DD14" charOffset="80-85" type="protein" text="C-KIT"/>
            <pair e1="DS3.d59.s0.e1" e2="DS3.d59.s0.e0" id="DS3.d59.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d60" origId="10022151">
        <sentence id="DS3.d60.s0" origId="10022151-10" text="The corresponding stimulated calcitonin levels were 45 to 417 (mean, 179) in CCH, 111 to 9,510 (mean, 1,407) in MTC-NED, and 449 to 5,093 (mean, 3,383) in MTC-REC.">
            <entity id="DS3.d60.s0.e0" origId="P06881,P01258" charOffset="29-39" type="protein" text="calcitonin"/>
            <entity id="DS3.d60.s0.e1" origId="P04629,X5DR71" charOffset="112-115" type="protein" text="MTC"/>
            <entity id="DS3.d60.s0.e2" origId="447806" charOffset="116-119" type="compound" text="NED"/>
            <entity id="DS3.d60.s0.e3" origId="P04629,X5DR71" charOffset="155-158" type="protein" text="MTC"/>
            <pair e1="DS3.d60.s0.e2" e2="DS3.d60.s0.e1" id="DS3.d60.s0.i0" interaction="False" />
            <pair e1="DS3.d60.s0.e2" e2="DS3.d60.s0.e0" id="DS3.d60.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d60.s1" origId="10022151-8" text="RESULTS: There was considerable overlap in both the basal and stimulated CT levels among the five children with CCH, the 13 with localized MTC (MTC-NED), and the four who later had recurrent MTC.">
            <entity id="DS3.d60.s1.e0" origId="P04629,X5DR71" charOffset="139-142" type="protein" text="MTC"/>
            <entity id="DS3.d60.s1.e1" origId="P04629,X5DR71" charOffset="144-147" type="protein" text="MTC"/>
            <entity id="DS3.d60.s1.e2" origId="447806" charOffset="148-151" type="compound" text="NED"/>
            <entity id="DS3.d60.s1.e3" origId="P04629,X5DR71" charOffset="144-147" type="protein" text="MTC"/>
            <pair e1="DS3.d60.s1.e2" e2="DS3.d60.s1.e0" id="DS3.d60.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d60.s2" origId="10022151-9" text="The basal calcitonin levels were between 25 and 110 (mean, 58) in the CCH patients, 30 to 1,130 (mean, 184) in the MTC-NED group, and 108 to 201 (mean, 140) in those with recurrent MTC.">
            <entity id="DS3.d60.s2.e0" origId="P06881,P01258" charOffset="10-20" type="protein" text="calcitonin"/>
            <entity id="DS3.d60.s2.e1" origId="P04629,X5DR71" charOffset="115-118" type="protein" text="MTC"/>
            <entity id="DS3.d60.s2.e2" origId="447806" charOffset="119-122" type="compound" text="NED"/>
            <entity id="DS3.d60.s2.e3" origId="P04629,X5DR71" charOffset="181-184" type="protein" text="MTC"/>
            <pair e1="DS3.d60.s2.e2" e2="DS3.d60.s2.e1" id="DS3.d60.s2.i0" interaction="False" />
            <pair e1="DS3.d60.s2.e2" e2="DS3.d60.s2.e0" id="DS3.d60.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d61" origId="10022175">
        <sentence id="DS3.d61.s0" origId="10022175-14" text="RESULTS: Meconium stimulation resulted in a significant increase in TNF-alpha compared with negative controls with a peak at 0.1% meconium (121 pg/mL v 11 pg/mL, P&amp;lt;.05).">
            <entity id="DS3.d61.s0.e0" origId="5288826" charOffset="9-17" type="compound" text="Meconium"/>
            <entity id="DS3.d61.s0.e1" origId="P01375,Q5STB3" charOffset="68-77" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d61.s0.e2" origId="5288826" charOffset="130-138" type="compound" text="meconium"/>
            <pair e1="DS3.d61.s0.e0" e2="DS3.d61.s0.e1" id="DS3.d61.s0.i0" interaction="False" />
            <pair e1="DS3.d61.s0.e2" e2="DS3.d61.s0.e1" id="DS3.d61.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d61.s1" origId="10022175-17" text="CONCLUSIONS: Sterile meconium results in a marked proinflammatory response in the peritoneal macrophage with elevations of both PCA and TNF-alpha.">
            <entity id="DS3.d61.s1.e0" origId="5288826" charOffset="21-29" type="compound" text="meconium"/>
            <entity id="DS3.d61.s1.e1" origId="P01375,Q5STB3" charOffset="136-145" type="protein" text="TNF-alpha"/>
            <pair e1="DS3.d61.s1.e0" e2="DS3.d61.s1.e1" id="DS3.d61.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d62" origId="10022193">
        <sentence id="DS3.d62.s0" origId="10022193-3" text="The nucleus accumbens contains two chemoarchitectonically different fields: a rostromedial field that stains heavily for substance P, dopamine, GABA(A) receptor, and a caudolateral field that stains only lightly to moderately for them, appearing more similar to the adjacent striatum.">
            <entity id="DS3.d62.s0.e0" origId="P20366,Q9Y494" charOffset="121-132" type="protein" text="substance P"/>
            <entity id="DS3.d62.s0.e1" origId="681" charOffset="134-142" type="compound" text="dopamine"/>
            <pair e1="DS3.d62.s0.e1" e2="DS3.d62.s0.e0" id="DS3.d62.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d63" origId="10022194">
        <sentence id="DS3.d63.s0" origId="10022194-2" text="For that purpose, the morphology and distribution of cells and fibers containing the calcium-binding proteins calbindin-D28k, parvalbumin, and calretinin were investigated by using immunohistochemical methods.">
            <entity id="DS3.d63.s0.e0" origId="22044544,5460341" charOffset="85-92" type="compound" text="calcium"/>
            <entity id="DS3.d63.s0.e1" origId="P05937" charOffset="110-119" type="protein" text="calbindin"/>
            <entity id="DS3.d63.s0.e2" origId="P22676,A6NER6" charOffset="126-153" type="protein" text="parvalbumin, and calretinin"/>
            <pair e1="DS3.d63.s0.e0" e2="DS3.d63.s0.e2" id="DS3.d63.s0.i0" interaction="False" />
            <pair e1="DS3.d63.s0.e0" e2="DS3.d63.s0.e1" id="DS3.d63.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d63.s1" origId="10022194-8" text="On the other hand, calbindin-containing neurons do not express GABA, and the possibility is discussed that these cells are projection neurons.">
            <entity id="DS3.d63.s1.e0" origId="P05937" charOffset="19-28" type="protein" text="calbindin"/>
            <entity id="DS3.d63.s1.e1" origId="119" charOffset="63-67" type="compound" text="GABA"/>
            <pair e1="DS3.d63.s1.e1" e2="DS3.d63.s1.e0" id="DS3.d63.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d64" origId="10022195">
        <sentence id="DS3.d64.s0" origId="10022195-2" text="In the peripheral nervous system, detectable expression of a beta-galactosidase transgene driven by the Talpha1 promoter (Talpha1:nlacZ) was coincident with neuronal birth dates, with the exception of sympathetic neuroblasts, which expressed the transgene prior to terminal mitosis.">
            <entity id="DS3.d64.s0.e0" origId="P23780,Q3TAW7" charOffset="61-79" type="protein" text="beta-galactosidase"/>
            <entity id="DS3.d64.s0.e1" origId="16130571" charOffset="104-111" type="compound" text="Talpha1"/>
            <entity id="DS3.d64.s0.e2" origId="16130571" charOffset="122-129" type="compound" text="Talpha1"/>
            <pair e1="DS3.d64.s0.e1" e2="DS3.d64.s0.e0" id="DS3.d64.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d64.s1" origId="10022195-8" text="Double-labeling studies showed that Talpha1:nlacZ expression was detectable in the same cells and at approximately the same time as was betaIII-tubulin, indicating that detectable transcription of the Talpha1 alpha-tubulin promoter commences at the time of terminal mitosis, at least in culture.">
            <entity id="DS3.d64.s1.e0" origId="16130571" charOffset="36-43" type="compound" text="Talpha1"/>
            <entity id="DS3.d64.s1.e1" origId="Q9ERD7" charOffset="136-151" type="protein" text="betaIII-tubulin"/>
            <entity id="DS3.d64.s1.e2" origId="P68369" charOffset="201-222" type="protein" text="Talpha1 alpha-tubulin"/>
            <pair e1="DS3.d64.s1.e0" e2="DS3.d64.s1.e2" id="DS3.d64.s1.i0" interaction="False" />
            <pair e1="DS3.d64.s1.e0" e2="DS3.d64.s1.e1" id="DS3.d64.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d65" origId="10022196">
        <sentence id="DS3.d65.s0" origId="10022196-4" text="Double immunocytochemistry showed that all Calbindin immunoreactive neurons in the deep plexiform layers were also gamma-aminobutyric acid immunoreactive.">
            <entity id="DS3.d65.s0.e0" origId="P05937" charOffset="43-52" type="protein" text="Calbindin"/>
            <entity id="DS3.d65.s0.e1" origId="119" charOffset="121-138" type="compound" text="aminobutyric acid"/>
            <pair e1="DS3.d65.s0.e1" e2="DS3.d65.s0.e0" id="DS3.d65.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d65.s1" origId="10022196-5" text="We consider them as a population of nonprincipal neurons different from those containing the calcium-binding proteins parvalbumin and calretinin.">
            <entity id="DS3.d65.s1.e0" origId="5460341,22044544" charOffset="93-100" type="compound" text="calcium"/>
            <entity id="DS3.d65.s1.e1" origId="P22676,A6NER6" charOffset="134-144" type="protein" text="calretinin"/>
            <pair e1="DS3.d65.s1.e0" e2="DS3.d65.s1.e1" id="DS3.d65.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d66" origId="10022197">
        <sentence id="DS3.d66.s0" origId="10022197-2" text="The conductance of these gap junctions seems to be regulated by dopamine acting through a cAMP-mediated cascade.">
            <entity id="DS3.d66.s0.e0" origId="681" charOffset="64-72" type="compound" text="dopamine"/>
            <entity id="DS3.d66.s0.e1" origId="P49913,J3KNB4" charOffset="90-94" type="protein" text="cAMP"/>
            <pair e1="DS3.d66.s0.e0" e2="DS3.d66.s0.e1" id="DS3.d66.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d67" origId="10022198">
        <sentence id="DS3.d67.s0" origId="10022198-2" text="We conducted immunocytochemical analyses by using antisera directed against gamma-aminobutyric acid (GABA), its synthetic enzyme glutamic acid decarboxylase (GAD67), GABA-A receptor subunits (alpha2, beta3, epsilon), estrogen receptor-alpha, and Neuropeptide Y (NPY) in the region of the VMH in embryonic mice to identify potential patterning elements for VMH formation.">
            <entity id="DS3.d67.s0.e0" origId="119" charOffset="82-99" type="compound" text="aminobutyric acid"/>
            <entity id="DS3.d67.s0.e1" origId="33032" charOffset="129-142" type="compound" text="glutamic acid"/>
            <entity id="DS3.d67.s0.e2" origId="P48318,Q548L6,D3Z1L8" charOffset="158-163" type="protein" text="GAD67"/>
            <entity id="DS3.d67.s0.e3" origId="P57774" charOffset="246-260" type="protein" text="Neuropeptide Y"/>
            <entity id="DS3.d67.s0.e4" origId="P57774" charOffset="262-265" type="protein" text="NPY"/>
            <pair e1="DS3.d67.s0.e0" e2="DS3.d67.s0.e2" id="DS3.d67.s0.i0" interaction="False" />
            <pair e1="DS3.d67.s0.e0" e2="DS3.d67.s0.e4" id="DS3.d67.s0.i1" interaction="False" />
            <pair e1="DS3.d67.s0.e0" e2="DS3.d67.s0.e3" id="DS3.d67.s0.i2" interaction="False" />
            <pair e1="DS3.d67.s0.e1" e2="DS3.d67.s0.e2" id="DS3.d67.s0.i3" interaction="False" />
            <pair e1="DS3.d67.s0.e1" e2="DS3.d67.s0.e4" id="DS3.d67.s0.i4" interaction="False" />
            <pair e1="DS3.d67.s0.e1" e2="DS3.d67.s0.e3" id="DS3.d67.s0.i5" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d68" origId="10022202">
        <sentence id="DS3.d68.s0" origId="10022202-4" text="The limit of detection was 0.1 ng/mg for cannabinol (CBN) and delta9-tetrahydrocannabinol (THC) and 0.2 ng/mg for cannabidiol (CBD).">
            <entity id="DS3.d68.s0.e0" origId="2543" charOffset="41-51" type="compound" text="cannabinol"/>
            <entity id="DS3.d68.s0.e1" origId="16078" charOffset="62-89" type="compound" text="delta9-tetrahydrocannabinol"/>
            <entity id="DS3.d68.s0.e2" origId="P42768,A0A024QYX8" charOffset="91-94" type="protein" text="THC"/>
            <pair e1="DS3.d68.s0.e1" e2="DS3.d68.s0.e2" id="DS3.d68.s0.i0" interaction="False" />
            <pair e1="DS3.d68.s0.e0" e2="DS3.d68.s0.e2" id="DS3.d68.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d69" origId="10022218">
        <sentence id="DS3.d69.s0" origId="10022218-7" text="The immunoexpression of p53 protein (60%) and rate of K-ras point mutation (84%) were also higher in the PTAH-positive group.">
            <entity id="DS3.d69.s0.e0" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="24-27" type="protein" text="p53"/>
            <entity id="DS3.d69.s0.e1" origId="P01116,L7RSL8,A0A024RAV5,I1SRC5" charOffset="54-59" type="protein" text="K-ras"/>
            <entity id="DS3.d69.s0.e2" origId="15914" charOffset="105-109" type="compound" text="PTAH"/>
            <pair e1="DS3.d69.s0.e2" e2="DS3.d69.s0.e1" id="DS3.d69.s0.i0" interaction="False" />
            <pair e1="DS3.d69.s0.e2" e2="DS3.d69.s0.e0" id="DS3.d69.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d70" origId="10022223">
        <sentence id="DS3.d70.s0" origId="10022223-3" text="Messenger RNA of carcinoembryonic antigen (CEA) was clearly demonstrated in CSF by reverse RT-PCR methods.">
            <entity id="DS3.d70.s0.e0" origId="P06731,A0A024R0K5,Q53G30" charOffset="17-41" type="protein" text="carcinoembryonic antigen"/>
            <entity id="DS3.d70.s0.e1" origId="P06731,A0A024R0K5,Q53G30" charOffset="43-46" type="protein" text="CEA"/>
            <entity id="DS3.d70.s0.e2" origId="16122568,16750043,4369303,448383" charOffset="76-79" type="compound" text="CSF"/>
            <pair e1="DS3.d70.s0.e2" e2="DS3.d70.s0.e0" id="DS3.d70.s0.i0" interaction="False" />
            <pair e1="DS3.d70.s0.e2" e2="DS3.d70.s0.e1" id="DS3.d70.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d71" origId="10022227">
        <sentence id="DS3.d71.s0" origId="10022227-2" text="The enterotoxic antimetabolite 5-fluorouracil (5-FU) induced acute p53-dependent apoptosis in the crypts of both small intestine and midcolon.">
            <entity id="DS3.d71.s0.e0" origId="3385" charOffset="33-45" type="compound" text="fluorouracil"/>
            <entity id="DS3.d71.s0.e1" origId="P02340,Q80ZA1,Q549C9,Q3UGQ1" charOffset="67-70" type="protein" text="p53"/>
            <pair e1="DS3.d71.s0.e0" e2="DS3.d71.s0.e1" id="DS3.d71.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d71.s1" origId="10022227-9" text="Importantly, the tissue toxicity of 5-fluorouracil was genetically determined at a locus (p53) separate from that directly associated with toxin action.">
            <entity id="DS3.d71.s1.e0" origId="3385" charOffset="38-50" type="compound" text="fluorouracil"/>
            <entity id="DS3.d71.s1.e1" origId="P02340,Q80ZA1,Q549C9,Q3UGQ1" charOffset="90-93" type="protein" text="p53"/>
            <pair e1="DS3.d71.s1.e0" e2="DS3.d71.s1.e1" id="DS3.d71.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d72" origId="10022232">
        <sentence id="DS3.d72.s0" origId="10022232-2" text="In this way AGT protects cells from the mutagenic and cytotoxic effects of O6-alkylguanine-type lesions such as O6-methylguanine (O6-meG), an observation which has during recent years been confirmed by studies in transgenic animals either over-expressing or completely lacking this activity.">
            <entity id="DS3.d72.s0.e0" origId="P01019,B0ZBE2,B2R5S1" charOffset="12-15" type="protein" text="AGT"/>
            <entity id="DS3.d72.s0.e1" origId="24828" charOffset="115-128" type="compound" text="methylguanine"/>
            <pair e1="DS3.d72.s0.e1" e2="DS3.d72.s0.e0" id="DS3.d72.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d73" origId="10022233">
        <sentence id="DS3.d73.s0" origId="10022233-6" text="Both CB1 and CB2 negatively regulate adenylate cyclase activity through a pertussis toxin sensitive GTP-binding protein.">
            <entity id="DS3.d73.s0.e0" origId="P21554,V5KA96,S5TLS4" charOffset="5-8" type="protein" text="CB1"/>
            <entity id="DS3.d73.s0.e1" origId="P34972,A0A024RAH7" charOffset="13-16" type="protein" text="CB2"/>
            <entity id="DS3.d73.s0.e2" origId="6083" charOffset="37-46" type="compound" text="adenylate"/>
            <entity id="DS3.d73.s0.e3" origId="6830" charOffset="100-103" type="compound" text="GTP"/>
            <pair e1="DS3.d73.s0.e3" e2="DS3.d73.s0.e1" id="DS3.d73.s0.i0" interaction="False" />
            <pair e1="DS3.d73.s0.e3" e2="DS3.d73.s0.e0" id="DS3.d73.s0.i1" interaction="False" />
            <pair e1="DS3.d73.s0.e2" e2="DS3.d73.s0.e1" id="DS3.d73.s0.i2" interaction="False" />
            <pair e1="DS3.d73.s0.e2" e2="DS3.d73.s0.e0" id="DS3.d73.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d73.s1" origId="10022233-7" text="Recent investigations addressing the mechanism by which cannabinoids disrupt leukocyte function have demonstrated that in the presence of cannabinoids the cAMP signaling cascade is markedly inhibited as evidenced by decreased adenylate cyclase and protein kinase A activity and decreased DNA binding by cAMP response element binding proteins.">
            <entity id="DS3.d73.s1.e0" origId="P49913,J3KNB4" charOffset="155-159" type="protein" text="cAMP"/>
            <entity id="DS3.d73.s1.e1" origId="6083" charOffset="226-235" type="compound" text="adenylate"/>
            <entity id="DS3.d73.s1.e2" origId="P49913,J3KNB4" charOffset="303-307" type="protein" text="cAMP"/>
            <pair e1="DS3.d73.s1.e1" e2="DS3.d73.s1.e0" id="DS3.d73.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d74" origId="10022234">
        <sentence id="DS3.d74.s0" origId="10022234-6" text="Koningic acid (KO), a chemical modifier and enzyme inhibitor of glyceraldehyde-3 phosphate dehydrogenase (GAPDH), induced the apoptosis too.">
            <entity id="DS3.d74.s0.e0" origId="124361" charOffset="0-13" type="compound" text="Koningic acid"/>
            <entity id="DS3.d74.s0.e1" origId="P04797" charOffset="64-104" type="protein" text="glyceraldehyde-3 phosphate dehydrogenase"/>
            <entity id="DS3.d74.s0.e2" origId="P04797" charOffset="106-111" type="protein" text="GAPDH"/>
            <pair e1="DS3.d74.s0.e0" e2="DS3.d74.s0.e2" id="DS3.d74.s0.i0" interaction="False" />
            <pair e1="DS3.d74.s0.e0" e2="DS3.d74.s0.e1" id="DS3.d74.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d75" origId="10022236">
        <sentence id="DS3.d75.s0" origId="10022236-4" text="Treatment of PMA resulted in the recovery of IQ-induced suppression of IL-2 production, but the addition of ionomycin (Io) had no effect.">
            <entity id="DS3.d75.s0.e0" origId="22833501,27924,4792,122634" charOffset="13-16" type="compound" text="PMA"/>
            <entity id="DS3.d75.s0.e1" origId="P04351" charOffset="71-75" type="protein" text="IL-2"/>
            <entity id="DS3.d75.s0.e2" origId="25134244,3733,5353687,6434517,6912226" charOffset="108-117" type="compound" text="ionomycin"/>
            <pair e1="DS3.d75.s0.e2" e2="DS3.d75.s0.e1" id="DS3.d75.s0.i0" interaction="False" />
            <pair e1="DS3.d75.s0.e0" e2="DS3.d75.s0.e1" id="DS3.d75.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d76" origId="10022238">
        <sentence id="DS3.d76.s0" origId="10022238-9" text="When introduced into primary rat liver cell cultures by transient transfection, hPPAR alpha-6/29 prevented the suppression of hepatocyte apoptosis by the PP nafenopin, but not that seen in response to phenobarbitone (PB), a non-genotoxic carcinogen whose action does not involve PPAR alpha.">
            <entity id="DS3.d76.s0.e0" origId="Q07869,F1D8S4" charOffset="80-96" type="protein" text="hPPAR alpha-6/29"/>
            <entity id="DS3.d76.s0.e1" origId="19592" charOffset="157-166" type="compound" text="nafenopin"/>
            <entity id="DS3.d76.s0.e2" origId="4763" charOffset="201-215" type="compound" text="phenobarbitone"/>
            <entity id="DS3.d76.s0.e3" origId="Q07869,F1D8S4" charOffset="81-91" type="protein" text="PPAR alpha"/>
            <pair e1="DS3.d76.s0.e1" e2="DS3.d76.s0.e0" id="DS3.d76.s0.i0" interaction="False" />
            <pair e1="DS3.d76.s0.e1" e2="DS3.d76.s0.e3" id="DS3.d76.s0.i1" interaction="False" />
            <pair e1="DS3.d76.s0.e2" e2="DS3.d76.s0.e0" id="DS3.d76.s0.i2" interaction="False" />
            <pair e1="DS3.d76.s0.e2" e2="DS3.d76.s0.e3" id="DS3.d76.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d77" origId="10022243">
        <sentence id="DS3.d77.s0" origId="10022243-3" text="The caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.fmk) blocked the activation of caspases, PS exposure and the reduction in delta psi(m) as well as the morphological changes associated with apoptosis but it did not inhibit the release of mitochondrial cytochrome c.">
            <entity id="DS3.d77.s0.e0" origId="7708" charOffset="23-40" type="compound" text="benzyloxycarbonyl"/>
            <entity id="DS3.d77.s0.e1" origId="4348752" charOffset="72-78" type="compound" text="ketone"/>
            <entity id="DS3.d77.s0.e2" origId="P99999,G4XXL9" charOffset="288-300" type="protein" text="cytochrome c"/>
            <pair e1="DS3.d77.s0.e1" e2="DS3.d77.s0.e2" id="DS3.d77.s0.i0" interaction="False" />
            <pair e1="DS3.d77.s0.e0" e2="DS3.d77.s0.e2" id="DS3.d77.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d78" origId="10022268">
        <sentence id="DS3.d78.s0" origId="10022268-7" text="This response is time-dependent and correlated with expression of inducible nitric oxide synthase (NOS II) protein and mRNA.">
            <entity id="DS3.d78.s0.e0" origId="145068" charOffset="76-88" type="compound" text="nitric oxide"/>
            <entity id="DS3.d78.s0.e1" origId="P35228" charOffset="99-105" type="protein" text="NOS II"/>
            <pair e1="DS3.d78.s0.e0" e2="DS3.d78.s0.e1" id="DS3.d78.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d79" origId="10022279">
        <sentence id="DS3.d79.s0" origId="10022279-3" text="In vitro studies, using retinas incubated in Ca2+ and/or Pb2+, demonstrate that rods selectively die by apoptosis, retinal mitochondrial ATP synthesis is decreased, mitochondrial cytochrome c is released and caspase activity is increased.">
            <entity id="DS3.d79.s0.e0" origId="638015" charOffset="115-122" type="compound" text="retinal"/>
            <entity id="DS3.d79.s0.e1" origId="5957" charOffset="137-140" type="compound" text="ATP"/>
            <entity id="DS3.d79.s0.e2" origId="P99999,G4XXL9" charOffset="179-191" type="protein" text="cytochrome c"/>
            <pair e1="DS3.d79.s0.e0" e2="DS3.d79.s0.e2" id="DS3.d79.s0.i0" interaction="False" />
            <pair e1="DS3.d79.s0.e1" e2="DS3.d79.s0.e2" id="DS3.d79.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d80" origId="10022280">
        <sentence id="DS3.d80.s0" origId="10022280-6" text="Induction of an immediate early gene, c-fos, is seen in neuronal cells exposed to glutamate or lead.">
            <entity id="DS3.d80.s0.e0" origId="P01100,Q6FG41" charOffset="38-43" type="protein" text="c-fos"/>
            <entity id="DS3.d80.s0.e1" origId="23327,33032,611,57109091" charOffset="82-91" type="compound" text="glutamate"/>
            <pair e1="DS3.d80.s0.e1" e2="DS3.d80.s0.e0" id="DS3.d80.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d80.s1" origId="10022280-7" text="Immediate early genes are important in regulating the expression of other neuronal genes; Elevated expressions of the genes encoding Hsp70 or cyclo-oxygenase-2 seem to be involved in the apoptosis or necrosis induced by glutamate, and may be associated with induction of several of the genes in cells exposed to lead, or to the glutamate-lead combination.">
            <entity id="DS3.d80.s1.e0" origId="P35354" charOffset="142-159" type="protein" text="cyclo-oxygenase-2"/>
            <entity id="DS3.d80.s1.e1" origId="23327,33032,611,57109091" charOffset="220-229" type="compound" text="glutamate"/>
            <entity id="DS3.d80.s1.e2" origId="23327,33032,611,57109091" charOffset="328-337" type="compound" text="glutamate"/>
            <pair e1="DS3.d80.s1.e1" e2="DS3.d80.s1.e0" id="DS3.d80.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d81" origId="10022281">
        <sentence id="DS3.d81.s0" origId="10022281-4" text="Antioxidants inhibited the inflammation in the early stage and cyclooxygenase inhibitors did in both the early and later stages, whereas 5-lipoxygenase inhibitors or histamine antagonists had no effect.">
            <entity id="DS3.d81.s0.e0" origId="P48999" charOffset="137-151" type="protein" text="5-lipoxygenase"/>
            <entity id="DS3.d81.s0.e1" origId="774" charOffset="166-175" type="compound" text="histamine"/>
            <pair e1="DS3.d81.s0.e1" e2="DS3.d81.s0.e0" id="DS3.d81.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d81.s1" origId="10022281-8" text="The PGE2 release was inhibited by cyclooxygenase inhibitors, antioxidants, protein kinase C (PKC) inhibitors and a tyrosine kinase (TK) inhibitor, but not by antibodies against tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1).">
            <entity id="DS3.d81.s1.e0" origId="6057,90983769" charOffset="115-123" type="compound" text="tyrosine"/>
            <entity id="DS3.d81.s1.e1" origId="P06804,Q3U593" charOffset="177-204" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d81.s1.e2" origId="P06804,Q3U593" charOffset="206-215" type="protein" text="TNF alpha"/>
            <pair e1="DS3.d81.s1.e0" e2="DS3.d81.s1.e1" id="DS3.d81.s1.i0" interaction="False" />
            <pair e1="DS3.d81.s1.e0" e2="DS3.d81.s1.e2" id="DS3.d81.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d81.s2" origId="10022281-9" text="These results lead to a hypothesis that reactive oxygen species generated from quinolones under UVA irradiation trigger PG release from dermal fibroblasts via PKC and TK activation, resulting in skin inflammation and that 5-lipoxygenase products, histamine, TNF alpha or IL-1 is ruled out from the mechanism.">
            <entity id="DS3.d81.s2.e0" origId="977" charOffset="49-55" type="compound" text="oxygen"/>
            <entity id="DS3.d81.s2.e1" origId="3036108" charOffset="79-89" type="compound" text="quinolones"/>
            <entity id="DS3.d81.s2.e2" origId="P48999" charOffset="222-236" type="protein" text="5-lipoxygenase"/>
            <entity id="DS3.d81.s2.e3" origId="774" charOffset="247-256" type="compound" text="histamine"/>
            <entity id="DS3.d81.s2.e4" origId="P06804,Q3U593" charOffset="258-267" type="protein" text="TNF alpha"/>
            <pair e1="DS3.d81.s2.e3" e2="DS3.d81.s2.e2" id="DS3.d81.s2.i0" interaction="False" />
            <pair e1="DS3.d81.s2.e3" e2="DS3.d81.s2.e4" id="DS3.d81.s2.i1" interaction="False" />
            <pair e1="DS3.d81.s2.e0" e2="DS3.d81.s2.e2" id="DS3.d81.s2.i2" interaction="False" />
            <pair e1="DS3.d81.s2.e0" e2="DS3.d81.s2.e4" id="DS3.d81.s2.i3" interaction="False" />
            <pair e1="DS3.d81.s2.e1" e2="DS3.d81.s2.e2" id="DS3.d81.s2.i4" interaction="False" />
            <pair e1="DS3.d81.s2.e1" e2="DS3.d81.s2.e4" id="DS3.d81.s2.i5" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d82" origId="10022303">
        <sentence id="DS3.d82.s0" origId="10022303-4" text="The testicular expression of RIP and FAP-1, components of the Fas activating complex, increased after exposure to mono-(2-ethylhexyl)phthalate (MEHP), a Sertoli cell toxicant which induces massive germ cell death.">
            <entity id="DS3.d82.s0.e0" origId="P52594" charOffset="29-32" type="protein" text="RIP"/>
            <entity id="DS3.d82.s0.e1" origId="Q12923" charOffset="37-42" type="protein" text="FAP-1"/>
            <entity id="DS3.d82.s0.e2" origId="1017" charOffset="133-142" type="compound" text="phthalate"/>
            <entity id="DS3.d82.s0.e3" origId="20393" charOffset="144-148" type="compound" text="MEHP"/>
            <pair e1="DS3.d82.s0.e2" e2="DS3.d82.s0.e1" id="DS3.d82.s0.i0" interaction="False" />
            <pair e1="DS3.d82.s0.e2" e2="DS3.d82.s0.e0" id="DS3.d82.s0.i1" interaction="False" />
            <pair e1="DS3.d82.s0.e3" e2="DS3.d82.s0.e1" id="DS3.d82.s0.i2" interaction="False" />
            <pair e1="DS3.d82.s0.e3" e2="DS3.d82.s0.e0" id="DS3.d82.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d83" origId="10022304">
        <sentence id="DS3.d83.s0" origId="10022304-2" text="Their acute toxic effect in the central and peripheral nervous system is due to inhibition of acetylcholinesterase (AChE) at nerve endings which causes accumulation of acetylcholine and consequently overstimulation of the nicotinic and muscarinic receptors.">
            <entity id="DS3.d83.s0.e0" origId="P22303" charOffset="116-120" type="protein" text="AChE"/>
            <entity id="DS3.d83.s0.e1" origId="187" charOffset="94-107" type="compound" text="acetylcholine"/>
            <pair e1="DS3.d83.s0.e1" e2="DS3.d83.s0.e0" id="DS3.d83.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d84" origId="10022319">
        <sentence id="DS3.d84.s0" origId="10022319-6" text="In the current study we investigated the status of CYP, glutathione S-transferases (GST) and antioxidant enzymes in mice carrying only the X gene under the control of the alpha-1 antitrypsin regulatory elements (ATX mice).">
            <entity id="DS3.d84.s0.e0" origId="124886,20725278,745" charOffset="56-67" type="compound" text="glutathione"/>
            <entity id="DS3.d84.s0.e1" origId="Q9R1E6,G3UXY9" charOffset="212-215" type="protein" text="ATX"/>
            <pair e1="DS3.d84.s0.e0" e2="DS3.d84.s0.e1" id="DS3.d84.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d84.s1" origId="10022319-8" text="Immunohistochemical staining for CYP1A, 2A5 and GST expression and determination of related enzymatic activities (7-ethoxyresorufin O-deethylation, 7-methoxyresorufin O-deethylation, coumarin 7-hydroxylation and GST activities) revealed no differences between control and ATX mice.">
            <entity id="DS3.d84.s1.e0" origId="44626338" charOffset="40-43" type="compound" text="2A5"/>
            <entity id="DS3.d84.s1.e1" origId="3294" charOffset="114-131" type="compound" text="7-ethoxyresorufin"/>
            <entity id="DS3.d84.s1.e2" origId="119220" charOffset="150-166" type="compound" text="methoxyresorufin"/>
            <entity id="DS3.d84.s1.e3" origId="323" charOffset="183-191" type="compound" text="coumarin"/>
            <entity id="DS3.d84.s1.e4" origId="Q9R1E6,G3UXY9" charOffset="272-275" type="protein" text="ATX"/>
            <pair e1="DS3.d84.s1.e3" e2="DS3.d84.s1.e4" id="DS3.d84.s1.i0" interaction="False" />
            <pair e1="DS3.d84.s1.e0" e2="DS3.d84.s1.e4" id="DS3.d84.s1.i1" interaction="False" />
            <pair e1="DS3.d84.s1.e1" e2="DS3.d84.s1.e4" id="DS3.d84.s1.i2" interaction="False" />
            <pair e1="DS3.d84.s1.e2" e2="DS3.d84.s1.e4" id="DS3.d84.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d85" origId="10022320">
        <sentence id="DS3.d85.s0" origId="10022320-2" text="Two genetic alterations have been identified: the first one is a GGC --&amp;gt; GAT (Gly --&amp;gt; Asp, Asp13p21) mutation at codon 13 in the Ki-ras gene, found in five out of six tumors.">
            <entity id="DS3.d85.s0.e0" origId="449471" charOffset="65-68" type="compound" text="GGC"/>
            <entity id="DS3.d85.s0.e1" origId="Q6IB77" charOffset="76-79" type="protein" text="GAT"/>
            <entity id="DS3.d85.s0.e2" origId="P01116,L7RSL8,A0A024RAV5,I1SRC5" charOffset="135-141" type="protein" text="Ki-ras"/>
            <pair e1="DS3.d85.s0.e0" e2="DS3.d85.s0.e1" id="DS3.d85.s0.i0" interaction="False" />
            <pair e1="DS3.d85.s0.e0" e2="DS3.d85.s0.e2" id="DS3.d85.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d86" origId="10022322">
        <sentence id="DS3.d86.s0" origId="10022322-5" text="Two recent examples (an EPA testing prioritization exercise for water disinfection byproducts and a regulatory action on 2,4,6-tribromophenol) illustrate issues involved in regulatory applications of SAR and commercial prediction systems.">
            <entity id="DS3.d86.s0.e0" origId="P01033,Q6FGX5,B4DJK3" charOffset="24-27" type="protein" text="EPA"/>
            <entity id="DS3.d86.s0.e1" origId="962" charOffset="64-69" type="compound" text="water"/>
            <entity id="DS3.d86.s0.e2" origId="1483" charOffset="121-141" type="compound" text="2,4,6-tribromophenol"/>
            <pair e1="DS3.d86.s0.e1" e2="DS3.d86.s0.e0" id="DS3.d86.s0.i0" interaction="False" />
            <pair e1="DS3.d86.s0.e2" e2="DS3.d86.s0.e0" id="DS3.d86.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d87" origId="10022329">
        <sentence id="DS3.d87.s0" origId="10022329-3" text="Phosphates (P=O) are biologically active as AChE inhibitors, whereas phosphorothioates (P=S) need bioactivation to their phosphate anologues (oxons) to become biologically active.">
            <entity id="DS3.d87.s0.e0" origId="P22303" charOffset="44-48" type="protein" text="AChE"/>
            <entity id="DS3.d87.s0.e1" origId="167704,644102,1061" charOffset="121-130" type="compound" text="phosphate"/>
            <pair e1="DS3.d87.s0.e1" e2="DS3.d87.s0.e0" id="DS3.d87.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d87.s1" origId="10022329-4" text="Oxons inhibit AChE by phosphorylation of the serine hydroxyl group in the substrate-binding domain of the enzyme.">
            <entity id="DS3.d87.s1.e0" origId="P22303" charOffset="14-18" type="protein" text="AChE"/>
            <entity id="DS3.d87.s1.e1" origId="5951" charOffset="45-51" type="compound" text="serine"/>
            <pair e1="DS3.d87.s1.e1" e2="DS3.d87.s1.e0" id="DS3.d87.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d88" origId="10022330">
        <sentence id="DS3.d88.s0" origId="10022330-9" text="Transferrin capacity is saturated after the absorption of a toxic dose resulting in much of the circulating iron being hydrated ferric ion.">
            <entity id="DS3.d88.s0.e0" origId="P02787,Q06AH7,A0PJA6" charOffset="0-11" type="protein" text="Transferrin"/>
            <entity id="DS3.d88.s0.e1" origId="23925,67172434" charOffset="108-112" type="compound" text="iron"/>
            <entity id="DS3.d88.s0.e2" origId="29936" charOffset="128-138" type="compound" text="ferric ion"/>
            <pair e1="DS3.d88.s0.e2" e2="DS3.d88.s0.e0" id="DS3.d88.s0.i0" interaction="False" />
            <pair e1="DS3.d88.s0.e1" e2="DS3.d88.s0.e0" id="DS3.d88.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d89" origId="10022335">
        <sentence id="DS3.d89.s0" origId="10022335-0" text="Localization of nicotinamide adenine dinucleotide phosphate-diaphorase reactivity and nitric oxide synthase immunoreactivity in the lumbosacral dorsal root ganglia in guinea pigs.">
            <entity id="DS3.d89.s0.e0" origId="5886,929,44415116" charOffset="16-59" type="compound" text="nicotinamide adenine dinucleotide phosphate"/>
            <entity id="DS3.d89.s0.e1" origId="O54705" charOffset="86-107" type="protein" text="nitric oxide synthase"/>
            <pair e1="DS3.d89.s0.e0" e2="DS3.d89.s0.e1" id="DS3.d89.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s1" origId="10022335-1" text="This study examined the distribution of reduced nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) reactivity and nitric oxide synthase (NOS) immunoreactivity in the lumbosacral dorsal root ganglia (DRG) in male guinea pigs.">
            <entity id="DS3.d89.s1.e0" origId="5886,929,44415116" charOffset="48-91" type="compound" text="nicotinamide adenine dinucleotide phosphate"/>
            <entity id="DS3.d89.s1.e1" origId="57369863" charOffset="104-111" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s1.e2" origId="O54705" charOffset="128-149" type="protein" text="nitric oxide synthase"/>
            <entity id="DS3.d89.s1.e3" origId="O54705" charOffset="151-154" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s1.e1" e2="DS3.d89.s1.e2" id="DS3.d89.s1.i0" interaction="False" />
            <pair e1="DS3.d89.s1.e1" e2="DS3.d89.s1.e3" id="DS3.d89.s1.i1" interaction="False" />
            <pair e1="DS3.d89.s1.e0" e2="DS3.d89.s1.e2" id="DS3.d89.s1.i2" interaction="False" />
            <pair e1="DS3.d89.s1.e0" e2="DS3.d89.s1.e3" id="DS3.d89.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s2" origId="10022335-2" text="A differential distribution of NADPH-d reactivity and NOS immunoreactivity was detected in neurons of DRG at different segmental levels.">
            <entity id="DS3.d89.s2.e0" origId="57369863" charOffset="31-38" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s2.e1" origId="O54705" charOffset="54-57" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s2.e0" e2="DS3.d89.s2.e1" id="DS3.d89.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s3" origId="10022335-3" text="There were numerically more intensely stained NADPH-d and NOS reactive cells in the rostral (L1-L3) DRG compared with those at the caudal (L6-S4) levels.">
            <entity id="DS3.d89.s3.e0" origId="57369863" charOffset="46-53" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s3.e1" origId="O54705" charOffset="58-61" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s3.e0" e2="DS3.d89.s3.e1" id="DS3.d89.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s4" origId="10022335-4" text="In the corresponding DRG, NADPH-d reactivity was not paralleled by NOS immunoreactivity.">
            <entity id="DS3.d89.s4.e0" origId="57369863" charOffset="26-33" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s4.e1" origId="O54705" charOffset="67-70" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s4.e0" e2="DS3.d89.s4.e1" id="DS3.d89.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s5" origId="10022335-5" text="This was evidenced by the wide distribution of afferent neurons in the lumbosacral DRG stained for NADPH-d, yet only a small number of them exhibited NOS immunoreactivity.">
            <entity id="DS3.d89.s5.e0" origId="57369863" charOffset="99-106" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s5.e1" origId="O54705" charOffset="150-153" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s5.e0" e2="DS3.d89.s5.e1" id="DS3.d89.s5.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s6" origId="10022335-6" text="Double labelling study has shown that some of the NADPH-d positive neurons were NOS negative.">
            <entity id="DS3.d89.s6.e0" origId="57369863" charOffset="50-57" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s6.e1" origId="O54705" charOffset="80-83" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s6.e0" e2="DS3.d89.s6.e1" id="DS3.d89.s6.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s7" origId="10022335-7" text="Ultrastructurally, NADPH-d reaction product was associated with the membranes of various subcellular organelles, including the rough endoplasmic reticulum (rER), Golgi saccules, mitochondria and some segments of the nuclear envelop, whereas NOS immune-precipitate was patchily distributed throughout the cytoplasm.">
            <entity id="DS3.d89.s7.e0" origId="57369863" charOffset="19-26" type="compound" text="NADPH-d"/>
            <entity id="DS3.d89.s7.e1" origId="O54705" charOffset="241-244" type="protein" text="NOS"/>
            <pair e1="DS3.d89.s7.e0" e2="DS3.d89.s7.e1" id="DS3.d89.s7.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d89.s8" origId="10022335-9" text="On the other hand, in view of their marked disparity in numbers and the lack of total one-to-one correspondence, it seems likely that the NOS positive neurons represent only a subpopulation of the NADPH-d positive cells in the lumbosacral DRG.">
            <entity id="DS3.d89.s8.e0" origId="O54705" charOffset="138-141" type="protein" text="NOS"/>
            <entity id="DS3.d89.s8.e1" origId="57369863" charOffset="197-204" type="compound" text="NADPH-d"/>
            <pair e1="DS3.d89.s8.e1" e2="DS3.d89.s8.e0" id="DS3.d89.s8.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d90" origId="10022336">
        <sentence id="DS3.d90.s0" origId="10022336-5" text="Some SPR-LI neurons were also positive for tyrosine hydroxylase-like immunoreactivity (TH-LI) .">
            <entity id="DS3.d90.s0.e0" origId="P18297,B2RYK3" charOffset="5-8" type="protein" text="SPR"/>
            <entity id="DS3.d90.s0.e1" origId="6057,90983769" charOffset="43-51" type="compound" text="tyrosine"/>
            <pair e1="DS3.d90.s0.e1" e2="DS3.d90.s0.e0" id="DS3.d90.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d90.s1" origId="10022336-6" text="After administration of vasopressin SPR-LI structures became denser, especially at levels of pyramidal decussation (PYX) and area postrema (AP).">
            <entity id="DS3.d90.s1.e0" origId="P18297,B2RYK3" charOffset="36-39" type="protein" text="SPR"/>
            <entity id="DS3.d90.s1.e1" origId="18648446" charOffset="93-102" type="compound" text="pyramidal"/>
            <entity id="DS3.d90.s1.e2" origId="14597089" charOffset="116-119" type="compound" text="PYX"/>
            <pair e1="DS3.d90.s1.e2" e2="DS3.d90.s1.e0" id="DS3.d90.s1.i0" interaction="False" />
            <pair e1="DS3.d90.s1.e1" e2="DS3.d90.s1.e0" id="DS3.d90.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d91" origId="10022344">
        <sentence id="DS3.d91.s0" origId="10022344-1" text="The present study examined the effect of maternal administration of dexamethasone (DEX) on amoeboid microglial cells (AMC) in fetal rats extending from 16 to 20 days postconception (E16 to E20).">
            <entity id="DS3.d91.s0.e0" origId="5743" charOffset="68-81" type="compound" text="dexamethasone"/>
            <entity id="DS3.d91.s0.e1" origId="Q63016" charOffset="182-185" type="protein" text="E16"/>
            <entity id="DS3.d91.s0.e2" origId="1150567" charOffset="189-192" type="compound" text="E20"/>
            <pair e1="DS3.d91.s0.e2" e2="DS3.d91.s0.e1" id="DS3.d91.s0.i0" interaction="False" />
            <pair e1="DS3.d91.s0.e0" e2="DS3.d91.s0.e1" id="DS3.d91.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d91.s1" origId="10022344-7" text="The number of GSA I-B4 labelled AMC was significantly increased at E16, declined at E18 and remained constant thereafter in DEX-treated rats when compared with that of the controls.">
            <entity id="DS3.d91.s1.e0" origId="5288473" charOffset="14-17" type="compound" text="GSA"/>
            <entity id="DS3.d91.s1.e1" origId="Q63016" charOffset="67-70" type="protein" text="E16"/>
            <pair e1="DS3.d91.s1.e0" e2="DS3.d91.s1.e1" id="DS3.d91.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d91.s2" origId="10022344-8" text="A major finding after DEX treatment was the wider occurrence of AMC double labelled with anti-BrdU antibody and GSA I-B4 or OX-42 at E16 compared with those in the controls suggesting that the initial increase of GSA I-B4 labelled AMC may be attributed to their proliferation.">
            <entity id="DS3.d91.s2.e0" origId="5288473" charOffset="112-115" type="compound" text="GSA"/>
            <entity id="DS3.d91.s2.e1" origId="Q63016" charOffset="133-136" type="protein" text="E16"/>
            <entity id="DS3.d91.s2.e2" origId="5288473" charOffset="213-216" type="compound" text="GSA"/>
            <pair e1="DS3.d91.s2.e0" e2="DS3.d91.s2.e1" id="DS3.d91.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d92" origId="10022345">
        <sentence id="DS3.d92.s0" origId="10022345-0" text="Temporal changes of preproenkephalin mRNA and leu-enkephalin-like immunoreactivity in the neurons of the caudal spinal trigeminal nucleus and upper cervical cord after noxious stimuli.">
            <entity id="DS3.d92.s0.e0" origId="P01210,A0A024R7V4" charOffset="20-36" type="protein" text="preproenkephalin"/>
            <entity id="DS3.d92.s0.e1" origId="57282044" charOffset="46-60" type="compound" text="leu-enkephalin"/>
            <pair e1="DS3.d92.s0.e1" e2="DS3.d92.s0.e0" id="DS3.d92.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d92.s1" origId="10022345-1" text="The changing levels of preproenkephalin (PPE) mRNA expression and leu-enkephalin-like immunoreactivity (L-ENK-LI) in the caudal spinal trigeminal nucleus (Vc) and the upper cervical cord subsequent to subcutaneous injection of formalin into orofacial region were examined using in situ hybridization histochemistry and immunohistochemistry.">
            <entity id="DS3.d92.s1.e0" origId="P01210,A0A024R7V4" charOffset="23-39" type="protein" text="preproenkephalin"/>
            <entity id="DS3.d92.s1.e1" origId="57282044" charOffset="66-80" type="compound" text="leu-enkephalin"/>
            <pair e1="DS3.d92.s1.e1" e2="DS3.d92.s1.e0" id="DS3.d92.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d93" origId="10022349">
        <sentence id="DS3.d93.s0" origId="10022349-0" text="Immunoreactivity to synaptosomal-associated protein-25 in developing rat retinas: effects of a glutamate agonist and retinal transplantation to a host brain.">
            <entity id="DS3.d93.s0.e0" origId="P60881" charOffset="20-54" type="protein" text="synaptosomal-associated protein-25"/>
            <entity id="DS3.d93.s0.e1" origId="23327,33032,611,57109091" charOffset="95-104" type="compound" text="glutamate"/>
            <entity id="DS3.d93.s0.e2" origId="638015" charOffset="117-124" type="compound" text="retinal"/>
            <pair e1="DS3.d93.s0.e2" e2="DS3.d93.s0.e0" id="DS3.d93.s0.i0" interaction="False" />
            <pair e1="DS3.d93.s0.e1" e2="DS3.d93.s0.e0" id="DS3.d93.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d93.s1" origId="10022349-5" text="These results provide new insights into the role of SNAP-25 in membrane remodelling in relation to specific cell types and functions, and into intraretinal regulatory mechanisms that seem to be independent of the levels of glutamate and the influence of retinal ganglion cells.">
            <entity id="DS3.d93.s1.e0" origId="P60881" charOffset="52-59" type="protein" text="SNAP-25"/>
            <entity id="DS3.d93.s1.e1" origId="23327,33032,611,57109091" charOffset="223-232" type="compound" text="glutamate"/>
            <entity id="DS3.d93.s1.e2" origId="638015" charOffset="148-155" type="compound" text="retinal"/>
            <pair e1="DS3.d93.s1.e2" e2="DS3.d93.s1.e0" id="DS3.d93.s1.i0" interaction="False" />
            <pair e1="DS3.d93.s1.e1" e2="DS3.d93.s1.e0" id="DS3.d93.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d94" origId="10022350">
        <sentence id="DS3.d94.s0" origId="10022350-1" text="Employing an immunocytochemical double-labeling technique, we investigated the co-localization of FOS protein, the expression product of c-FOS proto-oncogene induced by orofacial noxious stimulation, and serotonin in the rat brainstem.">
            <entity id="DS3.d94.s0.e0" origId="P12841" charOffset="98-101" type="protein" text="FOS"/>
            <entity id="DS3.d94.s0.e1" origId="P12841" charOffset="137-142" type="protein" text="c-FOS"/>
            <entity id="DS3.d94.s0.e2" origId="5202" charOffset="204-213" type="compound" text="serotonin"/>
            <pair e1="DS3.d94.s0.e2" e2="DS3.d94.s0.e1" id="DS3.d94.s0.i0" interaction="False" />
            <pair e1="DS3.d94.s0.e2" e2="DS3.d94.s0.e0" id="DS3.d94.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d94.s1" origId="10022350-2" text="About 3.2%-25.6% of serotonin-like immunoreactive neurons and 6.2%-46.7% of FOS-like immunoreactive neurons in the raphe nuclei, reticular formation and ventrolateral subdivision of the midbrain periaqueductal gray exhibit FOS-like immunoreactivity and serotonin-like immunoreactivity, respectively.">
            <entity id="DS3.d94.s1.e0" origId="5202" charOffset="20-29" type="compound" text="serotonin"/>
            <entity id="DS3.d94.s1.e1" origId="P12841" charOffset="76-79" type="protein" text="FOS"/>
            <entity id="DS3.d94.s1.e2" origId="P12841" charOffset="223-226" type="protein" text="FOS"/>
            <entity id="DS3.d94.s1.e3" origId="5202" charOffset="253-262" type="compound" text="serotonin"/>
            <pair e1="DS3.d94.s1.e0" e2="DS3.d94.s1.e1" id="DS3.d94.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d95" origId="10022351">
        <sentence id="DS3.d95.s0" origId="10022351-14" text="HPII does not bind NADPH and the equivalent region to the NADPH binding pocket of bovine catalase, partially occluded in HPII by residues 585-590, corresponds to the entrance to the second channel.">
            <entity id="DS3.d95.s0.e0" origId="5884" charOffset="19-24" type="compound" text="NADPH"/>
            <entity id="DS3.d95.s0.e1" origId="5884" charOffset="58-63" type="compound" text="NADPH"/>
            <entity id="DS3.d95.s0.e2" origId="P04762" charOffset="89-97" type="protein" text="catalase"/>
            <pair e1="DS3.d95.s0.e0" e2="DS3.d95.s0.e2" id="DS3.d95.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d95.s1" origId="10022351-8" text="The heme component of HPII is a cis-hydroxychlorin gamma-spirolactone in an orientation that is flipped 180 degrees with respect to the orientation of the heme found in beef liver catalase.">
            <entity id="DS3.d95.s1.e0" origId="4971" charOffset="4-8" type="compound" text="heme"/>
            <entity id="DS3.d95.s1.e1" origId="5833" charOffset="57-69" type="compound" text="spirolactone"/>
            <entity id="DS3.d95.s1.e2" origId="4971" charOffset="155-159" type="compound" text="heme"/>
            <entity id="DS3.d95.s1.e3" origId="P04762" charOffset="180-188" type="protein" text="catalase"/>
            <pair e1="DS3.d95.s1.e1" e2="DS3.d95.s1.e3" id="DS3.d95.s1.i0" interaction="False" />
            <pair e1="DS3.d95.s1.e0" e2="DS3.d95.s1.e3" id="DS3.d95.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d96" origId="10022353">
        <sentence id="DS3.d96.s0" origId="10022353-2" text="The AutoDock suite of programs is used to determine the binding modes of the synthetic inhibitors such as 3- and 4-amidinobenzylphenyl ether (ABP), amidinophenyl pyruvic acid (APPA), diamidinobenzofuranyl ethene (DABE), and DX-9065a 2-(5'-amidino-2'-benzofuranyl)-3-(7'amidino-2'-napthyl)-propionic acid (ABAP) to FXa.">
            <entity id="DS3.d96.s0.e0" origId="2332" charOffset="148-161" type="compound" text="amidinophenyl"/>
            <entity id="DS3.d96.s0.e1" origId="1060" charOffset="162-174" type="compound" text="pyruvic acid"/>
            <entity id="DS3.d96.s0.e2" origId="6325" charOffset="205-211" type="compound" text="ethene"/>
            <entity id="DS3.d96.s0.e3" origId="122129" charOffset="224-232" type="compound" text="DX-9065a"/>
            <entity id="DS3.d96.s0.e4" origId="68047" charOffset="115-122" type="compound" text="amidino"/>
            <entity id="DS3.d96.s0.e5" origId="68047" charOffset="148-155" type="compound" text="amidino"/>
            <entity id="DS3.d96.s0.e6" origId="1032" charOffset="289-303" type="compound" text="propionic acid"/>
            <entity id="DS3.d96.s0.e7" origId="1969" charOffset="305-309" type="compound" text="ABAP"/>
            <entity id="DS3.d96.s0.e8" origId="P00742,Q5JVE7,Q5JVE8" charOffset="314-317" type="protein" text="FXa"/>
            <pair e1="DS3.d96.s0.e4" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i0" interaction="False" />
            <pair e1="DS3.d96.s0.e6" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i1" interaction="False" />
            <pair e1="DS3.d96.s0.e3" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i2" interaction="False" />
            <pair e1="DS3.d96.s0.e2" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i3" interaction="False" />
            <pair e1="DS3.d96.s0.e7" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i4" interaction="False" />
            <pair e1="DS3.d96.s0.e0" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i5" interaction="False" />
            <pair e1="DS3.d96.s0.e1" e2="DS3.d96.s0.e8" id="DS3.d96.s0.i6" interaction="False" />
        </sentence>
        <sentence id="DS3.d96.s1" origId="10022353-7" text="In all the computationally predicted synthetic inhibitor complexes of FXa, the specificity pocket residue Asp-189 is involved in hydrogen bonding with the bound inhibitor.">
            <entity id="DS3.d96.s1.e0" origId="P00742,Q5JVE7,Q5JVE8" charOffset="70-73" type="protein" text="FXa"/>
            <entity id="DS3.d96.s1.e1" origId="783" charOffset="129-137" type="compound" text="hydrogen"/>
            <pair e1="DS3.d96.s1.e1" e2="DS3.d96.s1.e0" id="DS3.d96.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d97" origId="10022358">
        <sentence id="DS3.d97.s0" origId="10022358-4" text="Four chiral atoms of phycourobilin (PUB) were identified as C(4)-S, C(16)-S, C(21)-S, and C(20)-R. In addition to the coupling distances of 19 A to 45 A between the chromophores which were observed and involved in the energy transfer pathway, high resolution structure of R-PE suggested other pathways of energy transfer, such as the ultrashort distance between alpha140a and beta155.">
            <entity id="DS3.d97.s0.e0" origId="5289229" charOffset="21-34" type="compound" text="phycourobilin"/>
            <entity id="DS3.d97.s0.e1" origId="Q3MIF0,A0A0G2JW38" charOffset="272-276" type="protein" text="R-PE"/>
            <pair e1="DS3.d97.s0.e0" e2="DS3.d97.s0.e1" id="DS3.d97.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d98" origId="10022376">
        <sentence id="DS3.d98.s0" origId="10022376-3" text="Fluorescein-5-isothiocynate (FITC)-heparin was added to platelet factor 4 present in normal serum to form the neo-antigen which was captured by heparin-induced IgG.">
            <entity id="DS3.d98.s0.e0" origId="16850" charOffset="0-11" type="compound" text="Fluorescein"/>
            <entity id="DS3.d98.s0.e1" origId="18730" charOffset="29-33" type="compound" text="FITC"/>
            <entity id="DS3.d98.s0.e2" origId="P02776" charOffset="56-73" type="protein" text="platelet factor 4"/>
            <pair e1="DS3.d98.s0.e1" e2="DS3.d98.s0.e2" id="DS3.d98.s0.i0" interaction="False" />
            <pair e1="DS3.d98.s0.e0" e2="DS3.d98.s0.e2" id="DS3.d98.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d99" origId="10022378">
        <sentence id="DS3.d99.s0" origId="10022378-1" text="Enzyme-linked immunosorbent assays (ELISA) were developed to test, in serum and mucosal samples, total IgG, total IgA, serum albumin, and anti-gp120 MN and anti-p24 LAI IgG and IgA levels.">
            <entity id="DS3.d99.s0.e0" origId="P02768" charOffset="119-132" type="protein" text="serum albumin"/>
            <entity id="DS3.d99.s0.e1" origId="Q14624,B7ZKJ8,B2RMS9" charOffset="143-148" type="protein" text="gp120"/>
            <entity id="DS3.d99.s0.e2" origId="Q15363,Q6FHT8" charOffset="161-164" type="protein" text="p24"/>
            <entity id="DS3.d99.s0.e3" origId="5460291" charOffset="165-168" type="compound" text="LAI"/>
            <pair e1="DS3.d99.s0.e3" e2="DS3.d99.s0.e0" id="DS3.d99.s0.i0" interaction="False" />
            <pair e1="DS3.d99.s0.e3" e2="DS3.d99.s0.e1" id="DS3.d99.s0.i1" interaction="False" />
            <pair e1="DS3.d99.s0.e3" e2="DS3.d99.s0.e2" id="DS3.d99.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d99.s1" origId="10022378-5" text="For IgG and IgA titration against gp120 MN and p24 LAI, standards were made using pooled sera or gammaglobulins with assigned titres in ELISA units per ml (EU/ml).">
            <entity id="DS3.d99.s1.e0" origId="Q14624,B7ZKJ8,B2RMS9" charOffset="34-39" type="protein" text="gp120"/>
            <entity id="DS3.d99.s1.e1" origId="Q15363,Q6FHT8" charOffset="47-50" type="protein" text="p24"/>
            <entity id="DS3.d99.s1.e2" origId="5460291" charOffset="51-54" type="compound" text="LAI"/>
            <pair e1="DS3.d99.s1.e2" e2="DS3.d99.s1.e1" id="DS3.d99.s1.i0" interaction="False" />
            <pair e1="DS3.d99.s1.e2" e2="DS3.d99.s1.e0" id="DS3.d99.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d100" origId="10022380">
        <sentence id="DS3.d100.s0" origId="10022380-2" text="Geneticin-resistant transformants harboring human MBL cDNA in the expression vector pNOW/CMV-A were screened by immunoblot analysis for secretion of recombinant MBL.">
            <entity id="DS3.d100.s0.e0" origId="123865,2733531,447379,71308205" charOffset="0-9" type="compound" text="Geneticin"/>
            <entity id="DS3.d100.s0.e1" origId="P11226" charOffset="50-53" type="protein" text="MBL"/>
            <entity id="DS3.d100.s0.e2" origId="P11226" charOffset="161-164" type="protein" text="MBL"/>
            <pair e1="DS3.d100.s0.e0" e2="DS3.d100.s0.e1" id="DS3.d100.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d100.s1" origId="10022380-3" text="Cloning and selection by both geneticin and methotrexate resulted in the production of recombinant MBL to a final concentration of 128.8 microg/ml in media after four days of culture.">
            <entity id="DS3.d100.s1.e0" origId="123865,2733531,447379,71308205" charOffset="30-39" type="compound" text="geneticin"/>
            <entity id="DS3.d100.s1.e1" origId="126941" charOffset="44-56" type="compound" text="methotrexate"/>
            <entity id="DS3.d100.s1.e2" origId="P11226" charOffset="99-102" type="protein" text="MBL"/>
            <pair e1="DS3.d100.s1.e1" e2="DS3.d100.s1.e2" id="DS3.d100.s1.i0" interaction="False" />
            <pair e1="DS3.d100.s1.e0" e2="DS3.d100.s1.e2" id="DS3.d100.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d101" origId="10022390">
        <sentence id="DS3.d101.s0" origId="10022390-1" text="NAD+-dependent 15-hydroxy-PG dehydrogenase (PGDH) is the major enzyme involved in the initial inactivation of PGs, and its activity is reduced by glucocorticoids, cortisol (F), and dexamethasone (DEX).">
            <entity id="DS3.d101.s0.e0" origId="O43175" charOffset="44-48" type="protein" text="PGDH"/>
            <entity id="DS3.d101.s0.e1" origId="5754" charOffset="163-171" type="compound" text="cortisol"/>
            <entity id="DS3.d101.s0.e2" origId="5743" charOffset="181-194" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d101.s0.e1" e2="DS3.d101.s0.e0" id="DS3.d101.s0.i0" interaction="False" />
            <pair e1="DS3.d101.s0.e2" e2="DS3.d101.s0.e0" id="DS3.d101.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d101.s1" origId="10022390-3" text="In the placenta, 11beta-HSD2 is the dominant isoform, acting as a dehydrogenase (F to cortisone (E)); and in chorion, 11beta-HSD1 predominates as a reductase (E to F).">
            <entity id="DS3.d101.s1.e0" origId="222786" charOffset="86-95" type="compound" text="cortisone"/>
            <entity id="DS3.d101.s1.e1" origId="Q99932" charOffset="125-129" type="protein" text="HSD1"/>
            <pair e1="DS3.d101.s1.e0" e2="DS3.d101.s1.e1" id="DS3.d101.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d101.s2" origId="10022390-5" text="We obtained Percoll-purified human placental and chorion trophoblast cells from uncomplicated term pregnancies, cultured them for 72 h, then treated the cells with cortisol (100 nmol/L), cortisone (1 micromol/L), or DEX (100 nmol/L), in the presence or absence of carbenoxolone (CBX, 800 nmol/L), an 11beta-HSD inhibitor, for 24 h. Activity of PGDH was assessed by incubation (4 h) with PGF2alpha (282 nmol/L) and measurement of conversion to 13,14-dihydro-15-keto PGF2alpha.">
            <entity id="DS3.d101.s2.e0" origId="5754" charOffset="164-172" type="compound" text="cortisol"/>
            <entity id="DS3.d101.s2.e1" origId="222786" charOffset="187-196" type="compound" text="cortisone"/>
            <entity id="DS3.d101.s2.e2" origId="24720976,46936354,21913,5311038,56965767,636403" charOffset="264-277" type="compound" text="carbenoxolone"/>
            <entity id="DS3.d101.s2.e3" origId="O43175" charOffset="344-348" type="protein" text="PGDH"/>
            <entity id="DS3.d101.s2.e4" origId="5280363" charOffset="387-396" type="compound" text="PGF2alpha"/>
            <entity id="DS3.d101.s2.e5" origId="5280363" charOffset="465-474" type="compound" text="PGF2alpha"/>
            <pair e1="DS3.d101.s2.e1" e2="DS3.d101.s2.e3" id="DS3.d101.s2.i0" interaction="False" />
            <pair e1="DS3.d101.s2.e4" e2="DS3.d101.s2.e3" id="DS3.d101.s2.i1" interaction="False" />
            <pair e1="DS3.d101.s2.e0" e2="DS3.d101.s2.e3" id="DS3.d101.s2.i2" interaction="False" />
            <pair e1="DS3.d101.s2.e2" e2="DS3.d101.s2.e3" id="DS3.d101.s2.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d102" origId="10022395">
        <sentence id="DS3.d102.s0" origId="10022395-0" text="Maintenance of serum calcium by parathyroid hormone-related peptide during lactation in a hypoparathyroid patient.">
            <entity id="DS3.d102.s0.e0" origId="22044544,5460341" charOffset="21-28" type="compound" text="calcium"/>
            <entity id="DS3.d102.s0.e1" origId="P01270" charOffset="32-51" type="protein" text="parathyroid hormone"/>
            <pair e1="DS3.d102.s0.e0" e2="DS3.d102.s0.e1" id="DS3.d102.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d103" origId="10022396">
        <sentence id="DS3.d103.s0" origId="10022396-3" text="We hypothesized that ingestion of an entire day's calories at one time in the evening, a common eating practice among Americans, would lead to disruptions in glucose, insulin, and leptin metabolism and in menstrual cyclicity, even in healthy young women.">
            <entity id="DS3.d103.s0.e0" origId="206,64689,79025" charOffset="158-165" type="compound" text="glucose"/>
            <entity id="DS3.d103.s0.e1" origId="P01308,I3WAC9" charOffset="167-174" type="protein" text="insulin"/>
            <entity id="DS3.d103.s0.e2" origId="P41159,A4D0Y8" charOffset="180-186" type="protein" text="leptin"/>
            <pair e1="DS3.d103.s0.e0" e2="DS3.d103.s0.e2" id="DS3.d103.s0.i0" interaction="False" />
            <pair e1="DS3.d103.s0.e0" e2="DS3.d103.s0.e1" id="DS3.d103.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d103.s1" origId="10022396-7" text="Glucose, insulin, and leptin were measured frequently for 12-14 h beginning at 0800 h on the third day of each diet, and an insulin tolerance test was performed while the subjects were fasting on the fourth day.">
            <entity id="DS3.d103.s1.e0" origId="206,64689,79025" charOffset="0-7" type="compound" text="Glucose"/>
            <entity id="DS3.d103.s1.e1" origId="P01308,I3WAC9" charOffset="9-16" type="protein" text="insulin"/>
            <entity id="DS3.d103.s1.e2" origId="P41159,A4D0Y8" charOffset="22-28" type="protein" text="leptin"/>
            <entity id="DS3.d103.s1.e3" origId="P01308,I3WAC9" charOffset="124-131" type="protein" text="insulin"/>
            <pair e1="DS3.d103.s1.e0" e2="DS3.d103.s1.e2" id="DS3.d103.s1.i0" interaction="False" />
            <pair e1="DS3.d103.s1.e0" e2="DS3.d103.s1.e1" id="DS3.d103.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d103.s2" origId="10022396-9" text="Ingestion of an entire day's calories at dinner resulted in a significant increase in fasting glucose levels and a dramatic increase in insulin responses to the evening meal.">
            <entity id="DS3.d103.s2.e0" origId="206,64689,79025" charOffset="94-101" type="compound" text="glucose"/>
            <entity id="DS3.d103.s2.e1" origId="P01308,I3WAC9" charOffset="136-143" type="protein" text="insulin"/>
            <pair e1="DS3.d103.s2.e0" e2="DS3.d103.s2.e1" id="DS3.d103.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d104" origId="10022397">
        <sentence id="DS3.d104.s0" origId="10022397-5" text="The following measurements were made basally and for 6 months after carbimazole treatment: serum free T4, T3, bone-specific alkaline phosphatase (b-ALP), IL-6, IL-8, IL-1beta, tumor necrosis factor-alpha, IL-11, and urinary deoxypyridinoline (Udpd).">
            <entity id="DS3.d104.s0.e0" origId="31072" charOffset="68-79" type="compound" text="carbimazole"/>
            <entity id="DS3.d104.s0.e1" origId="5920" charOffset="106-108" type="compound" text="T3"/>
            <entity id="DS3.d104.s0.e2" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="154-158" type="protein" text="IL-6"/>
            <entity id="DS3.d104.s0.e3" origId="P10145,A0A024RDA5" charOffset="160-164" type="protein" text="IL-8"/>
            <entity id="DS3.d104.s0.e4" origId="P01584" charOffset="166-174" type="protein" text="IL-1beta"/>
            <entity id="DS3.d104.s0.e5" origId="P01375,Q5STB3" charOffset="176-203" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d104.s0.e6" origId="P20809,A8K3F7" charOffset="205-210" type="protein" text="IL-11"/>
            <entity id="DS3.d104.s0.e7" origId="3034763" charOffset="224-241" type="compound" text="deoxypyridinoline"/>
            <pair e1="DS3.d104.s0.e0" e2="DS3.d104.s0.e2" id="DS3.d104.s0.i0" interaction="False" />
            <pair e1="DS3.d104.s0.e0" e2="DS3.d104.s0.e4" id="DS3.d104.s0.i1" interaction="False" />
            <pair e1="DS3.d104.s0.e0" e2="DS3.d104.s0.e3" id="DS3.d104.s0.i2" interaction="False" />
            <pair e1="DS3.d104.s0.e0" e2="DS3.d104.s0.e5" id="DS3.d104.s0.i3" interaction="False" />
            <pair e1="DS3.d104.s0.e0" e2="DS3.d104.s0.e6" id="DS3.d104.s0.i4" interaction="False" />
            <pair e1="DS3.d104.s0.e7" e2="DS3.d104.s0.e2" id="DS3.d104.s0.i5" interaction="False" />
            <pair e1="DS3.d104.s0.e7" e2="DS3.d104.s0.e4" id="DS3.d104.s0.i6" interaction="False" />
            <pair e1="DS3.d104.s0.e7" e2="DS3.d104.s0.e3" id="DS3.d104.s0.i7" interaction="False" />
            <pair e1="DS3.d104.s0.e7" e2="DS3.d104.s0.e5" id="DS3.d104.s0.i8" interaction="False" />
            <pair e1="DS3.d104.s0.e7" e2="DS3.d104.s0.e6" id="DS3.d104.s0.i9" interaction="False" />
            <pair e1="DS3.d104.s0.e1" e2="DS3.d104.s0.e2" id="DS3.d104.s0.i10" interaction="False" />
            <pair e1="DS3.d104.s0.e1" e2="DS3.d104.s0.e4" id="DS3.d104.s0.i11" interaction="False" />
            <pair e1="DS3.d104.s0.e1" e2="DS3.d104.s0.e3" id="DS3.d104.s0.i12" interaction="False" />
            <pair e1="DS3.d104.s0.e1" e2="DS3.d104.s0.e5" id="DS3.d104.s0.i13" interaction="False" />
            <pair e1="DS3.d104.s0.e1" e2="DS3.d104.s0.e6" id="DS3.d104.s0.i14" interaction="False" />
        </sentence>
        <sentence id="DS3.d104.s1" origId="10022397-9" text="When data from all the patients were pooled, the levels of IL-6 and IL-8 correlated with serum T3 and free T4 but not with Udpd or b-ALP.">
            <entity id="DS3.d104.s1.e0" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="59-63" type="protein" text="IL-6"/>
            <entity id="DS3.d104.s1.e1" origId="P10145,A0A024RDA5" charOffset="68-72" type="protein" text="IL-8"/>
            <entity id="DS3.d104.s1.e2" origId="5920" charOffset="95-97" type="compound" text="T3"/>
            <pair e1="DS3.d104.s1.e2" e2="DS3.d104.s1.e0" id="DS3.d104.s1.i0" interaction="False" />
            <pair e1="DS3.d104.s1.e2" e2="DS3.d104.s1.e1" id="DS3.d104.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d105" origId="10022405">
        <sentence id="DS3.d105.s0" origId="10022405-14" text="The value of the combination of CRH and desmopressin stimulation requires more detailed investigation.">
            <entity id="DS3.d105.s0.e0" origId="P06850" charOffset="32-35" type="protein" text="CRH"/>
            <entity id="DS3.d105.s0.e1" origId="16051933,57201485,5311065" charOffset="40-52" type="compound" text="desmopressin"/>
            <pair e1="DS3.d105.s0.e1" e2="DS3.d105.s0.e0" id="DS3.d105.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d105.s1" origId="10022405-3" text="One hundred seven patients received human-sequence CRH (hCRH), and 11 received ovine CRH; another 6 patients underwent stimulation with desmopressin and hCRH, and 4 with desmopressin alone.">
            <entity id="DS3.d105.s1.e0" origId="P06850" charOffset="51-54" type="protein" text="CRH"/>
            <entity id="DS3.d105.s1.e1" origId="P06850" charOffset="56-60" type="protein" text="hCRH"/>
            <entity id="DS3.d105.s1.e2" origId="P06850" charOffset="57-60" type="protein" text="CRH"/>
            <entity id="DS3.d105.s1.e3" origId="16051933,57201485,5311065" charOffset="136-148" type="compound" text="desmopressin"/>
            <entity id="DS3.d105.s1.e4" origId="P06850" charOffset="153-157" type="protein" text="hCRH"/>
            <entity id="DS3.d105.s1.e5" origId="16051933,57201485,5311065" charOffset="170-182" type="compound" text="desmopressin"/>
            <pair e1="DS3.d105.s1.e3" e2="DS3.d105.s1.e0" id="DS3.d105.s1.i0" interaction="False" />
            <pair e1="DS3.d105.s1.e3" e2="DS3.d105.s1.e1" id="DS3.d105.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d106" origId="10022408">
        <sentence id="DS3.d106.s0" origId="10022408-3" text="The DAX-1 protein is structurally related to orphan nuclear receptors, although it lacks the characteristic zinc finger DNA-binding domain that is highly conserved in other members of this family.">
            <entity id="DS3.d106.s0.e0" origId="P51843,F1D8P4" charOffset="4-9" type="protein" text="DAX-1"/>
            <entity id="DS3.d106.s0.e1" origId="23994" charOffset="108-112" type="compound" text="zinc"/>
            <pair e1="DS3.d106.s0.e1" e2="DS3.d106.s0.e0" id="DS3.d106.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d107" origId="10022419">
        <sentence id="DS3.d107.s0" origId="10022419-10" text="In summary, insulin-mediated glucose disposal varied widely in nondiabetic, obese women, and there was no relationship between baseline insulin resistance or total integrated insulin response and weight loss.">
            <entity id="DS3.d107.s0.e0" origId="P01308,I3WAC9" charOffset="12-19" type="protein" text="insulin"/>
            <entity id="DS3.d107.s0.e1" origId="206,5793,64689,79025" charOffset="29-36" type="compound" text="glucose"/>
            <entity id="DS3.d107.s0.e2" origId="P01308,I3WAC9" charOffset="136-143" type="protein" text="insulin"/>
            <entity id="DS3.d107.s0.e3" origId="P01308,I3WAC9" charOffset="136-143" type="protein" text="insulin"/>
            <pair e1="DS3.d107.s0.e1" e2="DS3.d107.s0.e0" id="DS3.d107.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d107.s1" origId="10022419-3" text="Resistance to insulin-mediated glucose disposal was assessed by determining their steady state plasma insulin and glucose concentration during the last 30 min of a 180-min infusion of somatostatin, insulin, and glucose.">
            <entity id="DS3.d107.s1.e0" origId="P01308,I3WAC9" charOffset="14-21" type="protein" text="insulin"/>
            <entity id="DS3.d107.s1.e1" origId="206,5793,64689,79025" charOffset="31-38" type="compound" text="glucose"/>
            <entity id="DS3.d107.s1.e2" origId="P01308,I3WAC9" charOffset="102-109" type="protein" text="insulin"/>
            <entity id="DS3.d107.s1.e3" origId="206,5793,64689,79025" charOffset="114-121" type="compound" text="glucose"/>
            <entity id="DS3.d107.s1.e4" origId="P61278" charOffset="184-196" type="protein" text="somatostatin"/>
            <entity id="DS3.d107.s1.e5" origId="P01308,I3WAC9" charOffset="102-109" type="protein" text="insulin"/>
            <entity id="DS3.d107.s1.e6" origId="206,5793,64689,79025" charOffset="114-121" type="compound" text="glucose"/>
            <pair e1="DS3.d107.s1.e1" e2="DS3.d107.s1.e4" id="DS3.d107.s1.i0" interaction="False" />
            <pair e1="DS3.d107.s1.e1" e2="DS3.d107.s1.e0" id="DS3.d107.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d107.s2" origId="10022419-8" text="There was a mean (+/-SEM) weight loss at 60 days of 9.2 +/- 0.4 kg in the 20 individuals defined as weight loss successes, but there was no correlation between weight loss and either steady state plasma glucose or the total integrated insulin response (r &amp;lt; 0.1; P &amp;gt; 0.83).">
            <entity id="DS3.d107.s2.e0" origId="5289348" charOffset="21-24" type="compound" text="SEM"/>
            <entity id="DS3.d107.s2.e1" origId="206,5793,64689,79025" charOffset="203-210" type="compound" text="glucose"/>
            <entity id="DS3.d107.s2.e2" origId="P01308,I3WAC9" charOffset="235-242" type="protein" text="insulin"/>
            <pair e1="DS3.d107.s2.e0" e2="DS3.d107.s2.e2" id="DS3.d107.s2.i0" interaction="False" />
            <pair e1="DS3.d107.s2.e1" e2="DS3.d107.s2.e2" id="DS3.d107.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d108" origId="10022428">
        <sentence id="DS3.d108.s0" origId="10022428-2" text="intersex states result either from gonadal dysgenesis, in which both Leydig and Sertoli cell populations are affected, or from impaired secretion or action of either testosterone or AMH.">
            <entity id="DS3.d108.s0.e0" origId="Q9NX70,B4DUA7" charOffset="0-8" type="protein" text="intersex"/>
            <entity id="DS3.d108.s0.e1" origId="6013" charOffset="166-178" type="compound" text="testosterone"/>
            <pair e1="DS3.d108.s0.e1" e2="DS3.d108.s0.e0" id="DS3.d108.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d108.s1" origId="10022428-5" text="In XY patients, AMH was low when the intersex condition was caused by abnormal testicular determination (including pure and partial gonadal dysgenesis) but was normal or elevated in patients with impaired testosterone secretion, whereas serum testosterone was low in both groups.">
            <entity id="DS3.d108.s1.e0" origId="Q9NX70,B4DUA7" charOffset="37-45" type="protein" text="intersex"/>
            <entity id="DS3.d108.s1.e1" origId="6013" charOffset="205-217" type="compound" text="testosterone"/>
            <entity id="DS3.d108.s1.e2" origId="6013" charOffset="243-255" type="compound" text="testosterone"/>
            <pair e1="DS3.d108.s1.e1" e2="DS3.d108.s1.e0" id="DS3.d108.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d108.s2" origId="10022428-8" text="In conclusion, serum AMH determination is a powerful tool to assess Sertoli cell function in children with intersex states, and it helps to distinguish between defects of male sexual differentiation caused by abnormal testicular determination and those resulting from isolated impairment of testosterone secretion or action.">
            <entity id="DS3.d108.s2.e0" origId="Q9NX70,B4DUA7" charOffset="107-115" type="protein" text="intersex"/>
            <entity id="DS3.d108.s2.e1" origId="6013" charOffset="291-303" type="compound" text="testosterone"/>
            <pair e1="DS3.d108.s2.e1" e2="DS3.d108.s2.e0" id="DS3.d108.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d109" origId="10022434">
        <sentence id="DS3.d109.s0" origId="10022434-4" text="PDR subjects with neovascularization of iris, which suggests advanced retinal ischemia, showed a higher mean vitreous hHGF concentration than those without iridal neovascularization (7.33 +/- 1.16 ng/mL (n = 14) vs. 4.49 +/- 0.72 ng/mL (n = 19), P &amp;lt; 0.05).">
            <entity id="DS3.d109.s0.e0" origId="638015" charOffset="70-77" type="compound" text="retinal"/>
            <entity id="DS3.d109.s0.e1" origId="P14210" charOffset="118-122" type="protein" text="hHGF"/>
            <entity id="DS3.d109.s0.e2" origId="5318463" charOffset="156-162" type="compound" text="iridal"/>
            <pair e1="DS3.d109.s0.e0" e2="DS3.d109.s0.e1" id="DS3.d109.s0.i0" interaction="False" />
            <pair e1="DS3.d109.s0.e2" e2="DS3.d109.s0.e1" id="DS3.d109.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d109.s1" origId="10022434-5" text="The mean vitreous hHGF concentration was higher in PDR subjects with retinal neovascularization at the optic disc than in those with neovascularization elsewhere (7.3 +/- 1.1 ng/mL (n = 15) vs. 4.4 +/- 0.7 ng/mL (n = 18), P &amp;lt; 0.05).">
            <entity id="DS3.d109.s1.e0" origId="P14210" charOffset="18-22" type="protein" text="hHGF"/>
            <entity id="DS3.d109.s1.e1" origId="638015" charOffset="69-76" type="compound" text="retinal"/>
            <pair e1="DS3.d109.s1.e1" e2="DS3.d109.s1.e0" id="DS3.d109.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d109.s2" origId="10022434-6" text="Our results indicate that vitreous hHGF may play a role in retinal neovascularization in PDR.">
            <entity id="DS3.d109.s2.e0" origId="P14210" charOffset="35-39" type="protein" text="hHGF"/>
            <entity id="DS3.d109.s2.e1" origId="638015" charOffset="59-66" type="compound" text="retinal"/>
            <pair e1="DS3.d109.s2.e1" e2="DS3.d109.s2.e0" id="DS3.d109.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d110" origId="10022435">
        <sentence id="DS3.d110.s0" origId="10022435-6" text="A role for changes in immunophilins, causing glucocorticoid resistance in neotropical primates, is supported by the following: the changes in FKBP51 and FKBP52 were observed in cells from other neotropical primates with glucocorticoid resistance; the elevated level of FKBP51 was reflected in an abundance of FKBP51 in heat shock protein 90 complexes in SML; when cytosols of SML and L929 cells were mixed, the decrease in GR binding was associated with incorporation of FKBP51 into GR heterocomplexes; the effect of SML cytosol on GR binding was reproduced with cytosol from COS cells expressing squirrel monkey FKBP51; and both the effect of SML cytosol on GR binding and the incorporation of FKBP51 into GR heterocomplexes were blocked by FK506.">
            <entity id="DS3.d110.s0.e0" origId="Q64378,Q4FJN2" charOffset="142-148" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e1" origId="P30416" charOffset="153-159" type="protein" text="FKBP52"/>
            <entity id="DS3.d110.s0.e2" origId="Q64378,Q4FJN2" charOffset="269-275" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e3" origId="Q64378,Q4FJN2" charOffset="269-275" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e4" origId="Q64378,Q4FJN2" charOffset="269-275" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e5" origId="Q64378,Q4FJN2" charOffset="269-275" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e6" origId="Q64378,Q4FJN2" charOffset="269-275" type="protein" text="FKBP51"/>
            <entity id="DS3.d110.s0.e7" origId="445643" charOffset="742-747" type="compound" text="FK506"/>
            <pair e1="DS3.d110.s0.e7" e2="DS3.d110.s0.e1" id="DS3.d110.s0.i0" interaction="False" />
            <pair e1="DS3.d110.s0.e7" e2="DS3.d110.s0.e0" id="DS3.d110.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d111" origId="10022436">
        <sentence id="DS3.d111.s0" origId="10022436-1" text="Previously we demonstrated the expression of the long form of the Leptin receptor in rodent pancreatic beta-cells and an inhibition of insulin secretion by Leptin via activation of ATP-sensitive potassium channels.">
            <entity id="DS3.d111.s0.e0" origId="P41159,A4D0Y8" charOffset="66-72" type="protein" text="Leptin"/>
            <entity id="DS3.d111.s0.e1" origId="P01308,I3WAC9" charOffset="135-142" type="protein" text="insulin"/>
            <entity id="DS3.d111.s0.e2" origId="P41159,A4D0Y8" charOffset="156-162" type="protein" text="Leptin"/>
            <entity id="DS3.d111.s0.e3" origId="5957" charOffset="181-184" type="compound" text="ATP"/>
            <entity id="DS3.d111.s0.e4" origId="5462222" charOffset="195-204" type="compound" text="potassium"/>
            <pair e1="DS3.d111.s0.e4" e2="DS3.d111.s0.e0" id="DS3.d111.s0.i0" interaction="False" />
            <pair e1="DS3.d111.s0.e4" e2="DS3.d111.s0.e1" id="DS3.d111.s0.i1" interaction="False" />
            <pair e1="DS3.d111.s0.e3" e2="DS3.d111.s0.e0" id="DS3.d111.s0.i2" interaction="False" />
            <pair e1="DS3.d111.s0.e3" e2="DS3.d111.s0.e1" id="DS3.d111.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d111.s1" origId="10022436-4" text="Leptin (6.25 nM) suppressed insulin secretion of normal islets by 20% at 5.6 mM glucose.">
            <entity id="DS3.d111.s1.e0" origId="P41159,A4D0Y8" charOffset="0-6" type="protein" text="Leptin"/>
            <entity id="DS3.d111.s1.e1" origId="P01308,I3WAC9" charOffset="28-35" type="protein" text="insulin"/>
            <entity id="DS3.d111.s1.e2" origId="206,5793,64689,79025" charOffset="80-87" type="compound" text="glucose"/>
            <pair e1="DS3.d111.s1.e2" e2="DS3.d111.s1.e0" id="DS3.d111.s1.i0" interaction="False" />
            <pair e1="DS3.d111.s1.e2" e2="DS3.d111.s1.e1" id="DS3.d111.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d111.s2" origId="10022436-5" text="Intracellular calcium responses to 16.7 mM glucose were rapidly reduced by Leptin.">
            <entity id="DS3.d111.s2.e0" origId="22044544,5460341" charOffset="14-21" type="compound" text="calcium"/>
            <entity id="DS3.d111.s2.e1" origId="206,5793,64689,79025" charOffset="43-50" type="compound" text="glucose"/>
            <entity id="DS3.d111.s2.e2" origId="P41159,A4D0Y8" charOffset="75-81" type="protein" text="Leptin"/>
            <pair e1="DS3.d111.s2.e0" e2="DS3.d111.s2.e2" id="DS3.d111.s2.i0" interaction="False" />
            <pair e1="DS3.d111.s2.e1" e2="DS3.d111.s2.e2" id="DS3.d111.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d111.s3" origId="10022436-6" text="Proinsulin messenger ribonucleic acid expression in islets was inhibited by Leptin at 11.1 mM, but not at 5.6 mM glucose.">
            <entity id="DS3.d111.s3.e0" origId="P01308,I3WAC9" charOffset="0-10" type="protein" text="Proinsulin"/>
            <entity id="DS3.d111.s3.e1" origId="P41159,A4D0Y8" charOffset="76-82" type="protein" text="Leptin"/>
            <entity id="DS3.d111.s3.e2" origId="206,5793,64689,79025" charOffset="113-120" type="compound" text="glucose"/>
            <pair e1="DS3.d111.s3.e2" e2="DS3.d111.s3.e1" id="DS3.d111.s3.i0" interaction="False" />
            <pair e1="DS3.d111.s3.e2" e2="DS3.d111.s3.e0" id="DS3.d111.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d111.s4" origId="10022436-7" text="Leptin also reduced Proinsulin messenger ribonucleic acid levels that were increased in islets by treatment with 10 nM glucagon-like peptide-1 in the presence of either 5.6 or 11.1 mM glucose.">
            <entity id="DS3.d111.s4.e0" origId="P41159,A4D0Y8" charOffset="0-6" type="protein" text="Leptin"/>
            <entity id="DS3.d111.s4.e1" origId="P01308,I3WAC9" charOffset="20-30" type="protein" text="Proinsulin"/>
            <entity id="DS3.d111.s4.e2" origId="206,5793,64689,79025" charOffset="184-191" type="compound" text="glucose"/>
            <pair e1="DS3.d111.s4.e2" e2="DS3.d111.s4.e0" id="DS3.d111.s4.i0" interaction="False" />
            <pair e1="DS3.d111.s4.e2" e2="DS3.d111.s4.e1" id="DS3.d111.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d112" origId="10022440">
        <sentence id="DS3.d112.s0" origId="10022440-0" text="Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter.">
            <entity id="DS3.d112.s0.e0" origId="P11166,Q59GX2" charOffset="67-72" type="protein" text="GLUT1"/>
            <entity id="DS3.d112.s0.e1" origId="206,5793,64689,79025" charOffset="73-80" type="compound" text="glucose"/>
            <pair e1="DS3.d112.s0.e1" e2="DS3.d112.s0.e0" id="DS3.d112.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d112.s1" origId="10022440-3" text="These membranes were used to measure GLUT1 glucose transporter expression and D-glucose transport activity.">
            <entity id="DS3.d112.s1.e0" origId="P11166,Q59GX2" charOffset="37-42" type="protein" text="GLUT1"/>
            <entity id="DS3.d112.s1.e1" origId="206,5793,64689,79025" charOffset="43-50" type="compound" text="glucose"/>
            <entity id="DS3.d112.s1.e2" origId="206,5793,64689,79025" charOffset="80-87" type="compound" text="glucose"/>
            <pair e1="DS3.d112.s1.e1" e2="DS3.d112.s1.e0" id="DS3.d112.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d113" origId="10022441">
        <sentence id="DS3.d113.s0" origId="10022441-1" text="We used the secreted TSH receptor (TSHR) ectodomain variant TSHR-289 (truncated at amino acid residue 289 with a 6-histidine tail) to investigate properties of TSHR autoantibodies in Graves' disease.">
            <entity id="DS3.d113.s0.e0" origId="P16473,A0A0A0MTJ0" charOffset="21-33" type="protein" text="TSH receptor"/>
            <entity id="DS3.d113.s0.e1" origId="P16473,A0A0A0MTJ0" charOffset="35-39" type="protein" text="TSHR"/>
            <entity id="DS3.d113.s0.e2" origId="P16473,A0A0A0MTJ0" charOffset="60-64" type="protein" text="TSHR"/>
            <entity id="DS3.d113.s0.e3" origId="6274" charOffset="115-124" type="compound" text="histidine"/>
            <entity id="DS3.d113.s0.e4" origId="P16473,A0A0A0MTJ0" charOffset="60-64" type="protein" text="TSHR"/>
            <pair e1="DS3.d113.s0.e3" e2="DS3.d113.s0.e1" id="DS3.d113.s0.i0" interaction="False" />
            <pair e1="DS3.d113.s0.e3" e2="DS3.d113.s0.e0" id="DS3.d113.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d113.s1" origId="10022441-5" text="Screening of a TSHR complementary DNA fragment expression library localized the 3BD10 epitope to 27 amino acids at the N-terminus of the TSHR, a cysteine-rich segment predicted to be highly conformational.">
            <entity id="DS3.d113.s1.e0" origId="P16473,A0A0A0MTJ0" charOffset="15-19" type="protein" text="TSHR"/>
            <entity id="DS3.d113.s1.e1" origId="P16473,A0A0A0MTJ0" charOffset="137-141" type="protein" text="TSHR"/>
            <entity id="DS3.d113.s1.e2" origId="5862,90793998" charOffset="145-153" type="compound" text="cysteine"/>
            <pair e1="DS3.d113.s1.e2" e2="DS3.d113.s1.e0" id="DS3.d113.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d114" origId="10022444">
        <sentence id="DS3.d114.s0" origId="10022444-3" text="Plasma BNP, cGMP, and cortisol were significantly increased by all three treatments (P &amp;lt; 0.05-P &amp;lt; 0.001).">
            <entity id="DS3.d114.s0.e0" origId="P16860" charOffset="7-10" type="protein" text="BNP"/>
            <entity id="DS3.d114.s0.e1" origId="5754" charOffset="22-30" type="compound" text="cortisol"/>
            <pair e1="DS3.d114.s0.e1" e2="DS3.d114.s0.e0" id="DS3.d114.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d114.s1" origId="10022444-8" text="Urine sodium excretion, increased by NEP inhibition (P &amp;lt; 0.05) and by BNP (P = 0.05), was unchanged during combined treatment.">
            <entity id="DS3.d114.s1.e0" origId="5360545" charOffset="6-12" type="compound" text="sodium"/>
            <entity id="DS3.d114.s1.e1" origId="P08473" charOffset="37-40" type="protein" text="NEP"/>
            <entity id="DS3.d114.s1.e2" origId="P16860" charOffset="73-76" type="protein" text="BNP"/>
            <pair e1="DS3.d114.s1.e0" e2="DS3.d114.s1.e2" id="DS3.d114.s1.i0" interaction="False" />
            <pair e1="DS3.d114.s1.e0" e2="DS3.d114.s1.e1" id="DS3.d114.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d115" origId="10022445">
        <sentence id="DS3.d115.s0" origId="10022445-0" text="Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16.">
            <entity id="DS3.d115.s0.e0" origId="O00255,Q9GZQ5,A0A024R5E3,A0A024R5D2" charOffset="68-72" type="protein" text="MEN1"/>
            <entity id="DS3.d115.s0.e1" origId="10182969" charOffset="121-125" type="compound" text="2p16"/>
            <pair e1="DS3.d115.s0.e1" e2="DS3.d115.s0.e0" id="DS3.d115.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d116" origId="10022446">
        <sentence id="DS3.d116.s0" origId="10022446-5" text="Positive relationships were also found between the lipolytic sensitivity of s.c. abdominal adipocytes and plasma insulin concentrations measured in the fasting state and after an oral glucose load.">
            <entity id="DS3.d116.s0.e0" origId="P01308,I3WAC9" charOffset="113-120" type="protein" text="insulin"/>
            <entity id="DS3.d116.s0.e1" origId="206,5793,64689,79025" charOffset="184-191" type="compound" text="glucose"/>
            <pair e1="DS3.d116.s0.e1" e2="DS3.d116.s0.e0" id="DS3.d116.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d117" origId="10022454">
        <sentence id="DS3.d117.s0" origId="10022454-4" text="Pituitary hormone promoters (human GH or glycoprotein hormone alpha-subunit) were used to express either a marker gene (beta-galactosidase (beta-gal)) or a toxic gene (herpes simplex virus thymidine kinase (TK)).">
            <entity id="DS3.d117.s0.e0" origId="P16278" charOffset="120-138" type="protein" text="beta-galactosidase"/>
            <entity id="DS3.d117.s0.e1" origId="5789" charOffset="189-198" type="compound" text="thymidine"/>
            <pair e1="DS3.d117.s0.e1" e2="DS3.d117.s0.e0" id="DS3.d117.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d118" origId="10022455">
        <sentence id="DS3.d118.s0" origId="10022455-0" text="Reduced retinal vascularization in children with growth hormone deficiency.">
            <entity id="DS3.d118.s0.e0" origId="638015" charOffset="8-15" type="compound" text="retinal"/>
            <entity id="DS3.d118.s0.e1" origId="P01241,B1A4G6,B1A4G7" charOffset="49-63" type="protein" text="growth hormone"/>
            <pair e1="DS3.d118.s0.e0" e2="DS3.d118.s0.e1" id="DS3.d118.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d119" origId="10022458">
        <sentence id="DS3.d119.s0" origId="10022458-1" text="We have characterized two different mutations of the human androgen receptor (hAR) found in two unrelated subjects with androgen insensitivity syndrome (AIS): in one, the external genitalia were ambiguous (partial, PAIS); in the other, they were male, but small (mild, MAIS).">
            <entity id="DS3.d119.s0.e0" origId="P10275,F1D8N5,A0A0B4J1T2" charOffset="53-76" type="protein" text="human androgen receptor"/>
            <entity id="DS3.d119.s0.e1" origId="123895" charOffset="78-81" type="compound" text="hAR"/>
            <entity id="DS3.d119.s0.e2" origId="P22234,A0A024RD93" charOffset="215-219" type="protein" text="PAIS"/>
            <pair e1="DS3.d119.s0.e1" e2="DS3.d119.s0.e2" id="DS3.d119.s0.i0" interaction="False" />
            <pair e1="DS3.d119.s0.e1" e2="DS3.d119.s0.e0" id="DS3.d119.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d119.s1" origId="10022458-4" text="Nonetheless, the mutant hAR from the PAIS subject (E772A) has elevated nonequilibrium dissociation rate constants (k(diss)) for both androgens.">
            <entity id="DS3.d119.s1.e0" origId="123895" charOffset="24-27" type="compound" text="hAR"/>
            <entity id="DS3.d119.s1.e1" origId="P22234,A0A024RD93" charOffset="37-41" type="protein" text="PAIS"/>
            <pair e1="DS3.d119.s1.e0" e2="DS3.d119.s1.e1" id="DS3.d119.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d119.s2" origId="10022458-5" text="In contrast, the MAIS subject's hAR (R871G) has k(diss) values that are apparently normal for MB and methyltrienolone; in addition, the R871G hAR's ability to bind MB resists thermal stress better than the hAR from the PAIS subject.">
            <entity id="DS3.d119.s2.e0" origId="123895" charOffset="32-35" type="compound" text="hAR"/>
            <entity id="DS3.d119.s2.e1" origId="123895" charOffset="142-145" type="compound" text="hAR"/>
            <entity id="DS3.d119.s2.e2" origId="123895" charOffset="142-145" type="compound" text="hAR"/>
            <entity id="DS3.d119.s2.e3" origId="P22234,A0A024RD93" charOffset="219-223" type="protein" text="PAIS"/>
            <pair e1="DS3.d119.s2.e0" e2="DS3.d119.s2.e3" id="DS3.d119.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d120" origId="10022460">
        <sentence id="DS3.d120.s0" origId="10022460-2" text="17Beta-estradiol is known to inhibit endothelial vascular cell adhesion molecule (VCAM)-1 expression.">
            <entity id="DS3.d120.s0.e0" origId="56981346" charOffset="0-16" type="compound" text="17Beta-estradiol"/>
            <entity id="DS3.d120.s0.e1" origId="P19320" charOffset="49-89" type="protein" text="vascular cell adhesion molecule (VCAM)-1"/>
            <pair e1="DS3.d120.s0.e0" e2="DS3.d120.s0.e1" id="DS3.d120.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d120.s1" origId="10022460-3" text="We studied the relative effects of the raloxifene analogue LY117018 and of tamoxifen on lipopolysaccharide (LPS)-induced VCAM-1 expression in cultured human saphenous vein endothelial cells (HSVEC) and on HSVEC adhesiveness towards U937 monocytoid cells.">
            <entity id="DS3.d120.s1.e0" origId="5035" charOffset="39-49" type="compound" text="raloxifene"/>
            <entity id="DS3.d120.s1.e1" origId="2733526" charOffset="75-84" type="compound" text="tamoxifen"/>
            <entity id="DS3.d120.s1.e2" origId="11970143" charOffset="88-106" type="compound" text="lipopolysaccharide"/>
            <entity id="DS3.d120.s1.e3" origId="P19320" charOffset="121-127" type="protein" text="VCAM-1"/>
            <pair e1="DS3.d120.s1.e2" e2="DS3.d120.s1.e3" id="DS3.d120.s1.i0" interaction="False" />
            <pair e1="DS3.d120.s1.e1" e2="DS3.d120.s1.e3" id="DS3.d120.s1.i1" interaction="False" />
            <pair e1="DS3.d120.s1.e0" e2="DS3.d120.s1.e3" id="DS3.d120.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d120.s2" origId="10022460-4" text="We here demonstrate a concentration-dependent inhibitory action on VCAM-1 protein expression both for 17beta-estradiol and LY117018.">
            <entity id="DS3.d120.s2.e0" origId="P19320" charOffset="67-73" type="protein" text="VCAM-1"/>
            <entity id="DS3.d120.s2.e1" origId="56981346" charOffset="102-118" type="compound" text="17beta-estradiol"/>
            <pair e1="DS3.d120.s2.e1" e2="DS3.d120.s2.e0" id="DS3.d120.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d120.s3" origId="10022460-8" text="Both 17beta-estradiol and LY117018 inhibited HSVEC VCAM-1 expression at the mRNA level, while tamoxifen was ineffective.">
            <entity id="DS3.d120.s3.e0" origId="56981346" charOffset="5-21" type="compound" text="17beta-estradiol"/>
            <entity id="DS3.d120.s3.e1" origId="P19320" charOffset="51-57" type="protein" text="VCAM-1"/>
            <entity id="DS3.d120.s3.e2" origId="2733526" charOffset="94-103" type="compound" text="tamoxifen"/>
            <pair e1="DS3.d120.s3.e0" e2="DS3.d120.s3.e1" id="DS3.d120.s3.i0" interaction="False" />
            <pair e1="DS3.d120.s3.e2" e2="DS3.d120.s3.e1" id="DS3.d120.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d121" origId="10022481">
        <sentence id="DS3.d121.s0" origId="10022481-1" text="We studied the off-response of the rat ERG evoked with long duration, mesopic stimuli during light and dark adaptation, and after intravitreal injection of aspartate and (+/-)-cis-piperidine-2,3-dicarboxylic acid (PDA).">
            <entity id="DS3.d121.s0.e0" origId="A0A0G2JWE9,Q91XV5" charOffset="39-42" type="protein" text="ERG"/>
            <entity id="DS3.d121.s0.e1" origId="5960" charOffset="156-165" type="compound" text="aspartate"/>
            <entity id="DS3.d121.s0.e2" origId="11957663,1226" charOffset="176-212" type="compound" text="cis-piperidine-2,3-dicarboxylic acid"/>
            <pair e1="DS3.d121.s0.e2" e2="DS3.d121.s0.e0" id="DS3.d121.s0.i0" interaction="False" />
            <pair e1="DS3.d121.s0.e1" e2="DS3.d121.s0.e0" id="DS3.d121.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d121.s1" origId="10022481-7" text="In the presence of aspartate, the fast-positive component was absent from the ERG while the remaining positive-going decay of the receptor potential had a time course similar to that of the slow-positive component in the untreated eye.">
            <entity id="DS3.d121.s1.e0" origId="5960" charOffset="19-28" type="compound" text="aspartate"/>
            <entity id="DS3.d121.s1.e1" origId="A0A0G2JWE9,Q91XV5" charOffset="78-81" type="protein" text="ERG"/>
            <pair e1="DS3.d121.s1.e0" e2="DS3.d121.s1.e1" id="DS3.d121.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d122" origId="10022488">
        <sentence id="DS3.d122.s0" origId="10022488-1" text="The distribution of AMPA-selective glutamate receptor subunits was studied in the cat retina using antisera against GluR1 and GluR2/3.">
            <entity id="DS3.d122.s0.e0" origId="23327,33032,611,57109091" charOffset="35-44" type="compound" text="glutamate"/>
            <entity id="DS3.d122.s0.e1" origId="P42261,Q59GL5" charOffset="116-121" type="protein" text="GluR1"/>
            <entity id="DS3.d122.s0.e2" origId="P42262" charOffset="126-131" type="protein" text="GluR2"/>
            <pair e1="DS3.d122.s0.e0" e2="DS3.d122.s0.e1" id="DS3.d122.s0.i0" interaction="False" />
            <pair e1="DS3.d122.s0.e0" e2="DS3.d122.s0.e2" id="DS3.d122.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d123" origId="10022501">
        <sentence id="DS3.d123.s0" origId="10022501-1" text="We have isolated a mouse lysyl oxidase-like (LOXL) cDNA from a mouse embryo cDNA library and used this cDNA to measure changes in steady state levels of LOXL mRNA during the development of carbon tetrachloride-induced liver fibrosis in adult mice.">
            <entity id="DS3.d123.s0.e0" origId="P97873" charOffset="25-43" type="protein" text="lysyl oxidase-like"/>
            <entity id="DS3.d123.s0.e1" origId="P97873" charOffset="45-49" type="protein" text="LOXL"/>
            <entity id="DS3.d123.s0.e2" origId="P97873" charOffset="153-157" type="protein" text="LOXL"/>
            <entity id="DS3.d123.s0.e3" origId="5943" charOffset="189-209" type="compound" text="carbon tetrachloride"/>
            <pair e1="DS3.d123.s0.e3" e2="DS3.d123.s0.e0" id="DS3.d123.s0.i0" interaction="False" />
            <pair e1="DS3.d123.s0.e3" e2="DS3.d123.s0.e1" id="DS3.d123.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d123.s1" origId="10022501-4" text="These findings suggest that the LOXL protein (possibly an isoform of lysyl oxidase) is involved in the development of lysine-derived cross-links in collagenous substrates.">
            <entity id="DS3.d123.s1.e0" origId="P97873" charOffset="32-36" type="protein" text="LOXL"/>
            <entity id="DS3.d123.s1.e1" origId="447025" charOffset="69-74" type="compound" text="lysyl"/>
            <entity id="DS3.d123.s1.e2" origId="57449,5962,866" charOffset="118-124" type="compound" text="lysine"/>
            <pair e1="DS3.d123.s1.e2" e2="DS3.d123.s1.e0" id="DS3.d123.s1.i0" interaction="False" />
            <pair e1="DS3.d123.s1.e1" e2="DS3.d123.s1.e0" id="DS3.d123.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d123.s2" origId="10022501-5" text="Moreover, the substrate specificity of the LOXL protein may be different to that of lysyl oxidase and this difference may be collagen-type specific.">
            <entity id="DS3.d123.s2.e0" origId="P97873" charOffset="43-47" type="protein" text="LOXL"/>
            <entity id="DS3.d123.s2.e1" origId="447025" charOffset="84-89" type="compound" text="lysyl"/>
            <pair e1="DS3.d123.s2.e1" e2="DS3.d123.s2.e0" id="DS3.d123.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d124" origId="10022502">
        <sentence id="DS3.d124.s0" origId="10022502-11" text="Flow cytometric analysis of Chinese hamster ovary (CHO) cells expressing different human integrin chains revealed that MAbs 7A8 and 7B11 detect the alpha3 integrin subunit whereas MAbs 8C7 and 8H7 detect the beta1 integrin subunit.">
            <entity id="DS3.d124.s0.e0" origId="447259" charOffset="124-127" type="compound" text="7A8"/>
            <entity id="DS3.d124.s0.e1" origId="P05556" charOffset="208-222" type="protein" text="beta1 integrin"/>
            <pair e1="DS3.d124.s0.e0" e2="DS3.d124.s0.e1" id="DS3.d124.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d124.s1" origId="10022502-15" text="In addition, both alpha3 and beta1 integrin subunits express beta1-6 branched Asn-linked oligosaccharides and short poly-N-acetyllactosamine units (Galbeta1-4GlcNAc-R; n &amp;lt; or = 3), glycans previously implicated in cancer metastasis.Thus, alpha3beta1 integrin expressed by human colon carcinoma cells is a major carrier of oncodevelopmental carbohydrate epitopes whose presence may modulate tumor cell adhesion, migration, and/or invasion.">
            <entity id="DS3.d124.s1.e0" origId="P05556" charOffset="29-43" type="protein" text="beta1 integrin"/>
            <entity id="DS3.d124.s1.e1" origId="P04350" charOffset="61-68" type="protein" text="beta1-6"/>
            <entity id="DS3.d124.s1.e2" origId="119547" charOffset="116-140" type="compound" text="poly-N-acetyllactosamine"/>
            <entity id="DS3.d124.s1.e3" origId="871" charOffset="184-191" type="compound" text="glycans"/>
            <pair e1="DS3.d124.s1.e3" e2="DS3.d124.s1.e0" id="DS3.d124.s1.i0" interaction="False" />
            <pair e1="DS3.d124.s1.e3" e2="DS3.d124.s1.e1" id="DS3.d124.s1.i1" interaction="False" />
            <pair e1="DS3.d124.s1.e2" e2="DS3.d124.s1.e0" id="DS3.d124.s1.i2" interaction="False" />
            <pair e1="DS3.d124.s1.e2" e2="DS3.d124.s1.e1" id="DS3.d124.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d125" origId="10022506">
        <sentence id="DS3.d125.s0" origId="10022506-9" text="Histone H1 effect appeared to be mediated mainly by charge effect since a stretch of polylysine induced a similar effect.">
            <entity id="DS3.d125.s0.e0" origId="P07305" charOffset="0-10" type="protein" text="Histone H1"/>
            <entity id="DS3.d125.s0.e1" origId="162282" charOffset="85-95" type="compound" text="polylysine"/>
            <pair e1="DS3.d125.s0.e1" e2="DS3.d125.s0.e0" id="DS3.d125.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d126" origId="10022507">
        <sentence id="DS3.d126.s0" origId="10022507-4" text="OPGL (2-50 ng/ml), in combination with CSF-1, hydrocortisone (HC), and 1,25(OH)2D3, increases the size of osteoclast-like cells on bone, as defined by the acquisition of osteoclast markers: vitronectin receptor (VR), tartrate-resistant acid phosphatase (TRAP), multinuclearity, and bone resorption.">
            <entity id="DS3.d126.s0.e0" origId="O14788,Q5T9Y4,Q54A98" charOffset="0-4" type="protein" text="OPGL"/>
            <entity id="DS3.d126.s0.e1" origId="P09603,A0A024R0A1" charOffset="39-44" type="protein" text="CSF-1"/>
            <entity id="DS3.d126.s0.e2" origId="5754" charOffset="46-60" type="compound" text="hydrocortisone"/>
            <pair e1="DS3.d126.s0.e2" e2="DS3.d126.s0.e0" id="DS3.d126.s0.i0" interaction="False" />
            <pair e1="DS3.d126.s0.e2" e2="DS3.d126.s0.e1" id="DS3.d126.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d126.s1" origId="10022507-5" text="By 14 days, with 20 ng/ml OPGL, the largest cells/10x field have achieved an average diameter of 163+/-38 microm, but only approximately 10-20 microm in its absence and the number of osteoclast-like cells/mm2 bone surface is about 128.">
            <entity id="DS3.d126.s1.e0" origId="O14788,Q5T9Y4,Q54A98" charOffset="26-30" type="protein" text="OPGL"/>
            <entity id="DS3.d126.s1.e1" origId="60210992" charOffset="50-53" type="compound" text="10x"/>
            <entity id="DS3.d126.s1.e2" origId="Q9UL42,Q5U5Z3" charOffset="205-208" type="protein" text="mm2"/>
            <pair e1="DS3.d126.s1.e1" e2="DS3.d126.s1.e0" id="DS3.d126.s1.i0" interaction="False" />
            <pair e1="DS3.d126.s1.e1" e2="DS3.d126.s1.e2" id="DS3.d126.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d127" origId="10022508">
        <sentence id="DS3.d127.s0" origId="10022508-1" text="In osteoblast-like MC3T3-E1 cells, we have recently reported that sphingosine 1-phosphate among sphingomyelin metabolites acts as a second messenger for tumor necrosis factor-alpha (TNF)-induced interleukin-6 (IL-6) synthesis.">
            <entity id="DS3.d127.s0.e0" origId="31270,5280335" charOffset="66-77" type="compound" text="sphingosine"/>
            <entity id="DS3.d127.s0.e1" origId="1061,167704,644102" charOffset="80-89" type="compound" text="phosphate"/>
            <entity id="DS3.d127.s0.e2" origId="P06804,Q3U593" charOffset="153-180" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d127.s0.e3" origId="P08505,A2RTD1" charOffset="195-208" type="protein" text="interleukin-6"/>
            <entity id="DS3.d127.s0.e4" origId="P08505,A2RTD1" charOffset="210-214" type="protein" text="IL-6"/>
            <pair e1="DS3.d127.s0.e1" e2="DS3.d127.s0.e2" id="DS3.d127.s0.i0" interaction="False" />
            <pair e1="DS3.d127.s0.e1" e2="DS3.d127.s0.e4" id="DS3.d127.s0.i1" interaction="False" />
            <pair e1="DS3.d127.s0.e1" e2="DS3.d127.s0.e3" id="DS3.d127.s0.i2" interaction="False" />
            <pair e1="DS3.d127.s0.e0" e2="DS3.d127.s0.e2" id="DS3.d127.s0.i3" interaction="False" />
            <pair e1="DS3.d127.s0.e0" e2="DS3.d127.s0.e4" id="DS3.d127.s0.i4" interaction="False" />
            <pair e1="DS3.d127.s0.e0" e2="DS3.d127.s0.e3" id="DS3.d127.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d127.s1" origId="10022508-4" text="Calphostin C, a highly and potent inhibitor of protein kinase C, enhanced sphingomyelinase-induced IL-6 synthesis.">
            <entity id="DS3.d127.s1.e0" origId="2533" charOffset="0-12" type="compound" text="Calphostin C"/>
            <entity id="DS3.d127.s1.e1" origId="P08505,A2RTD1" charOffset="99-103" type="protein" text="IL-6"/>
            <pair e1="DS3.d127.s1.e0" e2="DS3.d127.s1.e1" id="DS3.d127.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d127.s2" origId="10022508-5" text="DL-Threo-dihydrosphingosine, an inhibitor of sphingosine kinase, significantly inhibited the IL-6 synthesis induced by sphingomyelinase.">
            <entity id="DS3.d127.s2.e0" origId="91486" charOffset="9-27" type="compound" text="dihydrosphingosine"/>
            <entity id="DS3.d127.s2.e1" origId="31270,5280335" charOffset="16-27" type="compound" text="sphingosine"/>
            <entity id="DS3.d127.s2.e2" origId="P08505,A2RTD1" charOffset="93-97" type="protein" text="IL-6"/>
            <pair e1="DS3.d127.s2.e0" e2="DS3.d127.s2.e2" id="DS3.d127.s2.i0" interaction="False" />
            <pair e1="DS3.d127.s2.e1" e2="DS3.d127.s2.e2" id="DS3.d127.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d128" origId="10022509">
        <sentence id="DS3.d128.s0" origId="10022509-4" text="Acetyl-YVAD-chloromethylketone, a caspase-1-like activity inhibitor, inhibits didemnin B-induced apoptosis in Daudi cells, whereas the caspase-3-like activity inhibitor, acetyl-DEVD-aldehyde, has no effect.">
            <entity id="DS3.d128.s0.e0" origId="56603797" charOffset="7-11" type="compound" text="YVAD"/>
            <entity id="DS3.d128.s0.e1" origId="122651,45280821,46173839,5458707,550898,6711227,13895197" charOffset="78-88" type="compound" text="didemnin B"/>
            <entity id="DS3.d128.s0.e2" origId="P42574" charOffset="135-144" type="protein" text="caspase-3"/>
            <pair e1="DS3.d128.s0.e0" e2="DS3.d128.s0.e2" id="DS3.d128.s0.i0" interaction="False" />
            <pair e1="DS3.d128.s0.e1" e2="DS3.d128.s0.e2" id="DS3.d128.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d128.s1" origId="10022509-8" text="These results indicate that a caspase(s) other than caspase-3 is required for didemnin B-induced apoptosis.">
            <entity id="DS3.d128.s1.e0" origId="P42574" charOffset="52-61" type="protein" text="caspase-3"/>
            <entity id="DS3.d128.s1.e1" origId="122651,45280821,46173839,5458707,550898,6711227,13895197" charOffset="78-88" type="compound" text="didemnin B"/>
            <pair e1="DS3.d128.s1.e1" e2="DS3.d128.s1.e0" id="DS3.d128.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d129" origId="10022511">
        <sentence id="DS3.d129.s0" origId="10022511-0" text="Effects of prolactin on aldosterone secretion in rat zona glomerulosa cells.">
            <entity id="DS3.d129.s0.e0" origId="P01237,B5DEM6,B2RYT1" charOffset="11-20" type="protein" text="prolactin"/>
            <entity id="DS3.d129.s0.e1" origId="5839" charOffset="24-35" type="compound" text="aldosterone"/>
            <pair e1="DS3.d129.s0.e1" e2="DS3.d129.s0.e0" id="DS3.d129.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d129.s1" origId="10022511-1" text="Acute effects and action mechanisms of prolactin (PRL) on aldosterone secretion in zona glomerulosa (ZG) cells were investigated in ovariectomized rats.">
            <entity id="DS3.d129.s1.e0" origId="P01237,B5DEM6,B2RYT1" charOffset="39-48" type="protein" text="prolactin"/>
            <entity id="DS3.d129.s1.e1" origId="P01237,B5DEM6,B2RYT1" charOffset="50-53" type="protein" text="PRL"/>
            <entity id="DS3.d129.s1.e2" origId="5839" charOffset="58-69" type="compound" text="aldosterone"/>
            <pair e1="DS3.d129.s1.e2" e2="DS3.d129.s1.e0" id="DS3.d129.s1.i0" interaction="False" />
            <pair e1="DS3.d129.s1.e2" e2="DS3.d129.s1.e1" id="DS3.d129.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d129.s2" origId="10022511-2" text="Administration of ovine PRL (oPRL) increased aldosterone secretion in a dose-dependent manner.">
            <entity id="DS3.d129.s2.e0" origId="P01237,B5DEM6,B2RYT1" charOffset="24-27" type="protein" text="PRL"/>
            <entity id="DS3.d129.s2.e1" origId="5839" charOffset="45-56" type="compound" text="aldosterone"/>
            <pair e1="DS3.d129.s2.e1" e2="DS3.d129.s2.e0" id="DS3.d129.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d129.s3" origId="10022511-4" text="Administration of oPRL produced a marked increase of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in ZG cells.">
            <entity id="DS3.d129.s3.e0" origId="57476835,60961" charOffset="53-62" type="compound" text="adenosine"/>
            <entity id="DS3.d129.s3.e1" origId="G3V8S9" charOffset="91-95" type="protein" text="cAMP"/>
            <pair e1="DS3.d129.s3.e0" e2="DS3.d129.s3.e1" id="DS3.d129.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d129.s4" origId="10022511-5" text="The stimulatory effect of oPRL on aldosterone secretion was attenuated by the administration of angiotensin II (Ang II) and high potassium.">
            <entity id="DS3.d129.s4.e0" origId="5839" charOffset="34-45" type="compound" text="aldosterone"/>
            <entity id="DS3.d129.s4.e1" origId="Q5GAM5" charOffset="96-118" type="protein" text="angiotensin II (Ang II"/>
            <entity id="DS3.d129.s4.e2" origId="5462222" charOffset="129-138" type="compound" text="potassium"/>
            <pair e1="DS3.d129.s4.e2" e2="DS3.d129.s4.e1" id="DS3.d129.s4.i0" interaction="False" />
            <pair e1="DS3.d129.s4.e0" e2="DS3.d129.s4.e1" id="DS3.d129.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d129.s5" origId="10022511-8" text="These data suggest that the increase of aldosterone secretion by oPRL is in part due to (1) the increase of cAMP production, (2) the activation of both L- and T-type Ca2+ channels, and (3) the activation of 21-hydroxylase and aldosterone synthase in rat ZG cells.">
            <entity id="DS3.d129.s5.e0" origId="5839" charOffset="40-51" type="compound" text="aldosterone"/>
            <entity id="DS3.d129.s5.e1" origId="G3V8S9" charOffset="108-112" type="protein" text="cAMP"/>
            <entity id="DS3.d129.s5.e2" origId="5839" charOffset="226-237" type="compound" text="aldosterone"/>
            <pair e1="DS3.d129.s5.e0" e2="DS3.d129.s5.e1" id="DS3.d129.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d130" origId="10022513">
        <sentence id="DS3.d130.s0" origId="10022513-3" text="Several chloramphenicol acetyltransferase constructs were examined in order to analyze the effect of ETS family proteins on the transduction of HO-1 in Xenopus oocytes and in microvessel endothelial cells.">
            <entity id="DS3.d130.s0.e0" origId="5959" charOffset="8-23" type="compound" text="chloramphenicol"/>
            <entity id="DS3.d130.s0.e1" origId="P09601,Q6FH11" charOffset="144-148" type="protein" text="HO-1"/>
            <pair e1="DS3.d130.s0.e0" e2="DS3.d130.s0.e1" id="DS3.d130.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d131" origId="10022515">
        <sentence id="DS3.d131.s0" origId="10022515-1" text="Swiss 3T3 mouse fibroblasts were exposed to 10 microM colchicine to disrupt microtubules, then stimulated with Insulin-like growth factor-I.">
            <entity id="DS3.d131.s0.e0" origId="6167" charOffset="54-64" type="compound" text="colchicine"/>
            <entity id="DS3.d131.s0.e1" origId="P05017,Q4VJC0,Q8CAR0,E9Q138,Q4VJB9,E9PU89,Q547V2" charOffset="111-139" type="protein" text="Insulin-like growth factor-I"/>
            <pair e1="DS3.d131.s0.e0" e2="DS3.d131.s0.e1" id="DS3.d131.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d131.s1" origId="10022515-2" text="Immunoprecipitation experiments showed that Insulin-like growth factor-I receptor and insulin receptor substrate-1 were tyrosine phosphorylated to the same extent in both cells treated with colchicine and in those not exposed to the drug.">
            <entity id="DS3.d131.s1.e0" origId="P05017,Q4VJC0,Q8CAR0,E9Q138,Q4VJB9,E9PU89,Q547V2" charOffset="44-72" type="protein" text="Insulin-like growth factor-I"/>
            <entity id="DS3.d131.s1.e1" origId="P35569,Q543V3" charOffset="86-114" type="protein" text="insulin receptor substrate-1"/>
            <entity id="DS3.d131.s1.e2" origId="6057,90983769" charOffset="120-128" type="compound" text="tyrosine"/>
            <entity id="DS3.d131.s1.e3" origId="6167" charOffset="190-200" type="compound" text="colchicine"/>
            <pair e1="DS3.d131.s1.e3" e2="DS3.d131.s1.e0" id="DS3.d131.s1.i0" interaction="False" />
            <pair e1="DS3.d131.s1.e3" e2="DS3.d131.s1.e1" id="DS3.d131.s1.i1" interaction="False" />
            <pair e1="DS3.d131.s1.e2" e2="DS3.d131.s1.e0" id="DS3.d131.s1.i2" interaction="False" />
            <pair e1="DS3.d131.s1.e2" e2="DS3.d131.s1.e1" id="DS3.d131.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d131.s2" origId="10022515-4" text="While in nuclei prepared from cells not exposed to colchicine it was possible to detect an Insulin-like growth factor-I-dependent increase in the mass of diacylglycerol, as well as stimulation of phospholipase C activity, no similar changes were observed in nuclei obtained from cells treated with colchicine.">
            <entity id="DS3.d131.s2.e0" origId="6167" charOffset="51-61" type="compound" text="colchicine"/>
            <entity id="DS3.d131.s2.e1" origId="P05017,Q4VJC0,Q8CAR0,E9Q138,Q4VJB9,E9PU89,Q547V2" charOffset="91-119" type="protein" text="Insulin-like growth factor-I"/>
            <entity id="DS3.d131.s2.e2" origId="6026790" charOffset="154-168" type="compound" text="diacylglycerol"/>
            <entity id="DS3.d131.s2.e3" origId="6167" charOffset="298-308" type="compound" text="colchicine"/>
            <pair e1="DS3.d131.s2.e2" e2="DS3.d131.s2.e1" id="DS3.d131.s2.i0" interaction="False" />
            <pair e1="DS3.d131.s2.e0" e2="DS3.d131.s2.e1" id="DS3.d131.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d131.s3" origId="10022515-7" text="These results show that in Swiss 3T3 cells some as yet unknown events necessary for the Insulin-like growth factor-I-dependent activation of nuclear polyphosphoinositide metabolism require the presence of an intact cytoskeleton and are situated down-stream the activation of insulin receptor substrate-1 and phosphatidylinositol 3-kinase.">
            <entity id="DS3.d131.s3.e0" origId="P05017,Q4VJC0,Q8CAR0,E9Q138,Q4VJB9,E9PU89,Q547V2" charOffset="88-116" type="protein" text="Insulin-like growth factor-I"/>
            <entity id="DS3.d131.s3.e1" origId="P35569,Q543V3" charOffset="275-303" type="protein" text="insulin receptor substrate-1"/>
            <entity id="DS3.d131.s3.e2" origId="16738692,53477912" charOffset="308-328" type="compound" text="phosphatidylinositol"/>
            <pair e1="DS3.d131.s3.e2" e2="DS3.d131.s3.e0" id="DS3.d131.s3.i0" interaction="False" />
            <pair e1="DS3.d131.s3.e2" e2="DS3.d131.s3.e1" id="DS3.d131.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d132" origId="10022517">
        <sentence id="DS3.d132.s0" origId="10022517-4" text="The peptide sequence responsible for the interaction of BPAG2 was restricted to amino acids 15-25, and substitution of a valine residue in the middle of this sequence by a proline (V23P) by site-directed mutagenesis abolished the interaction.">
            <entity id="DS3.d132.s0.e0" origId="Q9UMD9" charOffset="56-61" type="protein" text="BPAG2"/>
            <entity id="DS3.d132.s0.e1" origId="6287" charOffset="121-127" type="compound" text="valine"/>
            <entity id="DS3.d132.s0.e2" origId="57240853,614,8988" charOffset="172-179" type="compound" text="proline"/>
            <pair e1="DS3.d132.s0.e2" e2="DS3.d132.s0.e0" id="DS3.d132.s0.i0" interaction="False" />
            <pair e1="DS3.d132.s0.e1" e2="DS3.d132.s0.e0" id="DS3.d132.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d133" origId="10022519">
        <sentence id="DS3.d133.s0" origId="10022519-9" text="Gel-shift assay data indicate a decrease in specific binding to AP-1 oligonucleotide of nuclear extract from IFN-gamma and PMA/IFN-gamma-treated cells.">
            <entity id="DS3.d133.s0.e0" origId="P01579" charOffset="109-118" type="protein" text="IFN-gamma"/>
            <entity id="DS3.d133.s0.e1" origId="122634,22833501,4792,27924" charOffset="123-126" type="compound" text="PMA"/>
            <entity id="DS3.d133.s0.e2" origId="P01579" charOffset="127-136" type="protein" text="IFN-gamma"/>
            <pair e1="DS3.d133.s0.e1" e2="DS3.d133.s0.e0" id="DS3.d133.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d134" origId="10022520">
        <sentence id="DS3.d134.s0" origId="10022520-7" text="IL-1beta enhanced the formation of primitive myeloid colonies in response to GM-CSF by 160%.">
            <entity id="DS3.d134.s0.e0" origId="P01584" charOffset="0-8" type="protein" text="IL-1beta"/>
            <entity id="DS3.d134.s0.e1" origId="16122568,16750043,4369303,448383" charOffset="80-83" type="compound" text="CSF"/>
            <pair e1="DS3.d134.s0.e1" e2="DS3.d134.s0.e0" id="DS3.d134.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d134.s1" origId="10022520-9" text="Addition of IL-1beta to GM-CSF-stimulated cultures dampened the inhibitory effect of 1,25(OH)2D3.">
            <entity id="DS3.d134.s1.e0" origId="P01584" charOffset="12-20" type="protein" text="IL-1beta"/>
            <entity id="DS3.d134.s1.e1" origId="16122568,16750043,4369303,448383" charOffset="27-30" type="compound" text="CSF"/>
            <pair e1="DS3.d134.s1.e1" e2="DS3.d134.s1.e0" id="DS3.d134.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d135" origId="10022522">
        <sentence id="DS3.d135.s0" origId="10022522-3" text="Treatment with retinoic acid for periods of &amp;lt; or = 4 h resulted in dephosphorylation of nuclear U1 70K protein without affecting its abundance.">
            <entity id="DS3.d135.s0.e0" origId="444795" charOffset="15-28" type="compound" text="retinoic acid"/>
            <entity id="DS3.d135.s0.e1" origId="P08621,Q9UFS1,A0A024QZD5" charOffset="99-105" type="protein" text="U1 70K"/>
            <pair e1="DS3.d135.s0.e0" e2="DS3.d135.s0.e1" id="DS3.d135.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d135.s1" origId="10022522-6" text="Tumor necrosis factor-alpha, which enhances the posttranscriptional action of retinoic acid, reduced U1 70K mRNA expression, while an inhibition of retinoic acid action by transforming growth factor-beta was associated with a marked increase in U1 70K mRNA levels.">
            <entity id="DS3.d135.s1.e0" origId="P01375,Q5STB3" charOffset="0-27" type="protein" text="Tumor necrosis factor-alpha"/>
            <entity id="DS3.d135.s1.e1" origId="444795" charOffset="78-91" type="compound" text="retinoic acid"/>
            <entity id="DS3.d135.s1.e2" origId="P08621,Q9UFS1,A0A024QZD5" charOffset="101-107" type="protein" text="U1 70K"/>
            <entity id="DS3.d135.s1.e3" origId="444795" charOffset="148-161" type="compound" text="retinoic acid"/>
            <entity id="DS3.d135.s1.e4" origId="P08621,Q9UFS1,A0A024QZD5" charOffset="245-251" type="protein" text="U1 70K"/>
            <pair e1="DS3.d135.s1.e1" e2="DS3.d135.s1.e0" id="DS3.d135.s1.i0" interaction="False" />
            <pair e1="DS3.d135.s1.e1" e2="DS3.d135.s1.e2" id="DS3.d135.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d136" origId="10022523">
        <sentence id="DS3.d136.s0" origId="10022523-5" text="The cleavage of the membrane-anchored forms to release a secreted from of BTC was not enhanced by biological mediators such as a phorbol ester, which stimulates the cleavage of other membrane-anchored growth factors.">
            <entity id="DS3.d136.s0.e0" origId="Q9JJM4" charOffset="74-77" type="protein" text="BTC"/>
            <entity id="DS3.d136.s0.e1" origId="22833501,27924,70702034" charOffset="129-142" type="compound" text="phorbol ester"/>
            <pair e1="DS3.d136.s0.e1" e2="DS3.d136.s0.e0" id="DS3.d136.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d137" origId="10022524">
        <sentence id="DS3.d137.s0" origId="10022524-7" text="Sequence comparison showed that RS is almost identical to DJ-1, a recently discovered protein with an oncogenic potential, and CAP1, a rat sperm protein.">
            <entity id="DS3.d137.s0.e0" origId="7021454" charOffset="32-34" type="compound" text="RS"/>
            <entity id="DS3.d137.s0.e1" origId="O88767,Q5BKC3" charOffset="58-62" type="protein" text="DJ-1"/>
            <entity id="DS3.d137.s0.e2" origId="Q08163" charOffset="127-131" type="protein" text="CAP1"/>
            <pair e1="DS3.d137.s0.e0" e2="DS3.d137.s0.e1" id="DS3.d137.s0.i0" interaction="False" />
            <pair e1="DS3.d137.s0.e0" e2="DS3.d137.s0.e2" id="DS3.d137.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d138" origId="10022530">
        <sentence id="DS3.d138.s0" origId="10022530-3" text="Alginate-poly-L-lysine-alginate microcapsules enclosing mouse C2C12 myoblasts expressing the marker gene human growth hormone (hGH) at 95+/-20 ng/million cells/hr were implanted into the right lateral ventricles of mice under stereotaxic guidance.">
            <entity id="DS3.d138.s0.e0" origId="53627445" charOffset="9-22" type="compound" text="poly-L-lysine"/>
            <entity id="DS3.d138.s0.e1" origId="P01241,B1A4G6,B1A4G7" charOffset="105-125" type="protein" text="human growth hormone"/>
            <pair e1="DS3.d138.s0.e0" e2="DS3.d138.s0.e1" id="DS3.d138.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d139" origId="10022531">
        <sentence id="DS3.d139.s0" origId="10022531-7" text="Both hFVIII forms were correctly cleaved and activated by thrombin.">
            <entity id="DS3.d139.s0.e0" origId="P00451" charOffset="5-11" type="protein" text="hFVIII"/>
            <entity id="DS3.d139.s0.e1" origId="90470996" charOffset="58-66" type="compound" text="thrombin"/>
            <pair e1="DS3.d139.s0.e1" e2="DS3.d139.s0.e0" id="DS3.d139.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d140" origId="10022535">
        <sentence id="DS3.d140.s0" origId="10022535-0" text="Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.">
            <entity id="DS3.d140.s0.e0" origId="P04618,Q77YF8" charOffset="57-60" type="protein" text="Rev"/>
            <entity id="DS3.d140.s0.e1" origId="597" charOffset="85-93" type="compound" text="cytosine"/>
            <entity id="DS3.d140.s0.e2" origId="P04618,Q77YF8" charOffset="186-189" type="protein" text="Rev"/>
            <pair e1="DS3.d140.s0.e1" e2="DS3.d140.s0.e0" id="DS3.d140.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d141" origId="10022539">
        <sentence id="DS3.d141.s0" origId="10022539-0" text="Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol.">
            <entity id="DS3.d141.s0.e0" origId="P60568,Q0GK43" charOffset="150-155" type="protein" text="hIL-2"/>
            <entity id="DS3.d141.s0.e1" origId="6913074" charOffset="179-184" type="compound" text="DOTMA"/>
            <pair e1="DS3.d141.s0.e1" e2="DS3.d141.s0.e0" id="DS3.d141.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d141.s1" origId="10022539-9" text="We now perform a placebo-controlled, dose-rising study of the safety and tolerability of a single intratumoral injection of hIL-2 plasmid at four dose levels formulated in DOTMA/Chol in patients with primary untreated head and neck squamous cell cancer (HNSCC) TNM stage II-IV.">
            <entity id="DS3.d141.s1.e0" origId="P60568,Q0GK43" charOffset="124-129" type="protein" text="hIL-2"/>
            <entity id="DS3.d141.s1.e1" origId="6913074" charOffset="172-177" type="compound" text="DOTMA"/>
            <pair e1="DS3.d141.s1.e1" e2="DS3.d141.s1.e0" id="DS3.d141.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d142" origId="10022541">
        <sentence id="DS3.d142.s0" origId="10022541-3" text="We show, in a reporter gene assay, activation of HK II in non-small cell lung carcinomas NCI-H661 and NCI-H460 at 61 and 40%, respectively, relative to the activation observed with a constitutive promoter, while it was only 0.9% in different preparations of primary normal human bronchial epithelial cells (NHBECs).">
            <entity id="DS3.d142.s0.e0" origId="P52789" charOffset="49-54" type="protein" text="HK II"/>
            <entity id="DS3.d142.s0.e1" origId="5311065" charOffset="93-97" type="compound" text="H661"/>
            <pair e1="DS3.d142.s0.e1" e2="DS3.d142.s0.e0" id="DS3.d142.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d142.s1" origId="10022541-5" text="Moreover, treatment of the transfectants with glucagon did not inhibit promoter activation in the transformed H661 cells, while endogenous HK II in NHBECs is suppressed by glucagon.">
            <entity id="DS3.d142.s1.e0" origId="5311065" charOffset="110-114" type="compound" text="H661"/>
            <entity id="DS3.d142.s1.e1" origId="P52789" charOffset="139-144" type="protein" text="HK II"/>
            <pair e1="DS3.d142.s1.e0" e2="DS3.d142.s1.e1" id="DS3.d142.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d142.s2" origId="10022541-6" text="H460 and H661 cells infected with a recombinant adenovirus carrying an HK II/LacZ expression cassette, AdHexLacZ, demonstrated beta-galactosidase activity that correlated with the level of HK II promoter activation in these cells.">
            <entity id="DS3.d142.s2.e0" origId="5311065" charOffset="9-13" type="compound" text="H661"/>
            <entity id="DS3.d142.s2.e1" origId="P52789" charOffset="71-76" type="protein" text="HK II"/>
            <entity id="DS3.d142.s2.e2" origId="P16278" charOffset="127-145" type="protein" text="beta-galactosidase"/>
            <entity id="DS3.d142.s2.e3" origId="P52789" charOffset="189-194" type="protein" text="HK II"/>
            <pair e1="DS3.d142.s2.e0" e2="DS3.d142.s2.e1" id="DS3.d142.s2.i0" interaction="False" />
            <pair e1="DS3.d142.s2.e0" e2="DS3.d142.s2.e2" id="DS3.d142.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d143" origId="10022545">
        <sentence id="DS3.d143.s0" origId="10022545-2" text="Our aim was to test the effect of dose, route of delivery, and hydroxyurea treatment on brain expression of beta-galactosidase activity after cerebral inoculation with an rAAV-lacZ vector (rAAV-beta-gal).">
            <entity id="DS3.d143.s0.e0" origId="3657" charOffset="63-74" type="compound" text="hydroxyurea"/>
            <entity id="DS3.d143.s0.e1" origId="P23780,Q3TAW7" charOffset="108-126" type="protein" text="beta-galactosidase"/>
            <pair e1="DS3.d143.s0.e0" e2="DS3.d143.s0.e1" id="DS3.d143.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d144" origId="10022548">
        <sentence id="DS3.d144.s0" origId="10022548-1" text="In an effort to develop a gene-dependent enzyme/prodrug therapy (GDEPT) for tumor-specific delivery of methotrexate (MTX) we have chosen to construct mutant forms of carboxypeptidase A1 (CPA) that circumvent the requirement for trypsin-dependent activation.">
            <entity id="DS3.d144.s0.e0" origId="126941" charOffset="117-120" type="compound" text="MTX"/>
            <entity id="DS3.d144.s0.e1" origId="P15085" charOffset="166-185" type="protein" text="carboxypeptidase A1"/>
            <pair e1="DS3.d144.s0.e0" e2="DS3.d144.s0.e1" id="DS3.d144.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d145" origId="10022551">
        <sentence id="DS3.d145.s0" origId="10022551-7" text="In addition, cells were efficiently transduced by an adenoviral vector encoding human tyrosine hydroxylase (hTH) under the negative control of the tetracycline-based regulatory system (tet-off).">
            <entity id="DS3.d145.s0.e0" origId="P07101,P78428" charOffset="80-106" type="protein" text="human tyrosine hydroxylase"/>
            <entity id="DS3.d145.s0.e1" origId="54675776" charOffset="147-159" type="compound" text="tetracycline"/>
            <pair e1="DS3.d145.s0.e1" e2="DS3.d145.s0.e0" id="DS3.d145.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d146" origId="10022554">
        <sentence id="DS3.d146.s0" origId="10022554-10" text="Expression of hAT at levels 800- to 1500-fold higher than background conferred significant resistance (p &amp;lt; 0.001) to the toxic effects of mitozolomide.">
            <entity id="DS3.d146.s0.e0" origId="O60235,B4DL57" charOffset="14-17" type="protein" text="hAT"/>
            <entity id="DS3.d146.s0.e1" origId="71766" charOffset="141-153" type="compound" text="mitozolomide"/>
            <pair e1="DS3.d146.s0.e1" e2="DS3.d146.s0.e0" id="DS3.d146.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d146.s1" origId="10022554-11" text="We have therefore successfully conferred a protective advantage against mitozolomide toxicity to cells by rAAV-mediated hAT expression.">
            <entity id="DS3.d146.s1.e0" origId="71766" charOffset="72-84" type="compound" text="mitozolomide"/>
            <entity id="DS3.d146.s1.e1" origId="O60235,B4DL57" charOffset="120-123" type="protein" text="hAT"/>
            <pair e1="DS3.d146.s1.e0" e2="DS3.d146.s1.e1" id="DS3.d146.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d146.s2" origId="10022554-1" text="Recombinant adeno-associated virus (rAAV) encoding the human O6-alkylguanine-DNA-alkyltransferase (hAT) protein and a selectable marker (Neo(r)) was used to transduce human cervical carcinoma (HeLa) cells and erythroleukemic (K562) cells and clones were selected using G418 (0.4 mg/ml).">
            <entity id="DS3.d146.s2.e0" origId="O60235,B4DL57" charOffset="55-97" type="protein" text="human O6-alkylguanine-DNA-alkyltransferase"/>
            <entity id="DS3.d146.s2.e1" origId="O60235,B4DL57" charOffset="99-102" type="protein" text="hAT"/>
            <entity id="DS3.d146.s2.e2" origId="123865" charOffset="269-273" type="compound" text="G418"/>
            <pair e1="DS3.d146.s2.e2" e2="DS3.d146.s2.e1" id="DS3.d146.s2.i0" interaction="False" />
            <pair e1="DS3.d146.s2.e2" e2="DS3.d146.s2.e0" id="DS3.d146.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d146.s3" origId="10022554-5" text="Cell survival analysis following exposure to the chloroethylating agent mitozolomide revealed that expression of hAT at levels two- to fourfold higher than background conferred significant resistance (p &amp;lt; 0.001) to the toxic effects of this drug.">
            <entity id="DS3.d146.s3.e0" origId="71766" charOffset="72-84" type="compound" text="mitozolomide"/>
            <entity id="DS3.d146.s3.e1" origId="O60235,B4DL57" charOffset="113-116" type="protein" text="hAT"/>
            <pair e1="DS3.d146.s3.e0" e2="DS3.d146.s3.e1" id="DS3.d146.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d146.s4" origId="10022554-7" text="Three K562 clones, isolated using G418 selection, were studied in detail and were shown to express hAT activities of 1500, 1010, and 890 fmol/mg protein, respectively, at 40 days posttransduction (mock-transduced K562 cells contain &amp;lt;2 fmol of hAT/mg protein).">
            <entity id="DS3.d146.s4.e0" origId="123865" charOffset="34-38" type="compound" text="G418"/>
            <entity id="DS3.d146.s4.e1" origId="O60235,B4DL57" charOffset="99-102" type="protein" text="hAT"/>
            <entity id="DS3.d146.s4.e2" origId="O60235,B4DL57" charOffset="246-249" type="protein" text="hAT"/>
            <pair e1="DS3.d146.s4.e0" e2="DS3.d146.s4.e1" id="DS3.d146.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d147" origId="10022564">
        <sentence id="DS3.d147.s0" origId="10022564-4" text="In this study, we show that the presence of BMP-2 resulted in a dose-dependent increase in the number of tyrosine hydroxylase-immunoreactive ventral mesencephalic cells after 7 days in serum-free medium cultures.">
            <entity id="DS3.d147.s0.e0" origId="P49001" charOffset="44-49" type="protein" text="BMP-2"/>
            <entity id="DS3.d147.s0.e1" origId="6057,90983769" charOffset="105-113" type="compound" text="tyrosine"/>
            <pair e1="DS3.d147.s0.e1" e2="DS3.d147.s0.e0" id="DS3.d147.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d147.s1" origId="10022564-9" text="This is consistent with the fact that the BMP-2 effect on dopaminergic neurons was observed even when the cultures were treated with alpha-aminoadipic acid to exclude the presence of glial cells.">
            <entity id="DS3.d147.s1.e0" origId="P49001" charOffset="42-47" type="protein" text="BMP-2"/>
            <entity id="DS3.d147.s1.e1" origId="469" charOffset="133-155" type="compound" text="alpha-aminoadipic acid"/>
            <pair e1="DS3.d147.s1.e1" e2="DS3.d147.s1.e0" id="DS3.d147.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d148" origId="10022566">
        <sentence id="DS3.d148.s0" origId="10022566-10" text="It was found that the density of high voltage-activated (HVA) Ca2+ currents increased in parallel with the development of repetitive firing, while the density of Ni2+-sensitive low voltage-activated (LVA) Ca2+ currents decreased.">
            <entity id="DS3.d148.s0.e0" origId="Q99KU0" charOffset="162-165" type="protein" text="Ni2"/>
            <entity id="DS3.d148.s0.e1" origId="64727" charOffset="200-203" type="compound" text="LVA"/>
            <pair e1="DS3.d148.s0.e1" e2="DS3.d148.s0.e0" id="DS3.d148.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d149" origId="10022575">
        <sentence id="DS3.d149.s0" origId="10022575-1" text="Epidermal growth factor receptor (EGFR) levels were assayed by an enzyme-linked immunosorbent assay (ELISA) in microdissected organ of Corti (OC) from neonatal rats directly after isolation and after 3 days in culture with and without neomycin treatment.">
            <entity id="DS3.d149.s0.e0" origId="Q9QX70" charOffset="0-32" type="protein" text="Epidermal growth factor receptor"/>
            <entity id="DS3.d149.s0.e1" origId="Q9QX70" charOffset="34-38" type="protein" text="EGFR"/>
            <entity id="DS3.d149.s0.e2" origId="8378" charOffset="235-243" type="compound" text="neomycin"/>
            <pair e1="DS3.d149.s0.e2" e2="DS3.d149.s0.e0" id="DS3.d149.s0.i0" interaction="False" />
            <pair e1="DS3.d149.s0.e2" e2="DS3.d149.s0.e1" id="DS3.d149.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d149.s1" origId="10022575-3" text="The in vitro level of EGFR determined by ELISA assays doubled after neomycin damage to OC, suggesting that EGFR is subject to up-regulation following this treatment.">
            <entity id="DS3.d149.s1.e0" origId="Q9QX70" charOffset="22-26" type="protein" text="EGFR"/>
            <entity id="DS3.d149.s1.e1" origId="8378" charOffset="68-76" type="compound" text="neomycin"/>
            <entity id="DS3.d149.s1.e2" origId="Q9QX70" charOffset="107-111" type="protein" text="EGFR"/>
            <pair e1="DS3.d149.s1.e1" e2="DS3.d149.s1.e0" id="DS3.d149.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d149.s2" origId="10022575-8" text="The up-regulation of the EGFR and its redistribution within the OC following neomycin damage support the earlier observation that growth factors that act through EGFR, such as EGF and transforming growth factor-alpha can induce neonatal mammalian auditory hair cell replacement under culture conditions, after aminoglycoside treatment.">
            <entity id="DS3.d149.s2.e0" origId="Q9QX70" charOffset="25-29" type="protein" text="EGFR"/>
            <entity id="DS3.d149.s2.e1" origId="8378" charOffset="77-85" type="compound" text="neomycin"/>
            <entity id="DS3.d149.s2.e2" origId="Q9QX70" charOffset="162-166" type="protein" text="EGFR"/>
            <entity id="DS3.d149.s2.e3" origId="P01135,E7EPT6,F8VNR3" charOffset="176-216" type="protein" text="EGF and transforming growth factor-alpha"/>
            <pair e1="DS3.d149.s2.e1" e2="DS3.d149.s2.e0" id="DS3.d149.s2.i0" interaction="False" />
            <pair e1="DS3.d149.s2.e1" e2="DS3.d149.s2.e3" id="DS3.d149.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d150" origId="10022577">
        <sentence id="DS3.d150.s0" origId="10022577-1" text="Analyzing the thyroid hormone (TH)-dependent period of the inner ear, we observed that the presence of triiodothyronine (T3) between postnatal day 3 (P3) and P12 is sufficient for functional maturation of the auditory system.">
            <entity id="DS3.d150.s0.e0" origId="5920" charOffset="121-123" type="compound" text="T3"/>
            <entity id="DS3.d150.s0.e1" origId="Q9NR33" charOffset="158-161" type="protein" text="P12"/>
            <pair e1="DS3.d150.s0.e0" e2="DS3.d150.s0.e1" id="DS3.d150.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d151" origId="10022579">
        <sentence id="DS3.d151.s0" origId="10022579-3" text="We further demonstrate that a thrombin receptor-activating peptide (TRAP), SFLLRNPNDKYEPF, produces a decrement of synapse strength.">
            <entity id="DS3.d151.s0.e0" origId="P30558" charOffset="30-47" type="protein" text="thrombin receptor"/>
            <entity id="DS3.d151.s0.e1" origId="16133232" charOffset="75-89" type="compound" text="SFLLRNPNDKYEPF"/>
            <pair e1="DS3.d151.s0.e1" e2="DS3.d151.s0.e0" id="DS3.d151.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d151.s1" origId="10022579-5" text="Thus, we propose that muscle activity, thrombin release, and thrombin receptor and PKC activation are initial steps in the process of the activity-dependent synapse reduction expressed in our system.">
            <entity id="DS3.d151.s1.e0" origId="90470996" charOffset="39-47" type="compound" text="thrombin"/>
            <entity id="DS3.d151.s1.e1" origId="P30558" charOffset="61-78" type="protein" text="thrombin receptor"/>
            <pair e1="DS3.d151.s1.e0" e2="DS3.d151.s1.e1" id="DS3.d151.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d152" origId="10022580">
        <sentence id="DS3.d152.s0" origId="10022580-0" text="Glial cell line-derived neurotrophic factor (GDNF) promotes the survival of axotomized retinal ganglion cells in adult rats: comparison to and combination with brain-derived neurotrophic factor (BDNF).">
            <entity id="DS3.d152.s0.e0" origId="Q07731,A7UGJ1" charOffset="0-43" type="protein" text="Glial cell line-derived neurotrophic factor"/>
            <entity id="DS3.d152.s0.e1" origId="P39905" charOffset="45-49" type="protein" text="GDNF"/>
            <entity id="DS3.d152.s0.e2" origId="638015" charOffset="87-94" type="compound" text="retinal"/>
            <entity id="DS3.d152.s0.e3" origId="P23363,A0A0G2K624,A0A0H2UI28" charOffset="160-193" type="protein" text="brain-derived neurotrophic factor"/>
            <entity id="DS3.d152.s0.e4" origId="P23560,A0A0E3SU01" charOffset="195-199" type="protein" text="BDNF"/>
            <pair e1="DS3.d152.s0.e2" e2="DS3.d152.s0.e3" id="DS3.d152.s0.i0" interaction="False" />
            <pair e1="DS3.d152.s0.e2" e2="DS3.d152.s0.e4" id="DS3.d152.s0.i1" interaction="False" />
            <pair e1="DS3.d152.s0.e2" e2="DS3.d152.s0.e1" id="DS3.d152.s0.i2" interaction="False" />
            <pair e1="DS3.d152.s0.e2" e2="DS3.d152.s0.e0" id="DS3.d152.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d153" origId="10022594">
        <sentence id="DS3.d153.s0" origId="10022594-1" text="The purpose of this study was to examine the effect of dexamethasone (DEX) on the production of granulocyte and granulocyte-macrophage colony stimulating factors (G-CSF and GM-CSF) by neonatal mononuclear cells.">
            <entity id="DS3.d153.s0.e0" origId="5743" charOffset="55-68" type="compound" text="dexamethasone"/>
            <entity id="DS3.d153.s0.e1" origId="P09919,Q6FH65,Q8N4W3,Q13753" charOffset="163-168" type="protein" text="G-CSF"/>
            <entity id="DS3.d153.s0.e2" origId="Q13753" charOffset="173-179" type="protein" text="GM-CSF"/>
            <pair e1="DS3.d153.s0.e0" e2="DS3.d153.s0.e1" id="DS3.d153.s0.i0" interaction="False" />
            <pair e1="DS3.d153.s0.e0" e2="DS3.d153.s0.e2" id="DS3.d153.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d153.s1" origId="10022594-2" text="Mononuclear cells were isolated from umbilical cord blood and cultured with either phorbol myristate acetate/phytohemagglutinin (PMA/PHA) or Candida albicans with or without DEX (10(-8)-10(-6) M) for 48 h. Cell supernatants were assayed for G-CSF and GM-CSF by ELISA.">
            <entity id="DS3.d153.s1.e0" origId="4792" charOffset="83-108" type="compound" text="phorbol myristate acetate"/>
            <entity id="DS3.d153.s1.e1" origId="122634,27924" charOffset="129-132" type="compound" text="PMA"/>
            <entity id="DS3.d153.s1.e2" origId="P09919,Q6FH65,Q8N4W3,Q13753" charOffset="241-246" type="protein" text="G-CSF"/>
            <entity id="DS3.d153.s1.e3" origId="Q13753" charOffset="251-257" type="protein" text="GM-CSF"/>
            <pair e1="DS3.d153.s1.e0" e2="DS3.d153.s1.e2" id="DS3.d153.s1.i0" interaction="False" />
            <pair e1="DS3.d153.s1.e0" e2="DS3.d153.s1.e3" id="DS3.d153.s1.i1" interaction="False" />
            <pair e1="DS3.d153.s1.e1" e2="DS3.d153.s1.e2" id="DS3.d153.s1.i2" interaction="False" />
            <pair e1="DS3.d153.s1.e1" e2="DS3.d153.s1.e3" id="DS3.d153.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d153.s2" origId="10022594-3" text="Mononuclear cells from term and preterm infants responded to PMA/PHA stimulation with a significant increase in G-CSF production over baseline levels.">
            <entity id="DS3.d153.s2.e0" origId="122634,27924" charOffset="61-64" type="compound" text="PMA"/>
            <entity id="DS3.d153.s2.e1" origId="P09919,Q6FH65,Q8N4W3,Q13753" charOffset="112-117" type="protein" text="G-CSF"/>
            <pair e1="DS3.d153.s2.e0" e2="DS3.d153.s2.e1" id="DS3.d153.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d153.s3" origId="10022594-4" text="The PMA/PHA-induced increase in G-CSF production was markedly augmented by the addition of DEX to cell cultures.">
            <entity id="DS3.d153.s3.e0" origId="122634,27924" charOffset="4-7" type="compound" text="PMA"/>
            <entity id="DS3.d153.s3.e1" origId="P09919,Q6FH65,Q8N4W3,Q13753" charOffset="32-37" type="protein" text="G-CSF"/>
            <pair e1="DS3.d153.s3.e0" e2="DS3.d153.s3.e1" id="DS3.d153.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d153.s4" origId="10022594-7" text="In contrast, DEX significantly inhibited PMA/PHA-induced GM-CSF production.">
            <entity id="DS3.d153.s4.e0" origId="122634,27924" charOffset="41-44" type="compound" text="PMA"/>
            <entity id="DS3.d153.s4.e1" origId="Q13753" charOffset="57-63" type="protein" text="GM-CSF"/>
            <pair e1="DS3.d153.s4.e0" e2="DS3.d153.s4.e1" id="DS3.d153.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d154" origId="10022600">
        <sentence id="DS3.d154.s0" origId="10022600-10" text="In contrast to the increased expression of SSA/Ro reported for keratinocytes, incubation of cultured human cardiac myocytes with either 17beta-estradiol or progesterone did not alter mRNA expression or cellular localization of 48 kD SSB/La, 52 kD SSA/Ro, or 60 kD SSA/Ro.">
            <entity id="DS3.d154.s0.e0" origId="56981346" charOffset="136-152" type="compound" text="17beta-estradiol"/>
            <entity id="DS3.d154.s0.e1" origId="5994" charOffset="156-168" type="compound" text="progesterone"/>
            <entity id="DS3.d154.s0.e2" origId="P05455" charOffset="233-236" type="protein" text="SSB"/>
            <pair e1="DS3.d154.s0.e0" e2="DS3.d154.s0.e2" id="DS3.d154.s0.i0" interaction="False" />
            <pair e1="DS3.d154.s0.e1" e2="DS3.d154.s0.e2" id="DS3.d154.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d155" origId="10022602">
        <sentence id="DS3.d155.s0" origId="10022602-1" text="Mechanisms of adrenomedullin-induced increases in fetal pulmonary blood flow were examined in 19 near-term fetal sheep using four key blocker drugs: nitric oxide synthase inhibitor (N(omega)-nitro-L-arginine), calcitonin gene-related peptide (CGRP) receptor blocker, ATP-dependent potassium (K(ATP)) channel blocker (glibenclamide), and cyclooxygenase inhibitor (indomethacin).">
            <entity id="DS3.d155.s0.e0" origId="W5PP90" charOffset="14-28" type="protein" text="adrenomedullin"/>
            <entity id="DS3.d155.s0.e1" origId="145068" charOffset="149-161" type="compound" text="nitric oxide"/>
            <entity id="DS3.d155.s0.e2" origId="6322,90867653" charOffset="199-207" type="compound" text="arginine"/>
            <entity id="DS3.d155.s0.e3" origId="5957" charOffset="267-270" type="compound" text="ATP"/>
            <entity id="DS3.d155.s0.e4" origId="5462222" charOffset="281-290" type="compound" text="potassium"/>
            <entity id="DS3.d155.s0.e5" origId="5957" charOffset="294-297" type="compound" text="ATP"/>
            <entity id="DS3.d155.s0.e6" origId="3488" charOffset="317-330" type="compound" text="glibenclamide"/>
            <entity id="DS3.d155.s0.e7" origId="3715" charOffset="363-375" type="compound" text="indomethacin"/>
            <pair e1="DS3.d155.s0.e6" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i0" interaction="False" />
            <pair e1="DS3.d155.s0.e4" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i1" interaction="False" />
            <pair e1="DS3.d155.s0.e2" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i2" interaction="False" />
            <pair e1="DS3.d155.s0.e3" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i3" interaction="False" />
            <pair e1="DS3.d155.s0.e1" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i4" interaction="False" />
            <pair e1="DS3.d155.s0.e7" e2="DS3.d155.s0.e0" id="DS3.d155.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d155.s1" origId="10022602-4" text="adrenomedullin (mean 1.06 microg/kg) was injected into the left pulmonary artery before and after infusion of N(omega)-nitro-L-arginine (mean 96.5 mg/kg, n = 6), glibenclamide (mean 11.8 mg/kg, n = 6), CGRP receptor blocker (mean 312.0 microg/kg, n = 6), and indomethacin (mean 1.7 mg/kg, n = 8).">
            <entity id="DS3.d155.s1.e0" origId="W5PP90" charOffset="0-14" type="protein" text="adrenomedullin"/>
            <entity id="DS3.d155.s1.e1" origId="6322,90867653" charOffset="127-135" type="compound" text="arginine"/>
            <entity id="DS3.d155.s1.e2" origId="3488" charOffset="162-175" type="compound" text="glibenclamide"/>
            <entity id="DS3.d155.s1.e3" origId="3715" charOffset="259-271" type="compound" text="indomethacin"/>
            <pair e1="DS3.d155.s1.e3" e2="DS3.d155.s1.e0" id="DS3.d155.s1.i0" interaction="False" />
            <pair e1="DS3.d155.s1.e1" e2="DS3.d155.s1.e0" id="DS3.d155.s1.i1" interaction="False" />
            <pair e1="DS3.d155.s1.e2" e2="DS3.d155.s1.e0" id="DS3.d155.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d155.s2" origId="10022602-6" text="The adrenomedullin-induced response in left pulmonary artery blood flow was inhibited by N(omega)-nitro-L-arginine (inhibition rate 99%) and significantly attenuated by glibenclamide (inhibition rate 44%); however, no significant changes were found with CGRP receptor blocker or indomethacin (inhibition rate 0 and 17%, respectively).">
            <entity id="DS3.d155.s2.e0" origId="W5PP90" charOffset="4-18" type="protein" text="adrenomedullin"/>
            <entity id="DS3.d155.s2.e1" origId="6322,90867653" charOffset="106-114" type="compound" text="arginine"/>
            <entity id="DS3.d155.s2.e2" origId="3488" charOffset="169-182" type="compound" text="glibenclamide"/>
            <entity id="DS3.d155.s2.e3" origId="3715" charOffset="279-291" type="compound" text="indomethacin"/>
            <pair e1="DS3.d155.s2.e3" e2="DS3.d155.s2.e0" id="DS3.d155.s2.i0" interaction="False" />
            <pair e1="DS3.d155.s2.e1" e2="DS3.d155.s2.e0" id="DS3.d155.s2.i1" interaction="False" />
            <pair e1="DS3.d155.s2.e2" e2="DS3.d155.s2.e0" id="DS3.d155.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d155.s3" origId="10022602-8" text="Our data suggest that in the fetal pulmonary circulation, the adrenomedullin-induced increase in pulmonary blood flow depends largely on nitric oxide release and partly on K(ATP) channel activation, and does not involve the CGRP receptor or a cyclooxygenase-mediated mechanism.">
            <entity id="DS3.d155.s3.e0" origId="W5PP90" charOffset="62-76" type="protein" text="adrenomedullin"/>
            <entity id="DS3.d155.s3.e1" origId="145068" charOffset="137-149" type="compound" text="nitric oxide"/>
            <entity id="DS3.d155.s3.e2" origId="5957" charOffset="174-177" type="compound" text="ATP"/>
            <pair e1="DS3.d155.s3.e1" e2="DS3.d155.s3.e0" id="DS3.d155.s3.i0" interaction="False" />
            <pair e1="DS3.d155.s3.e2" e2="DS3.d155.s3.e0" id="DS3.d155.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d156" origId="10022608">
        <sentence id="DS3.d156.s0" origId="10022608-1" text="We have isolated and characterized cellular kinases which associate with the transactivation domain of c-Myc and phosphorylate Ser-62.">
            <entity id="DS3.d156.s0.e0" origId="P01106" charOffset="103-108" type="protein" text="c-Myc"/>
            <entity id="DS3.d156.s0.e1" origId="5951" charOffset="127-130" type="compound" text="Ser"/>
            <pair e1="DS3.d156.s0.e1" e2="DS3.d156.s0.e0" id="DS3.d156.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d156.s1" origId="10022608-2" text="We demonstrate that cellular Map kinases associate with c-Myc under stringent conditions and phosphorylate Ser-62.">
            <entity id="DS3.d156.s1.e0" origId="P01106" charOffset="56-61" type="protein" text="c-Myc"/>
            <entity id="DS3.d156.s1.e1" origId="5951" charOffset="107-110" type="compound" text="Ser"/>
            <pair e1="DS3.d156.s1.e1" e2="DS3.d156.s1.e0" id="DS3.d156.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d156.s2" origId="10022608-3" text="We also find that TPA stimulates the activity of the Myc-associated Map kinase to phosphorylate Ser-62.">
            <entity id="DS3.d156.s2.e0" origId="P40939,E9KL44" charOffset="18-21" type="protein" text="TPA"/>
            <entity id="DS3.d156.s2.e1" origId="5951" charOffset="96-99" type="compound" text="Ser"/>
            <pair e1="DS3.d156.s2.e1" e2="DS3.d156.s2.e0" id="DS3.d156.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d156.s3" origId="10022608-4" text="However, we do not observe an increase in Ser-62 phosphorylation in endogenous c-Myc after TPA treatment of cells.">
            <entity id="DS3.d156.s3.e0" origId="5951" charOffset="42-45" type="compound" text="Ser"/>
            <entity id="DS3.d156.s3.e1" origId="P01106" charOffset="79-84" type="protein" text="c-Myc"/>
            <entity id="DS3.d156.s3.e2" origId="P40939,E9KL44" charOffset="91-94" type="protein" text="TPA"/>
            <pair e1="DS3.d156.s3.e0" e2="DS3.d156.s3.e1" id="DS3.d156.s3.i0" interaction="False" />
            <pair e1="DS3.d156.s3.e0" e2="DS3.d156.s3.e2" id="DS3.d156.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d156.s4" origId="10022608-5" text="Since the regulation of the c-Myc-associated Map kinases does not correlate with the in vivo regulation of Ser-62 phosphorylation in c-Myc, we conclude that Map kinases are not the in vivo kinases for Ser-62.">
            <entity id="DS3.d156.s4.e0" origId="P01106" charOffset="28-33" type="protein" text="c-Myc"/>
            <entity id="DS3.d156.s4.e1" origId="5951" charOffset="107-110" type="compound" text="Ser"/>
            <entity id="DS3.d156.s4.e2" origId="P01106" charOffset="133-138" type="protein" text="c-Myc"/>
            <entity id="DS3.d156.s4.e3" origId="5951" charOffset="201-204" type="compound" text="Ser"/>
            <pair e1="DS3.d156.s4.e1" e2="DS3.d156.s4.e0" id="DS3.d156.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d156.s5" origId="10022608-6" text="Although Ser-62 phosphorylation was not affected by TPA, phosphorylation at a different serine residue was significantly upregulated by TPA.">
            <entity id="DS3.d156.s5.e0" origId="5951" charOffset="9-12" type="compound" text="Ser"/>
            <entity id="DS3.d156.s5.e1" origId="P40939,E9KL44" charOffset="52-55" type="protein" text="TPA"/>
            <entity id="DS3.d156.s5.e2" origId="P40939,E9KL44" charOffset="136-139" type="protein" text="TPA"/>
            <pair e1="DS3.d156.s5.e0" e2="DS3.d156.s5.e1" id="DS3.d156.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d157" origId="10022610">
        <sentence id="DS3.d157.s0" origId="10022610-5" text="To test if these elements were functionally responsive to YY1, we performed transient expression experiments in Drosophila S-2 cells transfected with heterologous reporter gene constructs driven by histone H4 gene segments fused to the thymidine kinase promoter.">
            <entity id="DS3.d157.s0.e0" origId="P25490,Q8ST83" charOffset="58-61" type="protein" text="YY1"/>
            <entity id="DS3.d157.s0.e1" origId="5789" charOffset="236-245" type="compound" text="thymidine"/>
            <pair e1="DS3.d157.s0.e1" e2="DS3.d157.s0.e0" id="DS3.d157.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d158" origId="10022611">
        <sentence id="DS3.d158.s0" origId="10022611-1" text="Human secretin receptor is a G protein-coupled receptor that is functionally linked to the cAMP second messenger system by stimulation of adenylate cyclase.">
            <entity id="DS3.d158.s0.e0" origId="P09683" charOffset="6-14" type="protein" text="secretin"/>
            <entity id="DS3.d158.s0.e1" origId="6083" charOffset="138-147" type="compound" text="adenylate"/>
            <pair e1="DS3.d158.s0.e1" e2="DS3.d158.s0.e0" id="DS3.d158.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d158.s1" origId="10022611-6" text="The secretin-stimulated response could be mimicked by forskolin and augmented by the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine, indicating that the extracellular acidification response is positively correlated with intracellular cAMP level.">
            <entity id="DS3.d158.s1.e0" origId="P09683" charOffset="4-12" type="protein" text="secretin"/>
            <entity id="DS3.d158.s1.e1" origId="47936" charOffset="54-63" type="compound" text="forskolin"/>
            <entity id="DS3.d158.s1.e2" origId="O60927,A2BEK1" charOffset="103-114" type="protein" text="inhibitor 3"/>
            <entity id="DS3.d158.s1.e3" origId="57296631" charOffset="115-140" type="compound" text="isobutyl-1-methylxanthine"/>
            <pair e1="DS3.d158.s1.e1" e2="DS3.d158.s1.e0" id="DS3.d158.s1.i0" interaction="False" />
            <pair e1="DS3.d158.s1.e1" e2="DS3.d158.s1.e2" id="DS3.d158.s1.i1" interaction="False" />
            <pair e1="DS3.d158.s1.e3" e2="DS3.d158.s1.e0" id="DS3.d158.s1.i2" interaction="False" />
            <pair e1="DS3.d158.s1.e3" e2="DS3.d158.s1.e2" id="DS3.d158.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d159" origId="10022613">
        <sentence id="DS3.d159.s0" origId="10022613-0" text="Cytosolic RAB3D is associated with RAB escort protein (REP), not RAB-GDP dissociation inhibitor (GDI), in dispersed chief cells from guinea pig stomach.">
            <entity id="DS3.d159.s0.e0" origId="H0VI43" charOffset="10-15" type="protein" text="RAB3D"/>
            <entity id="DS3.d159.s0.e1" origId="52999" charOffset="39-45" type="compound" text="escort"/>
            <entity id="DS3.d159.s0.e2" origId="8977" charOffset="69-72" type="compound" text="GDP"/>
            <entity id="DS3.d159.s0.e3" origId="73254829" charOffset="97-100" type="compound" text="GDI"/>
            <pair e1="DS3.d159.s0.e2" e2="DS3.d159.s0.e0" id="DS3.d159.s0.i0" interaction="False" />
            <pair e1="DS3.d159.s0.e3" e2="DS3.d159.s0.e0" id="DS3.d159.s0.i1" interaction="False" />
            <pair e1="DS3.d159.s0.e1" e2="DS3.d159.s0.e0" id="DS3.d159.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d159.s1" origId="10022613-1" text="RAB3D, a low-molecular-weight GTP-binding protein believed to be involved with regulated exocytosis, is associated with secretory granules in gastric chief cells.">
            <entity id="DS3.d159.s1.e0" origId="H0VI43" charOffset="0-5" type="protein" text="RAB3D"/>
            <entity id="DS3.d159.s1.e1" origId="6830" charOffset="30-33" type="compound" text="GTP"/>
            <pair e1="DS3.d159.s1.e1" e2="DS3.d159.s1.e0" id="DS3.d159.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d159.s2" origId="10022613-8" text="When chief cell cytosol was fractionated by gel filtration chromatography, RAB3D eluted with REP at &amp;gt;150 kDa, whereas rab-GDI eluted as a separate 65-kDa peak, suggesting that RAB3D exists as a complex with REP, but not with rab-GDI.">
            <entity id="DS3.d159.s2.e0" origId="H0VI43" charOffset="75-80" type="protein" text="RAB3D"/>
            <entity id="DS3.d159.s2.e1" origId="73254829" charOffset="125-128" type="compound" text="GDI"/>
            <entity id="DS3.d159.s2.e2" origId="H0VI43" charOffset="179-184" type="protein" text="RAB3D"/>
            <entity id="DS3.d159.s2.e3" origId="73254829" charOffset="232-235" type="compound" text="GDI"/>
            <pair e1="DS3.d159.s2.e1" e2="DS3.d159.s2.e0" id="DS3.d159.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d160" origId="10022617">
        <sentence id="DS3.d160.s0" origId="10022617-7" text="Staurosporine, a protein kinase C inhibitor, did not significantly affect transcriptional activity or DNase I hypersensitivity of the OC gene.">
            <entity id="DS3.d160.s0.e0" origId="44259,44299148,451705,5279,5311103,5459111,44120114,6419748,9956178,6711321,9937179" charOffset="0-13" type="compound" text="Staurosporine"/>
            <entity id="DS3.d160.s0.e1" origId="P21704" charOffset="102-109" type="protein" text="DNase I"/>
            <pair e1="DS3.d160.s0.e0" e2="DS3.d160.s0.e1" id="DS3.d160.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d161" origId="10022627">
        <sentence id="DS3.d161.s0" origId="10022627-6" text="Each stool was simultaneously tested for FOB with HemoQuant (HQ), Hemoccult II (HO II), Hemoccult II SENSA (SENSA), HemeSelect (HS), and FlexSure OBT (FS).">
            <entity id="DS3.d161.s0.e0" origId="70698420" charOffset="41-44" type="compound" text="FOB"/>
            <entity id="DS3.d161.s0.e1" origId="Q94FW6" charOffset="80-85" type="protein" text="HO II"/>
            <pair e1="DS3.d161.s0.e0" e2="DS3.d161.s0.e1" id="DS3.d161.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d162" origId="10022631">
        <sentence id="DS3.d162.s0" origId="10022631-4" text="On two consecutive days, participants ingested (13C)-urea (100 mg) 10 min after either 270 ml of a mixed formula meal (1 Kcal/ml) or an equivalent amount of tap water.">
            <entity id="DS3.d162.s0.e0" origId="1176" charOffset="53-57" type="compound" text="urea"/>
            <entity id="DS3.d162.s0.e1" origId="O76054,A0A024R1I5,B7Z3Z8" charOffset="157-160" type="protein" text="tap"/>
            <entity id="DS3.d162.s0.e2" origId="962" charOffset="161-166" type="compound" text="water"/>
            <pair e1="DS3.d162.s0.e2" e2="DS3.d162.s0.e1" id="DS3.d162.s0.i0" interaction="False" />
            <pair e1="DS3.d162.s0.e0" e2="DS3.d162.s0.e1" id="DS3.d162.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d163" origId="10022632">
        <sentence id="DS3.d163.s0" origId="10022632-13" text="The chronological relation between antral motility and gastrointestinal sounds, and the dissimilar effects of erythromycin and Somatostatin, suggest that antral contractions increase gastrointestinal sounds, perhaps by supplying gas into the intestine.">
            <entity id="DS3.d163.s0.e0" origId="35864" charOffset="35-41" type="compound" text="antral"/>
            <entity id="DS3.d163.s0.e1" origId="12560" charOffset="110-122" type="compound" text="erythromycin"/>
            <entity id="DS3.d163.s0.e2" origId="P61278" charOffset="127-139" type="protein" text="Somatostatin"/>
            <entity id="DS3.d163.s0.e3" origId="35864" charOffset="154-160" type="compound" text="antral"/>
            <pair e1="DS3.d163.s0.e0" e2="DS3.d163.s0.e2" id="DS3.d163.s0.i0" interaction="False" />
            <pair e1="DS3.d163.s0.e1" e2="DS3.d163.s0.e2" id="DS3.d163.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d163.s1" origId="10022632-9" text="Somatostatin analogue induced phase-3-like clustered contractions in the duodenum, but inhibited antral contractions and decreased the sound index.">
            <entity id="DS3.d163.s1.e0" origId="P61278" charOffset="0-12" type="protein" text="Somatostatin"/>
            <entity id="DS3.d163.s1.e1" origId="35864" charOffset="97-103" type="compound" text="antral"/>
            <pair e1="DS3.d163.s1.e1" e2="DS3.d163.s1.e0" id="DS3.d163.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d164" origId="10022654">
        <sentence id="DS3.d164.s0" origId="10022654-6" text="Plasma levels of estradiol, testosterone, substance P, calcitonin gene-related peptide, and nitrate/nitrite and forearm hemodynamics were measured.">
            <entity id="DS3.d164.s0.e0" origId="5757" charOffset="17-26" type="compound" text="estradiol"/>
            <entity id="DS3.d164.s0.e1" origId="6013" charOffset="28-40" type="compound" text="testosterone"/>
            <entity id="DS3.d164.s0.e2" origId="P20366,Q9Y494" charOffset="42-53" type="protein" text="substance P"/>
            <entity id="DS3.d164.s0.e3" origId="10313259,943" charOffset="92-99" type="compound" text="nitrate"/>
            <entity id="DS3.d164.s0.e4" origId="946" charOffset="100-107" type="compound" text="nitrite"/>
            <pair e1="DS3.d164.s0.e3" e2="DS3.d164.s0.e2" id="DS3.d164.s0.i0" interaction="False" />
            <pair e1="DS3.d164.s0.e4" e2="DS3.d164.s0.e2" id="DS3.d164.s0.i1" interaction="False" />
            <pair e1="DS3.d164.s0.e1" e2="DS3.d164.s0.e2" id="DS3.d164.s0.i2" interaction="False" />
            <pair e1="DS3.d164.s0.e0" e2="DS3.d164.s0.e2" id="DS3.d164.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d164.s1" origId="10022654-7" text="RESULTS: Cirrhotic patients showed higher plasma estradiol/testosterone ratios (28.3+/-47.2 x 10(-3), median 10.5 x 10(-3) vs 8.2+/-8.3 x 10(-3), median 5.7 x 10(-3), p = 0.003) and levels of nitrate/ nitrite (29.9+/-17.5, median 23.8 vs 21.4+/-10.0, median 20.6 micromol/L, p = 0.01) and substance P (47.5+/-62.5, median 29.2 vs 15.2+/-7.7, median 12.3 pg/ml, p &amp;lt; 0.001) than healthy controls.">
            <entity id="DS3.d164.s1.e0" origId="5757" charOffset="49-58" type="compound" text="estradiol"/>
            <entity id="DS3.d164.s1.e1" origId="6013" charOffset="59-71" type="compound" text="testosterone"/>
            <entity id="DS3.d164.s1.e2" origId="10313259,943" charOffset="192-199" type="compound" text="nitrate"/>
            <entity id="DS3.d164.s1.e3" origId="946" charOffset="201-208" type="compound" text="nitrite"/>
            <entity id="DS3.d164.s1.e4" origId="P20366,Q9Y494" charOffset="289-300" type="protein" text="substance P"/>
            <pair e1="DS3.d164.s1.e2" e2="DS3.d164.s1.e4" id="DS3.d164.s1.i0" interaction="False" />
            <pair e1="DS3.d164.s1.e3" e2="DS3.d164.s1.e4" id="DS3.d164.s1.i1" interaction="False" />
            <pair e1="DS3.d164.s1.e1" e2="DS3.d164.s1.e4" id="DS3.d164.s1.i2" interaction="False" />
            <pair e1="DS3.d164.s1.e0" e2="DS3.d164.s1.e4" id="DS3.d164.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d164.s2" origId="10022654-9" text="Cirrhotic patients with spider angiomas disclosed higher plasma levels of substance P (84.7+/-105.3, median 53.1 vs 34.5+/-30.7, median 25.8 pg/ml, p = 0.006) and serum levels of bilirubin (3.9+/-3.8, median 1.9 vs 1.9+/-1.9, median 1.2 mg/dl, p = 0.02) than those without.">
            <entity id="DS3.d164.s2.e0" origId="P20366,Q9Y494" charOffset="74-85" type="protein" text="substance P"/>
            <entity id="DS3.d164.s2.e1" origId="5280352" charOffset="179-188" type="compound" text="bilirubin"/>
            <pair e1="DS3.d164.s2.e1" e2="DS3.d164.s2.e0" id="DS3.d164.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d165" origId="10022683">
        <sentence id="DS3.d165.s0" origId="10022683-5" text="During the antigen pulse dendritic cells were activated with a combination of tumor necrosis factor-alpha and prostaglandin E2.">
            <entity id="DS3.d165.s0.e0" origId="P01375,Q5STB3" charOffset="78-105" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d165.s0.e1" origId="5280360" charOffset="110-126" type="compound" text="prostaglandin E2"/>
            <pair e1="DS3.d165.s0.e1" e2="DS3.d165.s0.e0" id="DS3.d165.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d166" origId="10022693">
        <sentence id="DS3.d166.s0" origId="10022693-18" text="Testosterone and sex hormone-binding globulin did not change significantly after orchiectomy.">
            <entity id="DS3.d166.s0.e0" origId="6013" charOffset="0-12" type="compound" text="Testosterone"/>
            <entity id="DS3.d166.s0.e1" origId="P04278,B0FWH2,I3L145,B4DYU0,B0FWH8" charOffset="17-45" type="protein" text="sex hormone-binding globulin"/>
            <pair e1="DS3.d166.s0.e0" e2="DS3.d166.s0.e1" id="DS3.d166.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d167" origId="10022731">
        <sentence id="DS3.d167.s0" origId="10022731-8" text="Testosterone treatment from 21 to 28 days post-castration resulted in an increase in Ki-67 antigen positive cells to 200% of intact controls and a concomitant reduction in p27 expressing cells to about 50% of intact controls.">
            <entity id="DS3.d167.s0.e0" origId="6013" charOffset="0-12" type="compound" text="Testosterone"/>
            <entity id="DS3.d167.s0.e1" origId="Q7TSF6,E9PVX6" charOffset="85-90" type="protein" text="Ki-67"/>
            <entity id="DS3.d167.s0.e2" origId="P46414" charOffset="172-175" type="protein" text="p27"/>
            <pair e1="DS3.d167.s0.e0" e2="DS3.d167.s0.e1" id="DS3.d167.s0.i0" interaction="False" />
            <pair e1="DS3.d167.s0.e0" e2="DS3.d167.s0.e2" id="DS3.d167.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d168" origId="10022737">
        <sentence id="DS3.d168.s0" origId="10022737-10" text="The combination of BCG and interferon alpha-2b also completely suppressed TGF-beta1 production in the MGH and RT112 cell lines.">
            <entity id="DS3.d168.s0.e0" origId="Q14766,B7ZLY3" charOffset="74-83" type="protein" text="TGF-beta1"/>
            <entity id="DS3.d168.s0.e1" origId="71664581" charOffset="102-105" type="compound" text="MGH"/>
            <pair e1="DS3.d168.s0.e1" e2="DS3.d168.s0.e0" id="DS3.d168.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d168.s1" origId="10022737-8" text="Compared with live BCG, autoclaved BCG had no antiproliferative effect on MGH cells and was less effective in stimulating the production of IL-6, IL-8 and GM-CSF.">
            <entity id="DS3.d168.s1.e0" origId="71664581" charOffset="74-77" type="compound" text="MGH"/>
            <entity id="DS3.d168.s1.e1" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="140-144" type="protein" text="IL-6"/>
            <entity id="DS3.d168.s1.e2" origId="P10145,A0A024RDA5" charOffset="146-150" type="protein" text="IL-8"/>
            <entity id="DS3.d168.s1.e3" origId="P04141" charOffset="155-161" type="protein" text="GM-CSF"/>
            <pair e1="DS3.d168.s1.e0" e2="DS3.d168.s1.e1" id="DS3.d168.s1.i0" interaction="False" />
            <pair e1="DS3.d168.s1.e0" e2="DS3.d168.s1.e2" id="DS3.d168.s1.i1" interaction="False" />
            <pair e1="DS3.d168.s1.e0" e2="DS3.d168.s1.e3" id="DS3.d168.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d168.s2" origId="10022737-9" text="However, autoclaved BCG was as effective as live BCG in inhibiting growth and stimulating IL-6 and TNF-alpha production of J82 cells.">
            <entity id="DS3.d168.s2.e0" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="90-94" type="protein" text="IL-6"/>
            <entity id="DS3.d168.s2.e1" origId="P01375,Q5STB3" charOffset="99-108" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d168.s2.e2" origId="49854424" charOffset="123-126" type="compound" text="J82"/>
            <pair e1="DS3.d168.s2.e2" e2="DS3.d168.s2.e0" id="DS3.d168.s2.i0" interaction="False" />
            <pair e1="DS3.d168.s2.e2" e2="DS3.d168.s2.e1" id="DS3.d168.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d169" origId="10022746">
        <sentence id="DS3.d169.s0" origId="10022746-0" text="Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.">
            <entity id="DS3.d169.s0.e0" origId="P10635,C1ID52,Q5Y7H2" charOffset="32-38" type="protein" text="CYP2D6"/>
            <entity id="DS3.d169.s0.e1" origId="P04798,A0N0X8" charOffset="40-46" type="protein" text="CYP1A1"/>
            <entity id="DS3.d169.s0.e2" origId="P05181" charOffset="48-54" type="protein" text="CYP2E1"/>
            <entity id="DS3.d169.s0.e3" origId="124886,20725278" charOffset="59-70" type="compound" text="glutathione"/>
            <entity id="DS3.d169.s0.e4" origId="P09488,X5D932,X5DR03" charOffset="86-91" type="protein" text="GSTM1"/>
            <entity id="DS3.d169.s0.e5" origId="P21266,Q6FGJ9" charOffset="93-98" type="protein" text="GSTM3"/>
            <entity id="DS3.d169.s0.e6" origId="P30711,A0A0G2JRN4,Q4W251,A0A0G2JRQ5,Q4GZS9" charOffset="100-105" type="protein" text="GSTT1"/>
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e1" id="DS3.d169.s0.i0" interaction="False" />
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e0" id="DS3.d169.s0.i1" interaction="False" />
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e6" id="DS3.d169.s0.i2" interaction="False" />
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e4" id="DS3.d169.s0.i3" interaction="False" />
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e5" id="DS3.d169.s0.i4" interaction="False" />
            <pair e1="DS3.d169.s0.e3" e2="DS3.d169.s0.e2" id="DS3.d169.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d169.s1" origId="10022746-14" text="Second, we conclude that the CYP2D6, CYP2E1, CYP1A1 and GSTT1 alleles studied, although putatively good candidates, either do not determine the effectiveness of detoxification of tobacco-derived carcinogens in the upper aerodigestive tract or, that chronic consumption of tobacco and alcohol overwhelms enzyme defences, irrespective of genotype.">
            <entity id="DS3.d169.s1.e0" origId="P10635,C1ID52,Q5Y7H2" charOffset="29-35" type="protein" text="CYP2D6"/>
            <entity id="DS3.d169.s1.e1" origId="P05181" charOffset="37-43" type="protein" text="CYP2E1"/>
            <entity id="DS3.d169.s1.e2" origId="P04798,A0N0X8" charOffset="45-51" type="protein" text="CYP1A1"/>
            <entity id="DS3.d169.s1.e3" origId="P30711,A0A0G2JRN4,Q4W251,A0A0G2JRQ5,Q4GZS9" charOffset="56-61" type="protein" text="GSTT1"/>
            <entity id="DS3.d169.s1.e4" origId="10982484,702" charOffset="284-291" type="compound" text="alcohol"/>
            <pair e1="DS3.d169.s1.e4" e2="DS3.d169.s1.e2" id="DS3.d169.s1.i0" interaction="False" />
            <pair e1="DS3.d169.s1.e4" e2="DS3.d169.s1.e3" id="DS3.d169.s1.i1" interaction="False" />
            <pair e1="DS3.d169.s1.e4" e2="DS3.d169.s1.e1" id="DS3.d169.s1.i2" interaction="False" />
            <pair e1="DS3.d169.s1.e4" e2="DS3.d169.s1.e0" id="DS3.d169.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d169.s2" origId="10022746-1" text="Glutathione S-transferase GSTM1, GSTM3 and GSTT1 and cytochrome P450 CYP2D6, CYP1A1 and CYP2E1 loci are susceptibility candidates for cancers of the upper aerodigestive tract because putatively protective and risk genotypes have been identified from studies in other diseases associated with alcohol and tobacco consumption.">
            <entity id="DS3.d169.s2.e0" origId="124886,20725278" charOffset="0-11" type="compound" text="Glutathione"/>
            <entity id="DS3.d169.s2.e1" origId="P09488,X5D932,X5DR03" charOffset="26-31" type="protein" text="GSTM1"/>
            <entity id="DS3.d169.s2.e2" origId="P21266,Q6FGJ9" charOffset="33-38" type="protein" text="GSTM3"/>
            <entity id="DS3.d169.s2.e3" origId="P30711,A0A0G2JRN4,Q4W251,A0A0G2JRQ5,Q4GZS9" charOffset="43-48" type="protein" text="GSTT1"/>
            <entity id="DS3.d169.s2.e4" origId="P10635,C1ID52,Q5Y7H2" charOffset="69-75" type="protein" text="CYP2D6"/>
            <entity id="DS3.d169.s2.e5" origId="P04798,A0N0X8" charOffset="77-83" type="protein" text="CYP1A1"/>
            <entity id="DS3.d169.s2.e6" origId="P05181" charOffset="88-94" type="protein" text="CYP2E1"/>
            <entity id="DS3.d169.s2.e7" origId="10982484,702" charOffset="292-299" type="compound" text="alcohol"/>
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e5" id="DS3.d169.s2.i0" interaction="False" />
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e3" id="DS3.d169.s2.i1" interaction="False" />
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e4" id="DS3.d169.s2.i2" interaction="False" />
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e1" id="DS3.d169.s2.i3" interaction="False" />
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e2" id="DS3.d169.s2.i4" interaction="False" />
            <pair e1="DS3.d169.s2.e0" e2="DS3.d169.s2.e6" id="DS3.d169.s2.i5" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e5" id="DS3.d169.s2.i6" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e3" id="DS3.d169.s2.i7" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e4" id="DS3.d169.s2.i8" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e1" id="DS3.d169.s2.i9" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e2" id="DS3.d169.s2.i10" interaction="False" />
            <pair e1="DS3.d169.s2.e7" e2="DS3.d169.s2.e6" id="DS3.d169.s2.i11" interaction="False" />
        </sentence>
        <sentence id="DS3.d169.s3" origId="10022746-3" text="Of the genotypes presumed to be protective, only GSTM1 A/B influenced susceptibility; the GSTM1 A/B frequency was lower in the patients than the control individuals both before (odds ratio = 0.3, 95% confidence interval (CI) 0.1-0.7) and after correction for imbalances in age, sex, smoking and alcohol consumption (odds ratio = 0.2, 95% CI 0.1-0.5).">
            <entity id="DS3.d169.s3.e0" origId="P09488,X5D932,X5DR03" charOffset="49-54" type="protein" text="GSTM1"/>
            <entity id="DS3.d169.s3.e1" origId="P09488,X5D932,X5DR03" charOffset="90-95" type="protein" text="GSTM1"/>
            <entity id="DS3.d169.s3.e2" origId="10982484,702" charOffset="295-302" type="compound" text="alcohol"/>
            <pair e1="DS3.d169.s3.e2" e2="DS3.d169.s3.e0" id="DS3.d169.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d169.s4" origId="10022746-8" text="CYP2D6 EM, CYP1A1 m1/m1, CYP1A1 Ile/Ile, CYP2E1 DD, CYP2E1 c1c1, GSTT1 null) or, interactions between genotypes and smoking or alcohol consumption.">
            <entity id="DS3.d169.s4.e0" origId="P10635,C1ID52,Q5Y7H2" charOffset="0-6" type="protein" text="CYP2D6"/>
            <entity id="DS3.d169.s4.e1" origId="P04798,A0N0X8" charOffset="11-17" type="protein" text="CYP1A1"/>
            <entity id="DS3.d169.s4.e2" origId="P04798,A0N0X8" charOffset="25-31" type="protein" text="CYP1A1"/>
            <entity id="DS3.d169.s4.e3" origId="P05181" charOffset="41-47" type="protein" text="CYP2E1"/>
            <entity id="DS3.d169.s4.e4" origId="P05181" charOffset="52-58" type="protein" text="CYP2E1"/>
            <entity id="DS3.d169.s4.e5" origId="P30711,A0A0G2JRN4,Q4W251,A0A0G2JRQ5,Q4GZS9" charOffset="65-70" type="protein" text="GSTT1"/>
            <entity id="DS3.d169.s4.e6" origId="10982484,702" charOffset="127-134" type="compound" text="alcohol"/>
            <pair e1="DS3.d169.s4.e6" e2="DS3.d169.s4.e1" id="DS3.d169.s4.i0" interaction="False" />
            <pair e1="DS3.d169.s4.e6" e2="DS3.d169.s4.e5" id="DS3.d169.s4.i1" interaction="False" />
            <pair e1="DS3.d169.s4.e6" e2="DS3.d169.s4.e3" id="DS3.d169.s4.i2" interaction="False" />
            <pair e1="DS3.d169.s4.e6" e2="DS3.d169.s4.e0" id="DS3.d169.s4.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d169.s5" origId="10022746-9" text="We conclude, first, that mu class glutathione S-transferase influence risk of upper aerodigestive tract cancers thereby complementing studies in skin cancer patients showing GSTM1 A/B is protective, while GSTM3 AA moderately increases risk.">
            <entity id="DS3.d169.s5.e0" origId="124886,20725278" charOffset="34-45" type="compound" text="glutathione"/>
            <entity id="DS3.d169.s5.e1" origId="P09488,X5D932,X5DR03" charOffset="174-179" type="protein" text="GSTM1"/>
            <entity id="DS3.d169.s5.e2" origId="P21266,Q6FGJ9" charOffset="205-210" type="protein" text="GSTM3"/>
            <pair e1="DS3.d169.s5.e0" e2="DS3.d169.s5.e1" id="DS3.d169.s5.i0" interaction="False" />
            <pair e1="DS3.d169.s5.e0" e2="DS3.d169.s5.e2" id="DS3.d169.s5.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d170" origId="10022747">
        <sentence id="DS3.d170.s0" origId="10022747-0" text="Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man.">
            <entity id="DS3.d170.s0.e0" origId="P05177" charOffset="38-57" type="protein" text="cytochrome P450 1A2"/>
            <entity id="DS3.d170.s0.e1" origId="1935" charOffset="69-76" type="compound" text="tacrine"/>
            <entity id="DS3.d170.s0.e2" origId="3404,5324346" charOffset="77-88" type="compound" text="fluvoxamine"/>
            <pair e1="DS3.d170.s0.e2" e2="DS3.d170.s0.e0" id="DS3.d170.s0.i0" interaction="False" />
            <pair e1="DS3.d170.s0.e1" e2="DS3.d170.s0.e0" id="DS3.d170.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d170.s1" origId="10022747-2" text="In vitro metabolism of tacrine (a CYP1A2 probe) in the presence and absence of fluvoxamine, a CYP1A2 inhibitor, was investigated in human liver mircrosomes and with different rH-CYP.">
            <entity id="DS3.d170.s1.e0" origId="1935" charOffset="23-30" type="compound" text="tacrine"/>
            <entity id="DS3.d170.s1.e1" origId="P05177" charOffset="34-40" type="protein" text="CYP1A2"/>
            <entity id="DS3.d170.s1.e2" origId="3404,5324346" charOffset="79-90" type="compound" text="fluvoxamine"/>
            <entity id="DS3.d170.s1.e3" origId="P05177" charOffset="94-100" type="protein" text="CYP1A2"/>
            <pair e1="DS3.d170.s1.e2" e2="DS3.d170.s1.e1" id="DS3.d170.s1.i0" interaction="False" />
            <pair e1="DS3.d170.s1.e0" e2="DS3.d170.s1.e1" id="DS3.d170.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d170.s2" origId="10022747-4" text="The extent of tacrine metabolism inhibition procured by fluvoxamine with rH-CYP1A2, was compared with previous results observed in man.">
            <entity id="DS3.d170.s2.e0" origId="1935" charOffset="14-21" type="compound" text="tacrine"/>
            <entity id="DS3.d170.s2.e1" origId="3404,5324346" charOffset="56-67" type="compound" text="fluvoxamine"/>
            <entity id="DS3.d170.s2.e2" origId="P05177" charOffset="76-82" type="protein" text="CYP1A2"/>
            <pair e1="DS3.d170.s2.e1" e2="DS3.d170.s2.e2" id="DS3.d170.s2.i0" interaction="False" />
            <pair e1="DS3.d170.s2.e0" e2="DS3.d170.s2.e2" id="DS3.d170.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d170.s3" origId="10022747-5" text="The Vax and Km for 1-hydroxytacrine formation rates obtained with rH-CYP1A2 were in good agreement with those observed in human liver microsomes (175+/-9 versus 140+/-60 pmol/min/mg for Vmax and 14+/-2 versus 16+/-2 microM for Km, respectively.">
            <entity id="DS3.d170.s3.e0" origId="445806" charOffset="4-7" type="compound" text="Vax"/>
            <entity id="DS3.d170.s3.e1" origId="3655" charOffset="19-35" type="compound" text="1-hydroxytacrine"/>
            <entity id="DS3.d170.s3.e2" origId="P05177" charOffset="69-75" type="protein" text="CYP1A2"/>
            <pair e1="DS3.d170.s3.e0" e2="DS3.d170.s3.e2" id="DS3.d170.s3.i0" interaction="False" />
            <pair e1="DS3.d170.s3.e1" e2="DS3.d170.s3.e2" id="DS3.d170.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d170.s4" origId="10022747-6" text="The Ki of fluvoxamine on 1-hydroxytacrine formation rate observed with rH-CYP1A2 was similar to that observed with human liver microsome (0.35+/-0.05 versus 0.20+/-0.20 microM, respectively).">
            <entity id="DS3.d170.s4.e0" origId="3404,5324346" charOffset="10-21" type="compound" text="fluvoxamine"/>
            <entity id="DS3.d170.s4.e1" origId="3655" charOffset="25-41" type="compound" text="1-hydroxytacrine"/>
            <entity id="DS3.d170.s4.e2" origId="P05177" charOffset="74-80" type="protein" text="CYP1A2"/>
            <pair e1="DS3.d170.s4.e0" e2="DS3.d170.s4.e2" id="DS3.d170.s4.i0" interaction="False" />
            <pair e1="DS3.d170.s4.e1" e2="DS3.d170.s4.e2" id="DS3.d170.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d170.s5" origId="10022747-7" text="Using the Km, Vmax and Ki determined with rH-CYP1A2, we calculated that fluvoxamine produced an inhibition of 1-, 2- and 4-hydroxytacrine formation rate of 91, 87 and 88%, respectively, in the range of tacrine and fluvoxamine concentrations observed in man.">
            <entity id="DS3.d170.s5.e0" origId="P05177" charOffset="45-51" type="protein" text="CYP1A2"/>
            <entity id="DS3.d170.s5.e1" origId="3404,5324346" charOffset="72-83" type="compound" text="fluvoxamine"/>
            <entity id="DS3.d170.s5.e2" origId="60576" charOffset="123-137" type="compound" text="hydroxytacrine"/>
            <entity id="DS3.d170.s5.e3" origId="1935" charOffset="130-137" type="compound" text="tacrine"/>
            <entity id="DS3.d170.s5.e4" origId="3404,5324346" charOffset="214-225" type="compound" text="fluvoxamine"/>
            <pair e1="DS3.d170.s5.e1" e2="DS3.d170.s5.e0" id="DS3.d170.s5.i0" interaction="False" />
            <pair e1="DS3.d170.s5.e2" e2="DS3.d170.s5.e0" id="DS3.d170.s5.i1" interaction="False" />
            <pair e1="DS3.d170.s5.e3" e2="DS3.d170.s5.e0" id="DS3.d170.s5.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d171" origId="10022748">
        <sentence id="DS3.d171.s0" origId="10022748-0" text="High benzo(a)pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.">
            <entity id="DS3.d171.s0.e0" origId="31423" charOffset="13-19" type="compound" text="pyrene"/>
            <entity id="DS3.d171.s0.e1" origId="P04798,A0N0X8" charOffset="106-112" type="protein" text="CYP1A1"/>
            <pair e1="DS3.d171.s0.e0" e2="DS3.d171.s0.e1" id="DS3.d171.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d171.s1" origId="10022748-8" text="Therefore, combination of homozygous mutated CYP1A1 and GSTM1*0/*0 genotypes lead, at a similar or even lower smoking dose, to a stronger increase of anti-benzo(a)pyrene diol-epoxide DNA adduct levels than found in individuals with CYP1A1 and GSTM1 wild-type.">
            <entity id="DS3.d171.s1.e0" origId="P04798,A0N0X8" charOffset="45-51" type="protein" text="CYP1A1"/>
            <entity id="DS3.d171.s1.e1" origId="31423" charOffset="163-169" type="compound" text="pyrene"/>
            <entity id="DS3.d171.s1.e2" origId="P04798,A0N0X8" charOffset="232-238" type="protein" text="CYP1A1"/>
            <pair e1="DS3.d171.s1.e1" e2="DS3.d171.s1.e0" id="DS3.d171.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d172" origId="10022749">
        <sentence id="DS3.d172.s0" origId="10022749-0" text="Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction.">
            <entity id="DS3.d172.s0.e0" origId="15939859,168213,3966,442965,644020,7014" charOffset="25-34" type="compound" text="sparteine"/>
            <entity id="DS3.d172.s0.e1" origId="P10635,C1ID52,Q5Y7H2" charOffset="73-79" type="protein" text="CYP2D6"/>
            <pair e1="DS3.d172.s0.e0" e2="DS3.d172.s0.e1" id="DS3.d172.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d173" origId="10022751">
        <sentence id="DS3.d173.s0" origId="10022751-0" text="An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians.">
            <entity id="DS3.d173.s0.e0" origId="P33261" charOffset="32-39" type="protein" text="CYP2C19"/>
            <entity id="DS3.d173.s0.e1" origId="107921" charOffset="62-75" type="compound" text="S-mephenytoin"/>
            <pair e1="DS3.d173.s0.e1" e2="DS3.d173.s0.e0" id="DS3.d173.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d173.s1" origId="10022751-10" text="The Arg433 to Trp mutation in the heme-binding region essentially abolishes activity of recombinant CYP2C19*5A toward S-mephenytoin and tolbutamide, which is consistent with the conclusion that CYP2C19*5 represents poor metabolizer alleles.">
            <entity id="DS3.d173.s1.e0" origId="4971" charOffset="34-38" type="compound" text="heme"/>
            <entity id="DS3.d173.s1.e1" origId="P33261" charOffset="100-107" type="protein" text="CYP2C19"/>
            <entity id="DS3.d173.s1.e2" origId="107921" charOffset="118-131" type="compound" text="S-mephenytoin"/>
            <entity id="DS3.d173.s1.e3" origId="5505" charOffset="136-147" type="compound" text="tolbutamide"/>
            <entity id="DS3.d173.s1.e4" origId="P33261" charOffset="194-201" type="protein" text="CYP2C19"/>
            <pair e1="DS3.d173.s1.e2" e2="DS3.d173.s1.e1" id="DS3.d173.s1.i0" interaction="False" />
            <pair e1="DS3.d173.s1.e3" e2="DS3.d173.s1.e1" id="DS3.d173.s1.i1" interaction="False" />
            <pair e1="DS3.d173.s1.e0" e2="DS3.d173.s1.e1" id="DS3.d173.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d173.s2" origId="10022751-6" text="A fourth rare mutation (CYP2C19*5A) (C99,A991,Ile331;C1297T,Arg433--&amp;gt;Trp) resulting in an Arg433 to Trp substitution in the heme-binding region has been reported in a single Chinese poor metaboliser outlier belonging to the Bai ethnic group.">
            <entity id="DS3.d173.s2.e0" origId="P33261" charOffset="24-31" type="protein" text="CYP2C19"/>
            <entity id="DS3.d173.s2.e1" origId="51059820" charOffset="41-45" type="compound" text="A991"/>
            <entity id="DS3.d173.s2.e2" origId="4971" charOffset="127-131" type="compound" text="heme"/>
            <entity id="DS3.d173.s2.e3" origId="1282" charOffset="227-230" type="compound" text="Bai"/>
            <pair e1="DS3.d173.s2.e1" e2="DS3.d173.s2.e0" id="DS3.d173.s2.i0" interaction="False" />
            <pair e1="DS3.d173.s2.e3" e2="DS3.d173.s2.e0" id="DS3.d173.s2.i1" interaction="False" />
            <pair e1="DS3.d173.s2.e2" e2="DS3.d173.s2.e0" id="DS3.d173.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d173.s3" origId="10022751-7" text="The present study identifies a second variant allele CYP2C19*5B (C99--&amp;gt;T; A991--&amp;gt;G, Ile331--&amp;gt;Val; C1297-T, Arg433--&amp;gt;Trp in one of 37 Caucasian poor metabolizers.">
            <entity id="DS3.d173.s3.e0" origId="P33261" charOffset="53-60" type="protein" text="CYP2C19"/>
            <entity id="DS3.d173.s3.e1" origId="18445697" charOffset="61-63" type="compound" text="5B"/>
            <entity id="DS3.d173.s3.e2" origId="51059820" charOffset="77-81" type="compound" text="A991"/>
            <pair e1="DS3.d173.s3.e2" e2="DS3.d173.s3.e0" id="DS3.d173.s3.i0" interaction="False" />
            <pair e1="DS3.d173.s3.e1" e2="DS3.d173.s3.e0" id="DS3.d173.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d173.s4" origId="10022751-8" text="The frequency of the CYP2C19*5 alleles is low in Chinese (approximately 0.25% in the Bai ethnic group) and Caucasians (&amp;lt; 0.9%).">
            <entity id="DS3.d173.s4.e0" origId="P33261" charOffset="21-28" type="protein" text="CYP2C19"/>
            <entity id="DS3.d173.s4.e1" origId="1282" charOffset="85-88" type="compound" text="Bai"/>
            <pair e1="DS3.d173.s4.e1" e2="DS3.d173.s4.e0" id="DS3.d173.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d174" origId="10022752">
        <sentence id="DS3.d174.s0" origId="10022752-11" text="Testosterone (10 and 100 microM) regioselectively stimulated (up to 269%) MDZ 4-OH formation by adult liver microsomes and expressed CYP3A4.">
            <entity id="DS3.d174.s0.e0" origId="6013" charOffset="0-12" type="compound" text="Testosterone"/>
            <entity id="DS3.d174.s0.e1" origId="5326860" charOffset="74-77" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s0.e2" origId="P08684,Q6GRK0" charOffset="133-139" type="protein" text="CYP3A4"/>
            <pair e1="DS3.d174.s0.e1" e2="DS3.d174.s0.e2" id="DS3.d174.s0.i0" interaction="False" />
            <pair e1="DS3.d174.s0.e0" e2="DS3.d174.s0.e2" id="DS3.d174.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s1" origId="10022752-13" text="With adult liver microsomes, aNF and terfenadine had little effect on the Km for MDZ 1'-OH formation.">
            <entity id="DS3.d174.s1.e0" origId="P01160" charOffset="29-32" type="protein" text="aNF"/>
            <entity id="DS3.d174.s1.e1" origId="5405" charOffset="37-48" type="compound" text="terfenadine"/>
            <entity id="DS3.d174.s1.e2" origId="5326860" charOffset="81-84" type="compound" text="MDZ"/>
            <pair e1="DS3.d174.s1.e1" e2="DS3.d174.s1.e0" id="DS3.d174.s1.i0" interaction="False" />
            <pair e1="DS3.d174.s1.e2" e2="DS3.d174.s1.e0" id="DS3.d174.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s2" origId="10022752-15" text="In the presence of CUOOH, no stimulation of MDZ metabolism was observed by aNF, terfenadine or testosterone in adult liver microsomes.">
            <entity id="DS3.d174.s2.e0" origId="5326860" charOffset="44-47" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s2.e1" origId="P01160" charOffset="75-78" type="protein" text="aNF"/>
            <entity id="DS3.d174.s2.e2" origId="5405" charOffset="80-91" type="compound" text="terfenadine"/>
            <entity id="DS3.d174.s2.e3" origId="6013" charOffset="95-107" type="compound" text="testosterone"/>
            <pair e1="DS3.d174.s2.e0" e2="DS3.d174.s2.e1" id="DS3.d174.s2.i0" interaction="False" />
            <pair e1="DS3.d174.s2.e2" e2="DS3.d174.s2.e1" id="DS3.d174.s2.i1" interaction="False" />
            <pair e1="DS3.d174.s2.e3" e2="DS3.d174.s2.e1" id="DS3.d174.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s3" origId="10022752-1" text="The effect of ionic strength, assay constituents, alpha-naphthoflavone (aNF), terfenadine and testosterone on human CYP3A mediated midazolam (MDZ) 1'-hydroxylation (MDZ 1'-OH) and 4-hydroxylation (MDZ 4-OH) in vitro was examined.">
            <entity id="DS3.d174.s3.e0" origId="P01160" charOffset="72-75" type="protein" text="aNF"/>
            <entity id="DS3.d174.s3.e1" origId="5405" charOffset="78-89" type="compound" text="terfenadine"/>
            <entity id="DS3.d174.s3.e2" origId="6013" charOffset="94-106" type="compound" text="testosterone"/>
            <entity id="DS3.d174.s3.e3" origId="4192" charOffset="131-140" type="compound" text="midazolam"/>
            <entity id="DS3.d174.s3.e4" origId="5326860" charOffset="142-145" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s3.e5" origId="5326860" charOffset="165-168" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s3.e6" origId="5326860" charOffset="165-168" type="compound" text="MDZ"/>
            <pair e1="DS3.d174.s3.e1" e2="DS3.d174.s3.e0" id="DS3.d174.s3.i0" interaction="False" />
            <pair e1="DS3.d174.s3.e4" e2="DS3.d174.s3.e0" id="DS3.d174.s3.i1" interaction="False" />
            <pair e1="DS3.d174.s3.e2" e2="DS3.d174.s3.e0" id="DS3.d174.s3.i2" interaction="False" />
            <pair e1="DS3.d174.s3.e3" e2="DS3.d174.s3.e0" id="DS3.d174.s3.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s4" origId="10022752-2" text="Increasing concentration of Tris-HCl (Tris) and sodium phosphate (PO4) buffers differentially affected MDZ 1'-OH and MDZ 4-OH formation rates and had a different effect on MDZ metabolism mediated by microsomes containing CYP3A4 versus CYP3A4 and CYP3A5.">
            <entity id="DS3.d174.s4.e0" origId="5360545" charOffset="48-54" type="compound" text="sodium"/>
            <entity id="DS3.d174.s4.e1" origId="1061,167704,644102" charOffset="55-64" type="compound" text="phosphate"/>
            <entity id="DS3.d174.s4.e2" origId="5326860" charOffset="103-106" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s4.e3" origId="5326860" charOffset="117-120" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s4.e4" origId="5326860" charOffset="117-120" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s4.e5" origId="P08684,Q6GRK0" charOffset="221-227" type="protein" text="CYP3A4"/>
            <entity id="DS3.d174.s4.e6" origId="P08684,Q6GRK0" charOffset="235-241" type="protein" text="CYP3A4"/>
            <entity id="DS3.d174.s4.e7" origId="P20815,B7Z3P6" charOffset="246-252" type="protein" text="CYP3A5"/>
            <pair e1="DS3.d174.s4.e2" e2="DS3.d174.s4.e5" id="DS3.d174.s4.i0" interaction="False" />
            <pair e1="DS3.d174.s4.e2" e2="DS3.d174.s4.e7" id="DS3.d174.s4.i1" interaction="False" />
            <pair e1="DS3.d174.s4.e1" e2="DS3.d174.s4.e5" id="DS3.d174.s4.i2" interaction="False" />
            <pair e1="DS3.d174.s4.e1" e2="DS3.d174.s4.e7" id="DS3.d174.s4.i3" interaction="False" />
            <pair e1="DS3.d174.s4.e0" e2="DS3.d174.s4.e5" id="DS3.d174.s4.i4" interaction="False" />
            <pair e1="DS3.d174.s4.e0" e2="DS3.d174.s4.e7" id="DS3.d174.s4.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s5" origId="10022752-4" text="Interestingly, the ammonium ion present in the solution of glucose 6-phosphate dehydrogenase was found to inhibit MDZ metabolism.">
            <entity id="DS3.d174.s5.e0" origId="223" charOffset="19-27" type="compound" text="ammonium"/>
            <entity id="DS3.d174.s5.e1" origId="P11413" charOffset="59-92" type="protein" text="glucose 6-phosphate dehydrogenase"/>
            <entity id="DS3.d174.s5.e2" origId="5326860" charOffset="114-117" type="compound" text="MDZ"/>
            <pair e1="DS3.d174.s5.e2" e2="DS3.d174.s5.e1" id="DS3.d174.s5.i0" interaction="False" />
            <pair e1="DS3.d174.s5.e0" e2="DS3.d174.s5.e1" id="DS3.d174.s5.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s6" origId="10022752-6" text="Formation of MDZ 1'-OH by microsomes from adult and fetal liver and expressed CYP3A4 was regioselectively stimulated by aNF (10 microM).">
            <entity id="DS3.d174.s6.e0" origId="5326860" charOffset="13-16" type="compound" text="MDZ"/>
            <entity id="DS3.d174.s6.e1" origId="P08684,Q6GRK0" charOffset="78-84" type="protein" text="CYP3A4"/>
            <entity id="DS3.d174.s6.e2" origId="P01160" charOffset="120-123" type="protein" text="aNF"/>
            <pair e1="DS3.d174.s6.e0" e2="DS3.d174.s6.e1" id="DS3.d174.s6.i0" interaction="False" />
            <pair e1="DS3.d174.s6.e0" e2="DS3.d174.s6.e2" id="DS3.d174.s6.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s7" origId="10022752-7" text="In human hepatocytes, aNF stimulated MDZ 1'-OH formation (up to 100%).">
            <entity id="DS3.d174.s7.e0" origId="P01160" charOffset="22-25" type="protein" text="aNF"/>
            <entity id="DS3.d174.s7.e1" origId="5326860" charOffset="37-40" type="compound" text="MDZ"/>
            <pair e1="DS3.d174.s7.e1" e2="DS3.d174.s7.e0" id="DS3.d174.s7.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d174.s8" origId="10022752-9" text="Surprisingly, with expressed CYP3A4, terfenadine (20 microM) inhibited MDZ 1'-OH formation.">
            <entity id="DS3.d174.s8.e0" origId="P08684,Q6GRK0" charOffset="29-35" type="protein" text="CYP3A4"/>
            <entity id="DS3.d174.s8.e1" origId="5405" charOffset="37-48" type="compound" text="terfenadine"/>
            <entity id="DS3.d174.s8.e2" origId="5326860" charOffset="71-74" type="compound" text="MDZ"/>
            <pair e1="DS3.d174.s8.e1" e2="DS3.d174.s8.e0" id="DS3.d174.s8.i0" interaction="False" />
            <pair e1="DS3.d174.s8.e2" e2="DS3.d174.s8.e0" id="DS3.d174.s8.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d175" origId="10022754">
        <sentence id="DS3.d175.s0" origId="10022754-2" text="N-acetyltransferase in feline liver showed high affinity (mean Km = 2.1 microM) for p-aminobenzoic acid, an NAT1 selective substrate in humans and rabbits, but showed a very poor affinity (mean Km &amp;gt; 10 mM) for sulfamethazine, an NAT2 selective substrate in humans and rabbits.">
            <entity id="DS3.d175.s0.e0" origId="978" charOffset="84-103" type="compound" text="p-aminobenzoic acid"/>
            <entity id="DS3.d175.s0.e1" origId="P18440,Q400J6,F5H5R8" charOffset="108-112" type="protein" text="NAT1"/>
            <entity id="DS3.d175.s0.e2" origId="5327" charOffset="213-227" type="compound" text="sulfamethazine"/>
            <entity id="DS3.d175.s0.e3" origId="P11246" charOffset="232-236" type="protein" text="NAT2"/>
            <pair e1="DS3.d175.s0.e2" e2="DS3.d175.s0.e3" id="DS3.d175.s0.i0" interaction="False" />
            <pair e1="DS3.d175.s0.e2" e2="DS3.d175.s0.e1" id="DS3.d175.s0.i1" interaction="False" />
            <pair e1="DS3.d175.s0.e0" e2="DS3.d175.s0.e3" id="DS3.d175.s0.i2" interaction="False" />
            <pair e1="DS3.d175.s0.e0" e2="DS3.d175.s0.e1" id="DS3.d175.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d175.s1" origId="10022754-5" text="The deduced amino acid sequence of the central portion of feline N-acetyltransferase, obtained by polymerase chain reaction amplification in both domestic cats and seven wild felids (lion, tiger, lynx, snow leopard, bobcat, Asian leopard cat and cheetah), contained three residues, Phe125, Arg127, and Tyr129, which determine NAT1-like substrate specificity in humans.">
            <entity id="DS3.d175.s1.e0" origId="86102" charOffset="196-200" type="compound" text="lynx"/>
            <entity id="DS3.d175.s1.e1" origId="P18440,Q400J6,F5H5R8" charOffset="326-330" type="protein" text="NAT1"/>
            <pair e1="DS3.d175.s1.e0" e2="DS3.d175.s1.e1" id="DS3.d175.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d176" origId="10022764">
        <sentence id="DS3.d176.s0" origId="10022764-5" text="In contrast, a strong interaction of RIP140 with the PPARalpha and LXRalpha heterodimerization partner retinoid-X-receptor alpha (RXRalpha) required the presence of its cognate ligand, 9-cis retinoic acid.">
            <entity id="DS3.d176.s0.e0" origId="Q07869,F1D8S4" charOffset="53-62" type="protein" text="PPARalpha"/>
            <entity id="DS3.d176.s0.e1" origId="Q13133,B4DXU5,F1D8N1,B5MBY7" charOffset="67-75" type="protein" text="LXRalpha"/>
            <entity id="DS3.d176.s0.e2" origId="P19793,F1D8Q5,Q6P3U7" charOffset="130-138" type="protein" text="RXRalpha"/>
            <entity id="DS3.d176.s0.e3" origId="449171" charOffset="185-204" type="compound" text="9-cis retinoic acid"/>
            <pair e1="DS3.d176.s0.e3" e2="DS3.d176.s0.e2" id="DS3.d176.s0.i0" interaction="False" />
            <pair e1="DS3.d176.s0.e3" e2="DS3.d176.s0.e1" id="DS3.d176.s0.i1" interaction="False" />
            <pair e1="DS3.d176.s0.e3" e2="DS3.d176.s0.e0" id="DS3.d176.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d177" origId="10022767">
        <sentence id="DS3.d177.s0" origId="10022767-4" text="Iodide uptake activity, thyroperoxidase protein and thyroglobulin mRNA taken as parameters of thyroid cell differentiation were 6 to 25-fold higher in RTF and TCM-T than in TCM.">
            <entity id="DS3.d177.s0.e0" origId="105054,30165" charOffset="0-6" type="compound" text="Iodide"/>
            <entity id="DS3.d177.s0.e1" origId="D1KKB3" charOffset="52-65" type="protein" text="thyroglobulin"/>
            <pair e1="DS3.d177.s0.e0" e2="DS3.d177.s0.e1" id="DS3.d177.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d178" origId="10022771">
        <sentence id="DS3.d178.s0" origId="10022771-4" text="Ten of the eleven 1/2 cysteine residues that in STC allow for dimerization of monomeric subunits were conserved in hSTCrP.">
            <entity id="DS3.d178.s0.e0" origId="5862,90793998" charOffset="22-30" type="compound" text="cysteine"/>
            <entity id="DS3.d178.s0.e1" origId="P52823" charOffset="48-51" type="protein" text="STC"/>
            <entity id="DS3.d178.s0.e2" origId="O76061,Q6FHC9" charOffset="115-121" type="protein" text="hSTCrP"/>
            <pair e1="DS3.d178.s0.e0" e2="DS3.d178.s0.e2" id="DS3.d178.s0.i0" interaction="False" />
            <pair e1="DS3.d178.s0.e0" e2="DS3.d178.s0.e1" id="DS3.d178.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d179" origId="10022774">
        <sentence id="DS3.d179.s0" origId="10022774-11" text="Prestimulation of the G-protein activity by sodium fluoride (NaF) or cholera toxin (CT), followed by rhFSH challenge, accounted for a decrease in the cAMP-mediated responsiveness, down to 69.4 +/- 2.8 or 74.2 +/- 1.9%, of control (P &amp;lt; 0.001), respectively, indicating that the post-receptor events are critical for desensitization.">
            <entity id="DS3.d179.s0.e0" origId="5360545" charOffset="44-50" type="compound" text="sodium"/>
            <entity id="DS3.d179.s0.e1" origId="28179" charOffset="51-59" type="compound" text="fluoride"/>
            <entity id="DS3.d179.s0.e2" origId="P49913,J3KNB4" charOffset="150-154" type="protein" text="cAMP"/>
            <pair e1="DS3.d179.s0.e1" e2="DS3.d179.s0.e2" id="DS3.d179.s0.i0" interaction="False" />
            <pair e1="DS3.d179.s0.e0" e2="DS3.d179.s0.e2" id="DS3.d179.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d179.s1" origId="10022774-7" text="The suppression by TPA preincubation of the rhFSH-induced cAMP synthesis was completely abolished by the protein kinase C (PKC) inhibitor staurosporine (STR).">
            <entity id="DS3.d179.s1.e0" origId="122634" charOffset="19-22" type="compound" text="TPA"/>
            <entity id="DS3.d179.s1.e1" origId="P49913,J3KNB4" charOffset="58-62" type="protein" text="cAMP"/>
            <entity id="DS3.d179.s1.e2" origId="44120114,44299148,451705,5279,5311103,5459111,6419748,6711321,9937179,9956178" charOffset="138-151" type="compound" text="staurosporine"/>
            <pair e1="DS3.d179.s1.e2" e2="DS3.d179.s1.e1" id="DS3.d179.s1.i0" interaction="False" />
            <pair e1="DS3.d179.s1.e0" e2="DS3.d179.s1.e1" id="DS3.d179.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d180" origId="10022776">
        <sentence id="DS3.d180.s0" origId="10022776-8" text="Moreover, treatment with dexamethasone or aldosterone did not affect AT1a, AT1b, or AT2 mRNA.">
            <entity id="DS3.d180.s0.e0" origId="5743" charOffset="25-38" type="compound" text="dexamethasone"/>
            <entity id="DS3.d180.s0.e1" origId="P25095" charOffset="69-73" type="protein" text="AT1a"/>
            <entity id="DS3.d180.s0.e2" origId="P29089" charOffset="75-79" type="protein" text="AT1b"/>
            <pair e1="DS3.d180.s0.e0" e2="DS3.d180.s0.e1" id="DS3.d180.s0.i0" interaction="False" />
            <pair e1="DS3.d180.s0.e0" e2="DS3.d180.s0.e2" id="DS3.d180.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d181" origId="10022777">
        <sentence id="DS3.d181.s0" origId="10022777-10" text="Furthermore, when several PKC-specific inhibitors (Gö 6976, GF 109203X or bisindolylmaleimide III) with different specificities for each isoform were used, there was a good correlation between inhibition of the enhancement of hGH-BP release and inhibition of the phosphorylation of PKC isoforms, another activation marker of PKC, in PKCalpha but not in PKCdelta and mu.">
            <entity id="DS3.d181.s0.e0" origId="2396" charOffset="60-70" type="compound" text="GF 109203X"/>
            <entity id="DS3.d181.s0.e1" origId="2398" charOffset="74-97" type="compound" text="bisindolylmaleimide III"/>
            <entity id="DS3.d181.s0.e2" origId="P10912,A0A087X0H5,A0A087X162" charOffset="226-232" type="protein" text="hGH-BP"/>
            <entity id="DS3.d181.s0.e3" origId="P17252,Q7Z727" charOffset="333-341" type="protein" text="PKCalpha"/>
            <entity id="DS3.d181.s0.e4" origId="Q05655,A0A024R328" charOffset="353-361" type="protein" text="PKCdelta"/>
            <pair e1="DS3.d181.s0.e0" e2="DS3.d181.s0.e4" id="DS3.d181.s0.i0" interaction="False" />
            <pair e1="DS3.d181.s0.e0" e2="DS3.d181.s0.e2" id="DS3.d181.s0.i1" interaction="False" />
            <pair e1="DS3.d181.s0.e0" e2="DS3.d181.s0.e3" id="DS3.d181.s0.i2" interaction="False" />
            <pair e1="DS3.d181.s0.e1" e2="DS3.d181.s0.e4" id="DS3.d181.s0.i3" interaction="False" />
            <pair e1="DS3.d181.s0.e1" e2="DS3.d181.s0.e2" id="DS3.d181.s0.i4" interaction="False" />
            <pair e1="DS3.d181.s0.e1" e2="DS3.d181.s0.e3" id="DS3.d181.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d181.s1" origId="10022777-1" text="The effect of phorbol ester on human growth hormone-binding protein (hGH-BP) release was investigated.">
            <entity id="DS3.d181.s1.e0" origId="22833501,27924,70702034" charOffset="14-27" type="compound" text="phorbol ester"/>
            <entity id="DS3.d181.s1.e1" origId="P10912,A0A087X0H5,A0A087X162" charOffset="31-67" type="protein" text="human growth hormone-binding protein"/>
            <entity id="DS3.d181.s1.e2" origId="P10912,A0A087X0H5,A0A087X162" charOffset="69-75" type="protein" text="hGH-BP"/>
            <pair e1="DS3.d181.s1.e0" e2="DS3.d181.s1.e1" id="DS3.d181.s1.i0" interaction="False" />
            <pair e1="DS3.d181.s1.e0" e2="DS3.d181.s1.e2" id="DS3.d181.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d181.s2" origId="10022777-2" text="The hGH-BP release from human IM-9 cells measured by immunoblotting was dose-dependently enhanced by a phorbol ester, phorbol 12, 13-dibutyrate (PDBu), and reached plateau at 100 nM.">
            <entity id="DS3.d181.s2.e0" origId="P10912,A0A087X0H5,A0A087X162" charOffset="4-10" type="protein" text="hGH-BP"/>
            <entity id="DS3.d181.s2.e1" origId="22833501,27924,70702034" charOffset="103-116" type="compound" text="phorbol ester"/>
            <entity id="DS3.d181.s2.e2" origId="442070" charOffset="103-110" type="compound" text="phorbol"/>
            <pair e1="DS3.d181.s2.e1" e2="DS3.d181.s2.e0" id="DS3.d181.s2.i0" interaction="False" />
            <pair e1="DS3.d181.s2.e2" e2="DS3.d181.s2.e0" id="DS3.d181.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d181.s3" origId="10022777-4" text="Similarly, a diacylglycerol analogue, 1-oleoyl-2-acetyl-sn-glycerol, enhanced hGH-BP release.">
            <entity id="DS3.d181.s3.e0" origId="6026790" charOffset="13-27" type="compound" text="diacylglycerol"/>
            <entity id="DS3.d181.s3.e1" origId="1394,5353264,6437055,6437085" charOffset="38-67" type="compound" text="1-oleoyl-2-acetyl-sn-glycerol"/>
            <entity id="DS3.d181.s3.e2" origId="P10912,A0A087X0H5,A0A087X162" charOffset="78-84" type="protein" text="hGH-BP"/>
            <pair e1="DS3.d181.s3.e0" e2="DS3.d181.s3.e2" id="DS3.d181.s3.i0" interaction="False" />
            <pair e1="DS3.d181.s3.e1" e2="DS3.d181.s3.e2" id="DS3.d181.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d181.s4" origId="10022777-5" text="The enhancement was not inhibited by cycloheximide pretreatment, suggesting that the enhanced hGH-BP release does not require de novo protein synthesis.">
            <entity id="DS3.d181.s4.e0" origId="6197" charOffset="37-50" type="compound" text="cycloheximide"/>
            <entity id="DS3.d181.s4.e1" origId="P10912,A0A087X0H5,A0A087X162" charOffset="94-100" type="protein" text="hGH-BP"/>
            <pair e1="DS3.d181.s4.e0" e2="DS3.d181.s4.e1" id="DS3.d181.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d181.s5" origId="10022777-6" text="The PDBu-enhanced hGH-BP release was strongly inhibited by extracellular EDTA, and was dose-dependently inhibited by protein kinase C (PKC)-specific inhibitor, Ro 31-8220.">
            <entity id="DS3.d181.s5.e0" origId="P10912,A0A087X0H5,A0A087X162" charOffset="18-24" type="protein" text="hGH-BP"/>
            <entity id="DS3.d181.s5.e1" origId="214797" charOffset="160-165" type="compound" text="Ro 31"/>
            <pair e1="DS3.d181.s5.e1" e2="DS3.d181.s5.e0" id="DS3.d181.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d182" origId="10022788">
        <sentence id="DS3.d182.s0" origId="10022788-4" text="An acidic saline solution (0.1 M lactic acid/0.1 M NaC1 (pH = 2)) and an artificial saliva were used as the corrosion media.">
            <entity id="DS3.d182.s0.e0" origId="612" charOffset="33-44" type="compound" text="lactic acid"/>
            <entity id="DS3.d182.s0.e1" origId="P35498" charOffset="51-55" type="protein" text="NaC1"/>
            <pair e1="DS3.d182.s0.e0" e2="DS3.d182.s0.e1" id="DS3.d182.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d183" origId="10022809">
        <sentence id="DS3.d183.s0" origId="10022809-0" text="Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells.">
            <entity id="DS3.d183.s0.e0" origId="P00519,Q59FK4,A0A024R8E2" charOffset="14-19" type="protein" text="c-Abl"/>
            <entity id="DS3.d183.s0.e1" origId="6057,90983769" charOffset="20-28" type="compound" text="tyrosine"/>
            <pair e1="DS3.d183.s0.e1" e2="DS3.d183.s0.e0" id="DS3.d183.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d183.s1" origId="10022809-8" text="Interestingly, c-Abl tyrosine kinase inhibition by CGP 57148 reduced apoptosis without interfering with JNK1/SAPK activation.">
            <entity id="DS3.d183.s1.e0" origId="P00519,Q59FK4,A0A024R8E2" charOffset="15-20" type="protein" text="c-Abl"/>
            <entity id="DS3.d183.s1.e1" origId="6057,90983769" charOffset="21-29" type="compound" text="tyrosine"/>
            <entity id="DS3.d183.s1.e2" origId="5291" charOffset="51-60" type="compound" text="CGP 57148"/>
            <entity id="DS3.d183.s1.e3" origId="P45983,A1L4K2" charOffset="104-108" type="protein" text="JNK1"/>
            <pair e1="DS3.d183.s1.e2" e2="DS3.d183.s1.e3" id="DS3.d183.s1.i0" interaction="False" />
            <pair e1="DS3.d183.s1.e2" e2="DS3.d183.s1.e0" id="DS3.d183.s1.i1" interaction="False" />
            <pair e1="DS3.d183.s1.e1" e2="DS3.d183.s1.e3" id="DS3.d183.s1.i2" interaction="False" />
            <pair e1="DS3.d183.s1.e1" e2="DS3.d183.s1.e0" id="DS3.d183.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d184" origId="10022810">
        <sentence id="DS3.d184.s0" origId="10022810-6" text="Filopodia and process outgrowth was significantly suppressed when full-length trkB.TK+ was cotransfected together with trkB.T1 and this inhibitory effect was blocked by tyrosine kinase inhibitor K252a.">
            <entity id="DS3.d184.s0.e0" origId="Q16620,A0A024R230,Q5VWE5,Q548C2" charOffset="78-82" type="protein" text="trkB"/>
            <entity id="DS3.d184.s0.e1" origId="Q16620,A0A024R230,Q5VWE5,Q548C2" charOffset="119-123" type="protein" text="trkB"/>
            <entity id="DS3.d184.s0.e2" origId="6057,90983769" charOffset="169-177" type="compound" text="tyrosine"/>
            <entity id="DS3.d184.s0.e3" origId="53378893" charOffset="178-194" type="compound" text="kinase inhibitor"/>
            <pair e1="DS3.d184.s0.e3" e2="DS3.d184.s0.e0" id="DS3.d184.s0.i0" interaction="False" />
            <pair e1="DS3.d184.s0.e2" e2="DS3.d184.s0.e0" id="DS3.d184.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d185" origId="10022812">
        <sentence id="DS3.d185.s0" origId="10022812-1" text="In COS cells, Ral GDP dissociation stimulator (RalGDS)-induced Ral activation was stimulated by RasG12V or a Rap1/Ras chimera in which the N-terminal region of Rap1 was ligated to the C-terminal region of Ras but not by Rap1G12V or a Ras/Rap1 chimera in which the N-terminal region of Ras was ligated to the C-terminal region of Rap1, although RalGDS interacted with these small GTP-binding proteins.">
            <entity id="DS3.d185.s0.e0" origId="8977" charOffset="18-21" type="compound" text="GDP"/>
            <entity id="DS3.d185.s0.e1" origId="Q91VL8" charOffset="109-113" type="protein" text="Rap1"/>
            <entity id="DS3.d185.s0.e2" origId="Q91VL8" charOffset="160-164" type="protein" text="Rap1"/>
            <entity id="DS3.d185.s0.e3" origId="Q91VL8" charOffset="160-164" type="protein" text="Rap1"/>
            <entity id="DS3.d185.s0.e4" origId="Q91VL8" charOffset="160-164" type="protein" text="Rap1"/>
            <entity id="DS3.d185.s0.e5" origId="6830" charOffset="379-382" type="compound" text="GTP"/>
            <pair e1="DS3.d185.s0.e0" e2="DS3.d185.s0.e1" id="DS3.d185.s0.i0" interaction="False" />
            <pair e1="DS3.d185.s0.e5" e2="DS3.d185.s0.e1" id="DS3.d185.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d186" origId="10022813">
        <sentence id="DS3.d186.s0" origId="10022813-0" text="Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.">
            <entity id="DS3.d186.s0.e0" origId="124886,20725278" charOffset="37-48" type="compound" text="glutathione"/>
            <entity id="DS3.d186.s0.e1" origId="P09211,V9HWE9" charOffset="67-72" type="protein" text="GSTP1"/>
            <pair e1="DS3.d186.s0.e0" e2="DS3.d186.s0.e1" id="DS3.d186.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d187" origId="10022814">
        <sentence id="DS3.d187.s0" origId="10022814-1" text="Increased breast cancer growth has been associated with increased expression of epidermal growth factor receptor (EGFR) and ErbB2 receptor tyrosine kinases (RTKs).">
            <entity id="DS3.d187.s0.e0" origId="P00533" charOffset="80-112" type="protein" text="epidermal growth factor receptor"/>
            <entity id="DS3.d187.s0.e1" origId="P00533" charOffset="114-118" type="protein" text="EGFR"/>
            <entity id="DS3.d187.s0.e2" origId="90983769,6057" charOffset="139-147" type="compound" text="tyrosine"/>
            <pair e1="DS3.d187.s0.e2" e2="DS3.d187.s0.e0" id="DS3.d187.s0.i0" interaction="False" />
            <pair e1="DS3.d187.s0.e2" e2="DS3.d187.s0.e1" id="DS3.d187.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d188" origId="10022818">
        <sentence id="DS3.d188.s0" origId="10022818-3" text="Although previous Northern blot analysis failed to detect the DNA-PKcs transcript in these cells, we show here through quantitative studies that the transcript is present, albeit at greatly reduced (approximately 20x) levels.">
            <entity id="DS3.d188.s0.e0" origId="P78527" charOffset="62-70" type="protein" text="DNA-PKcs"/>
            <entity id="DS3.d188.s0.e1" origId="49831054" charOffset="213-216" type="compound" text="20x"/>
            <pair e1="DS3.d188.s0.e1" e2="DS3.d188.s0.e0" id="DS3.d188.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d188.s1" origId="10022818-5" text="Nuclear run-on transcription assays indicated that the rate of DNA-PKcs transcription in M059J and DNA-PKcs proficient cell lines was similar, but the stability of the DNA-PKcs message in the M059J cell line was drastically (approximately 20x) reduced.">
            <entity id="DS3.d188.s1.e0" origId="P78527" charOffset="63-71" type="protein" text="DNA-PKcs"/>
            <entity id="DS3.d188.s1.e1" origId="P78527" charOffset="99-107" type="protein" text="DNA-PKcs"/>
            <entity id="DS3.d188.s1.e2" origId="P78527" charOffset="99-107" type="protein" text="DNA-PKcs"/>
            <entity id="DS3.d188.s1.e3" origId="49831054" charOffset="239-242" type="compound" text="20x"/>
            <pair e1="DS3.d188.s1.e3" e2="DS3.d188.s1.e0" id="DS3.d188.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d189" origId="10022820">
        <sentence id="DS3.d189.s0" origId="10022820-5" text="ETO-2 is 75% identical to murine ETO and shares very high sequence identities over four regions of the protein with ETO (domain I-III and zinc-finger).">
            <entity id="DS3.d189.s0.e0" origId="O54972,B7ZP57,E9QM80" charOffset="0-5" type="protein" text="ETO-2"/>
            <entity id="DS3.d189.s0.e1" origId="23994" charOffset="138-142" type="compound" text="zinc"/>
            <pair e1="DS3.d189.s0.e1" e2="DS3.d189.s0.e0" id="DS3.d189.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d189.s1" origId="10022820-7" text="ETO-2 is also expressed in myeloid and erythroid cell lines.">
            <entity id="DS3.d189.s1.e0" origId="O54972,B7ZP57,E9QM80" charOffset="0-5" type="protein" text="ETO-2"/>
            <entity id="DS3.d189.s1.e1" origId="439574" charOffset="39-48" type="compound" text="erythroid"/>
            <pair e1="DS3.d189.s1.e1" e2="DS3.d189.s1.e0" id="DS3.d189.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d189.s2" origId="10022820-8" text="We confirmed the nuclear localization of ETO-2 and demonstrated that domain III and the zinc-finger region are not required for nuclear localization.">
            <entity id="DS3.d189.s2.e0" origId="O54972,B7ZP57,E9QM80" charOffset="41-46" type="protein" text="ETO-2"/>
            <entity id="DS3.d189.s2.e1" origId="23994" charOffset="88-92" type="compound" text="zinc"/>
            <pair e1="DS3.d189.s2.e1" e2="DS3.d189.s2.e0" id="DS3.d189.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d190" origId="10022822">
        <sentence id="DS3.d190.s0" origId="10022822-5" text="The wedge shape and three-loop arrangement of the p41 fragment bound to the active site cleft of cathepsin L are reminiscent of the inhibitory edge of cystatins, thus demonstrating the first example of convergent evolution observed in cysteine protease inhibitors.">
            <entity id="DS3.d190.s0.e0" origId="P28482,Q1HBJ4,Q499G7" charOffset="50-53" type="protein" text="p41"/>
            <entity id="DS3.d190.s0.e1" origId="P07711,Q9HBQ7,A0A024R276" charOffset="97-108" type="protein" text="cathepsin L"/>
            <entity id="DS3.d190.s0.e2" origId="5862,90793998" charOffset="235-243" type="compound" text="cysteine"/>
            <pair e1="DS3.d190.s0.e2" e2="DS3.d190.s0.e1" id="DS3.d190.s0.i0" interaction="False" />
            <pair e1="DS3.d190.s0.e2" e2="DS3.d190.s0.e0" id="DS3.d190.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d191" origId="10022826">
        <sentence id="DS3.d191.s0" origId="10022826-6" text="In single dopaminergic SN neurons, co-expression of SUR1 + Kir6.2, but not of SUR2B + Kir6.2, correlated with functional K-ATP channels highly sensitive to metabolic inhibition.">
            <entity id="DS3.d191.s0.e0" origId="B2RUS7" charOffset="52-56" type="protein" text="SUR1"/>
            <entity id="DS3.d191.s0.e1" origId="Q61743" charOffset="59-65" type="protein" text="Kir6.2"/>
            <entity id="DS3.d191.s0.e2" origId="P70170,E9PUE8" charOffset="78-83" type="protein" text="SUR2B"/>
            <entity id="DS3.d191.s0.e3" origId="Q61743" charOffset="86-92" type="protein" text="Kir6.2"/>
            <entity id="DS3.d191.s0.e4" origId="5957" charOffset="123-126" type="compound" text="ATP"/>
            <pair e1="DS3.d191.s0.e4" e2="DS3.d191.s0.e2" id="DS3.d191.s0.i0" interaction="False" />
            <pair e1="DS3.d191.s0.e4" e2="DS3.d191.s0.e1" id="DS3.d191.s0.i1" interaction="False" />
            <pair e1="DS3.d191.s0.e4" e2="DS3.d191.s0.e0" id="DS3.d191.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d192" origId="10022827">
        <sentence id="DS3.d192.s0" origId="10022827-6" text="Systematic mutagenesis revealed a titratable C-terminal histidine residue (H216) in Kir6.2 to be the structural determinant, and electrostatic interaction between this residue and polyamines was shown to be the molecular mechanism underlying pH-dependent rectification.">
            <entity id="DS3.d192.s0.e0" origId="6274" charOffset="56-65" type="compound" text="histidine"/>
            <entity id="DS3.d192.s0.e1" origId="Q14654,B2RC52" charOffset="84-90" type="protein" text="Kir6.2"/>
            <pair e1="DS3.d192.s0.e0" e2="DS3.d192.s0.e1" id="DS3.d192.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d193" origId="10022829">
        <sentence id="DS3.d193.s0" origId="10022829-2" text="These fragments were compared with similar modules from the laminin alpha1 chain and from the C-terminal region of perlecan (PGV) in several binding studies.">
            <entity id="DS3.d193.s0.e0" origId="P19137,F8VQ40" charOffset="60-74" type="protein" text="laminin alpha1"/>
            <entity id="DS3.d193.s0.e1" origId="5289145" charOffset="125-128" type="compound" text="PGV"/>
            <pair e1="DS3.d193.s0.e1" e2="DS3.d193.s0.e0" id="DS3.d193.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d193.s1" origId="10022829-8" text="Both tandem fragments, but not the individual modules, bound strongly to alpha-dystroglycan and this interaction was abolished by EDTA but not by high concentrations of heparin and NaCl.">
            <entity id="DS3.d193.s1.e0" origId="Q62165,Q544G5,Q8BPJ7,Q8CBE6" charOffset="73-91" type="protein" text="alpha-dystroglycan"/>
            <entity id="DS3.d193.s1.e1" origId="6049" charOffset="130-134" type="compound" text="EDTA"/>
            <pair e1="DS3.d193.s1.e1" e2="DS3.d193.s1.e0" id="DS3.d193.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d193.s2" origId="10022829-9" text="The binding of perlecan fragment PGV to alpha-dystroglycan was even stronger and was also not sensitive to heparin.">
            <entity id="DS3.d193.s2.e0" origId="5289145" charOffset="33-36" type="compound" text="PGV"/>
            <entity id="DS3.d193.s2.e1" origId="Q62165,Q544G5,Q8BPJ7,Q8CBE6" charOffset="40-58" type="protein" text="alpha-dystroglycan"/>
            <pair e1="DS3.d193.s2.e0" e2="DS3.d193.s2.e1" id="DS3.d193.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d194" origId="10022830">
        <sentence id="DS3.d194.s0" origId="10022830-4" text="High-affinity binding sites for phosphoinositides in beta-arrestin (arrestin2) and arrestin3 (beta-arrestin2) were identified, and dissimilar effects of phosphoinositide and inositol phosphate on arrestin interactions with clathrin and receptor were characterized.">
            <entity id="DS3.d194.s0.e0" origId="P49407,B7Z1Q3" charOffset="68-77" type="protein" text="arrestin2"/>
            <entity id="DS3.d194.s0.e1" origId="P32121,Q68DZ5,Q59EM5,K7ENA6" charOffset="83-92" type="protein" text="arrestin3"/>
            <entity id="DS3.d194.s0.e2" origId="P49407,B7Z1Q3" charOffset="99-108" type="protein" text="arrestin2"/>
            <entity id="DS3.d194.s0.e3" origId="16738692" charOffset="32-48" type="compound" text="phosphoinositide"/>
            <entity id="DS3.d194.s0.e4" origId="161368,9" charOffset="174-192" type="compound" text="inositol phosphate"/>
            <pair e1="DS3.d194.s0.e3" e2="DS3.d194.s0.e1" id="DS3.d194.s0.i0" interaction="False" />
            <pair e1="DS3.d194.s0.e3" e2="DS3.d194.s0.e0" id="DS3.d194.s0.i1" interaction="False" />
            <pair e1="DS3.d194.s0.e4" e2="DS3.d194.s0.e1" id="DS3.d194.s0.i2" interaction="False" />
            <pair e1="DS3.d194.s0.e4" e2="DS3.d194.s0.e0" id="DS3.d194.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d194.s1" origId="10022830-5" text="Alteration of three basic residues in arrestin3 abolished phosphoinositide binding with complete retention of clathrin and receptor binding.">
            <entity id="DS3.d194.s1.e0" origId="P32121,Q68DZ5,Q59EM5,K7ENA6" charOffset="38-47" type="protein" text="arrestin3"/>
            <entity id="DS3.d194.s1.e1" origId="16738692" charOffset="58-74" type="compound" text="phosphoinositide"/>
            <pair e1="DS3.d194.s1.e1" e2="DS3.d194.s1.e0" id="DS3.d194.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d195" origId="10022831">
        <sentence id="DS3.d195.s0" origId="10022831-3" text="To determine a potential regulation of angiogenic inducer receptors by the integrin system, we investigated the interaction between alphavbeta3 integrin and tyrosine kinase vascular endothelial growth factor receptor-2 (VEGFR-2) in human endothelial cells.">
            <entity id="DS3.d195.s0.e0" origId="6057,90983769" charOffset="157-165" type="compound" text="tyrosine"/>
            <entity id="DS3.d195.s0.e1" origId="P35968,A0A024RD88" charOffset="173-218" type="protein" text="vascular endothelial growth factor receptor-2"/>
            <entity id="DS3.d195.s0.e2" origId="P35968,A0A024RD88" charOffset="220-227" type="protein" text="VEGFR-2"/>
            <pair e1="DS3.d195.s0.e0" e2="DS3.d195.s0.e2" id="DS3.d195.s0.i0" interaction="False" />
            <pair e1="DS3.d195.s0.e0" e2="DS3.d195.s0.e1" id="DS3.d195.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d195.s1" origId="10022831-4" text="We report that tyrosine-phosphorylated VEGFR-2 co-immunoprecipitated with beta3 integrin subunit, but not with beta1 or beta5, from cells stimulated with VEGF-A165.">
            <entity id="DS3.d195.s1.e0" origId="6057,90983769" charOffset="15-23" type="compound" text="tyrosine"/>
            <entity id="DS3.d195.s1.e1" origId="P35968,A0A024RD88" charOffset="39-46" type="protein" text="VEGFR-2"/>
            <entity id="DS3.d195.s1.e2" origId="Q16558" charOffset="111-116" type="protein" text="beta1"/>
            <entity id="DS3.d195.s1.e3" origId="P04350" charOffset="120-125" type="protein" text="beta5"/>
            <entity id="DS3.d195.s1.e4" origId="3314467" charOffset="159-163" type="compound" text="A165"/>
            <pair e1="DS3.d195.s1.e4" e2="DS3.d195.s1.e3" id="DS3.d195.s1.i0" interaction="False" />
            <pair e1="DS3.d195.s1.e4" e2="DS3.d195.s1.e1" id="DS3.d195.s1.i1" interaction="False" />
            <pair e1="DS3.d195.s1.e4" e2="DS3.d195.s1.e2" id="DS3.d195.s1.i2" interaction="False" />
            <pair e1="DS3.d195.s1.e0" e2="DS3.d195.s1.e3" id="DS3.d195.s1.i3" interaction="False" />
            <pair e1="DS3.d195.s1.e0" e2="DS3.d195.s1.e1" id="DS3.d195.s1.i4" interaction="False" />
            <pair e1="DS3.d195.s1.e0" e2="DS3.d195.s1.e2" id="DS3.d195.s1.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d195.s2" origId="10022831-5" text="VEGFR-2 phosphorylation and mitogenicity induced by VEGF-A165 were enhanced in cells plated on the alphavbeta3 ligand, vitronectin, compared with cells plated on the alpha5beta1 ligand, fibronectin or the alpha2beta1 ligand, collagen.">
            <entity id="DS3.d195.s2.e0" origId="P35968,A0A024RD88" charOffset="0-7" type="protein" text="VEGFR-2"/>
            <entity id="DS3.d195.s2.e1" origId="3314467" charOffset="57-61" type="compound" text="A165"/>
            <entity id="DS3.d195.s2.e2" origId="P04004,D9ZGG2" charOffset="119-130" type="protein" text="vitronectin"/>
            <entity id="DS3.d195.s2.e3" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="186-197" type="protein" text="fibronectin"/>
            <pair e1="DS3.d195.s2.e1" e2="DS3.d195.s2.e2" id="DS3.d195.s2.i0" interaction="False" />
            <pair e1="DS3.d195.s2.e1" e2="DS3.d195.s2.e3" id="DS3.d195.s2.i1" interaction="False" />
            <pair e1="DS3.d195.s2.e1" e2="DS3.d195.s2.e0" id="DS3.d195.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d195.s3" origId="10022831-6" text="BV4 anti-beta3 integrin mAb, which does not interfere with endothelial cell adhesion to vitronectin, reduced (i) the tyrosine phosphorylation of VEGFR-2; (ii) the activation of downstream transductor phosphoinositide 3-OH kinase; and (iii) biological effects triggered by VEGF-A165.">
            <entity id="DS3.d195.s3.e0" origId="446958" charOffset="0-3" type="compound" text="BV4"/>
            <entity id="DS3.d195.s3.e1" origId="P04004,D9ZGG2" charOffset="88-99" type="protein" text="vitronectin"/>
            <entity id="DS3.d195.s3.e2" origId="6057,90983769" charOffset="117-125" type="compound" text="tyrosine"/>
            <entity id="DS3.d195.s3.e3" origId="P35968,A0A024RD88" charOffset="145-152" type="protein" text="VEGFR-2"/>
            <entity id="DS3.d195.s3.e4" origId="3314467" charOffset="277-281" type="compound" text="A165"/>
            <pair e1="DS3.d195.s3.e4" e2="DS3.d195.s3.e3" id="DS3.d195.s3.i0" interaction="False" />
            <pair e1="DS3.d195.s3.e4" e2="DS3.d195.s3.e1" id="DS3.d195.s3.i1" interaction="False" />
            <pair e1="DS3.d195.s3.e2" e2="DS3.d195.s3.e3" id="DS3.d195.s3.i2" interaction="False" />
            <pair e1="DS3.d195.s3.e2" e2="DS3.d195.s3.e1" id="DS3.d195.s3.i3" interaction="False" />
            <pair e1="DS3.d195.s3.e0" e2="DS3.d195.s3.e3" id="DS3.d195.s3.i4" interaction="False" />
            <pair e1="DS3.d195.s3.e0" e2="DS3.d195.s3.e1" id="DS3.d195.s3.i5" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d196" origId="10022832">
        <sentence id="DS3.d196.s0" origId="10022832-7" text="EGF challenge of COS1 cells transfected to express PDE4D3 increased cAMP levels through a process ablated by PD98059.">
            <entity id="DS3.d196.s0.e0" origId="P49913,J3KNB4" charOffset="68-72" type="protein" text="cAMP"/>
            <entity id="DS3.d196.s0.e1" origId="4713" charOffset="109-116" type="compound" text="PD98059"/>
            <pair e1="DS3.d196.s0.e1" e2="DS3.d196.s0.e0" id="DS3.d196.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d197" origId="10022833">
        <sentence id="DS3.d197.s0" origId="10022833-1" text="We have identified Socs1 as a downstream component of the Kit receptor tyrosine kinase signalling pathway.">
            <entity id="DS3.d197.s0.e0" origId="O15524,Q4JHT5" charOffset="19-24" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s0.e1" origId="P10721,A0A024RDA0" charOffset="58-61" type="protein" text="Kit"/>
            <entity id="DS3.d197.s0.e2" origId="6057,90983769" charOffset="71-79" type="compound" text="tyrosine"/>
            <pair e1="DS3.d197.s0.e2" e2="DS3.d197.s0.e0" id="DS3.d197.s0.i0" interaction="False" />
            <pair e1="DS3.d197.s0.e2" e2="DS3.d197.s0.e1" id="DS3.d197.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d197.s1" origId="10022833-2" text="We show that the expression of Socs1 mRNA is rapidly increased in primary bone marrow-derived mast cells following exposure to steel factor, and Socs1 inducibly binds to the Kit receptor tyrosine kinase via its Src homology 2 (SH2) domain.">
            <entity id="DS3.d197.s1.e0" origId="O15524,Q4JHT5" charOffset="31-36" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s1.e1" origId="P21583,A0A024RBC0,A0A024RBF5" charOffset="127-139" type="protein" text="steel factor"/>
            <entity id="DS3.d197.s1.e2" origId="O15524,Q4JHT5" charOffset="145-150" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s1.e3" origId="P10721,A0A024RDA0" charOffset="174-177" type="protein" text="Kit"/>
            <entity id="DS3.d197.s1.e4" origId="6057,90983769" charOffset="187-195" type="compound" text="tyrosine"/>
            <pair e1="DS3.d197.s1.e4" e2="DS3.d197.s1.e0" id="DS3.d197.s1.i0" interaction="False" />
            <pair e1="DS3.d197.s1.e4" e2="DS3.d197.s1.e1" id="DS3.d197.s1.i1" interaction="False" />
            <pair e1="DS3.d197.s1.e4" e2="DS3.d197.s1.e3" id="DS3.d197.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d197.s2" origId="10022833-5" text="Unlike Janus kinases, Socs1 does not inhibit the catalytic activity of the Kit tyrosine kinase.">
            <entity id="DS3.d197.s2.e0" origId="O15524,Q4JHT5" charOffset="22-27" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s2.e1" origId="P10721,A0A024RDA0" charOffset="75-78" type="protein" text="Kit"/>
            <entity id="DS3.d197.s2.e2" origId="6057,90983769" charOffset="79-87" type="compound" text="tyrosine"/>
            <pair e1="DS3.d197.s2.e2" e2="DS3.d197.s2.e0" id="DS3.d197.s2.i0" interaction="False" />
            <pair e1="DS3.d197.s2.e2" e2="DS3.d197.s2.e1" id="DS3.d197.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d197.s3" origId="10022833-6" text="In order to define the mechanism by which Socs1-mediated suppression of Kit-dependent mitogenesis occurs, we demonstrate that Socs1 binds to the signalling proteins Grb-2 and the Rho-family guanine nucleotide exchange factors Vav.">
            <entity id="DS3.d197.s3.e0" origId="O15524,Q4JHT5" charOffset="42-47" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s3.e1" origId="P10721,A0A024RDA0" charOffset="72-75" type="protein" text="Kit"/>
            <entity id="DS3.d197.s3.e2" origId="O15524,Q4JHT5" charOffset="126-131" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s3.e3" origId="P62993,B0LPF3" charOffset="165-170" type="protein" text="Grb-2"/>
            <entity id="DS3.d197.s3.e4" origId="764" charOffset="190-197" type="compound" text="guanine"/>
            <entity id="DS3.d197.s3.e5" origId="P15498,Q96D37,A0A0A0MR07,B2R8B5" charOffset="226-229" type="protein" text="Vav"/>
            <pair e1="DS3.d197.s3.e4" e2="DS3.d197.s3.e5" id="DS3.d197.s3.i0" interaction="False" />
            <pair e1="DS3.d197.s3.e4" e2="DS3.d197.s3.e3" id="DS3.d197.s3.i1" interaction="False" />
            <pair e1="DS3.d197.s3.e4" e2="DS3.d197.s3.e0" id="DS3.d197.s3.i2" interaction="False" />
            <pair e1="DS3.d197.s3.e4" e2="DS3.d197.s3.e1" id="DS3.d197.s3.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d197.s4" origId="10022833-8" text="These data suggest that Socs1 is an inducible switch which modulates proliferative signals in favour of cell survival signals and functions as an adaptor protein in receptor tyrosine kinase signalling pathways.">
            <entity id="DS3.d197.s4.e0" origId="O15524,Q4JHT5" charOffset="24-29" type="protein" text="Socs1"/>
            <entity id="DS3.d197.s4.e1" origId="6057,90983769" charOffset="174-182" type="compound" text="tyrosine"/>
            <pair e1="DS3.d197.s4.e1" e2="DS3.d197.s4.e0" id="DS3.d197.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d198" origId="10022835">
        <sentence id="DS3.d198.s0" origId="10022835-3" text="Interaction between MyoD and cdk4 disrupts MyoD DNA-binding, muscle-specific gene activation and myogenic conversion of 10T1/2 cells independently of cyclin D1 and the CAK activation of cdk4.">
            <entity id="DS3.d198.s0.e0" origId="P15172" charOffset="20-24" type="protein" text="MyoD"/>
            <entity id="DS3.d198.s0.e1" origId="P11802,A0A024RBB6" charOffset="29-33" type="protein" text="cdk4"/>
            <entity id="DS3.d198.s0.e2" origId="P15172" charOffset="43-47" type="protein" text="MyoD"/>
            <entity id="DS3.d198.s0.e3" origId="P24385,Q6FI00" charOffset="150-159" type="protein" text="cyclin D1"/>
            <entity id="DS3.d198.s0.e4" origId="10491406" charOffset="168-171" type="compound" text="CAK"/>
            <entity id="DS3.d198.s0.e5" origId="P11802,A0A024RBB6" charOffset="186-190" type="protein" text="cdk4"/>
            <pair e1="DS3.d198.s0.e4" e2="DS3.d198.s0.e3" id="DS3.d198.s0.i0" interaction="False" />
            <pair e1="DS3.d198.s0.e4" e2="DS3.d198.s0.e1" id="DS3.d198.s0.i1" interaction="False" />
            <pair e1="DS3.d198.s0.e4" e2="DS3.d198.s0.e0" id="DS3.d198.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d199" origId="10022847">
        <sentence id="DS3.d199.s0" origId="10022847-1" text="The disulfide-bonded loop of chromogranin B (CgB), a regulated secretory protein with widespread distribution in neuroendocrine cells, is known to be essential for the sorting of CgB from the trans-Golgi network (TGN) to immature secretory granules.">
            <entity id="DS3.d199.s0.e0" origId="P05060" charOffset="29-43" type="protein" text="chromogranin B"/>
            <entity id="DS3.d199.s0.e1" origId="124434" charOffset="45-48" type="compound" text="CgB"/>
            <entity id="DS3.d199.s0.e2" origId="124434" charOffset="179-182" type="compound" text="CgB"/>
            <pair e1="DS3.d199.s0.e1" e2="DS3.d199.s0.e0" id="DS3.d199.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d200" origId="10022848">
        <sentence id="DS3.d200.s0" origId="10022848-3" text="Sec15p, an exocyst component, can associate with secretory vesicles and interact specifically with the rab GTPase, Sec4p, in its GTP-bound form.">
            <entity id="DS3.d200.s0.e0" origId="Q8TAG9,B3KXY5" charOffset="0-6" type="protein" text="Sec15p"/>
            <entity id="DS3.d200.s0.e1" origId="6830" charOffset="107-110" type="compound" text="GTP"/>
            <pair e1="DS3.d200.s0.e1" e2="DS3.d200.s0.e0" id="DS3.d200.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d201" origId="10022849">
        <sentence id="DS3.d201.s0" origId="10022849-2" text="Here we identify a 48 kDa type I transmembrane glycoprotein encoded by the MCMV early gene m06, which tightly binds to properly folded beta2-microglobulin (beta2m)-associated MHC class I molecules in the endoplasmic reticulum (ER).">
            <entity id="DS3.d201.s0.e0" origId="42644635" charOffset="91-94" type="compound" text="m06"/>
            <entity id="DS3.d201.s0.e1" origId="P01887" charOffset="135-154" type="protein" text="beta2-microglobulin"/>
            <entity id="DS3.d201.s0.e2" origId="P01887" charOffset="156-162" type="protein" text="beta2m"/>
            <pair e1="DS3.d201.s0.e0" e2="DS3.d201.s0.e2" id="DS3.d201.s0.i0" interaction="False" />
            <pair e1="DS3.d201.s0.e0" e2="DS3.d201.s0.e1" id="DS3.d201.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d202" origId="10022854">
        <sentence id="DS3.d202.s0" origId="10022854-7" text="Similarly, pretreatment with geldanamycin (GA), an Hsp90-specific inhibitor, prevented both the association of Raf-1 with the p50(cdc37)-Hsp90 heterodimer and Raf-1 kinase activation by serum.">
            <entity id="DS3.d202.s0.e0" origId="13017912,24196291,3460,45073431,46936377,5281885,5288382,5288451,56840921,5702269,57288407,71307093,71308206,71317043,73554183" charOffset="29-41" type="compound" text="geldanamycin"/>
            <entity id="DS3.d202.s0.e1" origId="P11346" charOffset="111-116" type="protein" text="Raf-1"/>
            <entity id="DS3.d202.s0.e2" origId="P48809,E1JHA4" charOffset="126-129" type="protein" text="p50"/>
            <entity id="DS3.d202.s0.e3" origId="Q24276,C4IY07" charOffset="130-135" type="protein" text="cdc37"/>
            <entity id="DS3.d202.s0.e4" origId="P11346" charOffset="159-164" type="protein" text="Raf-1"/>
            <pair e1="DS3.d202.s0.e0" e2="DS3.d202.s0.e1" id="DS3.d202.s0.i0" interaction="False" />
            <pair e1="DS3.d202.s0.e0" e2="DS3.d202.s0.e2" id="DS3.d202.s0.i1" interaction="False" />
            <pair e1="DS3.d202.s0.e0" e2="DS3.d202.s0.e3" id="DS3.d202.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d203" origId="10022857">
        <sentence id="DS3.d203.s0" origId="10022857-7" text="We characterized the cleavage activity in mouse liver extracts and found that the proteolytic cleavage activity is specific to prenatal and newborn livers, is sensitive to chymostatin, and is completely abolished in C/EBPalpha-/- animals.">
            <entity id="DS3.d203.s0.e0" origId="15942730,443119,46936189,5287931" charOffset="172-183" type="compound" text="chymostatin"/>
            <entity id="DS3.d203.s0.e1" origId="P53566" charOffset="216-226" type="protein" text="C/EBPalpha"/>
            <pair e1="DS3.d203.s0.e0" e2="DS3.d203.s0.e1" id="DS3.d203.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d204" origId="10022858">
        <sentence id="DS3.d204.s0" origId="10022858-6" text="Analysis of selected splicing enhancer elements and other enhancers in S100 complementation assays led to the identification of individual enhancers capable of being activated by specific serine/arginine (SR)-rich splicing factors (SC35, 9G8, and SF2/ASF).">
            <entity id="DS3.d204.s0.e0" origId="6322,90867653" charOffset="195-203" type="compound" text="arginine"/>
            <entity id="DS3.d204.s0.e1" origId="Q9V3V0,M9PC85" charOffset="238-241" type="protein" text="9G8"/>
            <entity id="DS3.d204.s0.e2" origId="Q9V3W7" charOffset="247-250" type="protein" text="SF2"/>
            <entity id="DS3.d204.s0.e3" origId="Q9V3W7" charOffset="251-254" type="protein" text="ASF"/>
            <pair e1="DS3.d204.s0.e0" e2="DS3.d204.s0.e2" id="DS3.d204.s0.i0" interaction="False" />
            <pair e1="DS3.d204.s0.e0" e2="DS3.d204.s0.e3" id="DS3.d204.s0.i1" interaction="False" />
            <pair e1="DS3.d204.s0.e0" e2="DS3.d204.s0.e1" id="DS3.d204.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d205" origId="10022861">
        <sentence id="DS3.d205.s0" origId="10022861-4" text="Glutamine synthetase is a glia-specific differentiation marker gene whose expression in the retinal tissue is regulated by glucocorticoids and is ultimately dependent on glia-neuron cell contacts.">
            <entity id="DS3.d205.s0.e0" origId="P15104,A8YXX4" charOffset="0-20" type="protein" text="Glutamine synthetase"/>
            <entity id="DS3.d205.s0.e1" origId="638015" charOffset="92-99" type="compound" text="retinal"/>
            <pair e1="DS3.d205.s0.e1" e2="DS3.d205.s0.e0" id="DS3.d205.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d205.s1" origId="10022861-6" text="Depolymerization of the cytoskeleton activates JNK and p38 mitogen-activated protein kinase and induces c-Jun expression by a signaling pathway that depends on tyrosine kinase activity.">
            <entity id="DS3.d205.s1.e0" origId="P28482,Q1HBJ4,Q499G7" charOffset="55-58" type="protein" text="p38"/>
            <entity id="DS3.d205.s1.e1" origId="6057,90983769" charOffset="160-168" type="compound" text="tyrosine"/>
            <pair e1="DS3.d205.s1.e1" e2="DS3.d205.s1.e0" id="DS3.d205.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d206" origId="10022862">
        <sentence id="DS3.d206.s0" origId="10022862-4" text="Mutation of the phosphorylation sites to alanine did not affect the sensitivity of p53 to binding to or degradation by Mdm2, although alteration of residues 15 and 37 to aspartic acid, which could mimic phosphorylation, resulted in a slight resistance to Mdm2-mediated degradation, consistent with recent reports that phosphorylation at these sites inhibits the p53-Mdm2 interaction.">
            <entity id="DS3.d206.s0.e0" origId="5950,602" charOffset="41-48" type="compound" text="alanine"/>
            <entity id="DS3.d206.s0.e1" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="83-86" type="protein" text="p53"/>
            <entity id="DS3.d206.s0.e2" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="119-123" type="protein" text="Mdm2"/>
            <entity id="DS3.d206.s0.e3" origId="57268516,5960" charOffset="170-183" type="compound" text="aspartic acid"/>
            <entity id="DS3.d206.s0.e4" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="255-259" type="protein" text="Mdm2"/>
            <entity id="DS3.d206.s0.e5" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="362-365" type="protein" text="p53"/>
            <entity id="DS3.d206.s0.e6" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="255-259" type="protein" text="Mdm2"/>
            <pair e1="DS3.d206.s0.e0" e2="DS3.d206.s0.e2" id="DS3.d206.s0.i0" interaction="False" />
            <pair e1="DS3.d206.s0.e0" e2="DS3.d206.s0.e1" id="DS3.d206.s0.i1" interaction="False" />
            <pair e1="DS3.d206.s0.e3" e2="DS3.d206.s0.e2" id="DS3.d206.s0.i2" interaction="False" />
            <pair e1="DS3.d206.s0.e3" e2="DS3.d206.s0.e1" id="DS3.d206.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d207" origId="10022864">
        <sentence id="DS3.d207.s0" origId="10022864-0" text="Activation of c-Jun N-terminal kinase 1 by UV irradiation is inhibited by wortmannin without affecting c-iun expression.">
            <entity id="DS3.d207.s0.e0" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="14-39" type="protein" text="c-Jun N-terminal kinase 1"/>
            <entity id="DS3.d207.s0.e1" origId="312145" charOffset="74-84" type="compound" text="wortmannin"/>
            <pair e1="DS3.d207.s0.e1" e2="DS3.d207.s0.e0" id="DS3.d207.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d207.s1" origId="10022864-4" text="Treatment of NIH 3T3 cells with UV light (UV-C) as well as with methyl methanesulfonate (MMS) caused activation of JNK1 and an increase in c-Jun protein and AP-1 binding activity, whereas antineoplastic drugs such as mafosfamide, mitomycin C, N-hydroxyethyl-N-chloroethylnitrosourea, and treosulfan did not elicit this response.">
            <entity id="DS3.d207.s1.e0" origId="4156" charOffset="64-87" type="compound" text="methyl methanesulfonate"/>
            <entity id="DS3.d207.s1.e1" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="115-119" type="protein" text="JNK1"/>
            <entity id="DS3.d207.s1.e2" origId="104746" charOffset="217-228" type="compound" text="mafosfamide"/>
            <entity id="DS3.d207.s1.e3" origId="5746" charOffset="230-239" type="compound" text="mitomycin"/>
            <entity id="DS3.d207.s1.e4" origId="68804" charOffset="243-282" type="compound" text="N-hydroxyethyl-N-chloroethylnitrosourea"/>
            <entity id="DS3.d207.s1.e5" origId="9296,95839,9882105" charOffset="288-298" type="compound" text="treosulfan"/>
            <pair e1="DS3.d207.s1.e5" e2="DS3.d207.s1.e1" id="DS3.d207.s1.i0" interaction="False" />
            <pair e1="DS3.d207.s1.e2" e2="DS3.d207.s1.e1" id="DS3.d207.s1.i1" interaction="False" />
            <pair e1="DS3.d207.s1.e0" e2="DS3.d207.s1.e1" id="DS3.d207.s1.i2" interaction="False" />
            <pair e1="DS3.d207.s1.e3" e2="DS3.d207.s1.e1" id="DS3.d207.s1.i3" interaction="False" />
            <pair e1="DS3.d207.s1.e4" e2="DS3.d207.s1.e1" id="DS3.d207.s1.i4" interaction="False" />
        </sentence>
        <sentence id="DS3.d207.s2" origId="10022864-5" text="The phosphatidylinositol 3-kinase inhibitor wortmannin specifically blocked the UV-stimulated activation of JNK1 but did not affect UV-driven activation of extracellular regulated kinase 2 (ERK2).">
            <entity id="DS3.d207.s2.e0" origId="16738692,53477912" charOffset="4-24" type="compound" text="phosphatidylinositol"/>
            <entity id="DS3.d207.s2.e1" origId="53378893" charOffset="27-43" type="compound" text="kinase inhibitor"/>
            <entity id="DS3.d207.s2.e2" origId="312145" charOffset="44-54" type="compound" text="wortmannin"/>
            <entity id="DS3.d207.s2.e3" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="108-112" type="protein" text="JNK1"/>
            <entity id="DS3.d207.s2.e4" origId="P63085" charOffset="156-188" type="protein" text="extracellular regulated kinase 2"/>
            <entity id="DS3.d207.s2.e5" origId="P63085" charOffset="190-194" type="protein" text="ERK2"/>
            <pair e1="DS3.d207.s2.e1" e2="DS3.d207.s2.e4" id="DS3.d207.s2.i0" interaction="False" />
            <pair e1="DS3.d207.s2.e1" e2="DS3.d207.s2.e3" id="DS3.d207.s2.i1" interaction="False" />
            <pair e1="DS3.d207.s2.e1" e2="DS3.d207.s2.e5" id="DS3.d207.s2.i2" interaction="False" />
            <pair e1="DS3.d207.s2.e0" e2="DS3.d207.s2.e4" id="DS3.d207.s2.i3" interaction="False" />
            <pair e1="DS3.d207.s2.e0" e2="DS3.d207.s2.e3" id="DS3.d207.s2.i4" interaction="False" />
            <pair e1="DS3.d207.s2.e0" e2="DS3.d207.s2.e5" id="DS3.d207.s2.i5" interaction="False" />
            <pair e1="DS3.d207.s2.e2" e2="DS3.d207.s2.e4" id="DS3.d207.s2.i6" interaction="False" />
            <pair e1="DS3.d207.s2.e2" e2="DS3.d207.s2.e3" id="DS3.d207.s2.i7" interaction="False" />
            <pair e1="DS3.d207.s2.e2" e2="DS3.d207.s2.e5" id="DS3.d207.s2.i8" interaction="False" />
        </sentence>
        <sentence id="DS3.d207.s3" origId="10022864-6" text="To investigate the significance of JNK1 for transactivation of c-jun, we analyzed the effect of UV irradiation on c-jun expression under conditions of wortmannin-mediated inhibition of UV-induced stimulation of JNK1.">
            <entity id="DS3.d207.s3.e0" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="35-39" type="protein" text="JNK1"/>
            <entity id="DS3.d207.s3.e1" origId="312145" charOffset="151-161" type="compound" text="wortmannin"/>
            <entity id="DS3.d207.s3.e2" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="211-215" type="protein" text="JNK1"/>
            <pair e1="DS3.d207.s3.e1" e2="DS3.d207.s3.e0" id="DS3.d207.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d207.s4" origId="10022864-8" text="In contrast, the mitogen-activated protein kinase/ERK kinase inhibitor PD98056, which blocked ERK2 but not JNK1 activation by UV irradiation, impaired UV-driven c-Jun protein induction and AP-1 binding.">
            <entity id="DS3.d207.s4.e0" origId="53378893" charOffset="54-70" type="compound" text="kinase inhibitor"/>
            <entity id="DS3.d207.s4.e1" origId="P63085" charOffset="94-98" type="protein" text="ERK2"/>
            <entity id="DS3.d207.s4.e2" origId="Q91Y86,Q7TSJ7,G3X8U9,A6P3E4,Q544A0" charOffset="107-111" type="protein" text="JNK1"/>
            <pair e1="DS3.d207.s4.e0" e2="DS3.d207.s4.e1" id="DS3.d207.s4.i0" interaction="False" />
            <pair e1="DS3.d207.s4.e0" e2="DS3.d207.s4.e2" id="DS3.d207.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d208" origId="10022866">
        <sentence id="DS3.d208.s0" origId="10022866-0" text="The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.">
            <entity id="DS3.d208.s0.e0" origId="Q13480,Q9HA84" charOffset="4-8" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s0.e1" origId="Q13480,Q9HA84" charOffset="51-55" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s0.e2" origId="6057,90983769" charOffset="148-156" type="compound" text="tyrosine"/>
            <pair e1="DS3.d208.s0.e2" e2="DS3.d208.s0.e0" id="DS3.d208.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d208.s1" origId="10022866-10" text="These data show that Gab1 is an important mediator of branching tubulogenesis downstream from the Met receptor and identify phosphatidylinositol 3-kinase and the Gab1 pleckstrin homology domain as crucial for subcellular localization of Gab1 and biological responses.">
            <entity id="DS3.d208.s1.e0" origId="Q13480,Q9HA84" charOffset="21-25" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s1.e1" origId="16738692,53477912" charOffset="124-144" type="compound" text="phosphatidylinositol"/>
            <entity id="DS3.d208.s1.e2" origId="Q13480,Q9HA84" charOffset="162-166" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s1.e3" origId="Q13480,Q9HA84" charOffset="162-166" type="protein" text="Gab1"/>
            <pair e1="DS3.d208.s1.e1" e2="DS3.d208.s1.e0" id="DS3.d208.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d208.s2" origId="10022866-1" text="Stimulation of the hepatocyte growth factor (HGF) receptor tyrosine kinase, Met, induces mitogenesis, motility, invasion, and branching tubulogenesis of epithelial and endothelial cell lines in culture.">
            <entity id="DS3.d208.s2.e0" origId="P14210" charOffset="45-48" type="protein" text="HGF"/>
            <entity id="DS3.d208.s2.e1" origId="6057,90983769" charOffset="59-67" type="compound" text="tyrosine"/>
            <pair e1="DS3.d208.s2.e1" e2="DS3.d208.s2.e0" id="DS3.d208.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d208.s3" origId="10022866-3" text="Gab1 is a member of the family of IRS-1-like multisubstrate docking proteins and, like IRS-1, contains an amino-terminal pleckstrin homology domain, in addition to multiple tyrosine residues that are potential binding sites for proteins that contain SH2 or PTB domains.">
            <entity id="DS3.d208.s3.e0" origId="Q13480,Q9HA84" charOffset="0-4" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s3.e1" origId="P35568,A0A024R499" charOffset="34-39" type="protein" text="IRS-1"/>
            <entity id="DS3.d208.s3.e2" origId="P35568,A0A024R499" charOffset="87-92" type="protein" text="IRS-1"/>
            <entity id="DS3.d208.s3.e3" origId="6057,90983769" charOffset="173-181" type="compound" text="tyrosine"/>
            <pair e1="DS3.d208.s3.e3" e2="DS3.d208.s3.e1" id="DS3.d208.s3.i0" interaction="False" />
            <pair e1="DS3.d208.s3.e3" e2="DS3.d208.s3.e0" id="DS3.d208.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d208.s4" origId="10022866-4" text="Following stimulation of epithelial cells with HGF, Gab1 associates with phosphatidylinositol 3-kinase and the tyrosine phosphatase SHP2.">
            <entity id="DS3.d208.s4.e0" origId="P14210" charOffset="47-50" type="protein" text="HGF"/>
            <entity id="DS3.d208.s4.e1" origId="Q13480,Q9HA84" charOffset="52-56" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s4.e2" origId="16738692,53477912" charOffset="73-93" type="compound" text="phosphatidylinositol"/>
            <entity id="DS3.d208.s4.e3" origId="6057,90983769" charOffset="111-119" type="compound" text="tyrosine"/>
            <entity id="DS3.d208.s4.e4" origId="Q06124" charOffset="132-136" type="protein" text="SHP2"/>
            <pair e1="DS3.d208.s4.e2" e2="DS3.d208.s4.e0" id="DS3.d208.s4.i0" interaction="False" />
            <pair e1="DS3.d208.s4.e2" e2="DS3.d208.s4.e4" id="DS3.d208.s4.i1" interaction="False" />
            <pair e1="DS3.d208.s4.e2" e2="DS3.d208.s4.e1" id="DS3.d208.s4.i2" interaction="False" />
            <pair e1="DS3.d208.s4.e3" e2="DS3.d208.s4.e0" id="DS3.d208.s4.i3" interaction="False" />
            <pair e1="DS3.d208.s4.e3" e2="DS3.d208.s4.e4" id="DS3.d208.s4.i4" interaction="False" />
            <pair e1="DS3.d208.s4.e3" e2="DS3.d208.s4.e1" id="DS3.d208.s4.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d208.s5" origId="10022866-9" text="Localization of Gab1 to areas of cell-cell contact is inhibited by LY294002, demonstrating that phosphatidylinositol 3-kinase activity is required.">
            <entity id="DS3.d208.s5.e0" origId="Q13480,Q9HA84" charOffset="16-20" type="protein" text="Gab1"/>
            <entity id="DS3.d208.s5.e1" origId="3973" charOffset="67-75" type="compound" text="LY294002"/>
            <entity id="DS3.d208.s5.e2" origId="16738692,53477912" charOffset="96-116" type="compound" text="phosphatidylinositol"/>
            <pair e1="DS3.d208.s5.e1" e2="DS3.d208.s5.e0" id="DS3.d208.s5.i0" interaction="False" />
            <pair e1="DS3.d208.s5.e2" e2="DS3.d208.s5.e0" id="DS3.d208.s5.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d209" origId="10022867">
        <sentence id="DS3.d209.s0" origId="10022867-3" text="Synthesis of mRNA from ETH1 in wild-type cells was induced sixfold relative to that in untreated cells after exposure to the alkylating agent methyl methanesulfonate (MMS).">
            <entity id="DS3.d209.s0.e0" origId="P38207" charOffset="23-27" type="protein" text="ETH1"/>
            <entity id="DS3.d209.s0.e1" origId="4156" charOffset="142-165" type="compound" text="methyl methanesulfonate"/>
            <pair e1="DS3.d209.s0.e1" e2="DS3.d209.s0.e0" id="DS3.d209.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d209.s1" origId="10022867-5" text="ETH1 strains were not more sensitive to killing by MMS, hydrogen peroxide, or phleomycin D1, whereas apn1 strains were approximately 3-fold more sensitive to MMS and approximately 10-fold more sensitive to hydrogen peroxide than was the wild type.">
            <entity id="DS3.d209.s1.e0" origId="P38207" charOffset="0-4" type="protein" text="ETH1"/>
            <entity id="DS3.d209.s1.e1" origId="784" charOffset="56-73" type="compound" text="hydrogen peroxide"/>
            <entity id="DS3.d209.s1.e2" origId="159333" charOffset="78-91" type="compound" text="phleomycin D1"/>
            <entity id="DS3.d209.s1.e3" origId="784" charOffset="206-223" type="compound" text="hydrogen peroxide"/>
            <pair e1="DS3.d209.s1.e2" e2="DS3.d209.s1.e0" id="DS3.d209.s1.i0" interaction="False" />
            <pair e1="DS3.d209.s1.e1" e2="DS3.d209.s1.e0" id="DS3.d209.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d209.s2" origId="10022867-6" text="Double-mutant strains (apn1 ETH1) were approximately 15-fold more sensitive to MMS and approximately 2- to 3-fold more sensitive to hydrogen peroxide and phleomycin D1 than were apn1 strains.">
            <entity id="DS3.d209.s2.e0" origId="P38207" charOffset="28-32" type="protein" text="ETH1"/>
            <entity id="DS3.d209.s2.e1" origId="784" charOffset="132-149" type="compound" text="hydrogen peroxide"/>
            <entity id="DS3.d209.s2.e2" origId="159333" charOffset="154-167" type="compound" text="phleomycin D1"/>
            <pair e1="DS3.d209.s2.e2" e2="DS3.d209.s2.e0" id="DS3.d209.s2.i0" interaction="False" />
            <pair e1="DS3.d209.s2.e1" e2="DS3.d209.s2.e0" id="DS3.d209.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d209.s3" origId="10022867-7" text="Elimination of ETH1 in apn1 strains also increased spontaneous mutation rates 9- or 31-fold compared to the wild type as determined by reversion to adenine or lysine prototrophy, respectively.">
            <entity id="DS3.d209.s3.e0" origId="P38207" charOffset="15-19" type="protein" text="ETH1"/>
            <entity id="DS3.d209.s3.e1" origId="190,57060554" charOffset="148-155" type="compound" text="adenine"/>
            <entity id="DS3.d209.s3.e2" origId="5962,57449,866" charOffset="159-165" type="compound" text="lysine"/>
            <pair e1="DS3.d209.s3.e2" e2="DS3.d209.s3.e0" id="DS3.d209.s3.i0" interaction="False" />
            <pair e1="DS3.d209.s3.e1" e2="DS3.d209.s3.e0" id="DS3.d209.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d209.s4" origId="10022867-9" text="Expression of ETH1 in a dut-1 xthA3 Escherichia coli strain demonstrated that the gene product functionally complements the missing AP endonuclease activity.">
            <entity id="DS3.d209.s4.e0" origId="P38207" charOffset="14-18" type="protein" text="ETH1"/>
            <entity id="DS3.d209.s4.e1" origId="65070" charOffset="24-27" type="compound" text="dut"/>
            <pair e1="DS3.d209.s4.e1" e2="DS3.d209.s4.e0" id="DS3.d209.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d210" origId="10022868">
        <sentence id="DS3.d210.s0" origId="10022868-0" text="The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness.">
            <entity id="DS3.d210.s0.e0" origId="Q92831" charOffset="22-26" type="protein" text="PCAF"/>
            <entity id="DS3.d210.s0.e1" origId="442070" charOffset="32-39" type="compound" text="phorbol"/>
            <pair e1="DS3.d210.s0.e1" e2="DS3.d210.s0.e0" id="DS3.d210.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d210.s1" origId="10022868-6" text="Further studies showed that expression of PCAF and other histone acetylases was markedly induced in U937 cells upon phorbol ester treatment, which led to increased recruitment of PCAF to the IRF-ISRE complexes.">
            <entity id="DS3.d210.s1.e0" origId="Q92831" charOffset="42-46" type="protein" text="PCAF"/>
            <entity id="DS3.d210.s1.e1" origId="70702034" charOffset="116-129" type="compound" text="phorbol ester"/>
            <entity id="DS3.d210.s1.e2" origId="Q92831" charOffset="179-183" type="protein" text="PCAF"/>
            <pair e1="DS3.d210.s1.e1" e2="DS3.d210.s1.e0" id="DS3.d210.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d210.s2" origId="10022868-7" text="Coinciding with the induction of histone acetylases, phorbol ester markedly enhanced IFN-alpha-stimulated gene expression in U937 cells.">
            <entity id="DS3.d210.s2.e0" origId="70702034" charOffset="53-66" type="compound" text="phorbol ester"/>
            <entity id="DS3.d210.s2.e1" origId="P01562,L0N195" charOffset="85-94" type="protein" text="IFN-alpha"/>
            <pair e1="DS3.d210.s2.e0" e2="DS3.d210.s2.e1" id="DS3.d210.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d210.s3" origId="10022868-9" text="These results demonstrate that PCAF is a phorbol ester-inducible coactivator of the IRF proteins which contributes to the establishment of type I IFN responsiveness.">
            <entity id="DS3.d210.s3.e0" origId="Q92831" charOffset="31-35" type="protein" text="PCAF"/>
            <entity id="DS3.d210.s3.e1" origId="70702034" charOffset="41-54" type="compound" text="phorbol ester"/>
            <pair e1="DS3.d210.s3.e1" e2="DS3.d210.s3.e0" id="DS3.d210.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d211" origId="10022870">
        <sentence id="DS3.d211.s0" origId="10022870-5" text="In support of this hypothesis, when expressed in Ras-transformed cells RhoB-GG induced phenotypic reversion, cell growth inhibition, and activation of the cell cycle kinase inhibitor p21WAF1.">
            <entity id="DS3.d211.s0.e0" origId="P62745" charOffset="71-75" type="protein" text="RhoB"/>
            <entity id="DS3.d211.s0.e1" origId="53378893" charOffset="166-182" type="compound" text="kinase inhibitor"/>
            <pair e1="DS3.d211.s0.e1" e2="DS3.d211.s0.e0" id="DS3.d211.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d212" origId="10022872">
        <sentence id="DS3.d212.s0" origId="10022872-6" text="The RS domains of SF2/ASF and SC35 can be exchanged without effect on substrate specificity.">
            <entity id="DS3.d212.s0.e0" origId="7021454" charOffset="4-6" type="compound" text="RS"/>
            <entity id="DS3.d212.s0.e1" origId="Q07955,Q59FA2" charOffset="18-21" type="protein" text="SF2"/>
            <entity id="DS3.d212.s0.e2" origId="Q07955,Q59FA2" charOffset="22-25" type="protein" text="ASF"/>
            <entity id="DS3.d212.s0.e3" origId="Q01130,A0A024R8U5,Q53FN0" charOffset="30-34" type="protein" text="SC35"/>
            <pair e1="DS3.d212.s0.e0" e2="DS3.d212.s0.e1" id="DS3.d212.s0.i0" interaction="False" />
            <pair e1="DS3.d212.s0.e0" e2="DS3.d212.s0.e2" id="DS3.d212.s0.i1" interaction="False" />
            <pair e1="DS3.d212.s0.e0" e2="DS3.d212.s0.e3" id="DS3.d212.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d212.s1" origId="10022872-7" text="The RNA recognition motifs (RRMs) of SF2/ASF are active only in the context of a two-RRM structure, and RRM2 has a dominant role in substrate specificity.">
            <entity id="DS3.d212.s1.e0" origId="Q07955,Q59FA2" charOffset="37-40" type="protein" text="SF2"/>
            <entity id="DS3.d212.s1.e1" origId="Q07955,Q59FA2" charOffset="41-44" type="protein" text="ASF"/>
            <entity id="DS3.d212.s1.e2" origId="78350428" charOffset="28-31" type="compound" text="RRM"/>
            <entity id="DS3.d212.s1.e3" origId="P31350" charOffset="104-108" type="protein" text="RRM2"/>
            <pair e1="DS3.d212.s1.e2" e2="DS3.d212.s1.e0" id="DS3.d212.s1.i0" interaction="False" />
            <pair e1="DS3.d212.s1.e2" e2="DS3.d212.s1.e1" id="DS3.d212.s1.i1" interaction="False" />
            <pair e1="DS3.d212.s1.e2" e2="DS3.d212.s1.e3" id="DS3.d212.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d212.s2" origId="10022872-8" text="In contrast, the single RRM of SC35 can function alone, but its substrate specificity can be influenced by the presence of an additional RRM.">
            <entity id="DS3.d212.s2.e0" origId="78350428" charOffset="24-27" type="compound" text="RRM"/>
            <entity id="DS3.d212.s2.e1" origId="Q01130,A0A024R8U5,Q53FN0" charOffset="31-35" type="protein" text="SC35"/>
            <entity id="DS3.d212.s2.e2" origId="78350428" charOffset="137-140" type="compound" text="RRM"/>
            <pair e1="DS3.d212.s2.e0" e2="DS3.d212.s2.e1" id="DS3.d212.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d213" origId="10022874">
        <sentence id="DS3.d213.s0" origId="10022874-5" text="Second, mitogens and stresses induce the phosphorylation of eIF4E at Ser 209, increasing the affinity of eIF4E for capped mRNA and for an associated scaffolding protein, eIF4G.">
            <entity id="DS3.d213.s0.e0" origId="P06730,X5D7E3,D6RBW1,Q32Q75" charOffset="60-65" type="protein" text="eIF4E"/>
            <entity id="DS3.d213.s0.e1" origId="5951" charOffset="69-72" type="compound" text="Ser"/>
            <entity id="DS3.d213.s0.e2" origId="P06730,X5D7E3,D6RBW1,Q32Q75" charOffset="105-110" type="protein" text="eIF4E"/>
            <entity id="DS3.d213.s0.e3" origId="Q04637,Q96I65,B2RU06,O95065,B4DSI9,B2RU10" charOffset="170-175" type="protein" text="eIF4G"/>
            <pair e1="DS3.d213.s0.e1" e2="DS3.d213.s0.e0" id="DS3.d213.s0.i0" interaction="False" />
            <pair e1="DS3.d213.s0.e1" e2="DS3.d213.s0.e3" id="DS3.d213.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d214" origId="10022878">
        <sentence id="DS3.d214.s0" origId="10022878-5" text="Stable tetramer formation of Stat5 is mediated through protein-protein interactions involving a tryptophan residue conserved in all STATs and a lysine residue in the Stat5 N-terminal domain (N domain).">
            <entity id="DS3.d214.s0.e0" origId="P51692" charOffset="29-34" type="protein" text="Stat5"/>
            <entity id="DS3.d214.s0.e1" origId="57175189,6305" charOffset="96-106" type="compound" text="tryptophan"/>
            <entity id="DS3.d214.s0.e2" origId="57449,5962" charOffset="144-150" type="compound" text="lysine"/>
            <entity id="DS3.d214.s0.e3" origId="P51692" charOffset="166-171" type="protein" text="Stat5"/>
            <pair e1="DS3.d214.s0.e2" e2="DS3.d214.s0.e0" id="DS3.d214.s0.i0" interaction="False" />
            <pair e1="DS3.d214.s0.e1" e2="DS3.d214.s0.e0" id="DS3.d214.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d215" origId="10022879">
        <sentence id="DS3.d215.s0" origId="10022879-5" text="We first demonstrated that the individual activation function 1 (AF-1) domains act in a dominant manner within the ERalpha-ERbeta heterodimer: the mixed agonist-antagonist 4-hydroxytamoxifen acts as an agonist in a promoter- and cell context-dependent manner via the ERalpha AF-1, while activation of the complex by the mitogen-activated protein kinase (MAPK) pathway requires only the ERalpha- or ERbeta-responsive MAPK site.">
            <entity id="DS3.d215.s0.e0" origId="P03372,Q9UBT1,G4XH65,A8KAF4" charOffset="115-122" type="protein" text="ERalpha"/>
            <entity id="DS3.d215.s0.e1" origId="Q92731,Q7LCB3,F1D8N3,Q0PTK2" charOffset="123-129" type="protein" text="ERbeta"/>
            <entity id="DS3.d215.s0.e2" origId="449459" charOffset="174-190" type="compound" text="hydroxytamoxifen"/>
            <entity id="DS3.d215.s0.e3" origId="P03372,Q9UBT1,G4XH65,A8KAF4" charOffset="267-274" type="protein" text="ERalpha"/>
            <entity id="DS3.d215.s0.e4" origId="P03372,Q9UBT1,G4XH65,A8KAF4" charOffset="267-274" type="protein" text="ERalpha"/>
            <entity id="DS3.d215.s0.e5" origId="Q92731,Q7LCB3,F1D8N3,Q0PTK2" charOffset="398-404" type="protein" text="ERbeta"/>
            <pair e1="DS3.d215.s0.e2" e2="DS3.d215.s0.e1" id="DS3.d215.s0.i0" interaction="False" />
            <pair e1="DS3.d215.s0.e2" e2="DS3.d215.s0.e0" id="DS3.d215.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d215.s1" origId="10022879-6" text="Using ligand-binding and AF-2-defective mutants, we further demonstrated that while the ERalpha-ERbeta heterodimer can be activated when only one E2-binding competent partner is present per dimer, two functional AF-2 domains are required for transcriptional activity.">
            <entity id="DS3.d215.s1.e0" origId="5280707" charOffset="25-29" type="compound" text="AF-2"/>
            <entity id="DS3.d215.s1.e1" origId="P03372,Q9UBT1,G4XH65,A8KAF4" charOffset="88-95" type="protein" text="ERalpha"/>
            <entity id="DS3.d215.s1.e2" origId="Q92731,Q7LCB3,F1D8N3,Q0PTK2" charOffset="96-102" type="protein" text="ERbeta"/>
            <entity id="DS3.d215.s1.e3" origId="5280707" charOffset="212-216" type="compound" text="AF-2"/>
            <pair e1="DS3.d215.s1.e0" e2="DS3.d215.s1.e2" id="DS3.d215.s1.i0" interaction="False" />
            <pair e1="DS3.d215.s1.e0" e2="DS3.d215.s1.e1" id="DS3.d215.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d216" origId="10022880">
        <sentence id="DS3.d216.s0" origId="10022880-4" text="RasGAP was tyrosine phosphorylated in embryos and its Src homology 2 (SH2) domains could bind in vitro to a small number of tyrosine-phosphorylated proteins expressed at various developmental stages.">
            <entity id="DS3.d216.s0.e0" origId="Q8IR23" charOffset="0-6" type="protein" text="RasGAP"/>
            <entity id="DS3.d216.s0.e1" origId="6057,90983769" charOffset="11-19" type="compound" text="tyrosine"/>
            <entity id="DS3.d216.s0.e2" origId="6057,90983769" charOffset="124-132" type="compound" text="tyrosine"/>
            <pair e1="DS3.d216.s0.e1" e2="DS3.d216.s0.e0" id="DS3.d216.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d216.s1" origId="10022880-5" text="Ectopic expression of RasGAP in the wing imaginal disc reduced the size of the adult wing by up to 45% and suppressed ectopic wing vein formation caused by expression of activated forms of Breathless and Heartless, two Drosophila receptor tyrosine kinases of the fibroblast growth factor receptor family.">
            <entity id="DS3.d216.s1.e0" origId="Q8IR23" charOffset="22-28" type="protein" text="RasGAP"/>
            <entity id="DS3.d216.s1.e1" origId="6057,90983769" charOffset="239-247" type="compound" text="tyrosine"/>
            <pair e1="DS3.d216.s1.e1" e2="DS3.d216.s1.e0" id="DS3.d216.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d216.s2" origId="10022880-6" text="The in vivo effects of RasGAP overexpression required intact SH2 domains, indicating that intracellular localization of RasGAP through SH2-phosphotyrosine interactions is important for its activity.">
            <entity id="DS3.d216.s2.e0" origId="Q8IR23" charOffset="23-29" type="protein" text="RasGAP"/>
            <entity id="DS3.d216.s2.e1" origId="Q8IR23" charOffset="120-126" type="protein" text="RasGAP"/>
            <entity id="DS3.d216.s2.e2" origId="30819" charOffset="139-154" type="compound" text="phosphotyrosine"/>
            <pair e1="DS3.d216.s2.e2" e2="DS3.d216.s2.e0" id="DS3.d216.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d216.s3" origId="10022880-7" text="These results show that RasGAP can function as an inhibitor of signaling pathways mediated by Ras and receptor tyrosine kinases in vivo.">
            <entity id="DS3.d216.s3.e0" origId="Q8IR23" charOffset="24-30" type="protein" text="RasGAP"/>
            <entity id="DS3.d216.s3.e1" origId="6057,90983769" charOffset="111-119" type="compound" text="tyrosine"/>
            <pair e1="DS3.d216.s3.e1" e2="DS3.d216.s3.e0" id="DS3.d216.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d217" origId="10022881">
        <sentence id="DS3.d217.s0" origId="10022881-11" text="The elimination of mRNA, protein, and JNK activities lasted 48 and 72 h following a single Lipofectin treatment with antisense JNK1 and JNK2, respectively, indicating sufficient duration for examining the impact of specific elimination on the phenotype.">
            <entity id="DS3.d217.s0.e0" origId="6437083" charOffset="91-101" type="compound" text="Lipofectin"/>
            <entity id="DS3.d217.s0.e1" origId="P45983,A1L4K2" charOffset="127-131" type="protein" text="JNK1"/>
            <entity id="DS3.d217.s0.e2" origId="P45984,D7R525" charOffset="136-140" type="protein" text="JNK2"/>
            <pair e1="DS3.d217.s0.e0" e2="DS3.d217.s0.e1" id="DS3.d217.s0.i0" interaction="False" />
            <pair e1="DS3.d217.s0.e0" e2="DS3.d217.s0.e2" id="DS3.d217.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d218" origId="10022882">
        <sentence id="DS3.d218.s0" origId="10022882-0" text="Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.">
            <entity id="DS3.d218.s0.e0" origId="977" charOffset="9-15" type="compound" text="oxygen"/>
            <entity id="DS3.d218.s0.e1" origId="P01584" charOffset="63-80" type="protein" text="interleukin-1beta"/>
            <entity id="DS3.d218.s0.e2" origId="P09917" charOffset="90-104" type="protein" text="5-lipoxygenase"/>
            <entity id="DS3.d218.s0.e3" origId="5884" charOffset="108-113" type="compound" text="NADPH"/>
            <pair e1="DS3.d218.s0.e3" e2="DS3.d218.s0.e2" id="DS3.d218.s0.i0" interaction="False" />
            <pair e1="DS3.d218.s0.e3" e2="DS3.d218.s0.e1" id="DS3.d218.s0.i1" interaction="False" />
            <pair e1="DS3.d218.s0.e0" e2="DS3.d218.s0.e2" id="DS3.d218.s0.i2" interaction="False" />
            <pair e1="DS3.d218.s0.e0" e2="DS3.d218.s0.e1" id="DS3.d218.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d218.s1" origId="10022882-2" text="However, the sources for ROIs in various cell types are yet to be determined and might include 5-lipoxygenase (5-LOX) and NADPH oxidase.">
            <entity id="DS3.d218.s1.e0" origId="P09917" charOffset="95-109" type="protein" text="5-lipoxygenase"/>
            <entity id="DS3.d218.s1.e1" origId="P09917" charOffset="111-116" type="protein" text="5-LOX"/>
            <entity id="DS3.d218.s1.e2" origId="5884" charOffset="122-127" type="compound" text="NADPH"/>
            <pair e1="DS3.d218.s1.e2" e2="DS3.d218.s1.e0" id="DS3.d218.s1.i0" interaction="False" />
            <pair e1="DS3.d218.s1.e2" e2="DS3.d218.s1.e1" id="DS3.d218.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d218.s2" origId="10022882-7" text="In monocytic cells, IL-1beta treatment led to a production of ROIs which is independent of the 5-LOX enzyme but requires the NADPH oxidase activity.">
            <entity id="DS3.d218.s2.e0" origId="P01584" charOffset="20-28" type="protein" text="IL-1beta"/>
            <entity id="DS3.d218.s2.e1" origId="P09917" charOffset="95-100" type="protein" text="5-LOX"/>
            <entity id="DS3.d218.s2.e2" origId="5884" charOffset="125-130" type="compound" text="NADPH"/>
            <pair e1="DS3.d218.s2.e2" e2="DS3.d218.s2.e0" id="DS3.d218.s2.i0" interaction="False" />
            <pair e1="DS3.d218.s2.e2" e2="DS3.d218.s2.e1" id="DS3.d218.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d218.s3" origId="10022882-9" text="In conclusion, three different cell-specific pathways lead to NF-kappaB activation by IL-1beta: a pathway dependent on ROI production by 5-LOX in lymphoid cells, an ROI- and 5-LOX-independent pathway in epithelial cells, and a pathway requiring ROI production by NADPH oxidase in monocytic cells.">
            <entity id="DS3.d218.s3.e0" origId="P01584" charOffset="86-94" type="protein" text="IL-1beta"/>
            <entity id="DS3.d218.s3.e1" origId="P09917" charOffset="137-142" type="protein" text="5-LOX"/>
            <entity id="DS3.d218.s3.e2" origId="P09917" charOffset="174-179" type="protein" text="5-LOX"/>
            <entity id="DS3.d218.s3.e3" origId="5884" charOffset="263-268" type="compound" text="NADPH"/>
            <pair e1="DS3.d218.s3.e3" e2="DS3.d218.s3.e0" id="DS3.d218.s3.i0" interaction="False" />
            <pair e1="DS3.d218.s3.e3" e2="DS3.d218.s3.e1" id="DS3.d218.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d219" origId="10022883">
        <sentence id="DS3.d219.s0" origId="10022883-1" text="Neu differentiation factors (NDFs), or neuregulins, are epidermal growth factor-like growth factors which bind to two tyrosine kinase receptors, ErbB-3 and ErbB-4.">
            <entity id="DS3.d219.s0.e0" origId="6057,90983769" charOffset="118-126" type="compound" text="tyrosine"/>
            <entity id="DS3.d219.s0.e1" origId="P21860" charOffset="145-151" type="protein" text="ErbB-3"/>
            <entity id="DS3.d219.s0.e2" origId="Q15303" charOffset="156-162" type="protein" text="ErbB-4"/>
            <pair e1="DS3.d219.s0.e0" e2="DS3.d219.s0.e1" id="DS3.d219.s0.i0" interaction="False" />
            <pair e1="DS3.d219.s0.e0" e2="DS3.d219.s0.e2" id="DS3.d219.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d219.s1" origId="10022883-3" text="Here, we have examined the promoter of the acetylcholine receptor epsilon subunit and delineated a minimal CA-rich sequence which mediates transcriptional activation by NDF (NDF-response element (NRE)).">
            <entity id="DS3.d219.s1.e0" origId="187" charOffset="43-56" type="compound" text="acetylcholine"/>
            <entity id="DS3.d219.s1.e1" origId="Q02297,Q7RTW5,A0A024QY88,Q7RTW3,B0FWZ3,B0FYA9,A6MW55,B0FYA8,Q6PK61,B0FYA7,A6MW56,F6RJN6,B7Z1D7" charOffset="169-172" type="protein" text="NDF"/>
            <entity id="DS3.d219.s1.e2" origId="Q02297,Q7RTW5,A0A024QY88,Q7RTW3,B0FWZ3,B0FYA9,A6MW55,B0FYA8,Q6PK61,B0FYA7,A6MW56,F6RJN6,B7Z1D7" charOffset="174-177" type="protein" text="NDF"/>
            <pair e1="DS3.d219.s1.e0" e2="DS3.d219.s1.e1" id="DS3.d219.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d219.s2" origId="10022883-4" text="Using gel mobility shift analysis with an NRE oligonucleotide, we detected two complexes that are induced by treatment with neuregulin and other growth factors and identified Sp1, a constitutively expressed zinc finger phosphoprotein, as a component of one of these complexes.">
            <entity id="DS3.d219.s2.e0" origId="P08047" charOffset="175-178" type="protein" text="Sp1"/>
            <entity id="DS3.d219.s2.e1" origId="23994" charOffset="207-211" type="compound" text="zinc"/>
            <pair e1="DS3.d219.s2.e1" e2="DS3.d219.s2.e0" id="DS3.d219.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d220" origId="10022885">
        <sentence id="DS3.d220.s0" origId="10022885-1" text="To investigate the mode of action of the p16(INK4a) tumor suppressor protein, we have established U2-OS cells in which the expression of p16(INK4a) can be regulated by addition or removal of isopropyl-beta-D-thiogalactopyranoside.">
            <entity id="DS3.d220.s0.e0" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="41-44" type="protein" text="p16"/>
            <entity id="DS3.d220.s0.e1" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="45-50" type="protein" text="INK4a"/>
            <entity id="DS3.d220.s0.e2" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="137-140" type="protein" text="p16"/>
            <entity id="DS3.d220.s0.e3" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="141-146" type="protein" text="INK4a"/>
            <entity id="DS3.d220.s0.e4" origId="656894" charOffset="191-229" type="compound" text="isopropyl-beta-D-thiogalactopyranoside"/>
            <pair e1="DS3.d220.s0.e4" e2="DS3.d220.s0.e1" id="DS3.d220.s0.i0" interaction="False" />
            <pair e1="DS3.d220.s0.e4" e2="DS3.d220.s0.e0" id="DS3.d220.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d220.s1" origId="10022885-8" text="Thus, upon the induction of p16(INK4a), p27(KIP1) appears to switch its allegiance from CDK4 to CDK2, and the accompanying reassortment of components leads to the inhibition of cyclin E-CDK2 by p27(KIP1) and p21(CIP1).">
            <entity id="DS3.d220.s1.e0" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="28-31" type="protein" text="p16"/>
            <entity id="DS3.d220.s1.e1" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="32-37" type="protein" text="INK4a"/>
            <entity id="DS3.d220.s1.e2" origId="P40305,A8K0H0,A0A087WZF8,Q7Z5R2" charOffset="40-43" type="protein" text="p27"/>
            <entity id="DS3.d220.s1.e3" origId="P46527,Q6I9V6" charOffset="44-48" type="protein" text="KIP1"/>
            <entity id="DS3.d220.s1.e4" origId="42586" charOffset="72-82" type="compound" text="allegiance"/>
            <entity id="DS3.d220.s1.e5" origId="P11802,A0A024RBB6" charOffset="88-92" type="protein" text="CDK4"/>
            <entity id="DS3.d220.s1.e6" origId="P24941,G3V5T9,A0A024RB10,A0A024RB77,E7ESI2,B4DDL9" charOffset="96-100" type="protein" text="CDK2"/>
            <entity id="DS3.d220.s1.e7" origId="P24941,G3V5T9,A0A024RB10,A0A024RB77,E7ESI2,B4DDL9" charOffset="186-190" type="protein" text="CDK2"/>
            <entity id="DS3.d220.s1.e8" origId="P40305,A8K0H0,A0A087WZF8,Q7Z5R2" charOffset="194-197" type="protein" text="p27"/>
            <entity id="DS3.d220.s1.e9" origId="P46527,Q6I9V6" charOffset="198-202" type="protein" text="KIP1"/>
            <entity id="DS3.d220.s1.e10" origId="P38936,A0A024RCX5" charOffset="208-211" type="protein" text="p21"/>
            <entity id="DS3.d220.s1.e11" origId="P38936,A0A024RCX5" charOffset="212-216" type="protein" text="CIP1"/>
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e11" id="DS3.d220.s1.i0" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e2" id="DS3.d220.s1.i1" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e3" id="DS3.d220.s1.i2" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e6" id="DS3.d220.s1.i3" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e5" id="DS3.d220.s1.i4" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e0" id="DS3.d220.s1.i5" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e10" id="DS3.d220.s1.i6" interaction="False" />
            <pair e1="DS3.d220.s1.e4" e2="DS3.d220.s1.e1" id="DS3.d220.s1.i7" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d221" origId="10022886">
        <sentence id="DS3.d221.s0" origId="10022886-3" text="In the frog Xenopus, the translation of mos protein requires the progesterone-induced polyadenylation of the maternal mos mRNA, which is present in the oocyte cytoplasm.">
            <entity id="DS3.d221.s0.e0" origId="P12965" charOffset="40-43" type="protein" text="mos"/>
            <entity id="DS3.d221.s0.e1" origId="5994" charOffset="65-77" type="compound" text="progesterone"/>
            <entity id="DS3.d221.s0.e2" origId="P12965" charOffset="118-121" type="protein" text="mos"/>
            <pair e1="DS3.d221.s0.e1" e2="DS3.d221.s0.e0" id="DS3.d221.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d221.s1" origId="10022886-6" text="We report that progesterone-induced mos mRNA polyadenylation was attenuated in oocytes expressing the MAPK phosphatase rVH6.">
            <entity id="DS3.d221.s1.e0" origId="5994" charOffset="15-27" type="compound" text="progesterone"/>
            <entity id="DS3.d221.s1.e1" origId="P12965" charOffset="36-39" type="protein" text="mos"/>
            <pair e1="DS3.d221.s1.e0" e2="DS3.d221.s1.e1" id="DS3.d221.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d221.s2" origId="10022886-7" text="Moreover, inhibition of MAPK signaling blocked progesterone-induced mos protein accumulation.">
            <entity id="DS3.d221.s2.e0" origId="5994" charOffset="47-59" type="compound" text="progesterone"/>
            <entity id="DS3.d221.s2.e1" origId="P12965" charOffset="68-71" type="protein" text="mos"/>
            <pair e1="DS3.d221.s2.e0" e2="DS3.d221.s2.e1" id="DS3.d221.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d222" origId="10022888">
        <sentence id="DS3.d222.s0" origId="10022888-11" text="Sad1p contains a putative zinc finger and is phylogenetically highly conserved, with homologues identified in human, Caenorhabditis elegans, Arabidospis, and Drosophila.">
            <entity id="DS3.d222.s0.e0" origId="P43589" charOffset="0-5" type="protein" text="Sad1p"/>
            <entity id="DS3.d222.s0.e1" origId="23994" charOffset="26-30" type="compound" text="zinc"/>
            <pair e1="DS3.d222.s0.e1" e2="DS3.d222.s0.e0" id="DS3.d222.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d223" origId="10022889">
        <sentence id="DS3.d223.s0" origId="10022889-9" text="In addition, inhibition of JNK activity by catalytically inactive MEKK (in which methionine was substituted for the lysine at position 432) also inhibits the ability of TCFbeta1 to drive inducible transcription from the interleukin-2 promoter.">
            <entity id="DS3.d223.s0.e0" origId="Q13233" charOffset="66-70" type="protein" text="MEKK"/>
            <entity id="DS3.d223.s0.e1" origId="6137,84815,876" charOffset="81-91" type="compound" text="methionine"/>
            <entity id="DS3.d223.s0.e2" origId="57449,5962,866" charOffset="116-122" type="compound" text="lysine"/>
            <entity id="DS3.d223.s0.e3" origId="P60568,Q0GK43" charOffset="220-233" type="protein" text="interleukin-2"/>
            <pair e1="DS3.d223.s0.e2" e2="DS3.d223.s0.e0" id="DS3.d223.s0.i0" interaction="False" />
            <pair e1="DS3.d223.s0.e2" e2="DS3.d223.s0.e3" id="DS3.d223.s0.i1" interaction="False" />
            <pair e1="DS3.d223.s0.e1" e2="DS3.d223.s0.e0" id="DS3.d223.s0.i2" interaction="False" />
            <pair e1="DS3.d223.s0.e1" e2="DS3.d223.s0.e3" id="DS3.d223.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d224" origId="10022890">
        <sentence id="DS3.d224.s0" origId="10022890-6" text="Strikingly, this site bound exclusively NFAT not only from nuclear extracts of HUVECs activated by VEGF, a stimulus that failed to induce NF-kappaB-binding activity, but also from extracts of cells activated with phorbol esters and calcium ionophore, a combination of stimuli that triggered the simultaneous activation of NFAT and NF-kappaB.">
            <entity id="DS3.d224.s0.e0" origId="P15692,A0A024RD37,A0A024RD33,A2A2V4" charOffset="99-103" type="protein" text="VEGF"/>
            <entity id="DS3.d224.s0.e1" origId="442070" charOffset="213-220" type="compound" text="phorbol"/>
            <entity id="DS3.d224.s0.e2" origId="22044544,5460341" charOffset="232-239" type="compound" text="calcium"/>
            <pair e1="DS3.d224.s0.e2" e2="DS3.d224.s0.e0" id="DS3.d224.s0.i0" interaction="False" />
            <pair e1="DS3.d224.s0.e1" e2="DS3.d224.s0.e0" id="DS3.d224.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d225" origId="10022891">
        <sentence id="DS3.d225.s0" origId="10022891-0" text="Nrg1 is a transcriptional repressor for glucose repression of STA1 gene expression in Saccharomyces cerevisiae.">
            <entity id="DS3.d225.s0.e0" origId="Q03125" charOffset="0-4" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s0.e1" origId="206,5793,64689,79025" charOffset="40-47" type="compound" text="glucose"/>
            <pair e1="DS3.d225.s0.e1" e2="DS3.d225.s0.e0" id="DS3.d225.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s1" origId="10022891-3" text="The Nrg1 gene encodes a 25-kDa C2H2 zinc finger protein which specifically binds to two regions in the upstream activation sequence of the STA1 gene, as judged by gel retardation and DNase I footprinting analyses.">
            <entity id="DS3.d225.s1.e0" origId="Q03125" charOffset="4-8" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s1.e1" origId="23994" charOffset="36-40" type="compound" text="zinc"/>
            <pair e1="DS3.d225.s1.e1" e2="DS3.d225.s1.e0" id="DS3.d225.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s2" origId="10022891-4" text="Disruption of the Nrg1 gene causes a fivefold increase in the level of the STA1 transcript in the presence of glucose.">
            <entity id="DS3.d225.s2.e0" origId="Q03125" charOffset="18-22" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s2.e1" origId="206,5793,64689,79025" charOffset="110-117" type="compound" text="glucose"/>
            <pair e1="DS3.d225.s2.e1" e2="DS3.d225.s2.e0" id="DS3.d225.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s3" origId="10022891-5" text="The expression of Nrg1 itself is inhibited in the absence of glucose.">
            <entity id="DS3.d225.s3.e0" origId="Q03125" charOffset="18-22" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s3.e1" origId="206,5793,64689,79025" charOffset="61-68" type="compound" text="glucose"/>
            <pair e1="DS3.d225.s3.e1" e2="DS3.d225.s3.e0" id="DS3.d225.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s4" origId="10022891-6" text="DNA-bound LexA-Nrg1 represses transcription of a target gene 10.7-fold in a glucose-dependent manner, and this repression is abolished in both ssn6 and tup1 mutants.">
            <entity id="DS3.d225.s4.e0" origId="Q03125" charOffset="15-19" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s4.e1" origId="206,5793,64689,79025" charOffset="76-83" type="compound" text="glucose"/>
            <entity id="DS3.d225.s4.e2" origId="P14922" charOffset="143-147" type="protein" text="ssn6"/>
            <entity id="DS3.d225.s4.e3" origId="P16649" charOffset="152-156" type="protein" text="tup1"/>
            <pair e1="DS3.d225.s4.e1" e2="DS3.d225.s4.e0" id="DS3.d225.s4.i0" interaction="False" />
            <pair e1="DS3.d225.s4.e1" e2="DS3.d225.s4.e2" id="DS3.d225.s4.i1" interaction="False" />
            <pair e1="DS3.d225.s4.e1" e2="DS3.d225.s4.e3" id="DS3.d225.s4.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s5" origId="10022891-7" text="Two-hybrid and glutathione S-transferase pull-down experiments show an interaction of Nrg1 with ssn6 both in vivo and in vitro.">
            <entity id="DS3.d225.s5.e0" origId="124886,20725278" charOffset="15-26" type="compound" text="glutathione"/>
            <entity id="DS3.d225.s5.e1" origId="Q03125" charOffset="86-90" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s5.e2" origId="P14922" charOffset="96-100" type="protein" text="ssn6"/>
            <pair e1="DS3.d225.s5.e0" e2="DS3.d225.s5.e1" id="DS3.d225.s5.i0" interaction="False" />
            <pair e1="DS3.d225.s5.e0" e2="DS3.d225.s5.e2" id="DS3.d225.s5.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d225.s6" origId="10022891-8" text="These findings indicate that Nrg1 acts as a DNA-binding repressor and mediates glucose repression of the STA1 gene expression by recruiting the ssn6-tup1 complex.">
            <entity id="DS3.d225.s6.e0" origId="Q03125" charOffset="29-33" type="protein" text="Nrg1"/>
            <entity id="DS3.d225.s6.e1" origId="206,5793,64689,79025" charOffset="79-86" type="compound" text="glucose"/>
            <entity id="DS3.d225.s6.e2" origId="P14922" charOffset="144-148" type="protein" text="ssn6"/>
            <entity id="DS3.d225.s6.e3" origId="P16649" charOffset="149-153" type="protein" text="tup1"/>
            <pair e1="DS3.d225.s6.e1" e2="DS3.d225.s6.e0" id="DS3.d225.s6.i0" interaction="False" />
            <pair e1="DS3.d225.s6.e1" e2="DS3.d225.s6.e2" id="DS3.d225.s6.i1" interaction="False" />
            <pair e1="DS3.d225.s6.e1" e2="DS3.d225.s6.e3" id="DS3.d225.s6.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d226" origId="10022892">
        <sentence id="DS3.d226.s0" origId="10022892-0" text="The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription.">
            <entity id="DS3.d226.s0.e0" origId="P51974,F1M4D7" charOffset="39-43" type="protein" text="Pax8"/>
            <entity id="DS3.d226.s0.e1" origId="5360545" charOffset="86-92" type="compound" text="sodium"/>
            <entity id="DS3.d226.s0.e2" origId="105054,30165" charOffset="93-99" type="compound" text="iodide"/>
            <entity id="DS3.d226.s0.e3" origId="6076" charOffset="161-171" type="compound" text="cyclic-AMP"/>
            <pair e1="DS3.d226.s0.e3" e2="DS3.d226.s0.e0" id="DS3.d226.s0.i0" interaction="False" />
            <pair e1="DS3.d226.s0.e2" e2="DS3.d226.s0.e0" id="DS3.d226.s0.i1" interaction="False" />
            <pair e1="DS3.d226.s0.e1" e2="DS3.d226.s0.e0" id="DS3.d226.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d226.s1" origId="10022892-3" text="When fused to either its own or a heterologous promoter, the NIS upstream enhancer, which we call NUE, stimulates transcription in a thyroid-specific and cAMP-dependent manner.">
            <entity id="DS3.d226.s1.e0" origId="Q63008,F1LR66" charOffset="61-64" type="protein" text="NIS"/>
            <entity id="DS3.d226.s1.e1" origId="73386671" charOffset="98-101" type="compound" text="NUE"/>
            <pair e1="DS3.d226.s1.e1" e2="DS3.d226.s1.e0" id="DS3.d226.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d226.s2" origId="10022892-6" text="Mutations that interfere with Pax8 binding also decrease transcriptional activity of the NUE.">
            <entity id="DS3.d226.s2.e0" origId="P51974,F1M4D7" charOffset="30-34" type="protein" text="Pax8"/>
            <entity id="DS3.d226.s2.e1" origId="73386671" charOffset="89-92" type="compound" text="NUE"/>
            <pair e1="DS3.d226.s2.e1" e2="DS3.d226.s2.e0" id="DS3.d226.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d226.s3" origId="10022892-7" text="Furthermore, expression of Pax8 in nonthyroid cells results in transcriptional activation of NUE, strongly suggesting that the paired-domain protein Pax8 plays an important role in NUE activity.">
            <entity id="DS3.d226.s3.e0" origId="P51974,F1M4D7" charOffset="27-31" type="protein" text="Pax8"/>
            <entity id="DS3.d226.s3.e1" origId="73386671" charOffset="93-96" type="compound" text="NUE"/>
            <entity id="DS3.d226.s3.e2" origId="P51974,F1M4D7" charOffset="149-153" type="protein" text="Pax8"/>
            <entity id="DS3.d226.s3.e3" origId="73386671" charOffset="181-184" type="compound" text="NUE"/>
            <pair e1="DS3.d226.s3.e1" e2="DS3.d226.s3.e0" id="DS3.d226.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d227" origId="10022895">
        <sentence id="DS3.d227.s0" origId="10022895-5" text="Here, we characterize a repressor domain from the Goosecoid (Gsc) developmental regulator that includes an eh1/GEH-like motif.">
            <entity id="DS3.d227.s0.e0" origId="5288474" charOffset="61-64" type="compound" text="Gsc"/>
            <entity id="DS3.d227.s0.e1" origId="E3CTP7,Q8MMD3,Q8MMD2,Q9W111" charOffset="107-110" type="protein" text="eh1"/>
            <pair e1="DS3.d227.s0.e0" e2="DS3.d227.s0.e1" id="DS3.d227.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d228" origId="10022897">
        <sentence id="DS3.d228.s0" origId="10022897-10" text="The functional contribution of the kappaB-Sp1 composite site in P/I-inducible fas promoter activation was verified by using kappaB-Sp1 concatamers (-295 to -286) in a thymidine kinase promoter-driven reporter construct and native promoter constructs in Jurkat cells overexpressing IkappaB-alpha.">
            <entity id="DS3.d228.s0.e0" origId="P08047" charOffset="42-45" type="protein" text="Sp1"/>
            <entity id="DS3.d228.s0.e1" origId="P08047" charOffset="131-134" type="protein" text="Sp1"/>
            <entity id="DS3.d228.s0.e2" origId="5789" charOffset="167-176" type="compound" text="thymidine"/>
            <entity id="DS3.d228.s0.e3" origId="P25963" charOffset="281-294" type="protein" text="IkappaB-alpha"/>
            <pair e1="DS3.d228.s0.e2" e2="DS3.d228.s0.e0" id="DS3.d228.s0.i0" interaction="False" />
            <pair e1="DS3.d228.s0.e2" e2="DS3.d228.s0.e3" id="DS3.d228.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d228.s1" origId="10022897-11" text="Site-directed mutagenesis of the critical guanine nucleotides in the kappaB-Sp1 element documented the essential role of this site in activation-dependent fas promoter induction.">
            <entity id="DS3.d228.s1.e0" origId="764" charOffset="42-49" type="compound" text="guanine"/>
            <entity id="DS3.d228.s1.e1" origId="P08047" charOffset="76-79" type="protein" text="Sp1"/>
            <pair e1="DS3.d228.s1.e0" e2="DS3.d228.s1.e1" id="DS3.d228.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d229" origId="10022898">
        <sentence id="DS3.d229.s0" origId="10022898-4" text="Accordingly, cyclin D1-associated phosphorylation of pRb at Ser-780 is lacking even in newly senescent fibroblasts that have a low amount of p16.">
            <entity id="DS3.d229.s0.e0" origId="P24385,Q6FI00" charOffset="13-22" type="protein" text="cyclin D1"/>
            <entity id="DS3.d229.s0.e1" origId="P06400,A0A024RDV3" charOffset="53-56" type="protein" text="pRb"/>
            <entity id="DS3.d229.s0.e2" origId="5951" charOffset="60-63" type="compound" text="Ser"/>
            <entity id="DS3.d229.s0.e3" origId="Q8N726,P42771,K7PML8,G3XAG3" charOffset="141-144" type="protein" text="p16"/>
            <pair e1="DS3.d229.s0.e2" e2="DS3.d229.s0.e0" id="DS3.d229.s0.i0" interaction="False" />
            <pair e1="DS3.d229.s0.e2" e2="DS3.d229.s0.e3" id="DS3.d229.s0.i1" interaction="False" />
            <pair e1="DS3.d229.s0.e2" e2="DS3.d229.s0.e1" id="DS3.d229.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d230" origId="10022901">
        <sentence id="DS3.d230.s0" origId="10022901-0" text="Pseudouridine mapping in the Saccharomyces cerevisiae spliceosomal U small nuclear RNAs (snRNAs) reveals that pseudouridine synthase Pus1p exhibits a dual substrate specificity for U2 snRNA and tRNA.">
            <entity id="DS3.d230.s0.e0" origId="15047" charOffset="0-13" type="compound" text="Pseudouridine"/>
            <entity id="DS3.d230.s0.e1" origId="15047" charOffset="110-123" type="compound" text="pseudouridine"/>
            <entity id="DS3.d230.s0.e2" origId="Q12211" charOffset="133-138" type="protein" text="Pus1p"/>
            <pair e1="DS3.d230.s0.e0" e2="DS3.d230.s0.e2" id="DS3.d230.s0.i0" interaction="False" />
            <pair e1="DS3.d230.s0.e1" e2="DS3.d230.s0.e2" id="DS3.d230.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d230.s1" origId="10022901-4" text="When yeast mutants disrupted for one of the several pseudouridine synthase genes (PUS1, PUS2, PUS3, and PUS4) or depleted in rRNA-pseudouridine synthase Cbf5p were tested for UsnRNA Psi content, only the loss of the Pus1p activity was found to affect Psi formation in spliceosomal UsnRNAs.">
            <entity id="DS3.d230.s1.e0" origId="15047" charOffset="52-65" type="compound" text="pseudouridine"/>
            <entity id="DS3.d230.s1.e1" origId="Q12211" charOffset="82-86" type="protein" text="PUS1"/>
            <entity id="DS3.d230.s1.e2" origId="P53167" charOffset="88-92" type="protein" text="PUS2"/>
            <entity id="DS3.d230.s1.e3" origId="P31115" charOffset="94-98" type="protein" text="PUS3"/>
            <entity id="DS3.d230.s1.e4" origId="P48567" charOffset="104-108" type="protein" text="PUS4"/>
            <entity id="DS3.d230.s1.e5" origId="15047" charOffset="130-143" type="compound" text="pseudouridine"/>
            <entity id="DS3.d230.s1.e6" origId="P33322" charOffset="153-158" type="protein" text="Cbf5p"/>
            <entity id="DS3.d230.s1.e7" origId="Q12211" charOffset="216-221" type="protein" text="Pus1p"/>
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e1" id="DS3.d230.s1.i0" interaction="False" />
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e2" id="DS3.d230.s1.i1" interaction="False" />
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e3" id="DS3.d230.s1.i2" interaction="False" />
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e4" id="DS3.d230.s1.i3" interaction="False" />
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e6" id="DS3.d230.s1.i4" interaction="False" />
            <pair e1="DS3.d230.s1.e0" e2="DS3.d230.s1.e7" id="DS3.d230.s1.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d230.s2" origId="10022901-7" text="Thus, Pus1p is the first UsnRNA pseudouridine synthase characterized so far which exhibits a dual substrate specificity, acting on both tRNAs and U2 snRNA.">
            <entity id="DS3.d230.s2.e0" origId="Q12211" charOffset="6-11" type="protein" text="Pus1p"/>
            <entity id="DS3.d230.s2.e1" origId="15047" charOffset="32-45" type="compound" text="pseudouridine"/>
            <pair e1="DS3.d230.s2.e1" e2="DS3.d230.s2.e0" id="DS3.d230.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d230.s3" origId="10022901-8" text="As depletion of rRNA-pseudouridine synthase Cbf5p had no effect on UsnRNA Psi content, formation of Psi residues in S. cerevisiae UsnRNAs is not dependent on the Cbf5p-snoRNA guided mechanism.">
            <entity id="DS3.d230.s3.e0" origId="15047" charOffset="21-34" type="compound" text="pseudouridine"/>
            <entity id="DS3.d230.s3.e1" origId="P33322" charOffset="44-49" type="protein" text="Cbf5p"/>
            <entity id="DS3.d230.s3.e2" origId="P33322" charOffset="162-167" type="protein" text="Cbf5p"/>
            <pair e1="DS3.d230.s3.e0" e2="DS3.d230.s3.e1" id="DS3.d230.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d231" origId="10022904">
        <sentence id="DS3.d231.s0" origId="10022904-8" text="We also show that cell stimulation with phorbol 12-myristate 13-acetate activates IKKbeta, which is entirely dependent on the activity of alphaPKC but not that of the atypical isoforms.">
            <entity id="DS3.d231.s0.e0" origId="71308525" charOffset="40-60" type="compound" text="phorbol 12-myristate"/>
            <entity id="DS3.d231.s0.e1" origId="176" charOffset="64-71" type="compound" text="acetate"/>
            <entity id="DS3.d231.s0.e2" origId="O14920" charOffset="82-89" type="protein" text="IKKbeta"/>
            <pair e1="DS3.d231.s0.e0" e2="DS3.d231.s0.e2" id="DS3.d231.s0.i0" interaction="False" />
            <pair e1="DS3.d231.s0.e1" e2="DS3.d231.s0.e2" id="DS3.d231.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d232" origId="10022910">
        <sentence id="DS3.d232.s0" origId="10022910-3" text="Previously, we showed that Pax-5 (B-cell-specific activator protein) recruits proteins of the Ets proto-oncogene family to bind a composite DNA site that is essential for efficient transcription of the early-B-cell-specific mb-1 promoter.">
            <entity id="DS3.d232.s0.e0" origId="Q02548,E7EQT0,E7ERW5,C0KTE5,E7ES87,E7ERK2,C0KTF5" charOffset="27-32" type="protein" text="Pax-5"/>
            <entity id="DS3.d232.s0.e1" origId="196528" charOffset="224-228" type="compound" text="mb-1"/>
            <pair e1="DS3.d232.s0.e1" e2="DS3.d232.s0.e0" id="DS3.d232.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d233" origId="10022911">
        <sentence id="DS3.d233.s0" origId="10022911-7" text="Analysis of Op18-mediated regulation of tubulin GTPase activity and taxol-promoted tubulin polymerization showed that while wild-type and Glu-substituted Op18 derivatives are active, the coiled-coil mutants are essentially inactive.">
            <entity id="DS3.d233.s0.e0" origId="P16949" charOffset="12-16" type="protein" text="Op18"/>
            <entity id="DS3.d233.s0.e1" origId="36314" charOffset="68-73" type="compound" text="taxol"/>
            <entity id="DS3.d233.s0.e2" origId="P16949" charOffset="154-158" type="protein" text="Op18"/>
            <pair e1="DS3.d233.s0.e1" e2="DS3.d233.s0.e0" id="DS3.d233.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d234" origId="10022912">
        <sentence id="DS3.d234.s0" origId="10022912-0" text="Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.">
            <entity id="DS3.d234.s0.e0" origId="5994" charOffset="0-12" type="compound" text="Progesterone"/>
            <entity id="DS3.d234.s0.e1" origId="P25322,Q790L7" charOffset="39-48" type="protein" text="cyclin D1"/>
            <entity id="DS3.d234.s0.e2" origId="P30285,Q545C3" charOffset="53-57" type="protein" text="cdk4"/>
            <entity id="DS3.d234.s0.e3" origId="P51943" charOffset="95-103" type="protein" text="cyclin A"/>
            <entity id="DS3.d234.s0.e4" origId="P97377,Q3UGB9,Q3U6X7" charOffset="104-108" type="protein" text="cdk2"/>
            <pair e1="DS3.d234.s0.e0" e2="DS3.d234.s0.e1" id="DS3.d234.s0.i0" interaction="False" />
            <pair e1="DS3.d234.s0.e0" e2="DS3.d234.s0.e4" id="DS3.d234.s0.i1" interaction="False" />
            <pair e1="DS3.d234.s0.e0" e2="DS3.d234.s0.e2" id="DS3.d234.s0.i2" interaction="False" />
            <pair e1="DS3.d234.s0.e0" e2="DS3.d234.s0.e3" id="DS3.d234.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d235" origId="10022913">
        <sentence id="DS3.d235.s0" origId="10022913-1" text="Pex14p is a central component of the peroxisomal protein import machinery, which has been suggested to provide the point of convergence for PTS1- and PTS2-dependent protein import in yeast cells.">
            <entity id="DS3.d235.s0.e0" origId="P53112,O75381" charOffset="0-6" type="protein" text="Pex14p"/>
            <entity id="DS3.d235.s0.e1" origId="2762662" charOffset="140-144" type="compound" text="PTS1"/>
            <entity id="DS3.d235.s0.e2" origId="16213034" charOffset="150-154" type="compound" text="PTS2"/>
            <pair e1="DS3.d235.s0.e1" e2="DS3.d235.s0.e0" id="DS3.d235.s0.i0" interaction="False" />
            <pair e1="DS3.d235.s0.e2" e2="DS3.d235.s0.e0" id="DS3.d235.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d236" origId="10022914">
        <sentence id="DS3.d236.s0" origId="10022914-10" text="Finally, the Nir1-encoding gene is located at human chromosome 17p13.1, in proximity to a locus responsible for several human retinal diseases.">
            <entity id="DS3.d236.s0.e0" origId="Q9BZ71,A1A5C9" charOffset="13-17" type="protein" text="Nir1"/>
            <entity id="DS3.d236.s0.e1" origId="638015" charOffset="126-133" type="compound" text="retinal"/>
            <pair e1="DS3.d236.s0.e1" e2="DS3.d236.s0.e0" id="DS3.d236.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d236.s1" origId="10022914-11" text="We propose that the Nir and rdgB proteins represent a new family of evolutionarily conserved PYK2-binding proteins that play a role in the control of calcium and phosphoinositide metabolism downstream of G-protein-coupled receptors.">
            <entity id="DS3.d236.s1.e0" origId="P43125,E1JJK8,M9PEJ5,M9PJM8,E1JJK6,E1JJK9,E1JJK7,X2JF93" charOffset="28-32" type="protein" text="rdgB"/>
            <entity id="DS3.d236.s1.e1" origId="Q14289" charOffset="93-97" type="protein" text="PYK2"/>
            <entity id="DS3.d236.s1.e2" origId="22044544,5460341" charOffset="150-157" type="compound" text="calcium"/>
            <entity id="DS3.d236.s1.e3" origId="16738692" charOffset="162-178" type="compound" text="phosphoinositide"/>
            <pair e1="DS3.d236.s1.e2" e2="DS3.d236.s1.e0" id="DS3.d236.s1.i0" interaction="False" />
            <pair e1="DS3.d236.s1.e2" e2="DS3.d236.s1.e1" id="DS3.d236.s1.i1" interaction="False" />
            <pair e1="DS3.d236.s1.e3" e2="DS3.d236.s1.e0" id="DS3.d236.s1.i2" interaction="False" />
            <pair e1="DS3.d236.s1.e3" e2="DS3.d236.s1.e1" id="DS3.d236.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d236.s2" origId="10022914-1" text="The protein tyrosine kinase PYK2 has been implicated in signaling pathways activated by G-protein-coupled receptors, intracellular calcium, and stress signals.">
            <entity id="DS3.d236.s2.e0" origId="6057,90983769" charOffset="12-20" type="compound" text="tyrosine"/>
            <entity id="DS3.d236.s2.e1" origId="Q14289" charOffset="28-32" type="protein" text="PYK2"/>
            <entity id="DS3.d236.s2.e2" origId="22044544,5460341" charOffset="131-138" type="compound" text="calcium"/>
            <pair e1="DS3.d236.s2.e2" e2="DS3.d236.s2.e1" id="DS3.d236.s2.i0" interaction="False" />
            <pair e1="DS3.d236.s2.e0" e2="DS3.d236.s2.e1" id="DS3.d236.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d236.s3" origId="10022914-7" text="Activation of PYK2 by agents that elevate intracellular calcium or by phorbol ester induce tyrosine phosphorylation of Nirs.">
            <entity id="DS3.d236.s3.e0" origId="Q14289" charOffset="14-18" type="protein" text="PYK2"/>
            <entity id="DS3.d236.s3.e1" origId="22044544,5460341" charOffset="56-63" type="compound" text="calcium"/>
            <entity id="DS3.d236.s3.e2" origId="22833501,27924,70702034" charOffset="70-83" type="compound" text="phorbol ester"/>
            <entity id="DS3.d236.s3.e3" origId="6057,90983769" charOffset="91-99" type="compound" text="tyrosine"/>
            <pair e1="DS3.d236.s3.e1" e2="DS3.d236.s3.e0" id="DS3.d236.s3.i0" interaction="False" />
            <pair e1="DS3.d236.s3.e2" e2="DS3.d236.s3.e0" id="DS3.d236.s3.i1" interaction="False" />
            <pair e1="DS3.d236.s3.e3" e2="DS3.d236.s3.e0" id="DS3.d236.s3.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d237" origId="10022917">
        <sentence id="DS3.d237.s0" origId="10022917-2" text="Here, we show that the S21 protein (rpS21) is bound to native 40S ribosomal subunits in a salt-labile association and is absent from polysomes, indicating that it acts as a translation initiation factor rather than as a core ribosomal protein.">
            <entity id="DS3.d237.s0.e0" origId="11065204" charOffset="23-26" type="compound" text="S21"/>
            <entity id="DS3.d237.s0.e1" origId="O76927,M9PEA6" charOffset="36-41" type="protein" text="rpS21"/>
            <pair e1="DS3.d237.s0.e0" e2="DS3.d237.s0.e1" id="DS3.d237.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d238" origId="10022918">
        <sentence id="DS3.d238.s0" origId="10022918-3" text="To elucidate the developmental function of the Drosophila p38's, we used various genetic and pharmacological manipulations to interfere with their functions: expression of a dominant-negative form of D-p38b, expression of antisense D-p38b RNA, reduction of the D-p38 gene dosage, and treatment with the p38 inhibitor SB203580.">
            <entity id="DS3.d238.s0.e0" origId="O61443" charOffset="58-61" type="protein" text="p38"/>
            <entity id="DS3.d238.s0.e1" origId="O61443" charOffset="200-206" type="protein" text="D-p38b"/>
            <entity id="DS3.d238.s0.e2" origId="O61443" charOffset="232-238" type="protein" text="D-p38b"/>
            <entity id="DS3.d238.s0.e3" origId="O61443" charOffset="202-205" type="protein" text="p38"/>
            <entity id="DS3.d238.s0.e4" origId="O61443" charOffset="202-205" type="protein" text="p38"/>
            <entity id="DS3.d238.s0.e5" origId="176155" charOffset="317-325" type="compound" text="SB203580"/>
            <pair e1="DS3.d238.s0.e5" e2="DS3.d238.s0.e0" id="DS3.d238.s0.i0" interaction="False" />
            <pair e1="DS3.d238.s0.e5" e2="DS3.d238.s0.e1" id="DS3.d238.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d239" origId="10022920">
        <sentence id="DS3.d239.s0" origId="10022920-1" text="Protein tyrosine kinase Pyk2 is activated by a variety of G-protein-coupled receptors and by extracellular signals that elevate intracellular Ca2+ concentration.">
            <entity id="DS3.d239.s0.e0" origId="6057,90983769" charOffset="8-16" type="compound" text="tyrosine"/>
            <entity id="DS3.d239.s0.e1" origId="Q14289" charOffset="24-28" type="protein" text="Pyk2"/>
            <pair e1="DS3.d239.s0.e0" e2="DS3.d239.s0.e1" id="DS3.d239.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d239.s1" origId="10022920-3" text="Pap is a multidomain protein composed of an N-terminal alpha-helical region with a coiled-coil motif, followed by a pleckstrin homology domain, an Arf-GAP domain, an ankyrin homology region, a proline-rich region, and a C-terminal SH3 domain.">
            <entity id="DS3.d239.s1.e0" origId="O43150" charOffset="0-3" type="protein" text="Pap"/>
            <entity id="DS3.d239.s1.e1" origId="145742,57240853,614,8988" charOffset="193-200" type="compound" text="proline"/>
            <pair e1="DS3.d239.s1.e1" e2="DS3.d239.s1.e0" id="DS3.d239.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d239.s2" origId="10022920-4" text="We demonstrate that Pap forms a stable complex with Pyk2 and that activation of Pyk2 leads to tyrosine phosphorylation of Pap in living cells.">
            <entity id="DS3.d239.s2.e0" origId="O43150" charOffset="20-23" type="protein" text="Pap"/>
            <entity id="DS3.d239.s2.e1" origId="Q14289" charOffset="52-56" type="protein" text="Pyk2"/>
            <entity id="DS3.d239.s2.e2" origId="Q14289" charOffset="80-84" type="protein" text="Pyk2"/>
            <entity id="DS3.d239.s2.e3" origId="6057,90983769" charOffset="94-102" type="compound" text="tyrosine"/>
            <entity id="DS3.d239.s2.e4" origId="O43150" charOffset="122-125" type="protein" text="Pap"/>
            <pair e1="DS3.d239.s2.e3" e2="DS3.d239.s2.e0" id="DS3.d239.s2.i0" interaction="False" />
            <pair e1="DS3.d239.s2.e3" e2="DS3.d239.s2.e1" id="DS3.d239.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d240" origId="10022925">
        <sentence id="DS3.d240.s0" origId="10022925-6" text="Nmd3p fractionated as a cytoplasmic protein and sedimented in the position of free 60S subunits in sucrose gradients.">
            <entity id="DS3.d240.s0.e0" origId="P38861" charOffset="0-5" type="protein" text="Nmd3p"/>
            <entity id="DS3.d240.s0.e1" origId="5988" charOffset="99-106" type="compound" text="sucrose"/>
            <pair e1="DS3.d240.s0.e1" e2="DS3.d240.s0.e0" id="DS3.d240.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d241" origId="10022927">
        <sentence id="DS3.d241.s0" origId="10022927-0" text="The yeast ser/thr phosphatases sit4 and ppz1 play opposite roles in regulation of the cell cycle.">
            <entity id="DS3.d241.s0.e0" origId="5951" charOffset="10-13" type="compound" text="ser"/>
            <entity id="DS3.d241.s0.e1" origId="P20604" charOffset="31-35" type="protein" text="sit4"/>
            <entity id="DS3.d241.s0.e2" origId="P26570" charOffset="40-44" type="protein" text="ppz1"/>
            <pair e1="DS3.d241.s0.e0" e2="DS3.d241.s0.e2" id="DS3.d241.s0.i0" interaction="False" />
            <pair e1="DS3.d241.s0.e0" e2="DS3.d241.s0.e1" id="DS3.d241.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d241.s1" origId="10022927-1" text="Yeast cells overexpressing the Ser/Thr protein phosphatase ppz1 display a slow-growth phenotype.">
            <entity id="DS3.d241.s1.e0" origId="5951" charOffset="31-34" type="compound" text="Ser"/>
            <entity id="DS3.d241.s1.e1" origId="P26570" charOffset="59-63" type="protein" text="ppz1"/>
            <pair e1="DS3.d241.s1.e0" e2="DS3.d241.s1.e1" id="DS3.d241.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d241.s2" origId="10022927-2" text="These cells recover slowly from alpha-factor or nutrient depletion-induced G1 arrest, showing a considerable delay in bud emergence as well as in the expression of the G1 cyclins Cln2 and Clb5.">
            <entity id="DS3.d241.s2.e0" origId="86289906" charOffset="32-44" type="compound" text="alpha-factor"/>
            <entity id="DS3.d241.s2.e1" origId="P30283" charOffset="188-192" type="protein" text="Clb5"/>
            <pair e1="DS3.d241.s2.e0" e2="DS3.d241.s2.e1" id="DS3.d241.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d241.s3" origId="10022927-7" text="The growth defect caused by overexpression of ppz1 is intensified in strains with low G1 cyclin levels (such as bck2Delta or cln3Delta mutants), whereas mutation of ppz1 rescues the synthetic lethal phenotype of sit4 cln3 mutants.">
            <entity id="DS3.d241.s3.e0" origId="P26570" charOffset="46-50" type="protein" text="ppz1"/>
            <entity id="DS3.d241.s3.e1" origId="P26570" charOffset="165-169" type="protein" text="ppz1"/>
            <entity id="DS3.d241.s3.e2" origId="P20604" charOffset="212-216" type="protein" text="sit4"/>
            <entity id="DS3.d241.s3.e3" origId="61708" charOffset="125-129" type="compound" text="cln3"/>
            <pair e1="DS3.d241.s3.e3" e2="DS3.d241.s3.e0" id="DS3.d241.s3.i0" interaction="False" />
            <pair e1="DS3.d241.s3.e3" e2="DS3.d241.s3.e2" id="DS3.d241.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d241.s4" origId="10022927-8" text="These results reveal a role for ppz1 as a regulatory component of the yeast cell cycle, reinforce the notion that HAL3/SIS2 serves as a negative modulator of the biological functions of ppz1, and indicate that the sit4 and ppz1 Ser/Thr phosphatases play opposite roles in control of the G1/S transition.">
            <entity id="DS3.d241.s4.e0" origId="P26570" charOffset="32-36" type="protein" text="ppz1"/>
            <entity id="DS3.d241.s4.e1" origId="P36024" charOffset="114-118" type="protein" text="HAL3"/>
            <entity id="DS3.d241.s4.e2" origId="P36024" charOffset="119-123" type="protein" text="SIS2"/>
            <entity id="DS3.d241.s4.e3" origId="P26570" charOffset="186-190" type="protein" text="ppz1"/>
            <entity id="DS3.d241.s4.e4" origId="P20604" charOffset="214-218" type="protein" text="sit4"/>
            <entity id="DS3.d241.s4.e5" origId="P26570" charOffset="186-190" type="protein" text="ppz1"/>
            <entity id="DS3.d241.s4.e6" origId="5951" charOffset="228-231" type="compound" text="Ser"/>
            <pair e1="DS3.d241.s4.e6" e2="DS3.d241.s4.e1" id="DS3.d241.s4.i0" interaction="False" />
            <pair e1="DS3.d241.s4.e6" e2="DS3.d241.s4.e0" id="DS3.d241.s4.i1" interaction="False" />
            <pair e1="DS3.d241.s4.e6" e2="DS3.d241.s4.e4" id="DS3.d241.s4.i2" interaction="False" />
            <pair e1="DS3.d241.s4.e6" e2="DS3.d241.s4.e2" id="DS3.d241.s4.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d242" origId="10022928">
        <sentence id="DS3.d242.s0" origId="10022928-0" text="Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway.">
            <entity id="DS3.d242.s0.e0" origId="P35235" charOffset="0-5" type="protein" text="Shp-2"/>
            <entity id="DS3.d242.s0.e1" origId="6057,90983769" charOffset="6-14" type="compound" text="tyrosine"/>
            <pair e1="DS3.d242.s0.e1" e2="DS3.d242.s0.e0" id="DS3.d242.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d242.s1" origId="10022928-1" text="Shp-2 is an SH2 domain-containing protein tyrosine phosphatase.">
            <entity id="DS3.d242.s1.e0" origId="P35235" charOffset="0-5" type="protein" text="Shp-2"/>
            <entity id="DS3.d242.s1.e1" origId="6057,90983769" charOffset="42-50" type="compound" text="tyrosine"/>
            <pair e1="DS3.d242.s1.e1" e2="DS3.d242.s1.e0" id="DS3.d242.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d242.s2" origId="10022928-7" text="Consistently, tyrosine phosphorylation levels of Stat1 upon IFN-gamma treatment and, to a lesser extent, upon IFN-alpha stimulation were markedly elevated in mutant cells.">
            <entity id="DS3.d242.s2.e0" origId="6057,90983769" charOffset="14-22" type="compound" text="tyrosine"/>
            <entity id="DS3.d242.s2.e1" origId="Q8C3V4,Q8CFQ1,Q99K94,A0A087WSP5,Q8C8M3,Q8C497" charOffset="49-54" type="protein" text="Stat1"/>
            <entity id="DS3.d242.s2.e2" origId="P01580" charOffset="60-69" type="protein" text="IFN-gamma"/>
            <pair e1="DS3.d242.s2.e0" e2="DS3.d242.s2.e2" id="DS3.d242.s2.i0" interaction="False" />
            <pair e1="DS3.d242.s2.e0" e2="DS3.d242.s2.e1" id="DS3.d242.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d243" origId="10022929">
        <sentence id="DS3.d243.s0" origId="10022929-1" text="PINCH is a widely expressed and evolutionarily conserved protein comprising primarily five LIM domains, which are cysteine-rich consensus sequences implicated in mediating protein-protein interactions.">
            <entity id="DS3.d243.s0.e0" origId="P48059" charOffset="0-5" type="protein" text="PINCH"/>
            <entity id="DS3.d243.s0.e1" origId="5862,90793998" charOffset="114-122" type="compound" text="cysteine"/>
            <pair e1="DS3.d243.s0.e1" e2="DS3.d243.s0.e0" id="DS3.d243.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d243.s1" origId="10022929-2" text="We report here that PINCH is a binding protein for integrin-linked kinase (ILK), an intracellular serine/threonine protein kinase that plays important roles in the cell adhesion, growth factor, and Wnt signaling pathways.">
            <entity id="DS3.d243.s1.e0" origId="P48059" charOffset="20-25" type="protein" text="PINCH"/>
            <entity id="DS3.d243.s1.e1" origId="Q13418,V9HWF0" charOffset="51-73" type="protein" text="integrin-linked kinase"/>
            <entity id="DS3.d243.s1.e2" origId="Q13418,V9HWF0" charOffset="75-78" type="protein" text="ILK"/>
            <entity id="DS3.d243.s1.e3" origId="194239,6288" charOffset="105-114" type="compound" text="threonine"/>
            <pair e1="DS3.d243.s1.e3" e2="DS3.d243.s1.e0" id="DS3.d243.s1.i0" interaction="False" />
            <pair e1="DS3.d243.s1.e3" e2="DS3.d243.s1.e1" id="DS3.d243.s1.i1" interaction="False" />
            <pair e1="DS3.d243.s1.e3" e2="DS3.d243.s1.e2" id="DS3.d243.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d244" origId="10022949">
        <sentence id="DS3.d244.s0" origId="10022949-1" text="Histidine auxotrophs of wild-type strain I-182 of Candida oleophila, produced using ethyl methanesulfonate, were transformed with plasmids containing the HIS3, HIS4 and HIS5 genes of Saccharomyces cerevisiae.">
            <entity id="DS3.d244.s0.e0" origId="6274" charOffset="0-9" type="compound" text="Histidine"/>
            <entity id="DS3.d244.s0.e1" origId="6113" charOffset="84-106" type="compound" text="ethyl methanesulfonate"/>
            <entity id="DS3.d244.s0.e2" origId="P07172" charOffset="169-173" type="protein" text="HIS5"/>
            <pair e1="DS3.d244.s0.e1" e2="DS3.d244.s0.e2" id="DS3.d244.s0.i0" interaction="False" />
            <pair e1="DS3.d244.s0.e0" e2="DS3.d244.s0.e2" id="DS3.d244.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d244.s1" origId="10022949-2" text="Histidine auxotrophy was complemented by the HIS5 gene of S. cerevisiae.">
            <entity id="DS3.d244.s1.e0" origId="6274" charOffset="0-9" type="compound" text="Histidine"/>
            <entity id="DS3.d244.s1.e1" origId="P07172" charOffset="45-49" type="protein" text="HIS5"/>
            <pair e1="DS3.d244.s1.e0" e2="DS3.d244.s1.e1" id="DS3.d244.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d245" origId="10022950">
        <sentence id="DS3.d245.s0" origId="10022950-7" text="By contrast, BMP-2 or BMP-4 plus activin A synergistically increased the numbers of both leukocytes and erythrocytes.">
            <entity id="DS3.d245.s0.e0" origId="Q498L8" charOffset="13-18" type="protein" text="BMP-2"/>
            <entity id="DS3.d245.s0.e1" origId="Q91703" charOffset="22-27" type="protein" text="BMP-4"/>
            <entity id="DS3.d245.s0.e2" origId="229455" charOffset="33-40" type="compound" text="activin"/>
            <pair e1="DS3.d245.s0.e2" e2="DS3.d245.s0.e1" id="DS3.d245.s0.i0" interaction="False" />
            <pair e1="DS3.d245.s0.e2" e2="DS3.d245.s0.e0" id="DS3.d245.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d246" origId="10022960">
        <sentence id="DS3.d246.s0" origId="10022960-0" text="Cellular and subcellular distribution of the calcium-binding protein NCS-1 in the central nervous system of the rat.">
            <entity id="DS3.d246.s0.e0" origId="5460341,22044544" charOffset="45-52" type="compound" text="calcium"/>
            <entity id="DS3.d246.s0.e1" origId="P62168" charOffset="69-74" type="protein" text="NCS-1"/>
            <pair e1="DS3.d246.s0.e0" e2="DS3.d246.s0.e1" id="DS3.d246.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d246.s1" origId="10022960-1" text="NCS-1 (neuronal calcium sensor) is a recently characterized member of a highly conserved neuron-specific family of calcium-binding proteins, which also includes frequenin and recoverin.">
            <entity id="DS3.d246.s1.e0" origId="P62168" charOffset="0-5" type="protein" text="NCS-1"/>
            <entity id="DS3.d246.s1.e1" origId="22044544,5460341" charOffset="16-23" type="compound" text="calcium"/>
            <entity id="DS3.d246.s1.e2" origId="22044544,5460341" charOffset="115-122" type="compound" text="calcium"/>
            <entity id="DS3.d246.s1.e3" origId="Q8VH47" charOffset="175-184" type="protein" text="recoverin"/>
            <pair e1="DS3.d246.s1.e1" e2="DS3.d246.s1.e3" id="DS3.d246.s1.i0" interaction="False" />
            <pair e1="DS3.d246.s1.e1" e2="DS3.d246.s1.e0" id="DS3.d246.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d246.s2" origId="10022960-8" text="The widespread distribution of NCS-1 indicates that it may be active in a variety of calcium-dependent neuronal functions, whereas the specific subcellular localization to the Golgi apparatus and neurofilament-rich structures suggests a specialized role in calcium regulated protein trafficking and cytoskeletal interactions.">
            <entity id="DS3.d246.s2.e0" origId="P62168" charOffset="31-36" type="protein" text="NCS-1"/>
            <entity id="DS3.d246.s2.e1" origId="5460341,22044544" charOffset="85-92" type="compound" text="calcium"/>
            <entity id="DS3.d246.s2.e2" origId="5460341,22044544" charOffset="257-264" type="compound" text="calcium"/>
            <pair e1="DS3.d246.s2.e1" e2="DS3.d246.s2.e0" id="DS3.d246.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d247" origId="10022965">
        <sentence id="DS3.d247.s0" origId="10022965-2" text="Because of the unique contractile properties of the SMMHC isoform SM-B, we analyzed its expression in the microvessels (&amp;lt;100 micrometers diameter) and in larger vessels (100-700 micrometers) quantitatualy by the labeled (strept)avidin-biotin technique (day 1-28), and related this to cell phenotype by transmission microscopy and protein A-gold labeling (at day 28).">
            <entity id="DS3.d247.s0.e0" origId="P35749,A0A024QZJ4,A0A024QZJ6" charOffset="52-57" type="protein" text="SMMHC"/>
            <entity id="DS3.d247.s0.e1" origId="171548,53700020" charOffset="238-244" type="compound" text="biotin"/>
            <entity id="DS3.d247.s0.e2" origId="23985" charOffset="343-347" type="compound" text="gold"/>
            <pair e1="DS3.d247.s0.e1" e2="DS3.d247.s0.e0" id="DS3.d247.s0.i0" interaction="False" />
            <pair e1="DS3.d247.s0.e2" e2="DS3.d247.s0.e0" id="DS3.d247.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d248" origId="10022968">
        <sentence id="DS3.d248.s0" origId="10022968-4" text="The present investigations with light- and electron-microscopic methods using fluorescent dextran, methylene blue and immunohistochemistry (F4/80, anti-kit receptor, anti-CD3, anti-CD45R/B220) show that macrophages are absent from the muscle layers, with only an occasional macrophage present in the subserosa.">
            <entity id="DS3.d248.s0.e0" origId="4125253,5460037" charOffset="90-97" type="compound" text="dextran"/>
            <entity id="DS3.d248.s0.e1" origId="4139" charOffset="99-113" type="compound" text="methylene blue"/>
            <entity id="DS3.d248.s0.e2" origId="Q61549,Q3U9R0" charOffset="140-174" type="protein" text="F4/80, anti-kit receptor, anti-CD3"/>
            <entity id="DS3.d248.s0.e3" origId="S4R2V1,Q8C6Q7,S4R1S4,S4R1M0" charOffset="181-191" type="protein" text="CD45R/B220"/>
            <pair e1="DS3.d248.s0.e1" e2="DS3.d248.s0.e2" id="DS3.d248.s0.i0" interaction="False" />
            <pair e1="DS3.d248.s0.e1" e2="DS3.d248.s0.e3" id="DS3.d248.s0.i1" interaction="False" />
            <pair e1="DS3.d248.s0.e0" e2="DS3.d248.s0.e2" id="DS3.d248.s0.i2" interaction="False" />
            <pair e1="DS3.d248.s0.e0" e2="DS3.d248.s0.e3" id="DS3.d248.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d249" origId="10022971">
        <sentence id="DS3.d249.s0" origId="10022971-0" text="Aquaporin-5 (AQP5), a water channel protein, in the rat salivary and lacrimal glands: immunolocalization and effect of secretory stimulation.">
            <entity id="DS3.d249.s0.e0" origId="P47864" charOffset="0-11" type="protein" text="Aquaporin-5"/>
            <entity id="DS3.d249.s0.e1" origId="P47864" charOffset="13-17" type="protein" text="AQP5"/>
            <entity id="DS3.d249.s0.e2" origId="962" charOffset="22-27" type="compound" text="water"/>
            <pair e1="DS3.d249.s0.e2" e2="DS3.d249.s0.e1" id="DS3.d249.s0.i0" interaction="False" />
            <pair e1="DS3.d249.s0.e2" e2="DS3.d249.s0.e0" id="DS3.d249.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d249.s1" origId="10022971-1" text="Aquaporin-5 (AQP5) is a water channel protein and is considered to play an important role in water movement across the plasma membrane.">
            <entity id="DS3.d249.s1.e0" origId="P47864" charOffset="0-11" type="protein" text="Aquaporin-5"/>
            <entity id="DS3.d249.s1.e1" origId="P47864" charOffset="13-17" type="protein" text="AQP5"/>
            <entity id="DS3.d249.s1.e2" origId="962" charOffset="24-29" type="compound" text="water"/>
            <entity id="DS3.d249.s1.e3" origId="962" charOffset="93-98" type="compound" text="water"/>
            <pair e1="DS3.d249.s1.e2" e2="DS3.d249.s1.e1" id="DS3.d249.s1.i0" interaction="False" />
            <pair e1="DS3.d249.s1.e2" e2="DS3.d249.s1.e0" id="DS3.d249.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d249.s2" origId="10022971-5" text="Upon stimulation by isoproterenol, apical staining for AQP5 in parotid acinar cells tended to appear as clusters of dots.">
            <entity id="DS3.d249.s2.e0" origId="3779" charOffset="20-33" type="compound" text="isoproterenol"/>
            <entity id="DS3.d249.s2.e1" origId="P47864" charOffset="55-59" type="protein" text="AQP5"/>
            <pair e1="DS3.d249.s2.e0" e2="DS3.d249.s2.e1" id="DS3.d249.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d249.s3" origId="10022971-6" text="These results suggest that AQP5 is one of the candidate molecules responsible for the water movement in the salivary glands.">
            <entity id="DS3.d249.s3.e0" origId="P47864" charOffset="27-31" type="protein" text="AQP5"/>
            <entity id="DS3.d249.s3.e1" origId="962" charOffset="86-91" type="compound" text="water"/>
            <pair e1="DS3.d249.s3.e1" e2="DS3.d249.s3.e0" id="DS3.d249.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d250" origId="10022976">
        <sentence id="DS3.d250.s0" origId="10022976-10" text="LG16 shares syntenic relationships with mouse chromosome (Mmu) 4, including GDF6.">
            <entity id="DS3.d250.s0.e0" origId="95700" charOffset="58-61" type="compound" text="Mmu"/>
            <entity id="DS3.d250.s0.e1" origId="P43028,A2AII0" charOffset="76-80" type="protein" text="GDF6"/>
            <pair e1="DS3.d250.s0.e0" e2="DS3.d250.s0.e1" id="DS3.d250.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d250.s1" origId="10022976-7" text="We have mapped zebrafish GDF7 to linkage group (LG) 17, contact to LG9, GDF6 to human chromosome (Hsa) 8 and GDF7 to Hsa2p.">
            <entity id="DS3.d250.s1.e0" origId="Q7Z4P5,Q75RY1" charOffset="25-29" type="protein" text="GDF7"/>
            <entity id="DS3.d250.s1.e1" origId="46897857" charOffset="67-70" type="compound" text="LG9"/>
            <entity id="DS3.d250.s1.e2" origId="P43028,A2AII0" charOffset="72-76" type="protein" text="GDF6"/>
            <entity id="DS3.d250.s1.e3" origId="Q9NZP0" charOffset="86-104" type="protein" text="chromosome (Hsa) 8"/>
            <entity id="DS3.d250.s1.e4" origId="Q7Z4P5,Q75RY1" charOffset="109-113" type="protein" text="GDF7"/>
            <pair e1="DS3.d250.s1.e1" e2="DS3.d250.s1.e0" id="DS3.d250.s1.i0" interaction="False" />
            <pair e1="DS3.d250.s1.e1" e2="DS3.d250.s1.e2" id="DS3.d250.s1.i1" interaction="False" />
            <pair e1="DS3.d250.s1.e1" e2="DS3.d250.s1.e3" id="DS3.d250.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d251" origId="10022987">
        <sentence id="DS3.d251.s0" origId="10022987-10" text="DNA repair gene XRCC1 mRNA expression in peripheral blood mononuclear cells was analyzed, using the reverse transcriptase-polymerase chain reaction, in 8 patients and was suppressed during etoposide infusion in 2.">
            <entity id="DS3.d251.s0.e0" origId="P18887,B2RCY5,Q59HH7" charOffset="16-21" type="protein" text="XRCC1"/>
            <entity id="DS3.d251.s0.e1" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="189-198" type="compound" text="etoposide"/>
            <pair e1="DS3.d251.s0.e1" e2="DS3.d251.s0.e0" id="DS3.d251.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d251.s1" origId="10022987-11" text="No relationship was observed between serum etoposide concentration and XRCC1 expression and clinical outcome.">
            <entity id="DS3.d251.s1.e0" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="43-52" type="compound" text="etoposide"/>
            <entity id="DS3.d251.s1.e1" origId="P18887,B2RCY5,Q59HH7" charOffset="71-76" type="protein" text="XRCC1"/>
            <pair e1="DS3.d251.s1.e0" e2="DS3.d251.s1.e1" id="DS3.d251.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d252" origId="10022995">
        <sentence id="DS3.d252.s0" origId="10022995-0" text="A phase I study of cisplatin i.p. and carboplatin i.v. with G-CSF in patients with ovarian cancer.">
            <entity id="DS3.d252.s0.e0" origId="2568" charOffset="38-49" type="compound" text="carboplatin"/>
            <entity id="DS3.d252.s0.e1" origId="P09919,Q6FH65,Q8N4W3" charOffset="60-65" type="protein" text="G-CSF"/>
            <pair e1="DS3.d252.s0.e0" e2="DS3.d252.s0.e1" id="DS3.d252.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d252.s1" origId="10022995-1" text="We conducted a dose-escalation study with a fixed dose of intraperitoneal cisplatin and G-CSF support of carboplatin using the Calvert formula in epithelial ovarian cancer.">
            <entity id="DS3.d252.s1.e0" origId="P09919,Q6FH65,Q8N4W3" charOffset="88-93" type="protein" text="G-CSF"/>
            <entity id="DS3.d252.s1.e1" origId="2568" charOffset="105-116" type="compound" text="carboplatin"/>
            <pair e1="DS3.d252.s1.e1" e2="DS3.d252.s1.e0" id="DS3.d252.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d253" origId="10023003">
        <sentence id="DS3.d253.s0" origId="10023003-0" text="Antitumor effect of 22-oxacalcitriol on estrogen receptor-negative MDA-MB-231 tumors in athymic mice.">
            <entity id="DS3.d253.s0.e0" origId="53779047,6398761" charOffset="20-36" type="compound" text="22-oxacalcitriol"/>
            <entity id="DS3.d253.s0.e1" origId="P19785,E7FJU2" charOffset="40-57" type="protein" text="estrogen receptor"/>
            <pair e1="DS3.d253.s0.e0" e2="DS3.d253.s0.e1" id="DS3.d253.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d253.s1" origId="10023003-1" text="The purpose of this study was to evaluate the usefulness of 22-oxacalcitriol (OCT) in the treatment of estrogen receptor (ER)-negative breast cancer.">
            <entity id="DS3.d253.s1.e0" origId="53779047,6398761" charOffset="60-76" type="compound" text="22-oxacalcitriol"/>
            <entity id="DS3.d253.s1.e1" origId="P19785,E7FJU2" charOffset="103-120" type="protein" text="estrogen receptor"/>
            <pair e1="DS3.d253.s1.e0" e2="DS3.d253.s1.e1" id="DS3.d253.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d254" origId="10023004">
        <sentence id="DS3.d254.s0" origId="10023004-3" text="To evaluate the anti-cancer activity of vesnarinone in combination with irradiation, we investigated the cytostatic and cytotoxic effects on human lung cancer cell lines (PC-9 and Lu 134A) using MTT assay and isobologram analysis.">
            <entity id="DS3.d254.s0.e0" origId="5663" charOffset="40-51" type="compound" text="vesnarinone"/>
            <entity id="DS3.d254.s0.e1" origId="Q8NBP7" charOffset="171-175" type="protein" text="PC-9"/>
            <entity id="DS3.d254.s0.e2" origId="64966" charOffset="195-198" type="compound" text="MTT"/>
            <pair e1="DS3.d254.s0.e0" e2="DS3.d254.s0.e1" id="DS3.d254.s0.i0" interaction="False" />
            <pair e1="DS3.d254.s0.e2" e2="DS3.d254.s0.e1" id="DS3.d254.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d254.s1" origId="10023004-5" text="Our study demonstrated that combination of vesnarinone with irradiation had an additive inhibitory effect on both PC-9 and Lu 134A tumor cell growth.">
            <entity id="DS3.d254.s1.e0" origId="5663" charOffset="43-54" type="compound" text="vesnarinone"/>
            <entity id="DS3.d254.s1.e1" origId="Q8NBP7" charOffset="114-118" type="protein" text="PC-9"/>
            <pair e1="DS3.d254.s1.e0" e2="DS3.d254.s1.e1" id="DS3.d254.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d255" origId="10023011">
        <sentence id="DS3.d255.s0" origId="10023011-3" text="The role of Bcl-2 in determining the response of AML cells to two chemotherapy drugs used in treatment of AML: cytarabine and fludarabine was investigated using human leukaemia cell lines expressing different levels of Bcl-2: U937 CD34 negative expressing low levels of Bcl-2 and MHH225 CD34 positive expressing high levels of Bcl-2.">
            <entity id="DS3.d255.s0.e0" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="12-17" type="protein" text="Bcl-2"/>
            <entity id="DS3.d255.s0.e1" origId="6253" charOffset="111-121" type="compound" text="cytarabine"/>
            <entity id="DS3.d255.s0.e2" origId="657237" charOffset="126-137" type="compound" text="fludarabine"/>
            <entity id="DS3.d255.s0.e3" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="219-224" type="protein" text="Bcl-2"/>
            <entity id="DS3.d255.s0.e4" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="219-224" type="protein" text="Bcl-2"/>
            <entity id="DS3.d255.s0.e5" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="219-224" type="protein" text="Bcl-2"/>
            <pair e1="DS3.d255.s0.e1" e2="DS3.d255.s0.e0" id="DS3.d255.s0.i0" interaction="False" />
            <pair e1="DS3.d255.s0.e2" e2="DS3.d255.s0.e0" id="DS3.d255.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d255.s1" origId="10023011-5" text="The IC50 of cytarabine and fludarabine were significantly higher in CD34 positive cells with high Bcl-2 than in CD34 negative cells with low Bcl-2.">
            <entity id="DS3.d255.s1.e0" origId="6253" charOffset="12-22" type="compound" text="cytarabine"/>
            <entity id="DS3.d255.s1.e1" origId="657237" charOffset="27-38" type="compound" text="fludarabine"/>
            <entity id="DS3.d255.s1.e2" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="98-103" type="protein" text="Bcl-2"/>
            <entity id="DS3.d255.s1.e3" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="141-146" type="protein" text="Bcl-2"/>
            <pair e1="DS3.d255.s1.e0" e2="DS3.d255.s1.e2" id="DS3.d255.s1.i0" interaction="False" />
            <pair e1="DS3.d255.s1.e1" e2="DS3.d255.s1.e2" id="DS3.d255.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d255.s2" origId="10023011-7" text="Both cytarabine and fludarabine have reduced Bcl-2 concentrations in both cell types.">
            <entity id="DS3.d255.s2.e0" origId="6253" charOffset="5-15" type="compound" text="cytarabine"/>
            <entity id="DS3.d255.s2.e1" origId="657237" charOffset="20-31" type="compound" text="fludarabine"/>
            <entity id="DS3.d255.s2.e2" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="45-50" type="protein" text="Bcl-2"/>
            <pair e1="DS3.d255.s2.e0" e2="DS3.d255.s2.e2" id="DS3.d255.s2.i0" interaction="False" />
            <pair e1="DS3.d255.s2.e1" e2="DS3.d255.s2.e2" id="DS3.d255.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d256" origId="10023014">
        <sentence id="DS3.d256.s0" origId="10023014-6" text="The following laboratory parameters were assessed before the study entry and during the study: hemoglobin (weekly); serum iron, transferrin and ferritin (before entry).">
            <entity id="DS3.d256.s0.e0" origId="23925,67172434" charOffset="122-126" type="compound" text="iron"/>
            <entity id="DS3.d256.s0.e1" origId="P02787,Q06AH7,A0PJA6" charOffset="128-139" type="protein" text="transferrin"/>
            <pair e1="DS3.d256.s0.e0" e2="DS3.d256.s0.e1" id="DS3.d256.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d257" origId="10023015">
        <sentence id="DS3.d257.s0" origId="10023015-2" text="The cell lines were stimulated transiently with interleukin-1 (IL-1 ), IL-6, interferon-ç (IFN-ç), lipopolysaccharide (LPS) and tetradecanoyl phorbol 13-acetate (TPA), respectively.">
            <entity id="DS3.d257.s0.e0" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="71-75" type="protein" text="IL-6"/>
            <entity id="DS3.d257.s0.e1" origId="11970143" charOffset="99-117" type="compound" text="lipopolysaccharide"/>
            <entity id="DS3.d257.s0.e2" origId="442070" charOffset="142-149" type="compound" text="phorbol"/>
            <entity id="DS3.d257.s0.e3" origId="176" charOffset="153-160" type="compound" text="acetate"/>
            <entity id="DS3.d257.s0.e4" origId="122634,22833501" charOffset="162-165" type="compound" text="TPA"/>
            <pair e1="DS3.d257.s0.e1" e2="DS3.d257.s0.e0" id="DS3.d257.s0.i0" interaction="False" />
            <pair e1="DS3.d257.s0.e4" e2="DS3.d257.s0.e0" id="DS3.d257.s0.i1" interaction="False" />
            <pair e1="DS3.d257.s0.e2" e2="DS3.d257.s0.e0" id="DS3.d257.s0.i2" interaction="False" />
            <pair e1="DS3.d257.s0.e3" e2="DS3.d257.s0.e0" id="DS3.d257.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d257.s1" origId="10023015-6" text="The strongest inducers were TPA and IL-1 ; weakly or not effective at all were IFN-ç, LPS and IL-6.">
            <entity id="DS3.d257.s1.e0" origId="122634,22833501" charOffset="28-31" type="compound" text="TPA"/>
            <entity id="DS3.d257.s1.e1" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="94-98" type="protein" text="IL-6"/>
            <pair e1="DS3.d257.s1.e0" e2="DS3.d257.s1.e1" id="DS3.d257.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d257.s2" origId="10023015-8" text="Especially in kidney cell lines, the levels of granulocyte-macrophage-CSF (GM-CSF), M-CSF and IL-6 were further strongly increased by the TPA and IL-1 pretreatment.">
            <entity id="DS3.d257.s2.e0" origId="P04141" charOffset="47-73" type="protein" text="granulocyte-macrophage-CSF"/>
            <entity id="DS3.d257.s2.e1" origId="P04141" charOffset="75-81" type="protein" text="GM-CSF"/>
            <entity id="DS3.d257.s2.e2" origId="P09603,A0A024R0A1" charOffset="76-81" type="protein" text="M-CSF"/>
            <entity id="DS3.d257.s2.e3" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="94-98" type="protein" text="IL-6"/>
            <entity id="DS3.d257.s2.e4" origId="122634,22833501" charOffset="138-141" type="compound" text="TPA"/>
            <pair e1="DS3.d257.s2.e4" e2="DS3.d257.s2.e3" id="DS3.d257.s2.i0" interaction="False" />
            <pair e1="DS3.d257.s2.e4" e2="DS3.d257.s2.e1" id="DS3.d257.s2.i1" interaction="False" />
            <pair e1="DS3.d257.s2.e4" e2="DS3.d257.s2.e0" id="DS3.d257.s2.i2" interaction="False" />
            <pair e1="DS3.d257.s2.e4" e2="DS3.d257.s2.e2" id="DS3.d257.s2.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d257.s3" origId="10023015-9" text="The by far highest amounts of granulocyte-CSF (G-CSF) were elaborated by the bladder cell line T-24 and could be further more than doubled by TPA.">
            <entity id="DS3.d257.s3.e0" origId="P09919,Q6FH65,Q8N4W3" charOffset="30-52" type="protein" text="granulocyte-CSF (G-CSF"/>
            <entity id="DS3.d257.s3.e1" origId="122634,22833501" charOffset="142-145" type="compound" text="TPA"/>
            <pair e1="DS3.d257.s3.e1" e2="DS3.d257.s3.e0" id="DS3.d257.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d258" origId="10023032">
        <sentence id="DS3.d258.s0" origId="10023032-0" text="Effects of glucose and related substrates on the recovery of the electrical activity of gonadotropin-releasing hormone pulse generator which is decreased by insulin-induced hypoglycemia in the estrogen-primed ovariectomized rat.">
            <entity id="DS3.d258.s0.e0" origId="5793,64689,79025" charOffset="11-18" type="compound" text="glucose"/>
            <entity id="DS3.d258.s0.e1" origId="P07490" charOffset="88-118" type="protein" text="gonadotropin-releasing hormone"/>
            <pair e1="DS3.d258.s0.e0" e2="DS3.d258.s0.e1" id="DS3.d258.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d258.s1" origId="10023032-2" text="We also examined the effect of glucose on the electrical activity of the gonadotropin-releasing hormone (GnRH) pulse generator which was suppressed by insulin.">
            <entity id="DS3.d258.s1.e0" origId="5793,64689,79025" charOffset="31-38" type="compound" text="glucose"/>
            <entity id="DS3.d258.s1.e1" origId="P07490" charOffset="73-109" type="protein" text="gonadotropin-releasing hormone (GnRH"/>
            <pair e1="DS3.d258.s1.e0" e2="DS3.d258.s1.e1" id="DS3.d258.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d259" origId="10023034">
        <sentence id="DS3.d259.s0" origId="10023034-0" text="Area postrema and the anorectic actions of dexfenfluramine and amylin.">
            <entity id="DS3.d259.s0.e0" origId="66265" charOffset="43-58" type="compound" text="dexfenfluramine"/>
            <entity id="DS3.d259.s0.e1" origId="P12969" charOffset="63-69" type="protein" text="amylin"/>
            <pair e1="DS3.d259.s0.e0" e2="DS3.d259.s0.e1" id="DS3.d259.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d259.s1" origId="10023034-2" text="The first agent is the serotonergic agonist, dexfenfluramine (DFEN) and the second is the pancreatic peptide, amylin.">
            <entity id="DS3.d259.s1.e0" origId="66265" charOffset="45-60" type="compound" text="dexfenfluramine"/>
            <entity id="DS3.d259.s1.e1" origId="P12969" charOffset="110-116" type="protein" text="amylin"/>
            <pair e1="DS3.d259.s1.e0" e2="DS3.d259.s1.e1" id="DS3.d259.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d260" origId="10023035">
        <sentence id="DS3.d260.s0" origId="10023035-6" text="Anterior pituitary cells were dispersed and cells were treated with different concentrations and combinations of OT, corticotrophin-releasing hormone (CRH), vasopressin (AVP) and cortisol.">
            <entity id="DS3.d260.s0.e0" origId="W5Q7H6" charOffset="117-149" type="protein" text="corticotrophin-releasing hormone"/>
            <entity id="DS3.d260.s0.e1" origId="W5Q7H6" charOffset="151-154" type="protein" text="CRH"/>
            <entity id="DS3.d260.s0.e2" origId="B2KPN5" charOffset="170-173" type="protein" text="AVP"/>
            <entity id="DS3.d260.s0.e3" origId="5754" charOffset="179-187" type="compound" text="cortisol"/>
            <pair e1="DS3.d260.s0.e3" e2="DS3.d260.s0.e2" id="DS3.d260.s0.i0" interaction="False" />
            <pair e1="DS3.d260.s0.e3" e2="DS3.d260.s0.e1" id="DS3.d260.s0.i1" interaction="False" />
            <pair e1="DS3.d260.s0.e3" e2="DS3.d260.s0.e0" id="DS3.d260.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d260.s1" origId="10023035-9" text="In vitro, OT stimulated adrenocorticotropin (ACTH) output in a dose-dependent fashion, but had no effect on cellular pro-opiomelanocortin (POMC) mRNA levels.">
            <entity id="DS3.d260.s1.e0" origId="16132265" charOffset="24-43" type="compound" text="adrenocorticotropin"/>
            <entity id="DS3.d260.s1.e1" origId="P01191" charOffset="117-137" type="protein" text="pro-opiomelanocortin"/>
            <entity id="DS3.d260.s1.e2" origId="P01191" charOffset="139-143" type="protein" text="POMC"/>
            <pair e1="DS3.d260.s1.e0" e2="DS3.d260.s1.e1" id="DS3.d260.s1.i0" interaction="False" />
            <pair e1="DS3.d260.s1.e0" e2="DS3.d260.s1.e2" id="DS3.d260.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d261" origId="10023038">
        <sentence id="DS3.d261.s0" origId="10023038-2" text="In DLF sham-operated animals, brush stimuli induced a significant increase in the number of Fos-labeled neurons in ipsilateral laminae I-IV, and a slight suppression of Fos expression in ipsilateral laminae V-VI when compared to sham-lesioned rats without brushing.">
            <entity id="DS3.d261.s0.e0" origId="447849" charOffset="3-6" type="compound" text="DLF"/>
            <entity id="DS3.d261.s0.e1" origId="P12841" charOffset="92-95" type="protein" text="Fos"/>
            <entity id="DS3.d261.s0.e2" origId="P12841" charOffset="169-172" type="protein" text="Fos"/>
            <pair e1="DS3.d261.s0.e0" e2="DS3.d261.s0.e1" id="DS3.d261.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d262" origId="10023040">
        <sentence id="DS3.d262.s0" origId="10023040-1" text="ferrochelatase (EC.4.99.1.1), the final step in the biosynthesis of heme, is widely expressed in various tissues and is induced in erythroid cells.">
            <entity id="DS3.d262.s0.e0" origId="Q544X6" charOffset="0-14" type="protein" text="ferrochelatase"/>
            <entity id="DS3.d262.s0.e1" origId="4971" charOffset="68-72" type="compound" text="heme"/>
            <entity id="DS3.d262.s0.e2" origId="439574" charOffset="131-140" type="compound" text="erythroid"/>
            <pair e1="DS3.d262.s0.e2" e2="DS3.d262.s0.e0" id="DS3.d262.s0.i0" interaction="False" />
            <pair e1="DS3.d262.s0.e1" e2="DS3.d262.s0.e0" id="DS3.d262.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d262.s1" origId="10023040-6" text="Function analysis of the promoter by transient transfection assay demonstrated that one Sp1 binding site located at -37/-32 is essential for basic expression of the ferrochelatase gene in both mouse erythroleukemia (MEL) and non-erythroid EL4 cells.">
            <entity id="DS3.d262.s1.e0" origId="O89090,G3X8Q0" charOffset="88-91" type="protein" text="Sp1"/>
            <entity id="DS3.d262.s1.e1" origId="Q544X6" charOffset="165-179" type="protein" text="ferrochelatase"/>
            <entity id="DS3.d262.s1.e2" origId="439574" charOffset="229-238" type="compound" text="erythroid"/>
            <pair e1="DS3.d262.s1.e2" e2="DS3.d262.s1.e0" id="DS3.d262.s1.i0" interaction="False" />
            <pair e1="DS3.d262.s1.e2" e2="DS3.d262.s1.e1" id="DS3.d262.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d263" origId="10023042">
        <sentence id="DS3.d263.s0" origId="10023042-2" text="A total ten compounds were investigated, i. e., two technical PCB mixtures (Aroclor 1221 and Aroclor 1254), DDT, PCP, tetrabromobisphenol A (TBBPA), 4,4'-bischlorophenyl sulfone (BCPS), hexabromocyclododecane (HBCD) and the three different polybrominated diphenylethers (PBDEs): 2-bromodiphenylether (MBDE), 3,4-dibromodiphenylether (DBDE) and 2,4,2', 4'-tetrabromodiphenylether (TBDE).">
            <entity id="DS3.d263.s0.e0" origId="40470" charOffset="93-105" type="compound" text="Aroclor 1254"/>
            <entity id="DS3.d263.s0.e1" origId="P30046,Q53Y51" charOffset="108-111" type="protein" text="DDT"/>
            <entity id="DS3.d263.s0.e2" origId="P13497" charOffset="113-116" type="protein" text="PCP"/>
            <entity id="DS3.d263.s0.e3" origId="6618" charOffset="118-139" type="compound" text="tetrabromobisphenol A"/>
            <entity id="DS3.d263.s0.e4" origId="11377211,11763618,13040187,18529" charOffset="210-214" type="compound" text="HBCD"/>
            <entity id="DS3.d263.s0.e5" origId="37483" charOffset="281-299" type="compound" text="bromodiphenylether"/>
            <entity id="DS3.d263.s0.e6" origId="13766701" charOffset="355-378" type="compound" text="tetrabromodiphenylether"/>
            <pair e1="DS3.d263.s0.e0" e2="DS3.d263.s0.e2" id="DS3.d263.s0.i0" interaction="False" />
            <pair e1="DS3.d263.s0.e0" e2="DS3.d263.s0.e1" id="DS3.d263.s0.i1" interaction="False" />
            <pair e1="DS3.d263.s0.e4" e2="DS3.d263.s0.e2" id="DS3.d263.s0.i2" interaction="False" />
            <pair e1="DS3.d263.s0.e4" e2="DS3.d263.s0.e1" id="DS3.d263.s0.i3" interaction="False" />
            <pair e1="DS3.d263.s0.e6" e2="DS3.d263.s0.e2" id="DS3.d263.s0.i4" interaction="False" />
            <pair e1="DS3.d263.s0.e6" e2="DS3.d263.s0.e1" id="DS3.d263.s0.i5" interaction="False" />
            <pair e1="DS3.d263.s0.e5" e2="DS3.d263.s0.e2" id="DS3.d263.s0.i6" interaction="False" />
            <pair e1="DS3.d263.s0.e5" e2="DS3.d263.s0.e1" id="DS3.d263.s0.i7" interaction="False" />
            <pair e1="DS3.d263.s0.e3" e2="DS3.d263.s0.e2" id="DS3.d263.s0.i8" interaction="False" />
            <pair e1="DS3.d263.s0.e3" e2="DS3.d263.s0.e1" id="DS3.d263.s0.i9" interaction="False" />
        </sentence>
        <sentence id="DS3.d263.s1" origId="10023042-3" text="In the SPD8 assay system statistically significant increases in recombination frequency were observed with Aroclor 1221, BCPS, DBDE, DDT, HBCD, MBDE and TBDE.">
            <entity id="DS3.d263.s1.e0" origId="P30046,Q53Y51" charOffset="133-136" type="protein" text="DDT"/>
            <entity id="DS3.d263.s1.e1" origId="11377211,11763618,13040187,18529" charOffset="138-142" type="compound" text="HBCD"/>
            <pair e1="DS3.d263.s1.e1" e2="DS3.d263.s1.e0" id="DS3.d263.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d263.s2" origId="10023042-4" text="In the Sp5 assay system, only DBDE, HBCD and MBDE caused statistically significant increases in recombination frequency.">
            <entity id="DS3.d263.s2.e0" origId="Q6BEB4" charOffset="7-10" type="protein" text="Sp5"/>
            <entity id="DS3.d263.s2.e1" origId="11377211,11763618,18529,13040187" charOffset="36-40" type="compound" text="HBCD"/>
            <pair e1="DS3.d263.s2.e1" e2="DS3.d263.s2.e0" id="DS3.d263.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d263.s3" origId="10023042-5" text="In conclusion, our findings indicate that the modern additives to plastic, i.e., HBCD and PBDEs, as well as the plastic monomer BCPS may have the same effect to human health as DDT and PCBs, in terms of inducing genetic recombination, which is known to provoke a number of diseases, including cancer.">
            <entity id="DS3.d263.s3.e0" origId="11377211,11763618,13040187,18529" charOffset="81-85" type="compound" text="HBCD"/>
            <entity id="DS3.d263.s3.e1" origId="P30046,Q53Y51" charOffset="177-180" type="protein" text="DDT"/>
            <entity id="DS3.d263.s3.e2" origId="6636" charOffset="185-189" type="compound" text="PCBs"/>
            <pair e1="DS3.d263.s3.e2" e2="DS3.d263.s3.e1" id="DS3.d263.s3.i0" interaction="False" />
            <pair e1="DS3.d263.s3.e0" e2="DS3.d263.s3.e1" id="DS3.d263.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d264" origId="10023043">
        <sentence id="DS3.d264.s0" origId="10023043-1" text="TTD is a rare human genetic disease caused by mutations in XPB and XPD, two subunits of the transcription/repair factor TFIIH, and whose outstanding clinical characteristic is a lack of most human UHS proteins resulting in sulfur-deficient brittle hair.">
            <entity id="DS3.d264.s0.e0" origId="P18074" charOffset="0-3" type="protein" text="TTD"/>
            <entity id="DS3.d264.s0.e1" origId="P19447,G3V1S1,B3KRG2,B3KTH1" charOffset="59-62" type="protein" text="XPB"/>
            <entity id="DS3.d264.s0.e2" origId="P18074" charOffset="67-70" type="protein" text="XPD"/>
            <entity id="DS3.d264.s0.e3" origId="402" charOffset="223-229" type="compound" text="sulfur"/>
            <pair e1="DS3.d264.s0.e3" e2="DS3.d264.s0.e1" id="DS3.d264.s0.i0" interaction="False" />
            <pair e1="DS3.d264.s0.e3" e2="DS3.d264.s0.e2" id="DS3.d264.s0.i1" interaction="False" />
            <pair e1="DS3.d264.s0.e3" e2="DS3.d264.s0.e0" id="DS3.d264.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d265" origId="10023049">
        <sentence id="DS3.d265.s0" origId="10023049-2" text="The V allele of alpha1-AT has been shown to be associated with focal glomerulosclerosis (FGS) in Negroid and mixed race South African patients.">
            <entity id="DS3.d265.s0.e0" origId="P01009,E9KL23" charOffset="16-25" type="protein" text="alpha1-AT"/>
            <entity id="DS3.d265.s0.e1" origId="44223986" charOffset="89-92" type="compound" text="FGS"/>
            <pair e1="DS3.d265.s0.e1" e2="DS3.d265.s0.e0" id="DS3.d265.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d265.s1" origId="10023049-3" text="To identify mutations and polymorphisms in the gene for the V allele of alpha1-AT in five South African patients with FGS nephrotic syndrome DNA sequence analysis and restriction fragment length polymorphisms of the coding exons were carried out.">
            <entity id="DS3.d265.s1.e0" origId="P01009,E9KL23" charOffset="72-81" type="protein" text="alpha1-AT"/>
            <entity id="DS3.d265.s1.e1" origId="44223986" charOffset="118-121" type="compound" text="FGS"/>
            <pair e1="DS3.d265.s1.e1" e2="DS3.d265.s1.e0" id="DS3.d265.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d265.s2" origId="10023049-7" text="Although the V allele of alpha1-AT is not associated with severe plasma deficiency, it may be in linkage disequilibrium with other genes on chromosome 14 that predispose to FGS.">
            <entity id="DS3.d265.s2.e0" origId="P01009,E9KL23" charOffset="25-34" type="protein" text="alpha1-AT"/>
            <entity id="DS3.d265.s2.e1" origId="44223986" charOffset="173-176" type="compound" text="FGS"/>
            <pair e1="DS3.d265.s2.e1" e2="DS3.d265.s2.e0" id="DS3.d265.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d266" origId="10023055">
        <sentence id="DS3.d266.s0" origId="10023055-1" text="We report the structure of the human gene encoding the putative glucose 6-phosphate translocase that is mutated in glycogen storage disease type Ib.">
            <entity id="DS3.d266.s0.e0" origId="O43826,A0A024R3H9,A0A024R3L1,B4DUH2,A8K0S7" charOffset="64-95" type="protein" text="glucose 6-phosphate translocase"/>
            <entity id="DS3.d266.s0.e1" origId="439177" charOffset="115-123" type="compound" text="glycogen"/>
            <pair e1="DS3.d266.s0.e1" e2="DS3.d266.s0.e0" id="DS3.d266.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d267" origId="10023057">
        <sentence id="DS3.d267.s0" origId="10023057-3" text="Several observations have suggested that sulfotransferases (SULTs) 1A1 and/or 1C1 may be important in the activation of P2N to a genotoxicant in rat liver, but a definite proof is lacking.">
            <entity id="DS3.d267.s0.e0" origId="P17988,P50237,A0A0G2K5J0" charOffset="41-81" type="protein" text="sulfotransferases (SULTs) 1A1 and/or 1C1"/>
            <entity id="DS3.d267.s0.e1" origId="11987828" charOffset="120-123" type="compound" text="P2N"/>
            <pair e1="DS3.d267.s0.e1" e2="DS3.d267.s0.e0" id="DS3.d267.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d267.s1" origId="10023057-9" text="By contrast, a clear and concentration-dependent induction of repair synthesis by P2N was observed in V79-rPST-IV and V79-rST1C1 cells, which express rat SULT1A1 and SULT1C1, respectively.">
            <entity id="DS3.d267.s1.e0" origId="11987828" charOffset="82-85" type="compound" text="P2N"/>
            <entity id="DS3.d267.s1.e1" origId="P17988" charOffset="154-161" type="protein" text="SULT1A1"/>
            <entity id="DS3.d267.s1.e2" origId="P50237,A0A0G2K5J0" charOffset="166-173" type="protein" text="SULT1C1"/>
            <pair e1="DS3.d267.s1.e0" e2="DS3.d267.s1.e2" id="DS3.d267.s1.i0" interaction="False" />
            <pair e1="DS3.d267.s1.e0" e2="DS3.d267.s1.e1" id="DS3.d267.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d268" origId="10023062">
        <sentence id="DS3.d268.s0" origId="10023062-0" text="Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1,2-epoxy-3-butene.">
            <entity id="DS3.d268.s0.e0" origId="P09488,X5D932,X5DR03" charOffset="0-28" type="protein" text="Glutathione S-transferase M1"/>
            <entity id="DS3.d268.s0.e1" origId="13586" charOffset="145-163" type="compound" text="1,2-epoxy-3-butene"/>
            <pair e1="DS3.d268.s0.e1" e2="DS3.d268.s0.e0" id="DS3.d268.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d268.s1" origId="10023062-1" text="Induction of sister chromatid exchanges (SCEs) by 1,2-epoxy-3-butene (monoepoxybutene, MEB), an epoxide metabolite of 1,3-butadiene, in human whole-blood lymphocyte cultures has previously been observed to depend on the Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genotype of the blood donor.">
            <entity id="DS3.d268.s1.e0" origId="13586" charOffset="50-68" type="compound" text="1,2-epoxy-3-butene"/>
            <entity id="DS3.d268.s1.e1" origId="Q8WZA1,B7Z7Q4,B7Z7F2" charOffset="87-90" type="protein" text="MEB"/>
            <entity id="DS3.d268.s1.e2" origId="P09488,X5D932,X5DR03" charOffset="220-248" type="protein" text="Glutathione S-transferase M1"/>
            <entity id="DS3.d268.s1.e3" origId="P09488,X5D932,X5DR03" charOffset="250-255" type="protein" text="GSTM1"/>
            <entity id="DS3.d268.s1.e4" origId="P30711,A0A0G2JRN4,Q4W251,A0A0G2JRQ5,Q4GZS9" charOffset="265-270" type="protein" text="GSTT1"/>
            <pair e1="DS3.d268.s1.e0" e2="DS3.d268.s1.e3" id="DS3.d268.s1.i0" interaction="False" />
            <pair e1="DS3.d268.s1.e0" e2="DS3.d268.s1.e2" id="DS3.d268.s1.i1" interaction="False" />
            <pair e1="DS3.d268.s1.e0" e2="DS3.d268.s1.e4" id="DS3.d268.s1.i2" interaction="False" />
            <pair e1="DS3.d268.s1.e0" e2="DS3.d268.s1.e1" id="DS3.d268.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d268.s2" origId="10023062-4" text="A higher mean number of induced SCEs per cell at 250 microM MEB was observed in lymphocytes of the GSTM1 null than positive donors, a statistically significant difference being obtained in the presence of the adaptive treatment (9.44 vs. 6.56; results from ethanol-treated controls subtracted).">
            <entity id="DS3.d268.s2.e0" origId="Q8WZA1,B7Z7Q4,B7Z7F2" charOffset="60-63" type="protein" text="MEB"/>
            <entity id="DS3.d268.s2.e1" origId="P09488,X5D932,X5DR03" charOffset="99-104" type="protein" text="GSTM1"/>
            <entity id="DS3.d268.s2.e2" origId="702" charOffset="257-264" type="compound" text="ethanol"/>
            <pair e1="DS3.d268.s2.e2" e2="DS3.d268.s2.e1" id="DS3.d268.s2.i0" interaction="False" />
            <pair e1="DS3.d268.s2.e2" e2="DS3.d268.s2.e0" id="DS3.d268.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d269" origId="10023065">
        <sentence id="DS3.d269.s0" origId="10023065-0" text="Identification and characterization of a zinc finger gene (ZNF213) from 16p13.3.">
            <entity id="DS3.d269.s0.e0" origId="23994" charOffset="41-45" type="compound" text="zinc"/>
            <entity id="DS3.d269.s0.e1" origId="O14771" charOffset="59-65" type="protein" text="ZNF213"/>
            <pair e1="DS3.d269.s0.e0" e2="DS3.d269.s0.e1" id="DS3.d269.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d269.s1" origId="10023065-7" text="The predicted 424 amino acid protein, designated ZNF213, contains three C2H2 zinc fingers, a Kruppel associated A box and a leucine rich motif (LeR domain/SCAN box), strongly suggestive of a transcription factor.">
            <entity id="DS3.d269.s1.e0" origId="O14771" charOffset="49-55" type="protein" text="ZNF213"/>
            <entity id="DS3.d269.s1.e1" origId="23994" charOffset="77-81" type="compound" text="zinc"/>
            <entity id="DS3.d269.s1.e2" origId="6106" charOffset="124-131" type="compound" text="leucine"/>
            <pair e1="DS3.d269.s1.e2" e2="DS3.d269.s1.e0" id="DS3.d269.s1.i0" interaction="False" />
            <pair e1="DS3.d269.s1.e1" e2="DS3.d269.s1.e0" id="DS3.d269.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d270" origId="10023068">
        <sentence id="DS3.d270.s0" origId="10023068-0" text="Functional studies by site-directed mutagenesis on the role of Sp1 in the expression of the pyruvate kinase M and aldolase A genes.">
            <entity id="DS3.d270.s0.e0" origId="Q01714" charOffset="63-66" type="protein" text="Sp1"/>
            <entity id="DS3.d270.s0.e1" origId="1060" charOffset="92-100" type="compound" text="pyruvate"/>
            <pair e1="DS3.d270.s0.e1" e2="DS3.d270.s0.e0" id="DS3.d270.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d270.s1" origId="10023068-5" text="In the aldolase AH1 promoter, five binding sites for Sp1 and Sp3 and a TPA responsive element were identified as essential for transcriptional regulation.">
            <entity id="DS3.d270.s1.e0" origId="444290" charOffset="16-19" type="compound" text="AH1"/>
            <entity id="DS3.d270.s1.e1" origId="Q01714" charOffset="53-56" type="protein" text="Sp1"/>
            <entity id="DS3.d270.s1.e2" origId="122634,22833501" charOffset="71-74" type="compound" text="TPA"/>
            <pair e1="DS3.d270.s1.e0" e2="DS3.d270.s1.e1" id="DS3.d270.s1.i0" interaction="False" />
            <pair e1="DS3.d270.s1.e2" e2="DS3.d270.s1.e1" id="DS3.d270.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d270.s2" origId="10023068-7" text="In the pyruvate kinase M promoter three out of five binding sites of Sp1 and Sp3 (B box and GC boxes 1 and 3) turned out to be functional in the transfection assays whereas the disruption of GC box 2 had no effect, and the disruption of the GC box 4 had only a minor effect on the promoter activity.">
            <entity id="DS3.d270.s2.e0" origId="1060" charOffset="7-15" type="compound" text="pyruvate"/>
            <entity id="DS3.d270.s2.e1" origId="Q01714" charOffset="69-72" type="protein" text="Sp1"/>
            <pair e1="DS3.d270.s2.e0" e2="DS3.d270.s2.e1" id="DS3.d270.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d270.s3" origId="10023068-9" text="Therefore, the Sp1- and Sp3-directed transcription provides a means for common regulatory mechanism of the aldolase A and the pyruvate kinase M genes.">
            <entity id="DS3.d270.s3.e0" origId="Q01714" charOffset="15-18" type="protein" text="Sp1"/>
            <entity id="DS3.d270.s3.e1" origId="1060" charOffset="126-134" type="compound" text="pyruvate"/>
            <pair e1="DS3.d270.s3.e1" e2="DS3.d270.s3.e0" id="DS3.d270.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d271" origId="10023069">
        <sentence id="DS3.d271.s0" origId="10023069-1" text="Transcriptional regulation in mammalian and plant cells is distinguished from fungi by the presence of blocks of multiple interacting DNA binding sites distributed over a relatively large upstream region of genes and the ability to use glutamine-rich enhancers such as Sp1.">
            <entity id="DS3.d271.s0.e0" origId="5961" charOffset="236-245" type="compound" text="glutamine"/>
            <entity id="DS3.d271.s0.e1" origId="P08047" charOffset="269-272" type="protein" text="Sp1"/>
            <pair e1="DS3.d271.s0.e0" e2="DS3.d271.s0.e1" id="DS3.d271.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d272" origId="10023074">
        <sentence id="DS3.d272.s0" origId="10023074-0" text="Duet is a novel serine/threonine kinase with Dbl-Homology (DH) and Pleckstrin-Homology (PH) domains.">
            <entity id="DS3.d272.s0.e0" origId="O60229,C9IZQ6,J3QSW6" charOffset="0-4" type="protein" text="Duet"/>
            <entity id="DS3.d272.s0.e1" origId="53903450" charOffset="16-32" type="compound" text="serine/threonine"/>
            <entity id="DS3.d272.s0.e2" origId="P10911,B2R9S6" charOffset="45-48" type="protein" text="Dbl"/>
            <pair e1="DS3.d272.s0.e1" e2="DS3.d272.s0.e0" id="DS3.d272.s0.i0" interaction="False" />
            <pair e1="DS3.d272.s0.e1" e2="DS3.d272.s0.e2" id="DS3.d272.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d272.s1" origId="10023074-1" text="We show here the identification of Duet, a novel molecule bearing serine/threonine kinase, Dbl-Homology (DH), and Pleckstrin-Homology (PH) domains.">
            <entity id="DS3.d272.s1.e0" origId="O60229,C9IZQ6,J3QSW6" charOffset="35-39" type="protein" text="Duet"/>
            <entity id="DS3.d272.s1.e1" origId="53903450" charOffset="66-82" type="compound" text="serine/threonine"/>
            <entity id="DS3.d272.s1.e2" origId="P10911,B2R9S6" charOffset="91-94" type="protein" text="Dbl"/>
            <pair e1="DS3.d272.s1.e1" e2="DS3.d272.s1.e0" id="DS3.d272.s1.i0" interaction="False" />
            <pair e1="DS3.d272.s1.e1" e2="DS3.d272.s1.e2" id="DS3.d272.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d273" origId="10023076">
        <sentence id="DS3.d273.s0" origId="10023076-1" text="Large conductance, calcium-activated potassium (maxiK) channels are expressed in nerve, muscle, and other cell types and are important determinants of smooth muscle tone.">
            <entity id="DS3.d273.s0.e0" origId="22044544,5460341" charOffset="19-26" type="compound" text="calcium"/>
            <entity id="DS3.d273.s0.e1" origId="5462222" charOffset="37-46" type="compound" text="potassium"/>
            <entity id="DS3.d273.s0.e2" origId="Q12791,Q59FH2,A0A0A0MRR0,B7ZMF5,S4R453,D5MRH1,A0A087WZL8" charOffset="48-53" type="protein" text="maxiK"/>
            <pair e1="DS3.d273.s0.e0" e2="DS3.d273.s0.e2" id="DS3.d273.s0.i0" interaction="False" />
            <pair e1="DS3.d273.s0.e1" e2="DS3.d273.s0.e2" id="DS3.d273.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d274" origId="10023084">
        <sentence id="DS3.d274.s0" origId="10023084-3" text="Comparison of the deduced amino acid sequence of this clone with Rab proteins revealed that it had highest homology to a small GTP-binding protein, murine Rab3D.">
            <entity id="DS3.d274.s0.e0" origId="6830" charOffset="127-130" type="compound" text="GTP"/>
            <entity id="DS3.d274.s0.e1" origId="O95716,A0A024R7G2,P35276,Q543Q4" charOffset="155-160" type="protein" text="Rab3D"/>
            <pair e1="DS3.d274.s0.e0" e2="DS3.d274.s0.e1" id="DS3.d274.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d275" origId="10023111">
        <sentence id="DS3.d275.s0" origId="10023111-5" text="(LAS) compared to 0.5 mg ergotamine s.c. in 56 patients (112 attacks) with acute migraine.">
            <entity id="DS3.d275.s0.e0" origId="O43766,Q6P5Q6,B4E0L7,A0A024R9W0" charOffset="1-4" type="protein" text="LAS"/>
            <entity id="DS3.d275.s0.e1" origId="8223" charOffset="25-35" type="compound" text="ergotamine"/>
            <pair e1="DS3.d275.s0.e1" e2="DS3.d275.s0.e0" id="DS3.d275.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d276" origId="10023114">
        <sentence id="DS3.d276.s0" origId="10023114-4" text="ACE (I/D) genotype was determined using polymerase chain reaction and 3% agarose gel electrophoresis.">
            <entity id="DS3.d276.s0.e0" origId="P12821,B4DKH4" charOffset="0-3" type="protein" text="ACE"/>
            <entity id="DS3.d276.s0.e1" origId="11966311" charOffset="73-80" type="compound" text="agarose"/>
            <pair e1="DS3.d276.s0.e1" e2="DS3.d276.s0.e0" id="DS3.d276.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d277" origId="10023137">
        <sentence id="DS3.d277.s0" origId="10023137-5" text="Lipopolysaccharide-induced tumor necrosis factor (TNF)-alpha release was enhanced when a monocyte cell line (J774) was pretreated with rmC5-3.">
            <entity id="DS3.d277.s0.e0" origId="11970143" charOffset="0-18" type="compound" text="Lipopolysaccharide"/>
            <entity id="DS3.d277.s0.e1" origId="P06804,Q3U593" charOffset="27-60" type="protein" text="tumor necrosis factor (TNF)-alpha"/>
            <pair e1="DS3.d277.s0.e0" e2="DS3.d277.s0.e1" id="DS3.d277.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d278" origId="10023151">
        <sentence id="DS3.d278.s0" origId="10023151-0" text="(The effect of polarizing mixture KIG (potassium + insulin + glucose) on some metabolites of glucose transformation in patients with ischemic stroke during the earliest period of illness).">
            <entity id="DS3.d278.s0.e0" origId="5462222" charOffset="39-48" type="compound" text="potassium"/>
            <entity id="DS3.d278.s0.e1" origId="P01308,I3WAC9" charOffset="51-58" type="protein" text="insulin"/>
            <entity id="DS3.d278.s0.e2" origId="206,5793,64689,79025" charOffset="61-68" type="compound" text="glucose"/>
            <entity id="DS3.d278.s0.e3" origId="206,5793,64689,79025" charOffset="93-100" type="compound" text="glucose"/>
            <pair e1="DS3.d278.s0.e0" e2="DS3.d278.s0.e1" id="DS3.d278.s0.i0" interaction="False" />
            <pair e1="DS3.d278.s0.e2" e2="DS3.d278.s0.e1" id="DS3.d278.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d279" origId="10023243">
        <sentence id="DS3.d279.s0" origId="10023243-2" text="The objective of this study was to identify integrins in human dental pulp cells and determine their role in human dental pulp cell attachment to the biological active molecules, laminin and fibronectin.">
            <entity id="DS3.d279.s0.e0" origId="44342165" charOffset="179-186" type="compound" text="laminin"/>
            <entity id="DS3.d279.s0.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="191-202" type="protein" text="fibronectin"/>
            <pair e1="DS3.d279.s0.e0" e2="DS3.d279.s0.e1" id="DS3.d279.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d279.s1" origId="10023243-4" text="The role of integrin in human dental pulp cell adhesion on laminin and fibronectin was determined by inhibition of cell adhesion with those antibodies.">
            <entity id="DS3.d279.s1.e0" origId="44342165" charOffset="59-66" type="compound" text="laminin"/>
            <entity id="DS3.d279.s1.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="71-82" type="protein" text="fibronectin"/>
            <pair e1="DS3.d279.s1.e0" e2="DS3.d279.s1.e1" id="DS3.d279.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d279.s2" origId="10023243-6" text="The adhesion of human dental pulp cells to laminin and fibronectin was not inhibited by monoclonal antibody to any subunit, except that anti-beta 1 antibody inhibited pulp cells adhesion on laminin.">
            <entity id="DS3.d279.s2.e0" origId="44342165" charOffset="43-50" type="compound" text="laminin"/>
            <entity id="DS3.d279.s2.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="55-66" type="protein" text="fibronectin"/>
            <entity id="DS3.d279.s2.e2" origId="Q16558" charOffset="141-147" type="protein" text="beta 1"/>
            <entity id="DS3.d279.s2.e3" origId="44342165" charOffset="190-197" type="compound" text="laminin"/>
            <pair e1="DS3.d279.s2.e0" e2="DS3.d279.s2.e2" id="DS3.d279.s2.i0" interaction="False" />
            <pair e1="DS3.d279.s2.e0" e2="DS3.d279.s2.e1" id="DS3.d279.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d280" origId="10023256">
        <sentence id="DS3.d280.s0" origId="10023256-4" text="A length of 16 mm from the tip was then lowered in distilled water for 5 s, the paper point was weighted again, and the difference between both measurements was taken as the value of the fluid absorbed.">
            <entity id="DS3.d280.s0.e0" origId="Q92993,A0A024R597,A0A024R5E8" charOffset="27-30" type="protein" text="tip"/>
            <entity id="DS3.d280.s0.e1" origId="962" charOffset="61-66" type="compound" text="water"/>
            <pair e1="DS3.d280.s0.e1" e2="DS3.d280.s0.e0" id="DS3.d280.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d281" origId="10023275">
        <sentence id="DS3.d281.s0" origId="10023275-1" text="We compared the effects of propofol-based (n = 15) and isoflurane-based anaesthesia (n = 15) on mucous host defences by measuring the salivary flow and the concentrations/activities of salivary total protein and amylase, and of salivary immunological (IgA, IgG and IgM) and nonimmunoglobulin defence factors (lysozyme, myeloperoxidase, total salivary peroxidase and thiocyanate) in patients undergoing elective abdominal hysterectomy.">
            <entity id="DS3.d281.s0.e0" origId="4943" charOffset="27-35" type="compound" text="propofol"/>
            <entity id="DS3.d281.s0.e1" origId="3763" charOffset="55-65" type="compound" text="isoflurane"/>
            <entity id="DS3.d281.s0.e2" origId="P05164" charOffset="319-334" type="protein" text="myeloperoxidase"/>
            <entity id="DS3.d281.s0.e3" origId="781" charOffset="366-377" type="compound" text="thiocyanate"/>
            <pair e1="DS3.d281.s0.e3" e2="DS3.d281.s0.e2" id="DS3.d281.s0.i0" interaction="False" />
            <pair e1="DS3.d281.s0.e1" e2="DS3.d281.s0.e2" id="DS3.d281.s0.i1" interaction="False" />
            <pair e1="DS3.d281.s0.e0" e2="DS3.d281.s0.e2" id="DS3.d281.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d281.s1" origId="10023275-4" text="The secretion rate of total protein, amylase, lysozyme, total peroxidase, thiocyanate and IgG, however, decreased owing to a marked decrease in the salivary flow, but no alterations were found in secretion rate of myeloperoxidase, IgA and IgM.">
            <entity id="DS3.d281.s1.e0" origId="781" charOffset="74-85" type="compound" text="thiocyanate"/>
            <entity id="DS3.d281.s1.e1" origId="P05164" charOffset="214-229" type="protein" text="myeloperoxidase"/>
            <pair e1="DS3.d281.s1.e0" e2="DS3.d281.s1.e1" id="DS3.d281.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d282" origId="10023281">
        <sentence id="DS3.d282.s0" origId="10023281-0" text="Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.">
            <entity id="DS3.d282.s0.e0" origId="5314" charOffset="0-13" type="compound" text="Suxamethonium"/>
            <entity id="DS3.d282.s0.e1" origId="5281042" charOffset="18-28" type="compound" text="mivacurium"/>
            <entity id="DS3.d282.s0.e2" origId="P06276,D3DNN4" charOffset="71-85" type="protein" text="cholinesterase"/>
            <pair e1="DS3.d282.s0.e0" e2="DS3.d282.s0.e2" id="DS3.d282.s0.i0" interaction="False" />
            <pair e1="DS3.d282.s0.e1" e2="DS3.d282.s0.e2" id="DS3.d282.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d282.s1" origId="10023281-5" text="Plasma cholinesterase levels at the time were reduced to one-third of normal, with normal dibucaine and fluoride numbers.">
            <entity id="DS3.d282.s1.e0" origId="P06276,D3DNN4" charOffset="7-21" type="protein" text="cholinesterase"/>
            <entity id="DS3.d282.s1.e1" origId="3025" charOffset="90-99" type="compound" text="dibucaine"/>
            <entity id="DS3.d282.s1.e2" origId="28179" charOffset="104-112" type="compound" text="fluoride"/>
            <pair e1="DS3.d282.s1.e1" e2="DS3.d282.s1.e0" id="DS3.d282.s1.i0" interaction="False" />
            <pair e1="DS3.d282.s1.e2" e2="DS3.d282.s1.e0" id="DS3.d282.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d283" origId="10023282">
        <sentence id="DS3.d283.s0" origId="10023282-5" text="Peak serum and urine myoglobin were 12,947 micrograms.l-1 and 54,571 micrograms.l-1, respectively, while maximum serum creatinine kinase was 17,300 IU.">
            <entity id="DS3.d283.s0.e0" origId="P02144" charOffset="21-30" type="protein" text="myoglobin"/>
            <entity id="DS3.d283.s0.e1" origId="588" charOffset="119-129" type="compound" text="creatinine"/>
            <pair e1="DS3.d283.s0.e1" e2="DS3.d283.s0.e0" id="DS3.d283.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d284" origId="10023303">
        <sentence id="DS3.d284.s0" origId="10023303-10" text="Two trials reported no acute or delayed but a 'worst day' outcome; in these ondansetron's antivomiting effect was significantly better than placebo (NNT 4.4, 95% CI 2.5-23) or prochlorperazine (NNT 3.8, 95% CI 2.4-10.3), but not its antinausea effect.">
            <entity id="DS3.d284.s0.e0" origId="4595" charOffset="76-87" type="compound" text="ondansetron"/>
            <entity id="DS3.d284.s0.e1" origId="Q13423,A0A024R0C3,E9PCX7" charOffset="149-152" type="protein" text="NNT"/>
            <entity id="DS3.d284.s0.e2" origId="4917" charOffset="176-192" type="compound" text="prochlorperazine"/>
            <entity id="DS3.d284.s0.e3" origId="Q13423,A0A024R0C3,E9PCX7" charOffset="194-197" type="protein" text="NNT"/>
            <pair e1="DS3.d284.s0.e0" e2="DS3.d284.s0.e1" id="DS3.d284.s0.i0" interaction="False" />
            <pair e1="DS3.d284.s0.e2" e2="DS3.d284.s0.e1" id="DS3.d284.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d284.s1" origId="10023303-8" text="In a larger (n = 105) placebo-controlled trial, ondansetron was significantly more efficacious than metoclopramide for complete control of acute vomiting (NNT 2.2, 95% confidence interval (CI) 1.7-3.3) and acute nausea (NNT 3.6, 95% CI 2.2-10.2).">
            <entity id="DS3.d284.s1.e0" origId="4595" charOffset="48-59" type="compound" text="ondansetron"/>
            <entity id="DS3.d284.s1.e1" origId="4168" charOffset="100-114" type="compound" text="metoclopramide"/>
            <entity id="DS3.d284.s1.e2" origId="Q13423,A0A024R0C3,E9PCX7" charOffset="155-158" type="protein" text="NNT"/>
            <entity id="DS3.d284.s1.e3" origId="Q13423,A0A024R0C3,E9PCX7" charOffset="220-223" type="protein" text="NNT"/>
            <pair e1="DS3.d284.s1.e0" e2="DS3.d284.s1.e2" id="DS3.d284.s1.i0" interaction="False" />
            <pair e1="DS3.d284.s1.e1" e2="DS3.d284.s1.e2" id="DS3.d284.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d285" origId="10023308">
        <sentence id="DS3.d285.s0" origId="10023308-5" text="439 patients were entered into a phase III trial comparing a novel thymidylate synthase (TS) inhibitor Tomudex (raltitrexed, formerly ZD1694) with 5-FU and leucovorin (LV) for the treatment of advanced colorectal cancer.">
            <entity id="DS3.d285.s0.e0" origId="P04818,Q53Y97" charOffset="67-87" type="protein" text="thymidylate synthase"/>
            <entity id="DS3.d285.s0.e1" origId="104758" charOffset="134-140" type="compound" text="ZD1694"/>
            <entity id="DS3.d285.s0.e2" origId="143,149436,54575,27950349,6006" charOffset="156-166" type="compound" text="leucovorin"/>
            <pair e1="DS3.d285.s0.e1" e2="DS3.d285.s0.e0" id="DS3.d285.s0.i0" interaction="False" />
            <pair e1="DS3.d285.s0.e2" e2="DS3.d285.s0.e0" id="DS3.d285.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d286" origId="10023317">
        <sentence id="DS3.d286.s0" origId="10023317-0" text="Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells.">
            <entity id="DS3.d286.s0.e0" origId="5280961" charOffset="0-9" type="compound" text="Genistein"/>
            <entity id="DS3.d286.s0.e1" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="22-27" type="protein" text="bcl-2"/>
            <pair e1="DS3.d286.s0.e0" e2="DS3.d286.s0.e1" id="DS3.d286.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d286.s1" origId="10023317-4" text="At 0.15 mM, genistein caused an increase in the steady-state levels of the wild-type tumour suppressor p53, which was attributed to stabilising the tumour suppressor protein, since p53 mRNA levels did not increase.">
            <entity id="DS3.d286.s1.e0" origId="5280961" charOffset="12-21" type="compound" text="genistein"/>
            <entity id="DS3.d286.s1.e1" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="103-106" type="protein" text="p53"/>
            <entity id="DS3.d286.s1.e2" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="181-184" type="protein" text="p53"/>
            <pair e1="DS3.d286.s1.e0" e2="DS3.d286.s1.e1" id="DS3.d286.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d286.s2" origId="10023317-5" text="Prior to the upregulation of p53, which became evident within 6 h of genistein treatment, there was increased bcl-2 phosphorylation at 30 min post-treatment.">
            <entity id="DS3.d286.s2.e0" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="29-32" type="protein" text="p53"/>
            <entity id="DS3.d286.s2.e1" origId="5280961" charOffset="69-78" type="compound" text="genistein"/>
            <entity id="DS3.d286.s2.e2" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="110-115" type="protein" text="bcl-2"/>
            <pair e1="DS3.d286.s2.e1" e2="DS3.d286.s2.e2" id="DS3.d286.s2.i0" interaction="False" />
            <pair e1="DS3.d286.s2.e1" e2="DS3.d286.s2.e0" id="DS3.d286.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d287" origId="10023321">
        <sentence id="DS3.d287.s0" origId="10023321-7" text="laminin, fibronectin and collagen IV, were detectable in the iECM isolated with the Lysis Method but not those isolated with the Digestion Method.">
            <entity id="DS3.d287.s0.e0" origId="44342165" charOffset="0-7" type="compound" text="laminin"/>
            <entity id="DS3.d287.s0.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="9-36" type="protein" text="fibronectin and collagen IV"/>
            <pair e1="DS3.d287.s0.e0" e2="DS3.d287.s0.e1" id="DS3.d287.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d288" origId="10023337">
        <sentence id="DS3.d288.s0" origId="10023337-12" text="It seems therefore that a high level of iNOS expression and, presumably, production of nitric oxide characterise cases which are refractory to clinical treatment; this suggests that specific inhibition of the enzyme may be a useful therapeutic adjunct.">
            <entity id="DS3.d288.s0.e0" origId="P35228" charOffset="40-44" type="protein" text="iNOS"/>
            <entity id="DS3.d288.s0.e1" origId="145068" charOffset="87-99" type="compound" text="nitric oxide"/>
            <pair e1="DS3.d288.s0.e1" e2="DS3.d288.s0.e0" id="DS3.d288.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d289" origId="10023340">
        <sentence id="DS3.d289.s0" origId="10023340-13" text="Infection with cagA positive H pylori induces greater gastric chemokine mRNA expression in the antral mucosa, which may be relevant to the increased mucosal damage associated with cagA positive H pylori infection.">
            <entity id="DS3.d289.s0.e0" origId="P05109" charOffset="15-19" type="protein" text="cagA"/>
            <entity id="DS3.d289.s0.e1" origId="35864" charOffset="95-101" type="compound" text="antral"/>
            <entity id="DS3.d289.s0.e2" origId="P05109" charOffset="180-184" type="protein" text="cagA"/>
            <pair e1="DS3.d289.s0.e1" e2="DS3.d289.s0.e0" id="DS3.d289.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d289.s1" origId="10023340-5" text="Each sample was also evaluated for the presence of cagA and ureA mRNA by RT-PCR.">
            <entity id="DS3.d289.s1.e0" origId="P05109" charOffset="51-55" type="protein" text="cagA"/>
            <entity id="DS3.d289.s1.e1" origId="1176" charOffset="60-64" type="compound" text="ureA"/>
            <pair e1="DS3.d289.s1.e1" e2="DS3.d289.s1.e0" id="DS3.d289.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d290" origId="10023343">
        <sentence id="DS3.d290.s0" origId="10023343-2" text="METHODS: 71 squamous cell carcinomas and 10 controls were stained for laminin, fibronectin, and collagen IV.">
            <entity id="DS3.d290.s0.e0" origId="44342165" charOffset="70-77" type="compound" text="laminin"/>
            <entity id="DS3.d290.s0.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="79-90" type="protein" text="fibronectin"/>
            <pair e1="DS3.d290.s0.e0" e2="DS3.d290.s0.e1" id="DS3.d290.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d290.s1" origId="10023343-5" text="RESULTS: Positive cytoplasmic staining for laminin, fibronectin, and collagen IV was observed in 17 (23.9%), 27 (38%), and 10 (14.1%) cases, respectively.">
            <entity id="DS3.d290.s1.e0" origId="44342165" charOffset="43-50" type="compound" text="laminin"/>
            <entity id="DS3.d290.s1.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="52-63" type="protein" text="fibronectin"/>
            <pair e1="DS3.d290.s1.e0" e2="DS3.d290.s1.e1" id="DS3.d290.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d290.s2" origId="10023343-6" text="Staining for laminin was most pronounced in the invasive front of tumour islands, while for fibronectin and collagen IV it appeared to be diffuse.">
            <entity id="DS3.d290.s2.e0" origId="44342165" charOffset="13-20" type="compound" text="laminin"/>
            <entity id="DS3.d290.s2.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="92-103" type="protein" text="fibronectin"/>
            <pair e1="DS3.d290.s2.e0" e2="DS3.d290.s2.e1" id="DS3.d290.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d290.s3" origId="10023343-9" text="Cytoplasmic staining for laminin correlated with positive staining for fibronectin and collagen IV, and with the presence of a peritumoral deposition of collagen IV and laminin.">
            <entity id="DS3.d290.s3.e0" origId="44342165" charOffset="25-32" type="compound" text="laminin"/>
            <entity id="DS3.d290.s3.e1" origId="P02751,Q6MZF4,Q6N084,B7ZLE5,Q6MZM7,Q9UQS6" charOffset="71-82" type="protein" text="fibronectin"/>
            <entity id="DS3.d290.s3.e2" origId="44342165" charOffset="169-176" type="compound" text="laminin"/>
            <pair e1="DS3.d290.s3.e0" e2="DS3.d290.s3.e1" id="DS3.d290.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d291" origId="10023360">
        <sentence id="DS3.d291.s0" origId="10023360-2" text='METHODS: An STI prevalence study in female prostitutes (n = 374) seen at the STD clinic in Dakar, Senegal was done; a history, clinical examination, simple laboratory tests, and "gold standard" microbiological tests were performed.'>
            <entity id="DS3.d291.s0.e0" origId="Q9Y2G2,E5RFV9,A0A024QZD3,I6L9C6" charOffset="91-96" type="protein" text="Dakar"/>
            <entity id="DS3.d291.s0.e1" origId="23985" charOffset="179-183" type="compound" text="gold"/>
            <pair e1="DS3.d291.s0.e1" e2="DS3.d291.s0.e0" id="DS3.d291.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d292" origId="10023442">
        <sentence id="DS3.d292.s0" origId="10023442-9" text="We also provided wild-type p53 and p53 delta 326 with tetracycline-regulated promoters and stably introduced these constructs into Saos2 and SKBR3 cells.">
            <entity id="DS3.d292.s0.e0" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="27-30" type="protein" text="p53"/>
            <entity id="DS3.d292.s0.e1" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="35-38" type="protein" text="p53"/>
            <entity id="DS3.d292.s0.e2" origId="54675776" charOffset="54-66" type="compound" text="tetracycline"/>
            <pair e1="DS3.d292.s0.e2" e2="DS3.d292.s0.e0" id="DS3.d292.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d293" origId="10023447">
        <sentence id="DS3.d293.s0" origId="10023447-3" text="In this study, we transfected methylcholanthrene-induced fibrosarcoma (MCA-D) with TNF gene and investigated the therapeutic effect of TNF gene-transduced cancer vaccine and whether the vaccination effect is enhanced by systemic administration of recombinant IL-12 (rIL-12), in a murine model.">
            <entity id="DS3.d293.s0.e0" origId="1674" charOffset="30-48" type="compound" text="methylcholanthrene"/>
            <entity id="DS3.d293.s0.e1" origId="P45952" charOffset="71-76" type="protein" text="MCA-D"/>
            <pair e1="DS3.d293.s0.e0" e2="DS3.d293.s0.e1" id="DS3.d293.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d294" origId="10023463">
        <sentence id="DS3.d294.s0" origId="10023463-10" text="At 10 years increases in SBP, cholesterol, BMI, and decreases in smoking habits, VC, FEV, and arm circumference had occurred (deltas).">
            <entity id="DS3.d294.s0.e0" origId="5997" charOffset="30-41" type="compound" text="cholesterol"/>
            <entity id="DS3.d294.s0.e1" origId="Q99581" charOffset="85-88" type="protein" text="FEV"/>
            <pair e1="DS3.d294.s0.e0" e2="DS3.d294.s0.e1" id="DS3.d294.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d294.s1" origId="10023463-3" text="DESIGN: Entry (1960-61) data included age, systolic blood pressure (SBP), smoking habits, total serum cholesterol, body mass index (BMI), arm circumference, vital capacity (VC), and forced expiratory volume in 3/4 seconds (FEV); the same data were obtained 10 years later.">
            <entity id="DS3.d294.s1.e0" origId="5997" charOffset="102-113" type="compound" text="cholesterol"/>
            <entity id="DS3.d294.s1.e1" origId="Q99581" charOffset="223-226" type="protein" text="FEV"/>
            <pair e1="DS3.d294.s1.e0" e2="DS3.d294.s1.e1" id="DS3.d294.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d294.s2" origId="10023463-5" text="MAIN RESULTS: Italian men had higher entry levels of SBP, arm circumference, BMI, and VC; Greek men had higher cholesterol levels, smoking habits, and FEV.">
            <entity id="DS3.d294.s2.e0" origId="5997" charOffset="111-122" type="compound" text="cholesterol"/>
            <entity id="DS3.d294.s2.e1" origId="Q99581" charOffset="151-154" type="protein" text="FEV"/>
            <pair e1="DS3.d294.s2.e0" e2="DS3.d294.s2.e1" id="DS3.d294.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d295" origId="10023491">
        <sentence id="DS3.d295.s0" origId="10023491-1" text="We compared the MTP immunoassay with EMIT for the screening of drugs of abuse (opiates, cannabinoids, cocaine metabolites and amphetamines) in whole blood samples.">
            <entity id="DS3.d295.s0.e0" origId="P07438" charOffset="16-19" type="protein" text="MTP"/>
            <entity id="DS3.d295.s0.e1" origId="446220" charOffset="102-109" type="compound" text="cocaine"/>
            <pair e1="DS3.d295.s0.e1" e2="DS3.d295.s0.e0" id="DS3.d295.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d296" origId="10023572">
        <sentence id="DS3.d296.s0" origId="10023572-2" text="In Arabidopsis thaliana, the RNA-binding protein AtGRP7 (Arabidopsis thaliana glycine-rich protein) has been identified as part of a negative-feedback loop through which AtGRP7 regulates the circadian oscillations of its own transcript.">
            <entity id="DS3.d296.s0.e0" origId="Q03250,F4IHK9" charOffset="49-55" type="protein" text="AtGRP7"/>
            <entity id="DS3.d296.s0.e1" origId="45934207,750" charOffset="78-85" type="compound" text="glycine"/>
            <entity id="DS3.d296.s0.e2" origId="Q03250,F4IHK9" charOffset="170-176" type="protein" text="AtGRP7"/>
            <pair e1="DS3.d296.s0.e1" e2="DS3.d296.s0.e0" id="DS3.d296.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d297" origId="10023621">
        <sentence id="DS3.d297.s0" origId="10023621-4" text="A method was developed to purify recombinant human insulin-like growth factor I by reversed-phase high-performance liquid chromatography using gradient elution with hexylene glycol, a non-flammable replacement for acetonitrile.">
            <entity id="DS3.d297.s0.e0" origId="P05019,Q5U743,Q13429,Q59GC5" charOffset="51-79" type="protein" text="insulin-like growth factor I"/>
            <entity id="DS3.d297.s0.e1" origId="7870" charOffset="165-180" type="compound" text="hexylene glycol"/>
            <pair e1="DS3.d297.s0.e1" e2="DS3.d297.s0.e0" id="DS3.d297.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d298" origId="10023638">
        <sentence id="DS3.d298.s0" origId="10023638-7" text="Patients with a glucose disposal rate less than the mean rate were considered to have a high degree of insulin resistance (n = 36).">
            <entity id="DS3.d298.s0.e0" origId="206,5793,64689" charOffset="16-23" type="compound" text="glucose"/>
            <entity id="DS3.d298.s0.e1" origId="P01308,I3WAC9" charOffset="103-110" type="protein" text="insulin"/>
            <pair e1="DS3.d298.s0.e0" e2="DS3.d298.s0.e1" id="DS3.d298.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d299" origId="10023646">
        <sentence id="DS3.d299.s0" origId="10023646-9" text="Multiple regression analysis identified that black race and weight were positively associated, whereas dialysate/plasma creatinine ratio (D/P(Creat)) and age had a negative effect on serum albumin level.">
            <entity id="DS3.d299.s0.e0" origId="588" charOffset="120-130" type="compound" text="creatinine"/>
            <entity id="DS3.d299.s0.e1" origId="P02768" charOffset="189-196" type="protein" text="albumin"/>
            <pair e1="DS3.d299.s0.e0" e2="DS3.d299.s0.e1" id="DS3.d299.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d300" origId="10023647">
        <sentence id="DS3.d300.s0" origId="10023647-5" text="Clearances of phosphate and beta2-microglobulin were similar between TPD and IPD independent of dialysate flow or peritoneal transport type.">
            <entity id="DS3.d300.s0.e0" origId="1061,167704,644102" charOffset="14-23" type="compound" text="phosphate"/>
            <entity id="DS3.d300.s0.e1" origId="P61769,H0YL18" charOffset="28-47" type="protein" text="beta2-microglobulin"/>
            <pair e1="DS3.d300.s0.e0" e2="DS3.d300.s0.e1" id="DS3.d300.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d301" origId="10023649">
        <sentence id="DS3.d301.s0" origId="10023649-5" text="After adjustments for case Mix, comorbidities, and urea Kt/V, the relative risk of mortality for a 10% higher calculated total cleared volume of vitamin B12 was 0.953 (P &amp;lt; 0.0001 v 1.000).">
            <entity id="DS3.d301.s0.e0" origId="Q9H2W2,A0A024R3T7" charOffset="27-30" type="protein" text="Mix"/>
            <entity id="DS3.d301.s0.e1" origId="1176" charOffset="51-55" type="compound" text="urea"/>
            <entity id="DS3.d301.s0.e2" origId="O43676,A0A024R413" charOffset="153-156" type="protein" text="B12"/>
            <pair e1="DS3.d301.s0.e1" e2="DS3.d301.s0.e0" id="DS3.d301.s0.i0" interaction="False" />
            <pair e1="DS3.d301.s0.e1" e2="DS3.d301.s0.e2" id="DS3.d301.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d302" origId="10023655">
        <sentence id="DS3.d302.s0" origId="10023655-0" text="Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport.">
            <entity id="DS3.d302.s0.e0" origId="P29972,A0A024RA31" charOffset="14-25" type="protein" text="aquaporin-1"/>
            <entity id="DS3.d302.s0.e1" origId="962" charOffset="97-102" type="compound" text="water"/>
            <pair e1="DS3.d302.s0.e1" e2="DS3.d302.s0.e0" id="DS3.d302.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d302.s1" origId="10023655-1" text="aquaporin-1 (AQP1) has been claimed to be the molecular counterpart of the transcellular pathway for free-water movement across the peritoneum during peritoneal dialysis.">
            <entity id="DS3.d302.s1.e0" origId="P29972,A0A024RA31" charOffset="0-11" type="protein" text="aquaporin-1"/>
            <entity id="DS3.d302.s1.e1" origId="P29972,A0A024RA31" charOffset="13-17" type="protein" text="AQP1"/>
            <entity id="DS3.d302.s1.e2" origId="962" charOffset="106-111" type="compound" text="water"/>
            <pair e1="DS3.d302.s1.e2" e2="DS3.d302.s1.e0" id="DS3.d302.s1.i0" interaction="False" />
            <pair e1="DS3.d302.s1.e2" e2="DS3.d302.s1.e1" id="DS3.d302.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d302.s2" origId="10023655-2" text="We report the case of a 67-year-old man, on peritoneal dialysis for 11 years, in whom ultrafiltration failure due to an abolition of the transcellular water transfer (documented by a loss of sodium sieving) was associated with an apparently normal expression of AQP1.">
            <entity id="DS3.d302.s2.e0" origId="962" charOffset="151-156" type="compound" text="water"/>
            <entity id="DS3.d302.s2.e1" origId="5360545" charOffset="191-197" type="compound" text="sodium"/>
            <entity id="DS3.d302.s2.e2" origId="P29972,A0A024RA31" charOffset="262-266" type="protein" text="AQP1"/>
            <pair e1="DS3.d302.s2.e0" e2="DS3.d302.s2.e2" id="DS3.d302.s2.i0" interaction="False" />
            <pair e1="DS3.d302.s2.e1" e2="DS3.d302.s2.e2" id="DS3.d302.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d303" origId="10023661">
        <sentence id="DS3.d303.s0" origId="10023661-12" text="The reduced expression of TbetaRII, increased expression of COX-2, and the ability to form colonies in Matrigel were all reversible upon withdrawal of exogenous TGF-beta1 for the RIE-Tr cells.">
            <entity id="DS3.d303.s0.e0" origId="Q62312,Q543C0,Q8BQS9,Q3UG22" charOffset="26-34" type="protein" text="TbetaRII"/>
            <entity id="DS3.d303.s0.e1" origId="P04202,Q3UNK5" charOffset="161-170" type="protein" text="TGF-beta1"/>
            <entity id="DS3.d303.s0.e2" origId="11656602" charOffset="179-182" type="compound" text="RIE"/>
            <pair e1="DS3.d303.s0.e2" e2="DS3.d303.s0.e1" id="DS3.d303.s0.i0" interaction="False" />
            <pair e1="DS3.d303.s0.e2" e2="DS3.d303.s0.e0" id="DS3.d303.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d303.s1" origId="10023661-3" text="Growth of RIE-1 cells was inhibited by &amp;gt;75% following TGF-beta1 treatment for 7 days, after which the cells resumed a normal growth despite the presence of TGF-beta1.">
            <entity id="DS3.d303.s1.e0" origId="11656602" charOffset="10-13" type="compound" text="RIE"/>
            <entity id="DS3.d303.s1.e1" origId="P04202,Q3UNK5" charOffset="57-66" type="protein" text="TGF-beta1"/>
            <entity id="DS3.d303.s1.e2" origId="P04202,Q3UNK5" charOffset="159-168" type="protein" text="TGF-beta1"/>
            <pair e1="DS3.d303.s1.e0" e2="DS3.d303.s1.e1" id="DS3.d303.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d303.s2" origId="10023661-8" text="The transformed phenotype of RIE-Tr cells was associated with a 95% decrease in the level of the type II TGF-beta receptor (TbetaRII) protein, a 40-fold increase in cyclooxygenase-2 (COX-2) protein, and 5.9-fold increase in the production of prostacyclin.">
            <entity id="DS3.d303.s2.e0" origId="11656602" charOffset="29-32" type="compound" text="RIE"/>
            <entity id="DS3.d303.s2.e1" origId="Q62312,Q543C0,Q8BQS9,Q3UG22" charOffset="124-132" type="protein" text="TbetaRII"/>
            <entity id="DS3.d303.s2.e2" origId="Q05769" charOffset="165-181" type="protein" text="cyclooxygenase-2"/>
            <entity id="DS3.d303.s2.e3" origId="114805,5280427,5282411,6434194" charOffset="242-254" type="compound" text="prostacyclin"/>
            <pair e1="DS3.d303.s2.e3" e2="DS3.d303.s2.e2" id="DS3.d303.s2.i0" interaction="False" />
            <pair e1="DS3.d303.s2.e3" e2="DS3.d303.s2.e1" id="DS3.d303.s2.i1" interaction="False" />
            <pair e1="DS3.d303.s2.e0" e2="DS3.d303.s2.e2" id="DS3.d303.s2.i2" interaction="False" />
            <pair e1="DS3.d303.s2.e0" e2="DS3.d303.s2.e1" id="DS3.d303.s2.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d303.s3" origId="10023661-9" text="Most RIE-Tr subclones that expressed low levels of TbetaRII and high levels of COX-2 were tumorigenic.">
            <entity id="DS3.d303.s3.e0" origId="11656602" charOffset="5-8" type="compound" text="RIE"/>
            <entity id="DS3.d303.s3.e1" origId="Q62312,Q543C0,Q8BQS9,Q3UG22" charOffset="51-59" type="protein" text="TbetaRII"/>
            <pair e1="DS3.d303.s3.e0" e2="DS3.d303.s3.e1" id="DS3.d303.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d304" origId="10023663">
        <sentence id="DS3.d304.s0" origId="10023663-2" text="MEN2B is caused by a specific mutation (Met918--&amp;gt;Thr) in the RET receptor tyrosine kinase.">
            <entity id="DS3.d304.s0.e0" origId="P35546" charOffset="64-67" type="protein" text="RET"/>
            <entity id="DS3.d304.s0.e1" origId="6057,90983769" charOffset="77-85" type="compound" text="tyrosine"/>
            <pair e1="DS3.d304.s0.e1" e2="DS3.d304.s0.e0" id="DS3.d304.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d304.s1" origId="10023663-4" text="Transgenic mice were created using the dopamine beta-hydroxylase promoter to direct expression of RET(MEN2B) in the developing sympathetic and enteric nervous systems and the adrenal medulla.">
            <entity id="DS3.d304.s1.e0" origId="681" charOffset="39-47" type="compound" text="dopamine"/>
            <entity id="DS3.d304.s1.e1" origId="P35546" charOffset="98-107" type="protein" text="RET(MEN2B"/>
            <pair e1="DS3.d304.s1.e0" e2="DS3.d304.s1.e1" id="DS3.d304.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d305" origId="10023667">
        <sentence id="DS3.d305.s0" origId="10023667-1" text="Krox-24 (NGFI-A, Egr-1) is an immediate-early gene encoding a zinc finger transcription factor.">
            <entity id="DS3.d305.s0.e0" origId="P08046,Q544D6,Q8CAT6" charOffset="0-7" type="protein" text="Krox-24"/>
            <entity id="DS3.d305.s0.e1" origId="P08046,Q544D6,Q8CAT6" charOffset="9-15" type="protein" text="NGFI-A"/>
            <entity id="DS3.d305.s0.e2" origId="P08046,Q544D6,Q8CAT6" charOffset="17-22" type="protein" text="Egr-1"/>
            <entity id="DS3.d305.s0.e3" origId="23994" charOffset="62-66" type="compound" text="zinc"/>
            <pair e1="DS3.d305.s0.e3" e2="DS3.d305.s0.e0" id="DS3.d305.s0.i0" interaction="False" />
            <pair e1="DS3.d305.s0.e3" e2="DS3.d305.s0.e2" id="DS3.d305.s0.i1" interaction="False" />
            <pair e1="DS3.d305.s0.e3" e2="DS3.d305.s0.e1" id="DS3.d305.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d305.s1" origId="10023667-4" text="In vivo T3-dependent Krox-24 transcription was studied by polyethylenimine-based gene transfer.">
            <entity id="DS3.d305.s1.e0" origId="P08046,Q544D6,Q8CAT6" charOffset="21-28" type="protein" text="Krox-24"/>
            <entity id="DS3.d305.s1.e1" origId="9033" charOffset="58-74" type="compound" text="polyethylenimine"/>
            <pair e1="DS3.d305.s1.e1" e2="DS3.d305.s1.e0" id="DS3.d305.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d306" origId="10023669">
        <sentence id="DS3.d306.s0" origId="10023669-10" text="The proteasome inhibitor MG132 abrogated the HSV-1-induced PML and Sp100 degradation and partially restored their NB-localization.">
            <entity id="DS3.d306.s0.e0" origId="462382" charOffset="25-30" type="compound" text="MG132"/>
            <entity id="DS3.d306.s0.e1" origId="P29590" charOffset="59-62" type="protein" text="PML"/>
            <entity id="DS3.d306.s0.e2" origId="P23497,Q6ZMK3" charOffset="67-72" type="protein" text="Sp100"/>
            <pair e1="DS3.d306.s0.e0" e2="DS3.d306.s0.e1" id="DS3.d306.s0.i0" interaction="False" />
            <pair e1="DS3.d306.s0.e0" e2="DS3.d306.s0.e2" id="DS3.d306.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d306.s1" origId="10023669-1" text="The PML protein is associated to nuclear bodies (NBs) whose functions are as yet unknown.">
            <entity id="DS3.d306.s1.e0" origId="P29590" charOffset="4-7" type="protein" text="PML"/>
            <entity id="DS3.d306.s1.e1" origId="67184" charOffset="49-52" type="compound" text="NBs"/>
            <pair e1="DS3.d306.s1.e1" e2="DS3.d306.s1.e0" id="DS3.d306.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d306.s2" origId="10023669-2" text="PML and two other NBs-associated proteins, Sp100 And ISG20 are directly induced by interferons (IFN).">
            <entity id="DS3.d306.s2.e0" origId="P29590" charOffset="0-3" type="protein" text="PML"/>
            <entity id="DS3.d306.s2.e1" origId="67184" charOffset="18-21" type="compound" text="NBs"/>
            <entity id="DS3.d306.s2.e2" origId="P23497,Q6ZMK3" charOffset="43-48" type="protein" text="Sp100"/>
            <entity id="DS3.d306.s2.e3" origId="Q96AZ6" charOffset="53-58" type="protein" text="ISG20"/>
            <pair e1="DS3.d306.s2.e1" e2="DS3.d306.s2.e0" id="DS3.d306.s2.i0" interaction="False" />
            <pair e1="DS3.d306.s2.e1" e2="DS3.d306.s2.e3" id="DS3.d306.s2.i1" interaction="False" />
            <pair e1="DS3.d306.s2.e1" e2="DS3.d306.s2.e2" id="DS3.d306.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d306.s3" origId="10023669-4" text="PML NBs are disorganized in acute promyelocytic leukemia and during several DNA virus infections.">
            <entity id="DS3.d306.s3.e0" origId="P29590" charOffset="0-3" type="protein" text="PML"/>
            <entity id="DS3.d306.s3.e1" origId="67184" charOffset="4-7" type="compound" text="NBs"/>
            <pair e1="DS3.d306.s3.e1" e2="DS3.d306.s3.e0" id="DS3.d306.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d306.s4" origId="10023669-5" text="In particular, the HSV-1 ICP0 protein is known to delocalize PML from NBs.">
            <entity id="DS3.d306.s4.e0" origId="P29590" charOffset="61-64" type="protein" text="PML"/>
            <entity id="DS3.d306.s4.e1" origId="67184" charOffset="70-73" type="compound" text="NBs"/>
            <pair e1="DS3.d306.s4.e1" e2="DS3.d306.s4.e0" id="DS3.d306.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d307" origId="10023670">
        <sentence id="DS3.d307.s0" origId="10023670-3" text="Whereas two cell lines (L428 and KMH-2) expressed inactive IkappaBalpha, no significant changes in NF-kappaB or IkappaB expression were seen in other H-RS cells (L591, L1236 and HDLM-2).">
            <entity id="DS3.d307.s0.e0" origId="P25963" charOffset="59-71" type="protein" text="IkappaBalpha"/>
            <entity id="DS3.d307.s0.e1" origId="7021454" charOffset="152-154" type="compound" text="RS"/>
            <pair e1="DS3.d307.s0.e1" e2="DS3.d307.s0.e0" id="DS3.d307.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d308" origId="10023672">
        <sentence id="DS3.d308.s0" origId="10023672-2" text="In this report, the effects of TNF on EGF receptor tyrosine phosphorylation in ME-180 cell variants selected for apoptotic sensitivity (Sen) or resistance (Res) to TNF, previously shown to differentially express EGFr, were examined.">
            <entity id="DS3.d308.s0.e0" origId="P00533" charOffset="38-50" type="protein" text="EGF receptor"/>
            <entity id="DS3.d308.s0.e1" origId="6057,90983769" charOffset="51-59" type="compound" text="tyrosine"/>
            <entity id="DS3.d308.s0.e2" origId="P00533" charOffset="212-216" type="protein" text="EGFr"/>
            <pair e1="DS3.d308.s0.e1" e2="DS3.d308.s0.e0" id="DS3.d308.s0.i0" interaction="False" />
            <pair e1="DS3.d308.s0.e1" e2="DS3.d308.s0.e2" id="DS3.d308.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d308.s1" origId="10023672-3" text="Prior to the onset of apoptosis, TNF caused a significant reduction in the level of EGFr tyrosine phosphorylation in Sen cells but mediated only limited suppression of EGFr tyrosine phosphorylation in apoptotically resistant Res cells.">
            <entity id="DS3.d308.s1.e0" origId="P00533" charOffset="84-88" type="protein" text="EGFr"/>
            <entity id="DS3.d308.s1.e1" origId="6057,90983769" charOffset="89-97" type="compound" text="tyrosine"/>
            <entity id="DS3.d308.s1.e2" origId="P00533" charOffset="168-172" type="protein" text="EGFr"/>
            <entity id="DS3.d308.s1.e3" origId="6057,90983769" charOffset="173-181" type="compound" text="tyrosine"/>
            <pair e1="DS3.d308.s1.e1" e2="DS3.d308.s1.e0" id="DS3.d308.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d308.s2" origId="10023672-4" text="In vitro incubation of cellular membranes with TNF derived from Sen cells stimulated a resident protein tyrosine phosphatase (PTP) activity which was able to dephosphorylate EGFr or tyrosine phosphopeptides mimicking an EGFr autophosphorylation site.">
            <entity id="DS3.d308.s2.e0" origId="6057,90983769" charOffset="104-112" type="compound" text="tyrosine"/>
            <entity id="DS3.d308.s2.e1" origId="Q93096,A0A024R8J2" charOffset="126-129" type="protein" text="PTP"/>
            <entity id="DS3.d308.s2.e2" origId="P00533" charOffset="174-178" type="protein" text="EGFr"/>
            <entity id="DS3.d308.s2.e3" origId="6057,90983769" charOffset="182-190" type="compound" text="tyrosine"/>
            <entity id="DS3.d308.s2.e4" origId="P00533" charOffset="220-224" type="protein" text="EGFr"/>
            <pair e1="DS3.d308.s2.e0" e2="DS3.d308.s2.e2" id="DS3.d308.s2.i0" interaction="False" />
            <pair e1="DS3.d308.s2.e0" e2="DS3.d308.s2.e1" id="DS3.d308.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d308.s3" origId="10023672-5" text="In membrane preparations, PTPIB complexed with tyrosine phosphorylated EGFr and this association was disrupted by TNF through an apparent stimulation of PTP activity and turnover of phosphotyrosine.">
            <entity id="DS3.d308.s3.e0" origId="P18031,B4DSN5,A8K3M3" charOffset="26-31" type="protein" text="PTPIB"/>
            <entity id="DS3.d308.s3.e1" origId="6057,90983769" charOffset="47-55" type="compound" text="tyrosine"/>
            <entity id="DS3.d308.s3.e2" origId="P00533" charOffset="71-75" type="protein" text="EGFr"/>
            <entity id="DS3.d308.s3.e3" origId="Q93096,A0A024R8J2" charOffset="26-29" type="protein" text="PTP"/>
            <pair e1="DS3.d308.s3.e1" e2="DS3.d308.s3.e0" id="DS3.d308.s3.i0" interaction="False" />
            <pair e1="DS3.d308.s3.e1" e2="DS3.d308.s3.e2" id="DS3.d308.s3.i1" interaction="False" />
            <pair e1="DS3.d308.s3.e1" e2="DS3.d308.s3.e3" id="DS3.d308.s3.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d309" origId="10023675">
        <sentence id="DS3.d309.s0" origId="10023675-1" text="The LYL1 gene was first identified upon the molecular characterization of the t(7;9)(q35;p13) translocation associated with some human T-cell acute leukemias (T-ALLs).">
            <entity id="DS3.d309.s0.e0" origId="P12980" charOffset="4-8" type="protein" text="LYL1"/>
            <entity id="DS3.d309.s0.e1" origId="71464518" charOffset="161-165" type="compound" text="ALLs"/>
            <pair e1="DS3.d309.s0.e1" e2="DS3.d309.s0.e0" id="DS3.d309.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d309.s1" origId="10023675-3" text="LYL1 encodes a basic helix-loop-helix (bHLH) protein highly related to TAL-1, whose activation is also associated with a high proportion of human T-ALLs.">
            <entity id="DS3.d309.s1.e0" origId="P12980" charOffset="0-4" type="protein" text="LYL1"/>
            <entity id="DS3.d309.s1.e1" origId="P17542,Q16509" charOffset="71-76" type="protein" text="TAL-1"/>
            <entity id="DS3.d309.s1.e2" origId="71464518" charOffset="148-152" type="compound" text="ALLs"/>
            <pair e1="DS3.d309.s1.e2" e2="DS3.d309.s1.e1" id="DS3.d309.s1.i0" interaction="False" />
            <pair e1="DS3.d309.s1.e2" e2="DS3.d309.s1.e0" id="DS3.d309.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d310" origId="10023678">
        <sentence id="DS3.d310.s0" origId="10023678-0" text="Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.">
            <entity id="DS3.d310.s0.e0" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="0-13" type="protein" text="Interleukin-6"/>
            <entity id="DS3.d310.s0.e1" origId="53378893" charOffset="58-74" type="compound" text="kinase inhibitor"/>
            <entity id="DS3.d310.s0.e2" origId="P38936,A0A024RCX5" charOffset="83-87" type="protein" text="CIP1"/>
            <pair e1="DS3.d310.s0.e1" e2="DS3.d310.s0.e2" id="DS3.d310.s0.i0" interaction="False" />
            <pair e1="DS3.d310.s0.e1" e2="DS3.d310.s0.e0" id="DS3.d310.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d311" origId="10023680">
        <sentence id="DS3.d311.s0" origId="10023680-0" text="Involvement of poly (ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina.">
            <entity id="DS3.d311.s0.e0" origId="192,44415180,445794" charOffset="21-31" type="compound" text="ADP-ribose"/>
            <entity id="DS3.d311.s0.e1" origId="P26367,F1T0F8,Q66SS1,D1KF47" charOffset="51-56" type="protein" text="Pax-6"/>
            <pair e1="DS3.d311.s0.e0" e2="DS3.d311.s0.e1" id="DS3.d311.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d311.s1" origId="10023680-6" text="Based on the peptide sequence of the purified protein, we have identified the p110 as the poly(ADP-ribose) polymerase (PARP).">
            <entity id="DS3.d311.s1.e0" origId="Q13948,P39880,Q3LIA3" charOffset="78-82" type="protein" text="p110"/>
            <entity id="DS3.d311.s1.e1" origId="192,44415180,445794" charOffset="95-105" type="compound" text="ADP-ribose"/>
            <pair e1="DS3.d311.s1.e1" e2="DS3.d311.s1.e0" id="DS3.d311.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d312" origId="10023685">
        <sentence id="DS3.d312.s0" origId="10023685-0" text="Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.">
            <entity id="DS3.d312.s0.e0" origId="P38936,A0A024RCX5" charOffset="36-41" type="protein" text="cip-1"/>
            <entity id="DS3.d312.s0.e1" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="46-50" type="protein" text="Mdm2"/>
            <entity id="DS3.d312.s0.e2" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="54-63" type="compound" text="etoposide"/>
            <entity id="DS3.d312.s0.e3" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="65-74" type="compound" text="etoposide"/>
            <entity id="DS3.d312.s0.e4" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="88-91" type="protein" text="p53"/>
            <entity id="DS3.d312.s0.e5" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="92-96" type="protein" text="Mdm2"/>
            <pair e1="DS3.d312.s0.e2" e2="DS3.d312.s0.e1" id="DS3.d312.s0.i0" interaction="False" />
            <pair e1="DS3.d312.s0.e2" e2="DS3.d312.s0.e0" id="DS3.d312.s0.i1" interaction="False" />
            <pair e1="DS3.d312.s0.e2" e2="DS3.d312.s0.e4" id="DS3.d312.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d312.s1" origId="10023685-3" text="We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis.">
            <entity id="DS3.d312.s1.e0" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="43-52" type="compound" text="etoposide"/>
            <entity id="DS3.d312.s1.e1" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="94-98" type="protein" text="Mdm2"/>
            <pair e1="DS3.d312.s1.e0" e2="DS3.d312.s1.e1" id="DS3.d312.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d312.s2" origId="10023685-4" text="Cytotoxic concentrations of etoposide (IC90 for &amp;gt; 3 h) result in inhibition of Mdm2 induction at both the RNA and protein level.">
            <entity id="DS3.d312.s2.e0" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="28-37" type="compound" text="etoposide"/>
            <entity id="DS3.d312.s2.e1" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="82-86" type="protein" text="Mdm2"/>
            <pair e1="DS3.d312.s2.e0" e2="DS3.d312.s2.e1" id="DS3.d312.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d312.s3" origId="10023685-7" text="Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription.">
            <entity id="DS3.d312.s3.e0" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="14-18" type="protein" text="Mdm2"/>
            <entity id="DS3.d312.s3.e1" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="67-76" type="compound" text="etoposide"/>
            <pair e1="DS3.d312.s3.e1" e2="DS3.d312.s3.e0" id="DS3.d312.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d312.s4" origId="10023685-9" text="When cells are -treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated.">
            <entity id="DS3.d312.s4.e0" origId="11758093,17571827,3310,36462,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="46-55" type="compound" text="etoposide"/>
            <entity id="DS3.d312.s4.e1" origId="Q00987,G3XA89,A7UKX8,Q96DS0,A7UKX9,A0A0A8KB75,A7UKX7" charOffset="93-97" type="protein" text="Mdm2"/>
            <entity id="DS3.d312.s4.e2" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="169-172" type="protein" text="p53"/>
            <pair e1="DS3.d312.s4.e0" e2="DS3.d312.s4.e1" id="DS3.d312.s4.i0" interaction="False" />
            <pair e1="DS3.d312.s4.e0" e2="DS3.d312.s4.e2" id="DS3.d312.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d313" origId="10023688">
        <sentence id="DS3.d313.s0" origId="10023688-0" text="Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.">
            <entity id="DS3.d313.s0.e0" origId="444795" charOffset="0-13" type="compound" text="Retinoic acid"/>
            <entity id="DS3.d313.s0.e1" origId="Q05516,A0A024R3C6" charOffset="54-58" type="protein" text="PLZF"/>
            <entity id="DS3.d313.s0.e2" origId="P10276,A8MUP8,F1D8N9,Q6I9R7,A8K840" charOffset="59-67" type="protein" text="RARalpha"/>
            <pair e1="DS3.d313.s0.e0" e2="DS3.d313.s0.e1" id="DS3.d313.s0.i0" interaction="False" />
            <pair e1="DS3.d313.s0.e0" e2="DS3.d313.s0.e2" id="DS3.d313.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d313.s1" origId="10023688-1" text="Primary blasts of a t(11;17)(q23;q21) acute promyelocytic leukaemia (APL) patient were analysed with respect to retinoic acid (RA) and arsenic trioxide (As2O3) sensitivity as well as PLZF/RARalpha status.">
            <entity id="DS3.d313.s1.e0" origId="444795" charOffset="112-125" type="compound" text="retinoic acid"/>
            <entity id="DS3.d313.s1.e1" origId="518605" charOffset="153-158" type="compound" text="As2O3"/>
            <entity id="DS3.d313.s1.e2" origId="Q05516,A0A024R3C6" charOffset="183-187" type="protein" text="PLZF"/>
            <entity id="DS3.d313.s1.e3" origId="P10276,A8MUP8,F1D8N9,Q6I9R7,A8K840" charOffset="188-196" type="protein" text="RARalpha"/>
            <pair e1="DS3.d313.s1.e0" e2="DS3.d313.s1.e2" id="DS3.d313.s1.i0" interaction="False" />
            <pair e1="DS3.d313.s1.e0" e2="DS3.d313.s1.e3" id="DS3.d313.s1.i1" interaction="False" />
            <pair e1="DS3.d313.s1.e1" e2="DS3.d313.s1.e2" id="DS3.d313.s1.i2" interaction="False" />
            <pair e1="DS3.d313.s1.e1" e2="DS3.d313.s1.e3" id="DS3.d313.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d314" origId="10023690">
        <sentence id="DS3.d314.s0" origId="10023690-5" text="Up-regulation of Hox a7, Hox b7 and Hox c9 was observed when 32Dcl3 cells were cultured with granulocyte colony stimulating factor (G-CSF) in place of interleukin 3 and induction of MLL-LTG9 and MLL-Zf(-) was shown to suppress this upregulation.">
            <entity id="DS3.d314.s0.e0" origId="P31268" charOffset="17-23" type="protein" text="Hox a7"/>
            <entity id="DS3.d314.s0.e1" origId="P09629" charOffset="25-31" type="protein" text="Hox b7"/>
            <entity id="DS3.d314.s0.e2" origId="P31274,A0A024RAZ6,Q8N561" charOffset="36-42" type="protein" text="Hox c9"/>
            <entity id="DS3.d314.s0.e3" origId="16122568,16750043,4369303,448383" charOffset="134-137" type="compound" text="CSF"/>
            <entity id="DS3.d314.s0.e4" origId="P08700" charOffset="151-164" type="protein" text="interleukin 3"/>
            <entity id="DS3.d314.s0.e5" origId="Q03164" charOffset="182-185" type="protein" text="MLL"/>
            <entity id="DS3.d314.s0.e6" origId="Q03164" charOffset="195-198" type="protein" text="MLL"/>
            <pair e1="DS3.d314.s0.e3" e2="DS3.d314.s0.e4" id="DS3.d314.s0.i0" interaction="False" />
            <pair e1="DS3.d314.s0.e3" e2="DS3.d314.s0.e1" id="DS3.d314.s0.i1" interaction="False" />
            <pair e1="DS3.d314.s0.e3" e2="DS3.d314.s0.e0" id="DS3.d314.s0.i2" interaction="False" />
            <pair e1="DS3.d314.s0.e3" e2="DS3.d314.s0.e5" id="DS3.d314.s0.i3" interaction="False" />
            <pair e1="DS3.d314.s0.e3" e2="DS3.d314.s0.e2" id="DS3.d314.s0.i4" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d315" origId="10023694">
        <sentence id="DS3.d315.s0" origId="10023694-0" text="A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).">
            <entity id="DS3.d315.s0.e0" origId="3385" charOffset="22-34" type="compound" text="fluorouracil"/>
            <entity id="DS3.d315.s0.e1" origId="143,149436,27950349,54575,6006" charOffset="36-46" type="compound" text="leucovorin"/>
            <entity id="DS3.d315.s0.e2" origId="P01562,L0N195" charOffset="52-68" type="protein" text="interferon-alpha"/>
            <pair e1="DS3.d315.s0.e1" e2="DS3.d315.s0.e2" id="DS3.d315.s0.i0" interaction="False" />
            <pair e1="DS3.d315.s0.e0" e2="DS3.d315.s0.e2" id="DS3.d315.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d315.s1" origId="10023694-2" text="Although biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (LV) and interferon-alpha (IFN-alpha) has improved the outcomes of patients with metastatic colorectal carcinoma compared with 5-FU alone, this approach has not been extensively evaluated in the treatment of advanced gastric carcinoma.">
            <entity id="DS3.d315.s1.e0" origId="3385" charOffset="37-49" type="compound" text="fluorouracil"/>
            <entity id="DS3.d315.s1.e1" origId="143,149436,27950349,54575,6006" charOffset="60-70" type="compound" text="leucovorin"/>
            <entity id="DS3.d315.s1.e2" origId="P01562,L0N195" charOffset="80-96" type="protein" text="interferon-alpha"/>
            <entity id="DS3.d315.s1.e3" origId="P01562,L0N195" charOffset="98-107" type="protein" text="IFN-alpha"/>
            <pair e1="DS3.d315.s1.e1" e2="DS3.d315.s1.e2" id="DS3.d315.s1.i0" interaction="False" />
            <pair e1="DS3.d315.s1.e1" e2="DS3.d315.s1.e3" id="DS3.d315.s1.i1" interaction="False" />
            <pair e1="DS3.d315.s1.e0" e2="DS3.d315.s1.e2" id="DS3.d315.s1.i2" interaction="False" />
            <pair e1="DS3.d315.s1.e0" e2="DS3.d315.s1.e3" id="DS3.d315.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d316" origId="10023698">
        <sentence id="DS3.d316.s0" origId="10023698-3" text="METHODS: Fifteen adenomas and 68 adenocarcinomas were immunohistochemically and histopathologically investigated for the relation of Bcl-2 expression to p53 status, apoptosis (apoptotic index, AI), and proliferation activity (mitotic index, MI; Ki-67 labeling index, Ki-67 LI).">
            <entity id="DS3.d316.s0.e0" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="133-138" type="protein" text="Bcl-2"/>
            <entity id="DS3.d316.s0.e1" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="153-156" type="protein" text="p53"/>
            <entity id="DS3.d316.s0.e2" origId="15942654" charOffset="193-195" type="compound" text="AI"/>
            <pair e1="DS3.d316.s0.e2" e2="DS3.d316.s0.e0" id="DS3.d316.s0.i0" interaction="False" />
            <pair e1="DS3.d316.s0.e2" e2="DS3.d316.s0.e1" id="DS3.d316.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d316.s1" origId="10023698-6" text="On the other hand, p53 score, MI, Ki-67 LI, and AI increased in the same order.">
            <entity id="DS3.d316.s1.e0" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="19-22" type="protein" text="p53"/>
            <entity id="DS3.d316.s1.e1" origId="15942654" charOffset="48-50" type="compound" text="AI"/>
            <pair e1="DS3.d316.s1.e1" e2="DS3.d316.s1.e0" id="DS3.d316.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d316.s2" origId="10023698-7" text="The Bcl-2 negative adenocarcinomas displayed higher AI and AI-to-MI ratios than the Bcl-2 positive group, especially in the early stage, well-differentiated lesions.">
            <entity id="DS3.d316.s2.e0" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="4-9" type="protein" text="Bcl-2"/>
            <entity id="DS3.d316.s2.e1" origId="15942654" charOffset="52-54" type="compound" text="AI"/>
            <entity id="DS3.d316.s2.e2" origId="15942654" charOffset="59-61" type="compound" text="AI"/>
            <entity id="DS3.d316.s2.e3" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="84-89" type="protein" text="Bcl-2"/>
            <pair e1="DS3.d316.s2.e1" e2="DS3.d316.s2.e0" id="DS3.d316.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d317" origId="10023703">
        <sentence id="DS3.d317.s0" origId="10023703-2" text="This study tested the efficacy and toxicity of mitoxantrone, etoposide, and intermediate dose cytarabine (MEC) with cyclosporine (CSP) as an MDR modulator in patients with recurrent and refractory acute myeloid leukemia, and also correlated P-gp expression in leukemia cells with response.">
            <entity id="DS3.d317.s0.e0" origId="4212" charOffset="47-59" type="compound" text="mitoxantrone"/>
            <entity id="DS3.d317.s0.e1" origId="11758093,17571827,3310,439525,45356822,50989217,5284558,59360017,6419930,6610299,6708815,90657341,9916469" charOffset="61-70" type="compound" text="etoposide"/>
            <entity id="DS3.d317.s0.e2" origId="6253" charOffset="94-104" type="compound" text="cytarabine"/>
            <entity id="DS3.d317.s0.e3" origId="Q9NRJ3,D6RC73,A0N0Q3" charOffset="106-109" type="protein" text="MEC"/>
            <pair e1="DS3.d317.s0.e2" e2="DS3.d317.s0.e3" id="DS3.d317.s0.i0" interaction="False" />
            <pair e1="DS3.d317.s0.e1" e2="DS3.d317.s0.e3" id="DS3.d317.s0.i1" interaction="False" />
            <pair e1="DS3.d317.s0.e0" e2="DS3.d317.s0.e3" id="DS3.d317.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d318" origId="10023712">
        <sentence id="DS3.d318.s0" origId="10023712-1" text="BACKGROUND: Expression of 67 kD laminin binding protein, 67LR, is reported to be associated with invasive and metastatic phenotypes in several types of human malignancies.">
            <entity id="DS3.d318.s0.e0" origId="44342165" charOffset="32-39" type="compound" text="laminin"/>
            <entity id="DS3.d318.s0.e1" origId="P08865,A0A0C4DG17,A0A024R2P0" charOffset="57-61" type="protein" text="67LR"/>
            <pair e1="DS3.d318.s0.e0" e2="DS3.d318.s0.e1" id="DS3.d318.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d318.s1" origId="10023712-4" text="METHODS: Formalin fixed, paraffin embedded histologic sections were immunohistochemically evaluated for 67LR using monoclonal antibody MLuC5.">
            <entity id="DS3.d318.s1.e0" origId="712" charOffset="9-17" type="compound" text="Formalin"/>
            <entity id="DS3.d318.s1.e1" origId="P08865,A0A0C4DG17,A0A024R2P0" charOffset="104-108" type="protein" text="67LR"/>
            <pair e1="DS3.d318.s1.e0" e2="DS3.d318.s1.e1" id="DS3.d318.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d319" origId="10023715">
        <sentence id="DS3.d319.s0" origId="10023715-2" text="METHODS: A total of 151 endometrial carcinomas (endometrioid type), along with 90 hyperplasias (23 simple, 30 complex, and 37 atypical) and 143 normal endometria (28 atrophic, 44 proliferative, and 71 secretory), were immunohistochemically investigated for expression of DCC as well as for estrogen and progesterone receptors (ER and PR).">
            <entity id="DS3.d319.s0.e0" origId="P43146,Q49AK4" charOffset="271-274" type="protein" text="DCC"/>
            <entity id="DS3.d319.s0.e1" origId="5994" charOffset="303-315" type="compound" text="progesterone"/>
            <pair e1="DS3.d319.s0.e1" e2="DS3.d319.s0.e0" id="DS3.d319.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d320" origId="10023716">
        <sentence id="DS3.d320.s0" origId="10023716-2" text="METHODS: Serum levels of inhibin A, inhibin B, pro-alpha C, activin A, and activin B were quantitated with sensitive and specific two-site enzyme-linked immunosorbent assays (ELISAs) in samples collected from 44 postmenopausal women diagnosed with EOC.">
            <entity id="DS3.d320.s0.e0" origId="P05111" charOffset="25-34" type="protein" text="inhibin A"/>
            <entity id="DS3.d320.s0.e1" origId="229455" charOffset="60-67" type="compound" text="activin"/>
            <entity id="DS3.d320.s0.e2" origId="229455" charOffset="75-82" type="compound" text="activin"/>
            <pair e1="DS3.d320.s0.e1" e2="DS3.d320.s0.e0" id="DS3.d320.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d321" origId="10023720">
        <sentence id="DS3.d321.s0" origId="10023720-1" text="BACKGROUND: insulin receptor (IR), a member of the receptor tyrosine kinase family, is expressed in normal thyroid cells and affects thyroid cell proliferation and differentiation.">
            <entity id="DS3.d321.s0.e0" origId="P06213" charOffset="12-28" type="protein" text="insulin receptor"/>
            <entity id="DS3.d321.s0.e1" origId="6057,90983769" charOffset="60-68" type="compound" text="tyrosine"/>
            <pair e1="DS3.d321.s0.e1" e2="DS3.d321.s0.e0" id="DS3.d321.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d321.s1" origId="10023720-4" text="To assess IR function in thyroid carcinoma cells, glucose uptake responsiveness to insulin was also studied in a human transformed thyroid cell line (B-CPAP) and in follicular carcinoma cells in primary culture.">
            <entity id="DS3.d321.s1.e0" origId="206,5793,64689,79025" charOffset="50-57" type="compound" text="glucose"/>
            <entity id="DS3.d321.s1.e1" origId="P01308,I3WAC9" charOffset="83-90" type="protein" text="insulin"/>
            <entity id="DS3.d321.s1.e2" origId="Q9HC77,F6VUX8,A8K8P1" charOffset="152-156" type="protein" text="CPAP"/>
            <pair e1="DS3.d321.s1.e0" e2="DS3.d321.s1.e2" id="DS3.d321.s1.i0" interaction="False" />
            <pair e1="DS3.d321.s1.e0" e2="DS3.d321.s1.e1" id="DS3.d321.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d322" origId="10023754">
        <sentence id="DS3.d322.s0" origId="10023754-7" text="True amino acid digestibility and TMEn of the lectin-free and conventional soybeans were determined using the precision-fed cecectomized rooster assay.">
            <entity id="DS3.d322.s0.e0" origId="8037" charOffset="34-38" type="compound" text="TMEn"/>
            <entity id="DS3.d322.s0.e1" origId="Q9XG10" charOffset="46-52" type="protein" text="lectin"/>
            <pair e1="DS3.d322.s0.e0" e2="DS3.d322.s0.e1" id="DS3.d322.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d322.s1" origId="10023754-9" text="Likewise, the TMEn for lectin-free soybeans was 11% higher than that for raw conventional soybeans (3.577 vs 3.227 kcal/g DM) but the difference was not significant (P &amp;gt; 0.05).">
            <entity id="DS3.d322.s1.e0" origId="8037" charOffset="14-18" type="compound" text="TMEn"/>
            <entity id="DS3.d322.s1.e1" origId="Q9XG10" charOffset="23-29" type="protein" text="lectin"/>
            <pair e1="DS3.d322.s1.e0" e2="DS3.d322.s1.e1" id="DS3.d322.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d323" origId="10023757">
        <sentence id="DS3.d323.s0" origId="10023757-1" text="Cytosolic and nuclear fractions of the uterus (shell gland) of the hen's oviduct were found to contain a specific (17alpha-methyl-3H)-methyltrienolone ((3H)R1881; a synthetic androgen) binding component having properties of an androgen receptor; i.e., binding specificity, high affinity, and limited capacity.">
            <entity id="DS3.d323.s0.e0" origId="261000" charOffset="156-161" type="compound" text="R1881"/>
            <entity id="DS3.d323.s0.e1" origId="P10275,F1D8N5,A0A0B4J1T2" charOffset="227-244" type="protein" text="androgen receptor"/>
            <pair e1="DS3.d323.s0.e0" e2="DS3.d323.s0.e1" id="DS3.d323.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d324" origId="10023760">
        <sentence id="DS3.d324.s0" origId="10023760-13" text="Plasma testosterone levels were significantly higher in birds reared under blue light.">
            <entity id="DS3.d324.s0.e0" origId="6013" charOffset="7-19" type="compound" text="testosterone"/>
            <entity id="DS3.d324.s0.e1" origId="O43557" charOffset="80-85" type="protein" text="light"/>
            <pair e1="DS3.d324.s0.e0" e2="DS3.d324.s0.e1" id="DS3.d324.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d325" origId="10023768">
        <sentence id="DS3.d325.s0" origId="10023768-1" text="The two genetically established antimicrobial mechanisms of macrophages are production of reactive oxygen intermediates by phagocyte oxidase (phox) and reactive nitrogen intermediates by inducible nitric oxide synthase (NOS2).">
            <entity id="DS3.d325.s0.e0" origId="977" charOffset="99-105" type="compound" text="oxygen"/>
            <entity id="DS3.d325.s0.e1" origId="947" charOffset="161-169" type="compound" text="nitrogen"/>
            <entity id="DS3.d325.s0.e2" origId="145068" charOffset="197-209" type="compound" text="nitric oxide"/>
            <entity id="DS3.d325.s0.e3" origId="P29477" charOffset="220-224" type="protein" text="NOS2"/>
            <pair e1="DS3.d325.s0.e2" e2="DS3.d325.s0.e3" id="DS3.d325.s0.i0" interaction="False" />
            <pair e1="DS3.d325.s0.e1" e2="DS3.d325.s0.e3" id="DS3.d325.s0.i1" interaction="False" />
            <pair e1="DS3.d325.s0.e0" e2="DS3.d325.s0.e3" id="DS3.d325.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d326" origId="10023773">
        <sentence id="DS3.d326.s0" origId="10023773-1" text="In H2-M- mice, the presence of a single peptide, CLIP, bound to MHC class II molecules generates a diverse repertoire of CD4+ cells.">
            <entity id="DS3.d326.s0.e0" origId="783" charOffset="3-5" type="compound" text="H2"/>
            <entity id="DS3.d326.s0.e1" origId="P04441,Q545Y5,Q3U4Q8" charOffset="49-53" type="protein" text="CLIP"/>
            <pair e1="DS3.d326.s0.e0" e2="DS3.d326.s0.e1" id="DS3.d326.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d327" origId="10023774">
        <sentence id="DS3.d327.s0" origId="10023774-0" text="RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes.">
            <entity id="DS3.d327.s0.e0" origId="Q9Y2Y9,X5DNR2" charOffset="0-7" type="protein" text="RFLAT-1"/>
            <entity id="DS3.d327.s0.e1" origId="23994" charOffset="15-19" type="compound" text="zinc"/>
            <entity id="DS3.d327.s0.e2" origId="P13501,D0EI67" charOffset="63-69" type="protein" text="RANTES"/>
            <pair e1="DS3.d327.s0.e1" e2="DS3.d327.s0.e0" id="DS3.d327.s0.i0" interaction="False" />
            <pair e1="DS3.d327.s0.e1" e2="DS3.d327.s0.e2" id="DS3.d327.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d327.s1" origId="10023774-4" text="RFLAT-1 is a novel, phosphorylated, zinc finger transcription factor that is expressed in T cells 3 days after activation, coincident with RANTES expression.">
            <entity id="DS3.d327.s1.e0" origId="Q9Y2Y9,X5DNR2" charOffset="0-7" type="protein" text="RFLAT-1"/>
            <entity id="DS3.d327.s1.e1" origId="23994" charOffset="36-40" type="compound" text="zinc"/>
            <entity id="DS3.d327.s1.e2" origId="P13501,D0EI67" charOffset="139-145" type="protein" text="RANTES"/>
            <pair e1="DS3.d327.s1.e1" e2="DS3.d327.s1.e0" id="DS3.d327.s1.i0" interaction="False" />
            <pair e1="DS3.d327.s1.e1" e2="DS3.d327.s1.e2" id="DS3.d327.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d328" origId="10023789">
        <sentence id="DS3.d328.s0" origId="10023789-11" text="Mean (SD) %Sup of the nasal maneuver after application of xylometazoline increased to 53.3 (14.0)%.">
            <entity id="DS3.d328.s0.e0" origId="Q15011,Q53FP9,A4UAE9" charOffset="11-14" type="protein" text="Sup"/>
            <entity id="DS3.d328.s0.e1" origId="5709" charOffset="58-72" type="compound" text="xylometazoline"/>
            <pair e1="DS3.d328.s0.e1" e2="DS3.d328.s0.e0" id="DS3.d328.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d329" origId="10023791">
        <sentence id="DS3.d329.s0" origId="10023791-10" text="We recommend the use of high-dose salmeterol in hospitalized patients with FVC values of 40% of predicted or greater, starting with 2 and increasing to 4 puffs BID as tolerated.">
            <entity id="DS3.d329.s0.e0" origId="5152,6604001" charOffset="34-44" type="compound" text="salmeterol"/>
            <entity id="DS3.d329.s0.e1" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="160-163" type="protein" text="BID"/>
            <pair e1="DS3.d329.s0.e0" e2="DS3.d329.s0.e1" id="DS3.d329.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d329.s1" origId="10023791-2" text="To determine whether this fall could be prevented by the long-acting beta-2 agonist salmeterol at both standard (2 puffs: 42 mcg BID) and high (4 puffs, 84 mcg BID) doses, we evaluated the effects of salmeterol vs. albuterol (2 puffs, 180 mcg QID, and 4 puffs, 360 mcg BID) in a placebo-controlled three-way random crossover, double-blind trial.">
            <entity id="DS3.d329.s1.e0" origId="Q13562" charOffset="69-75" type="protein" text="beta-2"/>
            <entity id="DS3.d329.s1.e1" origId="5152,6604001" charOffset="84-94" type="compound" text="salmeterol"/>
            <entity id="DS3.d329.s1.e2" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="129-132" type="protein" text="BID"/>
            <entity id="DS3.d329.s1.e3" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="160-163" type="protein" text="BID"/>
            <entity id="DS3.d329.s1.e4" origId="5152,6604001" charOffset="200-210" type="compound" text="salmeterol"/>
            <entity id="DS3.d329.s1.e5" origId="2083" charOffset="215-224" type="compound" text="albuterol"/>
            <entity id="DS3.d329.s1.e6" origId="51035439" charOffset="243-246" type="compound" text="QID"/>
            <entity id="DS3.d329.s1.e7" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="160-163" type="protein" text="BID"/>
            <pair e1="DS3.d329.s1.e1" e2="DS3.d329.s1.e0" id="DS3.d329.s1.i0" interaction="False" />
            <pair e1="DS3.d329.s1.e1" e2="DS3.d329.s1.e2" id="DS3.d329.s1.i1" interaction="False" />
            <pair e1="DS3.d329.s1.e5" e2="DS3.d329.s1.e0" id="DS3.d329.s1.i2" interaction="False" />
            <pair e1="DS3.d329.s1.e5" e2="DS3.d329.s1.e2" id="DS3.d329.s1.i3" interaction="False" />
            <pair e1="DS3.d329.s1.e6" e2="DS3.d329.s1.e0" id="DS3.d329.s1.i4" interaction="False" />
            <pair e1="DS3.d329.s1.e6" e2="DS3.d329.s1.e2" id="DS3.d329.s1.i5" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d330" origId="10023808">
        <sentence id="DS3.d330.s0" origId="10023808-11" text="GluR6/7 subunit in the receptor of these cells may be responsible for the dopamine-mediated enhancement of glutamate responses that have been observed previously in these cells.">
            <entity id="DS3.d330.s0.e0" origId="Q14831,B2R693,B9EGG9,Q59G95" charOffset="0-7" type="protein" text="GluR6/7"/>
            <entity id="DS3.d330.s0.e1" origId="681" charOffset="74-82" type="compound" text="dopamine"/>
            <entity id="DS3.d330.s0.e2" origId="23327,33032,611,57109091" charOffset="107-116" type="compound" text="glutamate"/>
            <pair e1="DS3.d330.s0.e2" e2="DS3.d330.s0.e0" id="DS3.d330.s0.i0" interaction="False" />
            <pair e1="DS3.d330.s0.e1" e2="DS3.d330.s0.e0" id="DS3.d330.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d330.s1" origId="10023808-3" text="By using immunocytochemistry with light and electron microscopy, we localized several subunits (GluR2/3, GluR4, and GluR6/7) in cat retinal neurons, postsynaptic to photoreceptors.">
            <entity id="DS3.d330.s1.e0" origId="Q14416,Q86YG3,Q14832,A4D1D0" charOffset="96-103" type="protein" text="GluR2/3"/>
            <entity id="DS3.d330.s1.e1" origId="P48058,Q1WWK6" charOffset="105-110" type="protein" text="GluR4"/>
            <entity id="DS3.d330.s1.e2" origId="Q14831,B2R693,B9EGG9,Q59G95" charOffset="116-123" type="protein" text="GluR6/7"/>
            <entity id="DS3.d330.s1.e3" origId="638015" charOffset="132-139" type="compound" text="retinal"/>
            <pair e1="DS3.d330.s1.e3" e2="DS3.d330.s1.e1" id="DS3.d330.s1.i0" interaction="False" />
            <pair e1="DS3.d330.s1.e3" e2="DS3.d330.s1.e2" id="DS3.d330.s1.i1" interaction="False" />
            <pair e1="DS3.d330.s1.e3" e2="DS3.d330.s1.e0" id="DS3.d330.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d331" origId="10023809">
        <sentence id="DS3.d331.s0" origId="10023809-1" text="On the basis of cytochemical and morphologic differences, two classes of gamma-aminobutyric acidergic (GABAergic) interneurons expressing calcium-binding proteins have been identified in the striatum of adult animals: neurons expressing either parvalbumin (PV) or calretinin (CR).">
            <entity id="DS3.d331.s0.e0" origId="22044544,5460341" charOffset="138-145" type="compound" text="calcium"/>
            <entity id="DS3.d331.s0.e1" origId="P02625" charOffset="244-255" type="protein" text="parvalbumin"/>
            <entity id="DS3.d331.s0.e2" origId="P47728" charOffset="264-274" type="protein" text="calretinin"/>
            <pair e1="DS3.d331.s0.e0" e2="DS3.d331.s0.e1" id="DS3.d331.s0.i0" interaction="False" />
            <pair e1="DS3.d331.s0.e0" e2="DS3.d331.s0.e2" id="DS3.d331.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d331.s1" origId="10023809-3" text="By using immunocytochemical techniques, we analyzed the postnatal maturation and the spatiotemporal distribution of PV- and CR-positive neurons in the rat neostriatum compared with a third class of interneurons characterized by the expression of the acetylcholine-synthesizing enzyme, choline acetyltransferase (ChAT).">
            <entity id="DS3.d331.s1.e0" origId="187" charOffset="250-263" type="compound" text="acetylcholine"/>
            <entity id="DS3.d331.s1.e1" origId="A0A0G2JYQ6" charOffset="285-310" type="protein" text="choline acetyltransferase"/>
            <pair e1="DS3.d331.s1.e0" e2="DS3.d331.s1.e1" id="DS3.d331.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d332" origId="10023810">
        <sentence id="DS3.d332.s0" origId="10023810-10" text="The authors demonstrate phosphorylation of the cyclic amino-3-hydroxy-5-methyl-4-isoxazolepropionate response element binding protein, a transcription factor known to interact with proenkephalin regulatory sequences within the transgene, in the PVN following LPS administration.">
            <entity id="DS3.d332.s0.e0" origId="2735344" charOffset="54-100" type="compound" text="amino-3-hydroxy-5-methyl-4-isoxazolepropionate"/>
            <entity id="DS3.d332.s0.e1" origId="P01210,A0A024R7V4" charOffset="181-194" type="protein" text="proenkephalin"/>
            <entity id="DS3.d332.s0.e2" origId="Q9QUK6,L0CL36" charOffset="259-262" type="protein" text="LPS"/>
            <pair e1="DS3.d332.s0.e0" e2="DS3.d332.s0.e2" id="DS3.d332.s0.i0" interaction="False" />
            <pair e1="DS3.d332.s0.e0" e2="DS3.d332.s0.e1" id="DS3.d332.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d332.s1" origId="10023810-11" text="LPS induced up-regulation of the transgene was blocked by pretreatment with naltrexone, indicating an additional role for endogenous opioid systems in regulation of the PVN response to immune challenge.">
            <entity id="DS3.d332.s1.e0" origId="Q9QUK6,L0CL36" charOffset="0-3" type="protein" text="LPS"/>
            <entity id="DS3.d332.s1.e1" origId="5360515" charOffset="76-86" type="compound" text="naltrexone"/>
            <pair e1="DS3.d332.s1.e1" e2="DS3.d332.s1.e0" id="DS3.d332.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d333" origId="10023812">
        <sentence id="DS3.d333.s0" origId="10023812-1" text="The subcellular localization of ionotropic glutamate receptor (GluR) subunits was examined with light and electron microscopy in the rat olfactory bulb by using antibodies to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor subunits: GluR1, GluR2/3, and GluR4; and kainate (KA) receptor subunits: GluR5/6/7.">
            <entity id="DS3.d333.s0.e0" origId="23327,33032,611,57109091" charOffset="43-52" type="compound" text="glutamate"/>
            <entity id="DS3.d333.s0.e1" origId="1221" charOffset="181-231" type="compound" text="amino-3-hydroxy-5-methylisoxazole-4-propionic acid"/>
            <entity id="DS3.d333.s0.e2" origId="P19490" charOffset="258-263" type="protein" text="GluR1"/>
            <entity id="DS3.d333.s0.e3" origId="P19492,G3V6Z5,G3V8Y9" charOffset="265-272" type="protein" text="GluR2/3"/>
            <entity id="DS3.d333.s0.e4" origId="P19493,G3V6W1,A0A0G2JU28,Q566D4" charOffset="278-283" type="protein" text="GluR4"/>
            <entity id="DS3.d333.s0.e5" origId="10255" charOffset="289-296" type="compound" text="kainate"/>
            <pair e1="DS3.d333.s0.e5" e2="DS3.d333.s0.e4" id="DS3.d333.s0.i0" interaction="False" />
            <pair e1="DS3.d333.s0.e5" e2="DS3.d333.s0.e2" id="DS3.d333.s0.i1" interaction="False" />
            <pair e1="DS3.d333.s0.e5" e2="DS3.d333.s0.e3" id="DS3.d333.s0.i2" interaction="False" />
            <pair e1="DS3.d333.s0.e1" e2="DS3.d333.s0.e4" id="DS3.d333.s0.i3" interaction="False" />
            <pair e1="DS3.d333.s0.e1" e2="DS3.d333.s0.e2" id="DS3.d333.s0.i4" interaction="False" />
            <pair e1="DS3.d333.s0.e1" e2="DS3.d333.s0.e3" id="DS3.d333.s0.i5" interaction="False" />
            <pair e1="DS3.d333.s0.e0" e2="DS3.d333.s0.e4" id="DS3.d333.s0.i6" interaction="False" />
            <pair e1="DS3.d333.s0.e0" e2="DS3.d333.s0.e2" id="DS3.d333.s0.i7" interaction="False" />
            <pair e1="DS3.d333.s0.e0" e2="DS3.d333.s0.e3" id="DS3.d333.s0.i8" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d334" origId="10023815">
        <sentence id="DS3.d334.s0" origId="10023815-8" text="Expression of alpha-tectorin mRNA ceases after P15, whereas beta-tectorin mRNA expression continues within the striolar region of the utricle until at least P150.">
            <entity id="DS3.d334.s0.e0" origId="O08523" charOffset="14-28" type="protein" text="alpha-tectorin"/>
            <entity id="DS3.d334.s0.e1" origId="P55271,Q549R4" charOffset="47-50" type="protein" text="P15"/>
            <entity id="DS3.d334.s0.e2" origId="O08524,Q1HL20" charOffset="60-73" type="protein" text="beta-tectorin"/>
            <entity id="DS3.d334.s0.e3" origId="69330660" charOffset="157-161" type="compound" text="P150"/>
            <pair e1="DS3.d334.s0.e3" e2="DS3.d334.s0.e2" id="DS3.d334.s0.i0" interaction="False" />
            <pair e1="DS3.d334.s0.e3" e2="DS3.d334.s0.e0" id="DS3.d334.s0.i1" interaction="False" />
            <pair e1="DS3.d334.s0.e3" e2="DS3.d334.s0.e1" id="DS3.d334.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d335" origId="10023822">
        <sentence id="DS3.d335.s0" origId="10023822-7" text="To promote intermethod calibration in clinical enzymology, a collaborative programme between the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), Institute for Reference Materials and Measurements (IRMM, Geel, Belgium) and IFCC corporate members is in progress for the development of a MECRM containing amylase, ALT, AST, ALP, CK, GGT, LDH, and lipase and exhibiting a wide and defined commutability.">
            <entity id="DS3.d335.s0.e0" origId="Q9NRA2" charOffset="347-350" type="protein" text="AST"/>
            <entity id="DS3.d335.s0.e1" origId="Q9H0A0" charOffset="352-355" type="protein" text="ALP"/>
            <entity id="DS3.d335.s0.e2" origId="5474737" charOffset="375-381" type="compound" text="lipase"/>
            <pair e1="DS3.d335.s0.e2" e2="DS3.d335.s0.e1" id="DS3.d335.s0.i0" interaction="False" />
            <pair e1="DS3.d335.s0.e2" e2="DS3.d335.s0.e0" id="DS3.d335.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d336" origId="10023853">
        <sentence id="DS3.d336.s0" origId="10023853-0" text="Complement receptor type 1 gene regulation: retinoic acid and cytosine arabinoside increase CR1 expression.">
            <entity id="DS3.d336.s0.e0" origId="P17927,E9PDY4" charOffset="0-26" type="protein" text="Complement receptor type 1"/>
            <entity id="DS3.d336.s0.e1" origId="444795" charOffset="44-57" type="compound" text="retinoic acid"/>
            <entity id="DS3.d336.s0.e2" origId="597" charOffset="62-70" type="compound" text="cytosine"/>
            <entity id="DS3.d336.s0.e3" origId="10877291" charOffset="71-82" type="compound" text="arabinoside"/>
            <entity id="DS3.d336.s0.e4" origId="P17927,E9PDY4" charOffset="92-95" type="protein" text="CR1"/>
            <pair e1="DS3.d336.s0.e1" e2="DS3.d336.s0.e4" id="DS3.d336.s0.i0" interaction="False" />
            <pair e1="DS3.d336.s0.e1" e2="DS3.d336.s0.e0" id="DS3.d336.s0.i1" interaction="False" />
            <pair e1="DS3.d336.s0.e2" e2="DS3.d336.s0.e4" id="DS3.d336.s0.i2" interaction="False" />
            <pair e1="DS3.d336.s0.e2" e2="DS3.d336.s0.e0" id="DS3.d336.s0.i3" interaction="False" />
            <pair e1="DS3.d336.s0.e3" e2="DS3.d336.s0.e4" id="DS3.d336.s0.i4" interaction="False" />
            <pair e1="DS3.d336.s0.e3" e2="DS3.d336.s0.e0" id="DS3.d336.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d336.s1" origId="10023853-4" text="While most of the compounds tested had minimal effects on CR1 message level, retinoic acid induced increases in mRNA levels in nearly all cell lines studied.">
            <entity id="DS3.d336.s1.e0" origId="P17927,E9PDY4" charOffset="58-61" type="protein" text="CR1"/>
            <entity id="DS3.d336.s1.e1" origId="444795" charOffset="77-90" type="compound" text="retinoic acid"/>
            <pair e1="DS3.d336.s1.e1" e2="DS3.d336.s1.e0" id="DS3.d336.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d336.s2" origId="10023853-5" text="Furthermore, in K-562 cells, the cytosine analogue Ara-C, an inducer of erythroid differentiation, caused the highest increases in CR1 mRNA levels as compared to untreated cells.">
            <entity id="DS3.d336.s2.e0" origId="472612" charOffset="33-50" type="compound" text="cytosine analogue"/>
            <entity id="DS3.d336.s2.e1" origId="6253" charOffset="51-56" type="compound" text="Ara-C"/>
            <entity id="DS3.d336.s2.e2" origId="P17927,E9PDY4" charOffset="131-134" type="protein" text="CR1"/>
            <pair e1="DS3.d336.s2.e1" e2="DS3.d336.s2.e2" id="DS3.d336.s2.i0" interaction="False" />
            <pair e1="DS3.d336.s2.e0" e2="DS3.d336.s2.e2" id="DS3.d336.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d336.s3" origId="10023853-6" text="Ara-C also induced significant increases in CR1 message in PBCs.">
            <entity id="DS3.d336.s3.e0" origId="6253" charOffset="0-5" type="compound" text="Ara-C"/>
            <entity id="DS3.d336.s3.e1" origId="P17927,E9PDY4" charOffset="44-47" type="protein" text="CR1"/>
            <pair e1="DS3.d336.s3.e0" e2="DS3.d336.s3.e1" id="DS3.d336.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d337" origId="10023854">
        <sentence id="DS3.d337.s0" origId="10023854-0" text="Mechanism of regulation of complement receptor type 1 transcription by cytosine arabinoside in a pre-erythroid model.">
            <entity id="DS3.d337.s0.e0" origId="P17927,E9PDY4" charOffset="27-53" type="protein" text="complement receptor type 1"/>
            <entity id="DS3.d337.s0.e1" origId="597" charOffset="71-79" type="compound" text="cytosine"/>
            <entity id="DS3.d337.s0.e2" origId="10877291" charOffset="80-91" type="compound" text="arabinoside"/>
            <entity id="DS3.d337.s0.e3" origId="439574" charOffset="101-110" type="compound" text="erythroid"/>
            <pair e1="DS3.d337.s0.e1" e2="DS3.d337.s0.e0" id="DS3.d337.s0.i0" interaction="False" />
            <pair e1="DS3.d337.s0.e3" e2="DS3.d337.s0.e0" id="DS3.d337.s0.i1" interaction="False" />
            <pair e1="DS3.d337.s0.e2" e2="DS3.d337.s0.e0" id="DS3.d337.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d337.s1" origId="10023854-2" text="Previous work has demonstrated that Ara-C, a cytosine analogue, induces an 11-fold increase in CR1 mRNA expression in K-562 erythroleukaemia cells.">
            <entity id="DS3.d337.s1.e0" origId="6253" charOffset="36-41" type="compound" text="Ara-C"/>
            <entity id="DS3.d337.s1.e1" origId="472612" charOffset="45-62" type="compound" text="cytosine analogue"/>
            <entity id="DS3.d337.s1.e2" origId="P17927,E9PDY4" charOffset="95-98" type="protein" text="CR1"/>
            <pair e1="DS3.d337.s1.e1" e2="DS3.d337.s1.e2" id="DS3.d337.s1.i0" interaction="False" />
            <pair e1="DS3.d337.s1.e0" e2="DS3.d337.s1.e2" id="DS3.d337.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d337.s2" origId="10023854-3" text="In this work we therefore investigated whether the Ara-C/K-562 system could be used as a model for studying the pre-erythroid regulation of CR1.">
            <entity id="DS3.d337.s2.e0" origId="6253" charOffset="51-56" type="compound" text="Ara-C"/>
            <entity id="DS3.d337.s2.e1" origId="439574" charOffset="116-125" type="compound" text="erythroid"/>
            <entity id="DS3.d337.s2.e2" origId="P17927,E9PDY4" charOffset="140-143" type="protein" text="CR1"/>
            <pair e1="DS3.d337.s2.e1" e2="DS3.d337.s2.e2" id="DS3.d337.s2.i0" interaction="False" />
            <pair e1="DS3.d337.s2.e0" e2="DS3.d337.s2.e2" id="DS3.d337.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d337.s3" origId="10023854-5" text="Increases in CR1 mRNA levels produced by Ara-C treatment were not a function of increased stability of the message.">
            <entity id="DS3.d337.s3.e0" origId="P17927,E9PDY4" charOffset="13-16" type="protein" text="CR1"/>
            <entity id="DS3.d337.s3.e1" origId="6253" charOffset="41-46" type="compound" text="Ara-C"/>
            <pair e1="DS3.d337.s3.e1" e2="DS3.d337.s3.e0" id="DS3.d337.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d337.s4" origId="10023854-9" text="These data suggest that TK, PKC and dCTP-adducted phospholipid signalling pathways may all play a role in the mechanism of Ara-C-induced CR1 transcription.">
            <entity id="DS3.d337.s4.e0" origId="65091" charOffset="36-40" type="compound" text="dCTP"/>
            <entity id="DS3.d337.s4.e1" origId="6253" charOffset="123-128" type="compound" text="Ara-C"/>
            <entity id="DS3.d337.s4.e2" origId="P17927,E9PDY4" charOffset="137-140" type="protein" text="CR1"/>
            <pair e1="DS3.d337.s4.e1" e2="DS3.d337.s4.e2" id="DS3.d337.s4.i0" interaction="False" />
            <pair e1="DS3.d337.s4.e0" e2="DS3.d337.s4.e2" id="DS3.d337.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d338" origId="10023858">
        <sentence id="DS3.d338.s0" origId="10023858-0" text="Genetic analysis of the maternally induced affinity enhancement in the non-Ox1 idiotypic antibody repertoire of the primary immune response to 2-phenyloxazolone.">
            <entity id="DS3.d338.s0.e0" origId="Q64669,Q542Y0" charOffset="75-78" type="protein" text="Ox1"/>
            <entity id="DS3.d338.s0.e1" origId="65073" charOffset="143-160" type="compound" text="2-phenyloxazolone"/>
            <pair e1="DS3.d338.s0.e1" e2="DS3.d338.s0.e0" id="DS3.d338.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d339" origId="10023860">
        <sentence id="DS3.d339.s0" origId="10023860-3" text="GF and SPF rats were injected with recombinant human granulocyte-colony-stimulating factor (rhG-CSF), or were transferred to natural environment.">
            <entity id="DS3.d339.s0.e0" origId="P09919,Q6FH65,Q8N4W3" charOffset="35-90" type="protein" text="recombinant human granulocyte-colony-stimulating factor"/>
            <entity id="DS3.d339.s0.e1" origId="16122568,16750043,4369303,448383" charOffset="96-99" type="compound" text="CSF"/>
            <pair e1="DS3.d339.s0.e1" e2="DS3.d339.s0.e0" id="DS3.d339.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d339.s1" origId="10023860-4" text="It was found that total number, phagocytosis, intracellular killing, ratio of phagocytosis versus killing (killing efficiency) and nitric oxide production induced by recombinant rat interferon-gamma (rrIFN-gamma) were normalized upon injection of rhG-CSF.">
            <entity id="DS3.d339.s1.e0" origId="145068" charOffset="131-143" type="compound" text="nitric oxide"/>
            <entity id="DS3.d339.s1.e1" origId="P01581" charOffset="166-198" type="protein" text="recombinant rat interferon-gamma"/>
            <entity id="DS3.d339.s1.e2" origId="16122568,16750043,4369303,448383" charOffset="251-254" type="compound" text="CSF"/>
            <pair e1="DS3.d339.s1.e0" e2="DS3.d339.s1.e1" id="DS3.d339.s1.i0" interaction="False" />
            <pair e1="DS3.d339.s1.e2" e2="DS3.d339.s1.e1" id="DS3.d339.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d340" origId="10023897">
        <sentence id="DS3.d340.s0" origId="10023897-1" text="BACKGROUND: The regulation of extracellular calcium concentration by parathyroid hormone is mediated by a calcium-sensing, G-protein-coupled cell-surface receptor (CASR).">
            <entity id="DS3.d340.s0.e0" origId="22044544,5460341" charOffset="44-51" type="compound" text="calcium"/>
            <entity id="DS3.d340.s0.e1" origId="P41180" charOffset="106-162" type="protein" text="calcium-sensing, G-protein-coupled cell-surface receptor"/>
            <pair e1="DS3.d340.s0.e0" e2="DS3.d340.s0.e1" id="DS3.d340.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d340.s1" origId="10023897-4" text="METHODS: We genotyped the CASR A986S variant (S allele frequency of 16.3%) in 163 healthy adult women and tested samples of their serum for total calcium, albumin, total protein, creatinine, phosphate, pH, and parathyroid hormone.">
            <entity id="DS3.d340.s1.e0" origId="22044544,5460341" charOffset="146-153" type="compound" text="calcium"/>
            <entity id="DS3.d340.s1.e1" origId="P02768" charOffset="155-162" type="protein" text="albumin"/>
            <entity id="DS3.d340.s1.e2" origId="588" charOffset="179-189" type="compound" text="creatinine"/>
            <entity id="DS3.d340.s1.e3" origId="1061,167704,644102" charOffset="191-200" type="compound" text="phosphate"/>
            <pair e1="DS3.d340.s1.e0" e2="DS3.d340.s1.e1" id="DS3.d340.s1.i0" interaction="False" />
            <pair e1="DS3.d340.s1.e2" e2="DS3.d340.s1.e1" id="DS3.d340.s1.i1" interaction="False" />
            <pair e1="DS3.d340.s1.e3" e2="DS3.d340.s1.e1" id="DS3.d340.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d340.s2" origId="10023897-6" text="FINDINGS: The A986S genotype showed no association with total serum concentration of calcium, until corrected for albumin.">
            <entity id="DS3.d340.s2.e0" origId="22044544,5460341" charOffset="85-92" type="compound" text="calcium"/>
            <entity id="DS3.d340.s2.e1" origId="P02768" charOffset="114-121" type="protein" text="albumin"/>
            <pair e1="DS3.d340.s2.e0" e2="DS3.d340.s2.e1" id="DS3.d340.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d340.s3" origId="10023897-8" text="The significant predictors of serum calcium were: albumin (p&amp;lt;0.001), phosphate (p=0.02), parathyroid hormone (p=0.007), pH (p=0.001), and A986S genotype (p=0.009).">
            <entity id="DS3.d340.s3.e0" origId="22044544,5460341" charOffset="36-43" type="compound" text="calcium"/>
            <entity id="DS3.d340.s3.e1" origId="P02768" charOffset="50-57" type="protein" text="albumin"/>
            <entity id="DS3.d340.s3.e2" origId="1061,167704,644102" charOffset="72-81" type="compound" text="phosphate"/>
            <pair e1="DS3.d340.s3.e0" e2="DS3.d340.s3.e1" id="DS3.d340.s3.i0" interaction="False" />
            <pair e1="DS3.d340.s3.e2" e2="DS3.d340.s3.e1" id="DS3.d340.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d341" origId="10023979">
        <sentence id="DS3.d341.s0" origId="10023979-0" text="Inducible nitric oxide synthase (NOS2) gene polymorphism and parasitic diseases.">
            <entity id="DS3.d341.s0.e0" origId="145068" charOffset="10-22" type="compound" text="nitric oxide"/>
            <entity id="DS3.d341.s0.e1" origId="P35228" charOffset="33-37" type="protein" text="NOS2"/>
            <pair e1="DS3.d341.s0.e0" e2="DS3.d341.s0.e1" id="DS3.d341.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d342" origId="10024011">
        <sentence id="DS3.d342.s0" origId="10024011-2" text="Experiments were performed with either mepacrine (0.2 microM) or bovine serum albumin (BSA, 0.02%) which inhibits phospholipase A2 activity or binds endogenously released arachidonic acid, respectively.">
            <entity id="DS3.d342.s0.e0" origId="P02769" charOffset="65-85" type="protein" text="bovine serum albumin"/>
            <entity id="DS3.d342.s0.e1" origId="P00593" charOffset="114-130" type="protein" text="phospholipase A2"/>
            <entity id="DS3.d342.s0.e2" origId="444899" charOffset="171-187" type="compound" text="arachidonic acid"/>
            <pair e1="DS3.d342.s0.e2" e2="DS3.d342.s0.e0" id="DS3.d342.s0.i0" interaction="False" />
            <pair e1="DS3.d342.s0.e2" e2="DS3.d342.s0.e1" id="DS3.d342.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d343" origId="10024023">
        <sentence id="DS3.d343.s0" origId="10024023-4" text="We demonstrate the techniques on three proteins: citrate synthase, which has been the subject of earlier domain analyses, HIV-1 reverse transcriptase, which has a rather complex domain structure, and aspartate transcarbamylase as an example of a very large protein.">
            <entity id="DS3.d343.s0.e0" origId="O75390,A0A024RB75" charOffset="49-65" type="protein" text="citrate synthase"/>
            <entity id="DS3.d343.s0.e1" origId="5960" charOffset="200-209" type="compound" text="aspartate"/>
            <pair e1="DS3.d343.s0.e1" e2="DS3.d343.s0.e0" id="DS3.d343.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d344" origId="10024025">
        <sentence id="DS3.d344.s0" origId="10024025-3" text="In this method, the absolute binding free energy of a ligand is estimated as deltaGbind = alpha&amp;lt;Vel(bound) - Vel(free)&amp;gt; + beta&amp;lt;Vvdw(bound) - Vvdw(free)&amp;gt;, where Vel(bound) and Vvdw(bound) are the electrostatic and van der Waals interaction energies between the ligand and the solvated protein from an molecular dynamics (MD) trajectory with ligand bound to protein and Vel(free) and Vel(free) and Vvdw(free) are the electrostatic and van der Waals interaction energies between the ligand and the water from an MD trajectory with the ligand in water.">
            <entity id="DS3.d344.s0.e0" origId="B2RUZ4,M4WDD3" charOffset="99-102" type="protein" text="Vel"/>
            <entity id="DS3.d344.s0.e1" origId="B2RUZ4,M4WDD3" charOffset="112-115" type="protein" text="Vel"/>
            <entity id="DS3.d344.s0.e2" origId="B2RUZ4,M4WDD3" charOffset="112-115" type="protein" text="Vel"/>
            <entity id="DS3.d344.s0.e3" origId="B2RUZ4,M4WDD3" charOffset="112-115" type="protein" text="Vel"/>
            <entity id="DS3.d344.s0.e4" origId="B2RUZ4,M4WDD3" charOffset="112-115" type="protein" text="Vel"/>
            <entity id="DS3.d344.s0.e5" origId="962" charOffset="507-512" type="compound" text="water"/>
            <entity id="DS3.d344.s0.e6" origId="962" charOffset="554-559" type="compound" text="water"/>
            <pair e1="DS3.d344.s0.e5" e2="DS3.d344.s0.e0" id="DS3.d344.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d345" origId="10024026">
        <sentence id="DS3.d345.s0" origId="10024026-4" text="The substrate-binding channel identified in CYP4A11 was found to have a much more sterically restricted active site than that in CYP102 that could cause limited access of long-chain fatty acid to the ferryl oxygen leading to the preferred omega-hydroxylation.">
            <entity id="DS3.d345.s0.e0" origId="Q02928" charOffset="44-51" type="protein" text="CYP4A11"/>
            <entity id="DS3.d345.s0.e1" origId="977" charOffset="207-213" type="compound" text="oxygen"/>
            <pair e1="DS3.d345.s0.e1" e2="DS3.d345.s0.e0" id="DS3.d345.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d345.s1" origId="10024026-5" text="Results of docking of a common substrate, lauric acid, into the binding site of both CYP4A11 and CYP102 and molecular dynamics simulations provided additional support for this hypothesis.">
            <entity id="DS3.d345.s1.e0" origId="3893,90784609" charOffset="42-53" type="compound" text="lauric acid"/>
            <entity id="DS3.d345.s1.e1" origId="Q02928" charOffset="85-92" type="protein" text="CYP4A11"/>
            <pair e1="DS3.d345.s1.e0" e2="DS3.d345.s1.e1" id="DS3.d345.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d345.s2" origId="10024026-6" text="Specifically, in the CYP4A11-lauric acid simulations, the omega hydrogens were closest to the ferryl oxygen most of the time.">
            <entity id="DS3.d345.s2.e0" origId="Q02928" charOffset="21-28" type="protein" text="CYP4A11"/>
            <entity id="DS3.d345.s2.e1" origId="3893,90784609" charOffset="29-40" type="compound" text="lauric acid"/>
            <entity id="DS3.d345.s2.e2" origId="977" charOffset="101-107" type="compound" text="oxygen"/>
            <pair e1="DS3.d345.s2.e1" e2="DS3.d345.s2.e0" id="DS3.d345.s2.i0" interaction="False" />
            <pair e1="DS3.d345.s2.e2" e2="DS3.d345.s2.e0" id="DS3.d345.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d346" origId="10024074">
        <sentence id="DS3.d346.s0" origId="10024074-0" text="Increased dependence of glucose production on peripheral insulin in diabetic depancreatized dogs.">
            <entity id="DS3.d346.s0.e0" origId="206,5793,64689,79025" charOffset="24-31" type="compound" text="glucose"/>
            <entity id="DS3.d346.s0.e1" origId="P01308,I3WAC9" charOffset="57-64" type="protein" text="insulin"/>
            <pair e1="DS3.d346.s0.e0" e2="DS3.d346.s0.e1" id="DS3.d346.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d346.s1" origId="10024074-12" text="In conclusion, during glucose clamps in moderately hyperglycemic depancreatized dogs, (1) suppression of GP was dominated by insulin's peripheral effects not only at postprandial but also postabsorptive insulin levels, and (2) we found no evidence for a hepatic effect of insulin in suppressing GP.">
            <entity id="DS3.d346.s1.e0" origId="206,5793,64689,79025" charOffset="22-29" type="compound" text="glucose"/>
            <entity id="DS3.d346.s1.e1" origId="P01308,I3WAC9" charOffset="125-132" type="protein" text="insulin"/>
            <entity id="DS3.d346.s1.e2" origId="P01308,I3WAC9" charOffset="203-210" type="protein" text="insulin"/>
            <entity id="DS3.d346.s1.e3" origId="P01308,I3WAC9" charOffset="203-210" type="protein" text="insulin"/>
            <pair e1="DS3.d346.s1.e0" e2="DS3.d346.s1.e1" id="DS3.d346.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d346.s2" origId="10024074-1" text="We have recently found that in nondiabetic dogs and humans, suppression of glucose production (GP) is mediated by both peripheral and hepatic effects of insulin.">
            <entity id="DS3.d346.s2.e0" origId="206,5793,64689,79025" charOffset="75-82" type="compound" text="glucose"/>
            <entity id="DS3.d346.s2.e1" origId="P01308,I3WAC9" charOffset="153-160" type="protein" text="insulin"/>
            <pair e1="DS3.d346.s2.e0" e2="DS3.d346.s2.e1" id="DS3.d346.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d346.s3" origId="10024074-7" text="In paired experiments, additional low-dose equimolar insulin infusions (0.75 pmol/kg x min) were administered peripherally (PER, n = 6) or portally (POR, n = 6) during glucose clamps.">
            <entity id="DS3.d346.s3.e0" origId="P01308,I3WAC9" charOffset="53-60" type="protein" text="insulin"/>
            <entity id="DS3.d346.s3.e1" origId="206,5793,64689,79025" charOffset="168-175" type="compound" text="glucose"/>
            <pair e1="DS3.d346.s3.e1" e2="DS3.d346.s3.e0" id="DS3.d346.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d347" origId="10024076">
        <sentence id="DS3.d347.s0" origId="10024076-2" text="Patients underwent a gonadotropin-releasing hormone (GnRH) test, an oral glucose tolerance test (OGTT), and basal evaluation of hormonal and biochemical parameters.">
            <entity id="DS3.d347.s0.e0" origId="P01148" charOffset="21-57" type="protein" text="gonadotropin-releasing hormone (GnRH"/>
            <entity id="DS3.d347.s0.e1" origId="206,5793,64689,79025" charOffset="73-80" type="compound" text="glucose"/>
            <pair e1="DS3.d347.s0.e1" e2="DS3.d347.s0.e0" id="DS3.d347.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d347.s1" origId="10024076-3" text="Basal androgens and lipids, basal and stimulated gonadotropins, insulin, and glucose levels were measured.">
            <entity id="DS3.d347.s1.e0" origId="P01308,I3WAC9" charOffset="64-71" type="protein" text="insulin"/>
            <entity id="DS3.d347.s1.e1" origId="206,5793,64689,79025" charOffset="77-84" type="compound" text="glucose"/>
            <pair e1="DS3.d347.s1.e1" e2="DS3.d347.s1.e0" id="DS3.d347.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d347.s2" origId="10024076-6" text="A trend toward increased plasma testosterone and decreased sex hormone-binding globulin (SHBG) was found in relation to hyperinsulinemia and obesity, thus resulting in a higher free androgen index (FAI) in groups HL and NO versus NL (HL, 5.54 +/- 0.51; NO, 5.64 +/- 0.49; NL, 4.13 +/- 0.33; P &amp;lt; .05 and P &amp;lt; .01, respectively).">
            <entity id="DS3.d347.s2.e0" origId="6013" charOffset="32-44" type="compound" text="testosterone"/>
            <entity id="DS3.d347.s2.e1" origId="P04278,B0FWH2,I3L145,B4DYU0,B0FWH8" charOffset="59-87" type="protein" text="sex hormone-binding globulin"/>
            <entity id="DS3.d347.s2.e2" origId="P04278,B0FWH2,I3L145,B4DYU0,B0FWH8" charOffset="89-93" type="protein" text="SHBG"/>
            <pair e1="DS3.d347.s2.e0" e2="DS3.d347.s2.e2" id="DS3.d347.s2.i0" interaction="False" />
            <pair e1="DS3.d347.s2.e0" e2="DS3.d347.s2.e1" id="DS3.d347.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d347.s3" origId="10024076-9" text="Higher low-density lipoprotein cholesterol (LDL-C) and very-low-density lipoprotein cholesterol (VLDL-C) and lower high-density lipoprotein cholesterol (HDL-C) levels were found in the obese groups compared with the lean counterparts, whereas the same parameters did not significantly differ in a comparison between normoinsulinemic and hyperinsulinemic groups.">
            <entity id="DS3.d347.s3.e0" origId="Q14746,B1ALW7" charOffset="7-42" type="protein" text="low-density lipoprotein cholesterol"/>
            <entity id="DS3.d347.s3.e1" origId="Q14746,B1ALW7" charOffset="44-49" type="protein" text="LDL-C"/>
            <entity id="DS3.d347.s3.e2" origId="Q14746,B1ALW7" charOffset="60-95" type="protein" text="low-density lipoprotein cholesterol"/>
            <entity id="DS3.d347.s3.e3" origId="5997" charOffset="31-42" type="compound" text="cholesterol"/>
            <pair e1="DS3.d347.s3.e3" e2="DS3.d347.s3.e0" id="DS3.d347.s3.i0" interaction="False" />
            <pair e1="DS3.d347.s3.e3" e2="DS3.d347.s3.e1" id="DS3.d347.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d348" origId="10024078">
        <sentence id="DS3.d348.s0" origId="10024078-0" text="Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs.">
            <entity id="DS3.d348.s0.e0" origId="145068" charOffset="0-12" type="compound" text="Nitric oxide"/>
            <entity id="DS3.d348.s0.e1" origId="P33711" charOffset="31-45" type="protein" text="growth hormone"/>
            <entity id="DS3.d348.s0.e2" origId="21885907,5464109,6918297" charOffset="68-77" type="compound" text="Hexarelin"/>
            <pair e1="DS3.d348.s0.e2" e2="DS3.d348.s0.e1" id="DS3.d348.s0.i0" interaction="False" />
            <pair e1="DS3.d348.s0.e0" e2="DS3.d348.s0.e1" id="DS3.d348.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d348.s1" origId="10024078-12" text="In conclusion, (1) NO donors are capable to further increase the strong GH-releasing activity of Hexarelin in both young and old dogs, although the site(s) and mechanism(s) of action of NO is still obscure; (2) the different GH response to the peptide after NOS inhibition in young and old dogs signifies in the latter an alteration of the somatotrope function; and (3) prostaglandins are the downstream effectors of the chain of events triggered by activation of the NO-ergic system.">
            <entity id="DS3.d348.s1.e0" origId="21885907,5464109,6918297" charOffset="97-106" type="compound" text="Hexarelin"/>
            <entity id="DS3.d348.s1.e1" origId="F1PV06" charOffset="258-261" type="protein" text="NOS"/>
            <pair e1="DS3.d348.s1.e0" e2="DS3.d348.s1.e1" id="DS3.d348.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d348.s2" origId="10024078-1" text="The growth hormone (GH)-releasing activity of Hexarelin, a potent GH-releasing peptide (GHRP) analog, was evaluated in eight young (aged 1 to 6 years) and five old (10 to 16 years) beagle dogs pretreated with erythrityl tetranitrate, a liposoluble nitric oxide (NO) donor, and/or indomethacin, an inhibitor of cyclooxygenase enzymes, and N-nitro-L- or N-nitro-D-arginine methylester (L-NAME and D-NAME), active and inactive NO synthase (NOS) inhibitors, respectively.">
            <entity id="DS3.d348.s2.e0" origId="P33711" charOffset="4-18" type="protein" text="growth hormone"/>
            <entity id="DS3.d348.s2.e1" origId="21885907,5464109,6918297" charOffset="46-55" type="compound" text="Hexarelin"/>
            <entity id="DS3.d348.s2.e2" origId="5486806" charOffset="66-86" type="compound" text="GH-releasing peptide"/>
            <entity id="DS3.d348.s2.e3" origId="6852372" charOffset="88-92" type="compound" text="GHRP"/>
            <entity id="DS3.d348.s2.e4" origId="23723,5284553" charOffset="209-232" type="compound" text="erythrityl tetranitrate"/>
            <entity id="DS3.d348.s2.e5" origId="145068" charOffset="248-260" type="compound" text="nitric oxide"/>
            <entity id="DS3.d348.s2.e6" origId="3715" charOffset="280-292" type="compound" text="indomethacin"/>
            <entity id="DS3.d348.s2.e7" origId="44593755" charOffset="354-370" type="compound" text="nitro-D-arginine"/>
            <entity id="DS3.d348.s2.e8" origId="3864,164441" charOffset="395-401" type="compound" text="D-NAME"/>
            <entity id="DS3.d348.s2.e9" origId="F1PV06" charOffset="424-435" type="protein" text="NO synthase"/>
            <entity id="DS3.d348.s2.e10" origId="F1PV06" charOffset="437-440" type="protein" text="NOS"/>
            <pair e1="DS3.d348.s2.e4" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i0" interaction="False" />
            <pair e1="DS3.d348.s2.e4" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i1" interaction="False" />
            <pair e1="DS3.d348.s2.e4" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i2" interaction="False" />
            <pair e1="DS3.d348.s2.e1" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i3" interaction="False" />
            <pair e1="DS3.d348.s2.e1" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i4" interaction="False" />
            <pair e1="DS3.d348.s2.e1" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i5" interaction="False" />
            <pair e1="DS3.d348.s2.e2" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i6" interaction="False" />
            <pair e1="DS3.d348.s2.e2" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i7" interaction="False" />
            <pair e1="DS3.d348.s2.e2" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i8" interaction="False" />
            <pair e1="DS3.d348.s2.e7" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i9" interaction="False" />
            <pair e1="DS3.d348.s2.e7" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i10" interaction="False" />
            <pair e1="DS3.d348.s2.e7" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i11" interaction="False" />
            <pair e1="DS3.d348.s2.e5" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i12" interaction="False" />
            <pair e1="DS3.d348.s2.e5" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i13" interaction="False" />
            <pair e1="DS3.d348.s2.e5" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i14" interaction="False" />
            <pair e1="DS3.d348.s2.e3" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i15" interaction="False" />
            <pair e1="DS3.d348.s2.e3" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i16" interaction="False" />
            <pair e1="DS3.d348.s2.e3" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i17" interaction="False" />
            <pair e1="DS3.d348.s2.e6" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i18" interaction="False" />
            <pair e1="DS3.d348.s2.e6" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i19" interaction="False" />
            <pair e1="DS3.d348.s2.e6" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i20" interaction="False" />
            <pair e1="DS3.d348.s2.e8" e2="DS3.d348.s2.e9" id="DS3.d348.s2.i21" interaction="False" />
            <pair e1="DS3.d348.s2.e8" e2="DS3.d348.s2.e10" id="DS3.d348.s2.i22" interaction="False" />
            <pair e1="DS3.d348.s2.e8" e2="DS3.d348.s2.e0" id="DS3.d348.s2.i23" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d349" origId="10024079">
        <sentence id="DS3.d349.s0" origId="10024079-0" text="Predictors of adipose tissue lipoprotein lipase in middle-aged and older men: relationship to leptin and obesity, but not cardiovascular fitness.">
            <entity id="DS3.d349.s0.e0" origId="5474737" charOffset="41-47" type="compound" text="lipase"/>
            <entity id="DS3.d349.s0.e1" origId="P41159,A4D0Y8" charOffset="94-100" type="protein" text="leptin"/>
            <pair e1="DS3.d349.s0.e0" e2="DS3.d349.s0.e1" id="DS3.d349.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d349.s1" origId="10024079-4" text="There were no differences in fasting values for total cholesterol or low-density lipoprotein cholesterol (LDL-C) among the groups, but master athletes had lower triglyceride (TG) values (P &amp;lt; .05) and higher high-density lipoprotein cholesterol (HDL-C) and HDL2-C (P &amp;lt; .05) than obese and lean sedentary men.">
            <entity id="DS3.d349.s1.e0" origId="5997" charOffset="54-65" type="compound" text="cholesterol"/>
            <entity id="DS3.d349.s1.e1" origId="Q14746,B1ALW7" charOffset="69-104" type="protein" text="low-density lipoprotein cholesterol"/>
            <entity id="DS3.d349.s1.e2" origId="Q14746,B1ALW7" charOffset="106-111" type="protein" text="LDL-C"/>
            <entity id="DS3.d349.s1.e3" origId="5997" charOffset="93-104" type="compound" text="cholesterol"/>
            <pair e1="DS3.d349.s1.e0" e2="DS3.d349.s1.e1" id="DS3.d349.s1.i0" interaction="False" />
            <pair e1="DS3.d349.s1.e0" e2="DS3.d349.s1.e2" id="DS3.d349.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d349.s2" origId="10024079-7" text="Both ABD and GLT AT-LPL activity correlated positively with percent body fat (r = .46 to .54, P &amp;lt; .001), fasting insulin (r = .37 to .45, P &amp;lt; .001), and leptin (r = .61 to .65, P &amp;lt; .0001), but not with VO2max.">
            <entity id="DS3.d349.s2.e0" origId="33032" charOffset="13-16" type="compound" text="GLT"/>
            <entity id="DS3.d349.s2.e1" origId="P01308,I3WAC9" charOffset="116-123" type="protein" text="insulin"/>
            <entity id="DS3.d349.s2.e2" origId="P41159,A4D0Y8" charOffset="159-165" type="protein" text="leptin"/>
            <pair e1="DS3.d349.s2.e0" e2="DS3.d349.s2.e2" id="DS3.d349.s2.i0" interaction="False" />
            <pair e1="DS3.d349.s2.e0" e2="DS3.d349.s2.e1" id="DS3.d349.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d349.s3" origId="10024079-8" text="In stepwise multiple regression analysis, leptin was the main independent predictor of ABD (R2 = .43, P &amp;lt; .0001) and GLT (R2 = .40, P &amp;lt; .0001) AT-LPL activity.">
            <entity id="DS3.d349.s3.e0" origId="P41159,A4D0Y8" charOffset="42-48" type="protein" text="leptin"/>
            <entity id="DS3.d349.s3.e1" origId="33032" charOffset="120-123" type="compound" text="GLT"/>
            <pair e1="DS3.d349.s3.e1" e2="DS3.d349.s3.e0" id="DS3.d349.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d350" origId="10024085">
        <sentence id="DS3.d350.s0" origId="10024085-3" text="The body fat mass, eating behavior score, and plasma Leptin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), triiodothyronine (T3), free thyroxine (T4), insulin, and cortisol levels were evaluated for each subject.">
            <entity id="DS3.d350.s0.e0" origId="P41159,A4D0Y8" charOffset="53-59" type="protein" text="Leptin"/>
            <entity id="DS3.d350.s0.e1" origId="5920" charOffset="123-139" type="compound" text="triiodothyronine"/>
            <entity id="DS3.d350.s0.e2" origId="853" charOffset="151-160" type="compound" text="thyroxine"/>
            <entity id="DS3.d350.s0.e3" origId="P01308,I3WAC9" charOffset="167-174" type="protein" text="insulin"/>
            <entity id="DS3.d350.s0.e4" origId="5754" charOffset="180-188" type="compound" text="cortisol"/>
            <pair e1="DS3.d350.s0.e2" e2="DS3.d350.s0.e0" id="DS3.d350.s0.i0" interaction="False" />
            <pair e1="DS3.d350.s0.e2" e2="DS3.d350.s0.e3" id="DS3.d350.s0.i1" interaction="False" />
            <pair e1="DS3.d350.s0.e1" e2="DS3.d350.s0.e0" id="DS3.d350.s0.i2" interaction="False" />
            <pair e1="DS3.d350.s0.e1" e2="DS3.d350.s0.e3" id="DS3.d350.s0.i3" interaction="False" />
            <pair e1="DS3.d350.s0.e4" e2="DS3.d350.s0.e0" id="DS3.d350.s0.i4" interaction="False" />
            <pair e1="DS3.d350.s0.e4" e2="DS3.d350.s0.e3" id="DS3.d350.s0.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d350.s1" origId="10024085-4" text="In patients with eating disorder, logarithmic values for Leptin were significantly correlated with the body fat mass (r = .828, P &amp;lt; .001), eating behavior score (r = .777, P &amp;lt; .001), and LH (r = .465, P &amp;lt; .001), FSH (r = .440, P &amp;lt; .001), T3 (r = .572, P &amp;lt; .001), insulin (r = .410, P &amp;lt; .001), and cortisol (r = -.389, P &amp;lt; .001) levels.">
            <entity id="DS3.d350.s1.e0" origId="P41159,A4D0Y8" charOffset="57-63" type="protein" text="Leptin"/>
            <entity id="DS3.d350.s1.e1" origId="P01308,I3WAC9" charOffset="278-285" type="protein" text="insulin"/>
            <entity id="DS3.d350.s1.e2" origId="5754" charOffset="315-323" type="compound" text="cortisol"/>
            <pair e1="DS3.d350.s1.e2" e2="DS3.d350.s1.e0" id="DS3.d350.s1.i0" interaction="False" />
            <pair e1="DS3.d350.s1.e2" e2="DS3.d350.s1.e1" id="DS3.d350.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d350.s2" origId="10024085-5" text="After adjusting for fat mass, the partial correlations of log Leptin with LH, FSH, insulin, and cortisol were not statistically significant, but log Leptin remained correlated with T3 (r = .390, P &amp;lt; .01).">
            <entity id="DS3.d350.s2.e0" origId="P41159,A4D0Y8" charOffset="62-68" type="protein" text="Leptin"/>
            <entity id="DS3.d350.s2.e1" origId="P01308,I3WAC9" charOffset="83-90" type="protein" text="insulin"/>
            <entity id="DS3.d350.s2.e2" origId="5754" charOffset="96-104" type="compound" text="cortisol"/>
            <entity id="DS3.d350.s2.e3" origId="P41159,A4D0Y8" charOffset="149-155" type="protein" text="Leptin"/>
            <pair e1="DS3.d350.s2.e2" e2="DS3.d350.s2.e0" id="DS3.d350.s2.i0" interaction="False" />
            <pair e1="DS3.d350.s2.e2" e2="DS3.d350.s2.e1" id="DS3.d350.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d351" origId="10024088">
        <sentence id="DS3.d351.s0" origId="10024088-0" text="Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis.">
            <entity id="DS3.d351.s0.e0" origId="54454" charOffset="10-21" type="compound" text="simvastatin"/>
            <entity id="DS3.d351.s0.e1" origId="10133" charOffset="37-58" type="compound" text="chenodeoxycholic acid"/>
            <entity id="DS3.d351.s0.e2" origId="Q02318" charOffset="76-106" type="protein" text="cerebrotendinous xanthomatosis"/>
            <pair e1="DS3.d351.s0.e0" e2="DS3.d351.s0.e2" id="DS3.d351.s0.i0" interaction="False" />
            <pair e1="DS3.d351.s0.e1" e2="DS3.d351.s0.e2" id="DS3.d351.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d351.s1" origId="10024088-1" text="The effects of combination therapy with chenodeoxycholic acid (CDCA) and simvastatin on serum cholestanol, low-density lipoprotein (LDL) cholesterol, and lathosterol levels were investigated in seven adult patients with cerebrotendinous xanthomatosis (CTX) who were on long-term treatment with CDCA.">
            <entity id="DS3.d351.s1.e0" origId="10133" charOffset="40-61" type="compound" text="chenodeoxycholic acid"/>
            <entity id="DS3.d351.s1.e1" origId="54454" charOffset="73-84" type="compound" text="simvastatin"/>
            <entity id="DS3.d351.s1.e2" origId="10992748,3240,6432729,6665,25201792" charOffset="94-105" type="compound" text="cholestanol"/>
            <entity id="DS3.d351.s1.e3" origId="5997" charOffset="137-148" type="compound" text="cholesterol"/>
            <entity id="DS3.d351.s1.e4" origId="65728" charOffset="154-165" type="compound" text="lathosterol"/>
            <entity id="DS3.d351.s1.e5" origId="Q02318" charOffset="220-250" type="protein" text="cerebrotendinous xanthomatosis"/>
            <entity id="DS3.d351.s1.e6" origId="Q02318" charOffset="252-255" type="protein" text="CTX"/>
            <pair e1="DS3.d351.s1.e0" e2="DS3.d351.s1.e6" id="DS3.d351.s1.i0" interaction="False" />
            <pair e1="DS3.d351.s1.e0" e2="DS3.d351.s1.e5" id="DS3.d351.s1.i1" interaction="False" />
            <pair e1="DS3.d351.s1.e3" e2="DS3.d351.s1.e6" id="DS3.d351.s1.i2" interaction="False" />
            <pair e1="DS3.d351.s1.e3" e2="DS3.d351.s1.e5" id="DS3.d351.s1.i3" interaction="False" />
            <pair e1="DS3.d351.s1.e4" e2="DS3.d351.s1.e6" id="DS3.d351.s1.i4" interaction="False" />
            <pair e1="DS3.d351.s1.e4" e2="DS3.d351.s1.e5" id="DS3.d351.s1.i5" interaction="False" />
            <pair e1="DS3.d351.s1.e1" e2="DS3.d351.s1.e6" id="DS3.d351.s1.i6" interaction="False" />
            <pair e1="DS3.d351.s1.e1" e2="DS3.d351.s1.e5" id="DS3.d351.s1.i7" interaction="False" />
            <pair e1="DS3.d351.s1.e2" e2="DS3.d351.s1.e6" id="DS3.d351.s1.i8" interaction="False" />
            <pair e1="DS3.d351.s1.e2" e2="DS3.d351.s1.e5" id="DS3.d351.s1.i9" interaction="False" />
        </sentence>
        <sentence id="DS3.d351.s2" origId="10024088-6" text="We conclude that a combination of 750 mg CDCA and 40 mg simvastatin daily is effective to further reduce serum cholestanol, LDL cholesterol, and lathosterol in adult CTX patients treated with long-term CDCA.">
            <entity id="DS3.d351.s2.e0" origId="54454" charOffset="56-67" type="compound" text="simvastatin"/>
            <entity id="DS3.d351.s2.e1" origId="10992748,3240,6432729,6665,25201792" charOffset="111-122" type="compound" text="cholestanol"/>
            <entity id="DS3.d351.s2.e2" origId="5997" charOffset="128-139" type="compound" text="cholesterol"/>
            <entity id="DS3.d351.s2.e3" origId="65728" charOffset="145-156" type="compound" text="lathosterol"/>
            <entity id="DS3.d351.s2.e4" origId="Q02318" charOffset="166-169" type="protein" text="CTX"/>
            <pair e1="DS3.d351.s2.e0" e2="DS3.d351.s2.e4" id="DS3.d351.s2.i0" interaction="False" />
            <pair e1="DS3.d351.s2.e2" e2="DS3.d351.s2.e4" id="DS3.d351.s2.i1" interaction="False" />
            <pair e1="DS3.d351.s2.e3" e2="DS3.d351.s2.e4" id="DS3.d351.s2.i2" interaction="False" />
            <pair e1="DS3.d351.s2.e1" e2="DS3.d351.s2.e4" id="DS3.d351.s2.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d352" origId="10024089">
        <sentence id="DS3.d352.s0" origId="10024089-0" text="Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers.">
            <entity id="DS3.d352.s0.e0" origId="P01308,I3WAC9" charOffset="35-42" type="protein" text="insulin"/>
            <entity id="DS3.d352.s0.e1" origId="206,5793,64689" charOffset="58-65" type="compound" text="glucose"/>
            <pair e1="DS3.d352.s0.e1" e2="DS3.d352.s0.e0" id="DS3.d352.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d352.s1" origId="10024089-10" text="Whole-body and skeletal muscle glucose uptake were similar in both groups during insulin infusion.">
            <entity id="DS3.d352.s1.e0" origId="206,5793,64689" charOffset="31-38" type="compound" text="glucose"/>
            <entity id="DS3.d352.s1.e1" origId="P01308,I3WAC9" charOffset="81-88" type="protein" text="insulin"/>
            <pair e1="DS3.d352.s1.e0" e2="DS3.d352.s1.e1" id="DS3.d352.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d352.s2" origId="10024089-12" text="The insulin-induced increase in muscle blood flow and insulin-stimulated glucose uptake appear normal, suggesting that the vasodilatory and metabolic effects of insulin are intact in smokers and the reduced muscle blood flow per se does not cause insulin resistance in these subjects.">
            <entity id="DS3.d352.s2.e0" origId="P01308,I3WAC9" charOffset="4-11" type="protein" text="insulin"/>
            <entity id="DS3.d352.s2.e1" origId="P01308,I3WAC9" charOffset="54-61" type="protein" text="insulin"/>
            <entity id="DS3.d352.s2.e2" origId="206,5793,64689" charOffset="73-80" type="compound" text="glucose"/>
            <entity id="DS3.d352.s2.e3" origId="P01308,I3WAC9" charOffset="54-61" type="protein" text="insulin"/>
            <entity id="DS3.d352.s2.e4" origId="P01308,I3WAC9" charOffset="54-61" type="protein" text="insulin"/>
            <pair e1="DS3.d352.s2.e2" e2="DS3.d352.s2.e0" id="DS3.d352.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d352.s3" origId="10024089-3" text="Since insulin-induced vasodilation is dependent on endothelial cell nitric oxide (NO) synthesis, we tested the hypothesis that decreased skeletal muscle blood flow causes insulin resistance in smokers.">
            <entity id="DS3.d352.s3.e0" origId="P01308,I3WAC9" charOffset="6-13" type="protein" text="insulin"/>
            <entity id="DS3.d352.s3.e1" origId="145068" charOffset="68-80" type="compound" text="nitric oxide"/>
            <entity id="DS3.d352.s3.e2" origId="P01308,I3WAC9" charOffset="171-178" type="protein" text="insulin"/>
            <pair e1="DS3.d352.s3.e1" e2="DS3.d352.s3.e0" id="DS3.d352.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d352.s4" origId="10024089-6" text="Basal and insulin-stimulated femoral muscle blood flow was measured using ((15)O)H2O and insulin-stimulated muscle glucose uptake using (18F)fluoro-2-deoxy-D-glucose ((18F)FDG) and positron emission tomography (PET).">
            <entity id="DS3.d352.s4.e0" origId="P01308,I3WAC9" charOffset="10-17" type="protein" text="insulin"/>
            <entity id="DS3.d352.s4.e1" origId="P01308,I3WAC9" charOffset="89-96" type="protein" text="insulin"/>
            <entity id="DS3.d352.s4.e2" origId="206,5793,64689" charOffset="115-122" type="compound" text="glucose"/>
            <entity id="DS3.d352.s4.e3" origId="53716604" charOffset="141-165" type="compound" text="fluoro-2-deoxy-D-glucose"/>
            <entity id="DS3.d352.s4.e4" origId="315411,445226,68196650" charOffset="172-175" type="compound" text="FDG"/>
            <pair e1="DS3.d352.s4.e3" e2="DS3.d352.s4.e0" id="DS3.d352.s4.i0" interaction="False" />
            <pair e1="DS3.d352.s4.e4" e2="DS3.d352.s4.e0" id="DS3.d352.s4.i1" interaction="False" />
            <pair e1="DS3.d352.s4.e2" e2="DS3.d352.s4.e0" id="DS3.d352.s4.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d352.s5" origId="10024089-7" text="Whole-body glucose uptake was measured using the hyperinsulinemic (insulin infusion 5 mU/kg x min)-euglycemic clamp technique.">
            <entity id="DS3.d352.s5.e0" origId="206,5793,64689" charOffset="11-18" type="compound" text="glucose"/>
            <entity id="DS3.d352.s5.e1" origId="P01308,I3WAC9" charOffset="67-97" type="protein" text="insulin infusion 5 mU/kg x min"/>
            <pair e1="DS3.d352.s5.e0" e2="DS3.d352.s5.e1" id="DS3.d352.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d353" origId="10024090">
        <sentence id="DS3.d353.s0" origId="10024090-10" text="The insulin response to the meal was lower in placebo compared with control and acipimox (P &amp;lt; .05).">
            <entity id="DS3.d353.s0.e0" origId="P01308,I3WAC9" charOffset="4-11" type="protein" text="insulin"/>
            <entity id="DS3.d353.s0.e1" origId="5310993" charOffset="80-88" type="compound" text="acipimox"/>
            <pair e1="DS3.d353.s0.e1" e2="DS3.d353.s0.e0" id="DS3.d353.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d354" origId="10024091">
        <sentence id="DS3.d354.s0" origId="10024091-4" text="Recently, it was reported that GLP-1 became resistant to DPPIV when the alanine residue at position 8 was replaced by a glycine (GLP-1-Gly8).">
            <entity id="DS3.d354.s0.e0" origId="P55095" charOffset="31-36" type="protein" text="GLP-1"/>
            <entity id="DS3.d354.s0.e1" origId="P27487" charOffset="57-62" type="protein" text="DPPIV"/>
            <entity id="DS3.d354.s0.e2" origId="5950" charOffset="72-79" type="compound" text="alanine"/>
            <entity id="DS3.d354.s0.e3" origId="45934207,750" charOffset="120-127" type="compound" text="glycine"/>
            <entity id="DS3.d354.s0.e4" origId="P55095" charOffset="129-134" type="protein" text="GLP-1"/>
            <pair e1="DS3.d354.s0.e2" e2="DS3.d354.s0.e0" id="DS3.d354.s0.i0" interaction="False" />
            <pair e1="DS3.d354.s0.e2" e2="DS3.d354.s0.e1" id="DS3.d354.s0.i1" interaction="False" />
            <pair e1="DS3.d354.s0.e3" e2="DS3.d354.s0.e0" id="DS3.d354.s0.i2" interaction="False" />
            <pair e1="DS3.d354.s0.e3" e2="DS3.d354.s0.e1" id="DS3.d354.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d354.s1" origId="10024091-5" text="We report here that this change slightly decreased the affinity of the peptide for its receptor (IC50, 0.41 +/- 0.14 and 1.39 +/- 0.61 nmol/L for GLP-1 and GLP-1-Gly8, respectively) but did not change the efficiency to stimulate accumulation of intracellular cyclic adenosine monophosphate (cAMP) (EC50, 0.25 +/- 0.05 and 0.36 +/- 0.06 nmol/L for GLP-1 and GLP-1-Gly8, respectively).">
            <entity id="DS3.d354.s1.e0" origId="P55095" charOffset="146-151" type="protein" text="GLP-1"/>
            <entity id="DS3.d354.s1.e1" origId="P55095" charOffset="156-161" type="protein" text="GLP-1"/>
            <entity id="DS3.d354.s1.e2" origId="6076" charOffset="259-289" type="compound" text="cyclic adenosine monophosphate"/>
            <entity id="DS3.d354.s1.e3" origId="P55095" charOffset="156-161" type="protein" text="GLP-1"/>
            <entity id="DS3.d354.s1.e4" origId="P55095" charOffset="156-161" type="protein" text="GLP-1"/>
            <pair e1="DS3.d354.s1.e2" e2="DS3.d354.s1.e0" id="DS3.d354.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d354.s2" origId="10024091-7" text="A single injection of 0.1 nmol GLP-1-Gly8 in diabetic mice fed a high-fat diet can correct fasting hyperglycemia and glucose intolerance for several hours, whereas the activity of 1 nmol GLP-1 vanishes a few minutes after injection.">
            <entity id="DS3.d354.s2.e0" origId="P55095" charOffset="31-36" type="protein" text="GLP-1"/>
            <entity id="DS3.d354.s2.e1" origId="206,5793,64689,79025" charOffset="117-124" type="compound" text="glucose"/>
            <entity id="DS3.d354.s2.e2" origId="P55095" charOffset="187-192" type="protein" text="GLP-1"/>
            <pair e1="DS3.d354.s2.e1" e2="DS3.d354.s2.e0" id="DS3.d354.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d355" origId="10024092">
        <sentence id="DS3.d355.s0" origId="10024092-2" text="Following a 90-minute saline infusion period, epinephrine ((EPI) 180 ng/kg x min) and norepinephrine ((NE) 500 ng/kg x min) were infused peripherally for 90 minutes into five 18-hour fasted, conscious dogs undergoing a pancreatic clamp (somatostatin plus basal insulin and glucagon).">
            <entity id="DS3.d355.s0.e0" origId="5816" charOffset="46-57" type="compound" text="epinephrine"/>
            <entity id="DS3.d355.s0.e1" origId="P01321" charOffset="261-268" type="protein" text="insulin"/>
            <entity id="DS3.d355.s0.e2" origId="P29794" charOffset="273-281" type="protein" text="glucagon"/>
            <pair e1="DS3.d355.s0.e0" e2="DS3.d355.s0.e2" id="DS3.d355.s0.i0" interaction="False" />
            <pair e1="DS3.d355.s0.e0" e2="DS3.d355.s0.e1" id="DS3.d355.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d356" origId="10024094">
        <sentence id="DS3.d356.s0" origId="10024094-0" text="Folate status, homocysteine metabolism, and methylene tetrahydrofolate reductase genotype in rural South African blacks with a history of pregnancy complicated by neural tube defects.">
            <entity id="DS3.d356.s0.e0" origId="6037" charOffset="0-6" type="compound" text="Folate"/>
            <entity id="DS3.d356.s0.e1" origId="91552" charOffset="15-27" type="compound" text="homocysteine"/>
            <entity id="DS3.d356.s0.e2" origId="P42898,Q8IU67,Q59GJ6" charOffset="44-80" type="protein" text="methylene tetrahydrofolate reductase"/>
            <pair e1="DS3.d356.s0.e1" e2="DS3.d356.s0.e2" id="DS3.d356.s0.i0" interaction="False" />
            <pair e1="DS3.d356.s0.e0" e2="DS3.d356.s0.e2" id="DS3.d356.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d357" origId="10024095">
        <sentence id="DS3.d357.s0" origId="10024095-5" text="A set of independent variables was also evaluated, including age, gender, APACHE III scores, the presence of preexisting medical conditions, the use of invasive monitoring (Swan-Ganz catheters, central and arterial lines), and the use of antibiotics, low-dose dopamine (LDD) for renal protection, vasopressors, TPN, and enteral feeding.">
            <entity id="DS3.d357.s0.e0" origId="681" charOffset="260-268" type="compound" text="dopamine"/>
            <entity id="DS3.d357.s0.e1" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="311-314" type="protein" text="TPN"/>
            <pair e1="DS3.d357.s0.e0" e2="DS3.d357.s0.e1" id="DS3.d357.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d358" origId="10024101">
        <sentence id="DS3.d358.s0" origId="10024101-9" text="Progesterone also significantly impairs gallbladder emptying in response to cholecystokinin.">
            <entity id="DS3.d358.s0.e0" origId="5994" charOffset="0-12" type="compound" text="Progesterone"/>
            <entity id="DS3.d358.s0.e1" origId="P06307,Q6FG82" charOffset="76-91" type="protein" text="cholecystokinin"/>
            <pair e1="DS3.d358.s0.e0" e2="DS3.d358.s0.e1" id="DS3.d358.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d359" origId="10024102">
        <sentence id="DS3.d359.s0" origId="10024102-6" text="RESULTS: Serum bilirubin and prothrombin time increased on postoperative day 1, and their speed of recovery was influenced by the severity of fibrosis.">
            <entity id="DS3.d359.s0.e0" origId="5280352" charOffset="15-24" type="compound" text="bilirubin"/>
            <entity id="DS3.d359.s0.e1" origId="P00734" charOffset="29-40" type="protein" text="prothrombin"/>
            <pair e1="DS3.d359.s0.e0" e2="DS3.d359.s0.e1" id="DS3.d359.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d360" origId="10024104">
        <sentence id="DS3.d360.s0" origId="10024104-2" text="METHODS: To examine gastric emptying, acetaminophen was given, admixed in a pasty liquid meal, to 16 patients undergoing PPPD before surgery and at 1, 3, 6, 9, and 12 months after surgery.">
            <entity id="DS3.d360.s0.e0" origId="1983" charOffset="38-51" type="compound" text="acetaminophen"/>
            <entity id="DS3.d360.s0.e1" origId="P30556,D3DNG8,A0A0A0MSE3,Q53YY0,Q6NUP5,P01008,A0A024R944" charOffset="145-158" type="protein" text="at 1, 3, 6, 9"/>
            <pair e1="DS3.d360.s0.e0" e2="DS3.d360.s0.e1" id="DS3.d360.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d361" origId="10024105">
        <sentence id="DS3.d361.s0" origId="10024105-11" text="Alveolar macrophages obtained after induction of pancreatitis generated increased levels of nitric oxide, tumor necrosis factor-alpha, and MIP-2, but not leukotriene B4.">
            <entity id="DS3.d361.s0.e0" origId="145068" charOffset="92-104" type="compound" text="nitric oxide"/>
            <entity id="DS3.d361.s0.e1" origId="P16599" charOffset="106-133" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d361.s0.e2" origId="P30348" charOffset="139-144" type="protein" text="MIP-2"/>
            <entity id="DS3.d361.s0.e3" origId="5280492" charOffset="154-168" type="compound" text="leukotriene B4"/>
            <pair e1="DS3.d361.s0.e0" e2="DS3.d361.s0.e1" id="DS3.d361.s0.i0" interaction="False" />
            <pair e1="DS3.d361.s0.e0" e2="DS3.d361.s0.e2" id="DS3.d361.s0.i1" interaction="False" />
            <pair e1="DS3.d361.s0.e3" e2="DS3.d361.s0.e1" id="DS3.d361.s0.i2" interaction="False" />
            <pair e1="DS3.d361.s0.e3" e2="DS3.d361.s0.e2" id="DS3.d361.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d361.s1" origId="10024105-8" text="The generation of nitric oxide, leukotriene B4, tumor necrosis factor-alpha, and MIP-2 by alveolar macrophages and the chemotactic activity of supernatants of cultured macrophages were evaluated.">
            <entity id="DS3.d361.s1.e0" origId="145068" charOffset="18-30" type="compound" text="nitric oxide"/>
            <entity id="DS3.d361.s1.e1" origId="5280492" charOffset="32-46" type="compound" text="leukotriene B4"/>
            <entity id="DS3.d361.s1.e2" origId="P16599" charOffset="48-75" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d361.s1.e3" origId="P30348" charOffset="81-86" type="protein" text="MIP-2"/>
            <pair e1="DS3.d361.s1.e0" e2="DS3.d361.s1.e2" id="DS3.d361.s1.i0" interaction="False" />
            <pair e1="DS3.d361.s1.e0" e2="DS3.d361.s1.e3" id="DS3.d361.s1.i1" interaction="False" />
            <pair e1="DS3.d361.s1.e1" e2="DS3.d361.s1.e2" id="DS3.d361.s1.i2" interaction="False" />
            <pair e1="DS3.d361.s1.e1" e2="DS3.d361.s1.e3" id="DS3.d361.s1.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d362" origId="10024112">
        <sentence id="DS3.d362.s0" origId="10024112-1" text="OBJECTIVE: To determine the sensitivity, specificity, and accuracy of positron emission tomography with 2-fluorine-18-fluorodeoxyglucose (PET-FDG) in the preoperative staging (N and M staging) of patients with lung cancer.">
            <entity id="DS3.d362.s0.e0" origId="105162" charOffset="106-117" type="compound" text="fluorine-18"/>
            <entity id="DS3.d362.s0.e1" origId="54303434" charOffset="118-136" type="compound" text="fluorodeoxyglucose"/>
            <entity id="DS3.d362.s0.e2" origId="Q53HV7,A0A024RAZ8" charOffset="142-145" type="protein" text="FDG"/>
            <pair e1="DS3.d362.s0.e1" e2="DS3.d362.s0.e2" id="DS3.d362.s0.i0" interaction="False" />
            <pair e1="DS3.d362.s0.e0" e2="DS3.d362.s0.e2" id="DS3.d362.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d363" origId="10024128">
        <sentence id="DS3.d363.s0" origId="10024128-1" text="A transgenic mouse model has been established in which the cytokine interferon-gamma (IFN-gamma) is overexpressed through the action of the acetylcholine receptor epsilon promoter acting at the neuromuscular junction.">
            <entity id="DS3.d363.s0.e0" origId="P01580" charOffset="68-84" type="protein" text="interferon-gamma"/>
            <entity id="DS3.d363.s0.e1" origId="P01580" charOffset="86-95" type="protein" text="IFN-gamma"/>
            <entity id="DS3.d363.s0.e2" origId="187" charOffset="140-153" type="compound" text="acetylcholine"/>
            <pair e1="DS3.d363.s0.e2" e2="DS3.d363.s0.e1" id="DS3.d363.s0.i0" interaction="False" />
            <pair e1="DS3.d363.s0.e2" e2="DS3.d363.s0.e0" id="DS3.d363.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d364" origId="10024133">
        <sentence id="DS3.d364.s0" origId="10024133-2" text="Before training, exercise was followed by severe muscle pain (delayed-onset muscle soreness; DOMS), and by significant increases in plasma IL-6 level and serum myoglobin concentration (SMb) (P &amp;lt; 0.001).">
            <entity id="DS3.d364.s0.e0" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="139-143" type="protein" text="IL-6"/>
            <entity id="DS3.d364.s0.e1" origId="448893" charOffset="185-188" type="compound" text="SMb"/>
            <pair e1="DS3.d364.s0.e1" e2="DS3.d364.s0.e0" id="DS3.d364.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d365" origId="10024134">
        <sentence id="DS3.d365.s0" origId="10024134-2" text="The steroid group received subcutaneous injection of triamcinolone, the IGF-treated group received IGF-I alone, and the steroid plus IGF group received both triamcinolone and IGF-I.">
            <entity id="DS3.d365.s0.e0" origId="31307" charOffset="53-66" type="compound" text="triamcinolone"/>
            <entity id="DS3.d365.s0.e1" origId="P08025,F8WFZ5,Q5RK13,A0A0G2JX40,Q63261" charOffset="99-104" type="protein" text="IGF-I"/>
            <entity id="DS3.d365.s0.e2" origId="31307" charOffset="157-170" type="compound" text="triamcinolone"/>
            <entity id="DS3.d365.s0.e3" origId="P08025,F8WFZ5,Q5RK13,A0A0G2JX40,Q63261" charOffset="175-180" type="protein" text="IGF-I"/>
            <pair e1="DS3.d365.s0.e0" e2="DS3.d365.s0.e1" id="DS3.d365.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d366" origId="10024175">
        <sentence id="DS3.d366.s0" origId="10024175-4" text="We compare the dynamics, hydrogen-bonding occupancies, and interfacial flexibility of both complexes and also describe a rigid-body motion in the U1A-internal loop complex that is not observed in the U1A-hairpin simulation.">
            <entity id="DS3.d366.s0.e0" origId="783" charOffset="25-33" type="compound" text="hydrogen"/>
            <entity id="DS3.d366.s0.e1" origId="P09012" charOffset="146-149" type="protein" text="U1A"/>
            <entity id="DS3.d366.s0.e2" origId="P09012" charOffset="200-203" type="protein" text="U1A"/>
            <pair e1="DS3.d366.s0.e0" e2="DS3.d366.s0.e1" id="DS3.d366.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d367" origId="10024178">
        <sentence id="DS3.d367.s0" origId="10024178-0" text="Arginine methylation and binding of Hrp1p to the efficiency element for mRNA 3'-end formation.">
            <entity id="DS3.d367.s0.e0" origId="6322,90867653" charOffset="0-8" type="compound" text="Arginine"/>
            <entity id="DS3.d367.s0.e1" origId="Q99383" charOffset="36-41" type="protein" text="Hrp1p"/>
            <pair e1="DS3.d367.s0.e0" e2="DS3.d367.s0.e1" id="DS3.d367.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d367.s1" origId="10024178-5" text="To examine the effect of methylation on specific RNA binding, purified recombinant arginine methyltransferase (Hmt1p) was used to methylate Hrp1p.">
            <entity id="DS3.d367.s1.e0" origId="6322,90867653" charOffset="83-91" type="compound" text="arginine"/>
            <entity id="DS3.d367.s1.e1" origId="P38074" charOffset="111-116" type="protein" text="Hmt1p"/>
            <entity id="DS3.d367.s1.e2" origId="Q99383" charOffset="140-145" type="protein" text="Hrp1p"/>
            <pair e1="DS3.d367.s1.e0" e2="DS3.d367.s1.e2" id="DS3.d367.s1.i0" interaction="False" />
            <pair e1="DS3.d367.s1.e0" e2="DS3.d367.s1.e1" id="DS3.d367.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d368" origId="10024188">
        <sentence id="DS3.d368.s0" origId="10024188-7" text="In women, a 15 mg/dl increase in HDL-cholesterol was associated with a 10 mg/dl decrease in fibrinogen (P &amp;lt; 0.01).">
            <entity id="DS3.d368.s0.e0" origId="5997" charOffset="37-48" type="compound" text="cholesterol"/>
            <entity id="DS3.d368.s0.e1" origId="P02675,V9HVY1" charOffset="92-102" type="protein" text="fibrinogen"/>
            <pair e1="DS3.d368.s0.e0" e2="DS3.d368.s0.e1" id="DS3.d368.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d369" origId="10024223">
        <sentence id="DS3.d369.s0" origId="10024223-10" text="The relationship between vascular VCAM-1 expression and sub-mucosal EG2 and CD25 positive cells, both at 16.00 h and 04.00 h, suggests a role for VCAM-1 in the ongoing airway wall inflammation of asthma.">
            <entity id="DS3.d369.s0.e0" origId="P19320" charOffset="34-40" type="protein" text="VCAM-1"/>
            <entity id="DS3.d369.s0.e1" origId="2144" charOffset="68-71" type="compound" text="EG2"/>
            <entity id="DS3.d369.s0.e2" origId="P01589,Q5W005" charOffset="76-80" type="protein" text="CD25"/>
            <entity id="DS3.d369.s0.e3" origId="P19320" charOffset="146-152" type="protein" text="VCAM-1"/>
            <pair e1="DS3.d369.s0.e1" e2="DS3.d369.s0.e0" id="DS3.d369.s0.i0" interaction="False" />
            <pair e1="DS3.d369.s0.e1" e2="DS3.d369.s0.e2" id="DS3.d369.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d369.s1" origId="10024223-7" text="The percentage of VCAM-1 positive vessels in biopsies of asthmatic patients was higher than in biopsies of healthy controls: 5.8 vs 2.5% (P &amp;lt; 0.05) at 16.00h and 11 vs 0% (P&amp;lt;0.05) at 04.00 h. In asthma, VCAM-1 expression was correlated with the number of EG2 positive cells: at 16.00 h (rho = 0.57, P &amp;lt; 0.01) as well as at 04.00 h (rho = 0.64, P&amp;lt; 0.01).">
            <entity id="DS3.d369.s1.e0" origId="P19320" charOffset="18-24" type="protein" text="VCAM-1"/>
            <entity id="DS3.d369.s1.e1" origId="P19320" charOffset="209-215" type="protein" text="VCAM-1"/>
            <entity id="DS3.d369.s1.e2" origId="2144" charOffset="261-264" type="compound" text="EG2"/>
            <pair e1="DS3.d369.s1.e2" e2="DS3.d369.s1.e0" id="DS3.d369.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d370" origId="10024225">
        <sentence id="DS3.d370.s0" origId="10024225-9" text="CONCLUSION: The results indicate that LEA confers protection against anaphylaxis to mice due to their ability to induce a high IFN-gamma:IL-4 ratio which may lead to decreased synthesis of IgE and reduced histamine release on challenge with FA.">
            <entity id="DS3.d370.s0.e0" origId="P01580" charOffset="127-136" type="protein" text="IFN-gamma"/>
            <entity id="DS3.d370.s0.e1" origId="P07750" charOffset="137-141" type="protein" text="IL-4"/>
            <entity id="DS3.d370.s0.e2" origId="774" charOffset="205-214" type="compound" text="histamine"/>
            <pair e1="DS3.d370.s0.e2" e2="DS3.d370.s0.e0" id="DS3.d370.s0.i0" interaction="False" />
            <pair e1="DS3.d370.s0.e2" e2="DS3.d370.s0.e1" id="DS3.d370.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d371" origId="10024303">
        <sentence id="DS3.d371.s0" origId="10024303-5" text="There was a 2-fold increase in bromodeoxyuridine labeling of 10T1/2 cells in response to ECs, which was completely inhibited by the inclusion of neutralizing antiserum against platelet-derived growth factor (PDGF)-B.">
            <entity id="DS3.d371.s0.e0" origId="6035,6918942" charOffset="31-48" type="compound" text="bromodeoxyuridine"/>
            <entity id="DS3.d371.s0.e1" origId="P01127" charOffset="176-215" type="protein" text="platelet-derived growth factor (PDGF)-B"/>
            <pair e1="DS3.d371.s0.e0" e2="DS3.d371.s0.e1" id="DS3.d371.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d372" origId="10024311">
        <sentence id="DS3.d372.s0" origId="10024311-5" text="Endothelium-dependent relaxation to acetylcholine was attenuated in aorta of PLB-deficient (PLB-KO) mice compared with wild-type (WT) controls.">
            <entity id="DS3.d372.s0.e0" origId="187" charOffset="36-49" type="compound" text="acetylcholine"/>
            <entity id="DS3.d372.s0.e1" origId="P61014" charOffset="77-80" type="protein" text="PLB"/>
            <entity id="DS3.d372.s0.e2" origId="P61014" charOffset="92-95" type="protein" text="PLB"/>
            <pair e1="DS3.d372.s0.e0" e2="DS3.d372.s0.e1" id="DS3.d372.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d372.s1" origId="10024311-6" text="This effect was not due to actions of nitric oxide on the smooth muscle, because sodium nitroprusside-mediated relaxation in either denuded or endothelium-intact aortas was unaffected by PLB ablation.">
            <entity id="DS3.d372.s1.e0" origId="145068" charOffset="38-50" type="compound" text="nitric oxide"/>
            <entity id="DS3.d372.s1.e1" origId="5360545" charOffset="81-87" type="compound" text="sodium"/>
            <entity id="DS3.d372.s1.e2" origId="11963622" charOffset="88-101" type="compound" text="nitroprusside"/>
            <entity id="DS3.d372.s1.e3" origId="P61014" charOffset="187-190" type="protein" text="PLB"/>
            <pair e1="DS3.d372.s1.e0" e2="DS3.d372.s1.e3" id="DS3.d372.s1.i0" interaction="False" />
            <pair e1="DS3.d372.s1.e2" e2="DS3.d372.s1.e3" id="DS3.d372.s1.i1" interaction="False" />
            <pair e1="DS3.d372.s1.e1" e2="DS3.d372.s1.e3" id="DS3.d372.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d373" origId="10024312">
        <sentence id="DS3.d373.s0" origId="10024312-8" text="In addition to pressure overload, nitric oxide (NO) participated in these alterations, because inhibition of NO synthase by Nomega-nitro-L-arginine methyl ester markedly depressed cardiac AVP mRNA and peptide induction.">
            <entity id="DS3.d373.s0.e0" origId="145068" charOffset="34-46" type="compound" text="nitric oxide"/>
            <entity id="DS3.d373.s0.e1" origId="440005" charOffset="124-147" type="compound" text="Nomega-nitro-L-arginine"/>
            <entity id="DS3.d373.s0.e2" origId="13468584" charOffset="148-160" type="compound" text="methyl ester"/>
            <entity id="DS3.d373.s0.e3" origId="P01186" charOffset="188-191" type="protein" text="AVP"/>
            <pair e1="DS3.d373.s0.e2" e2="DS3.d373.s0.e3" id="DS3.d373.s0.i0" interaction="False" />
            <pair e1="DS3.d373.s0.e0" e2="DS3.d373.s0.e3" id="DS3.d373.s0.i1" interaction="False" />
            <pair e1="DS3.d373.s0.e1" e2="DS3.d373.s0.e3" id="DS3.d373.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d374" origId="10024318">
        <sentence id="DS3.d374.s0" origId="10024318-5" text="Ouabain (10 to 100 nmol/L) and insulin (10 to 100 nmol/L) dose-dependently increased receptor density and mRNA level.">
            <entity id="DS3.d374.s0.e0" origId="439501" charOffset="0-7" type="compound" text="Ouabain"/>
            <entity id="DS3.d374.s0.e1" origId="P01308,I3WAC9" charOffset="31-38" type="protein" text="insulin"/>
            <pair e1="DS3.d374.s0.e0" e2="DS3.d374.s0.e1" id="DS3.d374.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d375" origId="10024323">
        <sentence id="DS3.d375.s0" origId="10024323-10" text="ANP injection after diet was followed by an increase of ANP levels similar to that observed before diet, but plasma cGMP, diuresis, and natriuresis increased significantly only after diet.">
            <entity id="DS3.d375.s0.e0" origId="P01160" charOffset="0-3" type="protein" text="ANP"/>
            <entity id="DS3.d375.s0.e1" origId="P01160" charOffset="56-59" type="protein" text="ANP"/>
            <entity id="DS3.d375.s0.e2" origId="24316" charOffset="116-120" type="compound" text="cGMP"/>
            <pair e1="DS3.d375.s0.e2" e2="DS3.d375.s0.e0" id="DS3.d375.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d375.s1" origId="10024323-5" text="Eight obese hypertensives received a bolus injection of ANP (0.6 mg/kg) after 2 weeks of a normal calorie/normal sodium diet, and blood pressure (BP), heart rate, ANP, cGMP, plasma renin activity, and aldosterone were evaluated for 2 hours before and after the injection.">
            <entity id="DS3.d375.s1.e0" origId="P01160" charOffset="56-59" type="protein" text="ANP"/>
            <entity id="DS3.d375.s1.e1" origId="5360545" charOffset="113-119" type="compound" text="sodium"/>
            <entity id="DS3.d375.s1.e2" origId="P01160" charOffset="163-166" type="protein" text="ANP"/>
            <entity id="DS3.d375.s1.e3" origId="24316" charOffset="168-172" type="compound" text="cGMP"/>
            <entity id="DS3.d375.s1.e4" origId="P00797" charOffset="181-186" type="protein" text="renin"/>
            <pair e1="DS3.d375.s1.e3" e2="DS3.d375.s1.e0" id="DS3.d375.s1.i0" interaction="False" />
            <pair e1="DS3.d375.s1.e3" e2="DS3.d375.s1.e4" id="DS3.d375.s1.i1" interaction="False" />
            <pair e1="DS3.d375.s1.e1" e2="DS3.d375.s1.e0" id="DS3.d375.s1.i2" interaction="False" />
            <pair e1="DS3.d375.s1.e1" e2="DS3.d375.s1.e4" id="DS3.d375.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d375.s2" origId="10024323-7" text="The patients then started a low calorie/normal sodium diet (510 kcal/150 mmol/d) for 4 days, and then the ANP injection protocol was repeated.">
            <entity id="DS3.d375.s2.e0" origId="5360545" charOffset="47-53" type="compound" text="sodium"/>
            <entity id="DS3.d375.s2.e1" origId="P01160" charOffset="106-109" type="protein" text="ANP"/>
            <pair e1="DS3.d375.s2.e0" e2="DS3.d375.s2.e1" id="DS3.d375.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d376" origId="10024324">
        <sentence id="DS3.d376.s0" origId="10024324-11" text="Given the known biological activities of osteopontin, including cell adhesion and regulation of inducible nitric oxide synthase gene expression, these data suggest that it could play a role in the pathophysiology of heart failure.">
            <entity id="DS3.d376.s0.e0" origId="P08721" charOffset="41-52" type="protein" text="osteopontin"/>
            <entity id="DS3.d376.s0.e1" origId="145068" charOffset="106-118" type="compound" text="nitric oxide"/>
            <pair e1="DS3.d376.s0.e1" e2="DS3.d376.s0.e0" id="DS3.d376.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d376.s1" origId="10024324-8" text="Treatment with captopril starting before or after the onset of failure in the SHR reduced the increase in left ventricular osteopontin mRNA levels.">
            <entity id="DS3.d376.s1.e0" origId="44093" charOffset="15-24" type="compound" text="captopril"/>
            <entity id="DS3.d376.s1.e1" origId="P08721" charOffset="123-134" type="protein" text="osteopontin"/>
            <pair e1="DS3.d376.s1.e0" e2="DS3.d376.s1.e1" id="DS3.d376.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d377" origId="10024328">
        <sentence id="DS3.d377.s0" origId="10024328-7" text="Arterioles of rats fed a normal salt diet dilated progressively up to 17+/-3% in response to the endothelium-dependent agent acetylcholine (10(-9) to 10(-6) mol/L) and dilated by 22+/-2% in response to the prostaglandin I2 receptor agonist iloprost (3x10(-11) mol/L).">
            <entity id="DS3.d377.s0.e0" origId="187" charOffset="125-138" type="compound" text="acetylcholine"/>
            <entity id="DS3.d377.s0.e1" origId="P43253" charOffset="206-231" type="protein" text="prostaglandin I2 receptor"/>
            <entity id="DS3.d377.s0.e2" origId="10937300,5311181,53394043,53486260,6443959,6435378" charOffset="240-248" type="compound" text="iloprost"/>
            <pair e1="DS3.d377.s0.e0" e2="DS3.d377.s0.e1" id="DS3.d377.s0.i0" interaction="False" />
            <pair e1="DS3.d377.s0.e2" e2="DS3.d377.s0.e1" id="DS3.d377.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d378" origId="10024329">
        <sentence id="DS3.d378.s0" origId="10024329-0" text="Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat.">
            <entity id="DS3.d378.s0.e0" origId="145068" charOffset="8-20" type="compound" text="nitric oxide"/>
            <entity id="DS3.d378.s0.e1" origId="P43145" charOffset="37-51" type="protein" text="adrenomedullin"/>
            <pair e1="DS3.d378.s0.e0" e2="DS3.d378.s0.e1" id="DS3.d378.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d378.s1" origId="10024329-1" text="We previously reported that adrenomedullin (AM), a potent vasodilator peptide discovered in pheochromocytoma cells, stimulates nitric oxide (NO) release in the rat kidney.">
            <entity id="DS3.d378.s1.e0" origId="P43145" charOffset="28-42" type="protein" text="adrenomedullin"/>
            <entity id="DS3.d378.s1.e1" origId="145068" charOffset="127-139" type="compound" text="nitric oxide"/>
            <pair e1="DS3.d378.s1.e1" e2="DS3.d378.s1.e0" id="DS3.d378.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d379" origId="10024330">
        <sentence id="DS3.d379.s0" origId="10024330-8" text="The contribution of alpha-adducin to fractional excretion of lithium was investigated by multiple regression analysis.">
            <entity id="DS3.d379.s0.e0" origId="P35611" charOffset="20-33" type="protein" text="alpha-adducin"/>
            <entity id="DS3.d379.s0.e1" origId="3028194" charOffset="61-68" type="compound" text="lithium"/>
            <pair e1="DS3.d379.s0.e1" e2="DS3.d379.s0.e0" id="DS3.d379.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d379.s1" origId="10024330-9" text="Adducin genotype was significantly (R2=0.11, F=6.5; P&amp;lt;0.01) and directly related to fraction excretion of lithium; gender, age, urinary Na+, urinary uric acid, mean blood pressure, and plasma renin activity were not related.">
            <entity id="DS3.d379.s1.e0" origId="3028194" charOffset="109-116" type="compound" text="lithium"/>
            <entity id="DS3.d379.s1.e1" origId="1175" charOffset="152-161" type="compound" text="uric acid"/>
            <entity id="DS3.d379.s1.e2" origId="P00797" charOffset="195-200" type="protein" text="renin"/>
            <pair e1="DS3.d379.s1.e0" e2="DS3.d379.s1.e2" id="DS3.d379.s1.i0" interaction="False" />
            <pair e1="DS3.d379.s1.e1" e2="DS3.d379.s1.e2" id="DS3.d379.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d380" origId="10024332">
        <sentence id="DS3.d380.s0" origId="10024332-0" text="Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2.">
            <entity id="DS3.d380.s0.e0" origId="5839" charOffset="0-11" type="compound" text="Aldosterone"/>
            <entity id="DS3.d380.s0.e1" origId="5839" charOffset="118-129" type="compound" text="aldosterone"/>
            <entity id="DS3.d380.s0.e2" origId="P19099" charOffset="144-151" type="protein" text="CYP11B2"/>
            <pair e1="DS3.d380.s0.e1" e2="DS3.d380.s0.e2" id="DS3.d380.s0.i0" interaction="False" />
            <pair e1="DS3.d380.s0.e0" e2="DS3.d380.s0.e2" id="DS3.d380.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d380.s1" origId="10024332-2" text="In patients with this disease, the ratio of plasma renin to plasma aldosterone may be lower than in control subjects and plasma aldosterone levels may be more sensitive to angiotensin II (Ang II) infusion.">
            <entity id="DS3.d380.s1.e0" origId="P00797" charOffset="51-56" type="protein" text="renin"/>
            <entity id="DS3.d380.s1.e1" origId="5839" charOffset="67-78" type="compound" text="aldosterone"/>
            <entity id="DS3.d380.s1.e2" origId="5839" charOffset="128-139" type="compound" text="aldosterone"/>
            <entity id="DS3.d380.s1.e3" origId="O15123" charOffset="172-194" type="protein" text="angiotensin II (Ang II"/>
            <pair e1="DS3.d380.s1.e1" e2="DS3.d380.s1.e3" id="DS3.d380.s1.i0" interaction="False" />
            <pair e1="DS3.d380.s1.e1" e2="DS3.d380.s1.e0" id="DS3.d380.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d381" origId="10024335">
        <sentence id="DS3.d381.s0" origId="10024335-7" text="Compared with baseline levels, simvastatin reduced total (TOT-C) and LDL cholesterol (LDL-C) (1.27 mmol/L, P&amp;lt;0.001 and 1.33 mmol/L, P&amp;lt;0.001, respectively).">
            <entity id="DS3.d381.s0.e0" origId="54454" charOffset="31-42" type="compound" text="simvastatin"/>
            <entity id="DS3.d381.s0.e1" origId="5997" charOffset="73-84" type="compound" text="cholesterol"/>
            <entity id="DS3.d381.s0.e2" origId="Q14746,B1ALW7" charOffset="86-91" type="protein" text="LDL-C"/>
            <pair e1="DS3.d381.s0.e0" e2="DS3.d381.s0.e2" id="DS3.d381.s0.i0" interaction="False" />
            <pair e1="DS3.d381.s0.e1" e2="DS3.d381.s0.e2" id="DS3.d381.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d381.s1" origId="10024335-8" text="Enalapril also reduced TOT-C and LDL-C (0.6 mmol/L, P&amp;lt;0.001 and 0.58 mmol/L, P&amp;lt;0.05, respectively).">
            <entity id="DS3.d381.s1.e0" origId="5388962" charOffset="0-9" type="compound" text="Enalapril"/>
            <entity id="DS3.d381.s1.e1" origId="Q14746,B1ALW7" charOffset="33-38" type="protein" text="LDL-C"/>
            <pair e1="DS3.d381.s1.e0" e2="DS3.d381.s1.e1" id="DS3.d381.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d382" origId="10024338">
        <sentence id="DS3.d382.s0" origId="10024338-1" text="Tissue and plasma levels of aminopeptidase A (APA), the principal enzyme that hydrolyzes angiotensin II (Ang II) to angiotensin III, were measured in spontaneously hypertensive rats (SHR) and their normotensive control strain at 3 different ages corresponding to prehypertensive (4 weeks), developing (8 weeks), and established (16 weeks) phases of hypertension.">
            <entity id="DS3.d382.s0.e0" origId="P50123" charOffset="28-44" type="protein" text="aminopeptidase A"/>
            <entity id="DS3.d382.s0.e1" origId="Q5GAM5" charOffset="89-111" type="protein" text="angiotensin II (Ang II"/>
            <entity id="DS3.d382.s0.e2" origId="3082042,4201862" charOffset="116-131" type="compound" text="angiotensin III"/>
            <pair e1="DS3.d382.s0.e2" e2="DS3.d382.s0.e0" id="DS3.d382.s0.i0" interaction="False" />
            <pair e1="DS3.d382.s0.e2" e2="DS3.d382.s0.e1" id="DS3.d382.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d382.s1" origId="10024338-7" text="To determine whether the increase in kidney APA activity in SHR was related to Ang II levels, SHR were treated for 2 weeks with the angiotensin-converting enzyme inhibitor captopril.">
            <entity id="DS3.d382.s1.e0" origId="P01015" charOffset="79-85" type="protein" text="Ang II"/>
            <entity id="DS3.d382.s1.e1" origId="44093" charOffset="172-181" type="compound" text="captopril"/>
            <pair e1="DS3.d382.s1.e1" e2="DS3.d382.s1.e0" id="DS3.d382.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d383" origId="10024339">
        <sentence id="DS3.d383.s0" origId="10024339-1" text="aminopeptidase A (APA) is the principal enzyme that metabolizes angiotensin II (Ang II) to angiotensin III.">
            <entity id="DS3.d383.s0.e0" origId="P50123" charOffset="0-16" type="protein" text="aminopeptidase A"/>
            <entity id="DS3.d383.s0.e1" origId="Q5GAM5" charOffset="64-86" type="protein" text="angiotensin II (Ang II"/>
            <entity id="DS3.d383.s0.e2" origId="3082042,4201862" charOffset="91-106" type="compound" text="angiotensin III"/>
            <pair e1="DS3.d383.s0.e2" e2="DS3.d383.s0.e0" id="DS3.d383.s0.i0" interaction="False" />
            <pair e1="DS3.d383.s0.e2" e2="DS3.d383.s0.e1" id="DS3.d383.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d384" origId="10024340">
        <sentence id="DS3.d384.s0" origId="10024340-2" text="Forearm blood flow (FBF) responses (strain-gauge plethysmography) to intraarterial infusion of blockers of endothelin-A (ETA) (BQ-123) and endothelin-B (ETB) (BQ-788) receptors, separately and in combination, were measured in hypertensive patients and normotensive control subjects.">
            <entity id="DS3.d384.s0.e0" origId="P25101" charOffset="107-119" type="protein" text="endothelin-A"/>
            <entity id="DS3.d384.s0.e1" origId="P25101" charOffset="121-124" type="protein" text="ETA"/>
            <entity id="DS3.d384.s0.e2" origId="16219006,52943236" charOffset="127-133" type="compound" text="BQ-123"/>
            <entity id="DS3.d384.s0.e3" origId="P24530,A0A024R645,A0A024R638" charOffset="139-151" type="protein" text="endothelin-B"/>
            <entity id="DS3.d384.s0.e4" origId="P24530,A0A024R645,A0A024R638" charOffset="153-156" type="protein" text="ETB"/>
            <entity id="DS3.d384.s0.e5" origId="5311032,44283453" charOffset="159-165" type="compound" text="BQ-788"/>
            <pair e1="DS3.d384.s0.e5" e2="DS3.d384.s0.e4" id="DS3.d384.s0.i0" interaction="False" />
            <pair e1="DS3.d384.s0.e5" e2="DS3.d384.s0.e3" id="DS3.d384.s0.i1" interaction="False" />
            <pair e1="DS3.d384.s0.e5" e2="DS3.d384.s0.e0" id="DS3.d384.s0.i2" interaction="False" />
            <pair e1="DS3.d384.s0.e5" e2="DS3.d384.s0.e1" id="DS3.d384.s0.i3" interaction="False" />
            <pair e1="DS3.d384.s0.e2" e2="DS3.d384.s0.e4" id="DS3.d384.s0.i4" interaction="False" />
            <pair e1="DS3.d384.s0.e2" e2="DS3.d384.s0.e3" id="DS3.d384.s0.i5" interaction="False" />
            <pair e1="DS3.d384.s0.e2" e2="DS3.d384.s0.e0" id="DS3.d384.s0.i6" interaction="False" />
            <pair e1="DS3.d384.s0.e2" e2="DS3.d384.s0.e1" id="DS3.d384.s0.i7" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d385" origId="10024341">
        <sentence id="DS3.d385.s0" origId="10024341-0" text="Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.">
            <entity id="DS3.d385.s0.e0" origId="P26684,A1Y2B8,A0A0G2JSX5" charOffset="27-39" type="protein" text="endothelin-A"/>
            <entity id="DS3.d385.s0.e1" origId="P21451" charOffset="44-56" type="protein" text="endothelin-B"/>
            <entity id="DS3.d385.s0.e2" origId="5952" charOffset="90-117" type="compound" text="deoxycorticosterone acetate"/>
            <pair e1="DS3.d385.s0.e2" e2="DS3.d385.s0.e1" id="DS3.d385.s0.i0" interaction="False" />
            <pair e1="DS3.d385.s0.e2" e2="DS3.d385.s0.e0" id="DS3.d385.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d385.s1" origId="10024341-1" text="We investigated the involvement of actions mediated by endothelin-A (ETA) and endothelin-B (ETB) receptors in the pathogenesis of deoxycorticosterone acetate (DOCA)-salt-induced hypertension in rats.">
            <entity id="DS3.d385.s1.e0" origId="P26684,A1Y2B8,A0A0G2JSX5" charOffset="55-67" type="protein" text="endothelin-A"/>
            <entity id="DS3.d385.s1.e1" origId="P26684,A1Y2B8,A0A0G2JSX5" charOffset="69-72" type="protein" text="ETA"/>
            <entity id="DS3.d385.s1.e2" origId="P21451" charOffset="78-90" type="protein" text="endothelin-B"/>
            <entity id="DS3.d385.s1.e3" origId="P21451" charOffset="92-95" type="protein" text="ETB"/>
            <entity id="DS3.d385.s1.e4" origId="5952" charOffset="130-157" type="compound" text="deoxycorticosterone acetate"/>
            <pair e1="DS3.d385.s1.e4" e2="DS3.d385.s1.e3" id="DS3.d385.s1.i0" interaction="False" />
            <pair e1="DS3.d385.s1.e4" e2="DS3.d385.s1.e2" id="DS3.d385.s1.i1" interaction="False" />
            <pair e1="DS3.d385.s1.e4" e2="DS3.d385.s1.e0" id="DS3.d385.s1.i2" interaction="False" />
            <pair e1="DS3.d385.s1.e4" e2="DS3.d385.s1.e1" id="DS3.d385.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d385.s2" origId="10024341-2" text="Two weeks after the start of DOCA-salt treatment, rats were given ABT-627 (10 (mg/kg)/d), a selective ETA receptor antagonist; A-192621 (30 (mg/kg)/d), a selective ETB receptor antagonist; or their vehicle for 2 weeks.">
            <entity id="DS3.d385.s2.e0" origId="159594" charOffset="66-73" type="compound" text="ABT-627"/>
            <entity id="DS3.d385.s2.e1" origId="P26684,A1Y2B8,A0A0G2JSX5" charOffset="102-105" type="protein" text="ETA"/>
            <entity id="DS3.d385.s2.e2" origId="P21451" charOffset="164-167" type="protein" text="ETB"/>
            <pair e1="DS3.d385.s2.e0" e2="DS3.d385.s2.e2" id="DS3.d385.s2.i0" interaction="False" />
            <pair e1="DS3.d385.s2.e0" e2="DS3.d385.s2.e1" id="DS3.d385.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d386" origId="10024356">
        <sentence id="DS3.d386.s0" origId="10024356-0" text="Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells.">
            <entity id="DS3.d386.s0.e0" origId="P35462,A1A4V4,E9PCM4,X5D2G4,A8K8E4" charOffset="20-40" type="protein" text="D3 dopamine receptor"/>
            <entity id="DS3.d386.s0.e1" origId="22044544,5460341" charOffset="59-66" type="compound" text="calcium"/>
            <pair e1="DS3.d386.s0.e1" e2="DS3.d386.s0.e0" id="DS3.d386.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d386.s1" origId="10024356-4" text="In this report we demonstrate that activation of the human D3 dopamine receptor expressed in the AtT-20 neuroendocrine cell line causes robust inhibition of P/Q-type calcium channels via pertussis toxin-sensitive G-proteins.">
            <entity id="DS3.d386.s1.e0" origId="P35462,A1A4V4,E9PCM4,X5D2G4,A8K8E4" charOffset="59-79" type="protein" text="D3 dopamine receptor"/>
            <entity id="DS3.d386.s1.e1" origId="22044544,5460341" charOffset="166-173" type="compound" text="calcium"/>
            <pair e1="DS3.d386.s1.e1" e2="DS3.d386.s1.e0" id="DS3.d386.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d387" origId="10024366">
        <sentence id="DS3.d387.s0" origId="10024366-5" text="The tissue levels of histamine and its first metabolite tele-methylhistamine were also elevated throughout the brain of hibernating animals, suggesting an increase in histamine turnover during hibernation, which occurs without an increase in histidine decarboxylase mRNA expression.">
            <entity id="DS3.d387.s0.e0" origId="774" charOffset="21-30" type="compound" text="histamine"/>
            <entity id="DS3.d387.s0.e1" origId="3614" charOffset="56-76" type="compound" text="tele-methylhistamine"/>
            <entity id="DS3.d387.s0.e2" origId="774" charOffset="67-76" type="compound" text="histamine"/>
            <entity id="DS3.d387.s0.e3" origId="P19113" charOffset="242-265" type="protein" text="histidine decarboxylase"/>
            <pair e1="DS3.d387.s0.e1" e2="DS3.d387.s0.e3" id="DS3.d387.s0.i0" interaction="False" />
            <pair e1="DS3.d387.s0.e0" e2="DS3.d387.s0.e3" id="DS3.d387.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d388" origId="10024368">
        <sentence id="DS3.d388.s0" origId="10024368-2" text="The recently cloned vanilloid receptor subtype 1 (VR1) is activated by capsaicin and noxious heat.">
            <entity id="DS3.d388.s0.e0" origId="O35433" charOffset="20-48" type="protein" text="vanilloid receptor subtype 1"/>
            <entity id="DS3.d388.s0.e1" origId="O35433" charOffset="50-53" type="protein" text="VR1"/>
            <entity id="DS3.d388.s0.e2" origId="1548943" charOffset="71-80" type="compound" text="capsaicin"/>
            <pair e1="DS3.d388.s0.e2" e2="DS3.d388.s0.e1" id="DS3.d388.s0.i0" interaction="False" />
            <pair e1="DS3.d388.s0.e2" e2="DS3.d388.s0.e0" id="DS3.d388.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d388.s1" origId="10024368-8" text="A previously uncharacterized population of very small cells that express the receptor tyrosine kinase (RET) and that do not label for trkA or IB4-binding has the highest relative levels of VR1 mRNA.">
            <entity id="DS3.d388.s1.e0" origId="6057,90983769" charOffset="86-94" type="compound" text="tyrosine"/>
            <entity id="DS3.d388.s1.e1" origId="G3V9H8" charOffset="103-106" type="protein" text="RET"/>
            <entity id="DS3.d388.s1.e2" origId="P35739" charOffset="134-138" type="protein" text="trkA"/>
            <entity id="DS3.d388.s1.e3" origId="O35433" charOffset="189-192" type="protein" text="VR1"/>
            <pair e1="DS3.d388.s1.e0" e2="DS3.d388.s1.e3" id="DS3.d388.s1.i0" interaction="False" />
            <pair e1="DS3.d388.s1.e0" e2="DS3.d388.s1.e2" id="DS3.d388.s1.i1" interaction="False" />
            <pair e1="DS3.d388.s1.e0" e2="DS3.d388.s1.e1" id="DS3.d388.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d389" origId="10024378">
        <sentence id="DS3.d389.s0" origId="10024378-5" text="The osteolytic activity of groEL was inhibited by indomethacin and the natural antagonist of interleukin-1 receptor antagonist (IL-1ra) but was unaffected by neutralization of tumor necrosis factor (TNF) or inhibition of 5-lipoxygenase.">
            <entity id="DS3.d389.s0.e0" origId="C4NV17,P10809,A0A024R3X4" charOffset="27-32" type="protein" text="groEL"/>
            <entity id="DS3.d389.s0.e1" origId="3715" charOffset="50-62" type="compound" text="indomethacin"/>
            <entity id="DS3.d389.s0.e2" origId="P18510,A0A024R528" charOffset="93-126" type="protein" text="interleukin-1 receptor antagonist"/>
            <entity id="DS3.d389.s0.e3" origId="P18510,A0A024R528" charOffset="128-134" type="protein" text="IL-1ra"/>
            <entity id="DS3.d389.s0.e4" origId="P09917" charOffset="221-235" type="protein" text="5-lipoxygenase"/>
            <pair e1="DS3.d389.s0.e1" e2="DS3.d389.s0.e0" id="DS3.d389.s0.i0" interaction="False" />
            <pair e1="DS3.d389.s0.e1" e2="DS3.d389.s0.e4" id="DS3.d389.s0.i1" interaction="False" />
            <pair e1="DS3.d389.s0.e1" e2="DS3.d389.s0.e3" id="DS3.d389.s0.i2" interaction="False" />
            <pair e1="DS3.d389.s0.e1" e2="DS3.d389.s0.e2" id="DS3.d389.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d390" origId="10024384">
        <sentence id="DS3.d390.s0" origId="10024384-11" text="Unlike previous findings in PTH-infused rats, Kg (measured from 2 to 20 minutes following glucose/insulin bolus) was not different between groups (4.5 +/- 0.3 versus 4.7 +/- 0.2, P = 0.92.)">
            <entity id="DS3.d390.s0.e0" origId="P04089" charOffset="28-31" type="protein" text="PTH"/>
            <entity id="DS3.d390.s0.e1" origId="206,5793,64689,79025" charOffset="90-97" type="compound" text="glucose"/>
            <pair e1="DS3.d390.s0.e1" e2="DS3.d390.s0.e0" id="DS3.d390.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d390.s1" origId="10024384-15" text="In order to define whether different effects of PTH (1-34) and vit D on intracellular calcium (Ca2+)i levels could partly explain the different effects of PTH and vit D infusion on glucose disposal, we investigated the effect of PTH and vit D infusions on basal and concanavalin A (con A)-stimulated changes in mononuclear (Ca+2)i levels.">
            <entity id="DS3.d390.s1.e0" origId="P04089" charOffset="48-51" type="protein" text="PTH"/>
            <entity id="DS3.d390.s1.e1" origId="22044544,5460341" charOffset="86-93" type="compound" text="calcium"/>
            <entity id="DS3.d390.s1.e2" origId="P04089" charOffset="155-158" type="protein" text="PTH"/>
            <entity id="DS3.d390.s1.e3" origId="206,5793,64689,79025" charOffset="181-188" type="compound" text="glucose"/>
            <entity id="DS3.d390.s1.e4" origId="P04089" charOffset="155-158" type="protein" text="PTH"/>
            <pair e1="DS3.d390.s1.e1" e2="DS3.d390.s1.e0" id="DS3.d390.s1.i0" interaction="False" />
            <pair e1="DS3.d390.s1.e3" e2="DS3.d390.s1.e0" id="DS3.d390.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d390.s2" origId="10024384-19" text="Consequently, we conclude that vit D-induced hypercalcemia associated with suppressed PTH levels has mild affects on glucose homeostasis but does not affect glucose disappearance rate in vivo (Kg) as does hypercalcemia induced by PTH infusion, and that neither chronic PTH infusion nor chronic vit D infusion are associated with long-standing changes in (Ca2+)i levels.">
            <entity id="DS3.d390.s2.e0" origId="P04089" charOffset="86-89" type="protein" text="PTH"/>
            <entity id="DS3.d390.s2.e1" origId="206,5793,64689,79025" charOffset="117-124" type="compound" text="glucose"/>
            <entity id="DS3.d390.s2.e2" origId="206,5793,64689,79025" charOffset="157-164" type="compound" text="glucose"/>
            <entity id="DS3.d390.s2.e3" origId="P04089" charOffset="230-233" type="protein" text="PTH"/>
            <entity id="DS3.d390.s2.e4" origId="P04089" charOffset="230-233" type="protein" text="PTH"/>
            <pair e1="DS3.d390.s2.e1" e2="DS3.d390.s2.e0" id="DS3.d390.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d390.s3" origId="10024384-1" text="We have previously demonstrated that parathyroid hormone (PTH) infusion decreases glucose disappearance rate (Kg) in vivo.">
            <entity id="DS3.d390.s3.e0" origId="P04089" charOffset="37-56" type="protein" text="parathyroid hormone"/>
            <entity id="DS3.d390.s3.e1" origId="P04089" charOffset="58-61" type="protein" text="PTH"/>
            <entity id="DS3.d390.s3.e2" origId="206,5793,64689,79025" charOffset="82-89" type="compound" text="glucose"/>
            <pair e1="DS3.d390.s3.e2" e2="DS3.d390.s3.e0" id="DS3.d390.s3.i0" interaction="False" />
            <pair e1="DS3.d390.s3.e2" e2="DS3.d390.s3.e1" id="DS3.d390.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d390.s4" origId="10024384-2" text="Because in the rodent model used it was not possible to determine whether the PTH itself, the induced hypercalcemia, or both contributed to the glucose intolerance, we examined the effect of vitamin D infusion on insulin-mediated glucose disposal.">
            <entity id="DS3.d390.s4.e0" origId="P04089" charOffset="78-81" type="protein" text="PTH"/>
            <entity id="DS3.d390.s4.e1" origId="206,5793,64689,79025" charOffset="144-151" type="compound" text="glucose"/>
            <entity id="DS3.d390.s4.e2" origId="5280795,5283711" charOffset="191-200" type="compound" text="vitamin D"/>
            <entity id="DS3.d390.s4.e3" origId="206,5793,64689,79025" charOffset="230-237" type="compound" text="glucose"/>
            <pair e1="DS3.d390.s4.e2" e2="DS3.d390.s4.e0" id="DS3.d390.s4.i0" interaction="False" />
            <pair e1="DS3.d390.s4.e1" e2="DS3.d390.s4.e0" id="DS3.d390.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d390.s5" origId="10024384-7" text="At the end of 5 days, plasma calcium levels were higher in the vit D-infused rats than in the control rats (12.8 +/- 0.1 versus 10.0 +/- 0.1 mg/dL, P &amp;lt; 0.01) and rat PTH levels were suppressed (2.1 +/- 0.1 versus 62 +/- 12 pg/ml, P &amp;lt; 0.">
            <entity id="DS3.d390.s5.e0" origId="22044544,5460341" charOffset="29-36" type="compound" text="calcium"/>
            <entity id="DS3.d390.s5.e1" origId="P04089" charOffset="169-172" type="protein" text="PTH"/>
            <pair e1="DS3.d390.s5.e0" e2="DS3.d390.s5.e1" id="DS3.d390.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d391" origId="10024441">
        <sentence id="DS3.d391.s0" origId="10024441-0" text="EGF-like domain calcium affinity modulated by N-terminal domain linkage in human fibrillin-1.">
            <entity id="DS3.d391.s0.e0" origId="22044544,5460341" charOffset="16-23" type="compound" text="calcium"/>
            <entity id="DS3.d391.s0.e1" origId="P35555" charOffset="81-92" type="protein" text="fibrillin-1"/>
            <pair e1="DS3.d391.s0.e0" e2="DS3.d391.s0.e1" id="DS3.d391.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d391.s1" origId="10024441-1" text="Calcium binding epidermal growth factor-like domains (cbEGFs) are present in many extracellular proteins, including fibrillin-1, Notch-3, protein S, factor IX and the low density lipoprotein (LDL) receptor, which perform a diverse range of functions.">
            <entity id="DS3.d391.s1.e0" origId="22044544,5460341" charOffset="0-7" type="compound" text="Calcium"/>
            <entity id="DS3.d391.s1.e1" origId="P35555" charOffset="116-127" type="protein" text="fibrillin-1"/>
            <entity id="DS3.d391.s1.e2" origId="Q9UM47" charOffset="129-158" type="protein" text="Notch-3, protein S, factor IX"/>
            <entity id="DS3.d391.s1.e3" origId="P01130,A0A024R7D5" charOffset="167-205" type="protein" text="low density lipoprotein (LDL) receptor"/>
            <pair e1="DS3.d391.s1.e0" e2="DS3.d391.s1.e3" id="DS3.d391.s1.i0" interaction="False" />
            <pair e1="DS3.d391.s1.e0" e2="DS3.d391.s1.e1" id="DS3.d391.s1.i1" interaction="False" />
            <pair e1="DS3.d391.s1.e0" e2="DS3.d391.s1.e2" id="DS3.d391.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d391.s2" origId="10024441-4" text="We have determined the calcium binding affinity of two sites within a cbEGF pair (cbEGF12-13) from human fibrillin-1 using two-dimensional nuclear magnetic resonance (NMR) and fluorescence techniques.">
            <entity id="DS3.d391.s2.e0" origId="22044544,5460341" charOffset="23-30" type="compound" text="calcium"/>
            <entity id="DS3.d391.s2.e1" origId="P35555" charOffset="105-116" type="protein" text="fibrillin-1"/>
            <pair e1="DS3.d391.s2.e0" e2="DS3.d391.s2.e1" id="DS3.d391.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d391.s3" origId="10024441-6" text="Our results show that the cbEGF13 site in the cbEGF12-13 pair possesses the highest calcium affinity of any cbEGF investigated from fibrillin-1.">
            <entity id="DS3.d391.s3.e0" origId="22044544,5460341" charOffset="84-91" type="compound" text="calcium"/>
            <entity id="DS3.d391.s3.e1" origId="P35555" charOffset="132-143" type="protein" text="fibrillin-1"/>
            <pair e1="DS3.d391.s3.e0" e2="DS3.d391.s3.e1" id="DS3.d391.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d391.s4" origId="10024441-7" text="A comparative analysis of these and previously reported calcium binding data from fibrillin-1 demonstrate that the affinity of cbEGF13 is enhanced more than 70-fold by the linkage of an N-terminal cbEGF domain.">
            <entity id="DS3.d391.s4.e0" origId="22044544,5460341" charOffset="56-63" type="compound" text="calcium"/>
            <entity id="DS3.d391.s4.e1" origId="P35555" charOffset="82-93" type="protein" text="fibrillin-1"/>
            <pair e1="DS3.d391.s4.e0" e2="DS3.d391.s4.e1" id="DS3.d391.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d392" origId="10024455">
        <sentence id="DS3.d392.s0" origId="10024455-13" text="The active site of PTPS seems to be optimised to carry out proton abstractions from two different side-chain C1' and C2' atoms, with no obvious preference for one of them.">
            <entity id="DS3.d392.s0.e0" origId="Q03393" charOffset="19-23" type="protein" text="PTPS"/>
            <entity id="DS3.d392.s0.e1" origId="1038,5460653" charOffset="59-65" type="compound" text="proton"/>
            <pair e1="DS3.d392.s0.e1" e2="DS3.d392.s0.e0" id="DS3.d392.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d392.s1" origId="10024455-1" text="The enzyme 6-pyruvoyl tetrahydropterin synthase (PTPS) catalyses the second step in the de novo biosynthesis of tetrahydrobiopterin, the conversion of dihydroneopterin triphosphate to 6-pyruvoyl tetrahydropterin.">
            <entity id="DS3.d392.s1.e0" origId="Q03393" charOffset="11-47" type="protein" text="6-pyruvoyl tetrahydropterin synthase"/>
            <entity id="DS3.d392.s1.e1" origId="Q03393" charOffset="49-53" type="protein" text="PTPS"/>
            <entity id="DS3.d392.s1.e2" origId="1125,40480037,44257,9816201" charOffset="112-131" type="compound" text="tetrahydrobiopterin"/>
            <entity id="DS3.d392.s1.e3" origId="121885" charOffset="151-180" type="compound" text="dihydroneopterin triphosphate"/>
            <entity id="DS3.d392.s1.e4" origId="122134" charOffset="22-38" type="compound" text="tetrahydropterin"/>
            <pair e1="DS3.d392.s1.e3" e2="DS3.d392.s1.e1" id="DS3.d392.s1.i0" interaction="False" />
            <pair e1="DS3.d392.s1.e3" e2="DS3.d392.s1.e0" id="DS3.d392.s1.i1" interaction="False" />
            <pair e1="DS3.d392.s1.e4" e2="DS3.d392.s1.e1" id="DS3.d392.s1.i2" interaction="False" />
            <pair e1="DS3.d392.s1.e4" e2="DS3.d392.s1.e0" id="DS3.d392.s1.i3" interaction="False" />
            <pair e1="DS3.d392.s1.e2" e2="DS3.d392.s1.e1" id="DS3.d392.s1.i4" interaction="False" />
            <pair e1="DS3.d392.s1.e2" e2="DS3.d392.s1.e0" id="DS3.d392.s1.i5" interaction="False" />
        </sentence>
        <sentence id="DS3.d392.s2" origId="10024455-5" text="The active site of PTPS consists of the pterin-anchoring Glu A107 neighboured by two catalytic motifs: a Zn(II) binding site and an intersubunit catalytic triad formed by Cys A42, Asp B88 and His B89.">
            <entity id="DS3.d392.s2.e0" origId="Q03393" charOffset="19-23" type="protein" text="PTPS"/>
            <entity id="DS3.d392.s2.e1" origId="73000" charOffset="40-46" type="compound" text="pterin"/>
            <entity id="DS3.d392.s2.e2" origId="54694609" charOffset="61-65" type="compound" text="A107"/>
            <entity id="DS3.d392.s2.e3" origId="46835142" charOffset="184-187" type="compound" text="B88"/>
            <entity id="DS3.d392.s2.e4" origId="44472895" charOffset="196-199" type="compound" text="B89"/>
            <pair e1="DS3.d392.s2.e4" e2="DS3.d392.s2.e0" id="DS3.d392.s2.i0" interaction="False" />
            <pair e1="DS3.d392.s2.e2" e2="DS3.d392.s2.e0" id="DS3.d392.s2.i1" interaction="False" />
            <pair e1="DS3.d392.s2.e1" e2="DS3.d392.s2.e0" id="DS3.d392.s2.i2" interaction="False" />
            <pair e1="DS3.d392.s2.e3" e2="DS3.d392.s2.e0" id="DS3.d392.s2.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d393" origId="10024457">
        <sentence id="DS3.d393.s0" origId="10024457-5" text="Here, we report the structural characterisation of triazine binding by crystallographic refinement of complexes of the RC either with the triazine inhibitor atrazine (Protein Data Bank (PDB) entry 5PRC) or with the chiral atrazine derivatives, DG-420314 (S(-) enantiomer, PDB entry 6PRC) or DG-420315 (R(+) enantiomer, PDB entry 7PRC).">
            <entity id="DS3.d393.s0.e0" origId="2256" charOffset="157-165" type="compound" text="atrazine"/>
            <entity id="DS3.d393.s0.e1" origId="Q13268" charOffset="167-184" type="protein" text="Protein Data Bank"/>
            <entity id="DS3.d393.s0.e2" origId="2256" charOffset="222-230" type="compound" text="atrazine"/>
            <entity id="DS3.d393.s0.e3" origId="449582" charOffset="244-253" type="compound" text="DG-420314"/>
            <entity id="DS3.d393.s0.e4" origId="449597" charOffset="291-300" type="compound" text="DG-420315"/>
            <pair e1="DS3.d393.s0.e0" e2="DS3.d393.s0.e1" id="DS3.d393.s0.i0" interaction="False" />
            <pair e1="DS3.d393.s0.e4" e2="DS3.d393.s0.e1" id="DS3.d393.s0.i1" interaction="False" />
            <pair e1="DS3.d393.s0.e3" e2="DS3.d393.s0.e1" id="DS3.d393.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d394" origId="10024464">
        <sentence id="DS3.d394.s0" origId="10024464-2" text="AT-CDA1 cDNA was subcloned into the expression vector pTrc99-A and the protein, expressed in Escherichia coli following induction with isopropyl 1-thio-beta-d-galactopyranoside, showed high cytidine deaminase activity.">
            <entity id="DS3.d394.s0.e0" origId="O65896" charOffset="0-7" type="protein" text="AT-CDA1"/>
            <entity id="DS3.d394.s0.e1" origId="656894" charOffset="135-176" type="compound" text="isopropyl 1-thio-beta-d-galactopyranoside"/>
            <entity id="DS3.d394.s0.e2" origId="O65571" charOffset="190-208" type="protein" text="cytidine deaminase"/>
            <pair e1="DS3.d394.s0.e1" e2="DS3.d394.s0.e0" id="DS3.d394.s0.i0" interaction="False" />
            <pair e1="DS3.d394.s0.e1" e2="DS3.d394.s0.e2" id="DS3.d394.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d395" origId="10024465">
        <sentence id="DS3.d395.s0" origId="10024465-3" text="cDNAs coding for bovine, rat, and human prolactin; human growth hormone; and bovine alpha-lactalbumin were amplified by PCR using primers that inserted restriction sites at the 5' and 3' ends and reduced the coding sequence to the mature methionyl protein with bacterially preferred codons in the 5' region.">
            <entity id="DS3.d395.s0.e0" origId="P01236,Q5I0G2,Q5THQ0" charOffset="40-49" type="protein" text="prolactin"/>
            <entity id="DS3.d395.s0.e1" origId="P01241,B1A4G6,B1A4G7" charOffset="57-71" type="protein" text="growth hormone"/>
            <entity id="DS3.d395.s0.e2" origId="P00711,B6V3I5" charOffset="84-101" type="protein" text="alpha-lactalbumin"/>
            <entity id="DS3.d395.s0.e3" origId="13091120" charOffset="238-247" type="compound" text="methionyl"/>
            <pair e1="DS3.d395.s0.e3" e2="DS3.d395.s0.e0" id="DS3.d395.s0.i0" interaction="False" />
            <pair e1="DS3.d395.s0.e3" e2="DS3.d395.s0.e2" id="DS3.d395.s0.i1" interaction="False" />
            <pair e1="DS3.d395.s0.e3" e2="DS3.d395.s0.e1" id="DS3.d395.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d396" origId="10024473">
        <sentence id="DS3.d396.s0" origId="10024473-3" text="We have studied the expression yield and folding efficiency of (i) a novel Arabidopsis thaliana peroxidase, ATP N; and (ii) barley grain peroxidase, BP 1.">
            <entity id="DS3.d396.s0.e0" origId="Q9SJZ2" charOffset="96-106" type="protein" text="peroxidase"/>
            <entity id="DS3.d396.s0.e1" origId="5957" charOffset="108-111" type="compound" text="ATP"/>
            <entity id="DS3.d396.s0.e2" origId="Q9SJZ2" charOffset="137-147" type="protein" text="peroxidase"/>
            <pair e1="DS3.d396.s0.e1" e2="DS3.d396.s0.e0" id="DS3.d396.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d396.s1" origId="10024473-6" text="Thus, the yield of active ATP N peroxidase can be increased 50-fold by using thioredoxin reductase negative strains, which facilitate the formation of disulfide bonds in inclusion body protein.">
            <entity id="DS3.d396.s1.e0" origId="5957" charOffset="26-29" type="compound" text="ATP"/>
            <entity id="DS3.d396.s1.e1" origId="Q9SJZ2" charOffset="32-42" type="protein" text="peroxidase"/>
            <pair e1="DS3.d396.s1.e0" e2="DS3.d396.s1.e1" id="DS3.d396.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d397" origId="10024503">
        <sentence id="DS3.d397.s0" origId="10024503-12" text="From these studies, we conclude that APOC1 specifically inhibits the apoE-mediated binding of triacylglycerol-rich lipoprotein particles to the VLDLR, whereas APOC1-enriched lipoproteins can still bind to the LDLR.">
            <entity id="DS3.d397.s0.e0" origId="P02654,A0A024R0T8" charOffset="37-42" type="protein" text="APOC1"/>
            <entity id="DS3.d397.s0.e1" origId="P08226,Q3TXU4" charOffset="69-73" type="protein" text="apoE"/>
            <entity id="DS3.d397.s0.e2" origId="11146" charOffset="94-109" type="compound" text="triacylglycerol"/>
            <entity id="DS3.d397.s0.e3" origId="P02654,A0A024R0T8" charOffset="159-164" type="protein" text="APOC1"/>
            <pair e1="DS3.d397.s0.e2" e2="DS3.d397.s0.e1" id="DS3.d397.s0.i0" interaction="False" />
            <pair e1="DS3.d397.s0.e2" e2="DS3.d397.s0.e0" id="DS3.d397.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d398" origId="10024504">
        <sentence id="DS3.d398.s0" origId="10024504-11" text="Stimulation of parent and SOD-overexpressing cells with a combination of lipopolysaccharide and murine interferon gamma produced equivalent amounts of nitrite/nitrate, which ruled out attenuated inducible NO.">
            <entity id="DS3.d398.s0.e0" origId="11970143" charOffset="73-91" type="compound" text="lipopolysaccharide"/>
            <entity id="DS3.d398.s0.e1" origId="P01580" charOffset="103-119" type="protein" text="interferon gamma"/>
            <entity id="DS3.d398.s0.e2" origId="946" charOffset="151-158" type="compound" text="nitrite"/>
            <entity id="DS3.d398.s0.e3" origId="10313259,943" charOffset="159-166" type="compound" text="nitrate"/>
            <pair e1="DS3.d398.s0.e2" e2="DS3.d398.s0.e1" id="DS3.d398.s0.i0" interaction="False" />
            <pair e1="DS3.d398.s0.e3" e2="DS3.d398.s0.e1" id="DS3.d398.s0.i1" interaction="False" />
            <pair e1="DS3.d398.s0.e0" e2="DS3.d398.s0.e1" id="DS3.d398.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d398.s1" origId="10024504-21" text="Therefore protection observed with CuZnSOD overexpression is unlikely to stem from interference with peroxynitrite formation and/or action.">
            <entity id="DS3.d398.s1.e0" origId="P08228" charOffset="35-42" type="protein" text="CuZnSOD"/>
            <entity id="DS3.d398.s1.e1" origId="104806" charOffset="101-114" type="compound" text="peroxynitrite"/>
            <pair e1="DS3.d398.s1.e1" e2="DS3.d398.s1.e0" id="DS3.d398.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d398.s2" origId="10024504-2" text=")-mediated apoptotic cell death in RAW 264.7 macrophages is associated with up-regulation of mitochondrial manganese superoxide dismutase (MnSOD; SOD2) and down-regulation of cytosolic copper zinc superoxide dismutase (CuZnSOD; SOD1) at their individual mRNA and protein levels.">
            <entity id="DS3.d398.s2.e0" origId="P09671,Q4FJX9" charOffset="107-137" type="protein" text="manganese superoxide dismutase"/>
            <entity id="DS3.d398.s2.e1" origId="P09671,Q4FJX9" charOffset="139-144" type="protein" text="MnSOD"/>
            <entity id="DS3.d398.s2.e2" origId="P09671,Q4FJX9" charOffset="146-150" type="protein" text="SOD2"/>
            <entity id="DS3.d398.s2.e3" origId="23978" charOffset="185-191" type="compound" text="copper"/>
            <entity id="DS3.d398.s2.e4" origId="14809" charOffset="192-207" type="compound" text="zinc superoxide"/>
            <entity id="DS3.d398.s2.e5" origId="P08228" charOffset="219-226" type="protein" text="CuZnSOD"/>
            <entity id="DS3.d398.s2.e6" origId="P08228" charOffset="228-232" type="protein" text="SOD1"/>
            <pair e1="DS3.d398.s2.e3" e2="DS3.d398.s2.e0" id="DS3.d398.s2.i0" interaction="False" />
            <pair e1="DS3.d398.s2.e3" e2="DS3.d398.s2.e2" id="DS3.d398.s2.i1" interaction="False" />
            <pair e1="DS3.d398.s2.e3" e2="DS3.d398.s2.e1" id="DS3.d398.s2.i2" interaction="False" />
            <pair e1="DS3.d398.s2.e3" e2="DS3.d398.s2.e5" id="DS3.d398.s2.i3" interaction="False" />
            <pair e1="DS3.d398.s2.e3" e2="DS3.d398.s2.e6" id="DS3.d398.s2.i4" interaction="False" />
            <pair e1="DS3.d398.s2.e4" e2="DS3.d398.s2.e0" id="DS3.d398.s2.i5" interaction="False" />
            <pair e1="DS3.d398.s2.e4" e2="DS3.d398.s2.e2" id="DS3.d398.s2.i6" interaction="False" />
            <pair e1="DS3.d398.s2.e4" e2="DS3.d398.s2.e1" id="DS3.d398.s2.i7" interaction="False" />
            <pair e1="DS3.d398.s2.e4" e2="DS3.d398.s2.e5" id="DS3.d398.s2.i8" interaction="False" />
            <pair e1="DS3.d398.s2.e4" e2="DS3.d398.s2.e6" id="DS3.d398.s2.i9" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d399" origId="10024505">
        <sentence id="DS3.d399.s0" origId="10024505-6" text="Liver was the most affected tissue in the MT-SSAT transgenic animals, revealed by putrescine overaccumulation, significant decrease in spermidine concentration and &amp;gt;90% reduction in the spermine pool.">
            <entity id="DS3.d399.s0.e0" origId="P48026,Q3V2Q2" charOffset="45-49" type="protein" text="SSAT"/>
            <entity id="DS3.d399.s0.e1" origId="1045" charOffset="82-92" type="compound" text="putrescine"/>
            <entity id="DS3.d399.s0.e2" origId="1102" charOffset="135-145" type="compound" text="spermidine"/>
            <entity id="DS3.d399.s0.e3" origId="1103" charOffset="189-197" type="compound" text="spermine"/>
            <pair e1="DS3.d399.s0.e3" e2="DS3.d399.s0.e0" id="DS3.d399.s0.i0" interaction="False" />
            <pair e1="DS3.d399.s0.e1" e2="DS3.d399.s0.e0" id="DS3.d399.s0.i1" interaction="False" />
            <pair e1="DS3.d399.s0.e2" e2="DS3.d399.s0.e0" id="DS3.d399.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d399.s1" origId="10024505-9" text="Treatment of the transgenic animals with the polyamine analogue N1,N11-diethylnorspermine (DENSPM) resulted in an immense induction, more than 40000-fold, of enzyme activity in the liver of transgenic animals, and minor changes in the SSAT mRNA level.">
            <entity id="DS3.d399.s1.e0" origId="4282" charOffset="64-89" type="compound" text="N1,N11-diethylnorspermine"/>
            <entity id="DS3.d399.s1.e1" origId="P48026,Q3V2Q2" charOffset="235-239" type="protein" text="SSAT"/>
            <pair e1="DS3.d399.s1.e0" e2="DS3.d399.s1.e1" id="DS3.d399.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d400" origId="10024507">
        <sentence id="DS3.d400.s0" origId="10024507-6" text="Like ASGP-2, which binds the receptor tyrosine kinase p185(neu), MUC4beta possesses two epidermal growth factor-like domains, a transmembrane sequence and a potential phosphorylated site.">
            <entity id="DS3.d400.s0.e0" origId="6057,90983769" charOffset="38-46" type="compound" text="tyrosine"/>
            <entity id="DS3.d400.s0.e1" origId="Q14152" charOffset="54-58" type="protein" text="p185"/>
            <pair e1="DS3.d400.s0.e0" e2="DS3.d400.s0.e1" id="DS3.d400.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d401" origId="10024510">
        <sentence id="DS3.d401.s0" origId="10024510-1" text="To investigate which retinoid receptors are critical in the regulation by all-trans-retinoic acid (RA) of the mucin genes MUC2, MUC5AC and MUC5B in cultured normal human tracheobronchial epithelial (NHTBE) cells, we used pan-RAR-, pan-RXR- and RAR- isotype (alpha, beta and gamma)-selective agonists and RARalpha- and RARgamma-selective antagonists (RAR is RA receptor and RXR is retinoid X receptor).">
            <entity id="DS3.d401.s0.e0" origId="444795" charOffset="78-97" type="compound" text="trans-retinoic acid"/>
            <entity id="DS3.d401.s0.e1" origId="Q02817" charOffset="122-126" type="protein" text="MUC2"/>
            <entity id="DS3.d401.s0.e2" origId="P98088" charOffset="128-134" type="protein" text="MUC5AC"/>
            <entity id="DS3.d401.s0.e3" origId="Q9HC84" charOffset="139-144" type="protein" text="MUC5B"/>
            <entity id="DS3.d401.s0.e4" origId="P10276,A8MUP8,F1D8N9,Q6I9R7,A8K840" charOffset="304-312" type="protein" text="RARalpha"/>
            <entity id="DS3.d401.s0.e5" origId="P13631,A8K3H3,B7Z4B4,F1D8P1" charOffset="318-326" type="protein" text="RARgamma"/>
            <pair e1="DS3.d401.s0.e0" e2="DS3.d401.s0.e2" id="DS3.d401.s0.i0" interaction="False" />
            <pair e1="DS3.d401.s0.e0" e2="DS3.d401.s0.e1" id="DS3.d401.s0.i1" interaction="False" />
            <pair e1="DS3.d401.s0.e0" e2="DS3.d401.s0.e4" id="DS3.d401.s0.i2" interaction="False" />
            <pair e1="DS3.d401.s0.e0" e2="DS3.d401.s0.e5" id="DS3.d401.s0.i3" interaction="False" />
            <pair e1="DS3.d401.s0.e0" e2="DS3.d401.s0.e3" id="DS3.d401.s0.i4" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d402" origId="10024512">
        <sentence id="DS3.d402.s0" origId="10024512-0" text="Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.">
            <entity id="DS3.d402.s0.e0" origId="P16612,Q541S7,A0A0G2K6Z7,B5DEK7" charOffset="27-61" type="protein" text="vascular endothelial growth factor"/>
            <entity id="DS3.d402.s0.e1" origId="6057,90983769" charOffset="88-96" type="compound" text="tyrosine"/>
            <entity id="DS3.d402.s0.e2" origId="145068" charOffset="119-131" type="compound" text="nitric oxide"/>
            <pair e1="DS3.d402.s0.e2" e2="DS3.d402.s0.e0" id="DS3.d402.s0.i0" interaction="False" />
            <pair e1="DS3.d402.s0.e1" e2="DS3.d402.s0.e0" id="DS3.d402.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d402.s1" origId="10024512-3" text="We identified vascular endothelial growth factor (VEGF) and its receptor fms-like tyrosine kinase (FLT-1) to be under the regulatory control of exogenously applied NO in these cells.">
            <entity id="DS3.d402.s1.e0" origId="P16612,Q541S7,A0A0G2K6Z7,B5DEK7" charOffset="14-48" type="protein" text="vascular endothelial growth factor"/>
            <entity id="DS3.d402.s1.e1" origId="P16612,Q541S7,A0A0G2K6Z7,B5DEK7" charOffset="50-54" type="protein" text="VEGF"/>
            <entity id="DS3.d402.s1.e2" origId="6057,90983769" charOffset="82-90" type="compound" text="tyrosine"/>
            <entity id="DS3.d402.s1.e3" origId="G3V633" charOffset="99-104" type="protein" text="FLT-1"/>
            <pair e1="DS3.d402.s1.e2" e2="DS3.d402.s1.e3" id="DS3.d402.s1.i0" interaction="False" />
            <pair e1="DS3.d402.s1.e2" e2="DS3.d402.s1.e0" id="DS3.d402.s1.i1" interaction="False" />
            <pair e1="DS3.d402.s1.e2" e2="DS3.d402.s1.e1" id="DS3.d402.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d402.s2" origId="10024512-4" text="Using S-nitroso-glutathione (GSNO) as an NO-donating agent, VEGF expression was strongly induced, whereas expression of its FLT-1 receptor simultaneously decreased.">
            <entity id="DS3.d402.s2.e0" origId="3514" charOffset="6-27" type="compound" text="S-nitroso-glutathione"/>
            <entity id="DS3.d402.s2.e1" origId="104858" charOffset="29-33" type="compound" text="GSNO"/>
            <entity id="DS3.d402.s2.e2" origId="P16612,Q541S7,A0A0G2K6Z7,B5DEK7" charOffset="60-64" type="protein" text="VEGF"/>
            <entity id="DS3.d402.s2.e3" origId="G3V633" charOffset="124-129" type="protein" text="FLT-1"/>
            <pair e1="DS3.d402.s2.e0" e2="DS3.d402.s2.e3" id="DS3.d402.s2.i0" interaction="False" />
            <pair e1="DS3.d402.s2.e0" e2="DS3.d402.s2.e2" id="DS3.d402.s2.i1" interaction="False" />
            <pair e1="DS3.d402.s2.e1" e2="DS3.d402.s2.e3" id="DS3.d402.s2.i2" interaction="False" />
            <pair e1="DS3.d402.s2.e1" e2="DS3.d402.s2.e2" id="DS3.d402.s2.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d402.s3" origId="10024512-5" text="Expressional regulation of VEGF and FLT-1 mRNA was transient and occurred rapidly within 1-3 h after GSNO treatment.">
            <entity id="DS3.d402.s3.e0" origId="P16612,Q541S7,A0A0G2K6Z7,B5DEK7" charOffset="27-31" type="protein" text="VEGF"/>
            <entity id="DS3.d402.s3.e1" origId="G3V633" charOffset="36-41" type="protein" text="FLT-1"/>
            <entity id="DS3.d402.s3.e2" origId="104858" charOffset="101-105" type="compound" text="GSNO"/>
            <pair e1="DS3.d402.s3.e2" e2="DS3.d402.s3.e1" id="DS3.d402.s3.i0" interaction="False" />
            <pair e1="DS3.d402.s3.e2" e2="DS3.d402.s3.e0" id="DS3.d402.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d403" origId="10024514">
        <sentence id="DS3.d403.s0" origId="10024514-8" text="V12 Cdc42 weakly activated JNK, but synergized with PDGF and not IL-1.">
            <entity id="DS3.d403.s0.e0" origId="16129592" charOffset="0-3" type="compound" text="V12"/>
            <entity id="DS3.d403.s0.e1" origId="P60953,A0A024RAE4,A0A024RAE6" charOffset="4-9" type="protein" text="Cdc42"/>
            <pair e1="DS3.d403.s0.e0" e2="DS3.d403.s0.e1" id="DS3.d403.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d404" origId="10024515">
        <sentence id="DS3.d404.s0" origId="10024515-0" text="canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.">
            <entity id="DS3.d404.s0.e0" origId="Q63120" charOffset="0-51" type="protein" text="canalicular multispecific organic anion transporter"/>
            <entity id="DS3.d404.s0.e1" origId="124886" charOffset="118-137" type="compound" text="reduced glutathione"/>
            <pair e1="DS3.d404.s0.e1" e2="DS3.d404.s0.e0" id="DS3.d404.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d404.s1" origId="10024515-10" text="In membrane vesicles isolated from cMOAT-expressing MDCKII cells, ATP-dependent S-(2,4-dinitrophenyl)glutathione uptake is competitively inhibited by high concentrations of GSH (Ki approximately 20 mM).">
            <entity id="DS3.d404.s1.e0" origId="Q92887" charOffset="35-40" type="protein" text="cMOAT"/>
            <entity id="DS3.d404.s1.e1" origId="5957" charOffset="66-69" type="compound" text="ATP"/>
            <entity id="DS3.d404.s1.e2" origId="97535" charOffset="80-112" type="compound" text="S-(2,4-dinitrophenyl)glutathione"/>
            <pair e1="DS3.d404.s1.e1" e2="DS3.d404.s1.e0" id="DS3.d404.s1.i0" interaction="False" />
            <pair e1="DS3.d404.s1.e2" e2="DS3.d404.s1.e0" id="DS3.d404.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d404.s2" origId="10024515-1" text="The canalicular multispecific organic anion transporter (cMOAT), a member of the ATP-binding cassette transporter family, mediates the transport of a broad range of non-bile salt organic anions from liver into bile.">
            <entity id="DS3.d404.s2.e0" origId="Q63120" charOffset="4-55" type="protein" text="canalicular multispecific organic anion transporter"/>
            <entity id="DS3.d404.s2.e1" origId="Q92887" charOffset="57-62" type="protein" text="cMOAT"/>
            <entity id="DS3.d404.s2.e2" origId="5957" charOffset="81-84" type="compound" text="ATP"/>
            <pair e1="DS3.d404.s2.e2" e2="DS3.d404.s2.e1" id="DS3.d404.s2.i0" interaction="False" />
            <pair e1="DS3.d404.s2.e2" e2="DS3.d404.s2.e0" id="DS3.d404.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d404.s3" origId="10024515-2" text="cMOAT-deficient Wistar rats (TR-) are mutated in the gene encoding cMOAT, leading to defective hepatobiliary transport of a whole range of substrates, including bilirubin glucuronide.">
            <entity id="DS3.d404.s3.e0" origId="Q92887" charOffset="0-5" type="protein" text="cMOAT"/>
            <entity id="DS3.d404.s3.e1" origId="Q92887" charOffset="67-72" type="protein" text="cMOAT"/>
            <entity id="DS3.d404.s3.e2" origId="5280352" charOffset="161-170" type="compound" text="bilirubin"/>
            <entity id="DS3.d404.s3.e3" origId="5281877" charOffset="171-182" type="compound" text="glucuronide"/>
            <pair e1="DS3.d404.s3.e2" e2="DS3.d404.s3.e0" id="DS3.d404.s3.i0" interaction="False" />
            <pair e1="DS3.d404.s3.e3" e2="DS3.d404.s3.e0" id="DS3.d404.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d404.s4" origId="10024515-9" text="Furthermore, we have shown, in cMOAT-transfected cells, that GSH is a low-affinity substrate for the transporter and that its excretion is reduced upon ATP depletion.">
            <entity id="DS3.d404.s4.e0" origId="Q92887" charOffset="31-36" type="protein" text="cMOAT"/>
            <entity id="DS3.d404.s4.e1" origId="5957" charOffset="152-155" type="compound" text="ATP"/>
            <pair e1="DS3.d404.s4.e1" e2="DS3.d404.s4.e0" id="DS3.d404.s4.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d405" origId="10024519">
        <sentence id="DS3.d405.s0" origId="10024519-11" text="Hormone potentiation of EGF-induced signal transduction and c-Fos expression was inhibited by CGP 41251, geldanamycin and PD 98059.">
            <entity id="DS3.d405.s0.e0" origId="P01100,Q6FG41" charOffset="60-65" type="protein" text="c-Fos"/>
            <entity id="DS3.d405.s0.e1" origId="13017912,24196291,3460,45073431,46936377,5281885,5288382,5288451,56840921,57288407,5702269,71307093,71308206,71317043,73554183" charOffset="105-117" type="compound" text="geldanamycin"/>
            <entity id="DS3.d405.s0.e2" origId="4713" charOffset="122-130" type="compound" text="PD 98059"/>
            <pair e1="DS3.d405.s0.e1" e2="DS3.d405.s0.e0" id="DS3.d405.s0.i0" interaction="False" />
            <pair e1="DS3.d405.s0.e2" e2="DS3.d405.s0.e0" id="DS3.d405.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d405.s1" origId="10024519-1" text="We have examined the effects of l-thyroxine (T4) on the activation of signal transducer and activator of transcription 3 (STAT3) and on the STAT3-dependent induction of c-Fos expression by epidermal growth factor (EGF).">
            <entity id="DS3.d405.s1.e0" origId="5819,853" charOffset="34-43" type="compound" text="thyroxine"/>
            <entity id="DS3.d405.s1.e1" origId="P40763" charOffset="70-120" type="protein" text="signal transducer and activator of transcription 3"/>
            <entity id="DS3.d405.s1.e2" origId="P40763" charOffset="122-127" type="protein" text="STAT3"/>
            <entity id="DS3.d405.s1.e3" origId="P40763" charOffset="140-145" type="protein" text="STAT3"/>
            <entity id="DS3.d405.s1.e4" origId="P01100,Q6FG41" charOffset="169-174" type="protein" text="c-Fos"/>
            <pair e1="DS3.d405.s1.e0" e2="DS3.d405.s1.e2" id="DS3.d405.s1.i0" interaction="False" />
            <pair e1="DS3.d405.s1.e0" e2="DS3.d405.s1.e1" id="DS3.d405.s1.i1" interaction="False" />
            <pair e1="DS3.d405.s1.e0" e2="DS3.d405.s1.e4" id="DS3.d405.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d405.s2" origId="10024519-6" text="This effect was reproduced by T4-agarose (100 nM) and blocked by CGP 41251, genistein, PD 98059 and geldanamycin, inhibitors of protein kinase C (PKC), protein tyrosine kinase (PTK), mitogen-activated protein kinase (MAPK) kinase and Raf-1 respectively.">
            <entity id="DS3.d405.s2.e0" origId="11966311" charOffset="33-40" type="compound" text="agarose"/>
            <entity id="DS3.d405.s2.e1" origId="5280961" charOffset="76-85" type="compound" text="genistein"/>
            <entity id="DS3.d405.s2.e2" origId="4713" charOffset="87-95" type="compound" text="PD 98059"/>
            <entity id="DS3.d405.s2.e3" origId="13017912,24196291,3460,45073431,46936377,5281885,5288382,5288451,56840921,5702269,57288407,71307093,71308206,71317043,73554183" charOffset="100-112" type="compound" text="geldanamycin"/>
            <entity id="DS3.d405.s2.e4" origId="6057,90983769" charOffset="160-168" type="compound" text="tyrosine"/>
            <entity id="DS3.d405.s2.e5" origId="P04049,L7RRS6,B4E0X2" charOffset="234-239" type="protein" text="Raf-1"/>
            <pair e1="DS3.d405.s2.e4" e2="DS3.d405.s2.e5" id="DS3.d405.s2.i0" interaction="False" />
            <pair e1="DS3.d405.s2.e0" e2="DS3.d405.s2.e5" id="DS3.d405.s2.i1" interaction="False" />
            <pair e1="DS3.d405.s2.e2" e2="DS3.d405.s2.e5" id="DS3.d405.s2.i2" interaction="False" />
            <pair e1="DS3.d405.s2.e3" e2="DS3.d405.s2.e5" id="DS3.d405.s2.i3" interaction="False" />
            <pair e1="DS3.d405.s2.e1" e2="DS3.d405.s2.e5" id="DS3.d405.s2.i4" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d406" origId="10024523">
        <sentence id="DS3.d406.s0" origId="10024523-1" text="The expression of a luciferase reporter gene under the control of the human glucose 6-phosphatase gene promoter was stimulated by both dexamethasone and dibutyryl cAMP in H4IIE hepatoma cells.">
            <entity id="DS3.d406.s0.e0" origId="P35575" charOffset="76-97" type="protein" text="glucose 6-phosphatase"/>
            <entity id="DS3.d406.s0.e1" origId="5743" charOffset="135-148" type="compound" text="dexamethasone"/>
            <entity id="DS3.d406.s0.e2" origId="P49913,J3KNB4" charOffset="163-167" type="protein" text="cAMP"/>
            <pair e1="DS3.d406.s0.e1" e2="DS3.d406.s0.e2" id="DS3.d406.s0.i0" interaction="False" />
            <pair e1="DS3.d406.s0.e1" e2="DS3.d406.s0.e0" id="DS3.d406.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d406.s1" origId="10024523-2" text="A cis-active element located between nucleotides -161 and -152 in the glucose 6-phosphatase gene promoter was identified and found to be necessary for both basal reporter-gene expression and induction of expression by both dibutyryl cAMP and dexamethasone.">
            <entity id="DS3.d406.s1.e0" origId="P35575" charOffset="70-91" type="protein" text="glucose 6-phosphatase"/>
            <entity id="DS3.d406.s1.e1" origId="P49913,J3KNB4" charOffset="233-237" type="protein" text="cAMP"/>
            <entity id="DS3.d406.s1.e2" origId="5743" charOffset="242-255" type="compound" text="dexamethasone"/>
            <pair e1="DS3.d406.s1.e2" e2="DS3.d406.s1.e1" id="DS3.d406.s1.i0" interaction="False" />
            <pair e1="DS3.d406.s1.e2" e2="DS3.d406.s1.e0" id="DS3.d406.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d407" origId="10024524">
        <sentence id="DS3.d407.s0" origId="10024524-2" text="In the present study, we found that in this phenotype, Bcl-2, an apoptosis inhibitor, affects mitogen-activated protein (MAP)-kinase activity, which is known as a key enzyme of the signal-transduction cascade for differentiation.">
            <entity id="DS3.d407.s0.e0" origId="P49950" charOffset="55-60" type="protein" text="Bcl-2"/>
            <entity id="DS3.d407.s0.e1" origId="2748618" charOffset="65-84" type="compound" text="apoptosis inhibitor"/>
            <pair e1="DS3.d407.s0.e1" e2="DS3.d407.s0.e0" id="DS3.d407.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d407.s1" origId="10024524-6" text="This Bcl-2 elevation was not affected by treatment with PD98059, suggesting that it did not directly induce neurite extension under hyperoxia.">
            <entity id="DS3.d407.s1.e0" origId="P49950" charOffset="5-10" type="protein" text="Bcl-2"/>
            <entity id="DS3.d407.s1.e1" origId="4713" charOffset="56-63" type="compound" text="PD98059"/>
            <pair e1="DS3.d407.s1.e1" e2="DS3.d407.s1.e0" id="DS3.d407.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d408" origId="10024525">
        <sentence id="DS3.d408.s0" origId="10024525-4" text="p120, originally discovered as a substrate of the tyrosine kinase Src, is also a target for a protein kinase C-stimulated pathway in epithelial cells, causing its serine/threonine dephosphorylation.">
            <entity id="DS3.d408.s0.e0" origId="O60716" charOffset="0-4" type="protein" text="p120"/>
            <entity id="DS3.d408.s0.e1" origId="6057,90983769" charOffset="50-58" type="compound" text="tyrosine"/>
            <entity id="DS3.d408.s0.e2" origId="194239,6288" charOffset="170-179" type="compound" text="threonine"/>
            <pair e1="DS3.d408.s0.e2" e2="DS3.d408.s0.e0" id="DS3.d408.s0.i0" interaction="False" />
            <pair e1="DS3.d408.s0.e1" e2="DS3.d408.s0.e0" id="DS3.d408.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d408.s1" origId="10024525-6" text="Activation of receptors for agents such as histamine (H1), thrombin and lysophosphatidic acid in the endothelial cells also caused serine/threonine dephosphorylation of p120 and p100, suggesting physiological relevance.">
            <entity id="DS3.d408.s1.e0" origId="774" charOffset="43-52" type="compound" text="histamine"/>
            <entity id="DS3.d408.s1.e1" origId="90470996" charOffset="59-67" type="compound" text="thrombin"/>
            <entity id="DS3.d408.s1.e2" origId="3988,5311263,5497152,5885531" charOffset="72-93" type="compound" text="lysophosphatidic acid"/>
            <entity id="DS3.d408.s1.e3" origId="194239,6288" charOffset="138-147" type="compound" text="threonine"/>
            <entity id="DS3.d408.s1.e4" origId="O60716" charOffset="169-173" type="protein" text="p120"/>
            <entity id="DS3.d408.s1.e5" origId="Q13948,P39880,Q3LIA3" charOffset="178-182" type="protein" text="p100"/>
            <pair e1="DS3.d408.s1.e1" e2="DS3.d408.s1.e5" id="DS3.d408.s1.i0" interaction="False" />
            <pair e1="DS3.d408.s1.e1" e2="DS3.d408.s1.e4" id="DS3.d408.s1.i1" interaction="False" />
            <pair e1="DS3.d408.s1.e3" e2="DS3.d408.s1.e5" id="DS3.d408.s1.i2" interaction="False" />
            <pair e1="DS3.d408.s1.e3" e2="DS3.d408.s1.e4" id="DS3.d408.s1.i3" interaction="False" />
            <pair e1="DS3.d408.s1.e0" e2="DS3.d408.s1.e5" id="DS3.d408.s1.i4" interaction="False" />
            <pair e1="DS3.d408.s1.e0" e2="DS3.d408.s1.e4" id="DS3.d408.s1.i5" interaction="False" />
            <pair e1="DS3.d408.s1.e2" e2="DS3.d408.s1.e5" id="DS3.d408.s1.i6" interaction="False" />
            <pair e1="DS3.d408.s1.e2" e2="DS3.d408.s1.e4" id="DS3.d408.s1.i7" interaction="False" />
        </sentence>
        <sentence id="DS3.d408.s2" origId="10024525-8" text="Calcium mobilization and the myosin-light-chain-kinase pathway do not participate in p120/p100 signalling.">
            <entity id="DS3.d408.s2.e0" origId="22044544,5460341" charOffset="0-7" type="compound" text="Calcium"/>
            <entity id="DS3.d408.s2.e1" origId="Q15746" charOffset="29-54" type="protein" text="myosin-light-chain-kinase"/>
            <entity id="DS3.d408.s2.e2" origId="O60716" charOffset="85-89" type="protein" text="p120"/>
            <entity id="DS3.d408.s2.e3" origId="Q13948,P39880,Q3LIA3" charOffset="90-94" type="protein" text="p100"/>
            <pair e1="DS3.d408.s2.e0" e2="DS3.d408.s2.e1" id="DS3.d408.s2.i0" interaction="False" />
            <pair e1="DS3.d408.s2.e0" e2="DS3.d408.s2.e3" id="DS3.d408.s2.i1" interaction="False" />
            <pair e1="DS3.d408.s2.e0" e2="DS3.d408.s2.e2" id="DS3.d408.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d408.s3" origId="10024525-9" text="In conclusion, endothelial cells possess protein kinase C-dependent and -independent pathways regulating p120/p100 serine/threonine phosphorylation.">
            <entity id="DS3.d408.s3.e0" origId="O60716" charOffset="105-109" type="protein" text="p120"/>
            <entity id="DS3.d408.s3.e1" origId="Q13948,P39880,Q3LIA3" charOffset="110-114" type="protein" text="p100"/>
            <entity id="DS3.d408.s3.e2" origId="194239,6288" charOffset="122-131" type="compound" text="threonine"/>
            <pair e1="DS3.d408.s3.e2" e2="DS3.d408.s3.e1" id="DS3.d408.s3.i0" interaction="False" />
            <pair e1="DS3.d408.s3.e2" e2="DS3.d408.s3.e0" id="DS3.d408.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d409" origId="10024526">
        <sentence id="DS3.d409.s0" origId="10024526-10" text="Finally, similar studies have demonstrated that a different situation exists during the oxidation of high-density lipoprotein, with enzyme(s) other than Lp-PLA2 apparently being responsible for generating lysophosphatidylcholine.">
            <entity id="DS3.d409.s0.e0" origId="Q13093" charOffset="153-160" type="protein" text="Lp-PLA2"/>
            <entity id="DS3.d409.s0.e1" origId="5311265" charOffset="205-228" type="compound" text="lysophosphatidylcholine"/>
            <pair e1="DS3.d409.s0.e1" e2="DS3.d409.s0.e0" id="DS3.d409.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d409.s1" origId="10024526-1" text="A novel and potent azetidinone inhibitor of the Lipoprotein-associated phospholipase A2 (Lp-PLA2), i.e.">
            <entity id="DS3.d409.s1.e0" origId="136721" charOffset="19-30" type="compound" text="azetidinone"/>
            <entity id="DS3.d409.s1.e1" origId="Q13093" charOffset="48-87" type="protein" text="Lipoprotein-associated phospholipase A2"/>
            <entity id="DS3.d409.s1.e2" origId="Q13093" charOffset="89-96" type="protein" text="Lp-PLA2"/>
            <pair e1="DS3.d409.s1.e0" e2="DS3.d409.s1.e1" id="DS3.d409.s1.i0" interaction="False" />
            <pair e1="DS3.d409.s1.e0" e2="DS3.d409.s1.e2" id="DS3.d409.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d409.s2" origId="10024526-4" text="6x10(5) M-1.s-1), is inactive against paraoxonase, is a poor inhibitor of lecithin:cholesterol acyltransferase and has been used to investigate the role of Lp-PLA2 in the oxidative modification of lipoproteins.">
            <entity id="DS3.d409.s2.e0" origId="5997" charOffset="83-94" type="compound" text="cholesterol"/>
            <entity id="DS3.d409.s2.e1" origId="Q13093" charOffset="156-163" type="protein" text="Lp-PLA2"/>
            <pair e1="DS3.d409.s2.e0" e2="DS3.d409.s2.e1" id="DS3.d409.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d409.s3" origId="10024526-8" text="Thus, in addition to generating lysophosphatidylcholine, a known biologically active lipid, these results demonstrate that Lp-PLA2 is capable of generating oxidized non-esterified fatty acid moieties that are also bioactive.">
            <entity id="DS3.d409.s3.e0" origId="5311265" charOffset="32-55" type="compound" text="lysophosphatidylcholine"/>
            <entity id="DS3.d409.s3.e1" origId="Q13093" charOffset="123-130" type="protein" text="Lp-PLA2"/>
            <pair e1="DS3.d409.s3.e0" e2="DS3.d409.s3.e1" id="DS3.d409.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d410" origId="10024527">
        <sentence id="DS3.d410.s0" origId="10024527-13" text="Expression and analysis in vitro of recombinant UGT1A7, UGT1A9, UGT1A10, UGT2B7 and UGT2B15 demonstrated that UGT1A7, UGT1A9 and UGT1A10 catalysed the glucuronidation of 7-hydroxybenzo(alpha)pyrene, as well as other environmental carcinogens, such as 2-hydroxyamino-1-methyl-6-phenylimidazo-(4, 5-beta)-pyridine.">
            <entity id="DS3.d410.s0.e0" origId="Q9HAW7,Q5DSZ7" charOffset="48-54" type="protein" text="UGT1A7"/>
            <entity id="DS3.d410.s0.e1" origId="O60656,Q5DSZ5" charOffset="56-62" type="protein" text="UGT1A9"/>
            <entity id="DS3.d410.s0.e2" origId="Q9HAW8,Q5DT02" charOffset="64-71" type="protein" text="UGT1A10"/>
            <entity id="DS3.d410.s0.e3" origId="P16662,E9PBP8" charOffset="73-79" type="protein" text="UGT2B7"/>
            <entity id="DS3.d410.s0.e4" origId="P54855,B7ZW53" charOffset="84-91" type="protein" text="UGT2B15"/>
            <entity id="DS3.d410.s0.e5" origId="Q9HAW7,Q5DSZ7" charOffset="110-116" type="protein" text="UGT1A7"/>
            <entity id="DS3.d410.s0.e6" origId="O60656,Q5DSZ5" charOffset="118-124" type="protein" text="UGT1A9"/>
            <entity id="DS3.d410.s0.e7" origId="Q9HAW8,Q5DT02" charOffset="129-136" type="protein" text="UGT1A10"/>
            <entity id="DS3.d410.s0.e8" origId="31423" charOffset="191-197" type="compound" text="pyrene"/>
            <entity id="DS3.d410.s0.e9" origId="69591" charOffset="277-290" type="compound" text="phenylimidazo"/>
            <entity id="DS3.d410.s0.e10" origId="1049" charOffset="303-311" type="compound" text="pyridine"/>
            <pair e1="DS3.d410.s0.e9" e2="DS3.d410.s0.e3" id="DS3.d410.s0.i0" interaction="False" />
            <pair e1="DS3.d410.s0.e9" e2="DS3.d410.s0.e0" id="DS3.d410.s0.i1" interaction="False" />
            <pair e1="DS3.d410.s0.e9" e2="DS3.d410.s0.e1" id="DS3.d410.s0.i2" interaction="False" />
            <pair e1="DS3.d410.s0.e9" e2="DS3.d410.s0.e2" id="DS3.d410.s0.i3" interaction="False" />
            <pair e1="DS3.d410.s0.e9" e2="DS3.d410.s0.e4" id="DS3.d410.s0.i4" interaction="False" />
            <pair e1="DS3.d410.s0.e10" e2="DS3.d410.s0.e3" id="DS3.d410.s0.i5" interaction="False" />
            <pair e1="DS3.d410.s0.e10" e2="DS3.d410.s0.e0" id="DS3.d410.s0.i6" interaction="False" />
            <pair e1="DS3.d410.s0.e10" e2="DS3.d410.s0.e1" id="DS3.d410.s0.i7" interaction="False" />
            <pair e1="DS3.d410.s0.e10" e2="DS3.d410.s0.e2" id="DS3.d410.s0.i8" interaction="False" />
            <pair e1="DS3.d410.s0.e10" e2="DS3.d410.s0.e4" id="DS3.d410.s0.i9" interaction="False" />
            <pair e1="DS3.d410.s0.e8" e2="DS3.d410.s0.e3" id="DS3.d410.s0.i10" interaction="False" />
            <pair e1="DS3.d410.s0.e8" e2="DS3.d410.s0.e0" id="DS3.d410.s0.i11" interaction="False" />
            <pair e1="DS3.d410.s0.e8" e2="DS3.d410.s0.e1" id="DS3.d410.s0.i12" interaction="False" />
            <pair e1="DS3.d410.s0.e8" e2="DS3.d410.s0.e2" id="DS3.d410.s0.i13" interaction="False" />
            <pair e1="DS3.d410.s0.e8" e2="DS3.d410.s0.e4" id="DS3.d410.s0.i14" interaction="False" />
        </sentence>
        <sentence id="DS3.d410.s1" origId="10024527-14" text="Although UGT1A9 was not regulated in the carcinoma tissue, the five-fold reduction in 7-hydroxybenzo(alpha)pyrene glucuronidation could be attributed to regulation of UGT1A7 and UGT1A10.">
            <entity id="DS3.d410.s1.e0" origId="O60656,Q5DSZ5" charOffset="9-15" type="protein" text="UGT1A9"/>
            <entity id="DS3.d410.s1.e1" origId="31423" charOffset="107-113" type="compound" text="pyrene"/>
            <entity id="DS3.d410.s1.e2" origId="Q9HAW7,Q5DSZ7" charOffset="167-173" type="protein" text="UGT1A7"/>
            <entity id="DS3.d410.s1.e3" origId="Q9HAW8,Q5DT02" charOffset="178-185" type="protein" text="UGT1A10"/>
            <pair e1="DS3.d410.s1.e1" e2="DS3.d410.s1.e2" id="DS3.d410.s1.i0" interaction="False" />
            <pair e1="DS3.d410.s1.e1" e2="DS3.d410.s1.e0" id="DS3.d410.s1.i1" interaction="False" />
            <pair e1="DS3.d410.s1.e1" e2="DS3.d410.s1.e3" id="DS3.d410.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d411" origId="10024528">
        <sentence id="DS3.d411.s0" origId="10024528-1" text="We previously purified an NADH-dependent Fe3+-chelate reductase (NFR) from maize roots with biochemical features of a cytochrome-b5 reductase (b5R) (Sparla, Bagnaresi, Scagliarini and Trost (1997) FEBS Lett.">
            <entity id="DS3.d411.s0.e0" origId="439153" charOffset="26-30" type="compound" text="NADH"/>
            <entity id="DS3.d411.s0.e1" origId="A0A096SN13,Q8W2K4" charOffset="118-141" type="protein" text="cytochrome-b5 reductase"/>
            <entity id="DS3.d411.s0.e2" origId="24892822" charOffset="143-146" type="compound" text="b5R"/>
            <pair e1="DS3.d411.s0.e2" e2="DS3.d411.s0.e1" id="DS3.d411.s0.i0" interaction="False" />
            <pair e1="DS3.d411.s0.e0" e2="DS3.d411.s0.e1" id="DS3.d411.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d412" origId="10024532">
        <sentence id="DS3.d412.s0" origId="10024532-7" text="Furthermore, we determined N-acetylgalactosamine in the Fab fragment of this antibody, suggesting the presence of O-linked carbohydrates.">
            <entity id="DS3.d412.s0.e0" origId="35717,440552,57455154,899,84265" charOffset="27-48" type="compound" text="N-acetylgalactosamine"/>
            <entity id="DS3.d412.s0.e1" origId="Q8NB91,A0A024RBW1" charOffset="56-59" type="protein" text="Fab"/>
            <pair e1="DS3.d412.s0.e0" e2="DS3.d412.s0.e1" id="DS3.d412.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d413" origId="10024533">
        <sentence id="DS3.d413.s0" origId="10024533-2" text="It interacts with early endosomes via binding to the membrane lipid phosphatidylinositol 3-phosphate (PtdIns3P) and the active form of the small GTPase Rab5.">
            <entity id="DS3.d413.s0.e0" origId="6857403" charOffset="68-100" type="compound" text="phosphatidylinositol 3-phosphate"/>
            <entity id="DS3.d413.s0.e1" origId="24755494" charOffset="102-110" type="compound" text="PtdIns3P"/>
            <entity id="DS3.d413.s0.e2" origId="P20339,A0A024R2K1" charOffset="152-156" type="protein" text="Rab5"/>
            <pair e1="DS3.d413.s0.e1" e2="DS3.d413.s0.e2" id="DS3.d413.s0.i0" interaction="False" />
            <pair e1="DS3.d413.s0.e0" e2="DS3.d413.s0.e2" id="DS3.d413.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d413.s1" origId="10024533-6" text="Glycerol gradient centrifugation experiments indicated that native EEA1 had the same hydrodynamic properties as the approximately 350-kDa crosslinked complex.">
            <entity id="DS3.d413.s1.e0" origId="24759880,753" charOffset="0-8" type="compound" text="Glycerol"/>
            <entity id="DS3.d413.s1.e1" origId="Q15075" charOffset="67-71" type="protein" text="EEA1"/>
            <pair e1="DS3.d413.s1.e0" e2="DS3.d413.s1.e1" id="DS3.d413.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d413.s2" origId="10024533-8" text="The ability of the C-terminus of EEA1 to dimerize correlates with its ability to bind to Rab5 and early endosomes, whereas its binding to PtdIns3P is independent of dimerization.">
            <entity id="DS3.d413.s2.e0" origId="Q15075" charOffset="33-37" type="protein" text="EEA1"/>
            <entity id="DS3.d413.s2.e1" origId="P20339,A0A024R2K1" charOffset="89-93" type="protein" text="Rab5"/>
            <entity id="DS3.d413.s2.e2" origId="24755494" charOffset="138-146" type="compound" text="PtdIns3P"/>
            <pair e1="DS3.d413.s2.e2" e2="DS3.d413.s2.e0" id="DS3.d413.s2.i0" interaction="False" />
            <pair e1="DS3.d413.s2.e2" e2="DS3.d413.s2.e1" id="DS3.d413.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d414" origId="10024536">
        <sentence id="DS3.d414.s0" origId="10024536-15" text="RA-treated P19 cells were about 4-fold more resistant to tunicamycin, a fungal antibiotic which inhibits GPT, than were control cells.">
            <entity id="DS3.d414.s0.e0" origId="16727450,25465,5282055,57369528,6433557,71308289" charOffset="57-68" type="compound" text="tunicamycin"/>
            <entity id="DS3.d414.s0.e1" origId="Q8QZR5,Q566C3" charOffset="105-108" type="protein" text="GPT"/>
            <pair e1="DS3.d414.s0.e0" e2="DS3.d414.s0.e1" id="DS3.d414.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d414.s1" origId="10024536-17" text="4-fold increased resistance to tunicamycin compared with activity in membranes from untreated control cells, demonstrating that resistance to tunicamycin is correlated with induced GPT activity.">
            <entity id="DS3.d414.s1.e0" origId="16727450,25465,5282055,57369528,6433557,71308289" charOffset="31-42" type="compound" text="tunicamycin"/>
            <entity id="DS3.d414.s1.e1" origId="16727450,25465,5282055,57369528,6433557,71308289" charOffset="142-153" type="compound" text="tunicamycin"/>
            <entity id="DS3.d414.s1.e2" origId="Q8QZR5,Q566C3" charOffset="181-184" type="protein" text="GPT"/>
            <pair e1="DS3.d414.s1.e0" e2="DS3.d414.s1.e2" id="DS3.d414.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d414.s2" origId="10024536-18" text="Furthermore, increased GPT activity had regulatory significance with regard to the rate of incorporation of (3H)mannose into Glc3Man9GlcNAc2-P-P-dolichol and into glycoproteins.">
            <entity id="DS3.d414.s2.e0" origId="Q8QZR5,Q566C3" charOffset="23-26" type="protein" text="GPT"/>
            <entity id="DS3.d414.s2.e1" origId="206" charOffset="112-119" type="compound" text="mannose"/>
            <entity id="DS3.d414.s2.e2" origId="90658561" charOffset="125-140" type="compound" text="Glc3Man9GlcNAc2"/>
            <pair e1="DS3.d414.s2.e2" e2="DS3.d414.s2.e0" id="DS3.d414.s2.i0" interaction="False" />
            <pair e1="DS3.d414.s2.e1" e2="DS3.d414.s2.e0" id="DS3.d414.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d414.s3" origId="10024536-1" text="UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase (GPT) is the first enzyme in the dolichol pathway of protein N-glycosylation, and is implicated in the developmental programmes of a variety of eukaryotes.">
            <entity id="DS3.d414.s3.e0" origId="445675" charOffset="0-23" type="compound" text="UDP-N-acetylglucosamine"/>
            <entity id="DS3.d414.s3.e1" origId="151435" charOffset="33-74" type="compound" text="phosphate N-acetylglucosamine-1-phosphate"/>
            <entity id="DS3.d414.s3.e2" origId="Q8QZR5,Q566C3" charOffset="88-91" type="protein" text="GPT"/>
            <pair e1="DS3.d414.s3.e1" e2="DS3.d414.s3.e2" id="DS3.d414.s3.i0" interaction="False" />
            <pair e1="DS3.d414.s3.e0" e2="DS3.d414.s3.e2" id="DS3.d414.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d414.s4" origId="10024536-2" text="In the present study we describe the effects of all-trans-retinoic acid (RA) on the levels of GPT protein and enzymic activity, and on the transcription rate of the GPT gene, in mouse P19 teratocarcinoma cells.">
            <entity id="DS3.d414.s4.e0" origId="444795" charOffset="58-71" type="compound" text="retinoic acid"/>
            <entity id="DS3.d414.s4.e1" origId="Q8QZR5,Q566C3" charOffset="94-97" type="protein" text="GPT"/>
            <entity id="DS3.d414.s4.e2" origId="Q8QZR5,Q566C3" charOffset="165-168" type="protein" text="GPT"/>
            <pair e1="DS3.d414.s4.e0" e2="DS3.d414.s4.e1" id="DS3.d414.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d414.s5" origId="10024536-5" text="Induced GPT activity also resulted in an increase in the rate of incorporation of (3H)mannose into Glc3Man9GlcNAc2.">
            <entity id="DS3.d414.s5.e0" origId="Q8QZR5,Q566C3" charOffset="8-11" type="protein" text="GPT"/>
            <entity id="DS3.d414.s5.e1" origId="206" charOffset="86-93" type="compound" text="mannose"/>
            <entity id="DS3.d414.s5.e2" origId="90658561" charOffset="99-114" type="compound" text="Glc3Man9GlcNAc2"/>
            <pair e1="DS3.d414.s5.e2" e2="DS3.d414.s5.e0" id="DS3.d414.s5.i0" interaction="False" />
            <pair e1="DS3.d414.s5.e1" e2="DS3.d414.s5.e0" id="DS3.d414.s5.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d415" origId="10024538">
        <sentence id="DS3.d415.s0" origId="10024538-0" text="Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model.">
            <entity id="DS3.d415.s0.e0" origId="145068" charOffset="8-20" type="compound" text="nitric oxide"/>
            <entity id="DS3.d415.s0.e1" origId="Q9QUK6,L0CL36" charOffset="24-42" type="protein" text="lipopolysaccharide"/>
            <pair e1="DS3.d415.s0.e0" e2="DS3.d415.s0.e1" id="DS3.d415.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d415.s1" origId="10024538-1" text="The role of nitric oxide (NO) in lipopolysaccharide (LPS)-induced hepatic injury was studied in D-galactosamine (D-GalN)-sensitized mice.">
            <entity id="DS3.d415.s1.e0" origId="145068" charOffset="12-24" type="compound" text="nitric oxide"/>
            <entity id="DS3.d415.s1.e1" origId="Q9QUK6,L0CL36" charOffset="33-51" type="protein" text="lipopolysaccharide"/>
            <entity id="DS3.d415.s1.e2" origId="Q9QUK6,L0CL36" charOffset="53-56" type="protein" text="LPS"/>
            <entity id="DS3.d415.s1.e3" origId="24154" charOffset="115-119" type="compound" text="GalN"/>
            <pair e1="DS3.d415.s1.e0" e2="DS3.d415.s1.e1" id="DS3.d415.s1.i0" interaction="False" />
            <pair e1="DS3.d415.s1.e0" e2="DS3.d415.s1.e2" id="DS3.d415.s1.i1" interaction="False" />
            <pair e1="DS3.d415.s1.e3" e2="DS3.d415.s1.e1" id="DS3.d415.s1.i2" interaction="False" />
            <pair e1="DS3.d415.s1.e3" e2="DS3.d415.s1.e2" id="DS3.d415.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d415.s2" origId="10024538-2" text="The inducible isoform of NO synthase (iNOS) was immunohistochemically detected on hepatocytes around blood vessels in livers of mice injected with D-GalN and LPS not on hepatocytes in mice injected with D-GalN or LPS alone, although mRNA for iNOS was found in those mice.">
            <entity id="DS3.d415.s2.e0" origId="P29477" charOffset="14-36" type="protein" text="isoform of NO synthase"/>
            <entity id="DS3.d415.s2.e1" origId="P29477" charOffset="38-42" type="protein" text="iNOS"/>
            <entity id="DS3.d415.s2.e2" origId="24154" charOffset="149-153" type="compound" text="GalN"/>
            <entity id="DS3.d415.s2.e3" origId="Q9QUK6,L0CL36" charOffset="158-161" type="protein" text="LPS"/>
            <entity id="DS3.d415.s2.e4" origId="24154" charOffset="205-209" type="compound" text="GalN"/>
            <entity id="DS3.d415.s2.e5" origId="Q9QUK6,L0CL36" charOffset="213-216" type="protein" text="LPS"/>
            <entity id="DS3.d415.s2.e6" origId="P29477" charOffset="242-246" type="protein" text="iNOS"/>
            <pair e1="DS3.d415.s2.e2" e2="DS3.d415.s2.e0" id="DS3.d415.s2.i0" interaction="False" />
            <pair e1="DS3.d415.s2.e2" e2="DS3.d415.s2.e3" id="DS3.d415.s2.i1" interaction="False" />
            <pair e1="DS3.d415.s2.e2" e2="DS3.d415.s2.e1" id="DS3.d415.s2.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d415.s3" origId="10024538-3" text="Nitrotyrosine (NT) was also found in livers of mice injected with D-GalN and LPS.">
            <entity id="DS3.d415.s3.e0" origId="24154" charOffset="68-72" type="compound" text="GalN"/>
            <entity id="DS3.d415.s3.e1" origId="Q9QUK6,L0CL36" charOffset="77-80" type="protein" text="LPS"/>
            <pair e1="DS3.d415.s3.e0" e2="DS3.d415.s3.e1" id="DS3.d415.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d415.s4" origId="10024538-5" text="Expression of iNOS and NT was detected exclusively in the hepatic lesions of mice injected with D-GalN and LPS.">
            <entity id="DS3.d415.s4.e0" origId="P29477" charOffset="14-18" type="protein" text="iNOS"/>
            <entity id="DS3.d415.s4.e1" origId="24154" charOffset="98-102" type="compound" text="GalN"/>
            <entity id="DS3.d415.s4.e2" origId="Q9QUK6,L0CL36" charOffset="107-110" type="protein" text="LPS"/>
            <pair e1="DS3.d415.s4.e1" e2="DS3.d415.s4.e2" id="DS3.d415.s4.i0" interaction="False" />
            <pair e1="DS3.d415.s4.e1" e2="DS3.d415.s4.e0" id="DS3.d415.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d415.s5" origId="10024538-7" text="The results suggested that NO from iNOS may play a role in LPS-induced hepatic injury on D-GalN-sensitized mice as an experimental endotoxic shock model.">
            <entity id="DS3.d415.s5.e0" origId="P29477" charOffset="35-39" type="protein" text="iNOS"/>
            <entity id="DS3.d415.s5.e1" origId="Q9QUK6,L0CL36" charOffset="59-62" type="protein" text="LPS"/>
            <entity id="DS3.d415.s5.e2" origId="24154" charOffset="91-95" type="compound" text="GalN"/>
            <pair e1="DS3.d415.s5.e2" e2="DS3.d415.s5.e1" id="DS3.d415.s5.i0" interaction="False" />
            <pair e1="DS3.d415.s5.e2" e2="DS3.d415.s5.e0" id="DS3.d415.s5.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d416" origId="10024546">
        <sentence id="DS3.d416.s0" origId="10024546-8" text="The inhibition of TNF-alpha secretion by administration of pentoxifylline 1 h before infection reduced muscle wasting and activation of proteolysis at day 2 and abolished them at day 6.">
            <entity id="DS3.d416.s0.e0" origId="P16599" charOffset="18-27" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d416.s0.e1" origId="4740" charOffset="59-73" type="compound" text="pentoxifylline"/>
            <pair e1="DS3.d416.s0.e1" e2="DS3.d416.s0.e0" id="DS3.d416.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d417" origId="10024547">
        <sentence id="DS3.d417.s0" origId="10024547-1" text="Staphylococcus aureus and Staphylococcus epidermidis possess a 42-kDa cell wall transferrin-binding protein (Tpn) which is involved in the acquisition of transferrin-bound iron.">
            <entity id="DS3.d417.s0.e0" origId="P02787,Q06AH7,A0PJA6" charOffset="80-91" type="protein" text="transferrin"/>
            <entity id="DS3.d417.s0.e1" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="109-112" type="protein" text="Tpn"/>
            <entity id="DS3.d417.s0.e2" origId="P02787,Q06AH7,A0PJA6" charOffset="154-165" type="protein" text="transferrin"/>
            <entity id="DS3.d417.s0.e3" origId="23925,67172434" charOffset="172-176" type="compound" text="iron"/>
            <pair e1="DS3.d417.s0.e3" e2="DS3.d417.s0.e1" id="DS3.d417.s0.i0" interaction="False" />
            <pair e1="DS3.d417.s0.e3" e2="DS3.d417.s0.e0" id="DS3.d417.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d417.s1" origId="10024547-2" text="To characterize this protein further, cell wall fractions were subjected to two-dimensional sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis blotted, and the N-terminus of Tpn was sequenced.">
            <entity id="DS3.d417.s1.e0" origId="5360545" charOffset="92-98" type="compound" text="sodium"/>
            <entity id="DS3.d417.s1.e1" origId="8778" charOffset="99-114" type="compound" text="dodecyl sulfate"/>
            <entity id="DS3.d417.s1.e2" origId="6579" charOffset="121-135" type="compound" text="polyacrylamide"/>
            <entity id="DS3.d417.s1.e3" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="187-190" type="protein" text="Tpn"/>
            <pair e1="DS3.d417.s1.e1" e2="DS3.d417.s1.e3" id="DS3.d417.s1.i0" interaction="False" />
            <pair e1="DS3.d417.s1.e2" e2="DS3.d417.s1.e3" id="DS3.d417.s1.i1" interaction="False" />
            <pair e1="DS3.d417.s1.e0" e2="DS3.d417.s1.e3" id="DS3.d417.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d417.s2" origId="10024547-4" text="Analysis of staphylococcal cell wall fractions for GAPDH activity confirmed the presence of a functional enzyme which, like Tpn, is regulated by the availability of iron in the growth medium.">
            <entity id="DS3.d417.s2.e0" origId="P04406,V9HVZ4" charOffset="51-56" type="protein" text="GAPDH"/>
            <entity id="DS3.d417.s2.e1" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="124-127" type="protein" text="Tpn"/>
            <entity id="DS3.d417.s2.e2" origId="23925,67172434" charOffset="165-169" type="compound" text="iron"/>
            <pair e1="DS3.d417.s2.e2" e2="DS3.d417.s2.e1" id="DS3.d417.s2.i0" interaction="False" />
            <pair e1="DS3.d417.s2.e2" e2="DS3.d417.s2.e0" id="DS3.d417.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d417.s3" origId="10024547-5" text="To determine whether Tpn is responsible for this GAPDH activity, it was affinity purified with NAD+ agarose.">
            <entity id="DS3.d417.s3.e0" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="21-24" type="protein" text="Tpn"/>
            <entity id="DS3.d417.s3.e1" origId="P04406,V9HVZ4" charOffset="49-54" type="protein" text="GAPDH"/>
            <entity id="DS3.d417.s3.e2" origId="11966311" charOffset="100-107" type="compound" text="agarose"/>
            <pair e1="DS3.d417.s3.e2" e2="DS3.d417.s3.e0" id="DS3.d417.s3.i0" interaction="False" />
            <pair e1="DS3.d417.s3.e2" e2="DS3.d417.s3.e1" id="DS3.d417.s3.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d417.s4" origId="10024547-6" text="Both S. epidermidis and S. aureus Tpn catalyzed the conversion of glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate.">
            <entity id="DS3.d417.s4.e0" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="34-37" type="protein" text="Tpn"/>
            <entity id="DS3.d417.s4.e1" origId="439168,446381" charOffset="66-92" type="compound" text="glyceraldehyde-3-phosphate"/>
            <entity id="DS3.d417.s4.e2" origId="683" charOffset="96-118" type="compound" text="1,3-diphosphoglycerate"/>
            <pair e1="DS3.d417.s4.e1" e2="DS3.d417.s4.e0" id="DS3.d417.s4.i0" interaction="False" />
            <pair e1="DS3.d417.s4.e2" e2="DS3.d417.s4.e0" id="DS3.d417.s4.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d417.s5" origId="10024547-8" text="Native polyacrylamide gel electrophoresis of the affinity-purified Tpn revealed that it was present in the cell wall as a tetramer, consistent with the structures of all known cytoplasmic GAPDHs.">
            <entity id="DS3.d417.s5.e0" origId="6579" charOffset="7-21" type="compound" text="polyacrylamide"/>
            <entity id="DS3.d417.s5.e1" origId="O15533,A0A0A0MT98,A0A0A0MSV9,A0A024RCT1" charOffset="67-70" type="protein" text="Tpn"/>
            <pair e1="DS3.d417.s5.e0" e2="DS3.d417.s5.e1" id="DS3.d417.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d418" origId="10024567">
        <sentence id="DS3.d418.s0" origId="10024567-2" text="One of these Yops, YopH, dephosphorylates multiple tyrosine-phosphorylated proteins in eukaryotic cells and is involved in the inhibition of phagocytosis of Y. enterocolitica by human granulocytes.">
            <entity id="DS3.d418.s0.e0" origId="Q93KS2" charOffset="19-23" type="protein" text="YopH"/>
            <entity id="DS3.d418.s0.e1" origId="6057,90983769" charOffset="51-59" type="compound" text="tyrosine"/>
            <pair e1="DS3.d418.s0.e1" e2="DS3.d418.s0.e0" id="DS3.d418.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d418.s1" origId="10024567-3" text="We investigated whether antibody- and complement-opsonized plasmid-bearing (pYV+) Y. enterocolitica inhibits O2- production by human granulocytes in response to various stimuli and whether YopH is involved.">
            <entity id="DS3.d418.s1.e0" origId="1125790" charOffset="76-79" type="compound" text="pYV"/>
            <entity id="DS3.d418.s1.e1" origId="Q93KS2" charOffset="189-193" type="protein" text="YopH"/>
            <pair e1="DS3.d418.s1.e0" e2="DS3.d418.s1.e1" id="DS3.d418.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d418.s2" origId="10024567-5" text="O2- production by granulocytes during stimulation was assessed by measuring the reduction of ferricytochrome c. PYV+ Y. enterocolitica inhibited O2- production by granulocytes incubated with opsonized Y. enterocolitica or N-formyl-Met-Leu-Phe (f-MLP).">
            <entity id="DS3.d418.s2.e0" origId="439170" charOffset="93-110" type="compound" text="ferricytochrome c"/>
            <entity id="DS3.d418.s2.e1" origId="1125790" charOffset="112-115" type="compound" text="PYV"/>
            <entity id="DS3.d418.s2.e2" origId="Q02817" charOffset="246-249" type="protein" text="MLP"/>
            <pair e1="DS3.d418.s2.e0" e2="DS3.d418.s2.e2" id="DS3.d418.s2.i0" interaction="False" />
            <pair e1="DS3.d418.s2.e1" e2="DS3.d418.s2.e2" id="DS3.d418.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d418.s3" origId="10024567-6" text="This inhibitory effect mediated by pYV did not affect receptor-independent O2- production by granulocytes in response to phorbol myristate acetate, indicating that NADPH activity remained unaffected after activation of protein kinase C. The inhibition of f-MLP-induced O2- production by granulocytes depends on the secretion of Yops and not on the expression of YadA.">
            <entity id="DS3.d418.s3.e0" origId="1125790" charOffset="35-38" type="compound" text="pYV"/>
            <entity id="DS3.d418.s3.e1" origId="22833501,27924,4792" charOffset="121-146" type="compound" text="phorbol myristate acetate"/>
            <entity id="DS3.d418.s3.e2" origId="5884" charOffset="164-169" type="compound" text="NADPH"/>
            <entity id="DS3.d418.s3.e3" origId="Q02817" charOffset="257-260" type="protein" text="MLP"/>
            <pair e1="DS3.d418.s3.e2" e2="DS3.d418.s3.e3" id="DS3.d418.s3.i0" interaction="False" />
            <pair e1="DS3.d418.s3.e1" e2="DS3.d418.s3.e3" id="DS3.d418.s3.i1" interaction="False" />
            <pair e1="DS3.d418.s3.e0" e2="DS3.d418.s3.e3" id="DS3.d418.s3.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d418.s4" origId="10024567-7" text="Insertional inactivation of the YopH gene abrogated the inhibition of phagocytosis of antibody- and complement-opsonized Y. enterocolitica by human granulocytes but not of the f-MLP-induced O2- production by granulocytes or tyrosine phosphorylation of granulocyte proteins.">
            <entity id="DS3.d418.s4.e0" origId="Q93KS2" charOffset="32-36" type="protein" text="YopH"/>
            <entity id="DS3.d418.s4.e1" origId="Q02817" charOffset="178-181" type="protein" text="MLP"/>
            <entity id="DS3.d418.s4.e2" origId="6057,90983769" charOffset="224-232" type="compound" text="tyrosine"/>
            <pair e1="DS3.d418.s4.e2" e2="DS3.d418.s4.e0" id="DS3.d418.s4.i0" interaction="False" />
            <pair e1="DS3.d418.s4.e2" e2="DS3.d418.s4.e1" id="DS3.d418.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d419" origId="10024574">
        <sentence id="DS3.d419.s0" origId="10024574-3" text="We have therefore examined the effect of blocking one such pathway, the extracellular signal-regulated protein kinase (ERK) cascade, using the specific inhibitor of the mitogen-activated protein kinase/ERK kinase, PD98059, on the ability of human neutrophils to kill S. aureus and C. albicans.">
            <entity id="DS3.d419.s0.e0" origId="P28482,Q1HBJ4,Q499G7" charOffset="72-117" type="protein" text="extracellular signal-regulated protein kinase"/>
            <entity id="DS3.d419.s0.e1" origId="P28482,Q1HBJ4,Q499G7" charOffset="119-122" type="protein" text="ERK"/>
            <entity id="DS3.d419.s0.e2" origId="P28482,Q1HBJ4,Q499G7" charOffset="202-205" type="protein" text="ERK"/>
            <entity id="DS3.d419.s0.e3" origId="4713" charOffset="214-221" type="compound" text="PD98059"/>
            <pair e1="DS3.d419.s0.e3" e2="DS3.d419.s0.e1" id="DS3.d419.s0.i0" interaction="False" />
            <pair e1="DS3.d419.s0.e3" e2="DS3.d419.s0.e0" id="DS3.d419.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d419.s1" origId="10024574-5" text="Upon stimulation with formyl methionyl leucyl phenylalanine (fMLP), the activities of both ERK2 and the 43-kDa form were stimulated.">
            <entity id="DS3.d419.s1.e0" origId="13091120" charOffset="29-38" type="compound" text="methionyl"/>
            <entity id="DS3.d419.s1.e1" origId="53877219" charOffset="39-59" type="compound" text="leucyl phenylalanine"/>
            <entity id="DS3.d419.s1.e2" origId="443295" charOffset="61-65" type="compound" text="fMLP"/>
            <entity id="DS3.d419.s1.e3" origId="P28482,Q1HBJ4,Q499G7" charOffset="91-95" type="protein" text="ERK2"/>
            <pair e1="DS3.d419.s1.e0" e2="DS3.d419.s1.e3" id="DS3.d419.s1.i0" interaction="False" />
            <pair e1="DS3.d419.s1.e1" e2="DS3.d419.s1.e3" id="DS3.d419.s1.i1" interaction="False" />
            <pair e1="DS3.d419.s1.e2" e2="DS3.d419.s1.e3" id="DS3.d419.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d419.s2" origId="10024574-6" text="Despite abrogating the activity of both ERK forms, PD98059 only slightly reduced the ability of neutrophils to kill S. aureus or C. albicans.">
            <entity id="DS3.d419.s2.e0" origId="P28482,Q1HBJ4,Q499G7" charOffset="40-43" type="protein" text="ERK"/>
            <entity id="DS3.d419.s2.e1" origId="4713" charOffset="51-58" type="compound" text="PD98059"/>
            <pair e1="DS3.d419.s2.e1" e2="DS3.d419.s2.e0" id="DS3.d419.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d419.s3" origId="10024574-9" text="These data demonstrate, for the first time, that the ERK cascade plays only a minor role in the microbicidal activity of neutrophils and that the ERK cascade is involved primarily in regulating neutrophil migration in response to fMLP.">
            <entity id="DS3.d419.s3.e0" origId="P28482,Q1HBJ4,Q499G7" charOffset="53-56" type="protein" text="ERK"/>
            <entity id="DS3.d419.s3.e1" origId="P28482,Q1HBJ4,Q499G7" charOffset="146-149" type="protein" text="ERK"/>
            <entity id="DS3.d419.s3.e2" origId="443295" charOffset="230-234" type="compound" text="fMLP"/>
            <pair e1="DS3.d419.s3.e2" e2="DS3.d419.s3.e0" id="DS3.d419.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d420" origId="10024582">
        <sentence id="DS3.d420.s0" origId="10024582-1" text="Endotoxin (lipopolysaccharide (LPS)) is the major pathogenic factor of gram-negative septic shock, and endotoxin-induced death is associated with the host overproduction of tumor necrosis factor alpha (TNF-alpha).">
            <entity id="DS3.d420.s0.e0" origId="11970143" charOffset="11-29" type="compound" text="lipopolysaccharide"/>
            <entity id="DS3.d420.s0.e1" origId="P01375,Q5STB3" charOffset="173-200" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d420.s0.e2" origId="P06804,Q3U593" charOffset="202-211" type="protein" text="TNF-alpha"/>
            <pair e1="DS3.d420.s0.e0" e2="DS3.d420.s0.e1" id="DS3.d420.s0.i0" interaction="False" />
            <pair e1="DS3.d420.s0.e0" e2="DS3.d420.s0.e2" id="DS3.d420.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d420.s1" origId="10024582-3" text="LF-33 inhibited the coagulation of the Limulus amebocyte lysate and the secretion of TNF-alpha by RAW 264.7 cells induced by lipid A and four different endotoxins with a potency comparable to that of polymyxin B.">
            <entity id="DS3.d420.s1.e0" origId="P06804,Q3U593" charOffset="85-94" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d420.s1.e1" origId="9877306" charOffset="125-132" type="compound" text="lipid A"/>
            <entity id="DS3.d420.s1.e2" origId="3083714" charOffset="200-209" type="compound" text="polymyxin"/>
            <pair e1="DS3.d420.s1.e2" e2="DS3.d420.s1.e0" id="DS3.d420.s1.i0" interaction="False" />
            <pair e1="DS3.d420.s1.e1" e2="DS3.d420.s1.e0" id="DS3.d420.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d421" origId="10024583">
        <sentence id="DS3.d421.s0" origId="10024583-2" text="It is established that this difference reflects, in part, carriage by Y. pestis of a unique 9.6-kb pesticin or Pst plasmid (pPCP) encoding plasminogen activator (Pla) rather than distinctions between shared approximately 70-kb low-calcium-response, or Lcr, plasmids (pCD in Y. pestis and pYV in enteropathogenic yersiniae) encoding cytotoxic Yops and anti-inflammatory V antigen.">
            <entity id="DS3.d421.s0.e0" origId="P17811,E5GAD2" charOffset="139-160" type="protein" text="plasminogen activator"/>
            <entity id="DS3.d421.s0.e1" origId="P17811,E5GAD2" charOffset="162-165" type="protein" text="Pla"/>
            <entity id="DS3.d421.s0.e2" origId="22044544,5460341" charOffset="231-238" type="compound" text="calcium"/>
            <entity id="DS3.d421.s0.e3" origId="1125790" charOffset="288-291" type="compound" text="pYV"/>
            <pair e1="DS3.d421.s0.e2" e2="DS3.d421.s0.e0" id="DS3.d421.s0.i0" interaction="False" />
            <pair e1="DS3.d421.s0.e2" e2="DS3.d421.s0.e1" id="DS3.d421.s0.i1" interaction="False" />
            <pair e1="DS3.d421.s0.e3" e2="DS3.d421.s0.e0" id="DS3.d421.s0.i2" interaction="False" />
            <pair e1="DS3.d421.s0.e3" e2="DS3.d421.s0.e1" id="DS3.d421.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d421.s1" origId="10024583-6" text="Pla-mediated posttranslational hydrolysis of pulse-labeled Yops in Y. pseudotuberculosis PB1/+/pPCP1 occurred more slowly than that in Y. pestis but was otherwise similar except for accumulation of stable degradation products of YadA, a pYV-mediated fibrillar adhesin not encoded in frame by pCD.">
            <entity id="DS3.d421.s1.e0" origId="P17811,E5GAD2" charOffset="0-3" type="protein" text="Pla"/>
            <entity id="DS3.d421.s1.e1" origId="1125790" charOffset="237-240" type="compound" text="pYV"/>
            <pair e1="DS3.d421.s1.e1" e2="DS3.d421.s1.e0" id="DS3.d421.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d422" origId="10024586">
        <sentence id="DS3.d422.s0" origId="10024586-0" text="Role of iron in Nramp1-mediated inhibition of mycobacterial growth.">
            <entity id="DS3.d422.s0.e0" origId="23925,67172434" charOffset="8-12" type="compound" text="iron"/>
            <entity id="DS3.d422.s0.e1" origId="P41251" charOffset="16-22" type="protein" text="Nramp1"/>
            <pair e1="DS3.d422.s0.e0" e2="DS3.d422.s0.e1" id="DS3.d422.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d422.s1" origId="10024586-3" text="Based on these observations and on reports that show that the closely related Nramp2 gene is a metal ion transporter, we evaluated the effect of iron on the growth of Mycobacterium avium within macrophages as well as on the stability of Nramp1 mRNA.">
            <entity id="DS3.d422.s1.e0" origId="23925,67172434" charOffset="145-149" type="compound" text="iron"/>
            <entity id="DS3.d422.s1.e1" origId="P41251" charOffset="237-243" type="protein" text="Nramp1"/>
            <pair e1="DS3.d422.s1.e0" e2="DS3.d422.s1.e1" id="DS3.d422.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d422.s2" origId="10024586-6" text="When we treated recombinant gamma interferon (IFN-gamma)-activated macrophages with iron, we found that iron abrogated the growth inhibitory effect of IFN-gamma-activated macrophages from Bcgs mice but that it did not affect the capacity of macrophages from Bcgr mice to control microbial growth.">
            <entity id="DS3.d422.s2.e0" origId="P01580" charOffset="46-55" type="protein" text="IFN-gamma"/>
            <entity id="DS3.d422.s2.e1" origId="67172434,23925" charOffset="84-88" type="compound" text="iron"/>
            <entity id="DS3.d422.s2.e2" origId="67172434,23925" charOffset="104-108" type="compound" text="iron"/>
            <entity id="DS3.d422.s2.e3" origId="P01580" charOffset="151-160" type="protein" text="IFN-gamma"/>
            <pair e1="DS3.d422.s2.e1" e2="DS3.d422.s2.e0" id="DS3.d422.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d422.s3" origId="10024586-8" text="The effect of iron on the growth inhibitory activity of macrophages from Bcgr mice was abrogated by the addition of catalase or mannitol to the culture medium.">
            <entity id="DS3.d422.s3.e0" origId="23925,67172434" charOffset="14-18" type="compound" text="iron"/>
            <entity id="DS3.d422.s3.e1" origId="P24270" charOffset="116-124" type="protein" text="catalase"/>
            <entity id="DS3.d422.s3.e2" origId="6251" charOffset="128-136" type="compound" text="mannitol"/>
            <pair e1="DS3.d422.s3.e2" e2="DS3.d422.s3.e1" id="DS3.d422.s3.i0" interaction="False" />
            <pair e1="DS3.d422.s3.e0" e2="DS3.d422.s3.e1" id="DS3.d422.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d423" origId="10024591">
        <sentence id="DS3.d423.s0" origId="10024591-4" text="The number of bacteria recovered in the spleens and in the livers of rTGF-beta1-treated mice 2 and 5 days after infection was significantly smaller than that found in the same organs after phosphate-buffered saline (PBS) inoculation.">
            <entity id="DS3.d423.s0.e0" origId="P17246" charOffset="69-79" type="protein" text="rTGF-beta1"/>
            <entity id="DS3.d423.s0.e1" origId="24978514" charOffset="189-214" type="compound" text="phosphate-buffered saline"/>
            <pair e1="DS3.d423.s0.e1" e2="DS3.d423.s0.e0" id="DS3.d423.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d423.s1" origId="10024591-9" text="A similar pattern was obtained with the mRNAs for interleukin-1alpha (IL-1alpha), IL-6, TGF-beta, and inducible nitric oxide synthase, which showed greater expression in cells obtained from rTGF-beta1-treated and S. typhimurium-infected mice 2 days after challenge.">
            <entity id="DS3.d423.s1.e0" origId="145068" charOffset="112-124" type="compound" text="nitric oxide"/>
            <entity id="DS3.d423.s1.e1" origId="P17246" charOffset="190-200" type="protein" text="rTGF-beta1"/>
            <pair e1="DS3.d423.s1.e0" e2="DS3.d423.s1.e1" id="DS3.d423.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d424" origId="10024660">
        <sentence id="DS3.d424.s0" origId="10024660-1" text="The detailed structures of N- glycans derived from bile salt-stimulated lipase (BSSL) found in human milk were determined by combining exoglycosidase digestion with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.">
            <entity id="DS3.d424.s0.e0" origId="871" charOffset="30-37" type="compound" text="glycans"/>
            <entity id="DS3.d424.s0.e1" origId="B4DSX9,X6R868,O75612,Q86SR3" charOffset="51-78" type="protein" text="bile salt-stimulated lipase"/>
            <entity id="DS3.d424.s0.e2" origId="B4DSX9,X6R868,O75612,Q86SR3" charOffset="80-84" type="protein" text="BSSL"/>
            <pair e1="DS3.d424.s0.e0" e2="DS3.d424.s0.e1" id="DS3.d424.s0.i0" interaction="False" />
            <pair e1="DS3.d424.s0.e0" e2="DS3.d424.s0.e2" id="DS3.d424.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d424.s1" origId="10024660-4" text="The molecular mass profile of esterified N- glycans present in BSSL further permitted the more detailed studies through collision-induced dissociation (CID) and sequential exoglycosidase cleavages.">
            <entity id="DS3.d424.s1.e0" origId="871" charOffset="44-51" type="compound" text="glycans"/>
            <entity id="DS3.d424.s1.e1" origId="B4DSX9,X6R868,O75612,Q86SR3" charOffset="63-67" type="protein" text="BSSL"/>
            <pair e1="DS3.d424.s1.e0" e2="DS3.d424.s1.e1" id="DS3.d424.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d425" origId="10024663">
        <sentence id="DS3.d425.s0" origId="10024663-2" text="The stable derivatives of the most common monosaccharides of these glycoconjugates (Ara, Rha, Xyl, Fuc, Gal, Man, Glc, GlcNAc, GalNAc, Neu5Ac, KDN) can be separated and quantitatively and reproducibly determined with a high degree of sensitivity level (down to 25 pmol) in the presence of lysine as an internal standard.">
            <entity id="DS3.d425.s0.e0" origId="O95255,A0A0G2JNS1" charOffset="84-87" type="protein" text="Ara"/>
            <entity id="DS3.d425.s0.e1" origId="Q08211,B3KU66" charOffset="89-92" type="protein" text="Rha"/>
            <entity id="DS3.d425.s0.e2" origId="3034742,57288387,6971003" charOffset="114-117" type="compound" text="Glc"/>
            <entity id="DS3.d425.s0.e3" origId="11861101,24139,439174,899" charOffset="119-125" type="compound" text="GlcNAc"/>
            <entity id="DS3.d425.s0.e4" origId="35717" charOffset="127-133" type="compound" text="GalNAc"/>
            <entity id="DS3.d425.s0.e5" origId="439197" charOffset="135-141" type="compound" text="Neu5Ac"/>
            <entity id="DS3.d425.s0.e6" origId="10869261" charOffset="143-146" type="compound" text="KDN"/>
            <entity id="DS3.d425.s0.e7" origId="57449,5962,866" charOffset="289-295" type="compound" text="lysine"/>
            <pair e1="DS3.d425.s0.e7" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i0" interaction="False" />
            <pair e1="DS3.d425.s0.e7" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i1" interaction="False" />
            <pair e1="DS3.d425.s0.e6" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i2" interaction="False" />
            <pair e1="DS3.d425.s0.e6" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i3" interaction="False" />
            <pair e1="DS3.d425.s0.e5" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i4" interaction="False" />
            <pair e1="DS3.d425.s0.e5" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i5" interaction="False" />
            <pair e1="DS3.d425.s0.e2" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i6" interaction="False" />
            <pair e1="DS3.d425.s0.e2" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i7" interaction="False" />
            <pair e1="DS3.d425.s0.e3" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i8" interaction="False" />
            <pair e1="DS3.d425.s0.e3" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i9" interaction="False" />
            <pair e1="DS3.d425.s0.e4" e2="DS3.d425.s0.e1" id="DS3.d425.s0.i10" interaction="False" />
            <pair e1="DS3.d425.s0.e4" e2="DS3.d425.s0.e0" id="DS3.d425.s0.i11" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d426" origId="10024664">
        <sentence id="DS3.d426.s0" origId="10024664-0" text="Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered.">
            <entity id="DS3.d426.s0.e0" origId="656387,906" charOffset="13-24" type="compound" text="sialic acid"/>
            <entity id="DS3.d426.s0.e1" origId="Q99519,Q5JQI0" charOffset="77-90" type="protein" text="neuraminidase"/>
            <pair e1="DS3.d426.s0.e0" e2="DS3.d426.s0.e1" id="DS3.d426.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d426.s1" origId="10024664-3" text='However, little progress has been made in either identifying explicit roles for sialic acid in this system or in hypothesizing mechanisms to explain the "neuraminidase effect."'>
            <entity id="DS3.d426.s1.e0" origId="656387,906" charOffset="80-91" type="compound" text="sialic acid"/>
            <entity id="DS3.d426.s1.e1" origId="Q99519,Q5JQI0" charOffset="154-167" type="protein" text="neuraminidase"/>
            <pair e1="DS3.d426.s1.e0" e2="DS3.d426.s1.e1" id="DS3.d426.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d426.s2" origId="10024664-4" text="Here we show for the first time that cell surface sialic acid on medium incubated B cells blocks access to costimulatory molecules on the B cell surface, and that this is the most likely explanation for the neuraminidase effect.">
            <entity id="DS3.d426.s2.e0" origId="656387,906" charOffset="50-61" type="compound" text="sialic acid"/>
            <entity id="DS3.d426.s2.e1" origId="Q99519,Q5JQI0" charOffset="207-220" type="protein" text="neuraminidase"/>
            <pair e1="DS3.d426.s2.e0" e2="DS3.d426.s2.e1" id="DS3.d426.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d426.s3" origId="10024664-5" text="Further, we show that it is likely to be upregulation of ICAM-1 and its subsequent engagement of LFA-1 rather than loss of cell surface sialic acid that in part regulates access to CD86 and other costimulatory molecules.">
            <entity id="DS3.d426.s3.e0" origId="P05362" charOffset="57-63" type="protein" text="ICAM-1"/>
            <entity id="DS3.d426.s3.e1" origId="P20701,B2RAL6" charOffset="97-102" type="protein" text="LFA-1"/>
            <entity id="DS3.d426.s3.e2" origId="656387,906" charOffset="136-147" type="compound" text="sialic acid"/>
            <entity id="DS3.d426.s3.e3" origId="P42081,A8K632" charOffset="181-185" type="protein" text="CD86"/>
            <pair e1="DS3.d426.s3.e2" e2="DS3.d426.s3.e0" id="DS3.d426.s3.i0" interaction="False" />
            <pair e1="DS3.d426.s3.e2" e2="DS3.d426.s3.e1" id="DS3.d426.s3.i1" interaction="False" />
            <pair e1="DS3.d426.s3.e2" e2="DS3.d426.s3.e3" id="DS3.d426.s3.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d426.s4" origId="10024664-6" text="However, we cannot exclude a role for CD86-bound sialic acid on the B cell in modulating binding to T cell CD28.">
            <entity id="DS3.d426.s4.e0" origId="P42081,A8K632" charOffset="38-42" type="protein" text="CD86"/>
            <entity id="DS3.d426.s4.e1" origId="656387,906" charOffset="49-60" type="compound" text="sialic acid"/>
            <entity id="DS3.d426.s4.e2" origId="P10747,B4E0L1" charOffset="107-111" type="protein" text="CD28"/>
            <pair e1="DS3.d426.s4.e1" e2="DS3.d426.s4.e2" id="DS3.d426.s4.i0" interaction="False" />
            <pair e1="DS3.d426.s4.e1" e2="DS3.d426.s4.e0" id="DS3.d426.s4.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d427" origId="10024665">
        <sentence id="DS3.d427.s0" origId="10024665-2" text="We previously reported the cDNA cloning of the alpha- and beta-subunits of mouse glucosidase II from T cells following copurification of these proteins with the highly glycosylated transmembrane protein-tyrosine phosphatase CD45.">
            <entity id="DS3.d427.s0.e0" origId="6057,90983769" charOffset="203-211" type="compound" text="tyrosine"/>
            <entity id="DS3.d427.s0.e1" origId="S4R2V1,Q8C6Q7,S4R1S4,S4R1M0" charOffset="224-228" type="protein" text="CD45"/>
            <pair e1="DS3.d427.s0.e0" e2="DS3.d427.s0.e1" id="DS3.d427.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d428" origId="10024667">
        <sentence id="DS3.d428.s0" origId="10024667-6" text="Western blots of agarose gel electrophoresis of fractions across the anion exchange distribution indicated that the polypeptide underlying the mucins was the product of the MUC5B gene.">
            <entity id="DS3.d428.s0.e0" origId="11966311" charOffset="17-24" type="compound" text="agarose"/>
            <entity id="DS3.d428.s0.e1" origId="Q9HC84" charOffset="173-178" type="protein" text="MUC5B"/>
            <pair e1="DS3.d428.s0.e0" e2="DS3.d428.s0.e1" id="DS3.d428.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d429" origId="10024668">
        <sentence id="DS3.d429.s0" origId="10024668-1" text="A human cDNA for UDP- N -acetylglucosamine:alpha1,3-d-mannoside beta1,4- N- acetylglucosaminyltransferase (GnT-IV) was isolated from a liver cDNA library using a probe based on a partial cDNA sequence of the bovine GnT-IV.">
            <entity id="DS3.d429.s0.e0" origId="6031" charOffset="17-20" type="compound" text="UDP"/>
            <entity id="DS3.d429.s0.e1" origId="24139" charOffset="25-42" type="compound" text="acetylglucosamine"/>
            <entity id="DS3.d429.s0.e2" origId="Q9UM21" charOffset="107-113" type="protein" text="GnT-IV"/>
            <entity id="DS3.d429.s0.e3" origId="Q9UM21" charOffset="215-221" type="protein" text="GnT-IV"/>
            <pair e1="DS3.d429.s0.e1" e2="DS3.d429.s0.e2" id="DS3.d429.s0.i0" interaction="False" />
            <pair e1="DS3.d429.s0.e0" e2="DS3.d429.s0.e2" id="DS3.d429.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d430" origId="10024669">
        <sentence id="DS3.d430.s0" origId="10024669-6" text="Thirty-six bronchial mucins out of 38 contained the sialyl-Lewis x epitope which was even expressed by subjects phenotyped as Lewis negative, indicating that at least one alpha1,3 fucosyltransferase different from the Lewis enzyme was involved in the biosynthesis of this epitope.">
            <entity id="DS3.d430.s0.e0" origId="44611539" charOffset="59-74" type="compound" text="Lewis x epitope"/>
            <entity id="DS3.d430.s0.e1" origId="Q11130" charOffset="171-198" type="protein" text="alpha1,3 fucosyltransferase"/>
            <pair e1="DS3.d430.s0.e0" e2="DS3.d430.s0.e1" id="DS3.d430.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d431" origId="10024673">
        <sentence id="DS3.d431.s0" origId="10024673-0" text="Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma.">
            <entity id="DS3.d431.s0.e0" origId="P15941,A6ZIE4,Q7Z551,A5YRU7,A6ZID7,A6ZID6,A0A087X0L2,A5YRV0,Q7Z538,A0A0A0MRB3,A0A087X2A4,A5YRV2,A0A0C4DGW3,B6ECB3,A6ZIE6,A5YRU5,Q02496" charOffset="21-26" type="protein" text="MUC-1"/>
            <entity id="DS3.d431.s0.e1" origId="4405380" charOffset="82-85" type="compound" text="DF3"/>
            <pair e1="DS3.d431.s0.e1" e2="DS3.d431.s0.e0" id="DS3.d431.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d431.s1" origId="10024673-10" text="These results suggest that an expression of DF3/MUC1 is highly associated with cell-invasiveness, and the DF3/MUC1-associated invasiveness is amplified by CRL.">
            <entity id="DS3.d431.s1.e0" origId="4405380" charOffset="44-47" type="compound" text="DF3"/>
            <entity id="DS3.d431.s1.e1" origId="Q02496" charOffset="48-52" type="protein" text="MUC1"/>
            <entity id="DS3.d431.s1.e2" origId="4405380" charOffset="106-109" type="compound" text="DF3"/>
            <entity id="DS3.d431.s1.e3" origId="Q02496" charOffset="110-114" type="protein" text="MUC1"/>
            <pair e1="DS3.d431.s1.e0" e2="DS3.d431.s1.e1" id="DS3.d431.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d431.s2" origId="10024673-11" text="Thus DF3+/CRL+-MUC-1 molecule seems to be closely involved in a poor prognosis for gastric cancer patients.">
            <entity id="DS3.d431.s2.e0" origId="4405380" charOffset="5-8" type="compound" text="DF3"/>
            <entity id="DS3.d431.s2.e1" origId="P15941,A6ZIE4,Q7Z551,A5YRU7,A6ZID7,A6ZID6,A0A087X0L2,A5YRV0,Q7Z538,A0A0A0MRB3,A0A087X2A4,A5YRV2,A0A0C4DGW3,B6ECB3,A6ZIE6,A5YRU5,Q02496" charOffset="15-20" type="protein" text="MUC-1"/>
            <pair e1="DS3.d431.s2.e0" e2="DS3.d431.s2.e1" id="DS3.d431.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d431.s3" origId="10024673-1" text="As recently reported, DF3/MUC-1 molecules having cytokine receptor-like sequences (CRL) at the extracellular region, are likely to function in signal transduction pathways.">
            <entity id="DS3.d431.s3.e0" origId="4405380" charOffset="22-25" type="compound" text="DF3"/>
            <entity id="DS3.d431.s3.e1" origId="P15941,A6ZIE4,Q7Z551,A5YRU7,A6ZID7,A6ZID6,A0A087X0L2,A5YRV0,Q7Z538,A0A0A0MRB3,A0A087X2A4,A5YRV2,A0A0C4DGW3,B6ECB3,A6ZIE6,A5YRU5,Q02496" charOffset="26-31" type="protein" text="MUC-1"/>
            <pair e1="DS3.d431.s3.e0" e2="DS3.d431.s3.e1" id="DS3.d431.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d431.s4" origId="10024673-2" text="To elucidate the functional significance of CRL expressed on the DF3/MUC1 molecule, immunohistochemical localization of CRL and/or DF3 was investigated in cases of 115 patients with gastric carcinomas, treated by surgical resection.">
            <entity id="DS3.d431.s4.e0" origId="4405380" charOffset="65-68" type="compound" text="DF3"/>
            <entity id="DS3.d431.s4.e1" origId="Q02496" charOffset="69-73" type="protein" text="MUC1"/>
            <entity id="DS3.d431.s4.e2" origId="4405380" charOffset="131-134" type="compound" text="DF3"/>
            <pair e1="DS3.d431.s4.e0" e2="DS3.d431.s4.e1" id="DS3.d431.s4.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d431.s5" origId="10024673-6" text="To investigate the biological role of the simultaneous expression of DF3 and CRL, we constructed DF3-/CRL+ (NR-MC-38) and DF3+/CRL+ (R-MC-38) cells by transducing a mouse colon adenocarcinoma cell line MC-38 expressing neither DF3 nor CRL with MUC-1 cDNA containing ten tandem repeats (R-MC-38) or MUC-1 cDNA devoid of tandem repeats (NR-MC-38).">
            <entity id="DS3.d431.s5.e0" origId="4405380" charOffset="69-72" type="compound" text="DF3"/>
            <entity id="DS3.d431.s5.e1" origId="4405380" charOffset="97-100" type="compound" text="DF3"/>
            <entity id="DS3.d431.s5.e2" origId="4405380" charOffset="97-100" type="compound" text="DF3"/>
            <entity id="DS3.d431.s5.e3" origId="4405380" charOffset="97-100" type="compound" text="DF3"/>
            <entity id="DS3.d431.s5.e4" origId="P15941,A6ZIE4,Q7Z551,A5YRU7,A6ZID7,A6ZID6,A0A087X0L2,A5YRV0,Q7Z538,A0A0A0MRB3,A0A087X2A4,A5YRV2,A0A0C4DGW3,B6ECB3,A6ZIE6,A5YRU5,Q02496" charOffset="244-249" type="protein" text="MUC-1"/>
            <entity id="DS3.d431.s5.e5" origId="P15941,A6ZIE4,Q7Z551,A5YRU7,A6ZID7,A6ZID6,A0A087X0L2,A5YRV0,Q7Z538,A0A0A0MRB3,A0A087X2A4,A5YRV2,A0A0C4DGW3,B6ECB3,A6ZIE6,A5YRU5,Q02496" charOffset="298-303" type="protein" text="MUC-1"/>
            <pair e1="DS3.d431.s5.e0" e2="DS3.d431.s5.e4" id="DS3.d431.s5.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d432" origId="10024679">
        <sentence id="DS3.d432.s0" origId="10024679-1" text="We examined the effects of interleukin (IL)-13 and IL-4 on growth of hematopoietic progenitors from 5-fluorouracil (5-FU)-treated mice, using an in vitro culture system.">
            <entity id="DS3.d432.s0.e0" origId="P20109" charOffset="27-46" type="protein" text="interleukin (IL)-13"/>
            <entity id="DS3.d432.s0.e1" origId="P07750" charOffset="51-55" type="protein" text="IL-4"/>
            <entity id="DS3.d432.s0.e2" origId="3385" charOffset="102-114" type="compound" text="fluorouracil"/>
            <pair e1="DS3.d432.s0.e2" e2="DS3.d432.s0.e1" id="DS3.d432.s0.i0" interaction="False" />
            <pair e1="DS3.d432.s0.e2" e2="DS3.d432.s0.e0" id="DS3.d432.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d433" origId="10024680">
        <sentence id="DS3.d433.s0" origId="10024680-5" text="Particular emphasis has been given to tumour necrosis factor-alpha (TNF-alpha) which seems to have a key role in mediating changes related to nitrogen metabolism in the tumour-bearing host.">
            <entity id="DS3.d433.s0.e0" origId="P01375,Q5STB3" charOffset="38-66" type="protein" text="tumour necrosis factor-alpha"/>
            <entity id="DS3.d433.s0.e1" origId="P01375,Q5STB3" charOffset="68-77" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d433.s0.e2" origId="947" charOffset="142-150" type="compound" text="nitrogen"/>
            <pair e1="DS3.d433.s0.e2" e2="DS3.d433.s0.e1" id="DS3.d433.s0.i0" interaction="False" />
            <pair e1="DS3.d433.s0.e2" e2="DS3.d433.s0.e0" id="DS3.d433.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d434" origId="10024685">
        <sentence id="DS3.d434.s0" origId="10024685-0" text="Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.">
            <entity id="DS3.d434.s0.e0" origId="36314" charOffset="0-5" type="compound" text="Taxol"/>
            <entity id="DS3.d434.s0.e1" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="14-19" type="protein" text="bcl-2"/>
            <pair e1="DS3.d434.s0.e0" e2="DS3.d434.s0.e1" id="DS3.d434.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d434.s1" origId="10024685-1" text="Expression of bcl-2, Bax, p53 and induction of apoptosis were studied in cisplatin or Taxol treated monolayer and spheroid cultures of ovarian cancer cell lines (SKOV-3, UL-1, UL-3C).">
            <entity id="DS3.d434.s1.e0" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="14-19" type="protein" text="bcl-2"/>
            <entity id="DS3.d434.s1.e1" origId="Q07812,I6LPK7,Q5ZPJ1,Q5ZPJ0" charOffset="21-24" type="protein" text="Bax"/>
            <entity id="DS3.d434.s1.e2" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="26-29" type="protein" text="p53"/>
            <entity id="DS3.d434.s1.e3" origId="36314" charOffset="86-91" type="compound" text="Taxol"/>
            <pair e1="DS3.d434.s1.e3" e2="DS3.d434.s1.e0" id="DS3.d434.s1.i0" interaction="False" />
            <pair e1="DS3.d434.s1.e3" e2="DS3.d434.s1.e1" id="DS3.d434.s1.i1" interaction="False" />
            <pair e1="DS3.d434.s1.e3" e2="DS3.d434.s1.e2" id="DS3.d434.s1.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d434.s2" origId="10024685-4" text="Taxol treatment of monolayers resulted in the characteristic phosphorylation of bcl-2, which was not demonstrated in spheroid cultures.">
            <entity id="DS3.d434.s2.e0" origId="36314" charOffset="0-5" type="compound" text="Taxol"/>
            <entity id="DS3.d434.s2.e1" origId="P10415,A0A024R2B3,A0A024R2C4" charOffset="80-85" type="protein" text="bcl-2"/>
            <pair e1="DS3.d434.s2.e0" e2="DS3.d434.s2.e1" id="DS3.d434.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d434.s3" origId="10024685-5" text="Bax expression was reduced in spheroids following cisplatin or Taxol treatment, while p53 levels remained unchanged.">
            <entity id="DS3.d434.s3.e0" origId="Q07812,I6LPK7,Q5ZPJ1,Q5ZPJ0" charOffset="0-3" type="protein" text="Bax"/>
            <entity id="DS3.d434.s3.e1" origId="36314" charOffset="63-68" type="compound" text="Taxol"/>
            <entity id="DS3.d434.s3.e2" origId="P04637,K7PPA8,A0A087X1Q1,A0A087WT22,Q53GA5,H2EHT1,A0A087WXZ1" charOffset="86-89" type="protein" text="p53"/>
            <pair e1="DS3.d434.s3.e1" e2="DS3.d434.s3.e0" id="DS3.d434.s3.i0" interaction="False" />
            <pair e1="DS3.d434.s3.e1" e2="DS3.d434.s3.e2" id="DS3.d434.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d435" origId="10024687">
        <sentence id="DS3.d435.s0" origId="10024687-0" text="Differential expression of stathmin during neoplastic conversion of human prostate epithelial cells is reversed by hypomethylating agent, 5-azacytidine.">
            <entity id="DS3.d435.s0.e0" origId="P16949" charOffset="27-35" type="protein" text="stathmin"/>
            <entity id="DS3.d435.s0.e1" origId="9444" charOffset="140-151" type="compound" text="azacytidine"/>
            <pair e1="DS3.d435.s0.e1" e2="DS3.d435.s0.e0" id="DS3.d435.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d436" origId="10024690">
        <sentence id="DS3.d436.s0" origId="10024690-0" text="dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.">
            <entity id="DS3.d436.s0.e0" origId="Q12882" charOffset="0-31" type="protein" text="dihydropyrimidine dehydrogenase"/>
            <entity id="DS3.d436.s0.e1" origId="O15438,Q86VN9" charOffset="33-72" type="protein" text="multidrug resistance-associated protein"/>
            <entity id="DS3.d436.s0.e2" origId="P04818,Q53Y97" charOffset="78-98" type="protein" text="thymidylate synthase"/>
            <entity id="DS3.d436.s0.e3" origId="3385" charOffset="134-148" type="compound" text="5-fluorouracil"/>
            <pair e1="DS3.d436.s0.e3" e2="DS3.d436.s0.e1" id="DS3.d436.s0.i0" interaction="False" />
            <pair e1="DS3.d436.s0.e3" e2="DS3.d436.s0.e0" id="DS3.d436.s0.i1" interaction="False" />
            <pair e1="DS3.d436.s0.e3" e2="DS3.d436.s0.e2" id="DS3.d436.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d437" origId="10024696">
        <sentence id="DS3.d437.s0" origId="10024696-4" text="One type of vaccine was derived from MHC class I-matched Mc12 sarcoma cells engineered to secrete IL-2 and the other from MHC class I-discordant IL-2 producing plasmacytoma X63-m-IL-2.">
            <entity id="DS3.d437.s0.e0" origId="P04351" charOffset="98-102" type="protein" text="IL-2"/>
            <entity id="DS3.d437.s0.e1" origId="P04351" charOffset="145-149" type="protein" text="IL-2"/>
            <entity id="DS3.d437.s0.e2" origId="57519663" charOffset="173-176" type="compound" text="X63"/>
            <entity id="DS3.d437.s0.e3" origId="P04351" charOffset="145-149" type="protein" text="IL-2"/>
            <pair e1="DS3.d437.s0.e2" e2="DS3.d437.s0.e0" id="DS3.d437.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d438" origId="10024837">
        <sentence id="DS3.d438.s0" origId="10024837-3" text="Quinaprilate (2.5, 5, or 10 mg BID) and quinapril (10, 20, or 40 mg OD) dosages were based on the patient's previous ACE inhibitor doses.">
            <entity id="DS3.d438.s0.e0" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="31-34" type="protein" text="BID"/>
            <entity id="DS3.d438.s0.e1" origId="54892" charOffset="40-49" type="compound" text="quinapril"/>
            <pair e1="DS3.d438.s0.e1" e2="DS3.d438.s0.e0" id="DS3.d438.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d438.s1" origId="10024837-9" text="CONCLUSION: Quinaprilate, at half the dose of quinapril, administered BID maintains blood pressure control, is well tolerated, and allows for safe conversion from previously applied oral ACE inhibitors.">
            <entity id="DS3.d438.s1.e0" origId="54892" charOffset="46-55" type="compound" text="quinapril"/>
            <entity id="DS3.d438.s1.e1" origId="P55957,A8ASI8,B2ZP79,B3KT21" charOffset="70-73" type="protein" text="BID"/>
            <pair e1="DS3.d438.s1.e0" e2="DS3.d438.s1.e1" id="DS3.d438.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d439" origId="10024874">
        <sentence id="DS3.d439.s0" origId="10024874-3" text="Studies of the human type 2 receptor (AGTR2) gene in two independent cohorts found that a significant association exists between CAKUT and a nucleotide transition within the lariat branchpoint motif of intron 1, which perturbs AGTR2 mRNA splicing efficiency.">
            <entity id="DS3.d439.s0.e0" origId="P35374,Q3US12" charOffset="38-43" type="protein" text="AGTR2"/>
            <entity id="DS3.d439.s0.e1" origId="165706" charOffset="174-180" type="compound" text="lariat"/>
            <entity id="DS3.d439.s0.e2" origId="P35374,Q3US12" charOffset="227-232" type="protein" text="AGTR2"/>
            <pair e1="DS3.d439.s0.e1" e2="DS3.d439.s0.e0" id="DS3.d439.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d440" origId="10024875">
        <sentence id="DS3.d440.s0" origId="10024875-4" text="The AP-3 deficiency results in increased surface expression of the lysosomal membrane proteins CD63, lamp-1, and lamp-2, but not of nonlysosomal proteins.">
            <entity id="DS3.d440.s0.e0" origId="3857" charOffset="4-8" type="compound" text="AP-3"/>
            <entity id="DS3.d440.s0.e1" origId="P08962,A0A024RB05" charOffset="95-99" type="protein" text="CD63"/>
            <entity id="DS3.d440.s0.e2" origId="P11279,A0A024RDY3" charOffset="101-107" type="protein" text="lamp-1"/>
            <entity id="DS3.d440.s0.e3" origId="P13473" charOffset="113-119" type="protein" text="lamp-2"/>
            <pair e1="DS3.d440.s0.e0" e2="DS3.d440.s0.e3" id="DS3.d440.s0.i0" interaction="False" />
            <pair e1="DS3.d440.s0.e0" e2="DS3.d440.s0.e2" id="DS3.d440.s0.i1" interaction="False" />
            <pair e1="DS3.d440.s0.e0" e2="DS3.d440.s0.e1" id="DS3.d440.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d441" origId="10024876">
        <sentence id="DS3.d441.s0" origId="10024876-0" text="Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 A resolution suggests a catalytic mechanism.">
            <entity id="DS3.d441.s0.e0" origId="896" charOffset="0-9" type="compound" text="Melatonin"/>
            <entity id="DS3.d441.s0.e1" origId="Q16613,F1T0I5" charOffset="41-70" type="protein" text="serotonin N-acetyltransferase"/>
            <pair e1="DS3.d441.s0.e0" e2="DS3.d441.s0.e1" id="DS3.d441.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d441.s1" origId="10024876-1" text="Conversion of serotonin to N-acetylserotonin, the precursor of the circadian neurohormone melatonin, is catalyzed by serotonin N-acetyltransferase (AANAT) in a reaction requiring acetyl coenzyme A (AcCoA).">
            <entity id="DS3.d441.s1.e0" origId="5202" charOffset="14-23" type="compound" text="serotonin"/>
            <entity id="DS3.d441.s1.e1" origId="903" charOffset="27-44" type="compound" text="N-acetylserotonin"/>
            <entity id="DS3.d441.s1.e2" origId="896" charOffset="90-99" type="compound" text="melatonin"/>
            <entity id="DS3.d441.s1.e3" origId="Q16613,F1T0I5" charOffset="117-146" type="protein" text="serotonin N-acetyltransferase"/>
            <entity id="DS3.d441.s1.e4" origId="Q16613,F1T0I5" charOffset="148-153" type="protein" text="AANAT"/>
            <entity id="DS3.d441.s1.e5" origId="317,44216777,444624,44246472,445126,447444,46936280,5326877,6816,448506,6914636,87642" charOffset="186-196" type="compound" text="coenzyme A"/>
            <pair e1="DS3.d441.s1.e0" e2="DS3.d441.s1.e4" id="DS3.d441.s1.i0" interaction="False" />
            <pair e1="DS3.d441.s1.e0" e2="DS3.d441.s1.e3" id="DS3.d441.s1.i1" interaction="False" />
            <pair e1="DS3.d441.s1.e1" e2="DS3.d441.s1.e4" id="DS3.d441.s1.i2" interaction="False" />
            <pair e1="DS3.d441.s1.e1" e2="DS3.d441.s1.e3" id="DS3.d441.s1.i3" interaction="False" />
            <pair e1="DS3.d441.s1.e2" e2="DS3.d441.s1.e4" id="DS3.d441.s1.i4" interaction="False" />
            <pair e1="DS3.d441.s1.e2" e2="DS3.d441.s1.e3" id="DS3.d441.s1.i5" interaction="False" />
            <pair e1="DS3.d441.s1.e5" e2="DS3.d441.s1.e4" id="DS3.d441.s1.i6" interaction="False" />
            <pair e1="DS3.d441.s1.e5" e2="DS3.d441.s1.e3" id="DS3.d441.s1.i7" interaction="False" />
        </sentence>
        <sentence id="DS3.d441.s2" origId="10024876-2" text="AANAT is a globular protein consisting of an eight-stranded beta sheet flanked by five alpha helices; a conserved motif in the center of the beta sheet forms the cofactor binding site.">
            <entity id="DS3.d441.s2.e0" origId="Q16613,F1T0I5" charOffset="0-5" type="protein" text="AANAT"/>
            <entity id="DS3.d441.s2.e1" origId="108194" charOffset="162-170" type="compound" text="cofactor"/>
            <pair e1="DS3.d441.s2.e1" e2="DS3.d441.s2.e0" id="DS3.d441.s2.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d442" origId="10024877">
        <sentence id="DS3.d442.s0" origId="10024877-3" text="With these proteins, the nucleotide excision repair enzyme XPG serves as a cofactor for the efficient function of hNth1.">
            <entity id="DS3.d442.s0.e0" origId="P28715" charOffset="59-62" type="protein" text="XPG"/>
            <entity id="DS3.d442.s0.e1" origId="108194" charOffset="75-83" type="compound" text="cofactor"/>
            <entity id="DS3.d442.s0.e2" origId="P78549,E5KTI5" charOffset="114-119" type="protein" text="hNth1"/>
            <pair e1="DS3.d442.s0.e1" e2="DS3.d442.s0.e2" id="DS3.d442.s0.i0" interaction="False" />
            <pair e1="DS3.d442.s0.e1" e2="DS3.d442.s0.e0" id="DS3.d442.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d443" origId="10024881">
        <sentence id="DS3.d443.s0" origId="10024881-5" text="LiCl, which specifically inhibits glycogen synthase kinase-3 (GSK-3), reduced Eve phosphorylation in nuclear extract and blocked inhibition of repression.">
            <entity id="DS3.d443.s0.e0" origId="433294" charOffset="0-4" type="compound" text="LiCl"/>
            <entity id="DS3.d443.s0.e1" origId="P18431,A4V3W2,Q7KVY5,C0PUX5,M9PGV7,H5V852,A4V3W1,A8JUV9,M9PGC4,Q0KHW6,B6IDN4" charOffset="34-60" type="protein" text="glycogen synthase kinase-3"/>
            <entity id="DS3.d443.s0.e2" origId="P18431,A4V3W2,Q7KVY5,C0PUX5,M9PGV7,H5V852,A4V3W1,A8JUV9,M9PGC4,Q0KHW6,B6IDN4" charOffset="62-67" type="protein" text="GSK-3"/>
            <entity id="DS3.d443.s0.e3" origId="P06602,F9W320" charOffset="78-81" type="protein" text="Eve"/>
            <pair e1="DS3.d443.s0.e0" e2="DS3.d443.s0.e2" id="DS3.d443.s0.i0" interaction="False" />
            <pair e1="DS3.d443.s0.e0" e2="DS3.d443.s0.e3" id="DS3.d443.s0.i1" interaction="False" />
            <pair e1="DS3.d443.s0.e0" e2="DS3.d443.s0.e1" id="DS3.d443.s0.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d444" origId="10024882">
        <sentence id="DS3.d444.s0" origId="10024882-3" text="Designing mutated recombinant subunits, we show that the XPB helicase is absolutely required for transcription to open the promoter around the start site whereas the XPD helicase, which is dispensable, stimulates transcription and allows the CAK complex to be anchored to TFIIH.">
            <entity id="DS3.d444.s0.e0" origId="P19447,G3V1S1,B3KRG2,B3KTH1" charOffset="57-60" type="protein" text="XPB"/>
            <entity id="DS3.d444.s0.e1" origId="P18074" charOffset="166-169" type="protein" text="XPD"/>
            <entity id="DS3.d444.s0.e2" origId="10491406" charOffset="242-245" type="compound" text="CAK"/>
            <pair e1="DS3.d444.s0.e2" e2="DS3.d444.s0.e0" id="DS3.d444.s0.i0" interaction="False" />
            <pair e1="DS3.d444.s0.e2" e2="DS3.d444.s0.e1" id="DS3.d444.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d445" origId="10024883">
        <sentence id="DS3.d445.s0" origId="10024883-0" text="A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation.">
            <entity id="DS3.d445.s0.e0" origId="108194" charOffset="33-41" type="compound" text="cofactor"/>
            <entity id="DS3.d445.s0.e1" origId="Q01995,Q5U0D2" charOffset="51-55" type="protein" text="SMCC"/>
            <pair e1="DS3.d445.s0.e0" e2="DS3.d445.s0.e1" id="DS3.d445.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d446" origId="10024900">
        <sentence id="DS3.d446.s0" origId="10024900-4" text="Serum TSH, T3 free T4, calcium, phosphorus, alkaline phosphatase, BGP, iPTH and urinary calcium (uCA) were measured.">
            <entity id="DS3.d446.s0.e0" origId="5920" charOffset="11-13" type="compound" text="T3"/>
            <entity id="DS3.d446.s0.e1" origId="22044544,5460341" charOffset="23-30" type="compound" text="calcium"/>
            <entity id="DS3.d446.s0.e2" origId="P02818" charOffset="66-69" type="protein" text="BGP"/>
            <entity id="DS3.d446.s0.e3" origId="22044544,5460341" charOffset="88-95" type="compound" text="calcium"/>
            <pair e1="DS3.d446.s0.e1" e2="DS3.d446.s0.e2" id="DS3.d446.s0.i0" interaction="False" />
            <pair e1="DS3.d446.s0.e0" e2="DS3.d446.s0.e2" id="DS3.d446.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d447" origId="10024915">
        <sentence id="DS3.d447.s0" origId="10024915-9" text="Two siblings in a pedigree without cardiomyopathy were wild-type at the HFE C282Y locus; although the brother harboured a single copy of the 187C--&amp;gt;G (H63D) allele, segregation analysis showed that in neither sibling was the iron-storage disease linked to MHC Class I markers on chromosome 6p.">
            <entity id="DS3.d447.s0.e0" origId="Q30201,Q6B0J5,B4DV50,F8W7W8" charOffset="72-75" type="protein" text="HFE"/>
            <entity id="DS3.d447.s0.e1" origId="23925,67172434" charOffset="228-232" type="compound" text="iron"/>
            <pair e1="DS3.d447.s0.e1" e2="DS3.d447.s0.e0" id="DS3.d447.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d448" origId="10024933">
        <sentence id="DS3.d448.s0" origId="10024933-4" text="A direct comparison was performed with results of two recent trials of double bolus (two 50 mg boli, 30 min apart) vs. accelerated infusion tPA: the Double Bolus Lytic Efficacy Trial (DBLE), an angiographic study, and the COBALT Trial, a mortality study.">
            <entity id="DS3.d448.s0.e0" origId="P00750" charOffset="140-143" type="protein" text="tPA"/>
            <entity id="DS3.d448.s0.e1" origId="104730" charOffset="222-228" type="compound" text="COBALT"/>
            <pair e1="DS3.d448.s0.e1" e2="DS3.d448.s0.e0" id="DS3.d448.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d448.s1" origId="10024933-7" text="The COBALT study demonstrated a 30-day mortality of 7.53% in patients treated with accelerated infusion tPA compared with 7.98% for double bolus tPA treated patients.">
            <entity id="DS3.d448.s1.e0" origId="104730" charOffset="4-10" type="compound" text="COBALT"/>
            <entity id="DS3.d448.s1.e1" origId="P00750" charOffset="104-107" type="protein" text="tPA"/>
            <entity id="DS3.d448.s1.e2" origId="P00750" charOffset="145-148" type="protein" text="tPA"/>
            <pair e1="DS3.d448.s1.e0" e2="DS3.d448.s1.e1" id="DS3.d448.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d449" origId="10024939">
        <sentence id="DS3.d449.s0" origId="10024939-3" text="Treatment with the anti-glucocorticoid hormones dehydroepiandrosterone or 3 beta, 17 beta-androstenediol, during the period of adrenal hyperplasia, maintains Th1 dominance and is protective.">
            <entity id="DS3.d449.s0.e0" origId="5881" charOffset="48-70" type="compound" text="dehydroepiandrosterone"/>
            <entity id="DS3.d449.s0.e1" origId="57002161" charOffset="85-104" type="compound" text="beta-androstenediol"/>
            <entity id="DS3.d449.s0.e2" origId="Q64279,Q5SQG1" charOffset="158-161" type="protein" text="Th1"/>
            <pair e1="DS3.d449.s0.e0" e2="DS3.d449.s0.e2" id="DS3.d449.s0.i0" interaction="False" />
            <pair e1="DS3.d449.s0.e1" e2="DS3.d449.s0.e2" id="DS3.d449.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d449.s1" origId="10024939-7" text="However when the corticosterone and the anti-glucocorticoid (AED or DHEA) were co-administered, there was protection, with restoration of a Th1-dominated cytokine profile, enhanced DTH responses, and enhanced expression of IL-1 alpha and TNF alpha.">
            <entity id="DS3.d449.s1.e0" origId="5753" charOffset="17-31" type="compound" text="corticosterone"/>
            <entity id="DS3.d449.s1.e1" origId="Q64279,Q5SQG1" charOffset="140-143" type="protein" text="Th1"/>
            <entity id="DS3.d449.s1.e2" origId="P01582,Q3U0Y6" charOffset="223-233" type="protein" text="IL-1 alpha"/>
            <entity id="DS3.d449.s1.e3" origId="P06804,Q3U593" charOffset="238-247" type="protein" text="TNF alpha"/>
            <pair e1="DS3.d449.s1.e0" e2="DS3.d449.s1.e3" id="DS3.d449.s1.i0" interaction="False" />
            <pair e1="DS3.d449.s1.e0" e2="DS3.d449.s1.e1" id="DS3.d449.s1.i1" interaction="False" />
            <pair e1="DS3.d449.s1.e0" e2="DS3.d449.s1.e2" id="DS3.d449.s1.i2" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d450" origId="10024949">
        <sentence id="DS3.d450.s0" origId="10024949-4" text="Pregnancies of Indo-Asian women were of shorter gestation, and babies in this group also had lower birth weight and ponderal index compared to those of White and Black women (all p &amp;lt; 0.05).">
            <entity id="DS3.d450.s0.e0" origId="P14902" charOffset="15-19" type="protein" text="Indo"/>
            <entity id="DS3.d450.s0.e1" origId="3337" charOffset="116-124" type="compound" text="ponderal"/>
            <pair e1="DS3.d450.s0.e1" e2="DS3.d450.s0.e0" id="DS3.d450.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d451" origId="10024976">
        <sentence id="DS3.d451.s0" origId="10024976-5" text="The zinc finger protein REST binds to the regulatory region of many neuronal genes and represses neuronal gene expression in nonneuronal tissues.">
            <entity id="DS3.d451.s0.e0" origId="23994" charOffset="4-8" type="compound" text="zinc"/>
            <entity id="DS3.d451.s0.e1" origId="Q13127" charOffset="24-28" type="protein" text="REST"/>
            <pair e1="DS3.d451.s0.e0" e2="DS3.d451.s0.e1" id="DS3.d451.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d452" origId="10025034">
        <sentence id="DS3.d452.s0" origId="10025034-2" text="Recent negative results obtained in placebo-controlled trials with the aromatase inhibitor atamestane raised doubts about the efficacy of estrogen reduction.">
            <entity id="DS3.d452.s0.e0" origId="P11511,A0A024R5S8,Q05CU4,A8K6W3,Q8TCA4,Q8IYG4" charOffset="71-80" type="protein" text="aromatase"/>
            <entity id="DS3.d452.s0.e1" origId="57050" charOffset="91-101" type="compound" text="atamestane"/>
            <pair e1="DS3.d452.s0.e1" e2="DS3.d452.s0.e0" id="DS3.d452.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d452.s1" origId="10025034-3" text="However, inhibition of aromatase not only reduces estrogens but also increases androgens which promote prostatic growth.">
            <entity id="DS3.d452.s1.e0" origId="P11511,A0A024R5S8,Q05CU4,A8K6W3,Q8TCA4,Q8IYG4" charOffset="23-32" type="protein" text="aromatase"/>
            <entity id="DS3.d452.s1.e1" origId="3001028" charOffset="50-59" type="compound" text="estrogens"/>
            <pair e1="DS3.d452.s1.e1" e2="DS3.d452.s1.e0" id="DS3.d452.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d453" origId="10025037">
        <sentence id="DS3.d453.s0" origId="10025037-1" text="Disturbances of glucose metabolism with hyperinsulinism and peripheral insulin resistance are frequently observed in patients with hyperparathyroidism.">
            <entity id="DS3.d453.s0.e0" origId="206,5793,64689,79025" charOffset="16-23" type="compound" text="glucose"/>
            <entity id="DS3.d453.s0.e1" origId="P01308,I3WAC9" charOffset="45-52" type="protein" text="insulin"/>
            <pair e1="DS3.d453.s0.e0" e2="DS3.d453.s0.e1" id="DS3.d453.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d454" origId="10025057">
        <sentence id="DS3.d454.s0" origId="10025057-14" text="Ornipressin infusion had no effect on circulating endothelin, but decreased the activation of the renin-aldosterone system and of the sympathetic activity.">
            <entity id="DS3.d454.s0.e0" origId="18830,24892846,14257660" charOffset="0-11" type="compound" text="Ornipressin"/>
            <entity id="DS3.d454.s0.e1" origId="44284481" charOffset="50-60" type="compound" text="endothelin"/>
            <entity id="DS3.d454.s0.e2" origId="P00797" charOffset="98-103" type="protein" text="renin"/>
            <entity id="DS3.d454.s0.e3" origId="5839" charOffset="104-115" type="compound" text="aldosterone"/>
            <pair e1="DS3.d454.s0.e1" e2="DS3.d454.s0.e2" id="DS3.d454.s0.i0" interaction="False" />
            <pair e1="DS3.d454.s0.e3" e2="DS3.d454.s0.e2" id="DS3.d454.s0.i1" interaction="False" />
            <pair e1="DS3.d454.s0.e0" e2="DS3.d454.s0.e2" id="DS3.d454.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d454.s1" origId="10025057-16" text="This is the first report of successful medical treatment of HRS type I with a three-week infusion of the vasopressin-l-receptor agonist ornipressin.">
            <entity id="DS3.d454.s1.e0" origId="P54259,Q86V38" charOffset="60-63" type="protein" text="HRS"/>
            <entity id="DS3.d454.s1.e1" origId="14257660,18830,24892846" charOffset="136-147" type="compound" text="ornipressin"/>
            <pair e1="DS3.d454.s1.e1" e2="DS3.d454.s1.e0" id="DS3.d454.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d454.s2" origId="10025057-2" text="Serum creatinine had increased from 1.6 to 4.3 mg/100 ml within the previous two weeks, creatinine clearance was 12 ml/min, and urinary sodium 12 mmol/24 h. The diagnosis of HRS type I was established.">
            <entity id="DS3.d454.s2.e0" origId="588" charOffset="6-16" type="compound" text="creatinine"/>
            <entity id="DS3.d454.s2.e1" origId="588" charOffset="88-98" type="compound" text="creatinine"/>
            <entity id="DS3.d454.s2.e2" origId="5360545" charOffset="136-142" type="compound" text="sodium"/>
            <entity id="DS3.d454.s2.e3" origId="P54259,Q86V38" charOffset="174-177" type="protein" text="HRS"/>
            <pair e1="DS3.d454.s2.e0" e2="DS3.d454.s2.e3" id="DS3.d454.s2.i0" interaction="False" />
            <pair e1="DS3.d454.s2.e2" e2="DS3.d454.s2.e3" id="DS3.d454.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d455" origId="10025074">
        <sentence id="DS3.d455.s0" origId="10025074-3" text="CGRP is the main mediator of the capsaicin-induced flare reaction in the mammalian skin (including humans).">
            <entity id="DS3.d455.s0.e0" origId="P80511" charOffset="0-4" type="protein" text="CGRP"/>
            <entity id="DS3.d455.s0.e1" origId="2548" charOffset="33-43" type="compound" text="capsaicin-"/>
            <pair e1="DS3.d455.s0.e1" e2="DS3.d455.s0.e0" id="DS3.d455.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d455.s1" origId="10025074-7" text="The neurogenic component of the histamine response (64%) appears to be mediated via NK2 receptors and can be modulated by CGRP.">
            <entity id="DS3.d455.s1.e0" origId="774" charOffset="32-41" type="compound" text="histamine"/>
            <entity id="DS3.d455.s1.e1" origId="P80511" charOffset="122-126" type="protein" text="CGRP"/>
            <pair e1="DS3.d455.s1.e0" e2="DS3.d455.s1.e1" id="DS3.d455.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d456" origId="10025083">
        <sentence id="DS3.d456.s0" origId="10025083-8" text="RESULTS: The Pyd/Dpyd ratios in the urine and serum and the Hyp in the urine were significantly lower in patients with fibromyalgia than in healthy controls.">
            <entity id="DS3.d456.s0.e0" origId="445779" charOffset="13-16" type="compound" text="Pyd"/>
            <entity id="DS3.d456.s0.e1" origId="P78562,B4DNS0,B4DWG8" charOffset="60-63" type="protein" text="Hyp"/>
            <pair e1="DS3.d456.s0.e0" e2="DS3.d456.s0.e1" id="DS3.d456.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d457" origId="10025090">
        <sentence id="DS3.d457.s0" origId="10025090-2" text="We found in FMS patients elevated basal values of ACTH and cortisol, lowered basal values of insulin-like growth factor I (IGF-I) and of triiodothyronine (T3), elevated basal values of follicle-stimulating hormone (FSH) and lowered basal values of estrogen.">
            <entity id="DS3.d457.s0.e0" origId="P07333,A2VDG3" charOffset="12-15" type="protein" text="FMS"/>
            <entity id="DS3.d457.s0.e1" origId="P01189,Q6FHC8" charOffset="50-54" type="protein" text="ACTH"/>
            <entity id="DS3.d457.s0.e2" origId="P05019,Q5U743,Q13429,Q59GC5" charOffset="93-121" type="protein" text="insulin-like growth factor I"/>
            <entity id="DS3.d457.s0.e3" origId="P05019,Q5U743,Q13429,Q59GC5" charOffset="123-128" type="protein" text="IGF-I"/>
            <entity id="DS3.d457.s0.e4" origId="5920" charOffset="137-153" type="compound" text="triiodothyronine"/>
            <pair e1="DS3.d457.s0.e4" e2="DS3.d457.s0.e1" id="DS3.d457.s0.i0" interaction="False" />
            <pair e1="DS3.d457.s0.e4" e2="DS3.d457.s0.e3" id="DS3.d457.s0.i1" interaction="False" />
            <pair e1="DS3.d457.s0.e4" e2="DS3.d457.s0.e0" id="DS3.d457.s0.i2" interaction="False" />
            <pair e1="DS3.d457.s0.e4" e2="DS3.d457.s0.e2" id="DS3.d457.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d458" origId="10025096">
        <sentence id="DS3.d458.s0" origId="10025096-4" text="On the endocrinological level cortisol responses to challenge tests with CRH as well as prolactin responses to TRH are higher in FMS patients than in high N healthy subjects indicating an endocrinological difference.">
            <entity id="DS3.d458.s0.e0" origId="5754" charOffset="30-38" type="compound" text="cortisol"/>
            <entity id="DS3.d458.s0.e1" origId="P06850" charOffset="73-76" type="protein" text="CRH"/>
            <pair e1="DS3.d458.s0.e0" e2="DS3.d458.s0.e1" id="DS3.d458.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d459" origId="10025098">
        <sentence id="DS3.d459.s0" origId="10025098-10" text="In contrast to the cysteine proteinases, MMP-1 and MMP-3 as well as MT complex are elevated in RA.">
            <entity id="DS3.d459.s0.e0" origId="5862,90793998" charOffset="19-27" type="compound" text="cysteine"/>
            <entity id="DS3.d459.s0.e1" origId="P03956,Q53G95,B4DN15" charOffset="41-46" type="protein" text="MMP-1"/>
            <entity id="DS3.d459.s0.e2" origId="P08254" charOffset="51-56" type="protein" text="MMP-3"/>
            <pair e1="DS3.d459.s0.e0" e2="DS3.d459.s0.e1" id="DS3.d459.s0.i0" interaction="False" />
            <pair e1="DS3.d459.s0.e0" e2="DS3.d459.s0.e2" id="DS3.d459.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d459.s1" origId="10025098-3" text="This study compares the validity of two classes of proteolytic enzymes, matrix metalloproteinases (MMP) and lysosomal cysteine proteinases (cathepsin B, H, and L) as well as their respective inhibitors to serve as parameters of RA disease activity.">
            <entity id="DS3.d459.s1.e0" origId="5862,90793998" charOffset="118-126" type="compound" text="cysteine"/>
            <entity id="DS3.d459.s1.e1" origId="P07858,A0A024R374" charOffset="140-151" type="protein" text="cathepsin B"/>
            <pair e1="DS3.d459.s1.e0" e2="DS3.d459.s1.e1" id="DS3.d459.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d460" origId="10025262">
        <sentence id="DS3.d460.s0" origId="10025262-0" text="Interview with Justine Clegg, CPM. Interview by Ina May Gaskin.">
            <entity id="DS3.d460.s0.e0" origId="402923" charOffset="15-22" type="compound" text="Justine"/>
            <entity id="DS3.d460.s0.e1" origId="P14384" charOffset="30-33" type="protein" text="CPM"/>
            <entity id="DS3.d460.s0.e2" origId="Q16352" charOffset="48-51" type="protein" text="Ina"/>
            <pair e1="DS3.d460.s0.e0" e2="DS3.d460.s0.e1" id="DS3.d460.s0.i0" interaction="False" />
            <pair e1="DS3.d460.s0.e0" e2="DS3.d460.s0.e2" id="DS3.d460.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d461" origId="10025283">
        <sentence id="DS3.d461.s0" origId="10025283-3" text="Other clients on social assistance wander down the hall of the Chilkoot Trail Inn to her clinic, or they come in off the street.">
            <entity id="DS3.d461.s0.e0" origId="65558" charOffset="35-41" type="compound" text="wander"/>
            <entity id="DS3.d461.s0.e1" origId="P01286" charOffset="78-81" type="protein" text="Inn"/>
            <pair e1="DS3.d461.s0.e0" e2="DS3.d461.s0.e1" id="DS3.d461.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d462" origId="10025362">
        <sentence id="DS3.d462.s0" origId="10025362-2" text="This study describes responses of normal human epidermal keratinocyte (NHEK) cells to 2,2'-dichlorodiethyl sulfide, sulfur mustard (HD), defined by interleukin-1 beta (IL-1beta), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) release.">
            <entity id="DS3.d462.s0.e0" origId="402" charOffset="116-122" type="compound" text="sulfur"/>
            <entity id="DS3.d462.s0.e1" origId="P01584" charOffset="148-166" type="protein" text="interleukin-1 beta"/>
            <entity id="DS3.d462.s0.e2" origId="P01584" charOffset="168-176" type="protein" text="IL-1beta"/>
            <entity id="DS3.d462.s0.e3" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="179-192" type="protein" text="interleukin-6"/>
            <entity id="DS3.d462.s0.e4" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="194-198" type="protein" text="IL-6"/>
            <entity id="DS3.d462.s0.e5" origId="P10145,A0A024RDA5" charOffset="201-214" type="protein" text="interleukin-8"/>
            <entity id="DS3.d462.s0.e6" origId="P10145,A0A024RDA5" charOffset="216-220" type="protein" text="IL-8"/>
            <entity id="DS3.d462.s0.e7" origId="P01375,Q5STB3" charOffset="227-254" type="protein" text="tumor necrosis factor-alpha"/>
            <entity id="DS3.d462.s0.e8" origId="P01375,Q5STB3" charOffset="256-265" type="protein" text="TNF-alpha"/>
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e7" id="DS3.d462.s0.i0" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e6" id="DS3.d462.s0.i1" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e1" id="DS3.d462.s0.i2" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e4" id="DS3.d462.s0.i3" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e2" id="DS3.d462.s0.i4" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e3" id="DS3.d462.s0.i5" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e5" id="DS3.d462.s0.i6" interaction="False" />
            <pair e1="DS3.d462.s0.e0" e2="DS3.d462.s0.e8" id="DS3.d462.s0.i7" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d463" origId="10025365">
        <sentence id="DS3.d463.s0" origId="10025365-4" text="Their liver, brain and kidneys were assayed for glutathione (GSH), glutathione disulfide (GSSG), malondialdehyde concentrations, and catalase activities.">
            <entity id="DS3.d463.s0.e0" origId="20725278,745" charOffset="48-59" type="compound" text="glutathione"/>
            <entity id="DS3.d463.s0.e1" origId="124886" charOffset="61-64" type="compound" text="GSH"/>
            <entity id="DS3.d463.s0.e2" origId="20725278,745" charOffset="67-78" type="compound" text="glutathione"/>
            <entity id="DS3.d463.s0.e3" origId="65359" charOffset="90-94" type="compound" text="GSSG"/>
            <entity id="DS3.d463.s0.e4" origId="10964" charOffset="97-112" type="compound" text="malondialdehyde"/>
            <entity id="DS3.d463.s0.e5" origId="P04762" charOffset="133-141" type="protein" text="catalase"/>
            <pair e1="DS3.d463.s0.e3" e2="DS3.d463.s0.e5" id="DS3.d463.s0.i0" interaction="False" />
            <pair e1="DS3.d463.s0.e1" e2="DS3.d463.s0.e5" id="DS3.d463.s0.i1" interaction="False" />
            <pair e1="DS3.d463.s0.e0" e2="DS3.d463.s0.e5" id="DS3.d463.s0.i2" interaction="False" />
            <pair e1="DS3.d463.s0.e4" e2="DS3.d463.s0.e5" id="DS3.d463.s0.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d464" origId="10025399">
        <sentence id="DS3.d464.s0" origId="10025399-4" text="These data indicate an important functional role for the insulin receptor in glucose sensing by the pancreatic beta cell and suggest that defects in insulin signaling at the level of the beta cell may contribute to the observed alterations in insulin secretion in type 2 diabetes.">
            <entity id="DS3.d464.s0.e0" origId="P15208,Q3TPM5,M4TKR7" charOffset="57-73" type="protein" text="insulin receptor"/>
            <entity id="DS3.d464.s0.e1" origId="206,5793,64689,79025" charOffset="77-84" type="compound" text="glucose"/>
            <pair e1="DS3.d464.s0.e1" e2="DS3.d464.s0.e0" id="DS3.d464.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d465" origId="10025402">
        <sentence id="DS3.d465.s0" origId="10025402-2" text="The crystal structure of activated Rab3A/GTP/Mg2+ bound to the effector domain of rabphilin-3A was solved to 2.6 A resolution.">
            <entity id="DS3.d465.s0.e0" origId="P20336,A0A024R7I7" charOffset="35-40" type="protein" text="Rab3A"/>
            <entity id="DS3.d465.s0.e1" origId="6830" charOffset="41-44" type="compound" text="GTP"/>
            <entity id="DS3.d465.s0.e2" origId="Q9Y2J0" charOffset="82-94" type="protein" text="rabphilin-3A"/>
            <pair e1="DS3.d465.s0.e1" e2="DS3.d465.s0.e2" id="DS3.d465.s0.i0" interaction="False" />
            <pair e1="DS3.d465.s0.e1" e2="DS3.d465.s0.e0" id="DS3.d465.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d466" origId="10025408">
        <sentence id="DS3.d466.s0" origId="10025408-1" text="Activation of the type I TGFbeta receptor (TbetaR-I) requires phosphorylation of a regulatory segment known as the GS region, located upstream of the serine/threonine kinase domain in the cytoplasmic portion of the receptor.">
            <entity id="DS3.d466.s0.e0" origId="P36897,B4DY26,Q5T7S2,B4DXN7" charOffset="43-51" type="protein" text="TbetaR-I"/>
            <entity id="DS3.d466.s0.e1" origId="194239,6288" charOffset="157-166" type="compound" text="threonine"/>
            <pair e1="DS3.d466.s0.e1" e2="DS3.d466.s0.e0" id="DS3.d466.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d466.s1" origId="10025408-2" text="The crystal structure of a fragment of unphosphorylated TbetaR-I, containing both the GS region and the catalytic domain, has been determined in complex with the FK506-binding protein FKBP12.">
            <entity id="DS3.d466.s1.e0" origId="P36897,B4DY26,Q5T7S2,B4DXN7" charOffset="56-64" type="protein" text="TbetaR-I"/>
            <entity id="DS3.d466.s1.e1" origId="445643" charOffset="162-167" type="compound" text="FK506"/>
            <entity id="DS3.d466.s1.e2" origId="P62942,Q0VDC6,A0A087WTS4" charOffset="184-190" type="protein" text="FKBP12"/>
            <pair e1="DS3.d466.s1.e1" e2="DS3.d466.s1.e0" id="DS3.d466.s1.i0" interaction="False" />
            <pair e1="DS3.d466.s1.e1" e2="DS3.d466.s1.e2" id="DS3.d466.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d466.s2" origId="10025408-5" text="Certain structural features at the catalytic center of TbetaR-I are characteristic of tyrosine kinases rather than Ser/Thr kinases.">
            <entity id="DS3.d466.s2.e0" origId="P36897,B4DY26,Q5T7S2,B4DXN7" charOffset="55-63" type="protein" text="TbetaR-I"/>
            <entity id="DS3.d466.s2.e1" origId="6057,90983769" charOffset="86-94" type="compound" text="tyrosine"/>
            <entity id="DS3.d466.s2.e2" origId="5951" charOffset="115-118" type="compound" text="Ser"/>
            <pair e1="DS3.d466.s2.e2" e2="DS3.d466.s2.e0" id="DS3.d466.s2.i0" interaction="False" />
            <pair e1="DS3.d466.s2.e1" e2="DS3.d466.s2.e0" id="DS3.d466.s2.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d467" origId="10025409">
        <sentence id="DS3.d467.s0" origId="10025409-0" text="KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness.">
            <entity id="DS3.d467.s0.e0" origId="P56696,B3KQH8" charOffset="0-5" type="protein" text="KCNQ4"/>
            <entity id="DS3.d467.s0.e1" origId="5462222" charOffset="15-24" type="compound" text="potassium"/>
            <pair e1="DS3.d467.s0.e1" e2="DS3.d467.s0.e0" id="DS3.d467.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d467.s1" origId="10025409-7" text="It abolishes the potassium currents of wild-type KCNQ4 on which it exerts a strong dominant-negative effect.">
            <entity id="DS3.d467.s1.e0" origId="5462222" charOffset="17-26" type="compound" text="potassium"/>
            <entity id="DS3.d467.s1.e1" origId="P56696,B3KQH8" charOffset="49-54" type="protein" text="KCNQ4"/>
            <pair e1="DS3.d467.s1.e0" e2="DS3.d467.s1.e1" id="DS3.d467.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d468" origId="10025422">
        <sentence id="DS3.d468.s0" origId="10025422-4" text="PATIENTS AND METHODS: Of 2800 serum samples tested by routine immunohistochemical procedures on sections of paraformaldehyde-fixed rat brain for the detection of autoantibodies associated with paraneoplastic neurological syndromes, 5 were selected because of labeling suggestive of antiamphiphysin antibodies and subsequently confirmed by the results of Western blot analysis using recombinant amphiphysin protein.">
            <entity id="DS3.d468.s0.e0" origId="712" charOffset="108-124" type="compound" text="paraformaldehyde"/>
            <entity id="DS3.d468.s0.e1" origId="O08838" charOffset="286-297" type="protein" text="amphiphysin"/>
            <pair e1="DS3.d468.s0.e0" e2="DS3.d468.s0.e1" id="DS3.d468.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d469" origId="10025424">
        <sentence id="DS3.d469.s0" origId="10025424-13" text="The inhibition of tyrosine hydroxylase was an early effect of cell injury by PD CSF and correlated with the viability assay.">
            <entity id="DS3.d469.s0.e0" origId="P07101,P78428" charOffset="18-38" type="protein" text="tyrosine hydroxylase"/>
            <entity id="DS3.d469.s0.e1" origId="16750043,16122568,4369303,448383" charOffset="80-83" type="compound" text="CSF"/>
            <pair e1="DS3.d469.s0.e1" e2="DS3.d469.s0.e0" id="DS3.d469.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s1" origId="10025424-14" text="The mean TNF-alpha level was 2.6-fold higher in CSF specimens from PD patients than in those of controls.">
            <entity id="DS3.d469.s1.e0" origId="P01375,Q5STB3" charOffset="9-18" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d469.s1.e1" origId="16122568,16750043,4369303,448383" charOffset="48-51" type="compound" text="CSF"/>
            <pair e1="DS3.d469.s1.e1" e2="DS3.d469.s1.e0" id="DS3.d469.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s2" origId="10025424-15" text="The addition of recombinant human TNF-alpha equivalent to the highest level determined in PD CSF was not cytotoxic to MES 23.5 cultures.">
            <entity id="DS3.d469.s2.e0" origId="P01375,Q5STB3" charOffset="34-43" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d469.s2.e1" origId="16122568,16750043,4369303,448383" charOffset="93-96" type="compound" text="CSF"/>
            <pair e1="DS3.d469.s2.e1" e2="DS3.d469.s2.e0" id="DS3.d469.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s3" origId="10025424-18" text="Levels of TNF-alpha are elevated in the CSF of PD patients, but TNF-alpha is not responsible for the cytotoxicity.">
            <entity id="DS3.d469.s3.e0" origId="P01375,Q5STB3" charOffset="10-19" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d469.s3.e1" origId="16122568,16750043,4369303,448383" charOffset="40-43" type="compound" text="CSF"/>
            <entity id="DS3.d469.s3.e2" origId="P01375,Q5STB3" charOffset="64-73" type="protein" text="TNF-alpha"/>
            <pair e1="DS3.d469.s3.e1" e2="DS3.d469.s3.e0" id="DS3.d469.s3.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s4" origId="10025424-3" text="OBJECTIVES: To determine whether the cytotoxic effects of CSF of PD patients are specific for dopaminergic neurons, dependent on prior levodopa therapy, and mediated by the cytokine tumor necrosis factor alpha (TNF-alpha).">
            <entity id="DS3.d469.s4.e0" origId="16122568,16750043,4369303,448383" charOffset="58-61" type="compound" text="CSF"/>
            <entity id="DS3.d469.s4.e1" origId="6047" charOffset="135-143" type="compound" text="levodopa"/>
            <entity id="DS3.d469.s4.e2" origId="P01375,Q5STB3" charOffset="182-209" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d469.s4.e3" origId="P01375,Q5STB3" charOffset="211-220" type="protein" text="TNF-alpha"/>
            <pair e1="DS3.d469.s4.e1" e2="DS3.d469.s4.e2" id="DS3.d469.s4.i0" interaction="False" />
            <pair e1="DS3.d469.s4.e1" e2="DS3.d469.s4.e3" id="DS3.d469.s4.i1" interaction="False" />
            <pair e1="DS3.d469.s4.e0" e2="DS3.d469.s4.e2" id="DS3.d469.s4.i2" interaction="False" />
            <pair e1="DS3.d469.s4.e0" e2="DS3.d469.s4.e3" id="DS3.d469.s4.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s5" origId="10025424-4" text="DESIGN: Specimens of CSF were evaluated in dopaminergic (MES 23.5) and nondopaminergic (N18TG2) cell lines for cytotoxicity by viability assay and by the inhibition of tyrosine hydroxylase.">
            <entity id="DS3.d469.s5.e0" origId="16750043,16122568,4369303,448383" charOffset="21-24" type="compound" text="CSF"/>
            <entity id="DS3.d469.s5.e1" origId="P07101,P78428" charOffset="168-188" type="protein" text="tyrosine hydroxylase"/>
            <pair e1="DS3.d469.s5.e0" e2="DS3.d469.s5.e1" id="DS3.d469.s5.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d469.s6" origId="10025424-6" text="The TNF-alpha levels in CSF were determined by enzyme-linked immunosorbent assay.">
            <entity id="DS3.d469.s6.e0" origId="P01375,Q5STB3" charOffset="4-13" type="protein" text="TNF-alpha"/>
            <entity id="DS3.d469.s6.e1" origId="16122568,16750043,4369303,448383" charOffset="24-27" type="compound" text="CSF"/>
            <pair e1="DS3.d469.s6.e1" e2="DS3.d469.s6.e0" id="DS3.d469.s6.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d470" origId="10025449">
        <sentence id="DS3.d470.s0" origId="10025449-13" text="Age, sex, duration of thyrotoxic symptoms, tumor size, histopathological findings, type of goiter, extent of surgery, 131I ablation, and 6-week postoperative serum concentrations of thyroglobulin or thyrotropin were not significant factors in predicting metastases.">
            <entity id="DS3.d470.s0.e0" origId="167195" charOffset="118-122" type="compound" text="131I"/>
            <entity id="DS3.d470.s0.e1" origId="P01266" charOffset="182-195" type="protein" text="thyroglobulin"/>
            <pair e1="DS3.d470.s0.e0" e2="DS3.d470.s0.e1" id="DS3.d470.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d471" origId="10025459">
        <sentence id="DS3.d471.s0" origId="10025459-0" text="Isolated limb perfusion with high-dose tumor necrosis factor alpha and melphalan for Kaposi sarcoma.">
            <entity id="DS3.d471.s0.e0" origId="P01375,Q5STB3" charOffset="39-66" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d471.s0.e1" origId="460612" charOffset="71-80" type="compound" text="melphalan"/>
            <pair e1="DS3.d471.s0.e1" e2="DS3.d471.s0.e0" id="DS3.d471.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d471.s1" origId="10025459-16" text="CONCLUSION: These findings suggest that hyperthermic ILP with tumor necrosis factor alpha and melphalan can be considered an effective palliative and limb-sparing treatment modality for extensive Kaposi sarcoma.">
            <entity id="DS3.d471.s1.e0" origId="446800" charOffset="53-56" type="compound" text="ILP"/>
            <entity id="DS3.d471.s1.e1" origId="P01375,Q5STB3" charOffset="62-89" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d471.s1.e2" origId="460612" charOffset="94-103" type="compound" text="melphalan"/>
            <pair e1="DS3.d471.s1.e2" e2="DS3.d471.s1.e1" id="DS3.d471.s1.i0" interaction="False" />
            <pair e1="DS3.d471.s1.e0" e2="DS3.d471.s1.e1" id="DS3.d471.s1.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d471.s2" origId="10025459-2" text="OBJECTIVE: To evaluate the efficacy of hyperthermic isolated limb perfusion (ILP) with tumor necrosis factor alpha and melphalan as a limb-sparing modality for extensive regional Kaposi sarcoma.">
            <entity id="DS3.d471.s2.e0" origId="446800" charOffset="77-80" type="compound" text="ILP"/>
            <entity id="DS3.d471.s2.e1" origId="P01375,Q5STB3" charOffset="87-114" type="protein" text="tumor necrosis factor alpha"/>
            <entity id="DS3.d471.s2.e2" origId="460612" charOffset="119-128" type="compound" text="melphalan"/>
            <pair e1="DS3.d471.s2.e2" e2="DS3.d471.s2.e1" id="DS3.d471.s2.i0" interaction="False" />
            <pair e1="DS3.d471.s2.e0" e2="DS3.d471.s2.e1" id="DS3.d471.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d471.s3" origId="10025459-7" text="tumor necrosis factor alpha, 4 mg, and melphalan, 1.5 mg/kg body weight, were perfused for an overall time of 90 minutes.">
            <entity id="DS3.d471.s3.e0" origId="P01375,Q5STB3" charOffset="0-30" type="protein" text="tumor necrosis factor alpha, 4"/>
            <entity id="DS3.d471.s3.e1" origId="460612" charOffset="39-48" type="compound" text="melphalan"/>
            <pair e1="DS3.d471.s3.e1" e2="DS3.d471.s3.e0" id="DS3.d471.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d472" origId="10025475">
        <sentence id="DS3.d472.s0" origId="10025475-6" text="Factors significantly associated with PAD in univariate analyses for both men and women included age, systolic blood pressure, hemoglobin A1c level, albuminuria, fibrinogen level, fasting glucose level, prevalence of diabetes mellitus, and duration of diabetes.">
            <entity id="DS3.d472.s0.e0" origId="5492869,19805081" charOffset="38-41" type="compound" text="PAD"/>
            <entity id="DS3.d472.s0.e1" origId="P02675,V9HVY1" charOffset="162-172" type="protein" text="fibrinogen"/>
            <entity id="DS3.d472.s0.e2" origId="206,5793,64689,79025" charOffset="188-195" type="compound" text="glucose"/>
            <pair e1="DS3.d472.s0.e0" e2="DS3.d472.s0.e1" id="DS3.d472.s0.i0" interaction="False" />
            <pair e1="DS3.d472.s0.e2" e2="DS3.d472.s0.e1" id="DS3.d472.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d472.s1" origId="10025475-8" text="Age, systolic blood pressure, current cigarette smoking, pack-years of smoking, albuminuria (micro- and macro-), low density lipoprotein cholesterol level, and fibrinogen level were significantly positively associated with PAD.">
            <entity id="DS3.d472.s1.e0" origId="5997" charOffset="137-148" type="compound" text="cholesterol"/>
            <entity id="DS3.d472.s1.e1" origId="P02675,V9HVY1" charOffset="160-170" type="protein" text="fibrinogen"/>
            <entity id="DS3.d472.s1.e2" origId="5492869,19805081" charOffset="223-226" type="compound" text="PAD"/>
            <pair e1="DS3.d472.s1.e2" e2="DS3.d472.s1.e1" id="DS3.d472.s1.i0" interaction="False" />
            <pair e1="DS3.d472.s1.e0" e2="DS3.d472.s1.e1" id="DS3.d472.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d473" origId="10025504">
        <sentence id="DS3.d473.s0" origId="10025504-7" text="The known-gene group was characterized by two main features: a large proportion (55%) of mitochondrial transcripts and an abundance in calcium-binding proteins, such as calmodulin and calbindin, for which expression has already been demonstrated in OHCs.">
            <entity id="DS3.d473.s0.e0" origId="22044544,5460341" charOffset="135-142" type="compound" text="calcium"/>
            <entity id="DS3.d473.s0.e1" origId="P05937" charOffset="184-193" type="protein" text="calbindin"/>
            <pair e1="DS3.d473.s0.e0" e2="DS3.d473.s0.e1" id="DS3.d473.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d474" origId="10025508">
        <sentence id="DS3.d474.s0" origId="10025508-10" text="Further, the synthetic glucocorticoid dexamethasone virtually abolished ctp-cAMP-stimulated OFQ peptide secretion.">
            <entity id="DS3.d474.s0.e0" origId="5743" charOffset="38-51" type="compound" text="dexamethasone"/>
            <entity id="DS3.d474.s0.e1" origId="6176" charOffset="72-75" type="compound" text="ctp"/>
            <entity id="DS3.d474.s0.e2" origId="P51437" charOffset="76-80" type="protein" text="cAMP"/>
            <pair e1="DS3.d474.s0.e1" e2="DS3.d474.s0.e2" id="DS3.d474.s0.i0" interaction="False" />
            <pair e1="DS3.d474.s0.e0" e2="DS3.d474.s0.e2" id="DS3.d474.s0.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d474.s1" origId="10025508-6" text="We have used reversed-phase high-performance liquid chromatography combined with a specific radioimmunoassay for OFQ(1-17) to determine if NS20Y cells secrete ppOFQ-derived peptides when stimulated by the cAMP analog ctp-cAMP.">
            <entity id="DS3.d474.s1.e0" origId="P51437" charOffset="205-209" type="protein" text="cAMP"/>
            <entity id="DS3.d474.s1.e1" origId="6176" charOffset="217-220" type="compound" text="ctp"/>
            <entity id="DS3.d474.s1.e2" origId="P51437" charOffset="221-225" type="protein" text="cAMP"/>
            <pair e1="DS3.d474.s1.e1" e2="DS3.d474.s1.e0" id="DS3.d474.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d475" origId="10025510">
        <sentence id="DS3.d475.s0" origId="10025510-5" text="We further show that tamoxifen, a downregulator of CD36, one of the major scavenger receptors which binds MM-LDL, can inhibit MM-LDL-mediated SAA induction in THP-1 cells.">
            <entity id="DS3.d475.s0.e0" origId="2733526" charOffset="21-30" type="compound" text="tamoxifen"/>
            <entity id="DS3.d475.s0.e1" origId="P16671,A4D1B1,E9PLT1,B7Z6C3" charOffset="51-55" type="protein" text="CD36"/>
            <pair e1="DS3.d475.s0.e0" e2="DS3.d475.s0.e1" id="DS3.d475.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d476" origId="10025512">
        <sentence id="DS3.d476.s0" origId="10025512-6" text="To develop a useful model system for analyzing muscle gene regulation, the promoter of the zebrafish MLC2f gene was isolated and linked to the chloramphenicol acetyltransferase (CAT) reporter gene.">
            <entity id="DS3.d476.s0.e0" origId="O93409" charOffset="101-106" type="protein" text="MLC2f"/>
            <entity id="DS3.d476.s0.e1" origId="5959" charOffset="143-158" type="compound" text="chloramphenicol"/>
            <pair e1="DS3.d476.s0.e1" e2="DS3.d476.s0.e0" id="DS3.d476.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d477" origId="10025565">
        <sentence id="DS3.d477.s0" origId="10025565-1" text="Two-laser and two-color approaches were used to observe the colocalization of the calcium-binding proteins, calbindin D28k and parvalbumin, and the retrograde tracer, Fluoro-Gold (FG) in the basolateral amygdala of the rat.">
            <entity id="DS3.d477.s0.e0" origId="22044544,5460341" charOffset="82-89" type="compound" text="calcium"/>
            <entity id="DS3.d477.s0.e1" origId="P02625" charOffset="127-138" type="protein" text="parvalbumin"/>
            <entity id="DS3.d477.s0.e2" origId="23985" charOffset="174-178" type="compound" text="Gold"/>
            <pair e1="DS3.d477.s0.e0" e2="DS3.d477.s0.e1" id="DS3.d477.s0.i0" interaction="False" />
            <pair e1="DS3.d477.s0.e2" e2="DS3.d477.s0.e1" id="DS3.d477.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d478" origId="10025568">
        <sentence id="DS3.d478.s0" origId="10025568-4" text="Using extracellular potential recordings in rat brain slices we tested whether application of the Glu uptake blockers dihydrokainate and L-trans-pyrrolidine-2,4-dicarboxylate (L-trans-2,4-PDC) affect stimulus-induced field potentials (FPs) in superficial layer III and deep layer V of the medial EC.">
            <entity id="DS3.d478.s0.e0" origId="107883" charOffset="118-132" type="compound" text="dihydrokainate"/>
            <entity id="DS3.d478.s0.e1" origId="3868" charOffset="145-174" type="compound" text="pyrrolidine-2,4-dicarboxylate"/>
            <entity id="DS3.d478.s0.e2" origId="P20942" charOffset="188-191" type="protein" text="PDC"/>
            <pair e1="DS3.d478.s0.e1" e2="DS3.d478.s0.e2" id="DS3.d478.s0.i0" interaction="False" />
            <pair e1="DS3.d478.s0.e0" e2="DS3.d478.s0.e2" id="DS3.d478.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d479" origId="10025569">
        <sentence id="DS3.d479.s0" origId="10025569-1" text="Organotypic hypothalamic cultures of neonatal rats comprising the suprachiasmatic nuclei (SCN) produce stable 20 h release patterns of vasoactive intestinal polypeptide (VIP) and arginine-vasopressin (AVP).">
            <entity id="DS3.d479.s0.e0" origId="781" charOffset="90-93" type="compound" text="SCN"/>
            <entity id="DS3.d479.s0.e1" origId="P01283,A0A090BZQ0,B0BNF3" charOffset="135-168" type="protein" text="vasoactive intestinal polypeptide"/>
            <entity id="DS3.d479.s0.e2" origId="P01283,A0A090BZQ0,B0BNF3" charOffset="170-173" type="protein" text="VIP"/>
            <entity id="DS3.d479.s0.e3" origId="P01186" charOffset="179-199" type="protein" text="arginine-vasopressin"/>
            <entity id="DS3.d479.s0.e4" origId="P01186" charOffset="201-204" type="protein" text="AVP"/>
            <pair e1="DS3.d479.s0.e0" e2="DS3.d479.s0.e1" id="DS3.d479.s0.i0" interaction="False" />
            <pair e1="DS3.d479.s0.e0" e2="DS3.d479.s0.e4" id="DS3.d479.s0.i1" interaction="False" />
            <pair e1="DS3.d479.s0.e0" e2="DS3.d479.s0.e2" id="DS3.d479.s0.i2" interaction="False" />
            <pair e1="DS3.d479.s0.e0" e2="DS3.d479.s0.e3" id="DS3.d479.s0.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d479.s1" origId="10025569-5" text="After 14 days of incubation, 2 h samples of medium were collected during 50 h. None of the vole SCN slices showed a circadian modulation in VIP release.">
            <entity id="DS3.d479.s1.e0" origId="781" charOffset="96-99" type="compound" text="SCN"/>
            <entity id="DS3.d479.s1.e1" origId="P01283,A0A090BZQ0,B0BNF3" charOffset="140-143" type="protein" text="VIP"/>
            <pair e1="DS3.d479.s1.e0" e2="DS3.d479.s1.e1" id="DS3.d479.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d479.s2" origId="10025569-6" text="Peaks in AVP occurred, 20 h apart from each other, in four of six vole SCN slices.">
            <entity id="DS3.d479.s2.e0" origId="P01186" charOffset="9-12" type="protein" text="AVP"/>
            <entity id="DS3.d479.s2.e1" origId="781" charOffset="71-74" type="compound" text="SCN"/>
            <pair e1="DS3.d479.s2.e1" e2="DS3.d479.s2.e0" id="DS3.d479.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d479.s3" origId="10025569-7" text="These findings contrast with the concurrent release patterns of VIP and AVP in rat SCN slices.">
            <entity id="DS3.d479.s3.e0" origId="P01283,A0A090BZQ0,B0BNF3" charOffset="64-67" type="protein" text="VIP"/>
            <entity id="DS3.d479.s3.e1" origId="P01186" charOffset="72-75" type="protein" text="AVP"/>
            <entity id="DS3.d479.s3.e2" origId="781" charOffset="83-86" type="compound" text="SCN"/>
            <pair e1="DS3.d479.s3.e2" e2="DS3.d479.s3.e0" id="DS3.d479.s3.i0" interaction="False" />
            <pair e1="DS3.d479.s3.e2" e2="DS3.d479.s3.e1" id="DS3.d479.s3.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d480" origId="10025570">
        <sentence id="DS3.d480.s0" origId="10025570-3" text="Subsequently retinal cell suspensions were incubated with biotinylated anti-rat Thy-1 antibody and MACS Streptavidin MicroBeads, and then applied onto the column in the magnetic fields.">
            <entity id="DS3.d480.s0.e0" origId="638015" charOffset="13-20" type="compound" text="retinal"/>
            <entity id="DS3.d480.s0.e1" origId="P01830" charOffset="80-85" type="protein" text="Thy-1"/>
            <pair e1="DS3.d480.s0.e0" e2="DS3.d480.s0.e1" id="DS3.d480.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d481" origId="10025574">
        <sentence id="DS3.d481.s0" origId="10025574-2" text="This study was conducted to evaluate the usefulness of tau proteins in cerebrospinal fluid (CSF) for the differentiation of these two diseases.">
            <entity id="DS3.d481.s0.e0" origId="P10636,A0A024R9Y0,A0A024RA17,A0A024R9Y1,A0A024RA19,B3KTM0" charOffset="55-58" type="protein" text="tau"/>
            <entity id="DS3.d481.s0.e1" origId="16122568,16750043,4369303,448383" charOffset="92-95" type="compound" text="CSF"/>
            <pair e1="DS3.d481.s0.e1" e2="DS3.d481.s0.e0" id="DS3.d481.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d481.s1" origId="10025574-5" text="CSF tau proteins were measured with the sandwich ELISA method (Innogenetics, Belgium).">
            <entity id="DS3.d481.s1.e0" origId="16122568,16750043,4369303,448383" charOffset="0-3" type="compound" text="CSF"/>
            <entity id="DS3.d481.s1.e1" origId="P10636,A0A024R9Y0,A0A024RA17,A0A024R9Y1,A0A024RA19,B3KTM0" charOffset="4-7" type="protein" text="tau"/>
            <pair e1="DS3.d481.s1.e0" e2="DS3.d481.s1.e1" id="DS3.d481.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d481.s2" origId="10025574-6" text="The CSF tau protein level was 320.1+/-86.5 pg/ml in the CBD group, 151.5+/-52.7 pg/ml in the PSP group and 128.7+/-91.7 pg/ml in the CTL group.">
            <entity id="DS3.d481.s2.e0" origId="16122568,16750043,4369303,448383" charOffset="4-7" type="compound" text="CSF"/>
            <entity id="DS3.d481.s2.e1" origId="P10636,A0A024R9Y0,A0A024RA17,A0A024R9Y1,A0A024RA19,B3KTM0" charOffset="8-11" type="protein" text="tau"/>
            <pair e1="DS3.d481.s2.e0" e2="DS3.d481.s2.e1" id="DS3.d481.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d481.s3" origId="10025574-8" text="We suggested that the measurement of CSF tau proteins may be useful for the differentiation between CBD and PSP.">
            <entity id="DS3.d481.s3.e0" origId="16122568,16750043,4369303,448383" charOffset="37-40" type="compound" text="CSF"/>
            <entity id="DS3.d481.s3.e1" origId="P10636,A0A024R9Y0,A0A024RA17,A0A024R9Y1,A0A024RA19,B3KTM0" charOffset="41-44" type="protein" text="tau"/>
            <pair e1="DS3.d481.s3.e0" e2="DS3.d481.s3.e1" id="DS3.d481.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d482" origId="10025577">
        <sentence id="DS3.d482.s0" origId="10025577-6" text="PC12 cells are refractory to the antiproliferative effect of rapamycin, although rapamycin does exert its expected inhibitory effect in PC12 cells on both basal and NGF-stimulated activation of one of its biochemical targets, the 70-kDa S6 protein kinase (p70S6K).">
            <entity id="DS3.d482.s0.e0" origId="16760631,478951,49652385,5040,5374464,5460439,60150249,6436030,71296106,5358081,53627520,86583604,91454826,9854380" charOffset="61-70" type="compound" text="rapamycin"/>
            <entity id="DS3.d482.s0.e1" origId="16760631,478951,49652385,5040,5374464,5460439,60150249,6436030,71296106,5358081,53627520,86583604,91454826,9854380" charOffset="81-90" type="compound" text="rapamycin"/>
            <entity id="DS3.d482.s0.e2" origId="P67999" charOffset="256-262" type="protein" text="p70S6K"/>
            <pair e1="DS3.d482.s0.e0" e2="DS3.d482.s0.e2" id="DS3.d482.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d483" origId="10025579">
        <sentence id="DS3.d483.s0" origId="10025579-2" text="We investigated whether cerebrospinal fluid (CSF) concentrations of Interleukin-6 (IL-6), the soluble IL-6 receptor (sIL-6R) and the soluble form of the signal transducing and affinity converting receptor gp130 (sgp130) are altered in geriatric patients with major depression (MD).">
            <entity id="DS3.d483.s0.e0" origId="16122568,16750043,4369303,448383" charOffset="45-48" type="compound" text="CSF"/>
            <entity id="DS3.d483.s0.e1" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="68-81" type="protein" text="Interleukin-6"/>
            <entity id="DS3.d483.s0.e2" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="83-87" type="protein" text="IL-6"/>
            <entity id="DS3.d483.s0.e3" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="102-106" type="protein" text="IL-6"/>
            <entity id="DS3.d483.s0.e4" origId="P40189,Q17RA0,D6RH03,A0A0A0N0L2" charOffset="205-210" type="protein" text="gp130"/>
            <pair e1="DS3.d483.s0.e0" e2="DS3.d483.s0.e2" id="DS3.d483.s0.i0" interaction="False" />
            <pair e1="DS3.d483.s0.e0" e2="DS3.d483.s0.e4" id="DS3.d483.s0.i1" interaction="False" />
            <pair e1="DS3.d483.s0.e0" e2="DS3.d483.s0.e1" id="DS3.d483.s0.i2" interaction="False" />
        </sentence>
        <sentence id="DS3.d483.s1" origId="10025579-5" text="We found statistically significant decreased CSF concentrations of IL-6 (P&amp;lt;0.001) and of the sIL-6R (P&amp;lt;0.001) of patients with MD.">
            <entity id="DS3.d483.s1.e0" origId="16122568,16750043,4369303,448383" charOffset="45-48" type="compound" text="CSF"/>
            <entity id="DS3.d483.s1.e1" origId="P05231,Q75MH2,B5MC21,B4DNQ5,B4DVM1" charOffset="67-71" type="protein" text="IL-6"/>
            <pair e1="DS3.d483.s1.e0" e2="DS3.d483.s1.e1" id="DS3.d483.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d484" origId="10025581">
        <sentence id="DS3.d484.s0" origId="10025581-5" text="Our previous experimental work on these neurons showed that they may be involved in energy metabolism and water balance, which is in agreement with the current literature about Hcrt functions.">
            <entity id="DS3.d484.s0.e0" origId="962" charOffset="106-111" type="compound" text="water"/>
            <entity id="DS3.d484.s0.e1" origId="O55232" charOffset="177-181" type="protein" text="Hcrt"/>
            <pair e1="DS3.d484.s0.e0" e2="DS3.d484.s0.e1" id="DS3.d484.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d485" origId="10025583">
        <sentence id="DS3.d485.s0" origId="10025583-9" text="Our results suggest that absence of the MAO-B gene or inhibition of the enzyme with L-deprenyl are not protective or detrimental in an animal model of acute cortical infarction.">
            <entity id="DS3.d485.s0.e0" origId="Q8BW75" charOffset="40-45" type="protein" text="MAO-B"/>
            <entity id="DS3.d485.s0.e1" origId="26757,5195" charOffset="86-94" type="compound" text="deprenyl"/>
            <pair e1="DS3.d485.s0.e1" e2="DS3.d485.s0.e0" id="DS3.d485.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d486" origId="10025591">
        <sentence id="DS3.d486.s0" origId="10025591-0" text="Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients.">
            <entity id="DS3.d486.s0.e0" origId="P20366,Q9Y494" charOffset="16-27" type="protein" text="substance P"/>
            <entity id="DS3.d486.s0.e1" origId="16054" charOffset="29-44" type="compound" text="5-hydroxyindole"/>
            <entity id="DS3.d486.s0.e2" origId="57175189,6305" charOffset="61-71" type="compound" text="tryptophan"/>
            <pair e1="DS3.d486.s0.e2" e2="DS3.d486.s0.e0" id="DS3.d486.s0.i0" interaction="False" />
            <pair e1="DS3.d486.s0.e1" e2="DS3.d486.s0.e0" id="DS3.d486.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d487" origId="10025599">
        <sentence id="DS3.d487.s0" origId="10025599-10" text="Mothers with HLA A1, Cw7, B8 and without B15 are at particularly high-risk of having CHB children.">
            <entity id="DS3.d487.s0.e0" origId="57345898" charOffset="21-24" type="compound" text="Cw7"/>
            <entity id="DS3.d487.s0.e1" origId="O95168" charOffset="41-44" type="protein" text="B15"/>
            <pair e1="DS3.d487.s0.e0" e2="DS3.d487.s0.e1" id="DS3.d487.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d488" origId="10025621">
        <sentence id="DS3.d488.s0" origId="10025621-1" text="High resolution NMR imaging of the isolated perfused rat hippocampal slice was used to quantitate ADC changes following ouabain-induced cell swelling.">
            <entity id="DS3.d488.s0.e0" origId="Q6AYN0,F5A6B1" charOffset="98-101" type="protein" text="ADC"/>
            <entity id="DS3.d488.s0.e1" origId="439501" charOffset="120-127" type="compound" text="ouabain"/>
            <pair e1="DS3.d488.s0.e1" e2="DS3.d488.s0.e0" id="DS3.d488.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d488.s1" origId="10025621-6" text="These data support the hypothesis that the decrease in the ADC of brain water following an ischemic attack is caused by cell swelling.">
            <entity id="DS3.d488.s1.e0" origId="Q6AYN0,F5A6B1" charOffset="59-62" type="protein" text="ADC"/>
            <entity id="DS3.d488.s1.e1" origId="962" charOffset="72-77" type="compound" text="water"/>
            <pair e1="DS3.d488.s1.e1" e2="DS3.d488.s1.e0" id="DS3.d488.s1.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d489" origId="10025661">
        <sentence id="DS3.d489.s0" origId="10025661-3" text="Glyoxal induced cross-linking of a number of cellular proteins, including glycosylphosphatidylinositol (GPI)-anchored cell surface Thy-1.">
            <entity id="DS3.d489.s0.e0" origId="7860" charOffset="0-7" type="compound" text="Glyoxal"/>
            <entity id="DS3.d489.s0.e1" origId="P01831" charOffset="131-136" type="protein" text="Thy-1"/>
            <pair e1="DS3.d489.s0.e0" e2="DS3.d489.s0.e1" id="DS3.d489.s0.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d490" origId="10025663">
        <sentence id="DS3.d490.s0" origId="10025663-3" text="This study evaluates the role of one such candidate, H16 of hEGF, by site-specific mutagenesis.">
            <entity id="DS3.d490.s0.e0" origId="448727" charOffset="53-56" type="compound" text="H16"/>
            <entity id="DS3.d490.s0.e1" origId="P01133" charOffset="60-64" type="protein" text="hEGF"/>
            <pair e1="DS3.d490.s0.e0" e2="DS3.d490.s0.e1" id="DS3.d490.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d490.s1" origId="10025663-4" text="When assayed for receptor tyrosine kinase stimulation using (Glu4,Tyr1)n as the exogenous substrate in vitro, the relative agonist activities of position 16 mutants range from 14-263% of wild-type hEGF.">
            <entity id="DS3.d490.s1.e0" origId="6057,90983769" charOffset="26-34" type="compound" text="tyrosine"/>
            <entity id="DS3.d490.s1.e1" origId="P01133" charOffset="197-201" type="protein" text="hEGF"/>
            <pair e1="DS3.d490.s1.e0" e2="DS3.d490.s1.e1" id="DS3.d490.s1.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d490.s2" origId="10025663-6" text="The mitogenic activity of the H16 mutants is similar to that of wild-type hEGF as determined by clonogenic assays using rat tracheal epithelial cells.">
            <entity id="DS3.d490.s2.e0" origId="448727" charOffset="30-33" type="compound" text="H16"/>
            <entity id="DS3.d490.s2.e1" origId="P01133" charOffset="74-78" type="protein" text="hEGF"/>
            <pair e1="DS3.d490.s2.e0" e2="DS3.d490.s2.e1" id="DS3.d490.s2.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d490.s3" origId="10025663-8" text="The results show that H16 of hEGF, although not essential for mitogenic activity, optimizes receptor recognition by hydrogen-bond donor/acceptor interactions and may share this feature with H18 of hTGFalpha.">
            <entity id="DS3.d490.s3.e0" origId="448727" charOffset="22-25" type="compound" text="H16"/>
            <entity id="DS3.d490.s3.e1" origId="P01133" charOffset="29-33" type="protein" text="hEGF"/>
            <entity id="DS3.d490.s3.e2" origId="783" charOffset="116-124" type="compound" text="hydrogen"/>
            <entity id="DS3.d490.s3.e3" origId="P01135,E7EPT6,F8VNR3" charOffset="197-206" type="protein" text="hTGFalpha"/>
            <pair e1="DS3.d490.s3.e2" e2="DS3.d490.s3.e3" id="DS3.d490.s3.i0" interaction="False" />
            <pair e1="DS3.d490.s3.e2" e2="DS3.d490.s3.e1" id="DS3.d490.s3.i1" interaction="False" />
            <pair e1="DS3.d490.s3.e0" e2="DS3.d490.s3.e3" id="DS3.d490.s3.i2" interaction="False" />
            <pair e1="DS3.d490.s3.e0" e2="DS3.d490.s3.e1" id="DS3.d490.s3.i3" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d491" origId="10025664">
        <sentence id="DS3.d491.s0" origId="10025664-0" text="Identification of a cis-acting element in the rat alpha-fetoprotein gene and its specific binding proteins in F9 cells during retinoic acid-induced differentiation.">
            <entity id="DS3.d491.s0.e0" origId="G3V6D0" charOffset="50-67" type="protein" text="alpha-fetoprotein"/>
            <entity id="DS3.d491.s0.e1" origId="444795" charOffset="126-139" type="compound" text="retinoic acid"/>
            <pair e1="DS3.d491.s0.e1" e2="DS3.d491.s0.e0" id="DS3.d491.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d491.s1" origId="10025664-2" text="Following retinoic acid (RA) treatment, alpha-fetoprotein (AFP), a differentiation marker, is expressed and secreted.">
            <entity id="DS3.d491.s1.e0" origId="444795" charOffset="10-23" type="compound" text="retinoic acid"/>
            <entity id="DS3.d491.s1.e1" origId="G3V6D0" charOffset="40-57" type="protein" text="alpha-fetoprotein"/>
            <entity id="DS3.d491.s1.e2" origId="G3V6D0" charOffset="59-62" type="protein" text="AFP"/>
            <pair e1="DS3.d491.s1.e0" e2="DS3.d491.s1.e1" id="DS3.d491.s1.i0" interaction="False" />
            <pair e1="DS3.d491.s1.e0" e2="DS3.d491.s1.e2" id="DS3.d491.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d492" origId="10025669">
        <sentence id="DS3.d492.s0" origId="10025669-3" text="We investigated the short- and long-term effects of recombinant human (rh)BMP-2 on cell growth and osteoblast phenotype in a new model of human neonatal pre-osteoblastic calvaria cells (HNC).">
            <entity id="DS3.d492.s0.e0" origId="P12643,C8C060" charOffset="74-79" type="protein" text="BMP-2"/>
            <entity id="DS3.d492.s0.e1" origId="5975" charOffset="186-189" type="compound" text="HNC"/>
            <pair e1="DS3.d492.s0.e1" e2="DS3.d492.s0.e0" id="DS3.d492.s0.i0" interaction="False" />
        </sentence>
        <sentence id="DS3.d492.s1" origId="10025669-5" text="When cultured for 3 weeks in the presence of ascorbic acid and inorganic phosphate to induce cell differentiation, HNC cells initially proliferated, type 1 collagen mRNA and protein levels rose, and then decreased, whereas OC mRNA and protein levels, and calcium accumulation into the extracellular matrix increased At 2 to 3 weeks.">
            <entity id="DS3.d492.s1.e0" origId="54670067" charOffset="45-58" type="compound" text="ascorbic acid"/>
            <entity id="DS3.d492.s1.e1" origId="1061,167704,644102" charOffset="73-82" type="compound" text="phosphate"/>
            <entity id="DS3.d492.s1.e2" origId="5975" charOffset="115-118" type="compound" text="HNC"/>
            <entity id="DS3.d492.s1.e3" origId="22044544,5460341" charOffset="255-262" type="compound" text="calcium"/>
            <entity id="DS3.d492.s1.e4" origId="P50052" charOffset="316-320" type="protein" text="At 2"/>
            <pair e1="DS3.d492.s1.e0" e2="DS3.d492.s1.e4" id="DS3.d492.s1.i0" interaction="False" />
            <pair e1="DS3.d492.s1.e3" e2="DS3.d492.s1.e4" id="DS3.d492.s1.i1" interaction="False" />
            <pair e1="DS3.d492.s1.e2" e2="DS3.d492.s1.e4" id="DS3.d492.s1.i2" interaction="False" />
            <pair e1="DS3.d492.s1.e1" e2="DS3.d492.s1.e4" id="DS3.d492.s1.i3" interaction="False" />
        </sentence>
        <sentence id="DS3.d492.s2" origId="10025669-6" text="A transient treatment with rhBMP-2 (50 ng/ml) for 1 to 7 days which affected immature HNC cells, decreased cell growth, increased ALP activity and mRNA, and induced cells to express ALP, osteopontin, and OC at 7 days, as shown by immunocytochemistry.">
            <entity id="DS3.d492.s2.e0" origId="5975" charOffset="86-89" type="compound" text="HNC"/>
            <entity id="DS3.d492.s2.e1" origId="P05187,B2R7C7" charOffset="130-133" type="protein" text="ALP"/>
            <entity id="DS3.d492.s2.e2" origId="P05187,B2R7C7" charOffset="182-185" type="protein" text="ALP"/>
            <entity id="DS3.d492.s2.e3" origId="P10451,A0A024RDE2,A0A024RDE6,B7Z351,A0A024RDJ0,Q3LGB0" charOffset="187-198" type="protein" text="osteopontin"/>
            <pair e1="DS3.d492.s2.e0" e2="DS3.d492.s2.e3" id="DS3.d492.s2.i0" interaction="False" />
            <pair e1="DS3.d492.s2.e0" e2="DS3.d492.s2.e1" id="DS3.d492.s2.i1" interaction="False" />
        </sentence>
        <sentence id="DS3.d492.s3" origId="10025669-8" text="A continuous treatment with rhBMP-2 for 3 weeks which affected immature and mature cells reduced cell growth, increased ALP activity and mRNA at 1 week and increased OC mRNA and protein levels and calcium content in the matrix at 3 weeks, indicating complete osteoblast differentiation.">
            <entity id="DS3.d492.s3.e0" origId="P05187,B2R7C7" charOffset="120-123" type="protein" text="ALP"/>
            <entity id="DS3.d492.s3.e1" origId="22044544,5460341" charOffset="197-204" type="compound" text="calcium"/>
            <pair e1="DS3.d492.s3.e1" e2="DS3.d492.s3.e0" id="DS3.d492.s3.i0" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d493" origId="10025670">
        <sentence id="DS3.d493.s0" origId="10025670-7" text="A metabolite of 2,2',6,6'-TeCB, 2,2',6,6'-tetrachloro-4-biphenylol (4-OH-2,6,2',6'-TCB), does bind rhERalpha and rhERbeta and is also 10-fold more estrogenic than 2,2',6,6'-TeCB in the MCF-7 focus assay; however, this metabolite is not detected in the medium of MCF-7 cultures exposed to 2,2',6,6'-TeCB.">
            <entity id="DS3.d493.s0.e0" origId="5326109" charOffset="42-54" type="compound" text="tetrachloro-"/>
            <entity id="DS3.d493.s0.e1" origId="7103" charOffset="54-66" type="compound" text="4-biphenylol"/>
            <entity id="DS3.d493.s0.e2" origId="P14618,B4DNK4,A0A024R5Z9,V9HWB8" charOffset="83-86" type="protein" text="TCB"/>
            <pair e1="DS3.d493.s0.e0" e2="DS3.d493.s0.e2" id="DS3.d493.s0.i0" interaction="False" />
            <pair e1="DS3.d493.s0.e1" e2="DS3.d493.s0.e2" id="DS3.d493.s0.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d494" origId="10025671">
        <sentence id="DS3.d494.s0" origId="10025671-6" text="The cytosolic PLA2 (cPLA2) inhibitor, arachidonyl trifluoromethyl ketone, was found to inhibit ATP-stimulated PC secretion, whereas the secretory PLA2 inhibitors, oleoyloxyethylphosphocholine, aristolochic acid, or p-bromophenacyl bromide, and the Ca2+-independent PLA2 inhibitors, palmitoyl trifluoromethyl ketone, or haloenol lactone suicide substrate, had no effect.">
            <entity id="DS3.d494.s0.e0" origId="Q6IRF5" charOffset="4-18" type="protein" text="cytosolic PLA2"/>
            <entity id="DS3.d494.s0.e1" origId="Q6IRF5" charOffset="20-25" type="protein" text="cPLA2"/>
            <entity id="DS3.d494.s0.e2" origId="5280436" charOffset="38-72" type="compound" text="arachidonyl trifluoromethyl ketone"/>
            <entity id="DS3.d494.s0.e3" origId="54522851" charOffset="163-191" type="compound" text="oleoyloxyethylphosphocholine"/>
            <entity id="DS3.d494.s0.e4" origId="2236" charOffset="193-210" type="compound" text="aristolochic acid"/>
            <entity id="DS3.d494.s0.e5" origId="7466" charOffset="215-230" type="compound" text="p-bromophenacyl"/>
            <entity id="DS3.d494.s0.e6" origId="259" charOffset="231-238" type="compound" text="bromide"/>
            <entity id="DS3.d494.s0.e7" origId="18670765" charOffset="282-314" type="compound" text="palmitoyl trifluoromethyl ketone"/>
            <entity id="DS3.d494.s0.e8" origId="5940264" charOffset="319-353" type="compound" text="haloenol lactone suicide substrate"/>
            <pair e1="DS3.d494.s0.e4" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i0" interaction="False" />
            <pair e1="DS3.d494.s0.e4" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i1" interaction="False" />
            <pair e1="DS3.d494.s0.e5" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i2" interaction="False" />
            <pair e1="DS3.d494.s0.e5" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i3" interaction="False" />
            <pair e1="DS3.d494.s0.e3" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i4" interaction="False" />
            <pair e1="DS3.d494.s0.e3" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i5" interaction="False" />
            <pair e1="DS3.d494.s0.e2" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i6" interaction="False" />
            <pair e1="DS3.d494.s0.e2" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i7" interaction="False" />
            <pair e1="DS3.d494.s0.e8" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i8" interaction="False" />
            <pair e1="DS3.d494.s0.e8" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i9" interaction="False" />
            <pair e1="DS3.d494.s0.e7" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i10" interaction="False" />
            <pair e1="DS3.d494.s0.e7" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i11" interaction="False" />
            <pair e1="DS3.d494.s0.e6" e2="DS3.d494.s0.e0" id="DS3.d494.s0.i12" interaction="False" />
            <pair e1="DS3.d494.s0.e6" e2="DS3.d494.s0.e1" id="DS3.d494.s0.i13" interaction="False" />
        </sentence>
        <sentence id="DS3.d494.s1" origId="10025671-9" text="The results suggest that both pathways for generating arachidonic acid via cPLA2 and DAG lipase may participate in lung surfactant secretion.">
            <entity id="DS3.d494.s1.e0" origId="444899" charOffset="54-70" type="compound" text="arachidonic acid"/>
            <entity id="DS3.d494.s1.e1" origId="Q6IRF5" charOffset="75-80" type="protein" text="cPLA2"/>
            <entity id="DS3.d494.s1.e2" origId="5474737" charOffset="89-95" type="compound" text="lipase"/>
            <pair e1="DS3.d494.s1.e2" e2="DS3.d494.s1.e1" id="DS3.d494.s1.i0" interaction="False" />
            <pair e1="DS3.d494.s1.e0" e2="DS3.d494.s1.e1" id="DS3.d494.s1.i1" interaction="False" />
        </sentence>
    </document>
    <document id="DS3.d495" origId="10025673">
        <sentence id="DS3.d495.s0" origId="10025673-0" text="CSF-1 stimulated multiubiquitination of the CSF-1 receptor and of Cbl follows their tyrosine phosphorylation and association with other signaling proteins.">
            <entity id="DS3.d495.s0.e0" origId="P09603,A0A024R0A1" charOffset="0-5" type="protein" text="CSF-1"/>
            <entity id="DS3.d495.s0.e1" origId="P07333,A2VDG3" charOffset="44-58" type="protein" text="CSF-1 receptor"/>
            <entity id="DS3.d495.s0.e2" origId="P22681" charOffset="66-69" type="protein" text="Cbl"/>
            <entity id="DS3.d495.s0.e3" origId="6057,90983769" charOffset="84-92" type="compound" text="tyrosine"/>
            <pair e1="DS3.d495.s0.e3" e2="DS3.d495.s0.e1" id="DS3.d495.s0.i0" interaction="False" />
            <pair e1="DS3.d495.s0.e3" e2="DS3.d495.s0.e0" id="DS3.d495.s0.i1" interaction="False" />
            <pair e1="DS3.d495.s0.e3" e2="DS3.d495.s0.e2" id="DS3.d495.s0.i2" interaction="False" />
        </sentence>
</document>
</corpus>
